{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "3c46af1a",
   "metadata": {},
   "source": [
    "# Interactoma Fármaco-GenSymbol\n",
    "Obtuvimos un total de 155 proteinas (gene symbol) que no se repiten y que fueron integradas entre el top 100 degree y el top 100 bottleneck. Posteriormente se extrajeron los genes y se cargaron en la plataforma CTD o Comparative Toxicogenomics Database, para obtener un set de datos de compuestos que interactúan con el gene-symbol. Posteriormente se realizó un filtrado de datos utilizando la Hoja de Cálculo de Google para obtener Fármacos que interactúen con el gene-symbol en humanos."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a62326ba",
   "metadata": {},
   "source": [
    "Construimos un archivo .csv de los datos Fármaco-GenSymbol"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f7437829",
   "metadata": {},
   "source": [
    "Cargar librerias: -pandas- para importar achivos, la libreria -networkx- para crear la red y la libreria -matplilib- para visualizar y analizar la red, cargaremos -numpy- para realizar graficos."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "50995e06",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import networkx as nx\n",
    "import numpy as np\n",
    "import networkx.algorithms as algs"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "259689ee",
   "metadata": {},
   "source": [
    "Importar el archivo CSV y darle un nombre (en este caso NetCTD) usaremos -pandas-"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "54f80f85",
   "metadata": {},
   "outputs": [],
   "source": [
    "NetCTD = pd.read_csv(\"e:/Users/Alberto/Desktop/CTD_Top_Curado_csv.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "987b25f7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#Input</th>\n",
       "      <th>ChemicalName</th>\n",
       "      <th>ID Compuond</th>\n",
       "      <th>Organism</th>\n",
       "      <th>Interaction</th>\n",
       "      <th>InteractionActions</th>\n",
       "      <th>PubMedIDs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>tp53</td>\n",
       "      <td>Calcimycin</td>\n",
       "      <td>D000001</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Calcimycin results in increased expression of ...</td>\n",
       "      <td>increases^expression</td>\n",
       "      <td>26419736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>il6</td>\n",
       "      <td>Calcimycin</td>\n",
       "      <td>D000001</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxan...</td>\n",
       "      <td>affects^cotreatment|decreases^reaction|increas...</td>\n",
       "      <td>30496664</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>il6</td>\n",
       "      <td>Calcimycin</td>\n",
       "      <td>D000001</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Calcimycin co-treated with phorbol-12-myrista...</td>\n",
       "      <td>affects^cotreatment|increases^expression</td>\n",
       "      <td>12789233</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>il6</td>\n",
       "      <td>Calcimycin</td>\n",
       "      <td>D000001</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Calcimycin co-treated with Tetradecanoylphorb...</td>\n",
       "      <td>affects^cotreatment|increases^expression</td>\n",
       "      <td>21515303</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>il6</td>\n",
       "      <td>Calcimycin</td>\n",
       "      <td>D000001</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Calcimycin inhibits the reaction [Calcium prom...</td>\n",
       "      <td>decreases^reaction|increases^expression|increa...</td>\n",
       "      <td>11238657</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36253</th>\n",
       "      <td>il6</td>\n",
       "      <td>Levofloxacin</td>\n",
       "      <td>D064704</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Levofloxacin co-treated with [TNF protein co-...</td>\n",
       "      <td>affects^cotreatment|increases^activity</td>\n",
       "      <td>30876886</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36254</th>\n",
       "      <td>tgfb1</td>\n",
       "      <td>Neurokinin-1 Receptor Antagonists</td>\n",
       "      <td>D064729</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Neurokinin-1 Receptor Antagonists inhibits the...</td>\n",
       "      <td>decreases^reaction|increases^expression</td>\n",
       "      <td>28647476</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36255</th>\n",
       "      <td>mapk3</td>\n",
       "      <td>Frankincense</td>\n",
       "      <td>D065260</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Frankincense co-treated with myrrh resin] res...</td>\n",
       "      <td>affects^cotreatment|decreases^phosphorylation</td>\n",
       "      <td>35317323</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36256</th>\n",
       "      <td>mapk8</td>\n",
       "      <td>Frankincense</td>\n",
       "      <td>D065260</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Frankincense co-treated with myrrh resin] res...</td>\n",
       "      <td>affects^cotreatment|decreases^phosphorylation</td>\n",
       "      <td>35317323</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36257</th>\n",
       "      <td>mapk1</td>\n",
       "      <td>Frankincense</td>\n",
       "      <td>D065260</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>[Frankincense co-treated with myrrh resin] res...</td>\n",
       "      <td>affects^cotreatment|decreases^phosphorylation</td>\n",
       "      <td>35317323</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>36258 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      #Input                       ChemicalName ID Compuond      Organism  \\\n",
       "0       tp53                         Calcimycin     D000001  Homo sapiens   \n",
       "1        il6                         Calcimycin     D000001  Homo sapiens   \n",
       "2        il6                         Calcimycin     D000001  Homo sapiens   \n",
       "3        il6                         Calcimycin     D000001  Homo sapiens   \n",
       "4        il6                         Calcimycin     D000001  Homo sapiens   \n",
       "...      ...                                ...         ...           ...   \n",
       "36253    il6                       Levofloxacin     D064704  Homo sapiens   \n",
       "36254  tgfb1  Neurokinin-1 Receptor Antagonists     D064729  Homo sapiens   \n",
       "36255  mapk3                       Frankincense     D065260  Homo sapiens   \n",
       "36256  mapk8                       Frankincense     D065260  Homo sapiens   \n",
       "36257  mapk1                       Frankincense     D065260  Homo sapiens   \n",
       "\n",
       "                                             Interaction  \\\n",
       "0      Calcimycin results in increased expression of ...   \n",
       "1      3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxan...   \n",
       "2      [Calcimycin co-treated with phorbol-12-myrista...   \n",
       "3      [Calcimycin co-treated with Tetradecanoylphorb...   \n",
       "4      Calcimycin inhibits the reaction [Calcium prom...   \n",
       "...                                                  ...   \n",
       "36253  [Levofloxacin co-treated with [TNF protein co-...   \n",
       "36254  Neurokinin-1 Receptor Antagonists inhibits the...   \n",
       "36255  [Frankincense co-treated with myrrh resin] res...   \n",
       "36256  [Frankincense co-treated with myrrh resin] res...   \n",
       "36257  [Frankincense co-treated with myrrh resin] res...   \n",
       "\n",
       "                                      InteractionActions PubMedIDs  \n",
       "0                                   increases^expression  26419736  \n",
       "1      affects^cotreatment|decreases^reaction|increas...  30496664  \n",
       "2               affects^cotreatment|increases^expression  12789233  \n",
       "3               affects^cotreatment|increases^expression  21515303  \n",
       "4      decreases^reaction|increases^expression|increa...  11238657  \n",
       "...                                                  ...       ...  \n",
       "36253             affects^cotreatment|increases^activity  30876886  \n",
       "36254            decreases^reaction|increases^expression  28647476  \n",
       "36255      affects^cotreatment|decreases^phosphorylation  35317323  \n",
       "36256      affects^cotreatment|decreases^phosphorylation  35317323  \n",
       "36257      affects^cotreatment|decreases^phosphorylation  35317323  \n",
       "\n",
       "[36258 rows x 7 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "NetCTD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "991df8e3",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8737ceca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "      #Input                       ChemicalName ID Compuond      Organism  \\\n",
      "0       tp53                         Calcimycin     D000001  Homo sapiens   \n",
      "1        il6                         Calcimycin     D000001  Homo sapiens   \n",
      "2        il6                         Calcimycin     D000001  Homo sapiens   \n",
      "3        il6                         Calcimycin     D000001  Homo sapiens   \n",
      "4        il6                         Calcimycin     D000001  Homo sapiens   \n",
      "...      ...                                ...         ...           ...   \n",
      "36253    il6                       Levofloxacin     D064704  Homo sapiens   \n",
      "36254  tgfb1  Neurokinin-1 Receptor Antagonists     D064729  Homo sapiens   \n",
      "36255  mapk3                       Frankincense     D065260  Homo sapiens   \n",
      "36256  mapk8                       Frankincense     D065260  Homo sapiens   \n",
      "36257  mapk1                       Frankincense     D065260  Homo sapiens   \n",
      "\n",
      "                                             Interaction  \\\n",
      "0      Calcimycin results in increased expression of ...   \n",
      "1      3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxan...   \n",
      "2      [Calcimycin co-treated with phorbol-12-myrista...   \n",
      "3      [Calcimycin co-treated with Tetradecanoylphorb...   \n",
      "4      Calcimycin inhibits the reaction [Calcium prom...   \n",
      "...                                                  ...   \n",
      "36253  [Levofloxacin co-treated with [TNF protein co-...   \n",
      "36254  Neurokinin-1 Receptor Antagonists inhibits the...   \n",
      "36255  [Frankincense co-treated with myrrh resin] res...   \n",
      "36256  [Frankincense co-treated with myrrh resin] res...   \n",
      "36257  [Frankincense co-treated with myrrh resin] res...   \n",
      "\n",
      "                                      InteractionActions PubMedIDs  \n",
      "0                                   increases^expression  26419736  \n",
      "1      affects^cotreatment|decreases^reaction|increas...  30496664  \n",
      "2               affects^cotreatment|increases^expression  12789233  \n",
      "3               affects^cotreatment|increases^expression  21515303  \n",
      "4      decreases^reaction|increases^expression|increa...  11238657  \n",
      "...                                                  ...       ...  \n",
      "36253             affects^cotreatment|increases^activity  30876886  \n",
      "36254            decreases^reaction|increases^expression  28647476  \n",
      "36255      affects^cotreatment|decreases^phosphorylation  35317323  \n",
      "36256      affects^cotreatment|decreases^phosphorylation  35317323  \n",
      "36257      affects^cotreatment|decreases^phosphorylation  35317323  \n",
      "\n",
      "[36258 rows x 7 columns]\n"
     ]
    }
   ],
   "source": [
    "print(NetCTD)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "39a7ddeb",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "a8da2ec7",
   "metadata": {},
   "source": [
    "Generar la red, usaremos -networkx-"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "83a99cfb",
   "metadata": {},
   "outputs": [],
   "source": [
    "RED_CTD = nx.DiGraph\n",
    "RED_CTD = nx.from_pandas_edgelist(NetCTD, source = \"#Input\", target = \"ChemicalName\", edge_attr = [\"Interaction\", \"InteractionActions\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "67a5cf66",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "56a45df5",
   "metadata": {},
   "source": [
    "### Analisis de la Red_CTD"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9365905f",
   "metadata": {},
   "source": [
    "los nodos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "125bf376",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NodeView(('tp53', 'Calcimycin', 'il6', 'mapk3', 'rela', 'mapk8', 'mapk1', 'sp1', 'cdkn1a', 'Aripiprazole', 'nfkb1', 'cebpb', 'mapkapk2', 'ets1', 'Risedronic Acid', 'Fluticasone', 'stat3', 'Salmeterol Xinafoate', 'myc', 'Everolimus', 'ccnd1', 'rb1', 'ccna2', 'akt1', 'sirt1', 'mtor', 'eif4ebp1', 'Pemetrexed', 'Dutasteride', 'Interferon beta-1b', 'Celecoxib', 'jun', 'cdk2', 'ccnb1', 'cdk4', 'h2ax', 'mapk14', 'cdkn1b', 'map2k1', 'Varenicline', 'Sildenafil Citrate', 'Emtricitabine', 'Tenofovir', 'Valsartan', 'tgfb1', 'serpine1', 'Formoterol Fumarate', 'Rivastigmine', 'Fingolimod Hydrochloride', 'Imatinib Mesylate', 'cdk1', 'pten', 'raf1', 'Atorvastatin', 'mdm2', 'pik3ca', 'Bortezomib', 'atm', 'e2f1', 'rnf2', 'ehmt2', 'phc3', 'tfdp1', 'vdac1', 'map2k6', 'anapc11', 'mapk9', 'map2k4', 'cdkn2a', 'Capecitabine', 'rbbp4', 'Erlotinib Hydrochloride', 'foxo3', 'cdk6', 'Dasatinib', 'ezh2', 'h2bc3', 'h2bc14', 'h2bc9', 'cdc25a', 'hmga2', 'h1-5', 'h1-1', 'h1-4', 'Atazanavir Sulfate', 'mapkapk3', 'Liraglutide', 'Bendamustine Hydrochloride', 'Dimethyl Fumarate', 'Febuxostat', 'ring1', 'Venlafaxine Hydrochloride', 'Mastic Resin', 'fos', 'Acebutolol', 'Polychlorinated Dibenzodioxins', 'Dibenzofurans, Polychlorinated', 'Sugars', 'Peanut Oil', 'Antineoplastic Agents, Immunological', 'Janus Kinase Inhibitors', 'Docetaxel', 'Clopidogrel', 'Irinotecan', 'h2ac6', 'chek2', 'chek1', 'ube2c', 'ets2', 'zfp36l2', 'Sevoflurane', 'smad2', 'Oxaliplatin', 'ccne1', 'txn', 'Olanzapine', 'Rosiglitazone', 'bmi1', 'h2bc5', 'tsc2', 'Gefitinib', 'Sorafenib', 'Resveratrol', 'ccna1', 'h2bc21', 'h2bc17', 'h2bc15', 'mapk11', 'kdm6b', 'eed', 'cdc27', 'kat5', 'foxo1', 'pik3cb', 'anapc1', 'dnajc7', 'ppp1cb', 'map2k7', 'ccne2', 'e2f2', 'hmga1', 'akt3', 'cbx6', 'vdac3', 'tgfb3', 'Interferon alpha-2', 'Wortmannin', 'Temozolomide', 'h2bc12', 'h2aj', 'rbbp7', 'cbx2', 'phc2', 'slc25a4', 'cdc16', 'slc25a6', 'capn1', 'capn2', 'rad9a', 'Pioglitazone', 'Gabapentin', 'Decitabine', 'h3-4', 'h2ac18', 'h1-0', 'hla-g', 'h1-2', 'cdkn2d', 'Sunitinib', 'h2ac20', 'ubb', 'h2ac14', 'h2az2', 'h2ac7', 'suz12', 'cbx4', 'phc1', 'mov10', 'tnrc6b', 'h1-3', 'ep400', 'Zoledronic Acid', 'rassf5', 'Limonene', 'Vinorelbine', 'Arsenic Trioxide', 'ubc', 'rps27a', 'ube2d1', 'gata4', 'vdac2', 'Meloxicam', 'Carvedilol', 'Donepezil', 'Moxifloxacin', 'Fulvestrant', 'trpv4', 'hipk3', 'cacna1d', 'Pamidronate', 'Imiquimod', 'Lycopene', 'Rimonabant', 'Troglitazone', 'Letrozole', 'Terbinafine', 'Bosentan', 'Artesunate', 'Telmisartan', 'Vorinostat', 'ehmt1', 'Leflunomide', 'h2bc11', 'tnrc6a', 'Fluvastatin', 'Lapatinib', 'Verteporfin', 'Silybin', 'Orlistat', 'Cidofovir', 'Irbesartan', 'Cilostazol', 'Aluminum Chloride', 'Nabumetone', 'Simendan', 'Vemurafenib', 'Meglumine Antimoniate', 'Tropisetron', 'Eptifibatide', 'Deferiprone', 'Eplerenone', 'Roscovitine', 'Crizotinib', 'Edaravone', 'Alitretinoin', 'Norethindrone Acetate', '2-Methoxyestradiol', 'Deferasirox', 'Eucalyptol', 'Fomepizole', 'Trabectedin', 'Aprepitant', 'O-(Chloroacetylcarbamoyl)fumagillol', 'Bexarotene', 'Tirapazamine', '17 alpha-Hydroxyprogesterone Caproate', 'Afatinib', 'Meropenem', 'Dronedarone', 'Panobinostat', 'ventx', 'Ciclopirox', 'Axitinib', 'Homoharringtonine', 'Clofarabine', '5-Methoxypsoralen', 'Tigecycline', 'Acetaldehyde', 'Ado-Trastuzumab Emtansine', 'Sand', 'Acetaminophen', 'h2bc4', 'h2bc13', 'tnrc6c', 'slc25a5', 'mcu', 'Acetates', 'Gemcitabine', 'Matrines', 'Betulinic Acid', 'Acetone', 'Acetylcysteine', 'Acetylmuramyl-Alanyl-Isoglutamine', 'Acids', 'Aconitine', 'Acridine Orange', 'Acrolein', 'fzr1', 'Acrylonitrile', 'Adenine', 'Adenosine', 'Cyclic AMP', 'Adenosine Diphosphate', 'Adenosine Monophosphate', 'Adenosine Triphosphate', 'Aerosols', 'Aflatoxins', 'Agglutinins', 'Agmatine', 'Air Pollutants', 'tfdp2', 'Air Pollutants, Occupational', 'h3c15', 'Albuterol', 'Ethanol', 'Alcohols', 'Aldehydes', 'Aldosterone', 'Allantoin', 'Allergens', 'Allethrins', 'Allopurinol', 'Alloxan', 'Alloys', 'alpha-Chlorohydrin', 'Alprazolam', 'Alprenolol', 'uba52', 'Aluminum', 'Aluminum Oxide', 'Amides', 'Amidines', 'Amiloride', 'Aminacrine', 'Amino Acids', 'Amino Acids, Peptides, and Proteins', 'Aminoglutethimide', 'Aminolevulinic Acid', 'Aminooxyacetic Acid', 'Aminopterin', 'Amiodarone', 'Ammonium Chloride', 'Amodiaquine', 'Amphetamine', 'Amphotericin B', 'Amsacrine', 'Amygdalin', 'Androgens', 'Androstenedione', 'Anethole Trithione', 'Angiotensin-Converting Enzyme Inhibitors', 'Aniline Compounds', 'Anisomycin', 'Anthocyanins', 'Anthralin', 'Anthraquinones', 'Anti-Inflammatory Agents', 'Antifungal Agents', 'Antigens, Bacterial', 'Antigens, Viral', 'Antimony', 'Antimony Potassium Tartrate', 'Antimony Sodium Gluconate', 'Antimycin A', 'Antineoplastic Agents', 'Antioxidants', 'Apomorphine', 'Arachidonic Acids', 'Arbutin', 'Arecoline', 'Armin', 'Arsenates', 'Arsenic', 'h2bc1', 'Arsenicals', 'Asbestos', 'Ascorbic Acid', 'Aspartame', 'Aspirin', 'Atenolol', 'Atractyloside', 'Atrazine', 'Atropine', 'Auranofin', 'Vehicle Emissions', 'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride', 'Azacitidine', 'Azathioprine', 'Azinphosmethyl', 'Aziridines', 'Barium Sulfate', '3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester', 'BCG Vaccine', 'Beclomethasone', 'Bee Venoms', 'Benomyl', 'Benzalkonium Compounds', 'Benzamides', 'Benzbromarone', 'Benzene', 'Hexachlorocyclohexane', 'Benzo(a)pyrene', 'cbx8', 'Benzoates', 'Benzofurans', 'Benzophenoneidum', 'Benzoyl Peroxide', 'Benztropine', 'Berberine', 'beta-Endorphin', 'Bezafibrate', 'Bibenzyls', 'Biguanides', 'Bile Acids and Salts', 'Bilirubin', 'Biliverdine', 'Biological Factors', 'Biological Products', 'Biphenyl Compounds', 'Dicumarol', 'Bithionol', 'Bleomycin', 'Bongkrekic Acid', 'Boron', 'Bumetanide', 'Bungarotoxins', 'Bupivacaine', 'Buprenorphine', 'Busulfan', 'Butylated Hydroxyanisole', 'Butylated Hydroxytoluene', 'Butyrates', 'Butyrophenones', 'Cacodylic Acid', 'Cadmium', 'Ceruletide', 'Caffeine', 'Calcifediol', 'Calcitriol', 'Calcium', 'Calcium Carbonate', 'Calcium Chloride', 'Calcium Oxalate', 'Camptothecin', 'Cannabidiol', 'h4c1', 'Cannabinoids', 'Cantharidin', 'Capsaicin', 'Carbachol', 'Carbamates', 'Carbamazepine', 'Carbenoxolone', 'Carbidopa', 'Carbocysteine', 'Carbofuran', 'Carbon', 'Carbon Monoxide', 'Carbon Tetrachloride', 'Carbonyl Cyanide m-Chlorophenyl Hydrazone', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone', 'Carmustine', 'Carnosine', 'Carrageenan', 'Catechin', 'Estrogens, Catechol', 'Cefadroxil', 'Cefazolin', 'Cefotaxime', 'Cephalothin', 'Ceramides', 'Cerium', 'Cetylpyridinium', 'Chalcone', 'Chelating Agents', 'Chenodeoxycholic Acid', 'Chitin', 'Chlorambucil', 'Chloramphenicol', 'Chloranil', 'Chlordan', 'Chlorfenvinphos', 'Chlorides', 'Chlorine', 'Chloroform', 'Chlorogenic Acid', 'Chloroquine', 'Chlorpromazine', 'Chlorpropamide', 'Cholecalciferol', 'Cholera Toxin', 'Cholestanols', 'Cholesterol', 'Cholic Acids', 'Choline', 'Chondroitin Sulfates', 'Chromium', 'Chromium Alloys', 'Chromones', 'Cimetidine', 'Ciprofloxacin', 'Cisplatin', 'Citrinin', 'Leucovorin', 'Clofibrate', 'Clofibric Acid', 'Clomiphene', 'Clomipramine', 'Clonidine', 'Clorgyline', 'Clotrimazole', 'Cloxacillin', 'Clozapine', 'Coal', 'Coal Tar', 'Cobalt', 'Cocaine', 'Colchicine', 'Colistin', 'Contrast Media', 'Copper', 'Cortisone', 'Cosmetics', 'Cotinine', 'Coumaphos', 'Coumarins', 'Coumestrol', 'Cuprizone', 'Curcumin', 'Cycloheximide', 'Cyclophosphamide', 'Cysteine', 'Cytarabine', 'Cytochalasin B', 'Dacarbazine', 'Dactinomycin', 'Danazol', 'Dapsone', 'Daunorubicin', 'Dichlorodiphenyl Dichloroethylene', 'DDT', 'Deferoxamine', 'Dehydroepiandrosterone', 'Demecolcine', 'Demeclocycline', 'Deoxycholic Acid', 'Deoxyglucose', 'Dequalinium', 'Desipramine', 'Dexamethasone', 'Diacetyl', 'Diamide', 'Dianhydrogalactitol', 'Diatrizoate', 'Diazepam', 'Diazinon', 'Diazoxide', 'Dibutyl Phthalate', 'Bucladesine', 'Clodronic Acid', 'Dichlorophen', 'Dichlororibofuranosylbenzimidazole', 'Diclofenac', 'Dieldrin', 'Dienestrol', 'Dietary Carbohydrates', 'Dietary Fats', 'Ditiocarb', 'Diethylhexyl Phthalate', 'Diethylnitrosamine', 'Diethylstilbestrol', 'Diflunisal', 'Digitoxin', 'Dihydro-beta-Erythroidine', 'Dihydroxyacetone', 'Diltiazem', 'Dimercaprol', 'Succimer', 'Dimethoate', 'Dimethyl Sulfoxide', 'Dimethyldithiocarbamate', 'Dimethylformamide', 'Dimethylnitrosamine', 'Dinitrochlorobenzene', 'Dinitrofluorobenzene', 'Diosgenin', 'Dioxins', 'Diphenhydramine', 'Diphenoxylate', 'Diphtheria Toxin', 'Dipyridamole', 'Diquat', 'Cromolyn Sodium', 'Disulfiram', 'Disulfoton', 'Dithiothreitol', 'Diuron', 'Dobutamine', 'Docosahexaenoic Acids', 'Domperidone', 'Dopamine', 'Doxorubicin', 'Doxycycline', 'Drugs, Chinese Herbal', 'Pentetic Acid', 'Chlorpyrifos', 'Dust', 'Dydrogesterone', 'Fonofos', 'Ecdysterone', 'Edetic Acid', 'Egtazic Acid', 'Ellagic Acid', 'Emetine', 'Emodin', 'Enalapril', 'Endosulfan', 'Endotoxins', 'Environmental Pollutants', 'Enzyme Inhibitors', 'Ephedrine', 'Epichlorohydrin', 'Epinephrine', 'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester', 'Epoxy Compounds', 'Erythromycin', 'Erythropoietin', 'Erythrosine', 'Estradiol', 'Estriol', 'Estrogens, Conjugated (USP)', 'Estrogens', 'Estrone', 'Ethacridine', 'Ethacrynic Acid', 'Ethidium', 'Ethinyl Estradiol', 'Amifostine', 'Ethyl Methanesulfonate', 'Ethylenebis(dithiocarbamates)', 'Ethylmaleimide', 'Ethylnitrosourea', 'Etoposide', 'Eugenol', 'Farnesol', 'Fatty Acids, Nonesterified', 'Fenbendazole', 'Fenitrothion', 'Fenoterol', 'Fentanyl', 'Fenthion', 'Ferric Compounds', 'Ficusin', 'Filipin', 'Fish Oils', 'Flame Retardants', 'Flavonoids', 'Flavoring Agents', 'Flecainide', 'Floxacillin', 'Flucytosine', 'Fluorides', 'Fluorocarbons', 'Floxuridine', 'Fluorometholone', 'Fluorouracil', 'Fluoxetine', 'Flurbiprofen', 'Flutamide', 'Folic Acid', 'Formaldehyde', 'Colforsin', 'Fructose', 'Tegafur', 'Furans', 'Furazolidone', 'Furosemide', 'Fusaric Acid', 'Gadolinium', 'Galactosamine', 'Galactose', 'Gallic Acid', 'Gasoline', 'Gentamicins', 'Gentian Violet', 'Glyburide', 'Gliclazide', 'Gliotoxin', 'Glucocorticoids', 'Glucosamine', 'Glucose', 'Glucosides', 'Glutamine', 'Glutaral', 'Glutathione', 'Glycerol', 'Nitroglycerin', 'Glycochenodeoxycholic Acid', 'Glycocholic Acid', 'Glycodeoxycholic Acid', 'Glyoxal', 'Gold', 'Gold Sodium Thiomalate', 'Gossypol', 'Graphite', 'Guanosine', 'Cyclic GMP', 'Guanosine Diphosphate', 'Guanosine Triphosphate', 'Haloperidol', 'Harmaline', 'Harmine', 'Hemagglutinins', 'Heme', 'Hemin', 'Hemocyanins', 'Heparin', 'Heptachlor', 'Hesperidin', 'Heterocyclic Compounds', 'Heterocyclic Compounds, 3-Ring', 'Hexachlorobenzene', 'Hexachlorophene', 'Hexanones', 'Hexestrol', 'Histamine', 'Homocysteine', 'Humic Substances', 'Hyaluronic Acid', 'Hycanthone', 'Hydralazine', 'Hydrazones', 'Hydrocarbons', 'Hydrocarbons, Chlorinated', 'Hydrochloric Acid', 'Hydrocortisone', 'Hydrogen', 'Hydrogen Peroxide', 'Hydrogen Sulfide', 'Hydroxamic Acids', 'Hydroxychloroquine', 'Hydroxyurea', 'Hymecromone', 'Hypochlorous Acid', 'Ibuprofen', 'Ifosfamide', 'Immunologic Factors', 'Indican', 'Indoles', 'Indomethacin', 'Indoprofen', 'Inosine', 'Inosine Diphosphate', 'Insulin', 'Iodoacetamide', 'Clioquinol', 'Iohexol', 'Iopamidol', 'Iron', 'Iron-Dextran Complex', 'Isatin', 'Isoflavones', 'Isoniazid', 'Isopropyl Thiogalactoside', 'Isoproterenol', 'Ivermectin', 'Ketamine', 'Ketanserin', 'Ketoconazole', 'Ketoglutaric Acids', 'Kynurenic Acid', 'Labetalol', 'Latex', 'Lead', 'Leukotriene B4', 'Levamisole', 'Levodopa', 'Lidocaine', 'Lipids', 'Thioctic Acid', 'Lipopolysaccharides', 'Cholesterol, HDL', 'Cholesterol, LDL', 'Lithium', 'Lithocholic Acid', 'Lobeline', 'Lomustine', 'Loperamide', 'Lovastatin', 'Lucanthone', 'Magnesium', 'Magnesium Oxide', 'Malathion', 'Maleates', 'Maleic Anhydrides', 'Malondialdehyde', 'Maneb', 'Manganese', 'Mannitol', 'Mebendazole', 'Mecamylamine', 'Mechlorethamine', 'Mefenamic Acid', 'Melarsoprol', 'Melatonin', 'Melitten', 'Melphalan', 'Memantine', 'Menthol', 'Mercaptoethanol', 'Mercuric Chloride', 'Mercury', 'Mestranol', 'Metformin', 'Methadone', 'Methamphetamine', 'Methapyrilene', 'Methimazole', 'Methionine', 'Methohexital', 'Methotrexate', 'Methoxsalen', 'Methoxychlor', 'Methyl Methanesulfonate', 'Methyl Parathion', 'Methylcholanthrene', 'Methylene Blue', 'Methylmercury Compounds', 'Methylnitronitrosoguanidine', 'Methylnitrosourea', 'Methylphenidate', 'Methylprednisolone', 'Methyltestosterone', 'Methylthiouracil', 'Mevalonic Acid', 'Mevinphos', 'Mexiletine', 'Miconazole', 'Mimosine', 'Minocycline', 'Plicamycin', 'Mitotane', 'Mitoxantrone', 'Molybdenum', 'Monensin', 'Monocrotophos', 'Morphine', 'Morpholines', 'Mustard Compounds', 'Mustard Gas', 'Mycophenolic Acid', 'N-Formylmethionine Leucyl-Phenylalanine', 'N-Nitrosopyrrolidine', 'NAD', 'NADP', 'Nafcillin', 'Naloxone', 'Naphthalenes', 'Naphthoquinones', 'Naphthyridines', 'Naproxen', 'Neomycin', 'Neurotensin', 'Niacin', 'Nicardipine', 'Nickel', 'Niclosamide', 'Niacinamide', 'Nicotinamide Mononucleotide', 'Nicotine', 'Nicotinic Acids', 'Nifedipine', 'Nimodipine', 'Ninhydrin', 'Nitric Oxide', 'Nitrobenzoates', 'Nitrofurantoin', 'Nitrofurazone', 'Nitrogen', 'Nitrogen Dioxide', 'Nitrogen Mustard Compounds', 'Nitrogen Oxides', 'Nitroprusside', 'Nitrosourea Compounds', 'Nitrous Oxide', 'Nitrovin', 'Masoprocol', 'Norepinephrine', 'Norethindrone', 'Nortriptyline', 'Noscapine', 'Novobiocin', 'Nystatin', 'o-Phthalaldehyde', 'Oils, Volatile', 'Oleanolic Acid', 'Oligomycins', 'Oligonucleotides', 'Oligopeptides', 'Oligoribonucleotides', 'Oligosaccharides', 'Omeprazole', 'Organometallic Compounds', 'Organotin Compounds', 'Orotic Acid', 'Ouabain', 'Ovalbumin', 'Oxalates', 'Oxazolone', 'Oxotremorine', 'Oxprenolol', 'Oxygen', 'Oxymetholone', 'Oxypurinol', 'Ozone', '4-Aminobenzoic Acid', 'Palmitates', 'Pantothenic Acid', 'Paraoxon', 'Paraquat', 'Parathion', 'Paromomycin', 'Patulin', 'Penicillamine', 'Pentachlorophenol', 'Pentamidine', 'Pentobarbital', 'Pentosan Sulfuric Polyester', 'Pentoxifylline', 'Peptides', 'Peptidoglycan', 'Perfume', 'Pergolide', 'Perhexiline', 'Pesticides', 'Phenanthrolines', 'Phenformin', 'Phenindione', 'Phenobarbital', 'Phenols', 'Phenolsulfonphthalein', 'Phentolamine', 'Phenylbutazone', 'Phenylbutyrates', 'Phenylephrine', 'Phenylmercuric Acetate', 'Phenylthiourea', 'Phenytoin', 'Phloretin', 'Phloroglucinol', 'Eosine I Bluish', 'Phorate', 'Phosmet', 'Phosphamidon', 'Phosphates', 'Phosphatidic Acids', 'Phosphatidylcholines', 'Phosphatidylinositols', 'Phosphatidylserines', 'Organophosphates', 'Phosphorus', 'Leptophos', 'Phycocyanin', 'Phytic Acid', 'Vitamin K 1', 'Pilocarpine', 'Pindolol', 'Piroxicam', 'Plant Extracts', 'Plant Oils', 'Plasticizers', 'Platelet Activating Factor', 'Platinum', 'Poly I-C', 'Polyamines', 'Polychlorinated Biphenyls', 'Polycyclic Aromatic Hydrocarbons', 'Polydeoxyribonucleotides', 'Polyethylene Glycols', 'Polyethyleneimine', 'Polymyxin B', 'Polyphosphates', 'Polyribonucleotides', 'Polysaccharides', 'Polystyrenes', 'Potassium Dichromate', 'Povidone', 'Practolol', 'Prednisolone', 'Prednisone', 'Proadifen', 'Probenecid', 'Probucol', 'Procainamide', 'Procaine', 'Fenofibrate', 'Prodigiosin', 'Proflavine', 'Progestins', 'Progesterone', 'Promegestone', 'Promethazine', 'Propanil', 'Propolis', 'Propranolol', 'Propyl Gallate', 'Propylthiouracil', 'Prostaglandins E', 'Epoprostenol', 'Protein Synthesis Inhibitors', 'Proteoglycans', 'Pyocyanine', 'Pyrazoles', 'Pyrethrins', 'Pyridazines', 'Pyrilamine', 'Pyrimethamine', 'Pyrimidines', 'Pyrogallol', 'Pyrones', 'Pyrroles', 'Pyruvaldehyde', 'Quartz', 'Quercetin', 'Quinacrine', 'Quinazolines', 'Quinic Acid', 'Quinidine', 'Quinine', 'Quinolines', 'Radon', 'Ranitidine', 'Razoxane', 'Batroxobin', 'Reserpine', 'Retinoids', 'Ribavirin', 'Riboflavin', 'Ribonucleotides', 'Rifampin', '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone', 'Rotenone', 'Ruthenium', 'Ruthenium Red', 'Rutin', 'S-Adenosylmethionine', 'Sulfasalazine', 'Saponins', 'Sarin', 'Secobarbital', 'Selegiline', 'Selenium', 'Selenomethionine', 'Serine', 'Serotonin', 'Sesquiterpenes', 'Carbaryl', 'Shikimic Acid', 'Silicon Dioxide', 'Silicon', 'Silver', 'Silver Nitrate', 'Silymarin', 'Simazine', 'Skatole', 'Smoke', 'Sodium', 'Sodium Chloride', 'Sodium Dodecyl Sulfate', 'Sodium Fluoride', 'Gold Sodium Thiosulfate', 'Sodium Hydroxide', 'Sodium Nitrite', 'Sodium Salicylate', 'Soil Pollutants', 'Sorbitol', 'Spermine', 'Spiro Compounds', 'Spironolactone', 'Dihydrotestosterone', 'Staphylococcal Protein A', 'Sterigmatocystin', 'Stilbenes', 'Streptozocin', 'Sucrose', 'Sulfadiazine', 'Sulfamethoxazole', 'Sulfates', 'Sulfonamides', 'Sulfonylurea Compounds', 'Sulfur Dioxide', 'Sulindac', 'Superoxides', 'Suramin', 'T-2 Toxin', 'Tacrine', 'Talc', 'Tamoxifen', 'Tartrazine', 'Taurine', 'Taurocholic Acid', 'Taurodeoxycholic Acid', 'Taurolithocholic Acid', 'Tea', 'Teniposide', 'Terbutaline', 'Testosterone', 'Tetracaine', 'Tetrachlorodibenzodioxin', 'Tetrachloroethylene', 'Tetrachlorvinphos', 'Tetracycline', 'Tetradecanoylphorbol Acetate', 'Dronabinol', 'Tetrodotoxin', 'Thalidomide', 'Theophylline', 'Thiamylal', 'Thimerosal', 'Thioacetamide', 'Thiocarbamates', 'Thioguanine', 'Thioinosine', 'Thiopental', 'Thiophenes', 'Thioridazine', 'Thiosemicarbazones', 'Thiostrepton', 'Thiourea', 'Thiram', 'Threonine', 'Thymidine', 'Thyroxine', 'Timolol', 'Tin Fluorides', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt', 'Titanium', 'Tobacco Smoke Pollution', 'Toluene', 'Toluene 2,4-Diisocyanate', 'Tosyllysine Chloromethyl Ketone', 'Tosylphenylalanyl Chloromethyl Ketone', 'Toxaphene', 'Tretinoin', 'Triamcinolone Acetonide', 'Triamterene', 'Triazoles', 'Trichlorfon', 'Trichloroacetic Acid', 'Trichloroethylene', 'Triclosan', 'Trientine', 'Trifluoperazine', 'Trifluridine', 'Triglycerides', 'Triiodothyronine', 'Trimethoprim', 'Trinitrotoluene', 'Triterpenes', 'Tritolyl Phosphates', 'Tubocurarine', 'Tunicamycin', 'Ubiquinone', 'Uracil', 'Uranium', 'Urea', 'Urethane', 'Uric Acid', 'Uridine', 'Uridine Diphosphate', 'Uridine Triphosphate', 'Ursodeoxycholic Acid', 'Valproic Acid', 'h2ab1', 'Vanadates', 'Vanadium', 'Vanillic Acid', 'Vecuronium Bromide', 'Verapamil', 'Vinblastine', 'Vincristine', 'Vinyl Chloride', 'Viper Venoms', 'Vitallium', 'Vitamin A', 'Vitamin B 12', 'Vitamin D', 'Vitamin E', 'Vitamin U', 'Warfarin', 'Water Pollutants', 'Water Pollutants, Chemical', 'Lutein', 'Xylenes', 'Zearalenone', 'Zeranol', 'Zinc', 'Zinc Oxide', 'Zineb', 'Ziram', 'Zymosan', '1-Methyl-3-isobutylxanthine', '1-Naphthylisothiocyanate', '1,2-Dipalmitoylphosphatidylcholine', '2-Acetylaminofluorene', '2-Naphthylamine', \"2,2'-Dipyridyl\", '2,4-Dichlorophenoxyacetic Acid', '2,6-Dichloroindophenol', \"3,3'-Dichlorobenzidine\", '4-Nitroquinoline-1-oxide', 'Eicosapentaenoic Acid', 'Mercaptopurine', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide', '8-Bromo Cyclic Adenosine Monophosphate', 'Oxyquinoline', '9,10-Dimethyl-1,2-benzanthracene', 'Zidovudine', 'Dinoprostone', 'Dinoprost', 'Phorbol 12,13-Dibutyrate', 'Thiorphan', 'Gemfibrozil', 'Epirubicin', 'Octreotide', 'Citalopram', 'Quinolones', 'Nimustine', 'Hazardous Substances', 'Isotretinoin', 'Fatty Acids, Omega-3', 'Josamycin', 'Roxithromycin', '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine', 'Magnesium Chloride', 'Cytochalasin D', '24,25-Dihydroxyvitamin D 3', '1-Methyl-4-phenylpyridinium', 'Mifepristone', 'Famotidine', 'Nocodazole', 'Metribolone', 'Propofol', 'Ionomycin', 'Albendazole', 'Ganciclovir', 'Eicosanoids', 'Cysteine Proteinase Inhibitors', 'Carboplatin', 'N-Methylaspartate', 'Dextran Sulfate', 'Iloprost', 'Dizocilpine Maleate', 'Tacrolimus', 'Organoselenium Compounds', 'Cyclosporine', 'Crack Cocaine', 'Aphidicolin', 'Terfenadine', 'Aflatoxin B1', 'Aflatoxin M1', 'Oxidopamine', 'Bupropion', 'Fluorescein-5-isothiocyanate', 'Mitomycin', 'Monocrotaline', 'Arachidonic Acid', 'Leuprolide', 'Levonorgestrel', 'Pravastatin', 'Paclitaxel', 'Foscarnet', 'Acitretin', 'Ramipril', 'Medroxyprogesterone Acetate', 'Dimaprit', 'Procaterol', 'Goserelin', 'Selenocysteine', 'Clarithromycin', 'Doxazosin', 'Bisoprolol', 'Xamoterol', 'Amlodipine', 'Fenretinide', 'Photosensitizing Agents', 'Cladribine', '8-Hydroxy-2-(di-n-propylamino)tetralin', 'Paroxetine', 'Reactive Oxygen Species', 'Bisphenol A-Glycidyl Methacrylate', 'Adenovirus E1A Proteins', 'Gold Compounds', 'Asbestos, Serpentine', 'Asbestos, Amphibole', 'Asbestos, Crocidolite', 'Asbestos, Amosite', 'Silicon Compounds', 'Hydroxyl Radical', 'Platinum Compounds', 'Lisinopril', \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\", 'Isothiocyanates', 'Durapatite', 'Isocyanates', 'Azithromycin', 'gamma-Linolenic Acid', 'Zinc Compounds', 'Vanadium Compounds', 'Tungsten Compounds', 'Uranium Compounds', 'Ruthenium Compounds', 'Leukotriene D4', 'Lithium Chloride', 'Silver Compounds', 'Sodium Selenite', 'Superantigens', 'Stavudine', 'Antirheumatic Agents', 'Excitatory Amino Acid Agonists', 'Excitatory Amino Acid Antagonists', 'Hexamethonium', 'N-Methyl-3,4-methylenedioxyamphetamine', 'Antineoplastic Agents, Alkylating', 'beta Carotene', 'Metals, Heavy', 'Cadmium Chloride', 'Quinpirole', 'Saquinavir', 'Lamivudine', 'Phosphatidylinositol 4,5-Diphosphate', 'Thapsigargin', 'Zinc Sulfate', 'Pyruvic Acid', 'Oleic Acid', '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine', 'Palmitic Acid', 'Staurosporine', 'Okadaic Acid', 'beta-Naphthoflavone', 'Copper Sulfate', 'Buthionine Sulfoximine', 'Acetic Acid', 'Citric Acid', 'Lactic Acid', 'Zinc Acetate', '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid', 'Ritonavir', 'Indinavir', 'Glycyrrhizic Acid', 'Topotecan', 'Riluzole', 'Gadolinium DTPA', 'Linoleic Acid', '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid', 'Phenol', 'Succinic Acid', 'Glutathione Disulfide', 'Losartan', 'Sodium Azide', 'Oxalic Acid', 'Benzoic Acid', 'Budesonide', 'Xanthine', 'Simvastatin', 'Nevirapine', 'Genistein', '2-Propanol', 'Nelfinavir', 'Polymethyl Methacrylate', 'Propylene Glycol', '1-Butanol', 'Nitric Oxide Donors', 'Styrene', 'Milrinone', 'Acrylamide', 'Chlorodiphenyl (54% Chlorine)', 'tert-Butylhydroperoxide', 'Sirolimus', 'Brefeldin A', 'Butyric Acid', '3-Hydroxybutyric Acid', 'Salicylic Acid', 'Sodium Benzoate', 'p-Chloromercuribenzoic Acid', 'Sertraline', 'Oligoribonucleotides, Antisense', 'Methylmethacrylate', 'Enzyme Activators', 'Selective Estrogen Receptor Modulators', 'Raloxifene Hydrochloride', 'Rolipram', 'Ketorolac', 'Perindopril', 'Polyethylene', 'Shiga Toxin', 'Shiga Toxin 2', 'Diphtheria-Tetanus-acellular Pertussis Vaccines', 'Vitamin K 2', 'Vitamin K 3', 'alpha-Tocopherol', 'gamma-Tocopherol', 'Tocopherols', 'Permethrin', 'Singlet Oxygen', 'S-Nitrosoglutathione', 'S-Nitroso-N-Acetylpenicillamine', 'Plant Preparations', 'F2-Isoprostanes', 'Peroxynitrous Acid', 'Aristolochic Acids', 'Ginsenosides', 'Diarylheptanoids', 'Pertussis Toxin', 'Fullerenes', 'Nanotubes, Carbon', 'Antigens, Dermatophagoides', 'Fatty Acids, Omega-6', 'Tetrahydroisoquinolines', 'Linoleic Acids, Conjugated', 'Proanthocyanidins', 'Flavonols', 'Flavanones', 'PQQ Cofactor', 'Diterpenes, Clerodane', 'Chalcones', 'Apigenin', 'Luteolin', 'Hydrolyzable Tannins', 'Protein Kinase Inhibitors', 'Depsipeptides', 'Chitosan', 'Phytoestrogens', 'Betalains', 'Aptamers, Nucleotide', 'Antigens, Plant', 'Ferrosoferric Oxide', 'Particulate Matter', 'Benzophenanthridines', 'Oseltamivir', 'Soot', 'Interleukin 1 Receptor Antagonist Protein', 'Oncostatin M', 'Diketopiperazines', 'Volatile Organic Compounds', 'Halogenated Diphenyl Ethers', 'Histone Deacetylase Inhibitors', 'Coordination Complexes', 'Iron Compounds', 'Magnetite Nanoparticles', 'Vaccines, Virus-Like Particle', 'Polyphenols', 'Coal Ash', 'Equol', 'Lopinavir', 'Matrix Metalloproteinase Inhibitors', 'Fungal Polysaccharides', 'Oxaloacetic Acid', 'Organothiophosphates', 'Phytochemicals', 'Selenic Acid', 'Selenium Oxides', 'Levofloxacin', 'Neurokinin-1 Receptor Antagonists', 'Frankincense'))"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "RED_CTD.nodes()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "083972c6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "5009a05f",
   "metadata": {},
   "source": [
    "Interacciones de la red."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "f0dba553",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "EdgeView([('tp53', 'Calcimycin'), ('tp53', 'Pemetrexed'), ('tp53', 'Celecoxib'), ('tp53', 'Sildenafil Citrate'), ('tp53', 'Emtricitabine'), ('tp53', 'Tenofovir'), ('tp53', 'Rivastigmine'), ('tp53', 'Fingolimod Hydrochloride'), ('tp53', 'Imatinib Mesylate'), ('tp53', 'Atorvastatin'), ('tp53', 'Bortezomib'), ('tp53', 'Erlotinib Hydrochloride'), ('tp53', 'Dasatinib'), ('tp53', 'Bendamustine Hydrochloride'), ('tp53', 'Polychlorinated Dibenzodioxins'), ('tp53', 'Dibenzofurans, Polychlorinated'), ('tp53', 'Antineoplastic Agents, Immunological'), ('tp53', 'Docetaxel'), ('tp53', 'Clopidogrel'), ('tp53', 'Irinotecan'), ('tp53', 'Sevoflurane'), ('tp53', 'Oxaliplatin'), ('tp53', 'Olanzapine'), ('tp53', 'Rosiglitazone'), ('tp53', 'Gefitinib'), ('tp53', 'Sorafenib'), ('tp53', 'Resveratrol'), ('tp53', 'Wortmannin'), ('tp53', 'Temozolomide'), ('tp53', 'Decitabine'), ('tp53', 'Zoledronic Acid'), ('tp53', 'Limonene'), ('tp53', 'Arsenic Trioxide'), ('tp53', 'Fulvestrant'), ('tp53', 'Lycopene'), ('tp53', 'Troglitazone'), ('tp53', 'Artesunate'), ('tp53', 'Vorinostat'), ('tp53', 'Silybin'), ('tp53', 'Cidofovir'), ('tp53', 'Cilostazol'), ('tp53', 'Simendan'), ('tp53', 'Meglumine Antimoniate'), ('tp53', 'Roscovitine'), ('tp53', 'O-(Chloroacetylcarbamoyl)fumagillol'), ('tp53', 'Bexarotene'), ('tp53', 'Tirapazamine'), ('tp53', 'Panobinostat'), ('tp53', 'Ciclopirox'), ('tp53', 'Axitinib'), ('tp53', 'Homoharringtonine'), ('tp53', 'Clofarabine'), ('tp53', '5-Methoxypsoralen'), ('tp53', 'Acetaminophen'), ('tp53', 'Gemcitabine'), ('tp53', 'Matrines'), ('tp53', 'Betulinic Acid'), ('tp53', 'Acetylcysteine'), ('tp53', 'Acridine Orange'), ('tp53', 'Acrolein'), ('tp53', 'Acrylonitrile'), ('tp53', 'Adenosine Triphosphate'), ('tp53', 'Aflatoxins'), ('tp53', 'Air Pollutants'), ('tp53', 'Air Pollutants, Occupational'), ('tp53', 'Albuterol'), ('tp53', 'Ethanol'), ('tp53', 'Aldehydes'), ('tp53', 'Allergens'), ('tp53', 'alpha-Chlorohydrin'), ('tp53', 'Aluminum Oxide'), ('tp53', 'Amides'), ('tp53', 'Amidines'), ('tp53', 'Aminacrine'), ('tp53', 'Aminolevulinic Acid'), ('tp53', 'Aminopterin'), ('tp53', 'Amiodarone'), ('tp53', 'Ammonium Chloride'), ('tp53', 'Amodiaquine'), ('tp53', 'Amsacrine'), ('tp53', 'Androgens'), ('tp53', 'Antineoplastic Agents'), ('tp53', 'Arecoline'), ('tp53', 'Armin'), ('tp53', 'Arsenic'), ('tp53', 'Asbestos'), ('tp53', 'Ascorbic Acid'), ('tp53', 'Aspirin'), ('tp53', 'Atrazine'), ('tp53', 'Atropine'), ('tp53', 'Vehicle Emissions'), ('tp53', 'Azacitidine'), ('tp53', 'Azathioprine'), ('tp53', 'Azinphosmethyl'), ('tp53', 'Benomyl'), ('tp53', 'Benzalkonium Compounds'), ('tp53', 'Benzene'), ('tp53', 'Hexachlorocyclohexane'), ('tp53', 'Benzo(a)pyrene'), ('tp53', 'Berberine'), ('tp53', 'Bile Acids and Salts'), ('tp53', 'Dicumarol'), ('tp53', 'Bithionol'), ('tp53', 'Bleomycin'), ('tp53', 'Busulfan'), ('tp53', 'Cacodylic Acid'), ('tp53', 'Cadmium'), ('tp53', 'Caffeine'), ('tp53', 'Calcitriol'), ('tp53', 'Calcium'), ('tp53', 'Camptothecin'), ('tp53', 'Cannabidiol'), ('tp53', 'Capsaicin'), ('tp53', 'Carbamates'), ('tp53', 'Carbamazepine'), ('tp53', 'Carbenoxolone'), ('tp53', 'Carbofuran'), ('tp53', 'Carmustine'), ('tp53', 'Catechin'), ('tp53', 'Cefotaxime'), ('tp53', 'Cephalothin'), ('tp53', 'Ceramides'), ('tp53', 'Cerium'), ('tp53', 'Chelating Agents'), ('tp53', 'Chlorambucil'), ('tp53', 'Chlorfenvinphos'), ('tp53', 'Chlorine'), ('tp53', 'Chloroform'), ('tp53', 'Chloroquine'), ('tp53', 'Cholestanols'), ('tp53', 'Cholesterol'), ('tp53', 'Chromium'), ('tp53', 'Cisplatin'), ('tp53', 'Citrinin'), ('tp53', 'Clotrimazole'), ('tp53', 'Clozapine'), ('tp53', 'Cobalt'), ('tp53', 'Colchicine'), ('tp53', 'Copper'), ('tp53', 'Coumaphos'), ('tp53', 'Curcumin'), ('tp53', 'Cycloheximide'), ('tp53', 'Cyclophosphamide'), ('tp53', 'Cytarabine'), ('tp53', 'Cytochalasin B'), ('tp53', 'Dactinomycin'), ('tp53', 'Daunorubicin'), ('tp53', 'Dichlorodiphenyl Dichloroethylene'), ('tp53', 'Deferoxamine'), ('tp53', 'Dehydroepiandrosterone'), ('tp53', 'Deoxyglucose'), ('tp53', 'Dequalinium'), ('tp53', 'Dexamethasone'), ('tp53', 'Diamide'), ('tp53', 'Dianhydrogalactitol'), ('tp53', 'Diazinon'), ('tp53', 'Dibutyl Phthalate'), ('tp53', 'Bucladesine'), ('tp53', 'Clodronic Acid'), ('tp53', 'Dichlorophen'), ('tp53', 'Dichlororibofuranosylbenzimidazole'), ('tp53', 'Diclofenac'), ('tp53', 'Dieldrin'), ('tp53', 'Dienestrol'), ('tp53', 'Ditiocarb'), ('tp53', 'Diethylhexyl Phthalate'), ('tp53', 'Diethylnitrosamine'), ('tp53', 'Diethylstilbestrol'), ('tp53', 'Digitoxin'), ('tp53', 'Dimethylformamide'), ('tp53', 'Dioxins'), ('tp53', 'Diphenoxylate'), ('tp53', 'Dipyridamole'), ('tp53', 'Disulfoton'), ('tp53', 'Dithiothreitol'), ('tp53', 'Docosahexaenoic Acids'), ('tp53', 'Dopamine'), ('tp53', 'Doxorubicin'), ('tp53', 'Drugs, Chinese Herbal'), ('tp53', 'Pentetic Acid'), ('tp53', 'Chlorpyrifos'), ('tp53', 'Dust'), ('tp53', 'Fonofos'), ('tp53', 'Edetic Acid'), ('tp53', 'Ellagic Acid'), ('tp53', 'Endosulfan'), ('tp53', 'Enzyme Inhibitors'), ('tp53', 'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester'), ('tp53', 'Erythrosine'), ('tp53', 'Estradiol'), ('tp53', 'Estrogens'), ('tp53', 'Ethacridine'), ('tp53', 'Ethacrynic Acid'), ('tp53', 'Ethidium'), ('tp53', 'Ethinyl Estradiol'), ('tp53', 'Amifostine'), ('tp53', 'Ethylenebis(dithiocarbamates)'), ('tp53', 'Ethylnitrosourea'), ('tp53', 'Etoposide'), ('tp53', 'Eugenol'), ('tp53', 'Fenbendazole'), ('tp53', 'Fenitrothion'), ('tp53', 'Fenthion'), ('tp53', 'Ferric Compounds'), ('tp53', 'Fish Oils'), ('tp53', 'Flame Retardants'), ('tp53', 'Flavonoids'), ('tp53', 'Flucytosine'), ('tp53', 'Floxuridine'), ('tp53', 'Fluorometholone'), ('tp53', 'Fluorouracil'), ('tp53', 'Fluoxetine'), ('tp53', 'Flurbiprofen'), ('tp53', 'Folic Acid'), ('tp53', 'Formaldehyde'), ('tp53', 'Colforsin'), ('tp53', 'Tegafur'), ('tp53', 'Galactose'), ('tp53', 'Gallic Acid'), ('tp53', 'Gentamicins'), ('tp53', 'Gentian Violet'), ('tp53', 'Glyburide'), ('tp53', 'Gliclazide'), ('tp53', 'Glucose'), ('tp53', 'Glucosides'), ('tp53', 'Glutaral'), ('tp53', 'Glutathione'), ('tp53', 'Glycerol'), ('tp53', 'Heparin'), ('tp53', 'Heptachlor'), ('tp53', 'Heterocyclic Compounds, 3-Ring'), ('tp53', 'Hexachlorophene'), ('tp53', 'Homocysteine'), ('tp53', 'Hycanthone'), ('tp53', 'Hydralazine'), ('tp53', 'Hydrazones'), ('tp53', 'Hydrogen Peroxide'), ('tp53', 'Hydroxamic Acids'), ('tp53', 'Hydroxyurea'), ('tp53', 'Hymecromone'), ('tp53', 'Ibuprofen'), ('tp53', 'Ifosfamide'), ('tp53', 'Indomethacin'), ('tp53', 'Clioquinol'), ('tp53', 'Iohexol'), ('tp53', 'Iopamidol'), ('tp53', 'Isatin'), ('tp53', 'Isoproterenol'), ('tp53', 'Ivermectin'), ('tp53', 'Ketamine'), ('tp53', 'Lead'), ('tp53', 'Levamisole'), ('tp53', 'Lithium'), ('tp53', 'Lovastatin'), ('tp53', 'Magnesium Oxide'), ('tp53', 'Malathion'), ('tp53', 'Malondialdehyde'), ('tp53', 'Mannitol'), ('tp53', 'Mechlorethamine'), ('tp53', 'Melatonin'), ('tp53', 'Melphalan'), ('tp53', 'Menthol'), ('tp53', 'Metformin'), ('tp53', 'Methotrexate'), ('tp53', 'Methoxsalen'), ('tp53', 'Methoxychlor'), ('tp53', 'Methyl Methanesulfonate'), ('tp53', 'Methyl Parathion'), ('tp53', 'Methylene Blue'), ('tp53', 'Methylmercury Compounds'), ('tp53', 'Methylnitronitrosoguanidine'), ('tp53', 'Methylnitrosourea'), ('tp53', 'Mevinphos'), ('tp53', 'Mitotane'), ('tp53', 'Mitoxantrone'), ('tp53', 'Molybdenum'), ('tp53', 'Morphine'), ('tp53', 'Mustard Compounds'), ('tp53', 'Mustard Gas'), ('tp53', 'Mycophenolic Acid'), ('tp53', 'NAD'), ('tp53', 'NADP'), ('tp53', 'Naloxone'), ('tp53', 'Naphthalenes'), ('tp53', 'Nickel'), ('tp53', 'Niclosamide'), ('tp53', 'Niacinamide'), ('tp53', 'Nicotine'), ('tp53', 'Nifedipine'), ('tp53', 'Ninhydrin'), ('tp53', 'Nitric Oxide'), ('tp53', 'Nitrofurazone'), ('tp53', 'Nitrogen Mustard Compounds'), ('tp53', 'Nitrogen Oxides'), ('tp53', 'Nitroprusside'), ('tp53', 'Nitrovin'), ('tp53', 'Masoprocol'), ('tp53', 'Norethindrone'), ('tp53', 'Noscapine'), ('tp53', 'o-Phthalaldehyde'), ('tp53', 'Organometallic Compounds'), ('tp53', 'Ouabain'), ('tp53', 'Oxalates'), ('tp53', 'Oxygen'), ('tp53', 'Ozone'), ('tp53', 'Palmitates'), ('tp53', 'Paraquat'), ('tp53', 'Parathion'), ('tp53', 'Patulin'), ('tp53', 'Penicillamine'), ('tp53', 'Pentachlorophenol'), ('tp53', 'Pentamidine'), ('tp53', 'Pergolide'), ('tp53', 'Pesticides'), ('tp53', 'Phenindione'), ('tp53', 'Phenylmercuric Acetate'), ('tp53', 'Phenytoin'), ('tp53', 'Phloretin'), ('tp53', 'Phorate'), ('tp53', 'Phosmet'), ('tp53', 'Phosphamidon'), ('tp53', 'Phosphatidylcholines'), ('tp53', 'Organophosphates'), ('tp53', 'Leptophos'), ('tp53', 'Phycocyanin'), ('tp53', 'Phytic Acid'), ('tp53', 'Piroxicam'), ('tp53', 'Plant Extracts'), ('tp53', 'Plant Oils'), ('tp53', 'Poly I-C'), ('tp53', 'Polychlorinated Biphenyls'), ('tp53', 'Polycyclic Aromatic Hydrocarbons'), ('tp53', 'Polyethyleneimine'), ('tp53', 'Polymyxin B'), ('tp53', 'Polysaccharides'), ('tp53', 'Potassium Dichromate'), ('tp53', 'Povidone'), ('tp53', 'Fenofibrate'), ('tp53', 'Proflavine'), ('tp53', 'Progestins'), ('tp53', 'Progesterone'), ('tp53', 'Pyrogallol'), ('tp53', 'Pyrroles'), ('tp53', 'Quartz'), ('tp53', 'Quercetin'), ('tp53', 'Quinacrine'), ('tp53', 'Razoxane'), ('tp53', 'Retinoids'), ('tp53', 'Ribavirin'), ('tp53', 'Riboflavin'), ('tp53', 'Ribonucleotides'), ('tp53', 'Rotenone'), ('tp53', 'Ruthenium'), ('tp53', 'Rutin'), ('tp53', 'Selenium'), ('tp53', 'Selenomethionine'), ('tp53', 'Silicon Dioxide'), ('tp53', 'Silver'), ('tp53', 'Silver Nitrate'), ('tp53', 'Skatole'), ('tp53', 'Smoke'), ('tp53', 'Sodium Chloride'), ('tp53', 'Sodium Fluoride'), ('tp53', 'Stilbenes'), ('tp53', 'Sulindac'), ('tp53', 'Suramin'), ('tp53', 'T-2 Toxin'), ('tp53', 'Tamoxifen'), ('tp53', 'Tea'), ('tp53', 'Testosterone'), ('tp53', 'Tetrachlorodibenzodioxin'), ('tp53', 'Tetrachloroethylene'), ('tp53', 'Tetrachlorvinphos'), ('tp53', 'Tetradecanoylphorbol Acetate'), ('tp53', 'Thalidomide'), ('tp53', 'Theophylline'), ('tp53', 'Thimerosal'), ('tp53', 'Thiocarbamates'), ('tp53', 'Thioguanine'), ('tp53', 'Thioinosine'), ('tp53', 'Thioridazine'), ('tp53', 'Thiosemicarbazones'), ('tp53', 'Thiostrepton'), ('tp53', 'Thiourea'), ('tp53', 'Tobacco Smoke Pollution'), ('tp53', 'Toluene'), ('tp53', 'Tosylphenylalanyl Chloromethyl Ketone'), ('tp53', 'Tretinoin'), ('tp53', 'Triamterene'), ('tp53', 'Trichlorfon'), ('tp53', 'Trichloroethylene'), ('tp53', 'Trientine'), ('tp53', 'Trifluridine'), ('tp53', 'Tritolyl Phosphates'), ('tp53', 'Tunicamycin'), ('tp53', 'Uracil'), ('tp53', 'Uridine'), ('tp53', 'Ursodeoxycholic Acid'), ('tp53', 'Valproic Acid'), ('tp53', 'Vanadium'), ('tp53', 'Vinblastine'), ('tp53', 'Vincristine'), ('tp53', 'Vinyl Chloride'), ('tp53', 'Viper Venoms'), ('tp53', 'Vitamin D'), ('tp53', 'Vitamin E'), ('tp53', 'Warfarin'), ('tp53', 'Water Pollutants'), ('tp53', 'Zearalenone'), ('tp53', 'Zinc'), ('tp53', 'Zinc Oxide'), ('tp53', '2-Acetylaminofluorene'), ('tp53', '2-Naphthylamine'), ('tp53', '2,6-Dichloroindophenol'), ('tp53', \"3,3'-Dichlorobenzidine\"), ('tp53', '4-Nitroquinoline-1-oxide'), ('tp53', 'Eicosapentaenoic Acid'), ('tp53', 'Mercaptopurine'), ('tp53', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('tp53', '8-Bromo Cyclic Adenosine Monophosphate'), ('tp53', '9,10-Dimethyl-1,2-benzanthracene'), ('tp53', 'Zidovudine'), ('tp53', 'Epirubicin'), ('tp53', 'Octreotide'), ('tp53', 'Nimustine'), ('tp53', 'Hazardous Substances'), ('tp53', 'Fatty Acids, Omega-3'), ('tp53', '1-Methyl-4-phenylpyridinium'), ('tp53', 'Nocodazole'), ('tp53', 'Metribolone'), ('tp53', 'Propofol'), ('tp53', 'Albendazole'), ('tp53', 'Ganciclovir'), ('tp53', 'Cysteine Proteinase Inhibitors'), ('tp53', 'Carboplatin'), ('tp53', 'Cyclosporine'), ('tp53', 'Terfenadine'), ('tp53', 'Aflatoxin B1'), ('tp53', 'Mitomycin'), ('tp53', 'Monocrotaline'), ('tp53', 'Arachidonic Acid'), ('tp53', 'Pravastatin'), ('tp53', 'Paclitaxel'), ('tp53', 'Medroxyprogesterone Acetate'), ('tp53', 'Goserelin'), ('tp53', 'Fenretinide'), ('tp53', 'Cladribine'), ('tp53', 'Reactive Oxygen Species'), ('tp53', 'Asbestos, Serpentine'), ('tp53', 'Asbestos, Amphibole'), ('tp53', 'Asbestos, Crocidolite'), ('tp53', 'Asbestos, Amosite'), ('tp53', 'Platinum Compounds'), ('tp53', \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\"), ('tp53', 'Isocyanates'), ('tp53', 'Zinc Compounds'), ('tp53', 'Vanadium Compounds'), ('tp53', 'Ruthenium Compounds'), ('tp53', 'Lithium Chloride'), ('tp53', 'Silver Compounds'), ('tp53', 'Sodium Selenite'), ('tp53', 'Cadmium Chloride'), ('tp53', 'Thapsigargin'), ('tp53', 'Zinc Sulfate'), ('tp53', 'Oleic Acid'), ('tp53', 'Palmitic Acid'), ('tp53', 'Staurosporine'), ('tp53', 'Okadaic Acid'), ('tp53', 'beta-Naphthoflavone'), ('tp53', 'Copper Sulfate'), ('tp53', 'Buthionine Sulfoximine'), ('tp53', 'Acetic Acid'), ('tp53', 'Zinc Acetate'), ('tp53', 'Ritonavir'), ('tp53', 'Glycyrrhizic Acid'), ('tp53', 'Topotecan'), ('tp53', 'Glutathione Disulfide'), ('tp53', 'Sodium Azide'), ('tp53', 'Budesonide'), ('tp53', 'Simvastatin'), ('tp53', 'Genistein'), ('tp53', 'Nitric Oxide Donors'), ('tp53', 'Acrylamide'), ('tp53', 'tert-Butylhydroperoxide'), ('tp53', 'Sirolimus'), ('tp53', 'Butyric Acid'), ('tp53', '3-Hydroxybutyric Acid'), ('tp53', 'Sodium Benzoate'), ('tp53', 'Raloxifene Hydrochloride'), ('tp53', 'Vitamin K 3'), ('tp53', 'alpha-Tocopherol'), ('tp53', 'Tocopherols'), ('tp53', 'S-Nitrosoglutathione'), ('tp53', 'S-Nitroso-N-Acetylpenicillamine'), ('tp53', 'Plant Preparations'), ('tp53', 'Aristolochic Acids'), ('tp53', 'Nanotubes, Carbon'), ('tp53', 'Linoleic Acids, Conjugated'), ('tp53', 'Proanthocyanidins'), ('tp53', 'Flavanones'), ('tp53', 'Chalcones'), ('tp53', 'Apigenin'), ('tp53', 'Hydrolyzable Tannins'), ('tp53', 'Betalains'), ('tp53', 'Ferrosoferric Oxide'), ('tp53', 'Particulate Matter'), ('tp53', 'Soot'), ('tp53', 'Halogenated Diphenyl Ethers'), ('tp53', 'Iron Compounds'), ('tp53', 'Magnetite Nanoparticles'), ('tp53', 'Polyphenols'), ('tp53', 'Fungal Polysaccharides'), ('tp53', 'Phytochemicals'), ('tp53', 'Selenium Oxides'), ('Calcimycin', 'il6'), ('Calcimycin', 'mapk3'), ('Calcimycin', 'rela'), ('Calcimycin', 'mapk8'), ('Calcimycin', 'mapk1'), ('Calcimycin', 'sp1'), ('il6', 'Aripiprazole'), ('il6', 'Fluticasone'), ('il6', 'Celecoxib'), ('il6', 'Atorvastatin'), ('il6', 'Bortezomib'), ('il6', 'Erlotinib Hydrochloride'), ('il6', 'Dasatinib'), ('il6', 'Atazanavir Sulfate'), ('il6', 'Sugars'), ('il6', 'Docetaxel'), ('il6', 'Clopidogrel'), ('il6', 'Irinotecan'), ('il6', 'Rosiglitazone'), ('il6', 'Sorafenib'), ('il6', 'Resveratrol'), ('il6', 'Wortmannin'), ('il6', 'Temozolomide'), ('il6', 'Decitabine'), ('il6', 'Sunitinib'), ('il6', 'Zoledronic Acid'), ('il6', 'Arsenic Trioxide'), ('il6', 'Donepezil'), ('il6', 'Fulvestrant'), ('il6', 'Pamidronate'), ('il6', 'Imiquimod'), ('il6', 'Troglitazone'), ('il6', 'Bosentan'), ('il6', 'Telmisartan'), ('il6', 'Vorinostat'), ('il6', 'Verteporfin'), ('il6', 'Silybin'), ('il6', 'Orlistat'), ('il6', 'Cilostazol'), ('il6', 'Aluminum Chloride'), ('il6', 'Eptifibatide'), ('il6', '17 alpha-Hydroxyprogesterone Caproate'), ('il6', 'Tigecycline'), ('il6', 'Acetaldehyde'), ('il6', 'Acetaminophen'), ('il6', 'Acetates'), ('il6', 'Gemcitabine'), ('il6', 'Acetylcysteine'), ('il6', 'Acetylmuramyl-Alanyl-Isoglutamine'), ('il6', 'Acids'), ('il6', 'Acrolein'), ('il6', 'Adenosine Triphosphate'), ('il6', 'Aerosols'), ('il6', 'Agglutinins'), ('il6', 'Air Pollutants'), ('il6', 'Air Pollutants, Occupational'), ('il6', 'Albuterol'), ('il6', 'Ethanol'), ('il6', 'Aldehydes'), ('il6', 'Aldosterone'), ('il6', 'Allantoin'), ('il6', 'Alloys'), ('il6', 'Aluminum'), ('il6', 'Aluminum Oxide'), ('il6', 'Amino Acids, Peptides, and Proteins'), ('il6', 'Amiodarone'), ('il6', 'Amphotericin B'), ('il6', 'Anthralin'), ('il6', 'Anti-Inflammatory Agents'), ('il6', 'Antigens, Bacterial'), ('il6', 'Antioxidants'), ('il6', 'Apomorphine'), ('il6', 'Arecoline'), ('il6', 'Arsenic'), ('il6', 'Arsenicals'), ('il6', 'Asbestos'), ('il6', 'Ascorbic Acid'), ('il6', 'Aspartame'), ('il6', 'Aspirin'), ('il6', 'Auranofin'), ('il6', 'Vehicle Emissions'), ('il6', 'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride'), ('il6', 'Azacitidine'), ('il6', 'Azathioprine'), ('il6', 'Aziridines'), ('il6', 'Barium Sulfate'), ('il6', 'BCG Vaccine'), ('il6', 'Beclomethasone'), ('il6', 'Benzalkonium Compounds'), ('il6', 'Benzbromarone'), ('il6', 'Benzene'), ('il6', 'Benzo(a)pyrene'), ('il6', 'Benzoates'), ('il6', 'Benzofurans'), ('il6', 'Benzoyl Peroxide'), ('il6', 'Berberine'), ('il6', 'Bezafibrate'), ('il6', 'Bile Acids and Salts'), ('il6', 'Bilirubin'), ('il6', 'Biological Factors'), ('il6', 'Bleomycin'), ('il6', 'Butyrates'), ('il6', 'Cadmium'), ('il6', 'Ceruletide'), ('il6', 'Calcitriol'), ('il6', 'Calcium'), ('il6', 'Cannabidiol'), ('il6', 'Cannabinoids'), ('il6', 'Capsaicin'), ('il6', 'Carbamates'), ('il6', 'Carbamazepine'), ('il6', 'Carbon'), ('il6', 'Carbon Monoxide'), ('il6', 'Carbon Tetrachloride'), ('il6', 'Carmustine'), ('il6', 'Carnosine'), ('il6', 'Catechin'), ('il6', 'Chelating Agents'), ('il6', 'Chenodeoxycholic Acid'), ('il6', 'Chlorine'), ('il6', 'Chloroquine'), ('il6', 'Chlorpromazine'), ('il6', 'Cholecalciferol'), ('il6', 'Chromium'), ('il6', 'Chromium Alloys'), ('il6', 'Ciprofloxacin'), ('il6', 'Cisplatin'), ('il6', 'Leucovorin'), ('il6', 'Clomipramine'), ('il6', 'Cloxacillin'), ('il6', 'Coal'), ('il6', 'Cobalt'), ('il6', 'Cocaine'), ('il6', 'Copper'), ('il6', 'Cortisone'), ('il6', 'Curcumin'), ('il6', 'Cycloheximide'), ('il6', 'Cytarabine'), ('il6', 'Dactinomycin'), ('il6', 'DDT'), ('il6', 'Deferoxamine'), ('il6', 'Demecolcine'), ('il6', 'Demeclocycline'), ('il6', 'Deoxycholic Acid'), ('il6', 'Desipramine'), ('il6', 'Dexamethasone'), ('il6', 'Diacetyl'), ('il6', 'Diazoxide'), ('il6', 'Dibutyl Phthalate'), ('il6', 'Bucladesine'), ('il6', 'Diclofenac'), ('il6', 'Dietary Carbohydrates'), ('il6', 'Diethylhexyl Phthalate'), ('il6', 'Diethylstilbestrol'), ('il6', 'Dihydroxyacetone'), ('il6', 'Dimethyl Sulfoxide'), ('il6', 'Dinitrochlorobenzene'), ('il6', 'Diphenhydramine'), ('il6', 'Disulfiram'), ('il6', 'Diuron'), ('il6', 'Dobutamine'), ('il6', 'Docosahexaenoic Acids'), ('il6', 'Domperidone'), ('il6', 'Doxorubicin'), ('il6', 'Doxycycline'), ('il6', 'Drugs, Chinese Herbal'), ('il6', 'Chlorpyrifos'), ('il6', 'Dust'), ('il6', 'Dydrogesterone'), ('il6', 'Edetic Acid'), ('il6', 'Egtazic Acid'), ('il6', 'Emodin'), ('il6', 'Enalapril'), ('il6', 'Endosulfan'), ('il6', 'Endotoxins'), ('il6', 'Environmental Pollutants'), ('il6', 'Epinephrine'), ('il6', 'Erythromycin'), ('il6', 'Estradiol'), ('il6', 'Estriol'), ('il6', 'Fatty Acids, Nonesterified'), ('il6', 'Fenbendazole'), ('il6', 'Flame Retardants'), ('il6', 'Flavoring Agents'), ('il6', 'Floxacillin'), ('il6', 'Fluorometholone'), ('il6', 'Fluorouracil'), ('il6', 'Folic Acid'), ('il6', 'Formaldehyde'), ('il6', 'Colforsin'), ('il6', 'Furosemide'), ('il6', 'Gadolinium'), ('il6', 'Galactose'), ('il6', 'Gallic Acid'), ('il6', 'Glucosamine'), ('il6', 'Glucose'), ('il6', 'Glutaral'), ('il6', 'Glutathione'), ('il6', 'Glycerol'), ('il6', 'Nitroglycerin'), ('il6', 'Glycochenodeoxycholic Acid'), ('il6', 'Glycocholic Acid'), ('il6', 'Glycodeoxycholic Acid'), ('il6', 'Glyoxal'), ('il6', 'Gold'), ('il6', 'Gold Sodium Thiomalate'), ('il6', 'Hemagglutinins'), ('il6', 'Heparin'), ('il6', 'Hesperidin'), ('il6', 'Histamine'), ('il6', 'Hyaluronic Acid'), ('il6', 'Hydralazine'), ('il6', 'Hydrocarbons'), ('il6', 'Hydrocortisone'), ('il6', 'Hydrogen Peroxide'), ('il6', 'Hydroxamic Acids'), ('il6', 'Hydroxychloroquine'), ('il6', 'Ibuprofen'), ('il6', 'Indomethacin'), ('il6', 'Indoprofen'), ('il6', 'Iron'), ('il6', 'Isoniazid'), ('il6', 'Isoproterenol'), ('il6', 'Ketamine'), ('il6', 'Ketanserin'), ('il6', 'Kynurenic Acid'), ('il6', 'Latex'), ('il6', 'Lidocaine'), ('il6', 'Lipids'), ('il6', 'Thioctic Acid'), ('il6', 'Lipopolysaccharides'), ('il6', 'Lucanthone'), ('il6', 'Malathion'), ('il6', 'Manganese'), ('il6', 'Mefenamic Acid'), ('il6', 'Melatonin'), ('il6', 'Menthol'), ('il6', 'Mercuric Chloride'), ('il6', 'Mercury'), ('il6', 'Metformin'), ('il6', 'Methimazole'), ('il6', 'Methotrexate'), ('il6', 'Methyl Methanesulfonate'), ('il6', 'Methyl Parathion'), ('il6', 'Methylcholanthrene'), ('il6', 'Methylmercury Compounds'), ('il6', 'Methylprednisolone'), ('il6', 'Methylthiouracil'), ('il6', 'Mevalonic Acid'), ('il6', 'Mexiletine'), ('il6', 'Monensin'), ('il6', 'Morphine'), ('il6', 'Mustard Gas'), ('il6', 'Mycophenolic Acid'), ('il6', 'N-Formylmethionine Leucyl-Phenylalanine'), ('il6', 'Nafcillin'), ('il6', 'Naloxone'), ('il6', 'Naphthoquinones'), ('il6', 'Niacin'), ('il6', 'Nickel'), ('il6', 'Niclosamide'), ('il6', 'Niacinamide'), ('il6', 'Nicotine'), ('il6', 'Nitrogen'), ('il6', 'Nitrogen Dioxide'), ('il6', 'Nitrogen Oxides'), ('il6', 'Norepinephrine'), ('il6', 'Nortriptyline'), ('il6', 'Oligoribonucleotides'), ('il6', 'Ouabain'), ('il6', 'Ovalbumin'), ('il6', 'Oxazolone'), ('il6', 'Oxygen'), ('il6', 'Oxymetholone'), ('il6', 'Ozone'), ('il6', 'Palmitates'), ('il6', 'Pantothenic Acid'), ('il6', 'Paraquat'), ('il6', 'Pentachlorophenol'), ('il6', 'Peptidoglycan'), ('il6', 'Perfume'), ('il6', 'Pesticides'), ('il6', 'Phenobarbital'), ('il6', 'Phenylbutyrates'), ('il6', 'Phenylmercuric Acetate'), ('il6', 'Phloretin'), ('il6', 'Phosphorus'), ('il6', 'Piroxicam'), ('il6', 'Plant Extracts'), ('il6', 'Platelet Activating Factor'), ('il6', 'Poly I-C'), ('il6', 'Polychlorinated Biphenyls'), ('il6', 'Polycyclic Aromatic Hydrocarbons'), ('il6', 'Polydeoxyribonucleotides'), ('il6', 'Polyethylene Glycols'), ('il6', 'Polyethyleneimine'), ('il6', 'Polymyxin B'), ('il6', 'Polyphosphates'), ('il6', 'Polyribonucleotides'), ('il6', 'Polystyrenes'), ('il6', 'Potassium Dichromate'), ('il6', 'Prednisolone'), ('il6', 'Fenofibrate'), ('il6', 'Progesterone'), ('il6', 'Propanil'), ('il6', 'Prostaglandins E'), ('il6', 'Proteoglycans'), ('il6', 'Pyruvaldehyde'), ('il6', 'Quartz'), ('il6', 'Quercetin'), ('il6', 'Quinazolines'), ('il6', 'Quinine'), ('il6', 'Radon'), ('il6', 'Batroxobin'), ('il6', 'Riboflavin'), ('il6', 'Rifampin'), ('il6', '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone'), ('il6', 'Rotenone'), ('il6', 'Ruthenium Red'), ('il6', 'Rutin'), ('il6', 'Sulfasalazine'), ('il6', 'Saponins'), ('il6', 'Selenium'), ('il6', 'Serotonin'), ('il6', 'Sesquiterpenes'), ('il6', 'Silicon Dioxide'), ('il6', 'Silver'), ('il6', 'Silymarin'), ('il6', 'Smoke'), ('il6', 'Sodium Chloride'), ('il6', 'Sodium Dodecyl Sulfate'), ('il6', 'Gold Sodium Thiosulfate'), ('il6', 'Sodium Nitrite'), ('il6', 'Sodium Salicylate'), ('il6', 'Spironolactone'), ('il6', 'Dihydrotestosterone'), ('il6', 'Staphylococcal Protein A'), ('il6', 'Sulfadiazine'), ('il6', 'Sulfur Dioxide'), ('il6', 'Suramin'), ('il6', 'Talc'), ('il6', 'Tamoxifen'), ('il6', 'Taurocholic Acid'), ('il6', 'Testosterone'), ('il6', 'Tetrachlorodibenzodioxin'), ('il6', 'Tetradecanoylphorbol Acetate'), ('il6', 'Thalidomide'), ('il6', 'Theophylline'), ('il6', 'Thimerosal'), ('il6', 'Thioacetamide'), ('il6', 'Thiophenes'), ('il6', 'Thiourea'), ('il6', 'Tin Fluorides'), ('il6', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('il6', 'Titanium'), ('il6', 'Tobacco Smoke Pollution'), ('il6', 'Toluene'), ('il6', 'Toluene 2,4-Diisocyanate'), ('il6', 'Tosylphenylalanyl Chloromethyl Ketone'), ('il6', 'Tretinoin'), ('il6', 'Trichloroacetic Acid'), ('il6', 'Trichloroethylene'), ('il6', 'Triclosan'), ('il6', 'Triiodothyronine'), ('il6', 'Trimethoprim'), ('il6', 'Triterpenes'), ('il6', 'Ubiquinone'), ('il6', 'Urethane'), ('il6', 'Uric Acid'), ('il6', 'Uridine Triphosphate'), ('il6', 'Ursodeoxycholic Acid'), ('il6', 'Valproic Acid'), ('il6', 'Vanadates'), ('il6', 'Vanadium'), ('il6', 'Verapamil'), ('il6', 'Vinblastine'), ('il6', 'Vincristine'), ('il6', 'Vitamin E'), ('il6', 'Water Pollutants'), ('il6', 'Zearalenone'), ('il6', 'Zinc'), ('il6', 'Zinc Oxide'), ('il6', 'Ziram'), ('il6', 'Zymosan'), ('il6', '1-Methyl-3-isobutylxanthine'), ('il6', '1,2-Dipalmitoylphosphatidylcholine'), ('il6', \"2,2'-Dipyridyl\"), ('il6', 'Eicosapentaenoic Acid'), ('il6', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('il6', '8-Bromo Cyclic Adenosine Monophosphate'), ('il6', 'Zidovudine'), ('il6', 'Dinoprostone'), ('il6', 'Epirubicin'), ('il6', 'Isotretinoin'), ('il6', 'Roxithromycin'), ('il6', 'Cytochalasin D'), ('il6', '1-Methyl-4-phenylpyridinium'), ('il6', 'Mifepristone'), ('il6', 'Metribolone'), ('il6', 'Propofol'), ('il6', 'Ionomycin'), ('il6', 'Carboplatin'), ('il6', 'Iloprost'), ('il6', 'Cyclosporine'), ('il6', 'Crack Cocaine'), ('il6', 'Terfenadine'), ('il6', 'Aflatoxin B1'), ('il6', 'Mitomycin'), ('il6', 'Arachidonic Acid'), ('il6', 'Pravastatin'), ('il6', 'Paclitaxel'), ('il6', 'Medroxyprogesterone Acetate'), ('il6', 'Procaterol'), ('il6', 'Clarithromycin'), ('il6', 'Bisoprolol'), ('il6', '8-Hydroxy-2-(di-n-propylamino)tetralin'), ('il6', 'Reactive Oxygen Species'), ('il6', 'Gold Compounds'), ('il6', 'Asbestos, Serpentine'), ('il6', 'Asbestos, Amphibole'), ('il6', 'Asbestos, Crocidolite'), ('il6', 'Durapatite'), ('il6', 'Isocyanates'), ('il6', 'Leukotriene D4'), ('il6', 'Silver Compounds'), ('il6', 'Sodium Selenite'), ('il6', 'Stavudine'), ('il6', 'Antirheumatic Agents'), ('il6', 'Cadmium Chloride'), ('il6', 'Saquinavir'), ('il6', 'Thapsigargin'), ('il6', 'Zinc Sulfate'), ('il6', 'Oleic Acid'), ('il6', 'Palmitic Acid'), ('il6', 'Okadaic Acid'), ('il6', 'beta-Naphthoflavone'), ('il6', 'Zinc Acetate'), ('il6', 'Ritonavir'), ('il6', 'Indinavir'), ('il6', 'Glycyrrhizic Acid'), ('il6', 'Riluzole'), ('il6', 'Gadolinium DTPA'), ('il6', 'Linoleic Acid'), ('il6', 'Losartan'), ('il6', 'Benzoic Acid'), ('il6', 'Budesonide'), ('il6', 'Simvastatin'), ('il6', 'Nevirapine'), ('il6', 'Genistein'), ('il6', '2-Propanol'), ('il6', 'Nelfinavir'), ('il6', 'Polymethyl Methacrylate'), ('il6', 'Propylene Glycol'), ('il6', 'Styrene'), ('il6', 'Milrinone'), ('il6', 'tert-Butylhydroperoxide'), ('il6', 'Sirolimus'), ('il6', 'Brefeldin A'), ('il6', 'Butyric Acid'), ('il6', 'Methylmethacrylate'), ('il6', 'Raloxifene Hydrochloride'), ('il6', 'Rolipram'), ('il6', 'Perindopril'), ('il6', 'Polyethylene'), ('il6', 'Diphtheria-Tetanus-acellular Pertussis Vaccines'), ('il6', 'Vitamin K 3'), ('il6', 'alpha-Tocopherol'), ('il6', 'Plant Preparations'), ('il6', 'Pertussis Toxin'), ('il6', 'Fullerenes'), ('il6', 'Nanotubes, Carbon'), ('il6', 'Antigens, Dermatophagoides'), ('il6', 'Linoleic Acids, Conjugated'), ('il6', 'Apigenin'), ('il6', 'Luteolin'), ('il6', 'Hydrolyzable Tannins'), ('il6', 'Protein Kinase Inhibitors'), ('il6', 'Chitosan'), ('il6', 'Phytoestrogens'), ('il6', 'Antigens, Plant'), ('il6', 'Ferrosoferric Oxide'), ('il6', 'Particulate Matter'), ('il6', 'Oseltamivir'), ('il6', 'Soot'), ('il6', 'Interleukin 1 Receptor Antagonist Protein'), ('il6', 'Diketopiperazines'), ('il6', 'Volatile Organic Compounds'), ('il6', 'Halogenated Diphenyl Ethers'), ('il6', 'Iron Compounds'), ('il6', 'Magnetite Nanoparticles'), ('il6', 'Vaccines, Virus-Like Particle'), ('il6', 'Polyphenols'), ('il6', 'Coal Ash'), ('il6', 'Lopinavir'), ('il6', 'Phytochemicals'), ('il6', 'Levofloxacin'), ('mapk3', 'Risedronic Acid'), ('mapk3', 'Salmeterol Xinafoate'), ('mapk3', 'Celecoxib'), ('mapk3', 'Varenicline'), ('mapk3', 'Formoterol Fumarate'), ('mapk3', 'Fingolimod Hydrochloride'), ('mapk3', 'Imatinib Mesylate'), ('mapk3', 'Atorvastatin'), ('mapk3', 'Bortezomib'), ('mapk3', 'Erlotinib Hydrochloride'), ('mapk3', 'Dasatinib'), ('mapk3', 'Acebutolol'), ('mapk3', 'Peanut Oil'), ('mapk3', 'Docetaxel'), ('mapk3', 'Irinotecan'), ('mapk3', 'Sevoflurane'), ('mapk3', 'Oxaliplatin'), ('mapk3', 'Rosiglitazone'), ('mapk3', 'Gefitinib'), ('mapk3', 'Sorafenib'), ('mapk3', 'Resveratrol'), ('mapk3', 'Wortmannin'), ('mapk3', 'Temozolomide'), ('mapk3', 'Pioglitazone'), ('mapk3', 'Decitabine'), ('mapk3', 'Sunitinib'), ('mapk3', 'Zoledronic Acid'), ('mapk3', 'Arsenic Trioxide'), ('mapk3', 'Meloxicam'), ('mapk3', 'Carvedilol'), ('mapk3', 'Moxifloxacin'), ('mapk3', 'Fulvestrant'), ('mapk3', 'Imiquimod'), ('mapk3', 'Lycopene'), ('mapk3', 'Rimonabant'), ('mapk3', 'Troglitazone'), ('mapk3', 'Terbinafine'), ('mapk3', 'Telmisartan'), ('mapk3', 'Vorinostat'), ('mapk3', 'Leflunomide'), ('mapk3', 'Lapatinib'), ('mapk3', 'Orlistat'), ('mapk3', 'Vemurafenib'), ('mapk3', 'Deferiprone'), ('mapk3', 'Eplerenone'), ('mapk3', 'Crizotinib'), ('mapk3', 'Panobinostat'), ('mapk3', 'Ciclopirox'), ('mapk3', 'Axitinib'), ('mapk3', 'Homoharringtonine'), ('mapk3', 'Acetaldehyde'), ('mapk3', 'Ado-Trastuzumab Emtansine'), ('mapk3', 'Acetaminophen'), ('mapk3', 'Gemcitabine'), ('mapk3', 'Betulinic Acid'), ('mapk3', 'Acetylcysteine'), ('mapk3', 'Acids'), ('mapk3', 'Acrolein'), ('mapk3', 'Acrylonitrile'), ('mapk3', 'Adenosine'), ('mapk3', 'Adenosine Diphosphate'), ('mapk3', 'Adenosine Triphosphate'), ('mapk3', 'Air Pollutants'), ('mapk3', 'Albuterol'), ('mapk3', 'Ethanol'), ('mapk3', 'Alcohols'), ('mapk3', 'Aldosterone'), ('mapk3', 'Allopurinol'), ('mapk3', 'Alprenolol'), ('mapk3', 'Amiloride'), ('mapk3', 'Amiodarone'), ('mapk3', 'Amodiaquine'), ('mapk3', 'Anisomycin'), ('mapk3', 'Anthraquinones'), ('mapk3', 'Antifungal Agents'), ('mapk3', 'Antimony Potassium Tartrate'), ('mapk3', 'Antimycin A'), ('mapk3', 'Antineoplastic Agents'), ('mapk3', 'Arachidonic Acids'), ('mapk3', 'Arecoline'), ('mapk3', 'Arsenic'), ('mapk3', 'Ascorbic Acid'), ('mapk3', 'Aspartame'), ('mapk3', 'Aspirin'), ('mapk3', 'Atenolol'), ('mapk3', 'Atrazine'), ('mapk3', 'Vehicle Emissions'), ('mapk3', 'Azathioprine'), ('mapk3', 'Bee Venoms'), ('mapk3', 'Benzene'), ('mapk3', 'Hexachlorocyclohexane'), ('mapk3', 'Benzo(a)pyrene'), ('mapk3', 'Benzofurans'), ('mapk3', 'beta-Endorphin'), ('mapk3', 'Bilirubin'), ('mapk3', 'Dicumarol'), ('mapk3', 'Bupivacaine'), ('mapk3', 'Buprenorphine'), ('mapk3', 'Busulfan'), ('mapk3', 'Butylated Hydroxyanisole'), ('mapk3', 'Butyrates'), ('mapk3', 'Cadmium'), ('mapk3', 'Caffeine'), ('mapk3', 'Calcifediol'), ('mapk3', 'Calcitriol'), ('mapk3', 'Calcium'), ('mapk3', 'Calcium Chloride'), ('mapk3', 'Camptothecin'), ('mapk3', 'Cannabidiol'), ('mapk3', 'Cantharidin'), ('mapk3', 'Capsaicin'), ('mapk3', 'Carbachol'), ('mapk3', 'Carbon Tetrachloride'), ('mapk3', 'Catechin'), ('mapk3', 'Estrogens, Catechol'), ('mapk3', 'Chelating Agents'), ('mapk3', 'Chlordan'), ('mapk3', 'Chlorogenic Acid'), ('mapk3', 'Chloroquine'), ('mapk3', 'Chlorpromazine'), ('mapk3', 'Ciprofloxacin'), ('mapk3', 'Cisplatin'), ('mapk3', 'Citrinin'), ('mapk3', 'Clofibrate'), ('mapk3', 'Cocaine'), ('mapk3', 'Contrast Media'), ('mapk3', 'Copper'), ('mapk3', 'Cotinine'), ('mapk3', 'Curcumin'), ('mapk3', 'Cycloheximide'), ('mapk3', 'Cytochalasin B'), ('mapk3', 'Dacarbazine'), ('mapk3', 'Dactinomycin'), ('mapk3', 'Dapsone'), ('mapk3', 'Daunorubicin'), ('mapk3', 'Dichlorodiphenyl Dichloroethylene'), ('mapk3', 'DDT'), ('mapk3', 'Deferoxamine'), ('mapk3', 'Deoxycholic Acid'), ('mapk3', 'Deoxyglucose'), ('mapk3', 'Desipramine'), ('mapk3', 'Dexamethasone'), ('mapk3', 'Diacetyl'), ('mapk3', 'Diatrizoate'), ('mapk3', 'Dibutyl Phthalate'), ('mapk3', 'Bucladesine'), ('mapk3', 'Diclofenac'), ('mapk3', 'Dieldrin'), ('mapk3', 'Diethylhexyl Phthalate'), ('mapk3', 'Digitoxin'), ('mapk3', 'Dihydroxyacetone'), ('mapk3', 'Dimethyl Sulfoxide'), ('mapk3', 'Dimethylformamide'), ('mapk3', 'Dinitrochlorobenzene'), ('mapk3', 'Dinitrofluorobenzene'), ('mapk3', 'Diphtheria Toxin'), ('mapk3', 'Cromolyn Sodium'), ('mapk3', 'Disulfiram'), ('mapk3', 'Dobutamine'), ('mapk3', 'Docosahexaenoic Acids'), ('mapk3', 'Dopamine'), ('mapk3', 'Doxorubicin'), ('mapk3', 'Drugs, Chinese Herbal'), ('mapk3', 'Chlorpyrifos'), ('mapk3', 'Egtazic Acid'), ('mapk3', 'Emetine'), ('mapk3', 'Emodin'), ('mapk3', 'Endosulfan'), ('mapk3', 'Enzyme Inhibitors'), ('mapk3', 'Epinephrine'), ('mapk3', 'Estradiol'), ('mapk3', 'Estrone'), ('mapk3', 'Ethacrynic Acid'), ('mapk3', 'Etoposide'), ('mapk3', 'Fenoterol'), ('mapk3', 'Fentanyl'), ('mapk3', 'Fish Oils'), ('mapk3', 'Fluorouracil'), ('mapk3', 'Fluoxetine'), ('mapk3', 'Flurbiprofen'), ('mapk3', 'Folic Acid'), ('mapk3', 'Formaldehyde'), ('mapk3', 'Colforsin'), ('mapk3', 'Gallic Acid'), ('mapk3', 'Gasoline'), ('mapk3', 'Gentamicins'), ('mapk3', 'Glucosamine'), ('mapk3', 'Glucose'), ('mapk3', 'Glutathione'), ('mapk3', 'Glycochenodeoxycholic Acid'), ('mapk3', 'Gossypol'), ('mapk3', 'Guanosine'), ('mapk3', 'Hemin'), ('mapk3', 'Heparin'), ('mapk3', 'Heptachlor'), ('mapk3', 'Hexachlorobenzene'), ('mapk3', 'Hexanones'), ('mapk3', 'Histamine'), ('mapk3', 'Homocysteine'), ('mapk3', 'Humic Substances'), ('mapk3', 'Hyaluronic Acid'), ('mapk3', 'Hydrocarbons, Chlorinated'), ('mapk3', 'Hydrogen Peroxide'), ('mapk3', 'Hydrogen Sulfide'), ('mapk3', 'Hypochlorous Acid'), ('mapk3', 'Ibuprofen'), ('mapk3', 'Indomethacin'), ('mapk3', 'Indoprofen'), ('mapk3', 'Clioquinol'), ('mapk3', 'Iohexol'), ('mapk3', 'Iron'), ('mapk3', 'Iron-Dextran Complex'), ('mapk3', 'Isoniazid'), ('mapk3', 'Isoproterenol'), ('mapk3', 'Ketanserin'), ('mapk3', 'Labetalol'), ('mapk3', 'Lead'), ('mapk3', 'Levodopa'), ('mapk3', 'Lipopolysaccharides'), ('mapk3', 'Cholesterol, HDL'), ('mapk3', 'Cholesterol, LDL'), ('mapk3', 'Lithium'), ('mapk3', 'Lithocholic Acid'), ('mapk3', 'Lobeline'), ('mapk3', 'Loperamide'), ('mapk3', 'Lovastatin'), ('mapk3', 'Maneb'), ('mapk3', 'Manganese'), ('mapk3', 'Mebendazole'), ('mapk3', 'Mechlorethamine'), ('mapk3', 'Melatonin'), ('mapk3', 'Melitten'), ('mapk3', 'Melphalan'), ('mapk3', 'Mercuric Chloride'), ('mapk3', 'Metformin'), ('mapk3', 'Methadone'), ('mapk3', 'Methamphetamine'), ('mapk3', 'Methapyrilene'), ('mapk3', 'Methimazole'), ('mapk3', 'Methohexital'), ('mapk3', 'Methoxychlor'), ('mapk3', 'Methylmercury Compounds'), ('mapk3', 'Methylnitronitrosoguanidine'), ('mapk3', 'Methylthiouracil'), ('mapk3', 'Mevalonic Acid'), ('mapk3', 'Morphine'), ('mapk3', 'Mycophenolic Acid'), ('mapk3', 'N-Formylmethionine Leucyl-Phenylalanine'), ('mapk3', 'Naloxone'), ('mapk3', 'Neomycin'), ('mapk3', 'Niacin'), ('mapk3', 'Nickel'), ('mapk3', 'Niclosamide'), ('mapk3', 'Nicotine'), ('mapk3', 'Nicotinic Acids'), ('mapk3', 'Nifedipine'), ('mapk3', 'Nitrogen'), ('mapk3', 'Nitroprusside'), ('mapk3', 'Nitrosourea Compounds'), ('mapk3', 'Masoprocol'), ('mapk3', 'Norepinephrine'), ('mapk3', 'Oleanolic Acid'), ('mapk3', 'Oligopeptides'), ('mapk3', 'Ouabain'), ('mapk3', 'Oxprenolol'), ('mapk3', 'Oxygen'), ('mapk3', 'Ozone'), ('mapk3', 'Paraquat'), ('mapk3', 'Patulin'), ('mapk3', 'Pentachlorophenol'), ('mapk3', 'Pentobarbital'), ('mapk3', 'Pentoxifylline'), ('mapk3', 'Peptidoglycan'), ('mapk3', 'Phenanthrolines'), ('mapk3', 'Phenobarbital'), ('mapk3', 'Phenols'), ('mapk3', 'Phentolamine'), ('mapk3', 'Phenylephrine'), ('mapk3', 'Phenytoin'), ('mapk3', 'Phosphates'), ('mapk3', 'Phosphatidylinositols'), ('mapk3', 'Phytic Acid'), ('mapk3', 'Vitamin K 1'), ('mapk3', 'Pindolol'), ('mapk3', 'Plant Extracts'), ('mapk3', 'Platinum'), ('mapk3', 'Polychlorinated Biphenyls'), ('mapk3', 'Polycyclic Aromatic Hydrocarbons'), ('mapk3', 'Polymyxin B'), ('mapk3', 'Polyphosphates'), ('mapk3', 'Polyribonucleotides'), ('mapk3', 'Polysaccharides'), ('mapk3', 'Potassium Dichromate'), ('mapk3', 'Practolol'), ('mapk3', 'Procaine'), ('mapk3', 'Prodigiosin'), ('mapk3', 'Progesterone'), ('mapk3', 'Promegestone'), ('mapk3', 'Propolis'), ('mapk3', 'Propranolol'), ('mapk3', 'Epoprostenol'), ('mapk3', 'Pyocyanine'), ('mapk3', 'Pyridazines'), ('mapk3', 'Pyrilamine'), ('mapk3', 'Pyruvaldehyde'), ('mapk3', 'Quercetin'), ('mapk3', 'Quinacrine'), ('mapk3', 'Quinazolines'), ('mapk3', 'Ranitidine'), ('mapk3', 'Retinoids'), ('mapk3', 'Rotenone'), ('mapk3', 'Ruthenium Red'), ('mapk3', 'Rutin'), ('mapk3', 'S-Adenosylmethionine'), ('mapk3', 'Saponins'), ('mapk3', 'Secobarbital'), ('mapk3', 'Selegiline'), ('mapk3', 'Selenomethionine'), ('mapk3', 'Serotonin'), ('mapk3', 'Silicon Dioxide'), ('mapk3', 'Silver'), ('mapk3', 'Silver Nitrate'), ('mapk3', 'Simazine'), ('mapk3', 'Smoke'), ('mapk3', 'Sodium Dodecyl Sulfate'), ('mapk3', 'Sodium Fluoride'), ('mapk3', 'Dihydrotestosterone'), ('mapk3', 'Stilbenes'), ('mapk3', 'Streptozocin'), ('mapk3', 'Sulindac'), ('mapk3', 'Superoxides'), ('mapk3', 'Suramin'), ('mapk3', 'Tamoxifen'), ('mapk3', 'Taurocholic Acid'), ('mapk3', 'Terbutaline'), ('mapk3', 'Testosterone'), ('mapk3', 'Tetrachlorodibenzodioxin'), ('mapk3', 'Tetracycline'), ('mapk3', 'Tetradecanoylphorbol Acetate'), ('mapk3', 'Dronabinol'), ('mapk3', 'Tetrodotoxin'), ('mapk3', 'Thalidomide'), ('mapk3', 'Thiamylal'), ('mapk3', 'Thimerosal'), ('mapk3', 'Thiosemicarbazones'), ('mapk3', 'Thiostrepton'), ('mapk3', 'Thyroxine'), ('mapk3', 'Timolol'), ('mapk3', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('mapk3', 'Tobacco Smoke Pollution'), ('mapk3', 'Toluene 2,4-Diisocyanate'), ('mapk3', 'Tretinoin'), ('mapk3', 'Trifluoperazine'), ('mapk3', 'Triterpenes'), ('mapk3', 'Tubocurarine'), ('mapk3', 'Tunicamycin'), ('mapk3', 'Uridine Diphosphate'), ('mapk3', 'Uridine Triphosphate'), ('mapk3', 'Ursodeoxycholic Acid'), ('mapk3', 'Valproic Acid'), ('mapk3', 'Vanadates'), ('mapk3', 'Vanadium'), ('mapk3', 'Vecuronium Bromide'), ('mapk3', 'Verapamil'), ('mapk3', 'Vitallium'), ('mapk3', 'Vitamin E'), ('mapk3', 'Vitamin U'), ('mapk3', 'Warfarin'), ('mapk3', 'Zeranol'), ('mapk3', 'Zinc'), ('mapk3', 'Zinc Oxide'), ('mapk3', 'Ziram'), ('mapk3', '1-Methyl-3-isobutylxanthine'), ('mapk3', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('mapk3', '8-Bromo Cyclic Adenosine Monophosphate'), ('mapk3', 'Dinoprostone'), ('mapk3', 'Phorbol 12,13-Dibutyrate'), ('mapk3', 'Thiorphan'), ('mapk3', 'Epirubicin'), ('mapk3', 'Nimustine'), ('mapk3', '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine'), ('mapk3', '1-Methyl-4-phenylpyridinium'), ('mapk3', 'Mifepristone'), ('mapk3', 'Famotidine'), ('mapk3', 'Nocodazole'), ('mapk3', 'Propofol'), ('mapk3', 'Ionomycin'), ('mapk3', 'N-Methylaspartate'), ('mapk3', 'Iloprost'), ('mapk3', 'Dizocilpine Maleate'), ('mapk3', 'Cyclosporine'), ('mapk3', 'Crack Cocaine'), ('mapk3', 'Aflatoxin B1'), ('mapk3', 'Oxidopamine'), ('mapk3', 'Fluorescein-5-isothiocyanate'), ('mapk3', 'Mitomycin'), ('mapk3', 'Paclitaxel'), ('mapk3', 'Acitretin'), ('mapk3', 'Xamoterol'), ('mapk3', 'Fenretinide'), ('mapk3', 'Reactive Oxygen Species'), ('mapk3', 'Asbestos, Serpentine'), ('mapk3', 'Asbestos, Amphibole'), ('mapk3', 'Asbestos, Crocidolite'), ('mapk3', 'Isothiocyanates'), ('mapk3', 'gamma-Linolenic Acid'), ('mapk3', 'Silver Compounds'), ('mapk3', 'Sodium Selenite'), ('mapk3', 'Excitatory Amino Acid Agonists'), ('mapk3', 'Excitatory Amino Acid Antagonists'), ('mapk3', 'Hexamethonium'), ('mapk3', 'beta Carotene'), ('mapk3', 'Cadmium Chloride'), ('mapk3', 'Quinpirole'), ('mapk3', 'Thapsigargin'), ('mapk3', 'Zinc Sulfate'), ('mapk3', 'Palmitic Acid'), ('mapk3', 'Staurosporine'), ('mapk3', 'Okadaic Acid'), ('mapk3', 'beta-Naphthoflavone'), ('mapk3', 'Copper Sulfate'), ('mapk3', 'Buthionine Sulfoximine'), ('mapk3', '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid'), ('mapk3', 'Linoleic Acid'), ('mapk3', '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid'), ('mapk3', 'Losartan'), ('mapk3', 'Simvastatin'), ('mapk3', 'Genistein'), ('mapk3', '1-Butanol'), ('mapk3', 'Acrylamide'), ('mapk3', 'tert-Butylhydroperoxide'), ('mapk3', 'Sirolimus'), ('mapk3', 'Butyric Acid'), ('mapk3', 'Sertraline'), ('mapk3', 'Oligoribonucleotides, Antisense'), ('mapk3', 'Selective Estrogen Receptor Modulators'), ('mapk3', 'Raloxifene Hydrochloride'), ('mapk3', 'Shiga Toxin'), ('mapk3', 'Shiga Toxin 2'), ('mapk3', 'Vitamin K 3'), ('mapk3', 'alpha-Tocopherol'), ('mapk3', 'Permethrin'), ('mapk3', 'Plant Preparations'), ('mapk3', 'Aristolochic Acids'), ('mapk3', 'Pertussis Toxin'), ('mapk3', 'Fullerenes'), ('mapk3', 'Nanotubes, Carbon'), ('mapk3', 'Tetrahydroisoquinolines'), ('mapk3', 'Flavonols'), ('mapk3', 'Flavanones'), ('mapk3', 'PQQ Cofactor'), ('mapk3', 'Apigenin'), ('mapk3', 'Luteolin'), ('mapk3', 'Hydrolyzable Tannins'), ('mapk3', 'Protein Kinase Inhibitors'), ('mapk3', 'Chitosan'), ('mapk3', 'Ferrosoferric Oxide'), ('mapk3', 'Particulate Matter'), ('mapk3', 'Diketopiperazines'), ('mapk3', 'Coordination Complexes'), ('mapk3', 'Iron Compounds'), ('mapk3', 'Polyphenols'), ('mapk3', 'Equol'), ('mapk3', 'Matrix Metalloproteinase Inhibitors'), ('mapk3', 'Organothiophosphates'), ('mapk3', 'Phytochemicals'), ('mapk3', 'Selenic Acid'), ('mapk3', 'Frankincense'), ('rela', 'Fluticasone'), ('rela', 'Salmeterol Xinafoate'), ('rela', 'Celecoxib'), ('rela', 'Imatinib Mesylate'), ('rela', 'Bortezomib'), ('rela', 'Erlotinib Hydrochloride'), ('rela', 'Dimethyl Fumarate'), ('rela', 'Mastic Resin'), ('rela', 'Antineoplastic Agents, Immunological'), ('rela', 'Irinotecan'), ('rela', 'Rosiglitazone'), ('rela', 'Gefitinib'), ('rela', 'Resveratrol'), ('rela', 'Temozolomide'), ('rela', 'Decitabine'), ('rela', 'Arsenic Trioxide'), ('rela', 'Moxifloxacin'), ('rela', 'Fulvestrant'), ('rela', 'Troglitazone'), ('rela', 'Bosentan'), ('rela', 'Telmisartan'), ('rela', 'Vorinostat'), ('rela', 'Fluvastatin'), ('rela', 'Lapatinib'), ('rela', 'Cilostazol'), ('rela', 'Aluminum Chloride'), ('rela', 'Tropisetron'), ('rela', 'Deferiprone'), ('rela', 'Eucalyptol'), ('rela', 'Afatinib'), ('rela', 'Panobinostat'), ('rela', 'Homoharringtonine'), ('rela', 'Acetaldehyde'), ('rela', 'Gemcitabine'), ('rela', 'Acetylcysteine'), ('rela', 'Acetylmuramyl-Alanyl-Isoglutamine'), ('rela', 'Acids'), ('rela', 'Acrolein'), ('rela', 'Adenosine'), ('rela', 'Adenosine Triphosphate'), ('rela', 'Aerosols'), ('rela', 'Air Pollutants'), ('rela', 'Ethanol'), ('rela', 'Allergens'), ('rela', 'Allopurinol'), ('rela', 'Alloxan'), ('rela', 'Amiloride'), ('rela', 'Amino Acids, Peptides, and Proteins'), ('rela', 'Aminolevulinic Acid'), ('rela', 'Anethole Trithione'), ('rela', 'Antigens, Viral'), ('rela', 'Antimycin A'), ('rela', 'Arsenic'), ('rela', 'Ascorbic Acid'), ('rela', 'Aspirin'), ('rela', 'Auranofin'), ('rela', 'Vehicle Emissions'), ('rela', 'Azacitidine'), ('rela', 'Bee Venoms'), ('rela', 'Benzene'), ('rela', 'Benzo(a)pyrene'), ('rela', 'Berberine'), ('rela', 'Bile Acids and Salts'), ('rela', 'Bilirubin'), ('rela', 'Dicumarol'), ('rela', 'Cacodylic Acid'), ('rela', 'Cadmium'), ('rela', 'Calcifediol'), ('rela', 'Calcitriol'), ('rela', 'Camptothecin'), ('rela', 'Cannabidiol'), ('rela', 'Capsaicin'), ('rela', 'Carbamazepine'), ('rela', 'Carbidopa'), ('rela', 'Carbon'), ('rela', 'Carbon Monoxide'), ('rela', 'Carmustine'), ('rela', 'Carrageenan'), ('rela', 'Catechin'), ('rela', 'Ceramides'), ('rela', 'Cetylpyridinium'), ('rela', 'Chelating Agents'), ('rela', 'Chloroform'), ('rela', 'Chloroquine'), ('rela', 'Cholesterol'), ('rela', 'Chondroitin Sulfates'), ('rela', 'Chromium'), ('rela', 'Cimetidine'), ('rela', 'Cisplatin'), ('rela', 'Clofibrate'), ('rela', 'Clonidine'), ('rela', 'Coal Tar'), ('rela', 'Copper'), ('rela', 'Coumarins'), ('rela', 'Curcumin'), ('rela', 'Cycloheximide'), ('rela', 'Cytarabine'), ('rela', 'Dactinomycin'), ('rela', 'Dapsone'), ('rela', 'Daunorubicin'), ('rela', 'Deoxycholic Acid'), ('rela', 'Dexamethasone'), ('rela', 'Diatrizoate'), ('rela', 'Diazepam'), ('rela', 'Diclofenac'), ('rela', 'Diethylhexyl Phthalate'), ('rela', 'Diethylstilbestrol'), ('rela', 'Diltiazem'), ('rela', 'Dinitrochlorobenzene'), ('rela', 'Diosgenin'), ('rela', 'Dithiothreitol'), ('rela', 'Docosahexaenoic Acids'), ('rela', 'Doxorubicin'), ('rela', 'Drugs, Chinese Herbal'), ('rela', 'Ellagic Acid'), ('rela', 'Enzyme Inhibitors'), ('rela', 'Estradiol'), ('rela', 'Estriol'), ('rela', 'Ethacrynic Acid'), ('rela', 'Amifostine'), ('rela', 'Etoposide'), ('rela', 'Eugenol'), ('rela', 'Fenbendazole'), ('rela', 'Fluorocarbons'), ('rela', 'Fluorouracil'), ('rela', 'Folic Acid'), ('rela', 'Formaldehyde'), ('rela', 'Fusaric Acid'), ('rela', 'Gadolinium'), ('rela', 'Galactosamine'), ('rela', 'Galactose'), ('rela', 'Gallic Acid'), ('rela', 'Gentamicins'), ('rela', 'Gliotoxin'), ('rela', 'Glucosamine'), ('rela', 'Glucose'), ('rela', 'Glutathione'), ('rela', 'Gold'), ('rela', 'Graphite'), ('rela', 'Harmaline'), ('rela', 'Heme'), ('rela', 'Heparin'), ('rela', 'Heterocyclic Compounds'), ('rela', 'Histamine'), ('rela', 'Homocysteine'), ('rela', 'Hyaluronic Acid'), ('rela', 'Hydralazine'), ('rela', 'Hydrocortisone'), ('rela', 'Hydrogen Peroxide'), ('rela', 'Hydroxychloroquine'), ('rela', 'Ibuprofen'), ('rela', 'Indomethacin'), ('rela', 'Iohexol'), ('rela', 'Iopamidol'), ('rela', 'Iron'), ('rela', 'Iron-Dextran Complex'), ('rela', 'Isoflavones'), ('rela', 'Ivermectin'), ('rela', 'Lead'), ('rela', 'Levamisole'), ('rela', 'Lipopolysaccharides'), ('rela', 'Cholesterol, HDL'), ('rela', 'Lithium'), ('rela', 'Lithocholic Acid'), ('rela', 'Malathion'), ('rela', 'Manganese'), ('rela', 'Melarsoprol'), ('rela', 'Melatonin'), ('rela', 'Melitten'), ('rela', 'Menthol'), ('rela', 'Mercaptoethanol'), ('rela', 'Mercuric Chloride'), ('rela', 'Mercury'), ('rela', 'Metformin'), ('rela', 'Methamphetamine'), ('rela', 'Methylmercury Compounds'), ('rela', 'Methylthiouracil'), ('rela', 'Mevalonic Acid'), ('rela', 'Morphine'), ('rela', 'Mustard Gas'), ('rela', 'Mycophenolic Acid'), ('rela', 'Naproxen'), ('rela', 'Neurotensin'), ('rela', 'Niacin'), ('rela', 'Nickel'), ('rela', 'Niclosamide'), ('rela', 'Niacinamide'), ('rela', 'Nicotine'), ('rela', 'Nitroprusside'), ('rela', 'Masoprocol'), ('rela', 'Norepinephrine'), ('rela', 'Oleanolic Acid'), ('rela', 'Oligomycins'), ('rela', 'Omeprazole'), ('rela', 'Oxygen'), ('rela', 'Oxypurinol'), ('rela', 'Ozone'), ('rela', 'Palmitates'), ('rela', 'Paraquat'), ('rela', 'Pentachlorophenol'), ('rela', 'Pentoxifylline'), ('rela', 'Peptides'), ('rela', 'Peptidoglycan'), ('rela', 'Pergolide'), ('rela', 'Phenobarbital'), ('rela', 'Phenylbutazone'), ('rela', 'Phenylbutyrates'), ('rela', 'Phenylthiourea'), ('rela', 'Phenytoin'), ('rela', 'Phosphorus'), ('rela', 'Plant Extracts'), ('rela', 'Poly I-C'), ('rela', 'Polyethyleneimine'), ('rela', 'Polyphosphates'), ('rela', 'Polysaccharides'), ('rela', 'Polystyrenes'), ('rela', 'Potassium Dichromate'), ('rela', 'Fenofibrate'), ('rela', 'Progesterone'), ('rela', 'Pyrones'), ('rela', 'Quercetin'), ('rela', 'Quinazolines'), ('rela', 'Rotenone'), ('rela', 'Rutin'), ('rela', 'Sulfasalazine'), ('rela', 'Selegiline'), ('rela', 'Selenium'), ('rela', 'Selenomethionine'), ('rela', 'Serotonin'), ('rela', 'Sesquiterpenes'), ('rela', 'Shikimic Acid'), ('rela', 'Silicon Dioxide'), ('rela', 'Smoke'), ('rela', 'Sodium Chloride'), ('rela', 'Sodium Fluoride'), ('rela', 'Sodium Salicylate'), ('rela', 'Streptozocin'), ('rela', 'Sulfates'), ('rela', 'Sulindac'), ('rela', 'T-2 Toxin'), ('rela', 'Tamoxifen'), ('rela', 'Taurocholic Acid'), ('rela', 'Tetrachlorodibenzodioxin'), ('rela', 'Tetradecanoylphorbol Acetate'), ('rela', 'Dronabinol'), ('rela', 'Thalidomide'), ('rela', 'Theophylline'), ('rela', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('rela', 'Tobacco Smoke Pollution'), ('rela', 'Tosyllysine Chloromethyl Ketone'), ('rela', 'Tosylphenylalanyl Chloromethyl Ketone'), ('rela', 'Tretinoin'), ('rela', 'Triclosan'), ('rela', 'Triterpenes'), ('rela', 'Tunicamycin'), ('rela', 'Valproic Acid'), ('rela', 'Viper Venoms'), ('rela', 'Vitamin E'), ('rela', 'Lutein'), ('rela', 'Zinc'), ('rela', 'Zinc Oxide'), ('rela', '1-Methyl-3-isobutylxanthine'), ('rela', '2-Acetylaminofluorene'), ('rela', 'Eicosapentaenoic Acid'), ('rela', 'Mercaptopurine'), ('rela', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('rela', 'Zidovudine'), ('rela', 'Dinoprostone'), ('rela', '1-Methyl-4-phenylpyridinium'), ('rela', 'Mifepristone'), ('rela', 'Metribolone'), ('rela', 'Carboplatin'), ('rela', 'Cyclosporine'), ('rela', 'Oxidopamine'), ('rela', 'Mitomycin'), ('rela', 'Paclitaxel'), ('rela', 'Medroxyprogesterone Acetate'), ('rela', 'Selenocysteine'), ('rela', 'Fenretinide'), ('rela', 'Gold Compounds'), ('rela', 'Asbestos, Serpentine'), ('rela', 'Asbestos, Crocidolite'), ('rela', 'Lithium Chloride'), ('rela', 'Sodium Selenite'), ('rela', 'Superantigens'), ('rela', 'Antirheumatic Agents'), ('rela', 'beta Carotene'), ('rela', 'Cadmium Chloride'), ('rela', 'Zinc Sulfate'), ('rela', 'Palmitic Acid'), ('rela', 'Staurosporine'), ('rela', 'Okadaic Acid'), ('rela', 'Buthionine Sulfoximine'), ('rela', '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid'), ('rela', 'Ritonavir'), ('rela', 'Glycyrrhizic Acid'), ('rela', 'Succinic Acid'), ('rela', 'Simvastatin'), ('rela', 'Genistein'), ('rela', '1-Butanol'), ('rela', 'Acrylamide'), ('rela', 'Sirolimus'), ('rela', 'Raloxifene Hydrochloride'), ('rela', 'Vitamin K 3'), ('rela', 'alpha-Tocopherol'), ('rela', 'S-Nitrosoglutathione'), ('rela', 'Peroxynitrous Acid'), ('rela', 'Nanotubes, Carbon'), ('rela', 'Apigenin'), ('rela', 'Luteolin'), ('rela', 'Protein Kinase Inhibitors'), ('rela', 'Particulate Matter'), ('rela', 'Soot'), ('rela', 'Diketopiperazines'), ('rela', 'Magnetite Nanoparticles'), ('rela', 'Polyphenols'), ('rela', 'Phytochemicals'), ('rela', 'Selenic Acid'), ('mapk8', 'Celecoxib'), ('mapk8', 'Tenofovir'), ('mapk8', 'Bortezomib'), ('mapk8', 'Febuxostat'), ('mapk8', 'Antineoplastic Agents, Immunological'), ('mapk8', 'Gefitinib'), ('mapk8', 'Sorafenib'), ('mapk8', 'Resveratrol'), ('mapk8', 'Wortmannin'), ('mapk8', 'Decitabine'), ('mapk8', 'Sunitinib'), ('mapk8', 'Zoledronic Acid'), ('mapk8', 'Arsenic Trioxide'), ('mapk8', 'Lycopene'), ('mapk8', 'Troglitazone'), ('mapk8', 'Vorinostat'), ('mapk8', 'Silybin'), ('mapk8', 'Edaravone'), ('mapk8', 'Eucalyptol'), ('mapk8', 'Acetaldehyde'), ('mapk8', 'Acetaminophen'), ('mapk8', 'Acetylcysteine'), ('mapk8', 'Acrolein'), ('mapk8', 'Adenosine Diphosphate'), ('mapk8', 'Aerosols'), ('mapk8', 'Air Pollutants'), ('mapk8', 'Ethanol'), ('mapk8', 'Amiodarone'), ('mapk8', 'Amodiaquine'), ('mapk8', 'Anisomycin'), ('mapk8', 'Anthraquinones'), ('mapk8', 'Arbutin'), ('mapk8', 'Arsenic'), ('mapk8', 'Arsenicals'), ('mapk8', 'Ascorbic Acid'), ('mapk8', 'Atrazine'), ('mapk8', 'Vehicle Emissions'), ('mapk8', 'Benzo(a)pyrene'), ('mapk8', 'Berberine'), ('mapk8', 'Dicumarol'), ('mapk8', 'Butylated Hydroxyanisole'), ('mapk8', 'Butyrates'), ('mapk8', 'Cadmium'), ('mapk8', 'Calcitriol'), ('mapk8', 'Camptothecin'), ('mapk8', 'Cannabidiol'), ('mapk8', 'Capsaicin'), ('mapk8', 'Carbamazepine'), ('mapk8', 'Chelating Agents'), ('mapk8', 'Chloroquine'), ('mapk8', 'Cisplatin'), ('mapk8', 'Citrinin'), ('mapk8', 'Coal'), ('mapk8', 'Colchicine'), ('mapk8', 'Copper'), ('mapk8', 'Curcumin'), ('mapk8', 'DDT'), ('mapk8', 'Deferoxamine'), ('mapk8', 'Desipramine'), ('mapk8', 'Dexamethasone'), ('mapk8', 'Diatrizoate'), ('mapk8', 'Diclofenac'), ('mapk8', 'Dietary Fats'), ('mapk8', 'Diethylhexyl Phthalate'), ('mapk8', 'Dinitrochlorobenzene'), ('mapk8', 'Dinitrofluorobenzene'), ('mapk8', 'Diphenhydramine'), ('mapk8', 'Dipyridamole'), ('mapk8', 'Disulfiram'), ('mapk8', 'Dithiothreitol'), ('mapk8', 'Doxorubicin'), ('mapk8', 'Drugs, Chinese Herbal'), ('mapk8', 'Egtazic Acid'), ('mapk8', 'Ellagic Acid'), ('mapk8', 'Estradiol'), ('mapk8', 'Ethacrynic Acid'), ('mapk8', 'Ficusin'), ('mapk8', 'Fish Oils'), ('mapk8', 'Gallic Acid'), ('mapk8', 'Glucosamine'), ('mapk8', 'Glucose'), ('mapk8', 'Glutathione'), ('mapk8', 'Cyclic GMP'), ('mapk8', 'Hesperidin'), ('mapk8', 'Homocysteine'), ('mapk8', 'Hydrogen Peroxide'), ('mapk8', 'Hypochlorous Acid'), ('mapk8', 'Clioquinol'), ('mapk8', 'Ivermectin'), ('mapk8', 'Ketoconazole'), ('mapk8', 'Lipopolysaccharides'), ('mapk8', 'Loperamide'), ('mapk8', 'Manganese'), ('mapk8', 'Mannitol'), ('mapk8', 'Mebendazole'), ('mapk8', 'Melatonin'), ('mapk8', 'Menthol'), ('mapk8', 'Mercaptoethanol'), ('mapk8', 'Metformin'), ('mapk8', 'Methionine'), ('mapk8', 'Methotrexate'), ('mapk8', 'Methylcholanthrene'), ('mapk8', 'Methylnitronitrosoguanidine'), ('mapk8', 'Minocycline'), ('mapk8', 'Mycophenolic Acid'), ('mapk8', 'N-Formylmethionine Leucyl-Phenylalanine'), ('mapk8', 'Nicotine'), ('mapk8', 'Nitrogen Oxides'), ('mapk8', 'Masoprocol'), ('mapk8', 'Oleanolic Acid'), ('mapk8', 'Oligosaccharides'), ('mapk8', 'Oxygen'), ('mapk8', 'Ozone'), ('mapk8', 'Paraquat'), ('mapk8', 'Pentoxifylline'), ('mapk8', 'Peptidoglycan'), ('mapk8', 'Phenobarbital'), ('mapk8', 'Phenylbutyrates'), ('mapk8', 'Eosine I Bluish'), ('mapk8', 'Pilocarpine'), ('mapk8', 'Plant Extracts'), ('mapk8', 'Polycyclic Aromatic Hydrocarbons'), ('mapk8', 'Polysaccharides'), ('mapk8', 'Prodigiosin'), ('mapk8', 'Pyruvaldehyde'), ('mapk8', 'Quercetin'), ('mapk8', 'Razoxane'), ('mapk8', 'Rifampin'), ('mapk8', 'Rotenone'), ('mapk8', 'Selenium'), ('mapk8', 'Selenomethionine'), ('mapk8', 'Silicon Dioxide'), ('mapk8', 'Silver'), ('mapk8', 'Smoke'), ('mapk8', 'Sorbitol'), ('mapk8', 'Spermine'), ('mapk8', 'Streptozocin'), ('mapk8', 'Sucrose'), ('mapk8', 'Sulindac'), ('mapk8', 'Tamoxifen'), ('mapk8', 'Tetrachlorodibenzodioxin'), ('mapk8', 'Tetradecanoylphorbol Acetate'), ('mapk8', 'Thimerosal'), ('mapk8', 'Tobacco Smoke Pollution'), ('mapk8', 'Toluene 2,4-Diisocyanate'), ('mapk8', 'Trifluoperazine'), ('mapk8', 'Urethane'), ('mapk8', 'Valproic Acid'), ('mapk8', 'Vanillic Acid'), ('mapk8', 'Vinblastine'), ('mapk8', 'Vitallium'), ('mapk8', 'Vitamin E'), ('mapk8', 'Zinc'), ('mapk8', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('mapk8', 'Zidovudine'), ('mapk8', '1-Methyl-4-phenylpyridinium'), ('mapk8', 'Mifepristone'), ('mapk8', 'Nocodazole'), ('mapk8', 'Ionomycin'), ('mapk8', 'Cyclosporine'), ('mapk8', 'Oxidopamine'), ('mapk8', 'Bupropion'), ('mapk8', 'Fluorescein-5-isothiocyanate'), ('mapk8', 'Mitomycin'), ('mapk8', 'Arachidonic Acid'), ('mapk8', 'Paclitaxel'), ('mapk8', 'Fenretinide'), ('mapk8', 'Reactive Oxygen Species'), ('mapk8', 'Asbestos, Serpentine'), ('mapk8', 'Asbestos, Crocidolite'), ('mapk8', 'Sodium Selenite'), ('mapk8', 'Stavudine'), ('mapk8', 'Cadmium Chloride'), ('mapk8', 'Zinc Sulfate'), ('mapk8', 'Palmitic Acid'), ('mapk8', 'Okadaic Acid'), ('mapk8', 'Buthionine Sulfoximine'), ('mapk8', 'tert-Butylhydroperoxide'), ('mapk8', 'Sirolimus'), ('mapk8', 'Butyric Acid'), ('mapk8', 'Vitamin K 3'), ('mapk8', 'alpha-Tocopherol'), ('mapk8', 'Pertussis Toxin'), ('mapk8', 'Fullerenes'), ('mapk8', 'Nanotubes, Carbon'), ('mapk8', 'Luteolin'), ('mapk8', 'Hydrolyzable Tannins'), ('mapk8', 'Protein Kinase Inhibitors'), ('mapk8', 'Ferrosoferric Oxide'), ('mapk8', 'Particulate Matter'), ('mapk8', 'Polyphenols'), ('mapk8', 'Frankincense'), ('mapk1', 'Risedronic Acid'), ('mapk1', 'Salmeterol Xinafoate'), ('mapk1', 'Celecoxib'), ('mapk1', 'Varenicline'), ('mapk1', 'Formoterol Fumarate'), ('mapk1', 'Fingolimod Hydrochloride'), ('mapk1', 'Imatinib Mesylate'), ('mapk1', 'Atorvastatin'), ('mapk1', 'Bortezomib'), ('mapk1', 'Erlotinib Hydrochloride'), ('mapk1', 'Dasatinib'), ('mapk1', 'Acebutolol'), ('mapk1', 'Peanut Oil'), ('mapk1', 'Docetaxel'), ('mapk1', 'Irinotecan'), ('mapk1', 'Sevoflurane'), ('mapk1', 'Oxaliplatin'), ('mapk1', 'Rosiglitazone'), ('mapk1', 'Gefitinib'), ('mapk1', 'Sorafenib'), ('mapk1', 'Resveratrol'), ('mapk1', 'Wortmannin'), ('mapk1', 'Temozolomide'), ('mapk1', 'Pioglitazone'), ('mapk1', 'Decitabine'), ('mapk1', 'Sunitinib'), ('mapk1', 'Zoledronic Acid'), ('mapk1', 'Arsenic Trioxide'), ('mapk1', 'Meloxicam'), ('mapk1', 'Carvedilol'), ('mapk1', 'Moxifloxacin'), ('mapk1', 'Fulvestrant'), ('mapk1', 'Pamidronate'), ('mapk1', 'Imiquimod'), ('mapk1', 'Rimonabant'), ('mapk1', 'Troglitazone'), ('mapk1', 'Terbinafine'), ('mapk1', 'Telmisartan'), ('mapk1', 'Vorinostat'), ('mapk1', 'Leflunomide'), ('mapk1', 'Lapatinib'), ('mapk1', 'Orlistat'), ('mapk1', 'Vemurafenib'), ('mapk1', 'Deferiprone'), ('mapk1', 'Eplerenone'), ('mapk1', 'Crizotinib'), ('mapk1', 'Panobinostat'), ('mapk1', 'Ciclopirox'), ('mapk1', 'Axitinib'), ('mapk1', 'Homoharringtonine'), ('mapk1', 'Acetaldehyde'), ('mapk1', 'Ado-Trastuzumab Emtansine'), ('mapk1', 'Acetaminophen'), ('mapk1', 'Gemcitabine'), ('mapk1', 'Betulinic Acid'), ('mapk1', 'Acetylcysteine'), ('mapk1', 'Acids'), ('mapk1', 'Acrolein'), ('mapk1', 'Acrylonitrile'), ('mapk1', 'Adenosine'), ('mapk1', 'Adenosine Diphosphate'), ('mapk1', 'Adenosine Triphosphate'), ('mapk1', 'Air Pollutants'), ('mapk1', 'Albuterol'), ('mapk1', 'Ethanol'), ('mapk1', 'Alcohols'), ('mapk1', 'Aldosterone'), ('mapk1', 'Allergens'), ('mapk1', 'Allopurinol'), ('mapk1', 'Alprenolol'), ('mapk1', 'Amiloride'), ('mapk1', 'Amiodarone'), ('mapk1', 'Amodiaquine'), ('mapk1', 'Anisomycin'), ('mapk1', 'Anthraquinones'), ('mapk1', 'Antifungal Agents'), ('mapk1', 'Antimony Potassium Tartrate'), ('mapk1', 'Antineoplastic Agents'), ('mapk1', 'Arachidonic Acids'), ('mapk1', 'Arecoline'), ('mapk1', 'Arsenic'), ('mapk1', 'Asbestos'), ('mapk1', 'Ascorbic Acid'), ('mapk1', 'Aspartame'), ('mapk1', 'Aspirin'), ('mapk1', 'Atenolol'), ('mapk1', 'Atrazine'), ('mapk1', 'Vehicle Emissions'), ('mapk1', 'Azathioprine'), ('mapk1', 'Bee Venoms'), ('mapk1', 'Benzene'), ('mapk1', 'Hexachlorocyclohexane'), ('mapk1', 'Benzo(a)pyrene'), ('mapk1', 'Benzofurans'), ('mapk1', 'beta-Endorphin'), ('mapk1', 'Bilirubin'), ('mapk1', 'Dicumarol'), ('mapk1', 'Bupivacaine'), ('mapk1', 'Buprenorphine'), ('mapk1', 'Busulfan'), ('mapk1', 'Butylated Hydroxyanisole'), ('mapk1', 'Butyrates'), ('mapk1', 'Cacodylic Acid'), ('mapk1', 'Cadmium'), ('mapk1', 'Caffeine'), ('mapk1', 'Calcifediol'), ('mapk1', 'Calcitriol'), ('mapk1', 'Calcium'), ('mapk1', 'Camptothecin'), ('mapk1', 'Cannabidiol'), ('mapk1', 'Cantharidin'), ('mapk1', 'Capsaicin'), ('mapk1', 'Carbachol'), ('mapk1', 'Carbamazepine'), ('mapk1', 'Catechin'), ('mapk1', 'Estrogens, Catechol'), ('mapk1', 'Chelating Agents'), ('mapk1', 'Chlordan'), ('mapk1', 'Chlorogenic Acid'), ('mapk1', 'Chloroquine'), ('mapk1', 'Chlorpromazine'), ('mapk1', 'Ciprofloxacin'), ('mapk1', 'Cisplatin'), ('mapk1', 'Citrinin'), ('mapk1', 'Coal'), ('mapk1', 'Cocaine'), ('mapk1', 'Contrast Media'), ('mapk1', 'Copper'), ('mapk1', 'Cotinine'), ('mapk1', 'Curcumin'), ('mapk1', 'Cycloheximide'), ('mapk1', 'Cytochalasin B'), ('mapk1', 'Dacarbazine'), ('mapk1', 'Dactinomycin'), ('mapk1', 'Dapsone'), ('mapk1', 'Daunorubicin'), ('mapk1', 'Dichlorodiphenyl Dichloroethylene'), ('mapk1', 'DDT'), ('mapk1', 'Deferoxamine'), ('mapk1', 'Deoxycholic Acid'), ('mapk1', 'Deoxyglucose'), ('mapk1', 'Desipramine'), ('mapk1', 'Dexamethasone'), ('mapk1', 'Diacetyl'), ('mapk1', 'Diatrizoate'), ('mapk1', 'Diazinon'), ('mapk1', 'Dibutyl Phthalate'), ('mapk1', 'Bucladesine'), ('mapk1', 'Diclofenac'), ('mapk1', 'Dieldrin'), ('mapk1', 'Diethylhexyl Phthalate'), ('mapk1', 'Digitoxin'), ('mapk1', 'Dihydroxyacetone'), ('mapk1', 'Dimethoate'), ('mapk1', 'Dimethylformamide'), ('mapk1', 'Dinitrochlorobenzene'), ('mapk1', 'Dinitrofluorobenzene'), ('mapk1', 'Diphtheria Toxin'), ('mapk1', 'Cromolyn Sodium'), ('mapk1', 'Disulfiram'), ('mapk1', 'Dithiothreitol'), ('mapk1', 'Dobutamine'), ('mapk1', 'Docosahexaenoic Acids'), ('mapk1', 'Dopamine'), ('mapk1', 'Doxorubicin'), ('mapk1', 'Drugs, Chinese Herbal'), ('mapk1', 'Chlorpyrifos'), ('mapk1', 'Dust'), ('mapk1', 'Egtazic Acid'), ('mapk1', 'Emetine'), ('mapk1', 'Emodin'), ('mapk1', 'Endosulfan'), ('mapk1', 'Enzyme Inhibitors'), ('mapk1', 'Epinephrine'), ('mapk1', 'Estradiol'), ('mapk1', 'Estrone'), ('mapk1', 'Ethinyl Estradiol'), ('mapk1', 'Ethyl Methanesulfonate'), ('mapk1', 'Ethylmaleimide'), ('mapk1', 'Etoposide'), ('mapk1', 'Fenoterol'), ('mapk1', 'Fentanyl'), ('mapk1', 'Fish Oils'), ('mapk1', 'Fluorouracil'), ('mapk1', 'Fluoxetine'), ('mapk1', 'Flurbiprofen'), ('mapk1', 'Folic Acid'), ('mapk1', 'Formaldehyde'), ('mapk1', 'Colforsin'), ('mapk1', 'Furazolidone'), ('mapk1', 'Gallic Acid'), ('mapk1', 'Gentamicins'), ('mapk1', 'Glucosamine'), ('mapk1', 'Glucose'), ('mapk1', 'Glutathione'), ('mapk1', 'Glycochenodeoxycholic Acid'), ('mapk1', 'Gossypol'), ('mapk1', 'Guanosine'), ('mapk1', 'Hemin'), ('mapk1', 'Heparin'), ('mapk1', 'Heptachlor'), ('mapk1', 'Hexachlorobenzene'), ('mapk1', 'Hexanones'), ('mapk1', 'Histamine'), ('mapk1', 'Homocysteine'), ('mapk1', 'Humic Substances'), ('mapk1', 'Hyaluronic Acid'), ('mapk1', 'Hydrocarbons, Chlorinated'), ('mapk1', 'Hydrogen Peroxide'), ('mapk1', 'Hydrogen Sulfide'), ('mapk1', 'Hypochlorous Acid'), ('mapk1', 'Ibuprofen'), ('mapk1', 'Indomethacin'), ('mapk1', 'Indoprofen'), ('mapk1', 'Clioquinol'), ('mapk1', 'Iohexol'), ('mapk1', 'Iron'), ('mapk1', 'Iron-Dextran Complex'), ('mapk1', 'Isoniazid'), ('mapk1', 'Isoproterenol'), ('mapk1', 'Ivermectin'), ('mapk1', 'Ketanserin'), ('mapk1', 'Labetalol'), ('mapk1', 'Lead'), ('mapk1', 'Levodopa'), ('mapk1', 'Lipopolysaccharides'), ('mapk1', 'Cholesterol, HDL'), ('mapk1', 'Cholesterol, LDL'), ('mapk1', 'Lithium'), ('mapk1', 'Lithocholic Acid'), ('mapk1', 'Lobeline'), ('mapk1', 'Loperamide'), ('mapk1', 'Lovastatin'), ('mapk1', 'Maneb'), ('mapk1', 'Manganese'), ('mapk1', 'Mannitol'), ('mapk1', 'Mebendazole'), ('mapk1', 'Mechlorethamine'), ('mapk1', 'Melatonin'), ('mapk1', 'Melitten'), ('mapk1', 'Melphalan'), ('mapk1', 'Mercuric Chloride'), ('mapk1', 'Metformin'), ('mapk1', 'Methadone'), ('mapk1', 'Methamphetamine'), ('mapk1', 'Methimazole'), ('mapk1', 'Methohexital'), ('mapk1', 'Methotrexate'), ('mapk1', 'Methoxychlor'), ('mapk1', 'Methyl Methanesulfonate'), ('mapk1', 'Methylmercury Compounds'), ('mapk1', 'Methylnitronitrosoguanidine'), ('mapk1', 'Methylthiouracil'), ('mapk1', 'Mevalonic Acid'), ('mapk1', 'Morphine'), ('mapk1', 'Mycophenolic Acid'), ('mapk1', 'N-Formylmethionine Leucyl-Phenylalanine'), ('mapk1', 'Naloxone'), ('mapk1', 'Neomycin'), ('mapk1', 'Niacin'), ('mapk1', 'Nickel'), ('mapk1', 'Niclosamide'), ('mapk1', 'Nicotine'), ('mapk1', 'Nicotinic Acids'), ('mapk1', 'Nifedipine'), ('mapk1', 'Nitrogen'), ('mapk1', 'Nitroprusside'), ('mapk1', 'Nitrosourea Compounds'), ('mapk1', 'Masoprocol'), ('mapk1', 'Norepinephrine'), ('mapk1', 'Oleanolic Acid'), ('mapk1', 'Oligopeptides'), ('mapk1', 'Ouabain'), ('mapk1', 'Oxprenolol'), ('mapk1', 'Oxygen'), ('mapk1', 'Ozone'), ('mapk1', 'Paraquat'), ('mapk1', 'Patulin'), ('mapk1', 'Pentachlorophenol'), ('mapk1', 'Pentobarbital'), ('mapk1', 'Pentoxifylline'), ('mapk1', 'Peptidoglycan'), ('mapk1', 'Phenanthrolines'), ('mapk1', 'Phenobarbital'), ('mapk1', 'Phenols'), ('mapk1', 'Phentolamine'), ('mapk1', 'Phenylephrine'), ('mapk1', 'Phenytoin'), ('mapk1', 'Phosphates'), ('mapk1', 'Phosphatidylinositols'), ('mapk1', 'Phytic Acid'), ('mapk1', 'Vitamin K 1'), ('mapk1', 'Pindolol'), ('mapk1', 'Plant Extracts'), ('mapk1', 'Platinum'), ('mapk1', 'Polycyclic Aromatic Hydrocarbons'), ('mapk1', 'Polymyxin B'), ('mapk1', 'Polyphosphates'), ('mapk1', 'Polyribonucleotides'), ('mapk1', 'Polysaccharides'), ('mapk1', 'Potassium Dichromate'), ('mapk1', 'Practolol'), ('mapk1', 'Procaine'), ('mapk1', 'Prodigiosin'), ('mapk1', 'Progesterone'), ('mapk1', 'Promegestone'), ('mapk1', 'Propolis'), ('mapk1', 'Propranolol'), ('mapk1', 'Epoprostenol'), ('mapk1', 'Pyocyanine'), ('mapk1', 'Pyridazines'), ('mapk1', 'Pyrilamine'), ('mapk1', 'Pyruvaldehyde'), ('mapk1', 'Quercetin'), ('mapk1', 'Quinacrine'), ('mapk1', 'Quinazolines'), ('mapk1', 'Ranitidine'), ('mapk1', 'Retinoids'), ('mapk1', 'Rotenone'), ('mapk1', 'Ruthenium Red'), ('mapk1', 'Rutin'), ('mapk1', 'S-Adenosylmethionine'), ('mapk1', 'Saponins'), ('mapk1', 'Secobarbital'), ('mapk1', 'Selegiline'), ('mapk1', 'Selenomethionine'), ('mapk1', 'Serotonin'), ('mapk1', 'Silicon Dioxide'), ('mapk1', 'Silver'), ('mapk1', 'Silver Nitrate'), ('mapk1', 'Simazine'), ('mapk1', 'Sodium Dodecyl Sulfate'), ('mapk1', 'Sodium Fluoride'), ('mapk1', 'Dihydrotestosterone'), ('mapk1', 'Stilbenes'), ('mapk1', 'Streptozocin'), ('mapk1', 'Sulindac'), ('mapk1', 'Superoxides'), ('mapk1', 'Suramin'), ('mapk1', 'Tamoxifen'), ('mapk1', 'Taurocholic Acid'), ('mapk1', 'Terbutaline'), ('mapk1', 'Testosterone'), ('mapk1', 'Tetrachlorodibenzodioxin'), ('mapk1', 'Tetracycline'), ('mapk1', 'Tetradecanoylphorbol Acetate'), ('mapk1', 'Dronabinol'), ('mapk1', 'Tetrodotoxin'), ('mapk1', 'Thalidomide'), ('mapk1', 'Thiamylal'), ('mapk1', 'Thimerosal'), ('mapk1', 'Thiosemicarbazones'), ('mapk1', 'Thiostrepton'), ('mapk1', 'Thyroxine'), ('mapk1', 'Timolol'), ('mapk1', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('mapk1', 'Tobacco Smoke Pollution'), ('mapk1', 'Toluene 2,4-Diisocyanate'), ('mapk1', 'Tretinoin'), ('mapk1', 'Trifluoperazine'), ('mapk1', 'Triterpenes'), ('mapk1', 'Tubocurarine'), ('mapk1', 'Tunicamycin'), ('mapk1', 'Uridine Diphosphate'), ('mapk1', 'Uridine Triphosphate'), ('mapk1', 'Ursodeoxycholic Acid'), ('mapk1', 'Valproic Acid'), ('mapk1', 'Vanadates'), ('mapk1', 'Vanadium'), ('mapk1', 'Vecuronium Bromide'), ('mapk1', 'Verapamil'), ('mapk1', 'Vitamin B 12'), ('mapk1', 'Vitamin E'), ('mapk1', 'Vitamin U'), ('mapk1', 'Warfarin'), ('mapk1', 'Zeranol'), ('mapk1', 'Zinc'), ('mapk1', 'Zinc Oxide'), ('mapk1', 'Ziram'), ('mapk1', '1-Methyl-3-isobutylxanthine'), ('mapk1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('mapk1', '8-Bromo Cyclic Adenosine Monophosphate'), ('mapk1', 'Dinoprostone'), ('mapk1', 'Phorbol 12,13-Dibutyrate'), ('mapk1', 'Thiorphan'), ('mapk1', 'Epirubicin'), ('mapk1', 'Nimustine'), ('mapk1', '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine'), ('mapk1', '1-Methyl-4-phenylpyridinium'), ('mapk1', 'Mifepristone'), ('mapk1', 'Famotidine'), ('mapk1', 'Nocodazole'), ('mapk1', 'Propofol'), ('mapk1', 'Ionomycin'), ('mapk1', 'N-Methylaspartate'), ('mapk1', 'Iloprost'), ('mapk1', 'Dizocilpine Maleate'), ('mapk1', 'Cyclosporine'), ('mapk1', 'Aflatoxin B1'), ('mapk1', 'Oxidopamine'), ('mapk1', 'Fluorescein-5-isothiocyanate'), ('mapk1', 'Mitomycin'), ('mapk1', 'Paclitaxel'), ('mapk1', 'Acitretin'), ('mapk1', 'Xamoterol'), ('mapk1', 'Fenretinide'), ('mapk1', 'Reactive Oxygen Species'), ('mapk1', 'Asbestos, Serpentine'), ('mapk1', 'Asbestos, Amphibole'), ('mapk1', 'Asbestos, Crocidolite'), ('mapk1', 'Isothiocyanates'), ('mapk1', 'Silver Compounds'), ('mapk1', 'Sodium Selenite'), ('mapk1', 'Antirheumatic Agents'), ('mapk1', 'Excitatory Amino Acid Agonists'), ('mapk1', 'Excitatory Amino Acid Antagonists'), ('mapk1', 'Hexamethonium'), ('mapk1', 'beta Carotene'), ('mapk1', 'Cadmium Chloride'), ('mapk1', 'Quinpirole'), ('mapk1', 'Thapsigargin'), ('mapk1', 'Zinc Sulfate'), ('mapk1', 'Palmitic Acid'), ('mapk1', 'Staurosporine'), ('mapk1', 'Okadaic Acid'), ('mapk1', 'beta-Naphthoflavone'), ('mapk1', 'Copper Sulfate'), ('mapk1', 'Buthionine Sulfoximine'), ('mapk1', '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid'), ('mapk1', '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid'), ('mapk1', 'Losartan'), ('mapk1', 'Simvastatin'), ('mapk1', 'Genistein'), ('mapk1', '2-Propanol'), ('mapk1', '1-Butanol'), ('mapk1', 'tert-Butylhydroperoxide'), ('mapk1', 'Sirolimus'), ('mapk1', 'Butyric Acid'), ('mapk1', 'Sertraline'), ('mapk1', 'Oligoribonucleotides, Antisense'), ('mapk1', 'Selective Estrogen Receptor Modulators'), ('mapk1', 'Raloxifene Hydrochloride'), ('mapk1', 'Shiga Toxin'), ('mapk1', 'Shiga Toxin 2'), ('mapk1', 'Vitamin K 3'), ('mapk1', 'alpha-Tocopherol'), ('mapk1', 'Permethrin'), ('mapk1', 'Plant Preparations'), ('mapk1', 'Aristolochic Acids'), ('mapk1', 'Pertussis Toxin'), ('mapk1', 'Fullerenes'), ('mapk1', 'Nanotubes, Carbon'), ('mapk1', 'Tetrahydroisoquinolines'), ('mapk1', 'Flavonols'), ('mapk1', 'Flavanones'), ('mapk1', 'PQQ Cofactor'), ('mapk1', 'Apigenin'), ('mapk1', 'Luteolin'), ('mapk1', 'Hydrolyzable Tannins'), ('mapk1', 'Protein Kinase Inhibitors'), ('mapk1', 'Chitosan'), ('mapk1', 'Ferrosoferric Oxide'), ('mapk1', 'Particulate Matter'), ('mapk1', 'Diketopiperazines'), ('mapk1', 'Coordination Complexes'), ('mapk1', 'Iron Compounds'), ('mapk1', 'Polyphenols'), ('mapk1', 'Equol'), ('mapk1', 'Matrix Metalloproteinase Inhibitors'), ('mapk1', 'Organothiophosphates'), ('mapk1', 'Phytochemicals'), ('mapk1', 'Selenic Acid'), ('mapk1', 'Frankincense'), ('sp1', 'Irinotecan'), ('sp1', 'Oxaliplatin'), ('sp1', 'Rosiglitazone'), ('sp1', 'Resveratrol'), ('sp1', 'Wortmannin'), ('sp1', 'Temozolomide'), ('sp1', 'Decitabine'), ('sp1', 'Zoledronic Acid'), ('sp1', 'Arsenic Trioxide'), ('sp1', 'Fulvestrant'), ('sp1', 'Troglitazone'), ('sp1', 'Artesunate'), ('sp1', 'Vorinostat'), ('sp1', 'Roscovitine'), ('sp1', 'Clofarabine'), ('sp1', 'Acetaldehyde'), ('sp1', 'Acetylcysteine'), ('sp1', 'Air Pollutants'), ('sp1', 'Ethanol'), ('sp1', 'Allethrins'), ('sp1', 'Asbestos'), ('sp1', 'Ascorbic Acid'), ('sp1', 'Azacitidine'), ('sp1', 'Benzene'), ('sp1', 'Benzo(a)pyrene'), ('sp1', 'Cadmium'), ('sp1', 'Caffeine'), ('sp1', 'Camptothecin'), ('sp1', 'Capsaicin'), ('sp1', 'Catechin'), ('sp1', 'Chloroquine'), ('sp1', 'Cisplatin'), ('sp1', 'Copper'), ('sp1', 'Curcumin'), ('sp1', 'Daunorubicin'), ('sp1', 'Deferoxamine'), ('sp1', 'Demecolcine'), ('sp1', 'Diazinon'), ('sp1', 'Dibutyl Phthalate'), ('sp1', 'Dieldrin'), ('sp1', 'Dimethyl Sulfoxide'), ('sp1', 'Doxorubicin'), ('sp1', 'Chlorpyrifos'), ('sp1', 'Enzyme Inhibitors'), ('sp1', 'Estradiol'), ('sp1', 'Ethinyl Estradiol'), ('sp1', 'Ethylmaleimide'), ('sp1', 'Etoposide'), ('sp1', 'Fluorouracil'), ('sp1', 'Folic Acid'), ('sp1', 'Gasoline'), ('sp1', 'Glucose'), ('sp1', 'Glutathione'), ('sp1', 'Hydrogen Peroxide'), ('sp1', 'Iodoacetamide'), ('sp1', 'Iron'), ('sp1', 'Lead'), ('sp1', 'Lipopolysaccharides'), ('sp1', 'Metformin'), ('sp1', 'Plicamycin'), ('sp1', 'Nickel'), ('sp1', 'Nicotine'), ('sp1', 'Oxygen'), ('sp1', 'Ozone'), ('sp1', 'Penicillamine'), ('sp1', 'Plant Extracts'), ('sp1', 'Polycyclic Aromatic Hydrocarbons'), ('sp1', 'Promegestone'), ('sp1', 'Quercetin'), ('sp1', 'Quinacrine'), ('sp1', 'S-Adenosylmethionine'), ('sp1', 'Selenium'), ('sp1', 'Silicon Dioxide'), ('sp1', 'Silver'), ('sp1', 'Silver Nitrate'), ('sp1', 'T-2 Toxin'), ('sp1', 'Tamoxifen'), ('sp1', 'Tetrachlorodibenzodioxin'), ('sp1', 'Tetradecanoylphorbol Acetate'), ('sp1', 'Thalidomide'), ('sp1', 'Tobacco Smoke Pollution'), ('sp1', 'Tretinoin'), ('sp1', 'Urethane'), ('sp1', 'Valproic Acid'), ('sp1', 'Vincristine'), ('sp1', 'Water Pollutants'), ('sp1', 'Zinc'), ('sp1', '9,10-Dimethyl-1,2-benzanthracene'), ('sp1', 'Nimustine'), ('sp1', '1-Methyl-4-phenylpyridinium'), ('sp1', 'Cyclosporine'), ('sp1', 'Asbestos, Crocidolite'), ('sp1', 'Sodium Selenite'), ('sp1', 'Antirheumatic Agents'), ('sp1', 'Cadmium Chloride'), ('sp1', 'Zinc Sulfate'), ('sp1', 'Copper Sulfate'), ('sp1', 'Buthionine Sulfoximine'), ('sp1', 'Zinc Acetate'), ('sp1', 'Simvastatin'), ('sp1', 'Genistein'), ('sp1', '1-Butanol'), ('sp1', 'S-Nitrosoglutathione'), ('sp1', 'Protein Kinase Inhibitors'), ('sp1', 'Particulate Matter'), ('cdkn1a', 'Aripiprazole'), ('cdkn1a', 'Pemetrexed'), ('cdkn1a', 'Celecoxib'), ('cdkn1a', 'Emtricitabine'), ('cdkn1a', 'Tenofovir'), ('cdkn1a', 'Atorvastatin'), ('cdkn1a', 'Bortezomib'), ('cdkn1a', 'Erlotinib Hydrochloride'), ('cdkn1a', 'Dasatinib'), ('cdkn1a', 'Dibenzofurans, Polychlorinated'), ('cdkn1a', 'Docetaxel'), ('cdkn1a', 'Irinotecan'), ('cdkn1a', 'Oxaliplatin'), ('cdkn1a', 'Rosiglitazone'), ('cdkn1a', 'Gefitinib'), ('cdkn1a', 'Resveratrol'), ('cdkn1a', 'Wortmannin'), ('cdkn1a', 'Temozolomide'), ('cdkn1a', 'Pioglitazone'), ('cdkn1a', 'Decitabine'), ('cdkn1a', 'Sunitinib'), ('cdkn1a', 'Zoledronic Acid'), ('cdkn1a', 'Arsenic Trioxide'), ('cdkn1a', 'Fulvestrant'), ('cdkn1a', 'Lycopene'), ('cdkn1a', 'Troglitazone'), ('cdkn1a', 'Letrozole'), ('cdkn1a', 'Vorinostat'), ('cdkn1a', 'Leflunomide'), ('cdkn1a', 'Lapatinib'), ('cdkn1a', 'Silybin'), ('cdkn1a', 'Orlistat'), ('cdkn1a', 'Cidofovir'), ('cdkn1a', 'Irbesartan'), ('cdkn1a', 'Cilostazol'), ('cdkn1a', 'Roscovitine'), ('cdkn1a', 'Alitretinoin'), ('cdkn1a', 'Aprepitant'), ('cdkn1a', 'O-(Chloroacetylcarbamoyl)fumagillol'), ('cdkn1a', 'Bexarotene'), ('cdkn1a', 'Tirapazamine'), ('cdkn1a', 'Panobinostat'), ('cdkn1a', 'Clofarabine'), ('cdkn1a', '5-Methoxypsoralen'), ('cdkn1a', 'Acetaldehyde'), ('cdkn1a', 'Acetaminophen'), ('cdkn1a', 'Gemcitabine'), ('cdkn1a', 'Betulinic Acid'), ('cdkn1a', 'Acetylcysteine'), ('cdkn1a', 'Acrolein'), ('cdkn1a', 'Acrylonitrile'), ('cdkn1a', 'Adenine'), ('cdkn1a', 'Aerosols'), ('cdkn1a', 'Air Pollutants'), ('cdkn1a', 'Ethanol'), ('cdkn1a', 'Allergens'), ('cdkn1a', 'Aluminum Oxide'), ('cdkn1a', 'Aminooxyacetic Acid'), ('cdkn1a', 'Amodiaquine'), ('cdkn1a', 'Aniline Compounds'), ('cdkn1a', 'Anthocyanins'), ('cdkn1a', 'Antimony'), ('cdkn1a', 'Antimony Potassium Tartrate'), ('cdkn1a', 'Arsenic'), ('cdkn1a', 'Asbestos'), ('cdkn1a', 'Ascorbic Acid'), ('cdkn1a', 'Aspartame'), ('cdkn1a', 'Aspirin'), ('cdkn1a', 'Atrazine'), ('cdkn1a', 'Auranofin'), ('cdkn1a', 'Vehicle Emissions'), ('cdkn1a', 'Azacitidine'), ('cdkn1a', 'Azathioprine'), ('cdkn1a', 'Benzene'), ('cdkn1a', 'Hexachlorocyclohexane'), ('cdkn1a', 'Benzo(a)pyrene'), ('cdkn1a', 'Berberine'), ('cdkn1a', 'Biological Products'), ('cdkn1a', 'Dicumarol'), ('cdkn1a', 'Busulfan'), ('cdkn1a', 'Butylated Hydroxyanisole'), ('cdkn1a', 'Butyrates'), ('cdkn1a', 'Cacodylic Acid'), ('cdkn1a', 'Cadmium'), ('cdkn1a', 'Caffeine'), ('cdkn1a', 'Calcifediol'), ('cdkn1a', 'Calcitriol'), ('cdkn1a', 'Camptothecin'), ('cdkn1a', 'Cannabidiol'), ('cdkn1a', 'Capsaicin'), ('cdkn1a', 'Carbamazepine'), ('cdkn1a', 'Carbocysteine'), ('cdkn1a', 'Carmustine'), ('cdkn1a', 'Ceramides'), ('cdkn1a', 'Chelating Agents'), ('cdkn1a', 'Chlorambucil'), ('cdkn1a', 'Chloramphenicol'), ('cdkn1a', 'Chloroquine'), ('cdkn1a', 'Cholecalciferol'), ('cdkn1a', 'Chromium'), ('cdkn1a', 'Ciprofloxacin'), ('cdkn1a', 'Cisplatin'), ('cdkn1a', 'Citrinin'), ('cdkn1a', 'Leucovorin'), ('cdkn1a', 'Clotrimazole'), ('cdkn1a', 'Cobalt'), ('cdkn1a', 'Colchicine'), ('cdkn1a', 'Copper'), ('cdkn1a', 'Coumestrol'), ('cdkn1a', 'Curcumin'), ('cdkn1a', 'Cycloheximide'), ('cdkn1a', 'Cyclophosphamide'), ('cdkn1a', 'Cytarabine'), ('cdkn1a', 'Cytochalasin B'), ('cdkn1a', 'Dactinomycin'), ('cdkn1a', 'Danazol'), ('cdkn1a', 'Daunorubicin'), ('cdkn1a', 'DDT'), ('cdkn1a', 'Deferoxamine'), ('cdkn1a', 'Dehydroepiandrosterone'), ('cdkn1a', 'Demecolcine'), ('cdkn1a', 'Deoxyglucose'), ('cdkn1a', 'Dexamethasone'), ('cdkn1a', 'Dianhydrogalactitol'), ('cdkn1a', 'Diazinon'), ('cdkn1a', 'Bucladesine'), ('cdkn1a', 'Clodronic Acid'), ('cdkn1a', 'Dichlororibofuranosylbenzimidazole'), ('cdkn1a', 'Diclofenac'), ('cdkn1a', 'Diethylhexyl Phthalate'), ('cdkn1a', 'Digitoxin'), ('cdkn1a', 'Dihydroxyacetone'), ('cdkn1a', 'Dimethylnitrosamine'), ('cdkn1a', 'Dinitrochlorobenzene'), ('cdkn1a', 'Docosahexaenoic Acids'), ('cdkn1a', 'Doxorubicin'), ('cdkn1a', 'Drugs, Chinese Herbal'), ('cdkn1a', 'Chlorpyrifos'), ('cdkn1a', 'Dust'), ('cdkn1a', 'Ellagic Acid'), ('cdkn1a', 'Endosulfan'), ('cdkn1a', 'Environmental Pollutants'), ('cdkn1a', 'Estradiol'), ('cdkn1a', 'Estrogens'), ('cdkn1a', 'Ethacrynic Acid'), ('cdkn1a', 'Amifostine'), ('cdkn1a', 'Ethyl Methanesulfonate'), ('cdkn1a', 'Ethylnitrosourea'), ('cdkn1a', 'Etoposide'), ('cdkn1a', 'Farnesol'), ('cdkn1a', 'Flame Retardants'), ('cdkn1a', 'Fluorometholone'), ('cdkn1a', 'Fluorouracil'), ('cdkn1a', 'Fluoxetine'), ('cdkn1a', 'Folic Acid'), ('cdkn1a', 'Formaldehyde'), ('cdkn1a', 'Furazolidone'), ('cdkn1a', 'Gallic Acid'), ('cdkn1a', 'Gasoline'), ('cdkn1a', 'Gentian Violet'), ('cdkn1a', 'Glucocorticoids'), ('cdkn1a', 'Glucose'), ('cdkn1a', 'Glutathione'), ('cdkn1a', 'Hemin'), ('cdkn1a', 'Hesperidin'), ('cdkn1a', 'Histamine'), ('cdkn1a', 'Hydrazones'), ('cdkn1a', 'Hydrogen Peroxide'), ('cdkn1a', 'Hydroxamic Acids'), ('cdkn1a', 'Hydroxyurea'), ('cdkn1a', 'Ifosfamide'), ('cdkn1a', 'Indican'), ('cdkn1a', 'Indomethacin'), ('cdkn1a', 'Clioquinol'), ('cdkn1a', 'Isatin'), ('cdkn1a', 'Isoflavones'), ('cdkn1a', 'Isopropyl Thiogalactoside'), ('cdkn1a', 'Ivermectin'), ('cdkn1a', 'Lead'), ('cdkn1a', 'Lipopolysaccharides'), ('cdkn1a', 'Lomustine'), ('cdkn1a', 'Loperamide'), ('cdkn1a', 'Lovastatin'), ('cdkn1a', 'Lucanthone'), ('cdkn1a', 'Melatonin'), ('cdkn1a', 'Menthol'), ('cdkn1a', 'Methotrexate'), ('cdkn1a', 'Methoxychlor'), ('cdkn1a', 'Methyl Methanesulfonate'), ('cdkn1a', 'Methyl Parathion'), ('cdkn1a', 'Methylcholanthrene'), ('cdkn1a', 'Methylnitronitrosoguanidine'), ('cdkn1a', 'Methylnitrosourea'), ('cdkn1a', 'Mimosine'), ('cdkn1a', 'Plicamycin'), ('cdkn1a', 'Morphine'), ('cdkn1a', 'Mustard Gas'), ('cdkn1a', 'Naphthoquinones'), ('cdkn1a', 'Nickel'), ('cdkn1a', 'Niclosamide'), ('cdkn1a', 'Niacinamide'), ('cdkn1a', 'Nicotine'), ('cdkn1a', 'Noscapine'), ('cdkn1a', 'Oleanolic Acid'), ('cdkn1a', 'Omeprazole'), ('cdkn1a', 'Organotin Compounds'), ('cdkn1a', 'Ouabain'), ('cdkn1a', 'Oxygen'), ('cdkn1a', 'Ozone'), ('cdkn1a', 'Paraquat'), ('cdkn1a', 'Parathion'), ('cdkn1a', 'Pergolide'), ('cdkn1a', 'Pesticides'), ('cdkn1a', 'Phenformin'), ('cdkn1a', 'Phenylbutyrates'), ('cdkn1a', 'Phenylephrine'), ('cdkn1a', 'Phenylmercuric Acetate'), ('cdkn1a', 'Phenytoin'), ('cdkn1a', 'Phloretin'), ('cdkn1a', 'Phosphatidylcholines'), ('cdkn1a', 'Organophosphates'), ('cdkn1a', 'Piroxicam'), ('cdkn1a', 'Plant Extracts'), ('cdkn1a', 'Plant Oils'), ('cdkn1a', 'Polychlorinated Biphenyls'), ('cdkn1a', 'Polycyclic Aromatic Hydrocarbons'), ('cdkn1a', 'Potassium Dichromate'), ('cdkn1a', 'Povidone'), ('cdkn1a', 'Prednisone'), ('cdkn1a', 'Probenecid'), ('cdkn1a', 'Progesterone'), ('cdkn1a', 'Quartz'), ('cdkn1a', 'Quercetin'), ('cdkn1a', 'Quinacrine'), ('cdkn1a', 'Quinidine'), ('cdkn1a', 'Retinoids'), ('cdkn1a', 'Rotenone'), ('cdkn1a', 'Ruthenium'), ('cdkn1a', 'Selenomethionine'), ('cdkn1a', 'Shikimic Acid'), ('cdkn1a', 'Silicon Dioxide'), ('cdkn1a', 'Silver'), ('cdkn1a', 'Smoke'), ('cdkn1a', 'Sodium Chloride'), ('cdkn1a', 'Sodium Fluoride'), ('cdkn1a', 'Sodium Salicylate'), ('cdkn1a', 'Soil Pollutants'), ('cdkn1a', 'Dihydrotestosterone'), ('cdkn1a', 'Sulindac'), ('cdkn1a', 'Tacrine'), ('cdkn1a', 'Tamoxifen'), ('cdkn1a', 'Teniposide'), ('cdkn1a', 'Testosterone'), ('cdkn1a', 'Tetrachlorodibenzodioxin'), ('cdkn1a', 'Tetradecanoylphorbol Acetate'), ('cdkn1a', 'Dronabinol'), ('cdkn1a', 'Thiophenes'), ('cdkn1a', 'Thioridazine'), ('cdkn1a', 'Thiostrepton'), ('cdkn1a', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('cdkn1a', 'Tobacco Smoke Pollution'), ('cdkn1a', 'Tosylphenylalanyl Chloromethyl Ketone'), ('cdkn1a', 'Toxaphene'), ('cdkn1a', 'Tretinoin'), ('cdkn1a', 'Triclosan'), ('cdkn1a', 'Triiodothyronine'), ('cdkn1a', 'Urethane'), ('cdkn1a', 'Valproic Acid'), ('cdkn1a', 'Vincristine'), ('cdkn1a', 'Viper Venoms'), ('cdkn1a', 'Vitallium'), ('cdkn1a', 'Vitamin E'), ('cdkn1a', 'Zinc'), ('cdkn1a', '2,6-Dichloroindophenol'), ('cdkn1a', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdkn1a', '8-Bromo Cyclic Adenosine Monophosphate'), ('cdkn1a', 'Oxyquinoline'), ('cdkn1a', '9,10-Dimethyl-1,2-benzanthracene'), ('cdkn1a', 'Zidovudine'), ('cdkn1a', 'Phorbol 12,13-Dibutyrate'), ('cdkn1a', 'Isotretinoin'), ('cdkn1a', '1-Methyl-4-phenylpyridinium'), ('cdkn1a', 'Mifepristone'), ('cdkn1a', 'Cysteine Proteinase Inhibitors'), ('cdkn1a', 'Carboplatin'), ('cdkn1a', 'Cyclosporine'), ('cdkn1a', 'Terfenadine'), ('cdkn1a', 'Aflatoxin B1'), ('cdkn1a', 'Mitomycin'), ('cdkn1a', 'Monocrotaline'), ('cdkn1a', 'Pravastatin'), ('cdkn1a', 'Paclitaxel'), ('cdkn1a', 'Medroxyprogesterone Acetate'), ('cdkn1a', 'Doxazosin'), ('cdkn1a', 'Amlodipine'), ('cdkn1a', 'Fenretinide'), ('cdkn1a', 'Cladribine'), ('cdkn1a', 'Asbestos, Amphibole'), ('cdkn1a', 'Asbestos, Crocidolite'), ('cdkn1a', 'Asbestos, Amosite'), ('cdkn1a', 'Lithium Chloride'), ('cdkn1a', 'Silver Compounds'), ('cdkn1a', 'Sodium Selenite'), ('cdkn1a', 'Antirheumatic Agents'), ('cdkn1a', 'Cadmium Chloride'), ('cdkn1a', 'Lamivudine'), ('cdkn1a', 'Thapsigargin'), ('cdkn1a', 'Zinc Sulfate'), ('cdkn1a', 'Oleic Acid'), ('cdkn1a', 'Palmitic Acid'), ('cdkn1a', 'Staurosporine'), ('cdkn1a', 'Copper Sulfate'), ('cdkn1a', 'Citric Acid'), ('cdkn1a', 'Zinc Acetate'), ('cdkn1a', 'Ritonavir'), ('cdkn1a', 'Glycyrrhizic Acid'), ('cdkn1a', 'Topotecan'), ('cdkn1a', 'Glutathione Disulfide'), ('cdkn1a', 'Losartan'), ('cdkn1a', 'Sodium Azide'), ('cdkn1a', 'Simvastatin'), ('cdkn1a', 'Genistein'), ('cdkn1a', '1-Butanol'), ('cdkn1a', 'Acrylamide'), ('cdkn1a', 'Chlorodiphenyl (54% Chlorine)'), ('cdkn1a', 'tert-Butylhydroperoxide'), ('cdkn1a', 'Sirolimus'), ('cdkn1a', 'Butyric Acid'), ('cdkn1a', 'p-Chloromercuribenzoic Acid'), ('cdkn1a', 'Raloxifene Hydrochloride'), ('cdkn1a', 'Vitamin K 2'), ('cdkn1a', 'Vitamin K 3'), ('cdkn1a', 'gamma-Tocopherol'), ('cdkn1a', 'Aristolochic Acids'), ('cdkn1a', 'Nanotubes, Carbon'), ('cdkn1a', 'Flavanones'), ('cdkn1a', 'Apigenin'), ('cdkn1a', 'Luteolin'), ('cdkn1a', 'Betalains'), ('cdkn1a', 'Particulate Matter'), ('cdkn1a', 'Volatile Organic Compounds'), ('cdkn1a', 'Halogenated Diphenyl Ethers'), ('cdkn1a', 'Histone Deacetylase Inhibitors'), ('cdkn1a', 'Polyphenols'), ('cdkn1a', 'Fungal Polysaccharides'), ('Aripiprazole', 'nfkb1'), ('Aripiprazole', 'cebpb'), ('Aripiprazole', 'mapkapk2'), ('Aripiprazole', 'ets1'), ('nfkb1', 'Fluticasone'), ('nfkb1', 'Celecoxib'), ('nfkb1', 'Imatinib Mesylate'), ('nfkb1', 'Bortezomib'), ('nfkb1', 'Irinotecan'), ('nfkb1', 'Gefitinib'), ('nfkb1', 'Resveratrol'), ('nfkb1', 'Decitabine'), ('nfkb1', 'Sunitinib'), ('nfkb1', 'Arsenic Trioxide'), ('nfkb1', 'Fulvestrant'), ('nfkb1', 'Troglitazone'), ('nfkb1', 'Vorinostat'), ('nfkb1', 'Afatinib'), ('nfkb1', 'Acetaldehyde'), ('nfkb1', 'Acetylcysteine'), ('nfkb1', 'Acrolein'), ('nfkb1', 'Air Pollutants'), ('nfkb1', 'Ethanol'), ('nfkb1', 'Allergens'), ('nfkb1', 'Amiloride'), ('nfkb1', 'Amiodarone'), ('nfkb1', 'Anethole Trithione'), ('nfkb1', 'Arsenic'), ('nfkb1', 'Ascorbic Acid'), ('nfkb1', 'Aspirin'), ('nfkb1', 'Atrazine'), ('nfkb1', 'Vehicle Emissions'), ('nfkb1', 'Bee Venoms'), ('nfkb1', 'Benzene'), ('nfkb1', 'Benzo(a)pyrene'), ('nfkb1', 'Bile Acids and Salts'), ('nfkb1', 'Dicumarol'), ('nfkb1', 'Bungarotoxins'), ('nfkb1', 'Busulfan'), ('nfkb1', 'Cacodylic Acid'), ('nfkb1', 'Cadmium'), ('nfkb1', 'Caffeine'), ('nfkb1', 'Calcitriol'), ('nfkb1', 'Cannabidiol'), ('nfkb1', 'Capsaicin'), ('nfkb1', 'Carbamazepine'), ('nfkb1', 'Carmustine'), ('nfkb1', 'Ceramides'), ('nfkb1', 'Cerium'), ('nfkb1', 'Chelating Agents'), ('nfkb1', 'Chloroform'), ('nfkb1', 'Chloroquine'), ('nfkb1', 'Chondroitin Sulfates'), ('nfkb1', 'Cimetidine'), ('nfkb1', 'Cisplatin'), ('nfkb1', 'Clonidine'), ('nfkb1', 'Copper'), ('nfkb1', 'Coumestrol'), ('nfkb1', 'Curcumin'), ('nfkb1', 'Cycloheximide'), ('nfkb1', 'Dactinomycin'), ('nfkb1', 'Danazol'), ('nfkb1', 'Dichlorodiphenyl Dichloroethylene'), ('nfkb1', 'DDT'), ('nfkb1', 'Deoxycholic Acid'), ('nfkb1', 'Deoxyglucose'), ('nfkb1', 'Dexamethasone'), ('nfkb1', 'Diacetyl'), ('nfkb1', 'Diazepam'), ('nfkb1', 'Diazoxide'), ('nfkb1', 'Diclofenac'), ('nfkb1', 'Diethylhexyl Phthalate'), ('nfkb1', 'Digitoxin'), ('nfkb1', 'Dihydroxyacetone'), ('nfkb1', 'Diltiazem'), ('nfkb1', 'Dinitrochlorobenzene'), ('nfkb1', 'Dinitrofluorobenzene'), ('nfkb1', 'Diosgenin'), ('nfkb1', 'Disulfiram'), ('nfkb1', 'Dithiothreitol'), ('nfkb1', 'Doxorubicin'), ('nfkb1', 'Drugs, Chinese Herbal'), ('nfkb1', 'Dust'), ('nfkb1', 'Endosulfan'), ('nfkb1', 'Estradiol'), ('nfkb1', 'Etoposide'), ('nfkb1', 'Eugenol'), ('nfkb1', 'Ferric Compounds'), ('nfkb1', 'Fluorouracil'), ('nfkb1', 'Folic Acid'), ('nfkb1', 'Formaldehyde'), ('nfkb1', 'Gadolinium'), ('nfkb1', 'Galactosamine'), ('nfkb1', 'Gliotoxin'), ('nfkb1', 'Glucosamine'), ('nfkb1', 'Glucose'), ('nfkb1', 'Glutathione'), ('nfkb1', 'Gold'), ('nfkb1', 'Harmaline'), ('nfkb1', 'Heme'), ('nfkb1', 'Histamine'), ('nfkb1', 'Hyaluronic Acid'), ('nfkb1', 'Hydrogen Peroxide'), ('nfkb1', 'Hydroxyurea'), ('nfkb1', 'Ibuprofen'), ('nfkb1', 'Indomethacin'), ('nfkb1', 'Ivermectin'), ('nfkb1', 'Lead'), ('nfkb1', 'Thioctic Acid'), ('nfkb1', 'Lipopolysaccharides'), ('nfkb1', 'Mecamylamine'), ('nfkb1', 'Melarsoprol'), ('nfkb1', 'Melitten'), ('nfkb1', 'Menthol'), ('nfkb1', 'Mercuric Chloride'), ('nfkb1', 'Mercury'), ('nfkb1', 'Metformin'), ('nfkb1', 'Methamphetamine'), ('nfkb1', 'Methotrexate'), ('nfkb1', 'Mevalonic Acid'), ('nfkb1', 'Mustard Gas'), ('nfkb1', 'Naproxen'), ('nfkb1', 'Neurotensin'), ('nfkb1', 'Nickel'), ('nfkb1', 'Niclosamide'), ('nfkb1', 'Nicotine'), ('nfkb1', 'Nitroprusside'), ('nfkb1', 'Norepinephrine'), ('nfkb1', 'Oleanolic Acid'), ('nfkb1', 'Oxygen'), ('nfkb1', 'Ozone'), ('nfkb1', '4-Aminobenzoic Acid'), ('nfkb1', 'Paraquat'), ('nfkb1', 'Pergolide'), ('nfkb1', 'Phenobarbital'), ('nfkb1', 'Phenylbutazone'), ('nfkb1', 'Phenytoin'), ('nfkb1', 'Plant Extracts'), ('nfkb1', 'Polystyrenes'), ('nfkb1', 'Fenofibrate'), ('nfkb1', 'Progesterone'), ('nfkb1', 'Pyrethrins'), ('nfkb1', 'Quercetin'), ('nfkb1', 'Rotenone'), ('nfkb1', 'Sulfasalazine'), ('nfkb1', 'Silicon Dioxide'), ('nfkb1', 'Silver'), ('nfkb1', 'Sodium Dodecyl Sulfate'), ('nfkb1', 'Sulindac'), ('nfkb1', 'Tamoxifen'), ('nfkb1', 'Terbutaline'), ('nfkb1', 'Tetrachlorodibenzodioxin'), ('nfkb1', 'Tetradecanoylphorbol Acetate'), ('nfkb1', 'Thalidomide'), ('nfkb1', 'Theophylline'), ('nfkb1', 'Thiostrepton'), ('nfkb1', 'Thiram'), ('nfkb1', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('nfkb1', 'Tobacco Smoke Pollution'), ('nfkb1', 'Tosyllysine Chloromethyl Ketone'), ('nfkb1', 'Tosylphenylalanyl Chloromethyl Ketone'), ('nfkb1', 'Tretinoin'), ('nfkb1', 'Ursodeoxycholic Acid'), ('nfkb1', 'Valproic Acid'), ('nfkb1', 'Viper Venoms'), ('nfkb1', 'Vitallium'), ('nfkb1', 'Vitamin E'), ('nfkb1', 'Water Pollutants'), ('nfkb1', 'Zinc'), ('nfkb1', 'Zineb'), ('nfkb1', '2-Acetylaminofluorene'), ('nfkb1', 'Mercaptopurine'), ('nfkb1', 'Mifepristone'), ('nfkb1', 'Carboplatin'), ('nfkb1', 'Aflatoxin B1'), ('nfkb1', 'Paclitaxel'), ('nfkb1', 'Fenretinide'), ('nfkb1', 'Gold Compounds'), ('nfkb1', 'Asbestos, Serpentine'), ('nfkb1', 'Asbestos, Amphibole'), ('nfkb1', 'Asbestos, Crocidolite'), ('nfkb1', 'Zinc Compounds'), ('nfkb1', 'Silver Compounds'), ('nfkb1', 'Antirheumatic Agents'), ('nfkb1', 'Cadmium Chloride'), ('nfkb1', 'Zinc Sulfate'), ('nfkb1', 'Palmitic Acid'), ('nfkb1', 'Staurosporine'), ('nfkb1', 'Okadaic Acid'), ('nfkb1', 'Copper Sulfate'), ('nfkb1', '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid'), ('nfkb1', 'Ritonavir'), ('nfkb1', 'Phenol'), ('nfkb1', 'Succinic Acid'), ('nfkb1', 'Simvastatin'), ('nfkb1', 'Genistein'), ('nfkb1', 'Chlorodiphenyl (54% Chlorine)'), ('nfkb1', 'tert-Butylhydroperoxide'), ('nfkb1', 'Sirolimus'), ('nfkb1', 'Butyric Acid'), ('nfkb1', 'Sertraline'), ('nfkb1', 'Shiga Toxin'), ('nfkb1', 'Vitamin K 3'), ('nfkb1', 'alpha-Tocopherol'), ('nfkb1', 'Fullerenes'), ('nfkb1', 'Apigenin'), ('nfkb1', 'Luteolin'), ('nfkb1', 'Protein Kinase Inhibitors'), ('nfkb1', 'Particulate Matter'), ('nfkb1', 'Soot'), ('nfkb1', 'Magnetite Nanoparticles'), ('nfkb1', 'Polyphenols'), ('nfkb1', 'Phytochemicals'), ('cebpb', 'Imatinib Mesylate'), ('cebpb', 'Bortezomib'), ('cebpb', 'Decitabine'), ('cebpb', 'Sunitinib'), ('cebpb', 'Zoledronic Acid'), ('cebpb', 'Arsenic Trioxide'), ('cebpb', 'Troglitazone'), ('cebpb', 'Leflunomide'), ('cebpb', 'Norethindrone Acetate'), ('cebpb', 'Panobinostat'), ('cebpb', 'Gemcitabine'), ('cebpb', 'Betulinic Acid'), ('cebpb', 'Aerosols'), ('cebpb', 'Air Pollutants'), ('cebpb', 'Allergens'), ('cebpb', 'Amiodarone'), ('cebpb', 'Antimycin A'), ('cebpb', 'Arsenic'), ('cebpb', 'Aspirin'), ('cebpb', 'Atrazine'), ('cebpb', 'Vehicle Emissions'), ('cebpb', 'Hexachlorocyclohexane'), ('cebpb', 'Benzo(a)pyrene'), ('cebpb', 'Berberine'), ('cebpb', 'Caffeine'), ('cebpb', 'Calcitriol'), ('cebpb', 'Cannabidiol'), ('cebpb', 'Capsaicin'), ('cebpb', 'Carbamazepine'), ('cebpb', 'Carmustine'), ('cebpb', 'Chloroquine'), ('cebpb', 'Cholic Acids'), ('cebpb', 'Choline'), ('cebpb', 'Cisplatin'), ('cebpb', 'Copper'), ('cebpb', 'Cyclophosphamide'), ('cebpb', 'Dactinomycin'), ('cebpb', 'Dichlorodiphenyl Dichloroethylene'), ('cebpb', 'Deoxycholic Acid'), ('cebpb', 'Dexamethasone'), ('cebpb', 'Diclofenac'), ('cebpb', 'Diethylhexyl Phthalate'), ('cebpb', 'Diethylstilbestrol'), ('cebpb', 'Diuron'), ('cebpb', 'Doxorubicin'), ('cebpb', 'Estradiol'), ('cebpb', 'Ethyl Methanesulfonate'), ('cebpb', 'Fluorouracil'), ('cebpb', 'Folic Acid'), ('cebpb', 'Formaldehyde'), ('cebpb', 'Glucose'), ('cebpb', 'Hydrocortisone'), ('cebpb', 'Hydrogen Peroxide'), ('cebpb', 'Indomethacin'), ('cebpb', 'Lead'), ('cebpb', 'Lipopolysaccharides'), ('cebpb', 'Melatonin'), ('cebpb', 'Methamphetamine'), ('cebpb', 'Methionine'), ('cebpb', 'Methotrexate'), ('cebpb', 'Methyl Methanesulfonate'), ('cebpb', 'Nickel'), ('cebpb', 'Niclosamide'), ('cebpb', 'Nicotine'), ('cebpb', 'Nitroprusside'), ('cebpb', 'Oxygen'), ('cebpb', 'Ozone'), ('cebpb', 'Paraquat'), ('cebpb', 'Phenylmercuric Acetate'), ('cebpb', 'Piroxicam'), ('cebpb', 'Quercetin'), ('cebpb', 'Rotenone'), ('cebpb', 'Serine'), ('cebpb', 'Silicon Dioxide'), ('cebpb', 'Silver'), ('cebpb', 'Smoke'), ('cebpb', 'Tamoxifen'), ('cebpb', 'Tetrachlorodibenzodioxin'), ('cebpb', 'Tetradecanoylphorbol Acetate'), ('cebpb', 'Dronabinol'), ('cebpb', 'Tobacco Smoke Pollution'), ('cebpb', 'Tretinoin'), ('cebpb', 'Triclosan'), ('cebpb', 'Tunicamycin'), ('cebpb', 'Urethane'), ('cebpb', 'Ursodeoxycholic Acid'), ('cebpb', 'Valproic Acid'), ('cebpb', 'Vincristine'), ('cebpb', 'Vitamin D'), ('cebpb', 'Vitamin E'), ('cebpb', 'Zearalenone'), ('cebpb', '1-Methyl-3-isobutylxanthine'), ('cebpb', '1-Naphthylisothiocyanate'), ('cebpb', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cebpb', 'Gemfibrozil'), ('cebpb', '1-Methyl-4-phenylpyridinium'), ('cebpb', 'Mifepristone'), ('cebpb', 'Cyclosporine'), ('cebpb', 'Aflatoxin B1'), ('cebpb', 'Reactive Oxygen Species'), ('cebpb', 'Asbestos, Crocidolite'), ('cebpb', 'Thapsigargin'), ('cebpb', 'Okadaic Acid'), ('cebpb', 'Copper Sulfate'), ('cebpb', 'Genistein'), ('cebpb', 'Acrylamide'), ('cebpb', 'tert-Butylhydroperoxide'), ('cebpb', 'p-Chloromercuribenzoic Acid'), ('cebpb', 'Raloxifene Hydrochloride'), ('cebpb', 'Particulate Matter'), ('cebpb', 'Soot'), ('mapkapk2', 'Bortezomib'), ('mapkapk2', 'Decitabine'), ('mapkapk2', 'Sunitinib'), ('mapkapk2', 'Arsenic Trioxide'), ('mapkapk2', 'Vorinostat'), ('mapkapk2', 'Acetaminophen'), ('mapkapk2', 'Arsenates'), ('mapkapk2', 'Atrazine'), ('mapkapk2', 'Benzene'), ('mapkapk2', 'Benzo(a)pyrene'), ('mapkapk2', 'Benzoates'), ('mapkapk2', 'Carbamazepine'), ('mapkapk2', 'Dexamethasone'), ('mapkapk2', 'Estradiol'), ('mapkapk2', 'Flurbiprofen'), ('mapkapk2', 'Gasoline'), ('mapkapk2', 'Hydrogen Peroxide'), ('mapkapk2', 'Ibuprofen'), ('mapkapk2', 'Indomethacin'), ('mapkapk2', 'Lipopolysaccharides'), ('mapkapk2', 'Methotrexate'), ('mapkapk2', 'Mustard Gas'), ('mapkapk2', 'Ozone'), ('mapkapk2', 'Polycyclic Aromatic Hydrocarbons'), ('mapkapk2', 'Potassium Dichromate'), ('mapkapk2', 'Rifampin'), ('mapkapk2', 'Smoke'), ('mapkapk2', 'Sodium Fluoride'), ('mapkapk2', 'Sorbitol'), ('mapkapk2', 'Sulfates'), ('mapkapk2', 'Tamoxifen'), ('mapkapk2', 'Tetradecanoylphorbol Acetate'), ('mapkapk2', 'Thimerosal'), ('mapkapk2', 'Tobacco Smoke Pollution'), ('mapkapk2', 'Tretinoin'), ('mapkapk2', 'Urethane'), ('mapkapk2', '1-Methyl-3-isobutylxanthine'), ('mapkapk2', 'Aflatoxin B1'), ('mapkapk2', 'Asbestos, Crocidolite'), ('mapkapk2', 'Cadmium Chloride'), ('mapkapk2', 'Copper Sulfate'), ('mapkapk2', '1-Butanol'), ('mapkapk2', 'Raloxifene Hydrochloride'), ('mapkapk2', 'Particulate Matter'), ('mapkapk2', 'Soot'), ('ets1', 'Resveratrol'), ('ets1', 'Decitabine'), ('ets1', 'Zoledronic Acid'), ('ets1', 'Arsenic Trioxide'), ('ets1', 'Vorinostat'), ('ets1', 'Leflunomide'), ('ets1', 'Panobinostat'), ('ets1', 'Acetaminophen'), ('ets1', 'Acetylcysteine'), ('ets1', 'Air Pollutants, Occupational'), ('ets1', 'Ethanol'), ('ets1', 'Antimycin A'), ('ets1', 'Arsenic'), ('ets1', 'Vehicle Emissions'), ('ets1', 'Azacitidine'), ('ets1', 'Benzo(a)pyrene'), ('ets1', 'Cadmium'), ('ets1', 'Chelating Agents'), ('ets1', 'Cisplatin'), ('ets1', 'Copper'), ('ets1', 'Disulfiram'), ('ets1', 'Diuron'), ('ets1', 'Doxorubicin'), ('ets1', 'Estradiol'), ('ets1', 'Etoposide'), ('ets1', 'Flavonoids'), ('ets1', 'Fluorouracil'), ('ets1', 'Gasoline'), ('ets1', 'Hydrogen Peroxide'), ('ets1', 'Methyl Methanesulfonate'), ('ets1', 'Methylnitronitrosoguanidine'), ('ets1', 'Nickel'), ('ets1', 'Ouabain'), ('ets1', 'Oxygen'), ('ets1', 'Ozone'), ('ets1', 'Phenylmercuric Acetate'), ('ets1', 'Plant Extracts'), ('ets1', 'Plant Oils'), ('ets1', 'Polycyclic Aromatic Hydrocarbons'), ('ets1', 'Silicon Dioxide'), ('ets1', 'Silver'), ('ets1', 'Smoke'), ('ets1', 'Streptozocin'), ('ets1', 'Sulindac'), ('ets1', 'Tobacco Smoke Pollution'), ('ets1', 'Tretinoin'), ('ets1', 'Valproic Acid'), ('ets1', 'Zinc'), ('ets1', 'Cyclosporine'), ('ets1', 'Aflatoxin B1'), ('ets1', 'Aflatoxin M1'), ('ets1', 'Gold Compounds'), ('ets1', 'Asbestos, Crocidolite'), ('ets1', 'Cadmium Chloride'), ('ets1', 'Lactic Acid'), ('ets1', '1-Butanol'), ('ets1', 'tert-Butylhydroperoxide'), ('ets1', 'Particulate Matter'), ('ets1', 'Benzophenanthridines'), ('ets1', 'Polyphenols'), ('Fluticasone', 'stat3'), ('stat3', 'Interferon beta-1b'), ('stat3', 'Valsartan'), ('stat3', 'Bortezomib'), ('stat3', 'Erlotinib Hydrochloride'), ('stat3', 'Dasatinib'), ('stat3', 'Janus Kinase Inhibitors'), ('stat3', 'Docetaxel'), ('stat3', 'Gefitinib'), ('stat3', 'Sorafenib'), ('stat3', 'Resveratrol'), ('stat3', 'Interferon alpha-2'), ('stat3', 'Decitabine'), ('stat3', 'Sunitinib'), ('stat3', 'Zoledronic Acid'), ('stat3', 'Arsenic Trioxide'), ('stat3', 'Fulvestrant'), ('stat3', 'Lycopene'), ('stat3', 'Leflunomide'), ('stat3', 'Lapatinib'), ('stat3', 'Crizotinib'), ('stat3', 'Panobinostat'), ('stat3', 'Acetaminophen'), ('stat3', 'Gemcitabine'), ('stat3', 'Betulinic Acid'), ('stat3', 'Acetylcysteine'), ('stat3', 'Acids'), ('stat3', 'Aerosols'), ('stat3', 'Allergens'), ('stat3', 'Arsenic'), ('stat3', 'Arsenicals'), ('stat3', 'Ascorbic Acid'), ('stat3', 'Aspirin'), ('stat3', 'Auranofin'), ('stat3', 'Vehicle Emissions'), ('stat3', 'Azacitidine'), ('stat3', 'Azathioprine'), ('stat3', 'Benzo(a)pyrene'), ('stat3', 'Benzoates'), ('stat3', 'Benztropine'), ('stat3', 'Bile Acids and Salts'), ('stat3', 'Butylated Hydroxyanisole'), ('stat3', 'Cacodylic Acid'), ('stat3', 'Cadmium'), ('stat3', 'Caffeine'), ('stat3', 'Cannabidiol'), ('stat3', 'Cannabinoids'), ('stat3', 'Capsaicin'), ('stat3', 'Carbamazepine'), ('stat3', 'Carbidopa'), ('stat3', 'Chitin'), ('stat3', 'Cisplatin'), ('stat3', 'Leucovorin'), ('stat3', 'Copper'), ('stat3', 'Cotinine'), ('stat3', 'Coumestrol'), ('stat3', 'Cuprizone'), ('stat3', 'Curcumin'), ('stat3', 'Dichlorodiphenyl Dichloroethylene'), ('stat3', 'DDT'), ('stat3', 'Demecolcine'), ('stat3', 'Dexamethasone'), ('stat3', 'Diamide'), ('stat3', 'Diatrizoate'), ('stat3', 'Diclofenac'), ('stat3', 'Digitoxin'), ('stat3', 'Dimethyl Sulfoxide'), ('stat3', 'Docosahexaenoic Acids'), ('stat3', 'Doxorubicin'), ('stat3', 'Ellagic Acid'), ('stat3', 'Emodin'), ('stat3', 'Endosulfan'), ('stat3', 'Estradiol'), ('stat3', 'Ethyl Methanesulfonate'), ('stat3', 'Fluorouracil'), ('stat3', 'Folic Acid'), ('stat3', 'Formaldehyde'), ('stat3', 'Gentian Violet'), ('stat3', 'Glucose'), ('stat3', 'Glutathione'), ('stat3', 'Hydrogen Peroxide'), ('stat3', 'Hydroxamic Acids'), ('stat3', 'Immunologic Factors'), ('stat3', 'Indomethacin'), ('stat3', 'Isoproterenol'), ('stat3', 'Ivermectin'), ('stat3', 'Thioctic Acid'), ('stat3', 'Lipopolysaccharides'), ('stat3', 'Lobeline'), ('stat3', 'Melitten'), ('stat3', 'Mercuric Chloride'), ('stat3', 'Methapyrilene'), ('stat3', 'Methotrexate'), ('stat3', 'Methoxychlor'), ('stat3', 'Methyl Methanesulfonate'), ('stat3', 'Methylmercury Compounds'), ('stat3', 'Methylthiouracil'), ('stat3', 'Mevalonic Acid'), ('stat3', 'Nickel'), ('stat3', 'Niclosamide'), ('stat3', 'Nicotine'), ('stat3', 'Nitrofurantoin'), ('stat3', 'Nitrous Oxide'), ('stat3', 'Masoprocol'), ('stat3', 'Oleanolic Acid'), ('stat3', 'Oxygen'), ('stat3', 'Pentachlorophenol'), ('stat3', 'Piroxicam'), ('stat3', 'Plant Extracts'), ('stat3', 'Potassium Dichromate'), ('stat3', 'Progesterone'), ('stat3', 'Propranolol'), ('stat3', 'Protein Synthesis Inhibitors'), ('stat3', 'Quercetin'), ('stat3', 'Ribonucleotides'), ('stat3', 'Rotenone'), ('stat3', 'Silicon Dioxide'), ('stat3', 'Smoke'), ('stat3', 'Spiro Compounds'), ('stat3', 'Stilbenes'), ('stat3', 'Sulindac'), ('stat3', 'Tamoxifen'), ('stat3', 'Taurine'), ('stat3', 'Taurocholic Acid'), ('stat3', 'Tetradecanoylphorbol Acetate'), ('stat3', 'Dronabinol'), ('stat3', 'Thalidomide'), ('stat3', 'Theophylline'), ('stat3', 'Thiosemicarbazones'), ('stat3', 'Thyroxine'), ('stat3', 'Tobacco Smoke Pollution'), ('stat3', 'Tosylphenylalanyl Chloromethyl Ketone'), ('stat3', 'Trichloroethylene'), ('stat3', 'Urethane'), ('stat3', 'Valproic Acid'), ('stat3', 'Vanadates'), ('stat3', 'Vinblastine'), ('stat3', 'Vitallium'), ('stat3', 'Zinc'), ('stat3', '1-Methyl-3-isobutylxanthine'), ('stat3', '2,6-Dichloroindophenol'), ('stat3', 'Eicosapentaenoic Acid'), ('stat3', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('stat3', 'Cytochalasin D'), ('stat3', '1-Methyl-4-phenylpyridinium'), ('stat3', 'Aflatoxin B1'), ('stat3', 'Paclitaxel'), ('stat3', 'Acitretin'), ('stat3', 'Cladribine'), ('stat3', 'Paroxetine'), ('stat3', 'Lithium Chloride'), ('stat3', 'Antirheumatic Agents'), ('stat3', 'Hexamethonium'), ('stat3', 'Cadmium Chloride'), ('stat3', 'Zinc Sulfate'), ('stat3', '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine'), ('stat3', 'Palmitic Acid'), ('stat3', 'Staurosporine'), ('stat3', 'Copper Sulfate'), ('stat3', 'Ritonavir'), ('stat3', 'Succinic Acid'), ('stat3', 'Losartan'), ('stat3', 'Benzoic Acid'), ('stat3', 'Simvastatin'), ('stat3', 'Genistein'), ('stat3', 'tert-Butylhydroperoxide'), ('stat3', 'Sirolimus'), ('stat3', 'Sertraline'), ('stat3', 'Raloxifene Hydrochloride'), ('stat3', 'Apigenin'), ('stat3', 'Luteolin'), ('stat3', 'Aptamers, Nucleotide'), ('stat3', 'Particulate Matter'), ('stat3', 'Oncostatin M'), ('stat3', 'Selenic Acid'), ('myc', 'Everolimus'), ('myc', 'Celecoxib'), ('myc', 'Atorvastatin'), ('myc', 'Bortezomib'), ('myc', 'Erlotinib Hydrochloride'), ('myc', 'Dasatinib'), ('myc', 'Sevoflurane'), ('myc', 'Oxaliplatin'), ('myc', 'Rosiglitazone'), ('myc', 'Gefitinib'), ('myc', 'Sorafenib'), ('myc', 'Resveratrol'), ('myc', 'Wortmannin'), ('myc', 'Temozolomide'), ('myc', 'Decitabine'), ('myc', 'Sunitinib'), ('myc', 'Arsenic Trioxide'), ('myc', 'Meloxicam'), ('myc', 'Fulvestrant'), ('myc', 'Troglitazone'), ('myc', 'Letrozole'), ('myc', 'Vorinostat'), ('myc', 'Leflunomide'), ('myc', 'Silybin'), ('myc', 'Cilostazol'), ('myc', 'Vemurafenib'), ('myc', 'Eucalyptol'), ('myc', 'Aprepitant'), ('myc', 'Panobinostat'), ('myc', 'Clofarabine'), ('myc', 'Acetaminophen'), ('myc', 'Gemcitabine'), ('myc', 'Matrines'), ('myc', 'Betulinic Acid'), ('myc', 'Acetylcysteine'), ('myc', 'Acids'), ('myc', 'Aconitine'), ('myc', 'Acrolein'), ('myc', 'Adenosine'), ('myc', 'Air Pollutants'), ('myc', 'Allethrins'), ('myc', 'Amsacrine'), ('myc', 'Anisomycin'), ('myc', 'Antimycin A'), ('myc', 'Aspartame'), ('myc', 'Aspirin'), ('myc', 'Atrazine'), ('myc', 'Vehicle Emissions'), ('myc', 'Azacitidine'), ('myc', 'Benzo(a)pyrene'), ('myc', 'Benzoates'), ('myc', 'Busulfan'), ('myc', 'Butyrates'), ('myc', 'Cacodylic Acid'), ('myc', 'Cadmium'), ('myc', 'Caffeine'), ('myc', 'Calcitriol'), ('myc', 'Camptothecin'), ('myc', 'Cannabidiol'), ('myc', 'Capsaicin'), ('myc', 'Carbamazepine'), ('myc', 'Carbofuran'), ('myc', 'Chalcone'), ('myc', 'Chelating Agents'), ('myc', 'Chlorambucil'), ('myc', 'Chlorpromazine'), ('myc', 'Cisplatin'), ('myc', 'Clofibrate'), ('myc', 'Clotrimazole'), ('myc', 'Copper'), ('myc', 'Coumestrol'), ('myc', 'Curcumin'), ('myc', 'Cycloheximide'), ('myc', 'Dactinomycin'), ('myc', 'Dichlorodiphenyl Dichloroethylene'), ('myc', 'DDT'), ('myc', 'Deferoxamine'), ('myc', 'Dexamethasone'), ('myc', 'Bucladesine'), ('myc', 'Diclofenac'), ('myc', 'Diethylhexyl Phthalate'), ('myc', 'Diethylstilbestrol'), ('myc', 'Dimethyl Sulfoxide'), ('myc', 'Dinitrochlorobenzene'), ('myc', 'Diosgenin'), ('myc', 'Doxorubicin'), ('myc', 'Drugs, Chinese Herbal'), ('myc', 'Chlorpyrifos'), ('myc', 'Endosulfan'), ('myc', 'Epichlorohydrin'), ('myc', 'Estradiol'), ('myc', 'Estrogens'), ('myc', 'Ethinyl Estradiol'), ('myc', 'Amifostine'), ('myc', 'Ethyl Methanesulfonate'), ('myc', 'Etoposide'), ('myc', 'Fenthion'), ('myc', 'Fluorouracil'), ('myc', 'Fluoxetine'), ('myc', 'Formaldehyde'), ('myc', 'Fructose'), ('myc', 'Glucose'), ('myc', 'Glutathione'), ('myc', 'Glycerol'), ('myc', 'Guanosine'), ('myc', 'Harmine'), ('myc', 'Hemin'), ('myc', 'Heparin'), ('myc', 'Hexachlorophene'), ('myc', 'Hydrocarbons, Chlorinated'), ('myc', 'Hydrogen Peroxide'), ('myc', 'Hydroxamic Acids'), ('myc', 'Immunologic Factors'), ('myc', 'Indomethacin'), ('myc', 'Iron'), ('myc', 'Thioctic Acid'), ('myc', 'Lipopolysaccharides'), ('myc', 'Maleic Anhydrides'), ('myc', 'Mebendazole'), ('myc', 'Memantine'), ('myc', 'Mercury'), ('myc', 'Metformin'), ('myc', 'Methotrexate'), ('myc', 'Methyl Methanesulfonate'), ('myc', 'Mitoxantrone'), ('myc', 'Nickel'), ('myc', 'Niclosamide'), ('myc', 'Nicotine'), ('myc', 'Nifedipine'), ('myc', 'Nitrobenzoates'), ('myc', 'Nitroprusside'), ('myc', 'Masoprocol'), ('myc', 'Oleanolic Acid'), ('myc', 'Oligonucleotides'), ('myc', 'Ouabain'), ('myc', 'Oxazolone'), ('myc', 'Oxygen'), ('myc', 'Ozone'), ('myc', 'Paraquat'), ('myc', 'Pesticides'), ('myc', 'Phenobarbital'), ('myc', 'Phenytoin'), ('myc', 'Plant Extracts'), ('myc', 'Poly I-C'), ('myc', 'Polychlorinated Biphenyls'), ('myc', 'Polyethyleneimine'), ('myc', 'Polystyrenes'), ('myc', 'Potassium Dichromate'), ('myc', 'Progesterone'), ('myc', 'Promegestone'), ('myc', 'Quartz'), ('myc', 'Quercetin'), ('myc', 'Quinacrine'), ('myc', 'Reserpine'), ('myc', 'Ribavirin'), ('myc', 'Riboflavin'), ('myc', 'Selegiline'), ('myc', 'Selenium'), ('myc', 'Silicon Dioxide'), ('myc', 'Smoke'), ('myc', 'Dihydrotestosterone'), ('myc', 'Sulfates'), ('myc', 'Sulindac'), ('myc', 'Tamoxifen'), ('myc', 'Taurocholic Acid'), ('myc', 'Teniposide'), ('myc', 'Testosterone'), ('myc', 'Tetrachlorodibenzodioxin'), ('myc', 'Tetradecanoylphorbol Acetate'), ('myc', 'Dronabinol'), ('myc', 'Theophylline'), ('myc', 'Thiophenes'), ('myc', 'Thiram'), ('myc', 'Thymidine'), ('myc', 'Tobacco Smoke Pollution'), ('myc', 'Tretinoin'), ('myc', 'Tunicamycin'), ('myc', 'Urethane'), ('myc', 'Uridine'), ('myc', 'Valproic Acid'), ('myc', 'Vinblastine'), ('myc', 'Vincristine'), ('myc', 'Vitallium'), ('myc', 'Vitamin A'), ('myc', 'Zearalenone'), ('myc', 'Zinc'), ('myc', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('myc', '8-Bromo Cyclic Adenosine Monophosphate'), ('myc', '9,10-Dimethyl-1,2-benzanthracene'), ('myc', 'Dinoprostone'), ('myc', 'Quinolones'), ('myc', '1-Methyl-4-phenylpyridinium'), ('myc', 'Mifepristone'), ('myc', 'Ionomycin'), ('myc', 'Carboplatin'), ('myc', 'Cyclosporine'), ('myc', 'Aflatoxin B1'), ('myc', 'Paclitaxel'), ('myc', 'Dimaprit'), ('myc', 'Fenretinide'), ('myc', 'Reactive Oxygen Species'), ('myc', 'Asbestos, Serpentine'), ('myc', 'Asbestos, Crocidolite'), ('myc', 'gamma-Linolenic Acid'), ('myc', 'Lithium Chloride'), ('myc', 'Sodium Selenite'), ('myc', 'Antirheumatic Agents'), ('myc', 'Cadmium Chloride'), ('myc', 'Thapsigargin'), ('myc', 'Staurosporine'), ('myc', 'Okadaic Acid'), ('myc', 'Lactic Acid'), ('myc', 'Ritonavir'), ('myc', 'Phenol'), ('myc', 'Succinic Acid'), ('myc', 'Benzoic Acid'), ('myc', 'Genistein'), ('myc', 'Acrylamide'), ('myc', 'tert-Butylhydroperoxide'), ('myc', 'Sirolimus'), ('myc', 'Butyric Acid'), ('myc', 'Sertraline'), ('myc', 'Raloxifene Hydrochloride'), ('myc', 'Vitamin K 3'), ('myc', 'Diarylheptanoids'), ('myc', 'Nanotubes, Carbon'), ('myc', 'Particulate Matter'), ('myc', 'Soot'), ('myc', 'Volatile Organic Compounds'), ('Everolimus', 'ccnd1'), ('Everolimus', 'rb1'), ('Everolimus', 'ccna2'), ('Everolimus', 'akt1'), ('Everolimus', 'sirt1'), ('Everolimus', 'mtor'), ('Everolimus', 'eif4ebp1'), ('ccnd1', 'Pemetrexed'), ('ccnd1', 'Dutasteride'), ('ccnd1', 'Celecoxib'), ('ccnd1', 'Fingolimod Hydrochloride'), ('ccnd1', 'Bortezomib'), ('ccnd1', 'Erlotinib Hydrochloride'), ('ccnd1', 'Dasatinib'), ('ccnd1', 'Docetaxel'), ('ccnd1', 'Oxaliplatin'), ('ccnd1', 'Rosiglitazone'), ('ccnd1', 'Gefitinib'), ('ccnd1', 'Sorafenib'), ('ccnd1', 'Resveratrol'), ('ccnd1', 'Wortmannin'), ('ccnd1', 'Temozolomide'), ('ccnd1', 'Pioglitazone'), ('ccnd1', 'Decitabine'), ('ccnd1', 'Zoledronic Acid'), ('ccnd1', 'Arsenic Trioxide'), ('ccnd1', 'Fulvestrant'), ('ccnd1', 'Lycopene'), ('ccnd1', 'Rimonabant'), ('ccnd1', 'Troglitazone'), ('ccnd1', 'Letrozole'), ('ccnd1', 'Vorinostat'), ('ccnd1', 'Leflunomide'), ('ccnd1', 'Lapatinib'), ('ccnd1', 'Silybin'), ('ccnd1', 'Orlistat'), ('ccnd1', 'Vemurafenib'), ('ccnd1', 'Roscovitine'), ('ccnd1', '2-Methoxyestradiol'), ('ccnd1', 'O-(Chloroacetylcarbamoyl)fumagillol'), ('ccnd1', 'Dronedarone'), ('ccnd1', 'Clofarabine'), ('ccnd1', 'Acetaminophen'), ('ccnd1', 'Gemcitabine'), ('ccnd1', 'Matrines'), ('ccnd1', 'Betulinic Acid'), ('ccnd1', 'Acetone'), ('ccnd1', 'Acetylcysteine'), ('ccnd1', 'Acids'), ('ccnd1', 'Acrylonitrile'), ('ccnd1', 'Cyclic AMP'), ('ccnd1', 'Aerosols'), ('ccnd1', 'Air Pollutants'), ('ccnd1', 'Ethanol'), ('ccnd1', 'Amodiaquine'), ('ccnd1', 'Arecoline'), ('ccnd1', 'Arsenic'), ('ccnd1', 'Ascorbic Acid'), ('ccnd1', 'Aspirin'), ('ccnd1', 'Atrazine'), ('ccnd1', 'Azacitidine'), ('ccnd1', 'Benzamides'), ('ccnd1', 'Benzene'), ('ccnd1', 'Benzo(a)pyrene'), ('ccnd1', 'Berberine'), ('ccnd1', 'Bilirubin'), ('ccnd1', 'Boron'), ('ccnd1', 'Butyrates'), ('ccnd1', 'Butyrophenones'), ('ccnd1', 'Cadmium'), ('ccnd1', 'Calcifediol'), ('ccnd1', 'Calcitriol'), ('ccnd1', 'Calcium'), ('ccnd1', 'Cannabidiol'), ('ccnd1', 'Capsaicin'), ('ccnd1', 'Carbamazepine'), ('ccnd1', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone'), ('ccnd1', 'Carmustine'), ('ccnd1', 'Catechin'), ('ccnd1', 'Chelating Agents'), ('ccnd1', 'Cisplatin'), ('ccnd1', 'Clomiphene'), ('ccnd1', 'Copper'), ('ccnd1', 'Cotinine'), ('ccnd1', 'Coumarins'), ('ccnd1', 'Coumestrol'), ('ccnd1', 'Curcumin'), ('ccnd1', 'Cycloheximide'), ('ccnd1', 'Cysteine'), ('ccnd1', 'Dichlorodiphenyl Dichloroethylene'), ('ccnd1', 'DDT'), ('ccnd1', 'Deferoxamine'), ('ccnd1', 'Dexamethasone'), ('ccnd1', 'Diazoxide'), ('ccnd1', 'Dibutyl Phthalate'), ('ccnd1', 'Bucladesine'), ('ccnd1', 'Diclofenac'), ('ccnd1', 'Diethylhexyl Phthalate'), ('ccnd1', 'Diethylstilbestrol'), ('ccnd1', 'Digitoxin'), ('ccnd1', 'Diosgenin'), ('ccnd1', 'Dithiothreitol'), ('ccnd1', 'Doxorubicin'), ('ccnd1', 'Drugs, Chinese Herbal'), ('ccnd1', 'Chlorpyrifos'), ('ccnd1', 'Endosulfan'), ('ccnd1', 'Epinephrine'), ('ccnd1', 'Erythrosine'), ('ccnd1', 'Estradiol'), ('ccnd1', 'Estrogens'), ('ccnd1', 'Ethacrynic Acid'), ('ccnd1', 'Ethidium'), ('ccnd1', 'Etoposide'), ('ccnd1', 'Flame Retardants'), ('ccnd1', 'Fluorides'), ('ccnd1', 'Fluorouracil'), ('ccnd1', 'Fluoxetine'), ('ccnd1', 'Folic Acid'), ('ccnd1', 'Formaldehyde'), ('ccnd1', 'Furazolidone'), ('ccnd1', 'Gentian Violet'), ('ccnd1', 'Glucose'), ('ccnd1', 'Glutamine'), ('ccnd1', 'Glutathione'), ('ccnd1', 'Gold'), ('ccnd1', 'Hesperidin'), ('ccnd1', 'Hexachlorobenzene'), ('ccnd1', 'Hexachlorophene'), ('ccnd1', 'Hexanones'), ('ccnd1', 'Hexestrol'), ('ccnd1', 'Histamine'), ('ccnd1', 'Hydrocarbons, Chlorinated'), ('ccnd1', 'Hydrochloric Acid'), ('ccnd1', 'Hydrogen Peroxide'), ('ccnd1', 'Hydroxamic Acids'), ('ccnd1', 'Hydroxyurea'), ('ccnd1', 'Ibuprofen'), ('ccnd1', 'Immunologic Factors'), ('ccnd1', 'Indomethacin'), ('ccnd1', 'Isoflavones'), ('ccnd1', 'Ivermectin'), ('ccnd1', 'Thioctic Acid'), ('ccnd1', 'Lipopolysaccharides'), ('ccnd1', 'Lovastatin'), ('ccnd1', 'Maleates'), ('ccnd1', 'Melatonin'), ('ccnd1', 'Melitten'), ('ccnd1', 'Memantine'), ('ccnd1', 'Menthol'), ('ccnd1', 'Mestranol'), ('ccnd1', 'Metformin'), ('ccnd1', 'Methotrexate'), ('ccnd1', 'Methoxychlor'), ('ccnd1', 'Mimosine'), ('ccnd1', 'Naproxen'), ('ccnd1', 'Nicardipine'), ('ccnd1', 'Nickel'), ('ccnd1', 'Niclosamide'), ('ccnd1', 'Nicotinamide Mononucleotide'), ('ccnd1', 'Nicotine'), ('ccnd1', 'Masoprocol'), ('ccnd1', 'Oleanolic Acid'), ('ccnd1', 'Oligomycins'), ('ccnd1', 'Organotin Compounds'), ('ccnd1', 'Ouabain'), ('ccnd1', 'Oxygen'), ('ccnd1', 'Ozone'), ('ccnd1', 'Paraquat'), ('ccnd1', 'Phenylbutazone'), ('ccnd1', 'Phenytoin'), ('ccnd1', 'Phosphatidylcholines'), ('ccnd1', 'Piroxicam'), ('ccnd1', 'Plant Extracts'), ('ccnd1', 'Polystyrenes'), ('ccnd1', 'Probenecid'), ('ccnd1', 'Fenofibrate'), ('ccnd1', 'Progestins'), ('ccnd1', 'Progesterone'), ('ccnd1', 'Promegestone'), ('ccnd1', 'Quercetin'), ('ccnd1', 'Quinacrine'), ('ccnd1', 'Reserpine'), ('ccnd1', 'Ribavirin'), ('ccnd1', 'Rotenone'), ('ccnd1', 'Selenium'), ('ccnd1', 'Shikimic Acid'), ('ccnd1', 'Silicon Dioxide'), ('ccnd1', 'Silver'), ('ccnd1', 'Silymarin'), ('ccnd1', 'Smoke'), ('ccnd1', 'Sodium Fluoride'), ('ccnd1', 'Spiro Compounds'), ('ccnd1', 'Dihydrotestosterone'), ('ccnd1', 'Sulindac'), ('ccnd1', 'Tamoxifen'), ('ccnd1', 'Taurocholic Acid'), ('ccnd1', 'Testosterone'), ('ccnd1', 'Tetracaine'), ('ccnd1', 'Tetrachlorodibenzodioxin'), ('ccnd1', 'Tetradecanoylphorbol Acetate'), ('ccnd1', 'Thalidomide'), ('ccnd1', 'Theophylline'), ('ccnd1', 'Thimerosal'), ('ccnd1', 'Thioridazine'), ('ccnd1', 'Thiosemicarbazones'), ('ccnd1', 'Thiostrepton'), ('ccnd1', 'Thyroxine'), ('ccnd1', 'Tobacco Smoke Pollution'), ('ccnd1', 'Tretinoin'), ('ccnd1', 'Trichloroethylene'), ('ccnd1', 'Triclosan'), ('ccnd1', 'Triiodothyronine'), ('ccnd1', 'Tunicamycin'), ('ccnd1', 'Urea'), ('ccnd1', 'Urethane'), ('ccnd1', 'Ursodeoxycholic Acid'), ('ccnd1', 'Valproic Acid'), ('ccnd1', 'Vitallium'), ('ccnd1', 'Vitamin A'), ('ccnd1', 'Vitamin E'), ('ccnd1', 'Lutein'), ('ccnd1', 'Zeranol'), ('ccnd1', 'Zinc'), ('ccnd1', '4-Nitroquinoline-1-oxide'), ('ccnd1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ccnd1', '9,10-Dimethyl-1,2-benzanthracene'), ('ccnd1', 'Zidovudine'), ('ccnd1', 'Quinolones'), ('ccnd1', 'Isotretinoin'), ('ccnd1', 'Fatty Acids, Omega-3'), ('ccnd1', '1-Methyl-4-phenylpyridinium'), ('ccnd1', 'Mifepristone'), ('ccnd1', 'Propofol'), ('ccnd1', 'Cyclosporine'), ('ccnd1', 'Aflatoxin B1'), ('ccnd1', 'Paclitaxel'), ('ccnd1', 'Acitretin'), ('ccnd1', 'Medroxyprogesterone Acetate'), ('ccnd1', 'Amlodipine'), ('ccnd1', 'Fenretinide'), ('ccnd1', 'Reactive Oxygen Species'), ('ccnd1', 'Gold Compounds'), ('ccnd1', 'Asbestos, Amphibole'), ('ccnd1', 'Asbestos, Crocidolite'), ('ccnd1', 'Lithium Chloride'), ('ccnd1', 'Sodium Selenite'), ('ccnd1', 'beta Carotene'), ('ccnd1', 'Cadmium Chloride'), ('ccnd1', 'Lamivudine'), ('ccnd1', 'Thapsigargin'), ('ccnd1', 'Zinc Sulfate'), ('ccnd1', 'Okadaic Acid'), ('ccnd1', 'Copper Sulfate'), ('ccnd1', 'Lactic Acid'), ('ccnd1', 'Ritonavir'), ('ccnd1', 'Glycyrrhizic Acid'), ('ccnd1', 'Benzoic Acid'), ('ccnd1', 'Simvastatin'), ('ccnd1', 'Genistein'), ('ccnd1', 'Acrylamide'), ('ccnd1', 'Sirolimus'), ('ccnd1', 'Raloxifene Hydrochloride'), ('ccnd1', 'Vitamin K 3'), ('ccnd1', 'gamma-Tocopherol'), ('ccnd1', 'Tocopherols'), ('ccnd1', 'Nanotubes, Carbon'), ('ccnd1', 'Fatty Acids, Omega-6'), ('ccnd1', 'Flavanones'), ('ccnd1', 'Diterpenes, Clerodane'), ('ccnd1', 'Depsipeptides'), ('ccnd1', 'Betalains'), ('ccnd1', 'Particulate Matter'), ('ccnd1', 'Benzophenanthridines'), ('ccnd1', 'Halogenated Diphenyl Ethers'), ('ccnd1', 'Magnetite Nanoparticles'), ('ccnd1', 'Polyphenols'), ('ccnd1', 'Fungal Polysaccharides'), ('rb1', 'Celecoxib'), ('rb1', 'Imatinib Mesylate'), ('rb1', 'Atorvastatin'), ('rb1', 'Bortezomib'), ('rb1', 'Capecitabine'), ('rb1', 'Erlotinib Hydrochloride'), ('rb1', 'Docetaxel'), ('rb1', 'Irinotecan'), ('rb1', 'Oxaliplatin'), ('rb1', 'Rosiglitazone'), ('rb1', 'Gefitinib'), ('rb1', 'Sorafenib'), ('rb1', 'Resveratrol'), ('rb1', 'Temozolomide'), ('rb1', 'Pioglitazone'), ('rb1', 'Decitabine'), ('rb1', 'Sunitinib'), ('rb1', 'Arsenic Trioxide'), ('rb1', 'Fulvestrant'), ('rb1', 'Lycopene'), ('rb1', 'Troglitazone'), ('rb1', 'Letrozole'), ('rb1', 'Vorinostat'), ('rb1', 'Fluvastatin'), ('rb1', 'Lapatinib'), ('rb1', 'Orlistat'), ('rb1', 'Roscovitine'), ('rb1', 'Alitretinoin'), ('rb1', 'O-(Chloroacetylcarbamoyl)fumagillol'), ('rb1', 'Bexarotene'), ('rb1', 'Acetaminophen'), ('rb1', 'Betulinic Acid'), ('rb1', 'Acetylcysteine'), ('rb1', 'Aconitine'), ('rb1', 'Acrolein'), ('rb1', 'Air Pollutants'), ('rb1', 'Air Pollutants, Occupational'), ('rb1', 'Albuterol'), ('rb1', 'Amodiaquine'), ('rb1', 'Aspirin'), ('rb1', 'Auranofin'), ('rb1', 'Benzene'), ('rb1', 'Benzo(a)pyrene'), ('rb1', 'Dicumarol'), ('rb1', 'Bungarotoxins'), ('rb1', 'Butyrates'), ('rb1', 'Caffeine'), ('rb1', 'Calcitriol'), ('rb1', 'Camptothecin'), ('rb1', 'Carbamazepine'), ('rb1', 'Ceramides'), ('rb1', 'Chelating Agents'), ('rb1', 'Chlordan'), ('rb1', 'Cholecalciferol'), ('rb1', 'Cisplatin'), ('rb1', 'Copper'), ('rb1', 'Curcumin'), ('rb1', 'Cycloheximide'), ('rb1', 'Cysteine'), ('rb1', 'Daunorubicin'), ('rb1', 'DDT'), ('rb1', 'Deferoxamine'), ('rb1', 'Dehydroepiandrosterone'), ('rb1', 'Dexamethasone'), ('rb1', 'Bucladesine'), ('rb1', 'Diclofenac'), ('rb1', 'Dioxins'), ('rb1', 'Doxorubicin'), ('rb1', 'Emodin'), ('rb1', 'Endosulfan'), ('rb1', 'Estradiol'), ('rb1', 'Ethyl Methanesulfonate'), ('rb1', 'Etoposide'), ('rb1', 'Eugenol'), ('rb1', 'Fluorometholone'), ('rb1', 'Fluorouracil'), ('rb1', 'Colforsin'), ('rb1', 'Glucocorticoids'), ('rb1', 'Glucose'), ('rb1', 'Glutathione'), ('rb1', 'Heparin'), ('rb1', 'Heptachlor'), ('rb1', 'Hexanones'), ('rb1', 'Hydrazones'), ('rb1', 'Hydrocarbons, Chlorinated'), ('rb1', 'Hydrogen Peroxide'), ('rb1', 'Indoles'), ('rb1', 'Indomethacin'), ('rb1', 'Ivermectin'), ('rb1', 'Lead'), ('rb1', 'Levamisole'), ('rb1', 'Lovastatin'), ('rb1', 'Menthol'), ('rb1', 'Methapyrilene'), ('rb1', 'Methotrexate'), ('rb1', 'Methoxsalen'), ('rb1', 'Methyl Methanesulfonate'), ('rb1', 'Mustard Gas'), ('rb1', 'Nickel'), ('rb1', 'Nicotine'), ('rb1', 'Masoprocol'), ('rb1', 'Oligomycins'), ('rb1', 'Ozone'), ('rb1', 'Phytic Acid'), ('rb1', 'Piroxicam'), ('rb1', 'Plant Extracts'), ('rb1', 'Polycyclic Aromatic Hydrocarbons'), ('rb1', 'Prednisone'), ('rb1', 'Quercetin'), ('rb1', 'Retinoids'), ('rb1', 'Sodium Dodecyl Sulfate'), ('rb1', 'Dihydrotestosterone'), ('rb1', 'Sulindac'), ('rb1', 'Tamoxifen'), ('rb1', 'Tetrachlorodibenzodioxin'), ('rb1', 'Tetradecanoylphorbol Acetate'), ('rb1', 'Theophylline'), ('rb1', 'Thiophenes'), ('rb1', 'Tobacco Smoke Pollution'), ('rb1', 'Toxaphene'), ('rb1', 'Tretinoin'), ('rb1', 'Ursodeoxycholic Acid'), ('rb1', 'Valproic Acid'), ('rb1', 'Vanadates'), ('rb1', 'Vincristine'), ('rb1', 'Zinc'), ('rb1', '1-Methyl-4-phenylpyridinium'), ('rb1', 'Mifepristone'), ('rb1', 'Aflatoxin B1'), ('rb1', 'Aflatoxin M1'), ('rb1', 'Mitomycin'), ('rb1', 'Paclitaxel'), ('rb1', 'Doxazosin'), ('rb1', 'Amlodipine'), ('rb1', 'Fenretinide'), ('rb1', 'Adenovirus E1A Proteins'), ('rb1', 'Asbestos, Crocidolite'), ('rb1', 'Lithium Chloride'), ('rb1', 'Antirheumatic Agents'), ('rb1', 'Cadmium Chloride'), ('rb1', 'Zinc Sulfate'), ('rb1', 'Oleic Acid'), ('rb1', 'Okadaic Acid'), ('rb1', 'Zinc Acetate'), ('rb1', 'Ritonavir'), ('rb1', 'Simvastatin'), ('rb1', 'Genistein'), ('rb1', 'tert-Butylhydroperoxide'), ('rb1', 'Sirolimus'), ('rb1', 'Butyric Acid'), ('rb1', 'Raloxifene Hydrochloride'), ('rb1', 'Vitamin K 2'), ('rb1', 'Vitamin K 3'), ('rb1', 'Tocopherols'), ('rb1', 'Particulate Matter'), ('rb1', 'Benzophenanthridines'), ('rb1', 'Volatile Organic Compounds'), ('rb1', 'Lopinavir'), ('ccna2', 'Imatinib Mesylate'), ('ccna2', 'Irinotecan'), ('ccna2', 'Oxaliplatin'), ('ccna2', 'Rosiglitazone'), ('ccna2', 'Resveratrol'), ('ccna2', 'Pioglitazone'), ('ccna2', 'Sunitinib'), ('ccna2', 'Zoledronic Acid'), ('ccna2', 'Arsenic Trioxide'), ('ccna2', 'Fulvestrant'), ('ccna2', 'Troglitazone'), ('ccna2', 'Vorinostat'), ('ccna2', 'Leflunomide'), ('ccna2', 'Lapatinib'), ('ccna2', 'Orlistat'), ('ccna2', 'Cilostazol'), ('ccna2', 'Roscovitine'), ('ccna2', 'Alitretinoin'), ('ccna2', '2-Methoxyestradiol'), ('ccna2', 'Trabectedin'), ('ccna2', 'Homoharringtonine'), ('ccna2', 'Acetaminophen'), ('ccna2', 'Acetylcysteine'), ('ccna2', 'Amsacrine'), ('ccna2', 'Antimycin A'), ('ccna2', 'Arsenic'), ('ccna2', 'Aspirin'), ('ccna2', 'Atrazine'), ('ccna2', 'Azacitidine'), ('ccna2', 'Azathioprine'), ('ccna2', 'Benzo(a)pyrene'), ('ccna2', 'Butyrates'), ('ccna2', 'Cadmium'), ('ccna2', 'Calcitriol'), ('ccna2', 'Camptothecin'), ('ccna2', 'Cannabidiol'), ('ccna2', 'Capsaicin'), ('ccna2', 'Cisplatin'), ('ccna2', 'Clofibrate'), ('ccna2', 'Cocaine'), ('ccna2', 'Copper'), ('ccna2', 'Coumestrol'), ('ccna2', 'Curcumin'), ('ccna2', 'Cycloheximide'), ('ccna2', 'Deferoxamine'), ('ccna2', 'Dexamethasone'), ('ccna2', 'Dibutyl Phthalate'), ('ccna2', 'Diethylhexyl Phthalate'), ('ccna2', 'Disulfiram'), ('ccna2', 'Doxorubicin'), ('ccna2', 'Drugs, Chinese Herbal'), ('ccna2', 'Dust'), ('ccna2', 'Estradiol'), ('ccna2', 'Etoposide'), ('ccna2', 'Farnesol'), ('ccna2', 'Fluorouracil'), ('ccna2', 'Fluoxetine'), ('ccna2', 'Folic Acid'), ('ccna2', 'Formaldehyde'), ('ccna2', 'Glutathione'), ('ccna2', 'Hydrogen Peroxide'), ('ccna2', 'Hydroxyurea'), ('ccna2', 'Indomethacin'), ('ccna2', 'Iron'), ('ccna2', 'Ivermectin'), ('ccna2', 'Lead'), ('ccna2', 'Lipopolysaccharides'), ('ccna2', 'Lucanthone'), ('ccna2', 'Malathion'), ('ccna2', 'Mechlorethamine'), ('ccna2', 'Methotrexate'), ('ccna2', 'Methyl Methanesulfonate'), ('ccna2', 'Methylmercury Compounds'), ('ccna2', 'Methylnitrosourea'), ('ccna2', 'Mustard Gas'), ('ccna2', 'N-Nitrosopyrrolidine'), ('ccna2', 'Nickel'), ('ccna2', 'Nicotine'), ('ccna2', 'Organotin Compounds'), ('ccna2', 'Ouabain'), ('ccna2', 'Oxygen'), ('ccna2', 'Ozone'), ('ccna2', 'Parathion'), ('ccna2', 'Pentoxifylline'), ('ccna2', 'Piroxicam'), ('ccna2', 'Plant Extracts'), ('ccna2', 'Polychlorinated Biphenyls'), ('ccna2', 'Potassium Dichromate'), ('ccna2', 'Pyrimidines'), ('ccna2', 'Quercetin'), ('ccna2', 'Quinazolines'), ('ccna2', 'Ribavirin'), ('ccna2', 'Rotenone'), ('ccna2', 'Silicon Dioxide'), ('ccna2', 'Silver Nitrate'), ('ccna2', 'Dihydrotestosterone'), ('ccna2', 'Sulindac'), ('ccna2', 'Tamoxifen'), ('ccna2', 'Testosterone'), ('ccna2', 'Tetrachlorodibenzodioxin'), ('ccna2', 'Tetradecanoylphorbol Acetate'), ('ccna2', 'Dronabinol'), ('ccna2', 'Thalidomide'), ('ccna2', 'Tobacco Smoke Pollution'), ('ccna2', 'Tretinoin'), ('ccna2', 'Triiodothyronine'), ('ccna2', 'Tunicamycin'), ('ccna2', 'Valproic Acid'), ('ccna2', 'Vitallium'), ('ccna2', 'Zinc'), ('ccna2', '1-Methyl-3-isobutylxanthine'), ('ccna2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ccna2', 'Zidovudine'), ('ccna2', '1-Methyl-4-phenylpyridinium'), ('ccna2', 'Mifepristone'), ('ccna2', 'Metribolone'), ('ccna2', 'Cyclosporine'), ('ccna2', 'Aphidicolin'), ('ccna2', 'Aflatoxin B1'), ('ccna2', 'Aflatoxin M1'), ('ccna2', 'Doxazosin'), ('ccna2', 'Fenretinide'), ('ccna2', 'gamma-Linolenic Acid'), ('ccna2', 'Lithium Chloride'), ('ccna2', 'Sodium Selenite'), ('ccna2', 'Cadmium Chloride'), ('ccna2', 'Lamivudine'), ('ccna2', 'Thapsigargin'), ('ccna2', 'Copper Sulfate'), ('ccna2', 'Ritonavir'), ('ccna2', 'Phenol'), ('ccna2', 'Sodium Azide'), ('ccna2', 'Simvastatin'), ('ccna2', 'Genistein'), ('ccna2', 'tert-Butylhydroperoxide'), ('ccna2', 'Sirolimus'), ('ccna2', 'Raloxifene Hydrochloride'), ('ccna2', 'Vitamin K 3'), ('ccna2', 'Nanotubes, Carbon'), ('ccna2', 'Luteolin'), ('ccna2', 'Phytoestrogens'), ('ccna2', 'Equol'), ('ccna2', 'Fungal Polysaccharides'), ('akt1', 'Celecoxib'), ('akt1', 'Fingolimod Hydrochloride'), ('akt1', 'Imatinib Mesylate'), ('akt1', 'Atorvastatin'), ('akt1', 'Bortezomib'), ('akt1', 'Erlotinib Hydrochloride'), ('akt1', 'Dasatinib'), ('akt1', 'Liraglutide'), ('akt1', 'Docetaxel'), ('akt1', 'Oxaliplatin'), ('akt1', 'Olanzapine'), ('akt1', 'Rosiglitazone'), ('akt1', 'Gefitinib'), ('akt1', 'Sorafenib'), ('akt1', 'Resveratrol'), ('akt1', 'Wortmannin'), ('akt1', 'Temozolomide'), ('akt1', 'Decitabine'), ('akt1', 'Zoledronic Acid'), ('akt1', 'Arsenic Trioxide'), ('akt1', 'Meloxicam'), ('akt1', 'Fulvestrant'), ('akt1', 'Imiquimod'), ('akt1', 'Lycopene'), ('akt1', 'Rimonabant'), ('akt1', 'Troglitazone'), ('akt1', 'Vorinostat'), ('akt1', 'Lapatinib'), ('akt1', 'Orlistat'), ('akt1', 'Cilostazol'), ('akt1', 'Vemurafenib'), ('akt1', 'Crizotinib'), ('akt1', 'Alitretinoin'), ('akt1', '2-Methoxyestradiol'), ('akt1', 'Afatinib'), ('akt1', 'Panobinostat'), ('akt1', 'Homoharringtonine'), ('akt1', '5-Methoxypsoralen'), ('akt1', 'Ado-Trastuzumab Emtansine'), ('akt1', 'Gemcitabine'), ('akt1', 'Matrines'), ('akt1', 'Betulinic Acid'), ('akt1', 'Acetylcysteine'), ('akt1', 'Acrolein'), ('akt1', 'Adenosine Triphosphate'), ('akt1', 'Agmatine'), ('akt1', 'Air Pollutants'), ('akt1', 'Ethanol'), ('akt1', 'Alcohols'), ('akt1', 'Allethrins'), ('akt1', 'Amiloride'), ('akt1', 'Amino Acids, Peptides, and Proteins'), ('akt1', 'Amiodarone'), ('akt1', 'Antimycin A'), ('akt1', 'Arbutin'), ('akt1', 'Arecoline'), ('akt1', 'Arsenic'), ('akt1', 'Arsenicals'), ('akt1', 'Aspartame'), ('akt1', 'Aspirin'), ('akt1', 'Atrazine'), ('akt1', 'Vehicle Emissions'), ('akt1', 'Azacitidine'), ('akt1', 'Azathioprine'), ('akt1', 'Benzo(a)pyrene'), ('akt1', 'Berberine'), ('akt1', 'Bibenzyls'), ('akt1', 'Bilirubin'), ('akt1', 'Biliverdine'), ('akt1', 'Biological Products'), ('akt1', 'Bungarotoxins'), ('akt1', 'Butyrates'), ('akt1', 'Cacodylic Acid'), ('akt1', 'Cadmium'), ('akt1', 'Caffeine'), ('akt1', 'Calcifediol'), ('akt1', 'Calcitriol'), ('akt1', 'Calcium'), ('akt1', 'Camptothecin'), ('akt1', 'Cannabidiol'), ('akt1', 'Cannabinoids'), ('akt1', 'Cantharidin'), ('akt1', 'Capsaicin'), ('akt1', 'Carbamazepine'), ('akt1', 'Carbenoxolone'), ('akt1', 'Carbon Monoxide'), ('akt1', 'Carmustine'), ('akt1', 'Catechin'), ('akt1', 'Chelating Agents'), ('akt1', 'Chlorides'), ('akt1', 'Chloroquine'), ('akt1', 'Cholesterol'), ('akt1', 'Chromones'), ('akt1', 'Ciprofloxacin'), ('akt1', 'Cisplatin'), ('akt1', 'Clozapine'), ('akt1', 'Colistin'), ('akt1', 'Contrast Media'), ('akt1', 'Copper'), ('akt1', 'Cotinine'), ('akt1', 'Curcumin'), ('akt1', 'Cycloheximide'), ('akt1', 'Dactinomycin'), ('akt1', 'Daunorubicin'), ('akt1', 'Deferoxamine'), ('akt1', 'Dexamethasone'), ('akt1', 'Diatrizoate'), ('akt1', 'Dibutyl Phthalate'), ('akt1', 'Diclofenac'), ('akt1', 'Diethylhexyl Phthalate'), ('akt1', 'Dihydro-beta-Erythroidine'), ('akt1', 'Diosgenin'), ('akt1', 'Diphtheria Toxin'), ('akt1', 'Dithiothreitol'), ('akt1', 'Dobutamine'), ('akt1', 'Docosahexaenoic Acids'), ('akt1', 'Doxorubicin'), ('akt1', 'Drugs, Chinese Herbal'), ('akt1', 'Ellagic Acid'), ('akt1', 'Emodin'), ('akt1', 'Endosulfan'), ('akt1', 'Environmental Pollutants'), ('akt1', 'Epinephrine'), ('akt1', 'Estradiol'), ('akt1', 'Estrone'), ('akt1', 'Etoposide'), ('akt1', 'Filipin'), ('akt1', 'Fluorometholone'), ('akt1', 'Fluorouracil'), ('akt1', 'Flutamide'), ('akt1', 'Folic Acid'), ('akt1', 'Formaldehyde'), ('akt1', 'Furazolidone'), ('akt1', 'Gallic Acid'), ('akt1', 'Gasoline'), ('akt1', 'Glucosamine'), ('akt1', 'Glucose'), ('akt1', 'Glutathione'), ('akt1', 'Gold'), ('akt1', 'Hemin'), ('akt1', 'Hexanones'), ('akt1', 'Humic Substances'), ('akt1', 'Hydrocarbons, Chlorinated'), ('akt1', 'Hydrogen Peroxide'), ('akt1', 'Indomethacin'), ('akt1', 'Insulin'), ('akt1', 'Clioquinol'), ('akt1', 'Ivermectin'), ('akt1', 'Lead'), ('akt1', 'Leukotriene B4'), ('akt1', 'Lipopolysaccharides'), ('akt1', 'Cholesterol, HDL'), ('akt1', 'Lithium'), ('akt1', 'Lovastatin'), ('akt1', 'Maleates'), ('akt1', 'Malondialdehyde'), ('akt1', 'Manganese'), ('akt1', 'Mecamylamine'), ('akt1', 'Melatonin'), ('akt1', 'Melitten'), ('akt1', 'Menthol'), ('akt1', 'Metformin'), ('akt1', 'Methamphetamine'), ('akt1', 'Methapyrilene'), ('akt1', 'Methimazole'), ('akt1', 'Methotrexate'), ('akt1', 'Mevalonic Acid'), ('akt1', 'Miconazole'), ('akt1', 'Morphine'), ('akt1', 'Morpholines'), ('akt1', 'Mycophenolic Acid'), ('akt1', 'N-Formylmethionine Leucyl-Phenylalanine'), ('akt1', 'NAD'), ('akt1', 'Nickel'), ('akt1', 'Niclosamide'), ('akt1', 'Nicotine'), ('akt1', 'Nifedipine'), ('akt1', 'Nitroprusside'), ('akt1', 'Masoprocol'), ('akt1', 'Novobiocin'), ('akt1', 'Nystatin'), ('akt1', 'Oleanolic Acid'), ('akt1', 'Oligopeptides'), ('akt1', 'Orotic Acid'), ('akt1', 'Oxygen'), ('akt1', 'Ozone'), ('akt1', 'Paraquat'), ('akt1', 'Patulin'), ('akt1', 'Phenolsulfonphthalein'), ('akt1', 'Phloretin'), ('akt1', 'Phloroglucinol'), ('akt1', 'Phosphates'), ('akt1', 'Phytic Acid'), ('akt1', 'Plant Extracts'), ('akt1', 'Polychlorinated Biphenyls'), ('akt1', 'Polycyclic Aromatic Hydrocarbons'), ('akt1', 'Potassium Dichromate'), ('akt1', 'Procaine'), ('akt1', 'Progesterone'), ('akt1', 'Propranolol'), ('akt1', 'Pyocyanine'), ('akt1', 'Pyrethrins'), ('akt1', 'Pyruvaldehyde'), ('akt1', 'Quartz'), ('akt1', 'Quercetin'), ('akt1', 'Ribavirin'), ('akt1', 'Rotenone'), ('akt1', 'Ruthenium'), ('akt1', 'Saponins'), ('akt1', 'Selenium'), ('akt1', 'Silicon Dioxide'), ('akt1', 'Simazine'), ('akt1', 'Smoke'), ('akt1', 'Sodium Fluoride'), ('akt1', 'Stilbenes'), ('akt1', 'Sulindac'), ('akt1', 'Tamoxifen'), ('akt1', 'Taurine'), ('akt1', 'Testosterone'), ('akt1', 'Tetrachlorodibenzodioxin'), ('akt1', 'Tetradecanoylphorbol Acetate'), ('akt1', 'Dronabinol'), ('akt1', 'Thalidomide'), ('akt1', 'Threonine'), ('akt1', 'Tobacco Smoke Pollution'), ('akt1', 'Tosylphenylalanyl Chloromethyl Ketone'), ('akt1', 'Tretinoin'), ('akt1', 'Trichloroethylene'), ('akt1', 'Triglycerides'), ('akt1', 'Triiodothyronine'), ('akt1', 'Tunicamycin'), ('akt1', 'Ursodeoxycholic Acid'), ('akt1', 'Valproic Acid'), ('akt1', 'Vanadates'), ('akt1', 'Vanillic Acid'), ('akt1', 'Vincristine'), ('akt1', 'Vitallium'), ('akt1', 'Vitamin E'), ('akt1', 'Zearalenone'), ('akt1', 'Zinc'), ('akt1', 'Zinc Oxide'), ('akt1', '2-Acetylaminofluorene'), ('akt1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('akt1', '8-Bromo Cyclic Adenosine Monophosphate'), ('akt1', 'Dinoprostone'), ('akt1', 'Thiorphan'), ('akt1', 'Citalopram'), ('akt1', '1-Methyl-4-phenylpyridinium'), ('akt1', 'Metribolone'), ('akt1', 'Propofol'), ('akt1', 'Ionomycin'), ('akt1', 'N-Methylaspartate'), ('akt1', 'Organoselenium Compounds'), ('akt1', 'Cyclosporine'), ('akt1', 'Terfenadine'), ('akt1', 'Aflatoxin B1'), ('akt1', 'Aflatoxin M1'), ('akt1', 'Mitomycin'), ('akt1', 'Leuprolide'), ('akt1', 'Paclitaxel'), ('akt1', 'Foscarnet'), ('akt1', 'Fenretinide'), ('akt1', 'Asbestos, Serpentine'), ('akt1', 'Asbestos, Crocidolite'), ('akt1', 'Lithium Chloride'), ('akt1', 'Sodium Selenite'), ('akt1', 'beta Carotene'), ('akt1', 'Cadmium Chloride'), ('akt1', 'Thapsigargin'), ('akt1', 'Zinc Sulfate'), ('akt1', 'Oleic Acid'), ('akt1', 'Palmitic Acid'), ('akt1', 'Staurosporine'), ('akt1', 'Okadaic Acid'), ('akt1', 'Copper Sulfate'), ('akt1', '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid'), ('akt1', 'Simvastatin'), ('akt1', 'Genistein'), ('akt1', '1-Butanol'), ('akt1', 'tert-Butylhydroperoxide'), ('akt1', 'Sirolimus'), ('akt1', 'Butyric Acid'), ('akt1', 'Raloxifene Hydrochloride'), ('akt1', 'alpha-Tocopherol'), ('akt1', 'Aristolochic Acids'), ('akt1', 'Pertussis Toxin'), ('akt1', 'Tetrahydroisoquinolines'), ('akt1', 'Apigenin'), ('akt1', 'Luteolin'), ('akt1', 'Chitosan'), ('akt1', 'Betalains'), ('akt1', 'Particulate Matter'), ('akt1', 'Benzophenanthridines'), ('akt1', 'Soot'), ('akt1', 'Equol'), ('akt1', 'Phytochemicals'), ('sirt1', 'Atorvastatin'), ('sirt1', 'Resveratrol'), ('sirt1', 'Wortmannin'), ('sirt1', 'Temozolomide'), ('sirt1', 'Sunitinib'), ('sirt1', 'Arsenic Trioxide'), ('sirt1', 'Fulvestrant'), ('sirt1', 'Lycopene'), ('sirt1', 'Cilostazol'), ('sirt1', 'Acetaminophen'), ('sirt1', 'Acetylcysteine'), ('sirt1', 'Adenosine Triphosphate'), ('sirt1', 'Ethanol'), ('sirt1', 'Amino Acids'), ('sirt1', 'Aspirin'), ('sirt1', 'Atrazine'), ('sirt1', 'Vehicle Emissions'), ('sirt1', 'Bee Venoms'), ('sirt1', 'Berberine'), ('sirt1', 'Cadmium'), ('sirt1', 'Caffeine'), ('sirt1', 'Calcium Oxalate'), ('sirt1', 'Camptothecin'), ('sirt1', 'Capsaicin'), ('sirt1', 'Cisplatin'), ('sirt1', 'Cobalt'), ('sirt1', 'Copper'), ('sirt1', 'Coumestrol'), ('sirt1', 'Cycloheximide'), ('sirt1', 'Dactinomycin'), ('sirt1', 'Deferoxamine'), ('sirt1', 'Dehydroepiandrosterone'), ('sirt1', 'Dexamethasone'), ('sirt1', 'Diethylhexyl Phthalate'), ('sirt1', 'Disulfiram'), ('sirt1', 'Doxorubicin'), ('sirt1', 'Chlorpyrifos'), ('sirt1', 'Enzyme Inhibitors'), ('sirt1', 'Erythropoietin'), ('sirt1', 'Estradiol'), ('sirt1', 'Fenbendazole'), ('sirt1', 'Folic Acid'), ('sirt1', 'Colforsin'), ('sirt1', 'Fructose'), ('sirt1', 'Galactose'), ('sirt1', 'Gallic Acid'), ('sirt1', 'Glucose'), ('sirt1', 'Glutathione'), ('sirt1', 'Hydrocortisone'), ('sirt1', 'Hydrogen'), ('sirt1', 'Hydrogen Peroxide'), ('sirt1', 'Iron'), ('sirt1', 'Isoniazid'), ('sirt1', 'Lipopolysaccharides'), ('sirt1', 'Lithocholic Acid'), ('sirt1', 'Maneb'), ('sirt1', 'Melatonin'), ('sirt1', 'Metformin'), ('sirt1', 'Plicamycin'), ('sirt1', 'NAD'), ('sirt1', 'Niacinamide'), ('sirt1', 'Nicotine'), ('sirt1', 'Nitric Oxide'), ('sirt1', 'Nitroprusside'), ('sirt1', 'Oxygen'), ('sirt1', 'Palmitates'), ('sirt1', 'Phenformin'), ('sirt1', 'Phenobarbital'), ('sirt1', 'Plant Extracts'), ('sirt1', 'Plant Oils'), ('sirt1', 'Polymyxin B'), ('sirt1', 'Fenofibrate'), ('sirt1', 'Quercetin'), ('sirt1', 'Rotenone'), ('sirt1', 'Selenium'), ('sirt1', 'Silicon Dioxide'), ('sirt1', 'Silver'), ('sirt1', 'Sulindac'), ('sirt1', 'Suramin'), ('sirt1', 'Taurine'), ('sirt1', 'Testosterone'), ('sirt1', 'Thimerosal'), ('sirt1', 'Thyroxine'), ('sirt1', 'Tobacco Smoke Pollution'), ('sirt1', 'Triglycerides'), ('sirt1', 'Urethane'), ('sirt1', 'Valproic Acid'), ('sirt1', 'Vitamin E'), ('sirt1', 'Zinc'), ('sirt1', '1-Methyl-3-isobutylxanthine'), ('sirt1', '8-Bromo Cyclic Adenosine Monophosphate'), ('sirt1', 'Dinoprostone'), ('sirt1', 'Dinoprost'), ('sirt1', '1-Methyl-4-phenylpyridinium'), ('sirt1', 'N-Methylaspartate'), ('sirt1', 'Dizocilpine Maleate'), ('sirt1', 'Cyclosporine'), ('sirt1', 'Aflatoxin M1'), ('sirt1', 'Oxidopamine'), ('sirt1', 'Pravastatin'), ('sirt1', 'Paclitaxel'), ('sirt1', 'Medroxyprogesterone Acetate'), ('sirt1', 'Asbestos, Crocidolite'), ('sirt1', 'Cadmium Chloride'), ('sirt1', 'Pyruvic Acid'), ('sirt1', 'Oleic Acid'), ('sirt1', 'Palmitic Acid'), ('sirt1', 'Copper Sulfate'), ('sirt1', 'Phenol'), ('sirt1', 'Genistein'), ('sirt1', 'tert-Butylhydroperoxide'), ('sirt1', 'Sirolimus'), ('sirt1', '3-Hydroxybutyric Acid'), ('sirt1', 'Enzyme Activators'), ('sirt1', 'Vitamin K 3'), ('sirt1', 'Singlet Oxygen'), ('sirt1', 'Ginsenosides'), ('sirt1', 'Particulate Matter'), ('sirt1', 'Benzophenanthridines'), ('sirt1', 'Polyphenols'), ('sirt1', 'Oxaloacetic Acid'), ('mtor', 'Fingolimod Hydrochloride'), ('mtor', 'Imatinib Mesylate'), ('mtor', 'Erlotinib Hydrochloride'), ('mtor', 'Dasatinib'), ('mtor', 'Peanut Oil'), ('mtor', 'Sevoflurane'), ('mtor', 'Oxaliplatin'), ('mtor', 'Gefitinib'), ('mtor', 'Sorafenib'), ('mtor', 'Resveratrol'), ('mtor', 'Wortmannin'), ('mtor', 'Temozolomide'), ('mtor', 'Pioglitazone'), ('mtor', 'Gabapentin'), ('mtor', 'Arsenic Trioxide'), ('mtor', 'Fulvestrant'), ('mtor', 'Letrozole'), ('mtor', 'Artesunate'), ('mtor', 'Vorinostat'), ('mtor', 'Lapatinib'), ('mtor', 'Trabectedin'), ('mtor', 'Homoharringtonine'), ('mtor', 'Acetaldehyde'), ('mtor', 'Acetaminophen'), ('mtor', 'Acetylcysteine'), ('mtor', 'Air Pollutants'), ('mtor', 'Ethanol'), ('mtor', 'alpha-Chlorohydrin'), ('mtor', 'Amino Acids'), ('mtor', 'Amino Acids, Peptides, and Proteins'), ('mtor', 'Amiodarone'), ('mtor', 'Androstenedione'), ('mtor', 'Antimycin A'), ('mtor', 'Arecoline'), ('mtor', 'Arsenic'), ('mtor', 'Aspirin'), ('mtor', 'Azathioprine'), ('mtor', 'Benzo(a)pyrene'), ('mtor', 'Bile Acids and Salts'), ('mtor', 'Biological Products'), ('mtor', 'Cadmium'), ('mtor', 'Caffeine'), ('mtor', 'Camptothecin'), ('mtor', 'Cannabidiol'), ('mtor', 'Capsaicin'), ('mtor', 'Chelating Agents'), ('mtor', 'Chloroquine'), ('mtor', 'Cholecalciferol'), ('mtor', 'Cisplatin'), ('mtor', 'Colchicine'), ('mtor', 'Copper'), ('mtor', 'Curcumin'), ('mtor', 'Daunorubicin'), ('mtor', 'Deferoxamine'), ('mtor', 'Deoxyglucose'), ('mtor', 'Dexamethasone'), ('mtor', 'Diamide'), ('mtor', 'Dieldrin'), ('mtor', 'Diethylhexyl Phthalate'), ('mtor', 'Diethylstilbestrol'), ('mtor', 'Dimercaprol'), ('mtor', 'Diosgenin'), ('mtor', 'Dopamine'), ('mtor', 'Doxorubicin'), ('mtor', 'Ecdysterone'), ('mtor', 'Estradiol'), ('mtor', 'Etoposide'), ('mtor', 'Ficusin'), ('mtor', 'Fluorouracil'), ('mtor', 'Glucose'), ('mtor', 'Gold'), ('mtor', 'Hydrogen Peroxide'), ('mtor', 'Hydroxyurea'), ('mtor', 'Ivermectin'), ('mtor', 'Ketoglutaric Acids'), ('mtor', 'Lead'), ('mtor', 'Lipopolysaccharides'), ('mtor', 'Loperamide'), ('mtor', 'Maleates'), ('mtor', 'Manganese'), ('mtor', 'Melatonin'), ('mtor', 'Metformin'), ('mtor', 'Methamphetamine'), ('mtor', 'Nickel'), ('mtor', 'Niclosamide'), ('mtor', 'Niacinamide'), ('mtor', 'Nicotine'), ('mtor', 'Oleanolic Acid'), ('mtor', 'Oligopeptides'), ('mtor', 'Oxygen'), ('mtor', 'Ozone'), ('mtor', 'Paraquat'), ('mtor', 'Patulin'), ('mtor', 'Perhexiline'), ('mtor', 'Phloretin'), ('mtor', 'Phosphatidic Acids'), ('mtor', 'Plant Oils'), ('mtor', 'Polychlorinated Biphenyls'), ('mtor', 'Polyribonucleotides'), ('mtor', 'Progesterone'), ('mtor', 'Promethazine'), ('mtor', 'Quercetin'), ('mtor', 'Radon'), ('mtor', 'Ribavirin'), ('mtor', 'Rotenone'), ('mtor', 'Ruthenium'), ('mtor', 'Saponins'), ('mtor', 'Serotonin'), ('mtor', 'Stilbenes'), ('mtor', 'Sulfadiazine'), ('mtor', 'Tamoxifen'), ('mtor', 'Tetrachlorodibenzodioxin'), ('mtor', 'Tetradecanoylphorbol Acetate'), ('mtor', 'Tobacco Smoke Pollution'), ('mtor', 'Trifluoperazine'), ('mtor', 'Tunicamycin'), ('mtor', 'Valproic Acid'), ('mtor', 'Thiorphan'), ('mtor', '1-Methyl-4-phenylpyridinium'), ('mtor', 'Mifepristone'), ('mtor', 'Propofol'), ('mtor', 'Dextran Sulfate'), ('mtor', 'Aflatoxin B1'), ('mtor', 'Arachidonic Acid'), ('mtor', 'Pravastatin'), ('mtor', 'Paclitaxel'), ('mtor', 'Photosensitizing Agents'), ('mtor', 'Reactive Oxygen Species'), ('mtor', 'Asbestos, Serpentine'), ('mtor', 'Lithium Chloride'), ('mtor', 'Silver Compounds'), ('mtor', 'Cadmium Chloride'), ('mtor', 'Palmitic Acid'), ('mtor', 'Topotecan'), ('mtor', 'tert-Butylhydroperoxide'), ('mtor', 'Sirolimus'), ('mtor', 'Butyric Acid'), ('mtor', 'Sertraline'), ('mtor', 'Raloxifene Hydrochloride'), ('mtor', 'Flavanones'), ('mtor', 'Betalains'), ('mtor', 'Particulate Matter'), ('mtor', 'Soot'), ('mtor', 'Iron Compounds'), ('eif4ebp1', 'Imatinib Mesylate'), ('eif4ebp1', 'Bortezomib'), ('eif4ebp1', 'Sorafenib'), ('eif4ebp1', 'Resveratrol'), ('eif4ebp1', 'Wortmannin'), ('eif4ebp1', 'Pioglitazone'), ('eif4ebp1', 'Sunitinib'), ('eif4ebp1', 'Arsenic Trioxide'), ('eif4ebp1', 'Letrozole'), ('eif4ebp1', 'Acetaldehyde'), ('eif4ebp1', 'Acetaminophen'), ('eif4ebp1', 'Acetylcysteine'), ('eif4ebp1', 'Acrolein'), ('eif4ebp1', 'Air Pollutants'), ('eif4ebp1', 'alpha-Chlorohydrin'), ('eif4ebp1', 'Amino Acids'), ('eif4ebp1', 'Amiodarone'), ('eif4ebp1', 'Antimycin A'), ('eif4ebp1', 'Arecoline'), ('eif4ebp1', 'Arsenic'), ('eif4ebp1', 'Aspirin'), ('eif4ebp1', 'Benzo(a)pyrene'), ('eif4ebp1', 'Berberine'), ('eif4ebp1', 'Caffeine'), ('eif4ebp1', 'Cannabidiol'), ('eif4ebp1', 'Carbamazepine'), ('eif4ebp1', 'Chelating Agents'), ('eif4ebp1', 'Cholecalciferol'), ('eif4ebp1', 'Cholesterol'), ('eif4ebp1', 'Cisplatin'), ('eif4ebp1', 'Copper'), ('eif4ebp1', 'Curcumin'), ('eif4ebp1', 'Cyclophosphamide'), ('eif4ebp1', 'Daunorubicin'), ('eif4ebp1', 'Deoxyglucose'), ('eif4ebp1', 'Dexamethasone'), ('eif4ebp1', 'Diclofenac'), ('eif4ebp1', 'Digitoxin'), ('eif4ebp1', 'Diosgenin'), ('eif4ebp1', 'Doxorubicin'), ('eif4ebp1', 'Enzyme Inhibitors'), ('eif4ebp1', 'Estradiol'), ('eif4ebp1', 'Fluorouracil'), ('eif4ebp1', 'Formaldehyde'), ('eif4ebp1', 'Gossypol'), ('eif4ebp1', 'Hydrogen Peroxide'), ('eif4ebp1', 'Ivermectin'), ('eif4ebp1', 'Maleates'), ('eif4ebp1', 'Melatonin'), ('eif4ebp1', 'Metformin'), ('eif4ebp1', 'Methamphetamine'), ('eif4ebp1', 'Nickel'), ('eif4ebp1', 'Niclosamide'), ('eif4ebp1', 'Niacinamide'), ('eif4ebp1', 'Nicotine'), ('eif4ebp1', 'Oxygen'), ('eif4ebp1', 'Ozone'), ('eif4ebp1', 'Perhexiline'), ('eif4ebp1', 'Phosphates'), ('eif4ebp1', 'Quercetin'), ('eif4ebp1', 'Ribavirin'), ('eif4ebp1', 'Rotenone'), ('eif4ebp1', 'Saponins'), ('eif4ebp1', 'Smoke'), ('eif4ebp1', 'Sorbitol'), ('eif4ebp1', 'Stilbenes'), ('eif4ebp1', 'Testosterone'), ('eif4ebp1', 'Tetradecanoylphorbol Acetate'), ('eif4ebp1', 'Thiophenes'), ('eif4ebp1', 'Thioridazine'), ('eif4ebp1', 'Tobacco Smoke Pollution'), ('eif4ebp1', 'Tretinoin'), ('eif4ebp1', 'Tunicamycin'), ('eif4ebp1', 'Valproic Acid'), ('eif4ebp1', 'Zidovudine'), ('eif4ebp1', 'Thiorphan'), ('eif4ebp1', 'Epirubicin'), ('eif4ebp1', '1-Methyl-4-phenylpyridinium'), ('eif4ebp1', 'Cyclosporine'), ('eif4ebp1', 'Cadmium Chloride'), ('eif4ebp1', 'Lamivudine'), ('eif4ebp1', 'Thapsigargin'), ('eif4ebp1', 'Palmitic Acid'), ('eif4ebp1', 'Copper Sulfate'), ('eif4ebp1', 'Lactic Acid'), ('eif4ebp1', 'Sirolimus'), ('eif4ebp1', 'Volatile Organic Compounds'), ('Celecoxib', 'jun'), ('Celecoxib', 'cdk2'), ('Celecoxib', 'ccnb1'), ('Celecoxib', 'cdk4'), ('Celecoxib', 'h2ax'), ('Celecoxib', 'mapk14'), ('Celecoxib', 'cdkn1b'), ('Celecoxib', 'map2k1'), ('jun', 'Imatinib Mesylate'), ('jun', 'Atorvastatin'), ('jun', 'Bortezomib'), ('jun', 'Dasatinib'), ('jun', 'Atazanavir Sulfate'), ('jun', 'Docetaxel'), ('jun', 'Irinotecan'), ('jun', 'Oxaliplatin'), ('jun', 'Sorafenib'), ('jun', 'Resveratrol'), ('jun', 'Decitabine'), ('jun', 'Arsenic Trioxide'), ('jun', 'Fulvestrant'), ('jun', 'Lycopene'), ('jun', 'Troglitazone'), ('jun', 'Vorinostat'), ('jun', 'Leflunomide'), ('jun', 'Alitretinoin'), ('jun', 'Panobinostat'), ('jun', 'Acetaldehyde'), ('jun', 'Acetaminophen'), ('jun', 'Gemcitabine'), ('jun', 'Acetylcysteine'), ('jun', 'Acrolein'), ('jun', 'Acrylonitrile'), ('jun', 'Cyclic AMP'), ('jun', 'Adenosine Triphosphate'), ('jun', 'Aerosols'), ('jun', 'Air Pollutants'), ('jun', 'Air Pollutants, Occupational'), ('jun', 'Ethanol'), ('jun', 'Aluminum Oxide'), ('jun', 'Amiodarone'), ('jun', 'Amphetamine'), ('jun', 'Anisomycin'), ('jun', 'Antimycin A'), ('jun', 'Apomorphine'), ('jun', 'Arbutin'), ('jun', 'Arsenic'), ('jun', 'Aspirin'), ('jun', 'Atrazine'), ('jun', 'Vehicle Emissions'), ('jun', 'Azathioprine'), ('jun', 'Benzene'), ('jun', 'Hexachlorocyclohexane'), ('jun', 'Benzo(a)pyrene'), ('jun', 'Benzofurans'), ('jun', 'Benzoyl Peroxide'), ('jun', 'Bezafibrate'), ('jun', 'Dicumarol'), ('jun', 'Butylated Hydroxyanisole'), ('jun', 'Cacodylic Acid'), ('jun', 'Cadmium'), ('jun', 'Calcitriol'), ('jun', 'Camptothecin'), ('jun', 'Cannabidiol'), ('jun', 'Cannabinoids'), ('jun', 'Cantharidin'), ('jun', 'Capsaicin'), ('jun', 'Carbamazepine'), ('jun', 'Catechin'), ('jun', 'Chelating Agents'), ('jun', 'Chenodeoxycholic Acid'), ('jun', 'Chloramphenicol'), ('jun', 'Cholic Acids'), ('jun', 'Chromium'), ('jun', 'Cisplatin'), ('jun', 'Citrinin'), ('jun', 'Clofibrate'), ('jun', 'Cocaine'), ('jun', 'Colchicine'), ('jun', 'Copper'), ('jun', 'Coumestrol'), ('jun', 'Curcumin'), ('jun', 'Cytarabine'), ('jun', 'DDT'), ('jun', 'Deferoxamine'), ('jun', 'Dehydroepiandrosterone'), ('jun', 'Demecolcine'), ('jun', 'Deoxycholic Acid'), ('jun', 'Bucladesine'), ('jun', 'Diclofenac'), ('jun', 'Dieldrin'), ('jun', 'Dimethyl Sulfoxide'), ('jun', 'Dinitrochlorobenzene'), ('jun', 'Diquat'), ('jun', 'Disulfiram'), ('jun', 'Dopamine'), ('jun', 'Doxorubicin'), ('jun', 'Drugs, Chinese Herbal'), ('jun', 'Chlorpyrifos'), ('jun', 'Dust'), ('jun', 'Ellagic Acid'), ('jun', 'Endosulfan'), ('jun', 'Enzyme Inhibitors'), ('jun', 'Epoxy Compounds'), ('jun', 'Estradiol'), ('jun', 'Ethacrynic Acid'), ('jun', 'Ethinyl Estradiol'), ('jun', 'Ethyl Methanesulfonate'), ('jun', 'Etoposide'), ('jun', 'Fenthion'), ('jun', 'Fish Oils'), ('jun', 'Fluorouracil'), ('jun', 'Fluoxetine'), ('jun', 'Folic Acid'), ('jun', 'Formaldehyde'), ('jun', 'Gallic Acid'), ('jun', 'Glucosamine'), ('jun', 'Glucose'), ('jun', 'Glutathione'), ('jun', 'Glycochenodeoxycholic Acid'), ('jun', 'Glycocholic Acid'), ('jun', 'Glycodeoxycholic Acid'), ('jun', 'Gold'), ('jun', 'Hemin'), ('jun', 'Heparin'), ('jun', 'Heptachlor'), ('jun', 'Hyaluronic Acid'), ('jun', 'Hydrogen Peroxide'), ('jun', 'Hydroxychloroquine'), ('jun', 'Indomethacin'), ('jun', 'Clioquinol'), ('jun', 'Iron'), ('jun', 'Isoflavones'), ('jun', 'Lead'), ('jun', 'Lipopolysaccharides'), ('jun', 'Manganese'), ('jun', 'Mechlorethamine'), ('jun', 'Melitten'), ('jun', 'Menthol'), ('jun', 'Metformin'), ('jun', 'Methamphetamine'), ('jun', 'Methohexital'), ('jun', 'Methotrexate'), ('jun', 'Methyl Methanesulfonate'), ('jun', 'Methyltestosterone'), ('jun', 'Minocycline'), ('jun', 'Mitoxantrone'), ('jun', 'Monocrotophos'), ('jun', 'Morphine'), ('jun', 'N-Nitrosopyrrolidine'), ('jun', 'Naphthoquinones'), ('jun', 'Nickel'), ('jun', 'Niclosamide'), ('jun', 'Nicotine'), ('jun', 'Nitrogen Oxides'), ('jun', 'Masoprocol'), ('jun', 'Oligomycins'), ('jun', 'Ouabain'), ('jun', 'Oxygen'), ('jun', 'Ozone'), ('jun', 'Paraquat'), ('jun', 'Pentobarbital'), ('jun', 'Pentosan Sulfuric Polyester'), ('jun', 'Pesticides'), ('jun', 'Phenobarbital'), ('jun', 'Phenylmercuric Acetate'), ('jun', 'Vitamin K 1'), ('jun', 'Plant Extracts'), ('jun', 'Polychlorinated Biphenyls'), ('jun', 'Polycyclic Aromatic Hydrocarbons'), ('jun', 'Potassium Dichromate'), ('jun', 'Fenofibrate'), ('jun', 'Prodigiosin'), ('jun', 'Quercetin'), ('jun', 'Razoxane'), ('jun', 'Rifampin'), ('jun', 'Rotenone'), ('jun', 'Rutin'), ('jun', 'Secobarbital'), ('jun', 'Selegiline'), ('jun', 'Silicon Dioxide'), ('jun', 'Silver'), ('jun', 'Smoke'), ('jun', 'Sorbitol'), ('jun', 'T-2 Toxin'), ('jun', 'Tamoxifen'), ('jun', 'Tartrazine'), ('jun', 'Taurolithocholic Acid'), ('jun', 'Tetrachlorodibenzodioxin'), ('jun', 'Tetrachloroethylene'), ('jun', 'Tetradecanoylphorbol Acetate'), ('jun', 'Dronabinol'), ('jun', 'Thalidomide'), ('jun', 'Thiamylal'), ('jun', 'Thimerosal'), ('jun', 'Thiopental'), ('jun', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('jun', 'Tobacco Smoke Pollution'), ('jun', 'Tretinoin'), ('jun', 'Triclosan'), ('jun', 'Tunicamycin'), ('jun', 'Urethane'), ('jun', 'Valproic Acid'), ('jun', 'Vinblastine'), ('jun', 'Vincristine'), ('jun', 'Vitallium'), ('jun', 'Vitamin D'), ('jun', 'Vitamin E'), ('jun', 'Zinc'), ('jun', 'Zinc Oxide'), ('jun', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('jun', 'Nimustine'), ('jun', '1-Methyl-4-phenylpyridinium'), ('jun', 'Nocodazole'), ('jun', 'Ionomycin'), ('jun', 'Organoselenium Compounds'), ('jun', 'Cyclosporine'), ('jun', 'Aflatoxin B1'), ('jun', 'Oxidopamine'), ('jun', 'Arachidonic Acid'), ('jun', 'Paclitaxel'), ('jun', 'Dimaprit'), ('jun', 'Fenretinide'), ('jun', 'Reactive Oxygen Species'), ('jun', 'Asbestos, Crocidolite'), ('jun', 'Silver Compounds'), ('jun', 'Sodium Selenite'), ('jun', 'Antirheumatic Agents'), ('jun', 'Cadmium Chloride'), ('jun', 'Thapsigargin'), ('jun', 'Zinc Sulfate'), ('jun', '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine'), ('jun', 'Palmitic Acid'), ('jun', 'Okadaic Acid'), ('jun', 'beta-Naphthoflavone'), ('jun', 'Copper Sulfate'), ('jun', 'Buthionine Sulfoximine'), ('jun', 'Lactic Acid'), ('jun', 'Ritonavir'), ('jun', 'Topotecan'), ('jun', 'Simvastatin'), ('jun', 'Genistein'), ('jun', '2-Propanol'), ('jun', 'Styrene'), ('jun', 'Chlorodiphenyl (54% Chlorine)'), ('jun', 'tert-Butylhydroperoxide'), ('jun', 'Butyric Acid'), ('jun', 'p-Chloromercuribenzoic Acid'), ('jun', 'Sertraline'), ('jun', 'Raloxifene Hydrochloride'), ('jun', 'Vitamin K 3'), ('jun', 'alpha-Tocopherol'), ('jun', 'Apigenin'), ('jun', 'Luteolin'), ('jun', 'Hydrolyzable Tannins'), ('jun', 'Ferrosoferric Oxide'), ('jun', 'Particulate Matter'), ('jun', 'Benzophenanthridines'), ('jun', 'Soot'), ('jun', 'Volatile Organic Compounds'), ('cdk2', 'Imatinib Mesylate'), ('cdk2', 'Bortezomib'), ('cdk2', 'Dasatinib'), ('cdk2', 'Docetaxel'), ('cdk2', 'Oxaliplatin'), ('cdk2', 'Rosiglitazone'), ('cdk2', 'Sorafenib'), ('cdk2', 'Resveratrol'), ('cdk2', 'Wortmannin'), ('cdk2', 'Pioglitazone'), ('cdk2', 'Sunitinib'), ('cdk2', 'Arsenic Trioxide'), ('cdk2', 'Fulvestrant'), ('cdk2', 'Troglitazone'), ('cdk2', 'Lapatinib'), ('cdk2', 'Silybin'), ('cdk2', 'Orlistat'), ('cdk2', 'Roscovitine'), ('cdk2', '2-Methoxyestradiol'), ('cdk2', 'Deferasirox'), ('cdk2', 'Dronedarone'), ('cdk2', 'Homoharringtonine'), ('cdk2', '5-Methoxypsoralen'), ('cdk2', 'Albuterol'), ('cdk2', 'Arsenic'), ('cdk2', 'Aspirin'), ('cdk2', 'Azacitidine'), ('cdk2', 'Benzene'), ('cdk2', 'Benzo(a)pyrene'), ('cdk2', 'Berberine'), ('cdk2', 'Butyrates'), ('cdk2', 'Caffeine'), ('cdk2', 'Calcitriol'), ('cdk2', 'Camptothecin'), ('cdk2', 'Cannabidiol'), ('cdk2', 'Capsaicin'), ('cdk2', 'Carbamazepine'), ('cdk2', 'Carbon Tetrachloride'), ('cdk2', 'Chelating Agents'), ('cdk2', 'Cholecalciferol'), ('cdk2', 'Ciprofloxacin'), ('cdk2', 'Cisplatin'), ('cdk2', 'Leucovorin'), ('cdk2', 'Copper'), ('cdk2', 'Coumestrol'), ('cdk2', 'Curcumin'), ('cdk2', 'Cycloheximide'), ('cdk2', 'DDT'), ('cdk2', 'Deferoxamine'), ('cdk2', 'Demecolcine'), ('cdk2', 'Dexamethasone'), ('cdk2', 'Diclofenac'), ('cdk2', 'Doxorubicin'), ('cdk2', 'Drugs, Chinese Herbal'), ('cdk2', 'Erythrosine'), ('cdk2', 'Estradiol'), ('cdk2', 'Etoposide'), ('cdk2', 'Farnesol'), ('cdk2', 'Fluorouracil'), ('cdk2', 'Folic Acid'), ('cdk2', 'Glutathione'), ('cdk2', 'Hexachlorobenzene'), ('cdk2', 'Histamine'), ('cdk2', 'Hydrogen Peroxide'), ('cdk2', 'Indomethacin'), ('cdk2', 'Ivermectin'), ('cdk2', 'Lovastatin'), ('cdk2', 'Malathion'), ('cdk2', 'Mechlorethamine'), ('cdk2', 'Metformin'), ('cdk2', 'Methotrexate'), ('cdk2', 'Methoxychlor'), ('cdk2', 'Methylcholanthrene'), ('cdk2', 'Mustard Gas'), ('cdk2', 'Nicardipine'), ('cdk2', 'Nickel'), ('cdk2', 'Niclosamide'), ('cdk2', 'Nicotine'), ('cdk2', 'Organotin Compounds'), ('cdk2', 'Ouabain'), ('cdk2', 'Oxygen'), ('cdk2', 'Ozone'), ('cdk2', 'Pentoxifylline'), ('cdk2', 'Phosphatidylcholines'), ('cdk2', 'Piroxicam'), ('cdk2', 'Plant Extracts'), ('cdk2', 'Polychlorinated Biphenyls'), ('cdk2', 'Progestins'), ('cdk2', 'Progesterone'), ('cdk2', 'Quercetin'), ('cdk2', 'Saponins'), ('cdk2', 'Selenium'), ('cdk2', 'Silver'), ('cdk2', 'Silymarin'), ('cdk2', 'Dihydrotestosterone'), ('cdk2', 'Sulindac'), ('cdk2', 'Tamoxifen'), ('cdk2', 'Testosterone'), ('cdk2', 'Tetracaine'), ('cdk2', 'Tetrachlorodibenzodioxin'), ('cdk2', 'Tetradecanoylphorbol Acetate'), ('cdk2', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('cdk2', 'Tretinoin'), ('cdk2', 'Trichloroethylene'), ('cdk2', 'Tunicamycin'), ('cdk2', 'Valproic Acid'), ('cdk2', 'Vinblastine'), ('cdk2', 'Vincristine'), ('cdk2', 'Vitallium'), ('cdk2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdk2', '8-Bromo Cyclic Adenosine Monophosphate'), ('cdk2', 'Mifepristone'), ('cdk2', 'Cyclosporine'), ('cdk2', 'Mitomycin'), ('cdk2', 'Monocrotaline'), ('cdk2', 'Paclitaxel'), ('cdk2', 'Amlodipine'), ('cdk2', 'Antirheumatic Agents'), ('cdk2', 'Cadmium Chloride'), ('cdk2', 'Thapsigargin'), ('cdk2', 'Okadaic Acid'), ('cdk2', 'Citric Acid'), ('cdk2', 'Zinc Acetate'), ('cdk2', 'Ritonavir'), ('cdk2', 'Simvastatin'), ('cdk2', 'Genistein'), ('cdk2', 'Nelfinavir'), ('cdk2', 'Acrylamide'), ('cdk2', 'tert-Butylhydroperoxide'), ('cdk2', 'Sirolimus'), ('cdk2', 'Tocopherols'), ('cdk2', 'Nanotubes, Carbon'), ('cdk2', 'Luteolin'), ('cdk2', 'Particulate Matter'), ('cdk2', 'Polyphenols'), ('cdk2', 'Fungal Polysaccharides'), ('ccnb1', 'Bortezomib'), ('ccnb1', 'Erlotinib Hydrochloride'), ('ccnb1', 'Docetaxel'), ('ccnb1', 'Oxaliplatin'), ('ccnb1', 'Rosiglitazone'), ('ccnb1', 'Resveratrol'), ('ccnb1', 'Wortmannin'), ('ccnb1', 'Temozolomide'), ('ccnb1', 'Pioglitazone'), ('ccnb1', 'Decitabine'), ('ccnb1', 'Sunitinib'), ('ccnb1', 'Zoledronic Acid'), ('ccnb1', 'Arsenic Trioxide'), ('ccnb1', 'Fulvestrant'), ('ccnb1', 'Rimonabant'), ('ccnb1', 'Troglitazone'), ('ccnb1', 'Vorinostat'), ('ccnb1', 'Leflunomide'), ('ccnb1', 'Silybin'), ('ccnb1', 'Vemurafenib'), ('ccnb1', '2-Methoxyestradiol'), ('ccnb1', 'Trabectedin'), ('ccnb1', 'Bexarotene'), ('ccnb1', 'Homoharringtonine'), ('ccnb1', 'Acetaminophen'), ('ccnb1', 'Gemcitabine'), ('ccnb1', 'Betulinic Acid'), ('ccnb1', 'Acetylcysteine'), ('ccnb1', 'Acrolein'), ('ccnb1', 'Air Pollutants'), ('ccnb1', 'Amiloride'), ('ccnb1', 'Amsacrine'), ('ccnb1', 'Anthocyanins'), ('ccnb1', 'Antimycin A'), ('ccnb1', 'Arsenates'), ('ccnb1', 'Arsenic'), ('ccnb1', 'Aspirin'), ('ccnb1', 'Atrazine'), ('ccnb1', 'Azacitidine'), ('ccnb1', 'Azathioprine'), ('ccnb1', 'Benomyl'), ('ccnb1', 'Benzene'), ('ccnb1', 'Benzo(a)pyrene'), ('ccnb1', 'Biphenyl Compounds'), ('ccnb1', 'Butyrates'), ('ccnb1', 'Cadmium'), ('ccnb1', 'Caffeine'), ('ccnb1', 'Calcitriol'), ('ccnb1', 'Camptothecin'), ('ccnb1', 'Cannabidiol'), ('ccnb1', 'Capsaicin'), ('ccnb1', 'Catechin'), ('ccnb1', 'Chelating Agents'), ('ccnb1', 'Ciprofloxacin'), ('ccnb1', 'Cisplatin'), ('ccnb1', 'Citrinin'), ('ccnb1', 'Colchicine'), ('ccnb1', 'Copper'), ('ccnb1', 'Coumestrol'), ('ccnb1', 'Curcumin'), ('ccnb1', 'Cytochalasin B'), ('ccnb1', 'Deferoxamine'), ('ccnb1', 'Demecolcine'), ('ccnb1', 'Dexamethasone'), ('ccnb1', 'Diacetyl'), ('ccnb1', 'Dibutyl Phthalate'), ('ccnb1', 'Bucladesine'), ('ccnb1', 'Digitoxin'), ('ccnb1', 'Doxorubicin'), ('ccnb1', 'Drugs, Chinese Herbal'), ('ccnb1', 'Dust'), ('ccnb1', 'Enzyme Inhibitors'), ('ccnb1', 'Estradiol'), ('ccnb1', 'Etoposide'), ('ccnb1', 'Farnesol'), ('ccnb1', 'Fluorouracil'), ('ccnb1', 'Flurbiprofen'), ('ccnb1', 'Folic Acid'), ('ccnb1', 'Formaldehyde'), ('ccnb1', 'Hydrogen Peroxide'), ('ccnb1', 'Hydroxyurea'), ('ccnb1', 'Indomethacin'), ('ccnb1', 'Ivermectin'), ('ccnb1', 'Latex'), ('ccnb1', 'Lead'), ('ccnb1', 'Lipopolysaccharides'), ('ccnb1', 'Lucanthone'), ('ccnb1', 'Malathion'), ('ccnb1', 'Mechlorethamine'), ('ccnb1', 'Melatonin'), ('ccnb1', 'Metformin'), ('ccnb1', 'Methotrexate'), ('ccnb1', 'Methyl Methanesulfonate'), ('ccnb1', 'Mitotane'), ('ccnb1', 'Mustard Gas'), ('ccnb1', 'N-Nitrosopyrrolidine'), ('ccnb1', 'Nickel'), ('ccnb1', 'Niclosamide'), ('ccnb1', 'Nicotine'), ('ccnb1', 'Organotin Compounds'), ('ccnb1', 'Oxygen'), ('ccnb1', 'Ozone'), ('ccnb1', 'Pentoxifylline'), ('ccnb1', 'Piroxicam'), ('ccnb1', 'Plant Extracts'), ('ccnb1', 'Polyethylene Glycols'), ('ccnb1', 'Progesterone'), ('ccnb1', 'Quercetin'), ('ccnb1', 'Quinolines'), ('ccnb1', 'Retinoids'), ('ccnb1', 'Riboflavin'), ('ccnb1', 'Ribonucleotides'), ('ccnb1', 'Rotenone'), ('ccnb1', 'Selenium'), ('ccnb1', 'Silicon Dioxide'), ('ccnb1', 'Silver'), ('ccnb1', 'Silver Nitrate'), ('ccnb1', 'Silymarin'), ('ccnb1', 'Sterigmatocystin'), ('ccnb1', 'Sulfonamides'), ('ccnb1', 'Sulindac'), ('ccnb1', 'Testosterone'), ('ccnb1', 'Thalidomide'), ('ccnb1', 'Thimerosal'), ('ccnb1', 'Tobacco Smoke Pollution'), ('ccnb1', 'Tretinoin'), ('ccnb1', 'Triazoles'), ('ccnb1', 'Tunicamycin'), ('ccnb1', 'Valproic Acid'), ('ccnb1', 'Vinblastine'), ('ccnb1', 'Vincristine'), ('ccnb1', 'Zinc'), ('ccnb1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ccnb1', 'Zidovudine'), ('ccnb1', '1-Methyl-4-phenylpyridinium'), ('ccnb1', 'Nocodazole'), ('ccnb1', 'Propofol'), ('ccnb1', 'Cyclosporine'), ('ccnb1', 'Aflatoxin B1'), ('ccnb1', 'Mitomycin'), ('ccnb1', 'Monocrotaline'), ('ccnb1', 'Paclitaxel'), ('ccnb1', 'Medroxyprogesterone Acetate'), ('ccnb1', 'Bisphenol A-Glycidyl Methacrylate'), ('ccnb1', 'Asbestos, Crocidolite'), ('ccnb1', 'Silicon Compounds'), ('ccnb1', 'Sodium Selenite'), ('ccnb1', 'Cadmium Chloride'), ('ccnb1', 'Thapsigargin'), ('ccnb1', 'Copper Sulfate'), ('ccnb1', 'Citric Acid'), ('ccnb1', 'Zinc Acetate'), ('ccnb1', 'Ritonavir'), ('ccnb1', 'Topotecan'), ('ccnb1', 'Sodium Azide'), ('ccnb1', 'Genistein'), ('ccnb1', 'Raloxifene Hydrochloride'), ('ccnb1', 'Flavanones'), ('ccnb1', 'Apigenin'), ('ccnb1', 'Luteolin'), ('ccnb1', 'Particulate Matter'), ('ccnb1', 'Volatile Organic Compounds'), ('cdk4', 'Imatinib Mesylate'), ('cdk4', 'Dasatinib'), ('cdk4', 'Rosiglitazone'), ('cdk4', 'Sorafenib'), ('cdk4', 'Resveratrol'), ('cdk4', 'Sunitinib'), ('cdk4', 'Arsenic Trioxide'), ('cdk4', 'Fulvestrant'), ('cdk4', 'Lycopene'), ('cdk4', 'Troglitazone'), ('cdk4', 'Vorinostat'), ('cdk4', 'Silybin'), ('cdk4', 'Orlistat'), ('cdk4', 'Vemurafenib'), ('cdk4', '2-Methoxyestradiol'), ('cdk4', 'Dronedarone'), ('cdk4', 'Acetaminophen'), ('cdk4', 'Acetylcysteine'), ('cdk4', 'Air Pollutants, Occupational'), ('cdk4', 'Albuterol'), ('cdk4', 'Arsenic'), ('cdk4', 'Ascorbic Acid'), ('cdk4', 'Aspirin'), ('cdk4', 'Atrazine'), ('cdk4', 'Azacitidine'), ('cdk4', 'Benzo(a)pyrene'), ('cdk4', 'Berberine'), ('cdk4', 'Bungarotoxins'), ('cdk4', 'Caffeine'), ('cdk4', 'Calcitriol'), ('cdk4', 'Cannabidiol'), ('cdk4', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone'), ('cdk4', 'Chelating Agents'), ('cdk4', 'Cholesterol'), ('cdk4', 'Cisplatin'), ('cdk4', 'Clofibrate'), ('cdk4', 'Clotrimazole'), ('cdk4', 'Copper'), ('cdk4', 'Curcumin'), ('cdk4', 'Dexamethasone'), ('cdk4', 'Diazinon'), ('cdk4', 'Dibutyl Phthalate'), ('cdk4', 'Dihydro-beta-Erythroidine'), ('cdk4', 'Dust'), ('cdk4', 'Emodin'), ('cdk4', 'Enzyme Inhibitors'), ('cdk4', 'Estradiol'), ('cdk4', 'Folic Acid'), ('cdk4', 'Hesperidin'), ('cdk4', 'Hydralazine'), ('cdk4', 'Indomethacin'), ('cdk4', 'Lead'), ('cdk4', 'Melatonin'), ('cdk4', 'Melitten'), ('cdk4', 'Memantine'), ('cdk4', 'Metformin'), ('cdk4', 'Methotrexate'), ('cdk4', 'Nickel'), ('cdk4', 'Niclosamide'), ('cdk4', 'Nicotine'), ('cdk4', 'Nitrogen'), ('cdk4', 'Oxygen'), ('cdk4', 'Ozone'), ('cdk4', 'Plant Extracts'), ('cdk4', 'Quercetin'), ('cdk4', 'Ribonucleotides'), ('cdk4', 'Rotenone'), ('cdk4', 'Selenium'), ('cdk4', 'Silymarin'), ('cdk4', 'Smoke'), ('cdk4', 'Sodium Fluoride'), ('cdk4', 'Sulindac'), ('cdk4', 'Tamoxifen'), ('cdk4', 'Tetracaine'), ('cdk4', 'Tetrachlorodibenzodioxin'), ('cdk4', 'Tetradecanoylphorbol Acetate'), ('cdk4', 'Thimerosal'), ('cdk4', 'Thioacetamide'), ('cdk4', 'Thioridazine'), ('cdk4', 'Tretinoin'), ('cdk4', 'Trichloroethylene'), ('cdk4', 'Tubocurarine'), ('cdk4', 'Urea'), ('cdk4', 'Urethane'), ('cdk4', 'Valproic Acid'), ('cdk4', 'Vitamin E'), ('cdk4', '1-Methyl-3-isobutylxanthine'), ('cdk4', 'Zidovudine'), ('cdk4', '1-Methyl-4-phenylpyridinium'), ('cdk4', 'Cyclosporine'), ('cdk4', 'Aflatoxin B1'), ('cdk4', 'Paclitaxel'), ('cdk4', 'Amlodipine'), ('cdk4', 'Sodium Selenite'), ('cdk4', 'Hexamethonium'), ('cdk4', 'Cadmium Chloride'), ('cdk4', 'Ritonavir'), ('cdk4', 'Glycyrrhizic Acid'), ('cdk4', 'Benzoic Acid'), ('cdk4', 'Simvastatin'), ('cdk4', 'Genistein'), ('cdk4', 'Sirolimus'), ('cdk4', 'Vitamin K 2'), ('cdk4', 'Vitamin K 3'), ('cdk4', 'Tocopherols'), ('cdk4', 'Nanotubes, Carbon'), ('cdk4', 'Chalcones'), ('cdk4', 'Particulate Matter'), ('cdk4', 'Polyphenols'), ('h2ax', 'Imatinib Mesylate'), ('h2ax', 'Bortezomib'), ('h2ax', 'Erlotinib Hydrochloride'), ('h2ax', 'Docetaxel'), ('h2ax', 'Irinotecan'), ('h2ax', 'Oxaliplatin'), ('h2ax', 'Resveratrol'), ('h2ax', 'Wortmannin'), ('h2ax', 'Temozolomide'), ('h2ax', 'Decitabine'), ('h2ax', 'Sunitinib'), ('h2ax', 'Zoledronic Acid'), ('h2ax', 'Arsenic Trioxide'), ('h2ax', 'Fulvestrant'), ('h2ax', 'Troglitazone'), ('h2ax', 'Artesunate'), ('h2ax', 'Vorinostat'), ('h2ax', 'Leflunomide'), ('h2ax', 'Silybin'), ('h2ax', 'Crizotinib'), ('h2ax', '2-Methoxyestradiol'), ('h2ax', 'Fomepizole'), ('h2ax', 'Dronedarone'), ('h2ax', 'Panobinostat'), ('h2ax', 'Clofarabine'), ('h2ax', 'Acetaminophen'), ('h2ax', 'Gemcitabine'), ('h2ax', 'Acetylcysteine'), ('h2ax', 'Acrolein'), ('h2ax', 'Adenosine'), ('h2ax', 'Adenosine Diphosphate'), ('h2ax', 'Adenosine Monophosphate'), ('h2ax', 'Adenosine Triphosphate'), ('h2ax', 'Air Pollutants'), ('h2ax', 'Ethanol'), ('h2ax', 'Aminacrine'), ('h2ax', 'Anthocyanins'), ('h2ax', 'Anthraquinones'), ('h2ax', 'Arsenic'), ('h2ax', 'Ascorbic Acid'), ('h2ax', 'Aspirin'), ('h2ax', 'Azacitidine'), ('h2ax', 'Azathioprine'), ('h2ax', 'Benzo(a)pyrene'), ('h2ax', 'Berberine'), ('h2ax', 'Bleomycin'), ('h2ax', 'Busulfan'), ('h2ax', 'Caffeine'), ('h2ax', 'Calcitriol'), ('h2ax', 'Camptothecin'), ('h2ax', 'Cannabidiol'), ('h2ax', 'Capsaicin'), ('h2ax', 'Carbamates'), ('h2ax', 'Carbamazepine'), ('h2ax', 'Carmustine'), ('h2ax', 'Catechin'), ('h2ax', 'Chlorambucil'), ('h2ax', 'Cholecalciferol'), ('h2ax', 'Cisplatin'), ('h2ax', 'Copper'), ('h2ax', 'Coumestrol'), ('h2ax', 'Curcumin'), ('h2ax', 'Cyclophosphamide'), ('h2ax', 'Cytarabine'), ('h2ax', 'Dactinomycin'), ('h2ax', 'Daunorubicin'), ('h2ax', 'Deoxyglucose'), ('h2ax', 'Dexamethasone'), ('h2ax', 'Diclofenac'), ('h2ax', 'Diethylhexyl Phthalate'), ('h2ax', 'Diethylnitrosamine'), ('h2ax', 'Dihydroxyacetone'), ('h2ax', 'Dimethylformamide'), ('h2ax', 'Dimethylnitrosamine'), ('h2ax', 'Dinitrofluorobenzene'), ('h2ax', 'Disulfiram'), ('h2ax', 'Doxorubicin'), ('h2ax', 'Chlorpyrifos'), ('h2ax', 'Emodin'), ('h2ax', 'Estradiol'), ('h2ax', 'Ethyl Methanesulfonate'), ('h2ax', 'Ethylnitrosourea'), ('h2ax', 'Etoposide'), ('h2ax', 'Fenbendazole'), ('h2ax', 'Fenthion'), ('h2ax', 'Fluorouracil'), ('h2ax', 'Formaldehyde'), ('h2ax', 'Glutathione'), ('h2ax', 'Guanosine'), ('h2ax', 'Guanosine Diphosphate'), ('h2ax', 'Guanosine Triphosphate'), ('h2ax', 'Heterocyclic Compounds, 3-Ring'), ('h2ax', 'Hexachlorobenzene'), ('h2ax', 'Hydrogen Peroxide'), ('h2ax', 'Hydroxyurea'), ('h2ax', 'Inosine'), ('h2ax', 'Inosine Diphosphate'), ('h2ax', 'Clioquinol'), ('h2ax', 'Isoflavones'), ('h2ax', 'Latex'), ('h2ax', 'Lead'), ('h2ax', 'Lovastatin'), ('h2ax', 'Melphalan'), ('h2ax', 'Metformin'), ('h2ax', 'Methapyrilene'), ('h2ax', 'Methotrexate'), ('h2ax', 'Methoxsalen'), ('h2ax', 'Methoxychlor'), ('h2ax', 'Methyl Methanesulfonate'), ('h2ax', 'Methylnitronitrosoguanidine'), ('h2ax', 'Methylnitrosourea'), ('h2ax', 'Mitoxantrone'), ('h2ax', 'Mustard Gas'), ('h2ax', 'N-Nitrosopyrrolidine'), ('h2ax', 'Nickel'), ('h2ax', 'Nicotine'), ('h2ax', 'Nitrogen Mustard Compounds'), ('h2ax', 'Norethindrone'), ('h2ax', 'Ouabain'), ('h2ax', 'Oxygen'), ('h2ax', 'Pentamidine'), ('h2ax', 'Phenobarbital'), ('h2ax', 'Piroxicam'), ('h2ax', 'Plant Extracts'), ('h2ax', 'Polychlorinated Biphenyls'), ('h2ax', 'Potassium Dichromate'), ('h2ax', 'Povidone'), ('h2ax', 'Proadifen'), ('h2ax', 'Propolis'), ('h2ax', 'Propyl Gallate'), ('h2ax', 'Pyrimethamine'), ('h2ax', 'Quercetin'), ('h2ax', 'Retinoids'), ('h2ax', 'Ribavirin'), ('h2ax', 'Rotenone'), ('h2ax', 'Selenium'), ('h2ax', 'Silicon Dioxide'), ('h2ax', 'Silver'), ('h2ax', 'Smoke'), ('h2ax', 'Sodium Salicylate'), ('h2ax', 'Soil Pollutants'), ('h2ax', 'Sterigmatocystin'), ('h2ax', 'Sulindac'), ('h2ax', 'T-2 Toxin'), ('h2ax', 'Testosterone'), ('h2ax', 'Dronabinol'), ('h2ax', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('h2ax', 'Tobacco Smoke Pollution'), ('h2ax', 'Tretinoin'), ('h2ax', 'Trichloroethylene'), ('h2ax', 'Triiodothyronine'), ('h2ax', 'Uridine Diphosphate'), ('h2ax', 'Uridine Triphosphate'), ('h2ax', 'Valproic Acid'), ('h2ax', 'Vanadates'), ('h2ax', 'Vincristine'), ('h2ax', 'Zinc'), ('h2ax', '2-Acetylaminofluorene'), ('h2ax', \"2,2'-Dipyridyl\"), ('h2ax', '4-Nitroquinoline-1-oxide'), ('h2ax', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2ax', '9,10-Dimethyl-1,2-benzanthracene'), ('h2ax', 'Zidovudine'), ('h2ax', 'Nimustine'), ('h2ax', 'Isotretinoin'), ('h2ax', '1-Methyl-4-phenylpyridinium'), ('h2ax', 'Nocodazole'), ('h2ax', 'Metribolone'), ('h2ax', 'Cysteine Proteinase Inhibitors'), ('h2ax', 'Carboplatin'), ('h2ax', 'Cyclosporine'), ('h2ax', 'Aphidicolin'), ('h2ax', 'Aflatoxin B1'), ('h2ax', 'Mitomycin'), ('h2ax', 'Monocrotaline'), ('h2ax', 'Paclitaxel'), ('h2ax', 'Isocyanates'), ('h2ax', 'Silver Compounds'), ('h2ax', 'Sodium Selenite'), ('h2ax', 'N-Methyl-3,4-methylenedioxyamphetamine'), ('h2ax', 'Antineoplastic Agents, Alkylating'), ('h2ax', 'Thapsigargin'), ('h2ax', 'Copper Sulfate'), ('h2ax', 'Topotecan'), ('h2ax', 'Phenol'), ('h2ax', 'Simvastatin'), ('h2ax', 'Genistein'), ('h2ax', 'tert-Butylhydroperoxide'), ('h2ax', 'Sirolimus'), ('h2ax', 'Butyric Acid'), ('h2ax', 'Vitamin K 2'), ('h2ax', 'Vitamin K 3'), ('h2ax', 'Plant Preparations'), ('h2ax', 'Nanotubes, Carbon'), ('h2ax', 'Flavanones'), ('h2ax', 'Luteolin'), ('h2ax', 'Protein Kinase Inhibitors'), ('h2ax', 'Particulate Matter'), ('h2ax', 'Histone Deacetylase Inhibitors'), ('mapk14', 'Atorvastatin'), ('mapk14', 'Bortezomib'), ('mapk14', 'Dasatinib'), ('mapk14', 'Sorafenib'), ('mapk14', 'Resveratrol'), ('mapk14', 'Temozolomide'), ('mapk14', 'Sunitinib'), ('mapk14', 'Arsenic Trioxide'), ('mapk14', 'Fulvestrant'), ('mapk14', 'Lycopene'), ('mapk14', 'Telmisartan'), ('mapk14', 'Vorinostat'), ('mapk14', 'Norethindrone Acetate'), ('mapk14', 'Acetaminophen'), ('mapk14', 'Acetylcysteine'), ('mapk14', 'Acrolein'), ('mapk14', 'Aerosols'), ('mapk14', 'Air Pollutants, Occupational'), ('mapk14', 'Aldosterone'), ('mapk14', 'Allergens'), ('mapk14', 'Allopurinol'), ('mapk14', 'Anisomycin'), ('mapk14', 'Antimycin A'), ('mapk14', 'Arsenic'), ('mapk14', 'Asbestos'), ('mapk14', 'Ascorbic Acid'), ('mapk14', 'Aspirin'), ('mapk14', 'Vehicle Emissions'), ('mapk14', 'Benzalkonium Compounds'), ('mapk14', 'Benzene'), ('mapk14', 'Benzo(a)pyrene'), ('mapk14', 'Butyrates'), ('mapk14', 'Cadmium'), ('mapk14', 'Calcitriol'), ('mapk14', 'Cannabidiol'), ('mapk14', 'Capsaicin'), ('mapk14', 'Carbamazepine'), ('mapk14', 'Carbon Monoxide'), ('mapk14', 'Chloroquine'), ('mapk14', 'Chlorpromazine'), ('mapk14', 'Clotrimazole'), ('mapk14', 'Curcumin'), ('mapk14', 'Cycloheximide'), ('mapk14', 'Cyclophosphamide'), ('mapk14', 'DDT'), ('mapk14', 'Desipramine'), ('mapk14', 'Dexamethasone'), ('mapk14', 'Diclofenac'), ('mapk14', 'Diethylstilbestrol'), ('mapk14', 'Dinitrochlorobenzene'), ('mapk14', 'Dinitrofluorobenzene'), ('mapk14', 'Doxorubicin'), ('mapk14', 'Drugs, Chinese Herbal'), ('mapk14', 'Dust'), ('mapk14', 'Egtazic Acid'), ('mapk14', 'Emetine'), ('mapk14', 'Emodin'), ('mapk14', 'Endosulfan'), ('mapk14', 'Estradiol'), ('mapk14', 'Ethacrynic Acid'), ('mapk14', 'Flurbiprofen'), ('mapk14', 'Formaldehyde'), ('mapk14', 'Glucosamine'), ('mapk14', 'Glucose'), ('mapk14', 'Hemin'), ('mapk14', 'Homocysteine'), ('mapk14', 'Hydrogen Peroxide'), ('mapk14', 'Ibuprofen'), ('mapk14', 'Iohexol'), ('mapk14', 'Iopamidol'), ('mapk14', 'Ivermectin'), ('mapk14', 'Ketoconazole'), ('mapk14', 'Lipopolysaccharides'), ('mapk14', 'Manganese'), ('mapk14', 'Mercuric Chloride'), ('mapk14', 'Metformin'), ('mapk14', 'Methotrexate'), ('mapk14', 'Methylnitronitrosoguanidine'), ('mapk14', 'Mustard Gas'), ('mapk14', 'N-Formylmethionine Leucyl-Phenylalanine'), ('mapk14', 'Naphthyridines'), ('mapk14', 'Nickel'), ('mapk14', 'Oleanolic Acid'), ('mapk14', 'Omeprazole'), ('mapk14', 'Oxygen'), ('mapk14', 'Plant Extracts'), ('mapk14', 'Polysaccharides'), ('mapk14', 'Pyrazoles'), ('mapk14', 'Pyrimidines'), ('mapk14', 'Quercetin'), ('mapk14', 'Rotenone'), ('mapk14', 'Silver'), ('mapk14', 'Sodium Dodecyl Sulfate'), ('mapk14', 'Sorbitol'), ('mapk14', 'Tamoxifen'), ('mapk14', 'Taurodeoxycholic Acid'), ('mapk14', 'Tetrachlorodibenzodioxin'), ('mapk14', 'Tetrachloroethylene'), ('mapk14', 'Tetradecanoylphorbol Acetate'), ('mapk14', 'Thalidomide'), ('mapk14', 'Thimerosal'), ('mapk14', 'Tobacco Smoke Pollution'), ('mapk14', 'Tretinoin'), ('mapk14', 'Trifluoperazine'), ('mapk14', 'Valproic Acid'), ('mapk14', 'Vanadates'), ('mapk14', 'Aflatoxin B1'), ('mapk14', 'Bupropion'), ('mapk14', 'Mitomycin'), ('mapk14', 'Arachidonic Acid'), ('mapk14', 'Paclitaxel'), ('mapk14', 'Fenretinide'), ('mapk14', 'Reactive Oxygen Species'), ('mapk14', 'Asbestos, Serpentine'), ('mapk14', 'Asbestos, Crocidolite'), ('mapk14', 'Silver Compounds'), ('mapk14', 'Cadmium Chloride'), ('mapk14', 'Palmitic Acid'), ('mapk14', 'Copper Sulfate'), ('mapk14', 'Buthionine Sulfoximine'), ('mapk14', 'Lactic Acid'), ('mapk14', 'tert-Butylhydroperoxide'), ('mapk14', 'alpha-Tocopherol'), ('mapk14', 'Fullerenes'), ('mapk14', 'Nanotubes, Carbon'), ('mapk14', 'Protein Kinase Inhibitors'), ('mapk14', 'Particulate Matter'), ('cdkn1b', 'Valsartan'), ('cdkn1b', 'Imatinib Mesylate'), ('cdkn1b', 'Atorvastatin'), ('cdkn1b', 'Bortezomib'), ('cdkn1b', 'Dasatinib'), ('cdkn1b', 'Oxaliplatin'), ('cdkn1b', 'Rosiglitazone'), ('cdkn1b', 'Gefitinib'), ('cdkn1b', 'Sorafenib'), ('cdkn1b', 'Resveratrol'), ('cdkn1b', 'Wortmannin'), ('cdkn1b', 'Temozolomide'), ('cdkn1b', 'Pioglitazone'), ('cdkn1b', 'Decitabine'), ('cdkn1b', 'Zoledronic Acid'), ('cdkn1b', 'Arsenic Trioxide'), ('cdkn1b', 'Fulvestrant'), ('cdkn1b', 'Rimonabant'), ('cdkn1b', 'Troglitazone'), ('cdkn1b', 'Vorinostat'), ('cdkn1b', 'Lapatinib'), ('cdkn1b', 'Silybin'), ('cdkn1b', 'Orlistat'), ('cdkn1b', 'Vemurafenib'), ('cdkn1b', 'Alitretinoin'), ('cdkn1b', '2-Methoxyestradiol'), ('cdkn1b', 'Panobinostat'), ('cdkn1b', 'Gemcitabine'), ('cdkn1b', 'Acetylcysteine'), ('cdkn1b', 'Acrylonitrile'), ('cdkn1b', 'Cyclic AMP'), ('cdkn1b', 'Aniline Compounds'), ('cdkn1b', 'Anthocyanins'), ('cdkn1b', 'Arsenates'), ('cdkn1b', 'Arsenic'), ('cdkn1b', 'Aspartame'), ('cdkn1b', 'Aspirin'), ('cdkn1b', 'Atrazine'), ('cdkn1b', 'Vehicle Emissions'), ('cdkn1b', 'Benzo(a)pyrene'), ('cdkn1b', 'Berberine'), ('cdkn1b', 'Butyrates'), ('cdkn1b', 'Cadmium'), ('cdkn1b', 'Calcitriol'), ('cdkn1b', 'Capsaicin'), ('cdkn1b', 'Carbamazepine'), ('cdkn1b', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone'), ('cdkn1b', 'Chelating Agents'), ('cdkn1b', 'Chenodeoxycholic Acid'), ('cdkn1b', 'Cholecalciferol'), ('cdkn1b', 'Cisplatin'), ('cdkn1b', 'Citrinin'), ('cdkn1b', 'Clotrimazole'), ('cdkn1b', 'Copper'), ('cdkn1b', 'Curcumin'), ('cdkn1b', 'Cyclophosphamide'), ('cdkn1b', 'Cysteine'), ('cdkn1b', 'Cytochalasin B'), ('cdkn1b', 'Deferoxamine'), ('cdkn1b', 'Dexamethasone'), ('cdkn1b', 'Diclofenac'), ('cdkn1b', 'Digitoxin'), ('cdkn1b', 'Dimethyldithiocarbamate'), ('cdkn1b', 'Disulfiram'), ('cdkn1b', 'Doxorubicin'), ('cdkn1b', 'Drugs, Chinese Herbal'), ('cdkn1b', 'Estradiol'), ('cdkn1b', 'Estrogens'), ('cdkn1b', 'Etoposide'), ('cdkn1b', 'Eugenol'), ('cdkn1b', 'Farnesol'), ('cdkn1b', 'Fluorouracil'), ('cdkn1b', 'Fluoxetine'), ('cdkn1b', 'Folic Acid'), ('cdkn1b', 'Formaldehyde'), ('cdkn1b', 'Gallic Acid'), ('cdkn1b', 'Glucocorticoids'), ('cdkn1b', 'Glucose'), ('cdkn1b', 'Gold'), ('cdkn1b', 'Hemin'), ('cdkn1b', 'Heparin'), ('cdkn1b', 'Hesperidin'), ('cdkn1b', 'Hexachlorobenzene'), ('cdkn1b', 'Histamine'), ('cdkn1b', 'Hydrazones'), ('cdkn1b', 'Hydrochloric Acid'), ('cdkn1b', 'Hydroxyurea'), ('cdkn1b', 'Indomethacin'), ('cdkn1b', 'Isoflavones'), ('cdkn1b', 'Ivermectin'), ('cdkn1b', 'Lovastatin'), ('cdkn1b', 'Melatonin'), ('cdkn1b', 'Metformin'), ('cdkn1b', 'Methotrexate'), ('cdkn1b', 'Methoxsalen'), ('cdkn1b', 'Methylcholanthrene'), ('cdkn1b', 'Mimosine'), ('cdkn1b', 'Minocycline'), ('cdkn1b', 'Mycophenolic Acid'), ('cdkn1b', 'Nicotine'), ('cdkn1b', 'Organotin Compounds'), ('cdkn1b', 'Oxygen'), ('cdkn1b', 'Phosphatidylcholines'), ('cdkn1b', 'Phytic Acid'), ('cdkn1b', 'Plant Extracts'), ('cdkn1b', 'Polychlorinated Biphenyls'), ('cdkn1b', 'Polyribonucleotides'), ('cdkn1b', 'Prednisone'), ('cdkn1b', 'Fenofibrate'), ('cdkn1b', 'Progesterone'), ('cdkn1b', 'Pyrimidines'), ('cdkn1b', 'Quercetin'), ('cdkn1b', 'Quinazolines'), ('cdkn1b', 'Silymarin'), ('cdkn1b', 'Smoke'), ('cdkn1b', 'Dihydrotestosterone'), ('cdkn1b', 'Stilbenes'), ('cdkn1b', 'Tamoxifen'), ('cdkn1b', 'Tetrachlorodibenzodioxin'), ('cdkn1b', 'Tetradecanoylphorbol Acetate'), ('cdkn1b', 'Dronabinol'), ('cdkn1b', 'Theophylline'), ('cdkn1b', 'Thiophenes'), ('cdkn1b', 'Tobacco Smoke Pollution'), ('cdkn1b', 'Tretinoin'), ('cdkn1b', 'Triiodothyronine'), ('cdkn1b', 'Valproic Acid'), ('cdkn1b', 'Vanadates'), ('cdkn1b', 'Vitamin E'), ('cdkn1b', '1-Methyl-3-isobutylxanthine'), ('cdkn1b', 'Zidovudine'), ('cdkn1b', 'Mifepristone'), ('cdkn1b', 'Cyclosporine'), ('cdkn1b', 'Terfenadine'), ('cdkn1b', 'Aflatoxin B1'), ('cdkn1b', 'Mitomycin'), ('cdkn1b', 'Paclitaxel'), ('cdkn1b', 'Medroxyprogesterone Acetate'), ('cdkn1b', 'Fenretinide'), ('cdkn1b', 'Gold Compounds'), ('cdkn1b', 'Lithium Chloride'), ('cdkn1b', 'Silver Compounds'), ('cdkn1b', 'Cadmium Chloride'), ('cdkn1b', 'Lamivudine'), ('cdkn1b', 'Palmitic Acid'), ('cdkn1b', 'Staurosporine'), ('cdkn1b', 'Lactic Acid'), ('cdkn1b', 'Zinc Acetate'), ('cdkn1b', 'Ritonavir'), ('cdkn1b', 'Simvastatin'), ('cdkn1b', 'Genistein'), ('cdkn1b', 'Acrylamide'), ('cdkn1b', 'tert-Butylhydroperoxide'), ('cdkn1b', 'Sirolimus'), ('cdkn1b', 'Raloxifene Hydrochloride'), ('cdkn1b', 'Vitamin K 3'), ('cdkn1b', 'gamma-Tocopherol'), ('cdkn1b', 'Luteolin'), ('cdkn1b', 'Particulate Matter'), ('cdkn1b', 'Fungal Polysaccharides'), ('map2k1', 'Bortezomib'), ('map2k1', 'Dasatinib'), ('map2k1', 'Sorafenib'), ('map2k1', 'Resveratrol'), ('map2k1', 'Decitabine'), ('map2k1', 'Sunitinib'), ('map2k1', 'Arsenic Trioxide'), ('map2k1', 'Lycopene'), ('map2k1', 'Troglitazone'), ('map2k1', 'Vorinostat'), ('map2k1', 'Acetylcysteine'), ('map2k1', 'Acrolein'), ('map2k1', 'Air Pollutants'), ('map2k1', 'Antimony Potassium Tartrate'), ('map2k1', 'Aspirin'), ('map2k1', 'Azathioprine'), ('map2k1', 'Hexachlorocyclohexane'), ('map2k1', 'Benzo(a)pyrene'), ('map2k1', 'Butyrates'), ('map2k1', 'Cadmium'), ('map2k1', 'Cannabidiol'), ('map2k1', 'Capsaicin'), ('map2k1', 'Catechin'), ('map2k1', 'Chelating Agents'), ('map2k1', 'Chenodeoxycholic Acid'), ('map2k1', 'Cisplatin'), ('map2k1', 'Cocaine'), ('map2k1', 'Copper'), ('map2k1', 'Curcumin'), ('map2k1', 'Daunorubicin'), ('map2k1', 'Deoxycholic Acid'), ('map2k1', 'Dexamethasone'), ('map2k1', 'Dieldrin'), ('map2k1', 'Diethylstilbestrol'), ('map2k1', 'Dimethyl Sulfoxide'), ('map2k1', 'Diuron'), ('map2k1', 'Doxorubicin'), ('map2k1', 'Drugs, Chinese Herbal'), ('map2k1', 'Endosulfan'), ('map2k1', 'Estradiol'), ('map2k1', 'Ethacrynic Acid'), ('map2k1', 'Ethyl Methanesulfonate'), ('map2k1', 'Flavonoids'), ('map2k1', 'Fluorouracil'), ('map2k1', 'Gallic Acid'), ('map2k1', 'Glycochenodeoxycholic Acid'), ('map2k1', 'Glycocholic Acid'), ('map2k1', 'Glycodeoxycholic Acid'), ('map2k1', 'Gold'), ('map2k1', 'Cyclic GMP'), ('map2k1', 'Heptachlor'), ('map2k1', 'Hyaluronic Acid'), ('map2k1', 'Hydrogen Peroxide'), ('map2k1', 'Ivermectin'), ('map2k1', 'Lead'), ('map2k1', 'Lipopolysaccharides'), ('map2k1', 'Lithocholic Acid'), ('map2k1', 'Menthol'), ('map2k1', 'Oxygen'), ('map2k1', 'Ozone'), ('map2k1', 'Phosphates'), ('map2k1', 'Plant Extracts'), ('map2k1', 'Pyocyanine'), ('map2k1', 'Quercetin'), ('map2k1', 'Dihydrotestosterone'), ('map2k1', 'Sulfates'), ('map2k1', 'Tamoxifen'), ('map2k1', 'Testosterone'), ('map2k1', 'Tetrachlorodibenzodioxin'), ('map2k1', 'Tetradecanoylphorbol Acetate'), ('map2k1', 'Tobacco Smoke Pollution'), ('map2k1', 'Tretinoin'), ('map2k1', 'Urethane'), ('map2k1', 'Mercaptopurine'), ('map2k1', 'Mifepristone'), ('map2k1', 'Cyclosporine'), ('map2k1', 'Crack Cocaine'), ('map2k1', 'Aflatoxin B1'), ('map2k1', 'Mitomycin'), ('map2k1', 'Arachidonic Acid'), ('map2k1', 'Paclitaxel'), ('map2k1', 'Reactive Oxygen Species'), ('map2k1', 'Asbestos, Serpentine'), ('map2k1', 'Asbestos, Crocidolite'), ('map2k1', 'Sodium Selenite'), ('map2k1', 'Cadmium Chloride'), ('map2k1', 'Zinc Sulfate'), ('map2k1', 'Copper Sulfate'), ('map2k1', 'Genistein'), ('map2k1', 'Sirolimus'), ('map2k1', 'Soot'), ('map2k1', 'Volatile Organic Compounds'), ('map2k1', 'Polyphenols'), ('Valsartan', 'tgfb1'), ('Valsartan', 'serpine1'), ('tgfb1', 'Erlotinib Hydrochloride'), ('tgfb1', 'Dasatinib'), ('tgfb1', 'Rosiglitazone'), ('tgfb1', 'Sorafenib'), ('tgfb1', 'Resveratrol'), ('tgfb1', 'Pioglitazone'), ('tgfb1', 'Decitabine'), ('tgfb1', 'Zoledronic Acid'), ('tgfb1', 'Vinorelbine'), ('tgfb1', 'Arsenic Trioxide'), ('tgfb1', 'Carvedilol'), ('tgfb1', 'Fulvestrant'), ('tgfb1', 'Imiquimod'), ('tgfb1', 'Troglitazone'), ('tgfb1', 'Bosentan'), ('tgfb1', 'Lapatinib'), ('tgfb1', 'Orlistat'), ('tgfb1', 'Irbesartan'), ('tgfb1', 'Aluminum Chloride'), ('tgfb1', 'Vemurafenib'), ('tgfb1', 'Alitretinoin'), ('tgfb1', 'Acetaldehyde'), ('tgfb1', 'Sand'), ('tgfb1', 'Acetaminophen'), ('tgfb1', 'Gemcitabine'), ('tgfb1', 'Betulinic Acid'), ('tgfb1', 'Acetylcysteine'), ('tgfb1', 'Adenosine Triphosphate'), ('tgfb1', 'Aerosols'), ('tgfb1', 'Air Pollutants'), ('tgfb1', 'Ethanol'), ('tgfb1', 'Allantoin'), ('tgfb1', 'Allergens'), ('tgfb1', 'Aluminum'), ('tgfb1', 'Aluminum Oxide'), ('tgfb1', 'Amphotericin B'), ('tgfb1', 'Amygdalin'), ('tgfb1', 'Androgens'), ('tgfb1', 'Antimony Sodium Gluconate'), ('tgfb1', 'Antimycin A'), ('tgfb1', 'Arsenic'), ('tgfb1', 'Asbestos'), ('tgfb1', 'Ascorbic Acid'), ('tgfb1', 'Aspirin'), ('tgfb1', 'Vehicle Emissions'), ('tgfb1', 'Azacitidine'), ('tgfb1', 'Azathioprine'), ('tgfb1', 'Benzene'), ('tgfb1', 'Benzo(a)pyrene'), ('tgfb1', 'Bezafibrate'), ('tgfb1', 'Bile Acids and Salts'), ('tgfb1', 'Biological Factors'), ('tgfb1', 'Bleomycin'), ('tgfb1', 'Busulfan'), ('tgfb1', 'Butylated Hydroxytoluene'), ('tgfb1', 'Cacodylic Acid'), ('tgfb1', 'Cadmium'), ('tgfb1', 'Calcitriol'), ('tgfb1', 'Calcium'), ('tgfb1', 'Calcium Chloride'), ('tgfb1', 'Cannabidiol'), ('tgfb1', 'Cantharidin'), ('tgfb1', 'Capsaicin'), ('tgfb1', 'Carbon'), ('tgfb1', 'Cholecalciferol'), ('tgfb1', 'Cholera Toxin'), ('tgfb1', 'Chromium'), ('tgfb1', 'Ciprofloxacin'), ('tgfb1', 'Cisplatin'), ('tgfb1', 'Clofibrate'), ('tgfb1', 'Coal'), ('tgfb1', 'Cobalt'), ('tgfb1', 'Colistin'), ('tgfb1', 'Curcumin'), ('tgfb1', 'Cycloheximide'), ('tgfb1', 'Dactinomycin'), ('tgfb1', 'Dexamethasone'), ('tgfb1', 'Diazinon'), ('tgfb1', 'Dibutyl Phthalate'), ('tgfb1', 'Bucladesine'), ('tgfb1', 'Diethylhexyl Phthalate'), ('tgfb1', 'Succimer'), ('tgfb1', 'Dimethyl Sulfoxide'), ('tgfb1', 'Dipyridamole'), ('tgfb1', 'Cromolyn Sodium'), ('tgfb1', 'Disulfiram'), ('tgfb1', 'Domperidone'), ('tgfb1', 'Doxorubicin'), ('tgfb1', 'Chlorpyrifos'), ('tgfb1', 'Dust'), ('tgfb1', 'Ellagic Acid'), ('tgfb1', 'Emetine'), ('tgfb1', 'Estradiol'), ('tgfb1', 'Fatty Acids, Nonesterified'), ('tgfb1', 'Fluorides'), ('tgfb1', 'Fluorouracil'), ('tgfb1', 'Folic Acid'), ('tgfb1', 'Formaldehyde'), ('tgfb1', 'Colforsin'), ('tgfb1', 'Gadolinium'), ('tgfb1', 'Glucose'), ('tgfb1', 'Glutathione'), ('tgfb1', 'Gold'), ('tgfb1', 'Heptachlor'), ('tgfb1', 'Hexachlorobenzene'), ('tgfb1', 'Hyaluronic Acid'), ('tgfb1', 'Hydrocortisone'), ('tgfb1', 'Hydrogen Peroxide'), ('tgfb1', 'Isoproterenol'), ('tgfb1', 'Ivermectin'), ('tgfb1', 'Latex'), ('tgfb1', 'Lipids'), ('tgfb1', 'Lipopolysaccharides'), ('tgfb1', 'Lithocholic Acid'), ('tgfb1', 'Lovastatin'), ('tgfb1', 'Malondialdehyde'), ('tgfb1', 'Mebendazole'), ('tgfb1', 'Melatonin'), ('tgfb1', 'Mercuric Chloride'), ('tgfb1', 'Methotrexate'), ('tgfb1', 'Methyl Methanesulfonate'), ('tgfb1', 'Methylmercury Compounds'), ('tgfb1', 'Mitotane'), ('tgfb1', 'Mustard Gas'), ('tgfb1', 'Niacin'), ('tgfb1', 'Nickel'), ('tgfb1', 'Niclosamide'), ('tgfb1', 'Ouabain'), ('tgfb1', 'Oxotremorine'), ('tgfb1', 'Oxygen'), ('tgfb1', 'Ozone'), ('tgfb1', 'Paraoxon'), ('tgfb1', 'Paraquat'), ('tgfb1', 'Parathion'), ('tgfb1', 'Perfume'), ('tgfb1', 'Phenylephrine'), ('tgfb1', 'Phenylmercuric Acetate'), ('tgfb1', 'Phloroglucinol'), ('tgfb1', 'Plant Extracts'), ('tgfb1', 'Poly I-C'), ('tgfb1', 'Polycyclic Aromatic Hydrocarbons'), ('tgfb1', 'Polyethyleneimine'), ('tgfb1', 'Polystyrenes'), ('tgfb1', 'Prednisolone'), ('tgfb1', 'Prednisone'), ('tgfb1', 'Probenecid'), ('tgfb1', 'Probucol'), ('tgfb1', 'Fenofibrate'), ('tgfb1', 'Progesterone'), ('tgfb1', 'Quartz'), ('tgfb1', 'Quercetin'), ('tgfb1', 'S-Adenosylmethionine'), ('tgfb1', 'Silicon Dioxide'), ('tgfb1', 'Smoke'), ('tgfb1', 'Sodium Chloride'), ('tgfb1', 'Streptozocin'), ('tgfb1', 'Sulfates'), ('tgfb1', 'Sulindac'), ('tgfb1', 'Superoxides'), ('tgfb1', 'Tamoxifen'), ('tgfb1', 'Taurine'), ('tgfb1', 'Tetrachlorodibenzodioxin'), ('tgfb1', 'Tetradecanoylphorbol Acetate'), ('tgfb1', 'Dronabinol'), ('tgfb1', 'Thalidomide'), ('tgfb1', 'Theophylline'), ('tgfb1', 'Thimerosal'), ('tgfb1', 'Thioacetamide'), ('tgfb1', 'Thiram'), ('tgfb1', 'Thyroxine'), ('tgfb1', '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'), ('tgfb1', 'Titanium'), ('tgfb1', 'Tobacco Smoke Pollution'), ('tgfb1', 'Tosylphenylalanyl Chloromethyl Ketone'), ('tgfb1', 'Tretinoin'), ('tgfb1', 'Triamcinolone Acetonide'), ('tgfb1', 'Triiodothyronine'), ('tgfb1', 'Urethane'), ('tgfb1', 'Uric Acid'), ('tgfb1', 'Valproic Acid'), ('tgfb1', 'Verapamil'), ('tgfb1', 'Vitamin D'), ('tgfb1', 'Zinc'), ('tgfb1', 'Ziram'), ('tgfb1', '1-Methyl-3-isobutylxanthine'), ('tgfb1', '1-Naphthylisothiocyanate'), ('tgfb1', '8-Bromo Cyclic Adenosine Monophosphate'), ('tgfb1', 'Dinoprostone'), ('tgfb1', '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine'), ('tgfb1', '24,25-Dihydroxyvitamin D 3'), ('tgfb1', '1-Methyl-4-phenylpyridinium'), ('tgfb1', 'Ionomycin'), ('tgfb1', 'Tacrolimus'), ('tgfb1', 'Cyclosporine'), ('tgfb1', 'Mitomycin'), ('tgfb1', 'Ramipril'), ('tgfb1', 'Amlodipine'), ('tgfb1', 'Reactive Oxygen Species'), ('tgfb1', 'Asbestos, Serpentine'), ('tgfb1', 'Asbestos, Crocidolite'), ('tgfb1', 'Leukotriene D4'), ('tgfb1', 'Silver Compounds'), ('tgfb1', 'Sodium Selenite'), ('tgfb1', 'Cadmium Chloride'), ('tgfb1', 'Lamivudine'), ('tgfb1', 'Oleic Acid'), ('tgfb1', '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine'), ('tgfb1', 'Palmitic Acid'), ('tgfb1', 'Copper Sulfate'), ('tgfb1', 'Lactic Acid'), ('tgfb1', 'Gadolinium DTPA'), ('tgfb1', 'Losartan'), ('tgfb1', 'Oxalic Acid'), ('tgfb1', 'Xanthine'), ('tgfb1', 'Simvastatin'), ('tgfb1', 'Genistein'), ('tgfb1', 'Polymethyl Methacrylate'), ('tgfb1', 'tert-Butylhydroperoxide'), ('tgfb1', 'Sirolimus'), ('tgfb1', 'Butyric Acid'), ('tgfb1', 'Raloxifene Hydrochloride'), ('tgfb1', 'F2-Isoprostanes'), ('tgfb1', 'Aristolochic Acids'), ('tgfb1', 'Pertussis Toxin'), ('tgfb1', 'Fullerenes'), ('tgfb1', 'Nanotubes, Carbon'), ('tgfb1', 'Particulate Matter'), ('tgfb1', 'Magnetite Nanoparticles'), ('tgfb1', 'Vaccines, Virus-Like Particle'), ('tgfb1', 'Neurokinin-1 Receptor Antagonists'), ('serpine1', 'Atazanavir Sulfate'), ('serpine1', 'Rosiglitazone'), ('serpine1', 'Resveratrol'), ('serpine1', 'Wortmannin'), ('serpine1', 'Temozolomide'), ('serpine1', 'Pioglitazone'), ('serpine1', 'Decitabine'), ('serpine1', 'Sunitinib'), ('serpine1', 'Arsenic Trioxide'), ('serpine1', 'Fulvestrant'), ('serpine1', 'Troglitazone'), ('serpine1', 'Leflunomide'), ('serpine1', 'Alitretinoin'), ('serpine1', 'Norethindrone Acetate'), ('serpine1', 'Acetaminophen'), ('serpine1', 'Aldosterone'), ('serpine1', 'Antimony Potassium Tartrate'), ('serpine1', 'Arsenates'), ('serpine1', 'Arsenic'), ('serpine1', 'Atrazine'), ('serpine1', 'Vehicle Emissions'), ('serpine1', 'Azathioprine'), ('serpine1', 'Benzo(a)pyrene'), ('serpine1', 'Bezafibrate'), ('serpine1', 'Bilirubin'), ('serpine1', 'Biological Factors'), ('serpine1', 'Busulfan'), ('serpine1', 'Butylated Hydroxytoluene'), ('serpine1', 'Cadmium'), ('serpine1', 'Calcitriol'), ('serpine1', 'Calcium'), ('serpine1', 'Cannabidiol'), ('serpine1', 'Cannabinoids'), ('serpine1', 'Capsaicin'), ('serpine1', 'Carbamazepine'), ('serpine1', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone'), ('serpine1', 'Catechin'), ('serpine1', 'Ceramides'), ('serpine1', 'Chelating Agents'), ('serpine1', 'Chenodeoxycholic Acid'), ('serpine1', 'Chloroquine'), ('serpine1', 'Cholic Acids'), ('serpine1', 'Choline'), ('serpine1', 'Cisplatin'), ('serpine1', 'Clofibric Acid'), ('serpine1', 'Cobalt'), ('serpine1', 'Copper'), ('serpine1', 'Curcumin'), ('serpine1', 'Cycloheximide'), ('serpine1', 'Daunorubicin'), ('serpine1', 'Deoxycholic Acid'), ('serpine1', 'Dexamethasone'), ('serpine1', 'Diclofenac'), ('serpine1', 'Dieldrin'), ('serpine1', 'Diethylhexyl Phthalate'), ('serpine1', 'Dinitrochlorobenzene'), ('serpine1', 'Diquat'), ('serpine1', 'Doxorubicin'), ('serpine1', 'Drugs, Chinese Herbal'), ('serpine1', 'Emodin'), ('serpine1', 'Estradiol'), ('serpine1', 'Estrogens, Conjugated (USP)'), ('serpine1', 'Ethinyl Estradiol'), ('serpine1', 'Ethyl Methanesulfonate'), ('serpine1', 'Ferric Compounds'), ('serpine1', 'Flame Retardants'), ('serpine1', 'Folic Acid'), ('serpine1', 'Formaldehyde'), ('serpine1', 'Gasoline'), ('serpine1', 'Glucose'), ('serpine1', 'Glycochenodeoxycholic Acid'), ('serpine1', 'Glycocholic Acid'), ('serpine1', 'Glycodeoxycholic Acid'), ('serpine1', 'Gold'), ('serpine1', 'Hydrogen Peroxide'), ('serpine1', 'Hydroxychloroquine'), ('serpine1', 'Indomethacin'), ('serpine1', 'Lipopolysaccharides'), ('serpine1', 'Magnesium'), ('serpine1', 'Manganese'), ('serpine1', 'Methotrexate'), ('serpine1', 'Methyl Methanesulfonate'), ('serpine1', 'Methylcholanthrene'), ('serpine1', 'N-Nitrosopyrrolidine'), ('serpine1', 'Naphthoquinones'), ('serpine1', 'Niacin'), ('serpine1', 'Nickel'), ('serpine1', 'Nicotine'), ('serpine1', 'Nitrogen'), ('serpine1', 'Norethindrone'), ('serpine1', 'Oxygen'), ('serpine1', 'Ozone'), ('serpine1', 'Paraquat'), ('serpine1', 'Pesticides'), ('serpine1', 'Phenylmercuric Acetate'), ('serpine1', 'Phosphorus'), ('serpine1', 'Plant Extracts'), ('serpine1', 'Poly I-C'), ('serpine1', 'Polychlorinated Biphenyls'), ('serpine1', 'Polycyclic Aromatic Hydrocarbons'), ('serpine1', 'Potassium Dichromate'), ('serpine1', 'Fenofibrate'), ('serpine1', 'Progesterone'), ('serpine1', 'Quercetin'), ('serpine1', 'Rifampin'), ('serpine1', 'Silicon Dioxide'), ('serpine1', 'Silver'), ('serpine1', 'Smoke'), ('serpine1', 'Sodium Dodecyl Sulfate'), ('serpine1', 'Spironolactone'), ('serpine1', 'Dihydrotestosterone'), ('serpine1', 'Sulfonylurea Compounds'), ('serpine1', 'Superoxides'), ('serpine1', 'Tamoxifen'), ('serpine1', 'Tartrazine'), ('serpine1', 'Tetrachlorodibenzodioxin'), ('serpine1', 'Tetradecanoylphorbol Acetate'), ('serpine1', 'Dronabinol'), ('serpine1', 'Thimerosal'), ('serpine1', 'Tobacco Smoke Pollution'), ('serpine1', 'Triclosan'), ('serpine1', 'Valproic Acid'), ('serpine1', 'Vinblastine'), ('serpine1', 'Vincristine'), ('serpine1', 'Vitamin B 12'), ('serpine1', 'Zearalenone'), ('serpine1', 'Zinc'), ('serpine1', '1-Methyl-3-isobutylxanthine'), ('serpine1', '1-Naphthylisothiocyanate'), ('serpine1', '8-Bromo Cyclic Adenosine Monophosphate'), ('serpine1', 'Oxyquinoline'), ('serpine1', 'Gemfibrozil'), ('serpine1', 'Magnesium Chloride'), ('serpine1', 'Mifepristone'), ('serpine1', 'Metribolone'), ('serpine1', 'Cyclosporine'), ('serpine1', 'Aflatoxin B1'), ('serpine1', 'Mitomycin'), ('serpine1', 'Levonorgestrel'), ('serpine1', 'Paclitaxel'), ('serpine1', 'Medroxyprogesterone Acetate'), ('serpine1', 'Asbestos, Amphibole'), ('serpine1', 'Asbestos, Crocidolite'), ('serpine1', 'Hydroxyl Radical'), ('serpine1', 'Zinc Compounds'), ('serpine1', 'Silver Compounds'), ('serpine1', 'Cadmium Chloride'), ('serpine1', 'Oleic Acid'), ('serpine1', 'Palmitic Acid'), ('serpine1', 'beta-Naphthoflavone'), ('serpine1', 'Copper Sulfate'), ('serpine1', 'Lactic Acid'), ('serpine1', 'Topotecan'), ('serpine1', 'Simvastatin'), ('serpine1', 'Genistein'), ('serpine1', '1-Butanol'), ('serpine1', 'tert-Butylhydroperoxide'), ('serpine1', 'Sirolimus'), ('serpine1', 'p-Chloromercuribenzoic Acid'), ('serpine1', 'Raloxifene Hydrochloride'), ('serpine1', 'Fullerenes'), ('serpine1', 'Nanotubes, Carbon'), ('serpine1', 'Particulate Matter'), ('serpine1', 'Halogenated Diphenyl Ethers'), ('Imatinib Mesylate', 'cdk1'), ('Imatinib Mesylate', 'pten'), ('Imatinib Mesylate', 'raf1'), ('cdk1', 'Bortezomib'), ('cdk1', 'Dasatinib'), ('cdk1', 'Docetaxel'), ('cdk1', 'Irinotecan'), ('cdk1', 'Oxaliplatin'), ('cdk1', 'Resveratrol'), ('cdk1', 'Wortmannin'), ('cdk1', 'Temozolomide'), ('cdk1', 'Decitabine'), ('cdk1', 'Sunitinib'), ('cdk1', 'Zoledronic Acid'), ('cdk1', 'Arsenic Trioxide'), ('cdk1', 'Fulvestrant'), ('cdk1', 'Lycopene'), ('cdk1', 'Troglitazone'), ('cdk1', 'Vorinostat'), ('cdk1', 'Leflunomide'), ('cdk1', 'Silybin'), ('cdk1', 'Orlistat'), ('cdk1', 'Roscovitine'), ('cdk1', '2-Methoxyestradiol'), ('cdk1', 'Bexarotene'), ('cdk1', 'Homoharringtonine'), ('cdk1', 'Acetaminophen'), ('cdk1', 'Acetylcysteine'), ('cdk1', 'Aconitine'), ('cdk1', 'Anthocyanins'), ('cdk1', 'Antimycin A'), ('cdk1', 'Arecoline'), ('cdk1', 'Arsenic'), ('cdk1', 'Atropine'), ('cdk1', 'Azacitidine'), ('cdk1', 'Azathioprine'), ('cdk1', 'Benzene'), ('cdk1', 'Benzo(a)pyrene'), ('cdk1', 'Butyrates'), ('cdk1', 'Cadmium'), ('cdk1', 'Caffeine'), ('cdk1', 'Calcitriol'), ('cdk1', 'Camptothecin'), ('cdk1', 'Cannabidiol'), ('cdk1', 'Carbon Tetrachloride'), ('cdk1', 'Chelating Agents'), ('cdk1', 'Chlorambucil'), ('cdk1', 'Chromium'), ('cdk1', 'Cisplatin'), ('cdk1', 'Citrinin'), ('cdk1', 'Leucovorin'), ('cdk1', 'Clofibrate'), ('cdk1', 'Clotrimazole'), ('cdk1', 'Copper'), ('cdk1', 'Coumestrol'), ('cdk1', 'Curcumin'), ('cdk1', 'Cytochalasin B'), ('cdk1', 'Demecolcine'), ('cdk1', 'Dexamethasone'), ('cdk1', 'Diacetyl'), ('cdk1', 'Dianhydrogalactitol'), ('cdk1', 'Dibutyl Phthalate'), ('cdk1', 'Diethylhexyl Phthalate'), ('cdk1', 'Digitoxin'), ('cdk1', 'Doxorubicin'), ('cdk1', 'Drugs, Chinese Herbal'), ('cdk1', 'Ellagic Acid'), ('cdk1', 'Enzyme Inhibitors'), ('cdk1', 'Estradiol'), ('cdk1', 'Amifostine'), ('cdk1', 'Fluorouracil'), ('cdk1', 'Folic Acid'), ('cdk1', 'Gold'), ('cdk1', 'Harmine'), ('cdk1', 'Hydrogen Peroxide'), ('cdk1', 'Ivermectin'), ('cdk1', 'Latex'), ('cdk1', 'Lipopolysaccharides'), ('cdk1', 'Lucanthone'), ('cdk1', 'Mechlorethamine'), ('cdk1', 'Melatonin'), ('cdk1', 'Metformin'), ('cdk1', 'Methotrexate'), ('cdk1', 'Methylnitrosourea'), ('cdk1', 'Mustard Gas'), ('cdk1', 'N-Nitrosopyrrolidine'), ('cdk1', 'Nickel'), ('cdk1', 'Nicotine'), ('cdk1', 'Nitroprusside'), ('cdk1', 'Organotin Compounds'), ('cdk1', 'Oxygen'), ('cdk1', 'Parathion'), ('cdk1', 'Pentoxifylline'), ('cdk1', 'Piroxicam'), ('cdk1', 'Plant Extracts'), ('cdk1', 'Polychlorinated Biphenyls'), ('cdk1', 'Progesterone'), ('cdk1', 'Quercetin'), ('cdk1', 'Quinolines'), ('cdk1', 'Retinoids'), ('cdk1', 'Rotenone'), ('cdk1', 'Selenium'), ('cdk1', 'Silicon Dioxide'), ('cdk1', 'Silver'), ('cdk1', 'Silver Nitrate'), ('cdk1', 'Silymarin'), ('cdk1', 'Sterigmatocystin'), ('cdk1', 'Sulfonamides'), ('cdk1', 'Sulindac'), ('cdk1', 'Tamoxifen'), ('cdk1', 'Testosterone'), ('cdk1', 'Tetrachlorodibenzodioxin'), ('cdk1', 'Dronabinol'), ('cdk1', 'Thalidomide'), ('cdk1', 'Thimerosal'), ('cdk1', 'Tobacco Smoke Pollution'), ('cdk1', 'Tretinoin'), ('cdk1', 'Triazoles'), ('cdk1', 'Tunicamycin'), ('cdk1', 'Urethane'), ('cdk1', 'Vinblastine'), ('cdk1', 'Vincristine'), ('cdk1', 'Vitallium'), ('cdk1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdk1', 'Zidovudine'), ('cdk1', '1-Methyl-4-phenylpyridinium'), ('cdk1', 'Mifepristone'), ('cdk1', 'Nocodazole'), ('cdk1', 'Propofol'), ('cdk1', 'Cyclosporine'), ('cdk1', 'Aflatoxin B1'), ('cdk1', 'Aflatoxin M1'), ('cdk1', 'Monocrotaline'), ('cdk1', 'Paclitaxel'), ('cdk1', 'Fenretinide'), ('cdk1', 'Reactive Oxygen Species'), ('cdk1', 'Bisphenol A-Glycidyl Methacrylate'), ('cdk1', 'Asbestos, Crocidolite'), ('cdk1', 'Silicon Compounds'), ('cdk1', 'gamma-Linolenic Acid'), ('cdk1', 'Cadmium Chloride'), ('cdk1', 'Thapsigargin'), ('cdk1', 'Okadaic Acid'), ('cdk1', 'beta-Naphthoflavone'), ('cdk1', 'Copper Sulfate'), ('cdk1', 'Simvastatin'), ('cdk1', 'Genistein'), ('cdk1', 'Acrylamide'), ('cdk1', 'Sirolimus'), ('cdk1', 'Raloxifene Hydrochloride'), ('cdk1', 'Apigenin'), ('cdk1', 'Luteolin'), ('cdk1', 'Phytoestrogens'), ('cdk1', 'Particulate Matter'), ('pten', 'Rosiglitazone'), ('pten', 'Resveratrol'), ('pten', 'Wortmannin'), ('pten', 'Pioglitazone'), ('pten', 'Decitabine'), ('pten', 'Sunitinib'), ('pten', 'Arsenic Trioxide'), ('pten', 'Fulvestrant'), ('pten', 'Vorinostat'), ('pten', 'Leflunomide'), ('pten', 'Orlistat'), ('pten', 'Cilostazol'), ('pten', 'Norethindrone Acetate'), ('pten', 'Homoharringtonine'), ('pten', '5-Methoxypsoralen'), ('pten', 'Gemcitabine'), ('pten', 'Acetylcysteine'), ('pten', 'Aerosols'), ('pten', 'Antimycin A'), ('pten', 'Arsenic'), ('pten', 'Azacitidine'), ('pten', 'Benzo(a)pyrene'), ('pten', 'Bilirubin'), ('pten', 'Biliverdine'), ('pten', 'Butyrates'), ('pten', 'Camptothecin'), ('pten', 'Cannabidiol'), ('pten', 'Cantharidin'), ('pten', 'Carbamazepine'), ('pten', 'Carbon Monoxide'), ('pten', 'Chelating Agents'), ('pten', 'Cholecalciferol'), ('pten', 'Cisplatin'), ('pten', 'Copper'), ('pten', 'Coumestrol'), ('pten', 'Curcumin'), ('pten', 'Cycloheximide'), ('pten', 'Cytarabine'), ('pten', 'Daunorubicin'), ('pten', 'Dexamethasone'), ('pten', 'Diazinon'), ('pten', 'Diclofenac'), ('pten', 'Dieldrin'), ('pten', 'Diethylhexyl Phthalate'), ('pten', 'Digitoxin'), ('pten', 'Disulfiram'), ('pten', 'Doxorubicin'), ('pten', 'Enzyme Inhibitors'), ('pten', 'Estradiol'), ('pten', 'Estrogens'), ('pten', 'Ethinyl Estradiol'), ('pten', 'Ethyl Methanesulfonate'), ('pten', 'Etoposide'), ('pten', 'Fluorouracil'), ('pten', 'Folic Acid'), ('pten', 'Formaldehyde'), ('pten', 'Gallic Acid'), ('pten', 'Hemin'), ('pten', 'Hydrazones'), ('pten', 'Hydrogen Peroxide'), ('pten', 'Indomethacin'), ('pten', 'Lead'), ('pten', 'Lipopolysaccharides'), ('pten', 'Lovastatin'), ('pten', 'Malondialdehyde'), ('pten', 'Mercuric Chloride'), ('pten', 'Methotrexate'), ('pten', 'Methyl Methanesulfonate'), ('pten', 'Niclosamide'), ('pten', 'Oleanolic Acid'), ('pten', 'Oxygen'), ('pten', 'Phosphatidylcholines'), ('pten', 'Phosphatidylserines'), ('pten', 'Polyribonucleotides'), ('pten', 'Quartz'), ('pten', 'Quercetin'), ('pten', 'Silicon Dioxide'), ('pten', 'Sodium Fluoride'), ('pten', 'Sorbitol'), ('pten', 'Tamoxifen'), ('pten', 'Testosterone'), ('pten', 'Tetrachlorodibenzodioxin'), ('pten', 'Thalidomide'), ('pten', 'Tobacco Smoke Pollution'), ('pten', 'Tretinoin'), ('pten', 'Urethane'), ('pten', 'Valproic Acid'), ('pten', 'Vanadates'), ('pten', 'Zinc'), ('pten', '1-Methyl-3-isobutylxanthine'), ('pten', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('pten', '1-Methyl-4-phenylpyridinium'), ('pten', 'Metribolone'), ('pten', 'Propofol'), ('pten', 'Aflatoxin B1'), ('pten', 'Paclitaxel'), ('pten', 'Cladribine'), ('pten', 'Reactive Oxygen Species'), ('pten', 'Asbestos, Crocidolite'), ('pten', 'Silver Compounds'), ('pten', 'Antirheumatic Agents'), ('pten', 'Cadmium Chloride'), ('pten', 'Zinc Sulfate'), ('pten', 'Copper Sulfate'), ('pten', 'Genistein'), ('pten', 'tert-Butylhydroperoxide'), ('pten', 'Sirolimus'), ('pten', 'Particulate Matter'), ('raf1', 'Bortezomib'), ('raf1', 'Docetaxel'), ('raf1', 'Sorafenib'), ('raf1', 'Resveratrol'), ('raf1', 'Wortmannin'), ('raf1', 'Zoledronic Acid'), ('raf1', 'Arsenic Trioxide'), ('raf1', 'Rimonabant'), ('raf1', 'Vorinostat'), ('raf1', 'Lapatinib'), ('raf1', 'Vemurafenib'), ('raf1', 'Panobinostat'), ('raf1', 'Acetaminophen'), ('raf1', 'Acetylcysteine'), ('raf1', 'Aconitine'), ('raf1', 'Aspirin'), ('raf1', 'Atrazine'), ('raf1', 'Hexachlorocyclohexane'), ('raf1', 'Benzo(a)pyrene'), ('raf1', 'Bungarotoxins'), ('raf1', 'Butyrates'), ('raf1', 'Cacodylic Acid'), ('raf1', 'Cadmium'), ('raf1', 'Caffeine'), ('raf1', 'Cannabidiol'), ('raf1', 'Chelating Agents'), ('raf1', 'Cholecalciferol'), ('raf1', 'Cisplatin'), ('raf1', 'Copper'), ('raf1', 'Deoxycholic Acid'), ('raf1', 'Dieldrin'), ('raf1', 'Dimethyl Sulfoxide'), ('raf1', 'Doxorubicin'), ('raf1', 'Emodin'), ('raf1', 'Endosulfan'), ('raf1', 'Estradiol'), ('raf1', 'Fluorouracil'), ('raf1', 'Folic Acid'), ('raf1', 'Heptachlor'), ('raf1', 'Lovastatin'), ('raf1', 'Menthol'), ('raf1', 'Metformin'), ('raf1', 'Methapyrilene'), ('raf1', 'Niclosamide'), ('raf1', 'Nicotine'), ('raf1', 'Ouabain'), ('raf1', 'Oxygen'), ('raf1', 'Ozone'), ('raf1', 'Phosphates'), ('raf1', 'Plant Extracts'), ('raf1', 'Potassium Dichromate'), ('raf1', 'Progesterone'), ('raf1', 'Quercetin'), ('raf1', 'Saponins'), ('raf1', 'Testosterone'), ('raf1', 'Dronabinol'), ('raf1', 'Thiosemicarbazones'), ('raf1', 'Tretinoin'), ('raf1', 'Tunicamycin'), ('raf1', 'Ursodeoxycholic Acid'), ('raf1', 'Valproic Acid'), ('raf1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('raf1', '1-Methyl-4-phenylpyridinium'), ('raf1', 'Paclitaxel'), ('raf1', 'Asbestos, Crocidolite'), ('raf1', 'Cadmium Chloride'), ('raf1', 'Thapsigargin'), ('raf1', 'Simvastatin'), ('raf1', 'Genistein'), ('raf1', 'Styrene'), ('raf1', 'Chlorodiphenyl (54% Chlorine)'), ('raf1', 'Sirolimus'), ('Atorvastatin', 'mdm2'), ('Atorvastatin', 'pik3ca'), ('mdm2', 'Bortezomib'), ('mdm2', 'Docetaxel'), ('mdm2', 'Irinotecan'), ('mdm2', 'Rosiglitazone'), ('mdm2', 'Sorafenib'), ('mdm2', 'Resveratrol'), ('mdm2', 'Wortmannin'), ('mdm2', 'Decitabine'), ('mdm2', 'Sunitinib'), ('mdm2', 'Arsenic Trioxide'), ('mdm2', 'Vorinostat'), ('mdm2', 'Leflunomide'), ('mdm2', 'Cidofovir'), ('mdm2', 'Acetaminophen'), ('mdm2', 'Gemcitabine'), ('mdm2', 'Amsacrine'), ('mdm2', 'Antimycin A'), ('mdm2', 'Arsenic'), ('mdm2', 'Aspirin'), ('mdm2', 'Vehicle Emissions'), ('mdm2', 'Azacitidine'), ('mdm2', 'Benzene'), ('mdm2', 'Benzo(a)pyrene'), ('mdm2', 'Cacodylic Acid'), ('mdm2', 'Caffeine'), ('mdm2', 'Camptothecin'), ('mdm2', 'Cannabidiol'), ('mdm2', 'Cantharidin'), ('mdm2', 'Capsaicin'), ('mdm2', 'Carbamazepine'), ('mdm2', 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone'), ('mdm2', 'Catechin'), ('mdm2', 'Chelating Agents'), ('mdm2', 'Chlorambucil'), ('mdm2', 'Cisplatin'), ('mdm2', 'Cobalt'), ('mdm2', 'Copper'), ('mdm2', 'Curcumin'), ('mdm2', 'Demecolcine'), ('mdm2', 'Diethylhexyl Phthalate'), ('mdm2', 'Doxorubicin'), ('mdm2', 'Chlorpyrifos'), ('mdm2', 'Estradiol'), ('mdm2', 'Ethinyl Estradiol'), ('mdm2', 'Amifostine'), ('mdm2', 'Ethyl Methanesulfonate'), ('mdm2', 'Etoposide'), ('mdm2', 'Flame Retardants'), ('mdm2', 'Flucytosine'), ('mdm2', 'Fluorouracil'), ('mdm2', 'Folic Acid'), ('mdm2', 'Formaldehyde'), ('mdm2', 'Gold'), ('mdm2', 'Hydrogen Peroxide'), ('mdm2', 'Hydroxyurea'), ('mdm2', 'Ifosfamide'), ('mdm2', 'Lipopolysaccharides'), ('mdm2', 'Methotrexate'), ('mdm2', 'Methyl Methanesulfonate'), ('mdm2', 'Methyl Parathion'), ('mdm2', 'Methylnitronitrosoguanidine'), ('mdm2', 'Mitoxantrone'), ('mdm2', 'Mustard Gas'), ('mdm2', 'Nickel'), ('mdm2', 'Niacinamide'), ('mdm2', 'Nicotine'), ('mdm2', 'Organometallic Compounds'), ('mdm2', 'Ouabain'), ('mdm2', 'Oxygen'), ('mdm2', 'Paraquat'), ('mdm2', 'Parathion'), ('mdm2', 'Phenobarbital'), ('mdm2', 'Phenylmercuric Acetate'), ('mdm2', 'Plant Extracts'), ('mdm2', 'Povidone'), ('mdm2', 'Quercetin'), ('mdm2', 'Rotenone'), ('mdm2', 'Ruthenium'), ('mdm2', 'Silver'), ('mdm2', 'Smoke'), ('mdm2', 'T-2 Toxin'), ('mdm2', 'Tamoxifen'), ('mdm2', 'Tetrachlorodibenzodioxin'), ('mdm2', 'Tobacco Smoke Pollution'), ('mdm2', 'Ursodeoxycholic Acid'), ('mdm2', 'Valproic Acid'), ('mdm2', 'Vincristine'), ('mdm2', 'Vinyl Chloride'), ('mdm2', 'Zinc'), ('mdm2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('mdm2', 'Zidovudine'), ('mdm2', 'Ganciclovir'), ('mdm2', 'Cyclosporine'), ('mdm2', 'Aflatoxin B1'), ('mdm2', 'Aflatoxin M1'), ('mdm2', 'Mitomycin'), ('mdm2', 'Pravastatin'), ('mdm2', 'Paclitaxel'), ('mdm2', 'Fenretinide'), ('mdm2', 'Reactive Oxygen Species'), ('mdm2', 'Asbestos, Amphibole'), ('mdm2', 'Ruthenium Compounds'), ('mdm2', 'Silver Compounds'), ('mdm2', 'Sodium Selenite'), ('mdm2', 'Cadmium Chloride'), ('mdm2', 'Staurosporine'), ('mdm2', 'Zinc Acetate'), ('mdm2', 'Topotecan'), ('mdm2', 'Simvastatin'), ('mdm2', 'tert-Butylhydroperoxide'), ('mdm2', 'Sirolimus'), ('mdm2', 'p-Chloromercuribenzoic Acid'), ('mdm2', 'Raloxifene Hydrochloride'), ('mdm2', 'Vitamin K 3'), ('mdm2', 'Flavanones'), ('mdm2', 'Particulate Matter'), ('mdm2', 'Halogenated Diphenyl Ethers'), ('pik3ca', 'Erlotinib Hydrochloride'), ('pik3ca', 'Sorafenib'), ('pik3ca', 'Resveratrol'), ('pik3ca', 'Wortmannin'), ('pik3ca', 'Pioglitazone'), ('pik3ca', 'Sunitinib'), ('pik3ca', 'Arsenic Trioxide'), ('pik3ca', 'Homoharringtonine'), ('pik3ca', 'Acetaminophen'), ('pik3ca', 'Adenosine Triphosphate'), ('pik3ca', 'Benzo(a)pyrene'), ('pik3ca', 'Cadmium'), ('pik3ca', 'Calcitriol'), ('pik3ca', 'Cannabidiol'), ('pik3ca', 'Cantharidin'), ('pik3ca', 'Carbamazepine'), ('pik3ca', 'Chelating Agents'), ('pik3ca', 'Cisplatin'), ('pik3ca', 'Copper'), ('pik3ca', 'Curcumin'), ('pik3ca', 'Dexamethasone'), ('pik3ca', 'Diclofenac'), ('pik3ca', 'Dietary Fats'), ('pik3ca', 'Diethylhexyl Phthalate'), ('pik3ca', 'Doxorubicin'), ('pik3ca', 'Drugs, Chinese Herbal'), ('pik3ca', 'Estradiol'), ('pik3ca', 'Hyaluronic Acid'), ('pik3ca', 'Hydrogen Peroxide'), ('pik3ca', 'Ivermectin'), ('pik3ca', 'Metformin'), ('pik3ca', 'Methyl Methanesulfonate'), ('pik3ca', 'Naphthoquinones'), ('pik3ca', 'Niclosamide'), ('pik3ca', 'Nicotine'), ('pik3ca', 'Nitric Oxide'), ('pik3ca', 'Oleanolic Acid'), ('pik3ca', 'Oligosaccharides'), ('pik3ca', 'Organotin Compounds'), ('pik3ca', 'Orotic Acid'), ('pik3ca', 'Plant Extracts'), ('pik3ca', 'Quercetin'), ('pik3ca', 'Sucrose'), ('pik3ca', 'Tamoxifen'), ('pik3ca', 'Thalidomide'), ('pik3ca', 'Thimerosal'), ('pik3ca', 'Tobacco Smoke Pollution'), ('pik3ca', 'Tretinoin'), ('pik3ca', 'Valproic Acid'), ('pik3ca', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('pik3ca', 'Lithium Chloride'), ('pik3ca', 'Cadmium Chloride'), ('pik3ca', 'Phosphatidylinositol 4,5-Diphosphate'), ('pik3ca', 'Copper Sulfate'), ('pik3ca', 'Acrylamide'), ('pik3ca', 'Sirolimus'), ('pik3ca', 'Chitosan'), ('Bortezomib', 'atm'), ('Bortezomib', 'e2f1'), ('Bortezomib', 'rnf2'), ('Bortezomib', 'ehmt2'), ('Bortezomib', 'phc3'), ('Bortezomib', 'tfdp1'), ('Bortezomib', 'vdac1'), ('Bortezomib', 'map2k6'), ('Bortezomib', 'anapc11'), ('Bortezomib', 'mapk9'), ('Bortezomib', 'map2k4'), ('atm', 'Erlotinib Hydrochloride'), ('atm', 'Irinotecan'), ('atm', 'Resveratrol'), ('atm', 'Wortmannin'), ('atm', 'Temozolomide'), ('atm', 'Decitabine'), ('atm', 'Sunitinib'), ('atm', 'Arsenic Trioxide'), ('atm', 'Vorinostat'), ('atm', 'Silybin'), ('atm', 'Bexarotene'), ('atm', 'Clofarabine'), ('atm', 'Acetaminophen'), ('atm', 'Acetylcysteine'), ('atm', 'Acrolein'), ('atm', 'Air Pollutants'), ('atm', 'Anthocyanins'), ('atm', 'Antimycin A'), ('atm', 'Arsenic'), ('atm', 'Asbestos'), ('atm', 'Ascorbic Acid'), ('atm', 'Aspirin'), ('atm', 'Benzo(a)pyrene'), ('atm', 'Dicumarol'), ('atm', 'Bleomycin'), ('atm', 'Busulfan'), ('atm', 'Caffeine'), ('atm', 'Calcitriol'), ('atm', 'Camptothecin'), ('atm', 'Cannabidiol'), ('atm', 'Capsaicin'), ('atm', 'Carbamates'), ('atm', 'Carbonyl Cyanide m-Chlorophenyl Hydrazone'), ('atm', 'Catechin'), ('atm', 'Chelating Agents'), ('atm', 'Chloroquine'), ('atm', 'Cisplatin'), ('atm', 'Copper'), ('atm', 'Curcumin'), ('atm', 'Dactinomycin'), ('atm', 'Daunorubicin'), ('atm', 'Deferoxamine'), ('atm', 'Dianhydrogalactitol'), ('atm', 'Diazinon'), ('atm', 'Diethylhexyl Phthalate'), ('atm', 'Dihydroxyacetone'), ('atm', 'Doxorubicin'), ('atm', 'Drugs, Chinese Herbal'), ('atm', 'Emodin'), ('atm', 'Endosulfan'), ('atm', 'Estradiol'), ('atm', 'Etoposide'), ('atm', 'Fluorouracil'), ('atm', 'Folic Acid'), ('atm', 'Formaldehyde'), ('atm', 'Gallic Acid'), ('atm', 'Gentamicins'), ('atm', 'Gold'), ('atm', 'Hydrogen Peroxide'), ('atm', 'Hydroxyurea'), ('atm', 'Clioquinol'), ('atm', 'Iron'), ('atm', 'Isoflavones'), ('atm', 'Lithium'), ('atm', 'Manganese'), ('atm', 'Menthol'), ('atm', 'Metformin'), ('atm', 'Methoxsalen'), ('atm', 'Mitoxantrone'), ('atm', 'Mustard Gas'), ('atm', 'Naphthoquinones'), ('atm', 'Nicotine'), ('atm', 'Ouabain'), ('atm', 'Ozone'), ('atm', 'Paraquat'), ('atm', 'Paromomycin'), ('atm', 'Pentamidine'), ('atm', 'Polycyclic Aromatic Hydrocarbons'), ('atm', 'Quercetin'), ('atm', 'Retinoids'), ('atm', 'Rifampin'), ('atm', 'Rotenone'), ('atm', 'Silicon Dioxide'), ('atm', 'Silver Nitrate'), ('atm', 'Sodium Fluoride'), ('atm', 'Sterigmatocystin'), ('atm', 'T-2 Toxin'), ('atm', 'Testosterone'), ('atm', 'Thimerosal'), ('atm', 'Tobacco Smoke Pollution'), ('atm', 'Tretinoin'), ('atm', 'Valproic Acid'), ('atm', 'Zinc'), ('atm', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('atm', 'Nocodazole'), ('atm', 'Metribolone'), ('atm', 'Cyclosporine'), ('atm', 'Aflatoxin M1'), ('atm', 'Monocrotaline'), ('atm', 'Asbestos, Amphibole'), ('atm', 'Asbestos, Crocidolite'), ('atm', 'Isocyanates'), ('atm', 'Sodium Selenite'), ('atm', 'Cadmium Chloride'), ('atm', 'Copper Sulfate'), ('atm', 'Zinc Acetate'), ('atm', 'Simvastatin'), ('atm', 'Genistein'), ('atm', 'Acrylamide'), ('atm', 'S-Nitrosoglutathione'), ('atm', 'Aristolochic Acids'), ('atm', 'Nanotubes, Carbon'), ('atm', 'Flavanones'), ('atm', 'Particulate Matter'), ('atm', 'Volatile Organic Compounds'), ('e2f1', 'Gefitinib'), ('e2f1', 'Resveratrol'), ('e2f1', 'Arsenic Trioxide'), ('e2f1', 'Fulvestrant'), ('e2f1', 'Troglitazone'), ('e2f1', 'Cilostazol'), ('e2f1', 'Vemurafenib'), ('e2f1', 'Trabectedin'), ('e2f1', 'Acetaminophen'), ('e2f1', 'Acetylcysteine'), ('e2f1', 'Adenine'), ('e2f1', 'Amodiaquine'), ('e2f1', 'Arsenic'), ('e2f1', 'Aspirin'), ('e2f1', 'Atrazine'), ('e2f1', 'Azacitidine'), ('e2f1', 'Benzo(a)pyrene'), ('e2f1', 'Cadmium'), ('e2f1', 'Calcitriol'), ('e2f1', 'Cannabidiol'), ('e2f1', 'Capsaicin'), ('e2f1', 'Carbamazepine'), ('e2f1', 'Carmustine'), ('e2f1', 'Chelating Agents'), ('e2f1', 'Chlorpromazine'), ('e2f1', 'Cisplatin'), ('e2f1', 'Colchicine'), ('e2f1', 'Copper'), ('e2f1', 'Coumestrol'), ('e2f1', 'Diclofenac'), ('e2f1', 'Dihydroxyacetone'), ('e2f1', 'Doxorubicin'), ('e2f1', 'Endosulfan'), ('e2f1', 'Estradiol'), ('e2f1', 'Etoposide'), ('e2f1', 'Eugenol'), ('e2f1', 'Fluorouracil'), ('e2f1', 'Harmine'), ('e2f1', 'Heparin'), ('e2f1', 'Hydroxyurea'), ('e2f1', 'Menthol'), ('e2f1', 'Methotrexate'), ('e2f1', 'Methylnitronitrosoguanidine'), ('e2f1', 'Niclosamide'), ('e2f1', 'Nicotine'), ('e2f1', 'Oligomycins'), ('e2f1', 'Oxygen'), ('e2f1', 'Ozone'), ('e2f1', 'Plant Extracts'), ('e2f1', 'Quercetin'), ('e2f1', 'Selenium'), ('e2f1', 'Silicon Dioxide'), ('e2f1', 'Silver Nitrate'), ('e2f1', 'Smoke'), ('e2f1', 'Dihydrotestosterone'), ('e2f1', 'Sulindac'), ('e2f1', 'Tamoxifen'), ('e2f1', 'Testosterone'), ('e2f1', 'Tetrachlorodibenzodioxin'), ('e2f1', 'Dronabinol'), ('e2f1', 'Tobacco Smoke Pollution'), ('e2f1', 'Tretinoin'), ('e2f1', 'Tunicamycin'), ('e2f1', 'Urethane'), ('e2f1', 'Valproic Acid'), ('e2f1', 'Vinblastine'), ('e2f1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('e2f1', 'Mifepristone'), ('e2f1', 'Aflatoxin B1'), ('e2f1', 'Mitomycin'), ('e2f1', 'Monocrotaline'), ('e2f1', 'Paclitaxel'), ('e2f1', 'Asbestos, Amphibole'), ('e2f1', 'Cadmium Chloride'), ('e2f1', 'Thapsigargin'), ('e2f1', 'Oleic Acid'), ('e2f1', 'Copper Sulfate'), ('e2f1', 'Zinc Acetate'), ('e2f1', 'Ritonavir'), ('e2f1', 'Simvastatin'), ('e2f1', 'Acrylamide'), ('e2f1', 'tert-Butylhydroperoxide'), ('e2f1', 'Sirolimus'), ('e2f1', 'Raloxifene Hydrochloride'), ('e2f1', 'Vitamin K 3'), ('e2f1', 'Tocopherols'), ('e2f1', 'Benzophenanthridines'), ('e2f1', 'Magnetite Nanoparticles'), ('rnf2', 'Acetaminophen'), ('rnf2', 'Air Pollutants'), ('rnf2', 'Benzo(a)pyrene'), ('rnf2', 'Caffeine'), ('rnf2', 'Calcitriol'), ('rnf2', 'Diethylstilbestrol'), ('rnf2', 'Doxorubicin'), ('rnf2', 'Fonofos'), ('rnf2', 'Enzyme Inhibitors'), ('rnf2', 'Gold'), ('rnf2', 'Ivermectin'), ('rnf2', 'Nitrogen Dioxide'), ('rnf2', 'Parathion'), ('rnf2', 'Phenobarbital'), ('rnf2', 'Valproic Acid'), ('rnf2', 'Cyclosporine'), ('rnf2', 'Lactic Acid'), ('ehmt2', 'Decitabine'), ('ehmt2', 'Arsenic Trioxide'), ('ehmt2', 'Afatinib'), ('ehmt2', 'Acetaminophen'), ('ehmt2', 'Arsenic'), ('ehmt2', 'Aspirin'), ('ehmt2', 'Benzo(a)pyrene'), ('ehmt2', 'Caffeine'), ('ehmt2', 'Carbamazepine'), ('ehmt2', 'Cisplatin'), ('ehmt2', 'Deferoxamine'), ('ehmt2', 'Doxorubicin'), ('ehmt2', 'Estradiol'), ('ehmt2', 'Hydralazine'), ('ehmt2', 'Ivermectin'), ('ehmt2', 'Lead'), ('ehmt2', 'Lipopolysaccharides'), ('ehmt2', 'Nickel'), ('ehmt2', 'Nitric Oxide'), ('ehmt2', 'Phenylmercuric Acetate'), ('ehmt2', 'Polychlorinated Biphenyls'), ('ehmt2', 'Potassium Dichromate'), ('ehmt2', 'Sulindac'), ('ehmt2', 'Tobacco Smoke Pollution'), ('ehmt2', 'Tretinoin'), ('ehmt2', 'Urethane'), ('ehmt2', 'Valproic Acid'), ('ehmt2', 'Zearalenone'), ('ehmt2', 'Cyclosporine'), ('ehmt2', 'Aflatoxin B1'), ('ehmt2', 'Copper Sulfate'), ('phc3', 'Temozolomide'), ('phc3', 'Leflunomide'), ('phc3', 'Acetaminophen'), ('phc3', 'Cadmium'), ('phc3', 'Caffeine'), ('phc3', 'Doxorubicin'), ('phc3', 'Enzyme Inhibitors'), ('phc3', 'Estradiol'), ('phc3', 'Ethyl Methanesulfonate'), ('phc3', 'Methapyrilene'), ('phc3', 'Methyl Methanesulfonate'), ('phc3', 'Nickel'), ('phc3', 'Valproic Acid'), ('phc3', 'Zinc'), ('phc3', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('phc3', 'Cyclosporine'), ('phc3', 'Aflatoxin B1'), ('phc3', 'Asbestos, Crocidolite'), ('phc3', 'Sodium Selenite'), ('phc3', 'Antirheumatic Agents'), ('phc3', 'Cadmium Chloride'), ('phc3', 'Copper Sulfate'), ('tfdp1', 'Resveratrol'), ('tfdp1', 'Temozolomide'), ('tfdp1', 'Arsenic Trioxide'), ('tfdp1', 'Acetaminophen'), ('tfdp1', 'Acrolein'), ('tfdp1', 'Antimycin A'), ('tfdp1', 'Arsenic'), ('tfdp1', 'Atrazine'), ('tfdp1', 'Azathioprine'), ('tfdp1', 'Benzo(a)pyrene'), ('tfdp1', 'Caffeine'), ('tfdp1', 'Cannabidiol'), ('tfdp1', 'Carbamazepine'), ('tfdp1', 'Carmustine'), ('tfdp1', 'Chlorpromazine'), ('tfdp1', 'Copper'), ('tfdp1', 'Cosmetics'), ('tfdp1', 'Coumestrol'), ('tfdp1', 'Diclofenac'), ('tfdp1', 'Drugs, Chinese Herbal'), ('tfdp1', 'Flame Retardants'), ('tfdp1', 'Fluorouracil'), ('tfdp1', 'Hydralazine'), ('tfdp1', 'Menthol'), ('tfdp1', 'Methapyrilene'), ('tfdp1', 'Methyl Methanesulfonate'), ('tfdp1', 'Mustard Gas'), ('tfdp1', 'Naphthoquinones'), ('tfdp1', 'Nicotine'), ('tfdp1', 'Plasticizers'), ('tfdp1', 'Quercetin'), ('tfdp1', 'Silver Nitrate'), ('tfdp1', 'Smoke'), ('tfdp1', 'Tetrachlorodibenzodioxin'), ('tfdp1', 'Thioacetamide'), ('tfdp1', 'Thiosemicarbazones'), ('tfdp1', 'Tretinoin'), ('tfdp1', 'Valproic Acid'), ('tfdp1', 'Vitallium'), ('tfdp1', '2-Naphthylamine'), ('tfdp1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('tfdp1', '1-Methyl-4-phenylpyridinium'), ('tfdp1', 'Cyclosporine'), ('tfdp1', 'Aflatoxin B1'), ('tfdp1', 'Asbestos, Crocidolite'), ('tfdp1', 'Sodium Selenite'), ('tfdp1', 'Cadmium Chloride'), ('tfdp1', 'tert-Butylhydroperoxide'), ('tfdp1', 'Phytoestrogens'), ('tfdp1', 'Particulate Matter'), ('vdac1', 'Arsenic Trioxide'), ('vdac1', 'Betulinic Acid'), ('vdac1', 'Acetylcysteine'), ('vdac1', 'Adenosine Triphosphate'), ('vdac1', 'Antimycin A'), ('vdac1', 'Ascorbic Acid'), ('vdac1', 'Bee Venoms'), ('vdac1', 'Benzo(a)pyrene'), ('vdac1', 'Cadmium'), ('vdac1', 'Caffeine'), ('vdac1', 'Cannabidiol'), ('vdac1', 'Cisplatin'), ('vdac1', 'Clozapine'), ('vdac1', 'Coumestrol'), ('vdac1', 'Curcumin'), ('vdac1', 'Dexamethasone'), ('vdac1', 'Disulfiram'), ('vdac1', 'Dopamine'), ('vdac1', 'Doxorubicin'), ('vdac1', 'Emodin'), ('vdac1', 'Erythropoietin'), ('vdac1', 'Ethinyl Estradiol'), ('vdac1', 'Formaldehyde'), ('vdac1', 'Hemocyanins'), ('vdac1', 'Homocysteine'), ('vdac1', 'Hydrogen Peroxide'), ('vdac1', 'Indomethacin'), ('vdac1', 'Ivermectin'), ('vdac1', 'Melitten'), ('vdac1', 'Melphalan'), ('vdac1', 'Menthol'), ('vdac1', 'Methyl Methanesulfonate'), ('vdac1', 'Methylmercury Compounds'), ('vdac1', 'Quercetin'), ('vdac1', 'Ribonucleotides'), ('vdac1', 'Rotenone'), ('vdac1', 'Sarin'), ('vdac1', 'Smoke'), ('vdac1', 'Tobacco Smoke Pollution'), ('vdac1', 'Tunicamycin'), ('vdac1', 'Valproic Acid'), ('vdac1', '1-Methyl-3-isobutylxanthine'), ('vdac1', 'Josamycin'), ('vdac1', '1-Methyl-4-phenylpyridinium'), ('vdac1', 'Oxidopamine'), ('vdac1', 'Reactive Oxygen Species'), ('vdac1', \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\"), ('vdac1', 'Cadmium Chloride'), ('vdac1', 'Thapsigargin'), ('vdac1', 'Sertraline'), ('vdac1', 'Vitamin K 3'), ('map2k6', 'Atazanavir Sulfate'), ('map2k6', 'Sevoflurane'), ('map2k6', 'Arsenic Trioxide'), ('map2k6', 'Fulvestrant'), ('map2k6', 'Lycopene'), ('map2k6', 'Troglitazone'), ('map2k6', 'Panobinostat'), ('map2k6', 'Acetaminophen'), ('map2k6', 'Gemcitabine'), ('map2k6', 'Acetylcysteine'), ('map2k6', 'Air Pollutants'), ('map2k6', 'Amino Acids'), ('map2k6', 'Arsenates'), ('map2k6', 'Arsenic'), ('map2k6', 'Arsenicals'), ('map2k6', 'Ascorbic Acid'), ('map2k6', 'Azathioprine'), ('map2k6', 'Benzene'), ('map2k6', 'Benzo(a)pyrene'), ('map2k6', 'Carbamazepine'), ('map2k6', 'Chelating Agents'), ('map2k6', 'Chenodeoxycholic Acid'), ('map2k6', 'Cisplatin'), ('map2k6', 'Copper'), ('map2k6', 'DDT'), ('map2k6', 'Deoxycholic Acid'), ('map2k6', 'Diclofenac'), ('map2k6', 'Diethylhexyl Phthalate'), ('map2k6', 'Doxorubicin'), ('map2k6', 'Estradiol'), ('map2k6', 'Flame Retardants'), ('map2k6', 'Folic Acid'), ('map2k6', 'Glucose'), ('map2k6', 'Glycochenodeoxycholic Acid'), ('map2k6', 'Glycocholic Acid'), ('map2k6', 'Glycodeoxycholic Acid'), ('map2k6', 'Hydrogen Peroxide'), ('map2k6', 'Menthol'), ('map2k6', 'Mercuric Chloride'), ('map2k6', 'Methotrexate'), ('map2k6', 'Mustard Gas'), ('map2k6', 'Ouabain'), ('map2k6', 'Phenylmercuric Acetate'), ('map2k6', 'Progesterone'), ('map2k6', 'Quercetin'), ('map2k6', 'Silicon Dioxide'), ('map2k6', 'Sulfates'), ('map2k6', 'Tartrazine'), ('map2k6', 'Tetrachlorodibenzodioxin'), ('map2k6', 'Tetradecanoylphorbol Acetate'), ('map2k6', 'Tobacco Smoke Pollution'), ('map2k6', 'Tretinoin'), ('map2k6', 'Triclosan'), ('map2k6', 'Urethane'), ('map2k6', 'Valproic Acid'), ('map2k6', 'Vanadium'), ('map2k6', 'Organoselenium Compounds'), ('map2k6', 'Cyclosporine'), ('map2k6', 'Aflatoxin B1'), ('map2k6', 'Fenretinide'), ('map2k6', 'Asbestos, Crocidolite'), ('map2k6', 'Sodium Selenite'), ('map2k6', 'Antirheumatic Agents'), ('map2k6', 'Metals, Heavy'), ('map2k6', 'Cadmium Chloride'), ('map2k6', 'Copper Sulfate'), ('map2k6', 'Genistein'), ('map2k6', 'tert-Butylhydroperoxide'), ('map2k6', 'p-Chloromercuribenzoic Acid'), ('map2k6', 'Raloxifene Hydrochloride'), ('map2k6', 'Soot'), ('map2k6', 'Halogenated Diphenyl Ethers'), ('map2k6', 'Coal Ash'), ('anapc11', 'Acrolein'), ('anapc11', 'Air Pollutants'), ('anapc11', 'Chelating Agents'), ('anapc11', 'Copper'), ('anapc11', 'Doxorubicin'), ('anapc11', 'Estradiol'), ('anapc11', 'Gallic Acid'), ('anapc11', 'Hydralazine'), ('anapc11', 'Ozone'), ('anapc11', 'Smoke'), ('anapc11', 'Tretinoin'), ('anapc11', 'Tunicamycin'), ('anapc11', 'Valproic Acid'), ('anapc11', 'Cyclosporine'), ('anapc11', 'Sodium Selenite'), ('anapc11', 'Copper Sulfate'), ('anapc11', 'Lactic Acid'), ('anapc11', 'Chlorodiphenyl (54% Chlorine)'), ('anapc11', 'Volatile Organic Compounds'), ('mapk9', 'Antineoplastic Agents, Immunological'), ('mapk9', 'Sorafenib'), ('mapk9', 'Resveratrol'), ('mapk9', 'Temozolomide'), ('mapk9', 'Sunitinib'), ('mapk9', 'Arsenic Trioxide'), ('mapk9', 'Silybin'), ('mapk9', 'Eucalyptol'), ('mapk9', 'Acetaldehyde'), ('mapk9', 'Acetaminophen'), ('mapk9', 'Acetylcysteine'), ('mapk9', 'Adenosine Diphosphate'), ('mapk9', 'Air Pollutants'), ('mapk9', 'Ethanol'), ('mapk9', 'Anisomycin'), ('mapk9', 'Arsenic'), ('mapk9', 'Ascorbic Acid'), ('mapk9', 'Vehicle Emissions'), ('mapk9', 'Benzo(a)pyrene'), ('mapk9', 'Biological Products'), ('mapk9', 'Dicumarol'), ('mapk9', 'Cadmium'), ('mapk9', 'Caffeine'), ('mapk9', 'Camptothecin'), ('mapk9', 'Cannabidiol'), ('mapk9', 'Capsaicin'), ('mapk9', 'Chenodeoxycholic Acid'), ('mapk9', 'Chromones'), ('mapk9', 'Cisplatin'), ('mapk9', 'Citrinin'), ('mapk9', 'Colchicine'), ('mapk9', 'Copper'), ('mapk9', 'Curcumin'), ('mapk9', 'DDT'), ('mapk9', 'Deferoxamine'), ('mapk9', 'Deoxycholic Acid'), ('mapk9', 'Diatrizoate'), ('mapk9', 'Dietary Fats'), ('mapk9', 'Dinitrofluorobenzene'), ('mapk9', 'Disulfiram'), ('mapk9', 'Doxorubicin'), ('mapk9', 'Drugs, Chinese Herbal'), ('mapk9', 'Egtazic Acid'), ('mapk9', 'Ellagic Acid'), ('mapk9', 'Enzyme Inhibitors'), ('mapk9', 'Estradiol'), ('mapk9', 'Formaldehyde'), ('mapk9', 'Gallic Acid'), ('mapk9', 'Glycochenodeoxycholic Acid'), ('mapk9', 'Glycocholic Acid'), ('mapk9', 'Glycodeoxycholic Acid'), ('mapk9', 'Hesperidin'), ('mapk9', 'Homocysteine'), ('mapk9', 'Hydrogen Peroxide'), ('mapk9', 'Hypochlorous Acid'), ('mapk9', 'Lead'), ('mapk9', 'Lipopolysaccharides'), ('mapk9', 'Manganese'), ('mapk9', 'Mebendazole'), ('mapk9', 'Melatonin'), ('mapk9', 'Metformin'), ('mapk9', 'Methotrexate'), ('mapk9', 'Methylnitronitrosoguanidine'), ('mapk9', 'Mycophenolic Acid'), ('mapk9', 'Masoprocol'), ('mapk9', 'Oligomycins'), ('mapk9', 'Oligosaccharides'), ('mapk9', 'Oxygen'), ('mapk9', 'Ozone'), ('mapk9', 'Paraquat'), ('mapk9', 'Pentoxifylline'), ('mapk9', 'Eosine I Bluish'), ('mapk9', 'Plant Extracts'), ('mapk9', 'Polycyclic Aromatic Hydrocarbons'), ('mapk9', 'Polysaccharides'), ('mapk9', 'Prodigiosin'), ('mapk9', 'Pyruvaldehyde'), ('mapk9', 'Quercetin'), ('mapk9', 'Rotenone'), ('mapk9', 'Selenium'), ('mapk9', 'Silicon Dioxide'), ('mapk9', 'Smoke'), ('mapk9', 'Sorbitol'), ('mapk9', 'Dihydrotestosterone'), ('mapk9', 'Streptozocin'), ('mapk9', 'Sucrose'), ('mapk9', 'Sulfates'), ('mapk9', 'Tamoxifen'), ('mapk9', 'Tetradecanoylphorbol Acetate'), ('mapk9', 'Thimerosal'), ('mapk9', 'Tobacco Smoke Pollution'), ('mapk9', 'Toluene 2,4-Diisocyanate'), ('mapk9', 'Tretinoin'), ('mapk9', 'Triclosan'), ('mapk9', 'Trifluoperazine'), ('mapk9', 'Valproic Acid'), ('mapk9', 'Vinblastine'), ('mapk9', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('mapk9', '1-Methyl-4-phenylpyridinium'), ('mapk9', 'Nocodazole'), ('mapk9', 'Cyclosporine'), ('mapk9', 'Aflatoxin B1'), ('mapk9', 'Oxidopamine'), ('mapk9', 'Fluorescein-5-isothiocyanate'), ('mapk9', 'Paclitaxel'), ('mapk9', 'Fenretinide'), ('mapk9', 'Reactive Oxygen Species'), ('mapk9', 'Asbestos, Serpentine'), ('mapk9', 'Asbestos, Crocidolite'), ('mapk9', 'Sodium Selenite'), ('mapk9', 'Antirheumatic Agents'), ('mapk9', 'Cadmium Chloride'), ('mapk9', 'Palmitic Acid'), ('mapk9', 'Copper Sulfate'), ('mapk9', 'Buthionine Sulfoximine'), ('mapk9', 'tert-Butylhydroperoxide'), ('mapk9', 'alpha-Tocopherol'), ('mapk9', 'Luteolin'), ('mapk9', 'Hydrolyzable Tannins'), ('mapk9', 'Protein Kinase Inhibitors'), ('mapk9', 'Ferrosoferric Oxide'), ('mapk9', 'Particulate Matter'), ('mapk9', 'Soot'), ('map2k4', 'Sorafenib'), ('map2k4', 'Arsenic Trioxide'), ('map2k4', 'Fulvestrant'), ('map2k4', 'Lycopene'), ('map2k4', 'Acetylcysteine'), ('map2k4', 'Antimycin A'), ('map2k4', 'Vehicle Emissions'), ('map2k4', 'Benzo(a)pyrene'), ('map2k4', 'Benzophenoneidum'), ('map2k4', 'Butylated Hydroxyanisole'), ('map2k4', 'Caffeine'), ('map2k4', 'Chelating Agents'), ('map2k4', 'Cisplatin'), ('map2k4', 'Copper'), ('map2k4', 'Curcumin'), ('map2k4', 'Dactinomycin'), ('map2k4', 'Docosahexaenoic Acids'), ('map2k4', 'Doxorubicin'), ('map2k4', 'Endosulfan'), ('map2k4', 'Estradiol'), ('map2k4', 'Fish Oils'), ('map2k4', 'Gallic Acid'), ('map2k4', 'Hydrogen Peroxide'), ('map2k4', 'Indomethacin'), ('map2k4', 'Ivermectin'), ('map2k4', 'Lipopolysaccharides'), ('map2k4', 'Menthol'), ('map2k4', 'Methotrexate'), ('map2k4', 'Polycyclic Aromatic Hydrocarbons'), ('map2k4', 'Quercetin'), ('map2k4', 'Dihydrotestosterone'), ('map2k4', 'Tamoxifen'), ('map2k4', 'Testosterone'), ('map2k4', 'Tobacco Smoke Pollution'), ('map2k4', 'Valproic Acid'), ('map2k4', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('map2k4', 'Aflatoxin B1'), ('map2k4', 'Paclitaxel'), ('map2k4', 'Fenretinide'), ('map2k4', 'Reactive Oxygen Species'), ('map2k4', 'Asbestos, Crocidolite'), ('map2k4', 'Antirheumatic Agents'), ('map2k4', 'Cadmium Chloride'), ('map2k4', 'Acrylamide'), ('map2k4', 'tert-Butylhydroperoxide'), ('map2k4', 'Particulate Matter'), ('cdkn2a', 'Capecitabine'), ('cdkn2a', 'Docetaxel'), ('cdkn2a', 'Irinotecan'), ('cdkn2a', 'Resveratrol'), ('cdkn2a', 'Decitabine'), ('cdkn2a', 'Vinorelbine'), ('cdkn2a', 'Arsenic Trioxide'), ('cdkn2a', 'Acetaminophen'), ('cdkn2a', 'Acetylcysteine'), ('cdkn2a', 'Air Pollutants, Occupational'), ('cdkn2a', 'Ethanol'), ('cdkn2a', 'Arsenates'), ('cdkn2a', 'Arsenic'), ('cdkn2a', 'Arsenicals'), ('cdkn2a', 'Asbestos'), ('cdkn2a', 'Vehicle Emissions'), ('cdkn2a', 'Azacitidine'), ('cdkn2a', 'Benzene'), ('cdkn2a', 'Benzo(a)pyrene'), ('cdkn2a', 'Cacodylic Acid'), ('cdkn2a', 'Cadmium'), ('cdkn2a', 'Cannabidiol'), ('cdkn2a', 'Capsaicin'), ('cdkn2a', 'Carmustine'), ('cdkn2a', 'Chelating Agents'), ('cdkn2a', 'Chloramphenicol'), ('cdkn2a', 'Chromium'), ('cdkn2a', 'Cisplatin'), ('cdkn2a', 'Copper'), ('cdkn2a', 'Curcumin'), ('cdkn2a', 'Cycloheximide'), ('cdkn2a', 'Daunorubicin'), ('cdkn2a', 'Dibutyl Phthalate'), ('cdkn2a', 'Diethylhexyl Phthalate'), ('cdkn2a', 'Dioxins'), ('cdkn2a', 'Diuron'), ('cdkn2a', 'Doxorubicin'), ('cdkn2a', 'Drugs, Chinese Herbal'), ('cdkn2a', 'Estradiol'), ('cdkn2a', 'Fluorides'), ('cdkn2a', 'Fluorouracil'), ('cdkn2a', 'Folic Acid'), ('cdkn2a', 'Gasoline'), ('cdkn2a', 'Glucocorticoids'), ('cdkn2a', 'Glucose'), ('cdkn2a', 'Harmine'), ('cdkn2a', 'Hydralazine'), ('cdkn2a', 'Hydrogen Peroxide'), ('cdkn2a', 'Hydroxyurea'), ('cdkn2a', 'Ivermectin'), ('cdkn2a', 'Menthol'), ('cdkn2a', 'Mustard Gas'), ('cdkn2a', 'Masoprocol'), ('cdkn2a', 'Oxygen'), ('cdkn2a', 'Ozone'), ('cdkn2a', 'Parathion'), ('cdkn2a', 'Pesticides'), ('cdkn2a', 'Phenylmercuric Acetate'), ('cdkn2a', 'Polycyclic Aromatic Hydrocarbons'), ('cdkn2a', 'Potassium Dichromate'), ('cdkn2a', 'Prednisone'), ('cdkn2a', 'Procainamide'), ('cdkn2a', 'Quercetin'), ('cdkn2a', 'Radon'), ('cdkn2a', 'Ribonucleotides'), ('cdkn2a', 'Silver Nitrate'), ('cdkn2a', 'Sodium Fluoride'), ('cdkn2a', 'Tetrachlorodibenzodioxin'), ('cdkn2a', 'Tetradecanoylphorbol Acetate'), ('cdkn2a', 'Dronabinol'), ('cdkn2a', 'Thioridazine'), ('cdkn2a', 'Tobacco Smoke Pollution'), ('cdkn2a', 'Tretinoin'), ('cdkn2a', 'Triclosan'), ('cdkn2a', 'Valproic Acid'), ('cdkn2a', 'Vincristine'), ('cdkn2a', 'Vinyl Chloride'), ('cdkn2a', 'Vitallium'), ('cdkn2a', 'Zearalenone'), ('cdkn2a', 'Zidovudine'), ('cdkn2a', '1-Methyl-4-phenylpyridinium'), ('cdkn2a', 'Metribolone'), ('cdkn2a', 'Aflatoxin B1'), ('cdkn2a', 'Fenretinide'), ('cdkn2a', 'Asbestos, Crocidolite'), ('cdkn2a', 'Lithium Chloride'), ('cdkn2a', 'Sodium Selenite'), ('cdkn2a', 'Metals, Heavy'), ('cdkn2a', 'Cadmium Chloride'), ('cdkn2a', 'Copper Sulfate'), ('cdkn2a', 'Losartan'), ('cdkn2a', 'Vitamin K 2'), ('cdkn2a', 'Vitamin K 3'), ('cdkn2a', 'gamma-Tocopherol'), ('cdkn2a', 'Nanotubes, Carbon'), ('cdkn2a', 'Particulate Matter'), ('Capecitabine', 'rbbp4'), ('rbbp4', 'Temozolomide'), ('rbbp4', 'Arsenic Trioxide'), ('rbbp4', 'Acetaminophen'), ('rbbp4', 'Cadmium'), ('rbbp4', 'Cannabidiol'), ('rbbp4', 'Carbamazepine'), ('rbbp4', 'Clozapine'), ('rbbp4', 'Coumestrol'), ('rbbp4', 'Demecolcine'), ('rbbp4', 'Dexamethasone'), ('rbbp4', 'Diethylhexyl Phthalate'), ('rbbp4', 'Doxorubicin'), ('rbbp4', 'Drugs, Chinese Herbal'), ('rbbp4', 'Estradiol'), ('rbbp4', 'Fluorouracil'), ('rbbp4', 'Formaldehyde'), ('rbbp4', 'Indomethacin'), ('rbbp4', 'Ivermectin'), ('rbbp4', 'Piroxicam'), ('rbbp4', 'Selenium'), ('rbbp4', 'Tetrachlorodibenzodioxin'), ('rbbp4', 'Tretinoin'), ('rbbp4', 'Valproic Acid'), ('rbbp4', 'Vincristine'), ('rbbp4', 'Vitamin E'), ('rbbp4', '1-Methyl-3-isobutylxanthine'), ('rbbp4', 'Cyclosporine'), ('rbbp4', 'Aflatoxin B1'), ('rbbp4', 'Fenretinide'), ('rbbp4', 'Sodium Selenite'), ('rbbp4', 'Cadmium Chloride'), ('Erlotinib Hydrochloride', 'foxo3'), ('Erlotinib Hydrochloride', 'cdk6'), ('foxo3', 'Gefitinib'), ('foxo3', 'Resveratrol'), ('foxo3', 'Wortmannin'), ('foxo3', 'Arsenic Trioxide'), ('foxo3', 'Fulvestrant'), ('foxo3', 'Leflunomide'), ('foxo3', 'Acetaminophen'), ('foxo3', 'Acetylcysteine'), ('foxo3', 'Air Pollutants'), ('foxo3', 'Ethanol'), ('foxo3', 'Ascorbic Acid'), ('foxo3', 'Atrazine'), ('foxo3', 'Benzo(a)pyrene'), ('foxo3', 'Berberine'), ('foxo3', 'Caffeine'), ('foxo3', 'Carbamazepine'), ('foxo3', 'Catechin'), ('foxo3', 'Chelating Agents'), ('foxo3', 'Cisplatin'), ('foxo3', 'Copper'), ('foxo3', 'Coumestrol'), ('foxo3', 'Dichlorodiphenyl Dichloroethylene'), ('foxo3', 'Diatrizoate'), ('foxo3', 'Diazinon'), ('foxo3', 'Diclofenac'), ('foxo3', 'Doxorubicin'), ('foxo3', 'Drugs, Chinese Herbal'), ('foxo3', 'Enzyme Inhibitors'), ('foxo3', 'Estradiol'), ('foxo3', 'Etoposide'), ('foxo3', 'Fluorides'), ('foxo3', 'Fluorouracil'), ('foxo3', 'Gasoline'), ('foxo3', 'Hydrogen'), ('foxo3', 'Hydrogen Peroxide'), ('foxo3', 'Isoflavones'), ('foxo3', 'Lead'), ('foxo3', 'Methapyrilene'), ('foxo3', 'Niacinamide'), ('foxo3', 'Oleanolic Acid'), ('foxo3', 'Organotin Compounds'), ('foxo3', 'Oxygen'), ('foxo3', 'Ozone'), ('foxo3', 'Polycyclic Aromatic Hydrocarbons'), ('foxo3', 'Quercetin'), ('foxo3', 'Selenium'), ('foxo3', 'Silver'), ('foxo3', 'Smoke'), ('foxo3', 'Sodium Fluoride'), ('foxo3', 'Dihydrotestosterone'), ('foxo3', 'Tamoxifen'), ('foxo3', 'Tetrachlorodibenzodioxin'), ('foxo3', 'Tetradecanoylphorbol Acetate'), ('foxo3', 'Tobacco Smoke Pollution'), ('foxo3', 'Tretinoin'), ('foxo3', 'Urethane'), ('foxo3', 'Valproic Acid'), ('foxo3', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('foxo3', '8-Bromo Cyclic Adenosine Monophosphate'), ('foxo3', 'Mifepristone'), ('foxo3', 'Cyclosporine'), ('foxo3', 'Aflatoxin B1'), ('foxo3', 'Medroxyprogesterone Acetate'), ('foxo3', 'Asbestos, Crocidolite'), ('foxo3', 'Cadmium Chloride'), ('foxo3', 'Zinc Sulfate'), ('foxo3', 'Okadaic Acid'), ('foxo3', 'Copper Sulfate'), ('foxo3', 'Zinc Acetate'), ('foxo3', 'Genistein'), ('foxo3', 'Sirolimus'), ('foxo3', 'Raloxifene Hydrochloride'), ('foxo3', 'Nanotubes, Carbon'), ('foxo3', 'Luteolin'), ('foxo3', 'Chitosan'), ('foxo3', 'Particulate Matter'), ('cdk6', 'Dasatinib'), ('cdk6', 'Irinotecan'), ('cdk6', 'Rosiglitazone'), ('cdk6', 'Gefitinib'), ('cdk6', 'Sorafenib'), ('cdk6', 'Resveratrol'), ('cdk6', 'Temozolomide'), ('cdk6', 'Arsenic Trioxide'), ('cdk6', 'Fulvestrant'), ('cdk6', 'Troglitazone'), ('cdk6', 'Vorinostat'), ('cdk6', 'Silybin'), ('cdk6', 'Dronedarone'), ('cdk6', 'Panobinostat'), ('cdk6', 'Acetaminophen'), ('cdk6', 'Betulinic Acid'), ('cdk6', 'Acrolein'), ('cdk6', 'Air Pollutants'), ('cdk6', 'Arsenic'), ('cdk6', 'Atrazine'), ('cdk6', 'Benzo(a)pyrene'), ('cdk6', 'Berberine'), ('cdk6', 'Caffeine'), ('cdk6', 'Cannabidiol'), ('cdk6', 'Cantharidin'), ('cdk6', 'Carbamazepine'), ('cdk6', 'Cisplatin'), ('cdk6', 'Curcumin'), ('cdk6', 'Dexamethasone'), ('cdk6', 'Clodronic Acid'), ('cdk6', 'Diclofenac'), ('cdk6', 'Diethylhexyl Phthalate'), ('cdk6', 'Doxorubicin'), ('cdk6', 'Endosulfan'), ('cdk6', 'Enzyme Inhibitors'), ('cdk6', 'Estradiol'), ('cdk6', 'Ethyl Methanesulfonate'), ('cdk6', 'Eugenol'), ('cdk6', 'Formaldehyde'), ('cdk6', 'Furazolidone'), ('cdk6', 'Hesperidin'), ('cdk6', 'Ibuprofen'), ('cdk6', 'Ifosfamide'), ('cdk6', 'Indomethacin'), ('cdk6', 'Ivermectin'), ('cdk6', 'Methotrexate'), ('cdk6', 'Methyl Methanesulfonate'), ('cdk6', 'Nicotine'), ('cdk6', 'Ouabain'), ('cdk6', 'Oxygen'), ('cdk6', 'Ozone'), ('cdk6', 'Phenylmercuric Acetate'), ('cdk6', 'Plant Extracts'), ('cdk6', 'Potassium Dichromate'), ('cdk6', 'Quercetin'), ('cdk6', 'Dihydrotestosterone'), ('cdk6', 'Sulindac'), ('cdk6', 'Tetracaine'), ('cdk6', 'Tetrachlorodibenzodioxin'), ('cdk6', 'Tetradecanoylphorbol Acetate'), ('cdk6', 'Thimerosal'), ('cdk6', 'Tobacco Smoke Pollution'), ('cdk6', 'Tretinoin'), ('cdk6', 'Triclosan'), ('cdk6', 'Valproic Acid'), ('cdk6', 'Vanadium'), ('cdk6', '1-Methyl-3-isobutylxanthine'), ('cdk6', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdk6', 'Zidovudine'), ('cdk6', '1-Methyl-4-phenylpyridinium'), ('cdk6', 'Cyclosporine'), ('cdk6', 'Cadmium Chloride'), ('cdk6', 'Copper Sulfate'), ('cdk6', 'Ritonavir'), ('cdk6', 'Genistein'), ('cdk6', 'Butyric Acid'), ('cdk6', 'p-Chloromercuribenzoic Acid'), ('cdk6', 'Nanotubes, Carbon'), ('cdk6', 'Particulate Matter'), ('cdk6', 'Volatile Organic Compounds'), ('cdk6', 'Coal Ash'), ('Dasatinib', 'ezh2'), ('Dasatinib', 'h2bc3'), ('Dasatinib', 'h2bc14'), ('Dasatinib', 'h2bc9'), ('Dasatinib', 'cdc25a'), ('Dasatinib', 'hmga2'), ('Dasatinib', 'h1-5'), ('Dasatinib', 'h1-1'), ('Dasatinib', 'h1-4'), ('ezh2', 'Resveratrol'), ('ezh2', 'Sunitinib'), ('ezh2', 'Arsenic Trioxide'), ('ezh2', 'Troglitazone'), ('ezh2', 'Vorinostat'), ('ezh2', 'Vemurafenib'), ('ezh2', 'Acetaminophen'), ('ezh2', 'Acetylcysteine'), ('ezh2', 'Ethanol'), ('ezh2', 'Arsenic'), ('ezh2', 'Arsenicals'), ('ezh2', 'Ascorbic Acid'), ('ezh2', 'Vehicle Emissions'), ('ezh2', 'Azathioprine'), ('ezh2', 'Benzo(a)pyrene'), ('ezh2', 'Calcitriol'), ('ezh2', 'Carmustine'), ('ezh2', 'Cisplatin'), ('ezh2', 'Clorgyline'), ('ezh2', 'Coumestrol'), ('ezh2', 'Dexamethasone'), ('ezh2', 'Bucladesine'), ('ezh2', 'Diethylstilbestrol'), ('ezh2', 'Doxorubicin'), ('ezh2', 'Doxycycline'), ('ezh2', 'Endosulfan'), ('ezh2', 'Estradiol'), ('ezh2', 'Formaldehyde'), ('ezh2', 'Hydrogen Peroxide'), ('ezh2', 'Lead'), ('ezh2', 'Lipopolysaccharides'), ('ezh2', 'Lucanthone'), ('ezh2', 'Methapyrilene'), ('ezh2', 'Methotrexate'), ('ezh2', 'Methyl Methanesulfonate'), ('ezh2', 'Oxygen'), ('ezh2', 'Piroxicam'), ('ezh2', 'Potassium Dichromate'), ('ezh2', 'Progesterone'), ('ezh2', 'Quercetin'), ('ezh2', 'Smoke'), ('ezh2', 'Tamoxifen'), ('ezh2', 'Testosterone'), ('ezh2', 'Tetrachlorodibenzodioxin'), ('ezh2', 'Tobacco Smoke Pollution'), ('ezh2', 'Tretinoin'), ('ezh2', 'Urethane'), ('ezh2', 'Valproic Acid'), ('ezh2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ezh2', '8-Bromo Cyclic Adenosine Monophosphate'), ('ezh2', 'Cyclosporine'), ('ezh2', 'Aflatoxin B1'), ('ezh2', 'Medroxyprogesterone Acetate'), ('ezh2', 'Silver Compounds'), ('ezh2', 'Cadmium Chloride'), ('ezh2', 'Topotecan'), ('ezh2', 'tert-Butylhydroperoxide'), ('ezh2', 'Vitamin K 3'), ('ezh2', 'Particulate Matter'), ('h2bc3', 'Acetaminophen'), ('h2bc3', 'Antimycin A'), ('h2bc3', 'Benzo(a)pyrene'), ('h2bc3', 'Catechin'), ('h2bc3', 'Cisplatin'), ('h2bc3', 'Demecolcine'), ('h2bc3', 'Drugs, Chinese Herbal'), ('h2bc3', 'Folic Acid'), ('h2bc3', 'Formaldehyde'), ('h2bc3', 'Hydrogen Peroxide'), ('h2bc3', 'Methotrexate'), ('h2bc3', 'N-Nitrosopyrrolidine'), ('h2bc3', 'Naphthoquinones'), ('h2bc3', 'Oxygen'), ('h2bc3', 'Paraquat'), ('h2bc3', 'Rotenone'), ('h2bc3', 'Silicon Dioxide'), ('h2bc3', 'Urethane'), ('h2bc3', 'Vincristine'), ('h2bc3', 'Aflatoxin B1'), ('h2bc3', 'Antirheumatic Agents'), ('h2bc3', 'Copper Sulfate'), ('h2bc3', 'Vitamin K 3'), ('h2bc3', 'Particulate Matter'), ('h2bc14', 'Arsenic Trioxide'), ('h2bc14', 'Fulvestrant'), ('h2bc14', 'Acetaminophen'), ('h2bc14', 'Air Pollutants'), ('h2bc14', 'Ethanol'), ('h2bc14', 'Antimycin A'), ('h2bc14', 'Ascorbic Acid'), ('h2bc14', 'Benzo(a)pyrene'), ('h2bc14', 'Berberine'), ('h2bc14', 'Drugs, Chinese Herbal'), ('h2bc14', 'Enzyme Inhibitors'), ('h2bc14', 'Estradiol'), ('h2bc14', 'Folic Acid'), ('h2bc14', 'Hydrocortisone'), ('h2bc14', 'Lucanthone'), ('h2bc14', 'Methotrexate'), ('h2bc14', 'Oxygen'), ('h2bc14', 'Paraquat'), ('h2bc14', 'Silicon Dioxide'), ('h2bc14', 'Aflatoxin B1'), ('h2bc14', 'Copper Sulfate'), ('h2bc9', 'Sunitinib'), ('h2bc9', 'Arsenic Trioxide'), ('h2bc9', 'Troglitazone'), ('h2bc9', 'Acetaminophen'), ('h2bc9', 'Benzo(a)pyrene'), ('h2bc9', 'Berberine'), ('h2bc9', 'Cadmium'), ('h2bc9', 'Caffeine'), ('h2bc9', 'Catechin'), ('h2bc9', 'Copper'), ('h2bc9', 'Coumestrol'), ('h2bc9', 'Doxorubicin'), ('h2bc9', 'Estradiol'), ('h2bc9', 'Ethyl Methanesulfonate'), ('h2bc9', 'Folic Acid'), ('h2bc9', 'Lucanthone'), ('h2bc9', 'Methotrexate'), ('h2bc9', 'Paraquat'), ('h2bc9', 'Progesterone'), ('h2bc9', 'Silicon Dioxide'), ('h2bc9', 'Tetrachlorodibenzodioxin'), ('h2bc9', 'Tretinoin'), ('h2bc9', 'Valproic Acid'), ('h2bc9', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc9', 'Isotretinoin'), ('h2bc9', 'Aflatoxin B1'), ('h2bc9', 'Asbestos, Crocidolite'), ('h2bc9', 'Cadmium Chloride'), ('h2bc9', 'Copper Sulfate'), ('h2bc9', 'Lactic Acid'), ('h2bc9', 'Vitamin K 3'), ('cdc25a', 'Resveratrol'), ('cdc25a', 'Sunitinib'), ('cdc25a', 'Arsenic Trioxide'), ('cdc25a', 'Troglitazone'), ('cdc25a', 'Silybin'), ('cdc25a', 'Vemurafenib'), ('cdc25a', 'Acetaminophen'), ('cdc25a', 'Adenine'), ('cdc25a', 'Ethanol'), ('cdc25a', 'Amiodarone'), ('cdc25a', 'Arsenic'), ('cdc25a', 'Aspirin'), ('cdc25a', 'Atrazine'), ('cdc25a', 'Azathioprine'), ('cdc25a', 'Benzo(a)pyrene'), ('cdc25a', 'Calcitriol'), ('cdc25a', 'Cannabidiol'), ('cdc25a', 'Chelating Agents'), ('cdc25a', 'Cisplatin'), ('cdc25a', 'Citrinin'), ('cdc25a', 'Colchicine'), ('cdc25a', 'Copper'), ('cdc25a', 'Coumestrol'), ('cdc25a', 'Daunorubicin'), ('cdc25a', 'Doxorubicin'), ('cdc25a', 'Estradiol'), ('cdc25a', 'Etoposide'), ('cdc25a', 'Fluorouracil'), ('cdc25a', 'Folic Acid'), ('cdc25a', 'Harmine'), ('cdc25a', 'Heterocyclic Compounds, 3-Ring'), ('cdc25a', 'Hydrogen Peroxide'), ('cdc25a', 'Metformin'), ('cdc25a', 'Methotrexate'), ('cdc25a', 'Methyl Methanesulfonate'), ('cdc25a', 'Mustard Gas'), ('cdc25a', 'Nickel'), ('cdc25a', 'Nicotine'), ('cdc25a', 'Oxygen'), ('cdc25a', 'Piroxicam'), ('cdc25a', 'Plant Extracts'), ('cdc25a', 'Rotenone'), ('cdc25a', 'Silicon Dioxide'), ('cdc25a', 'Silymarin'), ('cdc25a', 'Sodium Dodecyl Sulfate'), ('cdc25a', 'Tamoxifen'), ('cdc25a', 'Tetrachlorodibenzodioxin'), ('cdc25a', 'Thioridazine'), ('cdc25a', 'Tobacco Smoke Pollution'), ('cdc25a', 'Tretinoin'), ('cdc25a', 'Valproic Acid'), ('cdc25a', 'Zinc'), ('cdc25a', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdc25a', 'Zidovudine'), ('cdc25a', '1-Methyl-4-phenylpyridinium'), ('cdc25a', 'Cyclosporine'), ('cdc25a', 'Aflatoxin B1'), ('cdc25a', 'Monocrotaline'), ('cdc25a', 'Paclitaxel'), ('cdc25a', 'Copper Sulfate'), ('cdc25a', 'Nelfinavir'), ('cdc25a', 'Chlorodiphenyl (54% Chlorine)'), ('cdc25a', 'Nanotubes, Carbon'), ('hmga2', 'Sunitinib'), ('hmga2', 'Acetaminophen'), ('hmga2', 'Acetylcysteine'), ('hmga2', 'Antimycin A'), ('hmga2', 'Arsenic'), ('hmga2', 'Azacitidine'), ('hmga2', 'Benzo(a)pyrene'), ('hmga2', 'Cadmium'), ('hmga2', 'Caffeine'), ('hmga2', 'Cannabidiol'), ('hmga2', 'Catechin'), ('hmga2', 'Cisplatin'), ('hmga2', 'Demecolcine'), ('hmga2', 'Deoxyglucose'), ('hmga2', 'Dexamethasone'), ('hmga2', 'Diethylnitrosamine'), ('hmga2', 'Doxorubicin'), ('hmga2', 'Dust'), ('hmga2', 'Estradiol'), ('hmga2', 'Ethyl Methanesulfonate'), ('hmga2', 'Etoposide'), ('hmga2', 'Flame Retardants'), ('hmga2', 'Formaldehyde'), ('hmga2', 'Indomethacin'), ('hmga2', 'Ivermectin'), ('hmga2', 'Lead'), ('hmga2', 'Melphalan'), ('hmga2', 'Methyl Methanesulfonate'), ('hmga2', 'Oxygen'), ('hmga2', 'Piroxicam'), ('hmga2', 'Potassium Dichromate'), ('hmga2', 'Rotenone'), ('hmga2', 'Silicon Dioxide'), ('hmga2', 'Smoke'), ('hmga2', 'Tobacco Smoke Pollution'), ('hmga2', 'Tretinoin'), ('hmga2', 'Triclosan'), ('hmga2', 'Tunicamycin'), ('hmga2', 'Urethane'), ('hmga2', 'Valproic Acid'), ('hmga2', 'Vincristine'), ('hmga2', '1-Methyl-3-isobutylxanthine'), ('hmga2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('hmga2', '1-Methyl-4-phenylpyridinium'), ('hmga2', 'Cyclosporine'), ('hmga2', 'Aflatoxin B1'), ('hmga2', 'Aflatoxin M1'), ('hmga2', 'Mitomycin'), ('hmga2', 'Asbestos, Crocidolite'), ('hmga2', 'Cadmium Chloride'), ('hmga2', 'Copper Sulfate'), ('hmga2', 'Topotecan'), ('hmga2', 'Genistein'), ('hmga2', 'Acrylamide'), ('hmga2', 'Raloxifene Hydrochloride'), ('hmga2', 'Permethrin'), ('hmga2', 'Halogenated Diphenyl Ethers'), ('h1-5', 'Sunitinib'), ('h1-5', 'Fulvestrant'), ('h1-5', 'Benzo(a)pyrene'), ('h1-5', 'Caffeine'), ('h1-5', 'Calcitriol'), ('h1-5', 'Cannabidiol'), ('h1-5', 'Cisplatin'), ('h1-5', 'Copper'), ('h1-5', 'Dopamine'), ('h1-5', 'Doxorubicin'), ('h1-5', 'Estradiol'), ('h1-5', 'Folic Acid'), ('h1-5', 'Hydrogen Peroxide'), ('h1-5', 'Lipopolysaccharides'), ('h1-5', 'Lucanthone'), ('h1-5', 'Methotrexate'), ('h1-5', 'N-Nitrosopyrrolidine'), ('h1-5', 'Oxygen'), ('h1-5', 'Phenobarbital'), ('h1-5', 'Plant Oils'), ('h1-5', 'Quercetin'), ('h1-5', 'Ribonucleotides'), ('h1-5', 'Silicon Dioxide'), ('h1-5', 'Silver Nitrate'), ('h1-5', 'Smoke'), ('h1-5', 'Testosterone'), ('h1-5', 'Tetrachlorodibenzodioxin'), ('h1-5', 'Tobacco Smoke Pollution'), ('h1-5', 'Tretinoin'), ('h1-5', 'Triiodothyronine'), ('h1-5', '1-Methyl-4-phenylpyridinium'), ('h1-5', 'Gold Compounds'), ('h1-5', 'Copper Sulfate'), ('h1-5', 'Genistein'), ('h1-5', 'Vitamin K 3'), ('h1-1', 'Acetaminophen'), ('h1-1', 'Arbutin'), ('h1-1', 'Arsenic'), ('h1-1', 'Benzo(a)pyrene'), ('h1-1', 'Cadmium'), ('h1-1', 'Oxygen'), ('h1-1', 'Pesticides'), ('h1-1', 'Plant Oils'), ('h1-1', 'Silicon Dioxide'), ('h1-1', 'Tobacco Smoke Pollution'), ('h1-1', 'Triclosan'), ('h1-1', 'Cadmium Chloride'), ('h1-4', 'Sunitinib'), ('h1-4', 'Benzo(a)pyrene'), ('h1-4', 'Bilirubin'), ('h1-4', 'Caffeine'), ('h1-4', 'Cisplatin'), ('h1-4', 'Diethylhexyl Phthalate'), ('h1-4', 'Doxorubicin'), ('h1-4', 'Lipopolysaccharides'), ('h1-4', 'Lucanthone'), ('h1-4', 'N-Nitrosopyrrolidine'), ('h1-4', 'Paraquat'), ('h1-4', 'Ribonucleotides'), ('h1-4', 'Rotenone'), ('h1-4', 'Silicon Dioxide'), ('h1-4', 'Smoke'), ('h1-4', 'Tetrachlorodibenzodioxin'), ('h1-4', 'Thimerosal'), ('h1-4', 'Tobacco Smoke Pollution'), ('h1-4', 'Valproic Acid'), ('h1-4', 'Cyclosporine'), ('h1-4', 'Aflatoxin B1'), ('h1-4', 'Okadaic Acid'), ('h1-4', 'Copper Sulfate'), ('h1-4', 'Genistein'), ('h1-4', 'Vitamin K 3'), ('Atazanavir Sulfate', 'mapkapk3'), ('mapkapk3', 'Temozolomide'), ('mapkapk3', 'Zoledronic Acid'), ('mapkapk3', 'Fulvestrant'), ('mapkapk3', 'Acetaminophen'), ('mapkapk3', 'Acrolein'), ('mapkapk3', 'Air Pollutants'), ('mapkapk3', 'Aspirin'), ('mapkapk3', 'Benzo(a)pyrene'), ('mapkapk3', 'Caffeine'), ('mapkapk3', 'Chelating Agents'), ('mapkapk3', 'Chenodeoxycholic Acid'), ('mapkapk3', 'Cisplatin'), ('mapkapk3', 'Copper'), ('mapkapk3', 'Cycloheximide'), ('mapkapk3', 'Deoxycholic Acid'), ('mapkapk3', 'Diazinon'), ('mapkapk3', 'Flurbiprofen'), ('mapkapk3', 'Glycochenodeoxycholic Acid'), ('mapkapk3', 'Glycocholic Acid'), ('mapkapk3', 'Glycodeoxycholic Acid'), ('mapkapk3', 'Ibuprofen'), ('mapkapk3', 'Nickel'), ('mapkapk3', 'Ozone'), ('mapkapk3', 'Potassium Dichromate'), ('mapkapk3', 'Smoke'), ('mapkapk3', 'Tartrazine'), ('mapkapk3', 'Tobacco Smoke Pollution'), ('mapkapk3', 'Tretinoin'), ('mapkapk3', 'Urethane'), ('mapkapk3', 'Valproic Acid'), ('mapkapk3', 'Vanadates'), ('mapkapk3', 'Vanadium'), ('mapkapk3', 'Cyclosporine'), ('mapkapk3', 'Aflatoxin B1'), ('mapkapk3', 'Antirheumatic Agents'), ('mapkapk3', 'Acrylamide'), ('mapkapk3', 'Volatile Organic Compounds'), ('ring1', 'Venlafaxine Hydrochloride'), ('ring1', 'Fulvestrant'), ('ring1', 'Benzo(a)pyrene'), ('ring1', 'Cadmium'), ('ring1', 'Caffeine'), ('ring1', 'Catechin'), ('ring1', 'Cisplatin'), ('ring1', 'Diazinon'), ('ring1', 'Doxorubicin'), ('ring1', 'Ivermectin'), ('ring1', 'Methyl Methanesulfonate'), ('ring1', 'Quercetin'), ('ring1', 'Selenium'), ('ring1', 'Sodium Selenite'), ('fos', 'Acebutolol'), ('fos', 'Irinotecan'), ('fos', 'Gefitinib'), ('fos', 'Resveratrol'), ('fos', 'Wortmannin'), ('fos', 'Decitabine'), ('fos', 'Zoledronic Acid'), ('fos', 'Arsenic Trioxide'), ('fos', 'Fulvestrant'), ('fos', 'Lycopene'), ('fos', 'Troglitazone'), ('fos', 'Leflunomide'), ('fos', 'Nabumetone'), ('fos', 'Acetaldehyde'), ('fos', 'Acetaminophen'), ('fos', 'Acetylcysteine'), ('fos', 'Acrolein'), ('fos', 'Acrylonitrile'), ('fos', 'Cyclic AMP'), ('fos', 'Aerosols'), ('fos', 'Air Pollutants'), ('fos', 'Ethanol'), ('fos', 'Allopurinol'), ('fos', 'Aluminum Oxide'), ('fos', 'Amiloride'), ('fos', 'Amiodarone'), ('fos', 'Amphetamine'), ('fos', 'Anisomycin'), ('fos', 'Antimony Potassium Tartrate'), ('fos', 'Antimycin A'), ('fos', 'Arsenic'), ('fos', 'Aspirin'), ('fos', 'Atrazine'), ('fos', 'Atropine'), ('fos', 'Vehicle Emissions'), ('fos', 'Azathioprine'), ('fos', '3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester'), ('fos', 'Beclomethasone'), ('fos', 'Benzene'), ('fos', 'Benzo(a)pyrene'), ('fos', 'Benzofurans'), ('fos', 'Benzoyl Peroxide'), ('fos', 'Bezafibrate'), ('fos', 'Butylated Hydroxyanisole'), ('fos', 'Cacodylic Acid'), ('fos', 'Cadmium'), ('fos', 'Calcitriol'), ('fos', 'Cannabidiol'), ('fos', 'Capsaicin'), ('fos', 'Carbamazepine'), ('fos', 'Catechin'), ('fos', 'Chelating Agents'), ('fos', 'Chenodeoxycholic Acid'), ('fos', 'Chlorpropamide'), ('fos', 'Chromium'), ('fos', 'Chromium Alloys'), ('fos', 'Cisplatin'), ('fos', 'Citrinin'), ('fos', 'Clotrimazole'), ('fos', 'Cobalt'), ('fos', 'Cocaine'), ('fos', 'Copper'), ('fos', 'Coumestrol'), ('fos', 'Curcumin'), ('fos', 'Cycloheximide'), ('fos', 'Dactinomycin'), ('fos', 'Dichlorodiphenyl Dichloroethylene'), ('fos', 'DDT'), ('fos', 'Dehydroepiandrosterone'), ('fos', 'Demecolcine'), ('fos', 'Dexamethasone'), ('fos', 'Bucladesine'), ('fos', 'Diclofenac'), ('fos', 'Dieldrin'), ('fos', 'Diethylhexyl Phthalate'), ('fos', 'Diflunisal'), ('fos', 'Dinitrochlorobenzene'), ('fos', 'Dioxins'), ('fos', 'Dipyridamole'), ('fos', 'Disulfiram'), ('fos', 'Dopamine'), ('fos', 'Doxorubicin'), ('fos', 'Drugs, Chinese Herbal'), ('fos', 'Dust'), ('fos', 'Endosulfan'), ('fos', 'Ephedrine'), ('fos', 'Epoxy Compounds'), ('fos', 'Erythromycin'), ('fos', 'Estradiol'), ('fos', 'Estrogens'), ('fos', 'Ethinyl Estradiol'), ('fos', 'Etoposide'), ('fos', 'Fenthion'), ('fos', 'Fish Oils'), ('fos', 'Flecainide'), ('fos', 'Fluorouracil'), ('fos', 'Fluoxetine'), ('fos', 'Flurbiprofen'), ('fos', 'Folic Acid'), ('fos', 'Formaldehyde'), ('fos', 'Gasoline'), ('fos', 'Glucosamine'), ('fos', 'Glucose'), ('fos', 'Hemin'), ('fos', 'Heparin'), ('fos', 'Histamine'), ('fos', 'Hydrogen Peroxide'), ('fos', 'Clioquinol'), ('fos', 'Lead'), ('fos', 'Lipopolysaccharides'), ('fos', 'Lithium'), ('fos', 'Manganese'), ('fos', 'Mebendazole'), ('fos', 'Mechlorethamine'), ('fos', 'Mercuric Chloride'), ('fos', 'Metformin'), ('fos', 'Methotrexate'), ('fos', 'Methyl Methanesulfonate'), ('fos', 'Methylphenidate'), ('fos', 'Morphine'), ('fos', 'Mycophenolic Acid'), ('fos', 'N-Nitrosopyrrolidine'), ('fos', 'Naphthoquinones'), ('fos', 'Neurotensin'), ('fos', 'Nickel'), ('fos', 'Niclosamide'), ('fos', 'Nicotine'), ('fos', 'Nifedipine'), ('fos', 'Nimodipine'), ('fos', 'Oligomycins'), ('fos', 'Oxygen'), ('fos', 'Ozone'), ('fos', 'Paraoxon'), ('fos', 'Paraquat'), ('fos', 'Pentachlorophenol'), ('fos', 'Pentoxifylline'), ('fos', 'Pesticides'), ('fos', 'Phenylthiourea'), ('fos', 'Vitamin K 1'), ('fos', 'Plant Extracts'), ('fos', 'Plant Oils'), ('fos', 'Polychlorinated Biphenyls'), ('fos', 'Polycyclic Aromatic Hydrocarbons'), ('fos', 'Polystyrenes'), ('fos', 'Progesterone'), ('fos', 'Promegestone'), ('fos', 'Pyrimethamine'), ('fos', 'Quercetin'), ('fos', 'Rotenone'), ('fos', 'Selegiline'), ('fos', 'Selenomethionine'), ('fos', 'Carbaryl'), ('fos', 'Silicon Dioxide'), ('fos', 'Silver'), ('fos', 'Silver Nitrate'), ('fos', 'Smoke'), ('fos', 'Sodium Chloride'), ('fos', 'Sodium Dodecyl Sulfate'), ('fos', 'Dihydrotestosterone'), ('fos', 'Tamoxifen'), ('fos', 'Taurolithocholic Acid'), ('fos', 'Testosterone'), ('fos', 'Tetrachlorodibenzodioxin'), ('fos', 'Tetrachloroethylene'), ('fos', 'Tetradecanoylphorbol Acetate'), ('fos', 'Dronabinol'), ('fos', 'Thalidomide'), ('fos', 'Thimerosal'), ('fos', 'Tobacco Smoke Pollution'), ('fos', 'Toluene'), ('fos', 'Tretinoin'), ('fos', 'Trinitrotoluene'), ('fos', 'Tubocurarine'), ('fos', 'Tunicamycin'), ('fos', 'Uranium'), ('fos', 'Urethane'), ('fos', 'Valproic Acid'), ('fos', 'Verapamil'), ('fos', 'Vitamin D'), ('fos', 'Zinc'), ('fos', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('fos', 'Oxyquinoline'), ('fos', 'Dinoprostone'), ('fos', 'Nimustine'), ('fos', 'Josamycin'), ('fos', 'Roxithromycin'), ('fos', '1-Methyl-4-phenylpyridinium'), ('fos', 'Famotidine'), ('fos', 'Ionomycin'), ('fos', 'Organoselenium Compounds'), ('fos', 'Cyclosporine'), ('fos', 'Aflatoxin B1'), ('fos', 'Bupropion'), ('fos', 'Mitomycin'), ('fos', 'Arachidonic Acid'), ('fos', 'Dimaprit'), ('fos', 'Selenocysteine'), ('fos', 'Clarithromycin'), ('fos', 'Reactive Oxygen Species'), ('fos', 'Gold Compounds'), ('fos', 'Asbestos, Crocidolite'), ('fos', 'Azithromycin'), ('fos', 'Tungsten Compounds'), ('fos', 'Silver Compounds'), ('fos', 'Sodium Selenite'), ('fos', 'Antirheumatic Agents'), ('fos', 'Cadmium Chloride'), ('fos', 'Thapsigargin'), ('fos', 'Zinc Sulfate'), ('fos', '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine'), ('fos', 'Okadaic Acid'), ('fos', 'beta-Naphthoflavone'), ('fos', 'Copper Sulfate'), ('fos', 'Lactic Acid'), ('fos', 'Ritonavir'), ('fos', 'Topotecan'), ('fos', 'Simvastatin'), ('fos', 'Genistein'), ('fos', '2-Propanol'), ('fos', '1-Butanol'), ('fos', 'Styrene'), ('fos', 'Acrylamide'), ('fos', 'tert-Butylhydroperoxide'), ('fos', 'p-Chloromercuribenzoic Acid'), ('fos', 'Sertraline'), ('fos', 'Polyethylene'), ('fos', 'Shiga Toxin'), ('fos', 'Vitamin K 3'), ('fos', 'Peroxynitrous Acid'), ('fos', 'Pertussis Toxin'), ('fos', 'Nanotubes, Carbon'), ('fos', 'Apigenin'), ('fos', 'Luteolin'), ('fos', 'Ferrosoferric Oxide'), ('fos', 'Particulate Matter'), ('fos', 'Volatile Organic Compounds'), ('fos', 'Magnetite Nanoparticles'), ('Irinotecan', 'h2ac6'), ('Irinotecan', 'chek2'), ('Irinotecan', 'chek1'), ('Irinotecan', 'ube2c'), ('Irinotecan', 'ets2'), ('Irinotecan', 'zfp36l2'), ('h2ac6', 'Resveratrol'), ('h2ac6', 'Sunitinib'), ('h2ac6', 'Zoledronic Acid'), ('h2ac6', 'Vorinostat'), ('h2ac6', 'Leflunomide'), ('h2ac6', 'Acetaminophen'), ('h2ac6', 'Acrolein'), ('h2ac6', 'Air Pollutants'), ('h2ac6', 'Antimycin A'), ('h2ac6', 'Arbutin'), ('h2ac6', 'Arsenic'), ('h2ac6', 'Benzo(a)pyrene'), ('h2ac6', 'Berberine'), ('h2ac6', 'Catechin'), ('h2ac6', 'Cisplatin'), ('h2ac6', 'Copper'), ('h2ac6', 'Coumestrol'), ('h2ac6', 'Demecolcine'), ('h2ac6', 'Dimethyl Sulfoxide'), ('h2ac6', 'Diuron'), ('h2ac6', 'Doxorubicin'), ('h2ac6', 'Estradiol'), ('h2ac6', 'Formaldehyde'), ('h2ac6', 'Methyl Methanesulfonate'), ('h2ac6', 'Ozone'), ('h2ac6', 'Phenylmercuric Acetate'), ('h2ac6', 'Polychlorinated Biphenyls'), ('h2ac6', 'Quercetin'), ('h2ac6', 'Silicon Dioxide'), ('h2ac6', 'Smoke'), ('h2ac6', 'Dronabinol'), ('h2ac6', 'Tobacco Smoke Pollution'), ('h2ac6', 'Tretinoin'), ('h2ac6', 'Tunicamycin'), ('h2ac6', 'Urethane'), ('h2ac6', 'Valproic Acid'), ('h2ac6', 'Vincristine'), ('h2ac6', 'Zinc'), ('h2ac6', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2ac6', '1-Methyl-4-phenylpyridinium'), ('h2ac6', 'Aflatoxin B1'), ('h2ac6', 'Aflatoxin M1'), ('h2ac6', 'Asbestos, Crocidolite'), ('h2ac6', 'gamma-Linolenic Acid'), ('h2ac6', 'Antirheumatic Agents'), ('h2ac6', 'Cadmium Chloride'), ('h2ac6', 'Thapsigargin'), ('h2ac6', 'Okadaic Acid'), ('h2ac6', 'Copper Sulfate'), ('h2ac6', 'Genistein'), ('h2ac6', 'Volatile Organic Compounds'), ('chek2', 'Oxaliplatin'), ('chek2', 'Resveratrol'), ('chek2', 'Wortmannin'), ('chek2', 'Temozolomide'), ('chek2', 'Sunitinib'), ('chek2', 'Arsenic Trioxide'), ('chek2', 'Artesunate'), ('chek2', 'Silybin'), ('chek2', 'Clofarabine'), ('chek2', 'Acetaminophen'), ('chek2', 'Acetylcysteine'), ('chek2', 'Acrolein'), ('chek2', 'Anthocyanins'), ('chek2', 'Arsenic'), ('chek2', 'Ascorbic Acid'), ('chek2', 'Aspirin'), ('chek2', 'Vehicle Emissions'), ('chek2', 'Benzo(a)pyrene'), ('chek2', 'Berberine'), ('chek2', 'Bleomycin'), ('chek2', 'Busulfan'), ('chek2', 'Caffeine'), ('chek2', 'Calcitriol'), ('chek2', 'Camptothecin'), ('chek2', 'Cannabidiol'), ('chek2', 'Capsaicin'), ('chek2', 'Chelating Agents'), ('chek2', 'Cisplatin'), ('chek2', 'Copper'), ('chek2', 'Coumestrol'), ('chek2', 'Curcumin'), ('chek2', 'Dianhydrogalactitol'), ('chek2', 'Diethylhexyl Phthalate'), ('chek2', 'Digitoxin'), ('chek2', 'Dihydroxyacetone'), ('chek2', 'Dimethyl Sulfoxide'), ('chek2', 'Doxorubicin'), ('chek2', 'Estradiol'), ('chek2', 'Etoposide'), ('chek2', 'Floxuridine'), ('chek2', 'Fluorouracil'), ('chek2', 'Flutamide'), ('chek2', 'Formaldehyde'), ('chek2', 'Gold'), ('chek2', 'Heterocyclic Compounds, 3-Ring'), ('chek2', 'Hydrogen Peroxide'), ('chek2', 'Hydroxyurea'), ('chek2', 'Isoflavones'), ('chek2', 'Lead'), ('chek2', 'Melphalan'), ('chek2', 'Metformin'), ('chek2', 'Methoxsalen'), ('chek2', 'Methoxychlor'), ('chek2', 'Methylnitronitrosoguanidine'), ('chek2', 'Mustard Gas'), ('chek2', 'Nicotine'), ('chek2', 'Platinum'), ('chek2', 'Quercetin'), ('chek2', 'Silicon Dioxide'), ('chek2', 'Silver Nitrate'), ('chek2', 'Silymarin'), ('chek2', 'Dihydrotestosterone'), ('chek2', 'Sterigmatocystin'), ('chek2', 'T-2 Toxin'), ('chek2', 'Testosterone'), ('chek2', 'Thiosemicarbazones'), ('chek2', 'Tobacco Smoke Pollution'), ('chek2', 'Urethane'), ('chek2', 'Valproic Acid'), ('chek2', 'Vincristine'), ('chek2', 'Zidovudine'), ('chek2', 'Metribolone'), ('chek2', 'Aphidicolin'), ('chek2', 'Mitomycin'), ('chek2', 'Levonorgestrel'), ('chek2', 'Paclitaxel'), ('chek2', 'Asbestos, Amphibole'), ('chek2', 'Silver Compounds'), ('chek2', 'Antirheumatic Agents'), ('chek2', 'Copper Sulfate'), ('chek2', 'Buthionine Sulfoximine'), ('chek2', 'Genistein'), ('chek2', 'Aristolochic Acids'), ('chek2', 'Flavanones'), ('chek2', 'Particulate Matter'), ('chek1', 'Resveratrol'), ('chek1', 'Wortmannin'), ('chek1', 'Temozolomide'), ('chek1', 'Decitabine'), ('chek1', 'Sunitinib'), ('chek1', 'Arsenic Trioxide'), ('chek1', 'Rimonabant'), ('chek1', 'Troglitazone'), ('chek1', 'Artesunate'), ('chek1', 'Vemurafenib'), ('chek1', 'Clofarabine'), ('chek1', 'Acetaminophen'), ('chek1', 'Acetylcysteine'), ('chek1', 'Acrolein'), ('chek1', 'Anthocyanins'), ('chek1', 'Antimycin A'), ('chek1', 'Atrazine'), ('chek1', 'Vehicle Emissions'), ('chek1', 'Azathioprine'), ('chek1', 'Benzo(a)pyrene'), ('chek1', 'Berberine'), ('chek1', 'Busulfan'), ('chek1', 'Cadmium'), ('chek1', 'Caffeine'), ('chek1', 'Camptothecin'), ('chek1', 'Cannabidiol'), ('chek1', 'Carbamazepine'), ('chek1', 'Carmustine'), ('chek1', 'Chelating Agents'), ('chek1', 'Choline'), ('chek1', 'Cisplatin'), ('chek1', 'Copper'), ('chek1', 'Coumestrol'), ('chek1', 'Curcumin'), ('chek1', 'Diclofenac'), ('chek1', 'Diethylhexyl Phthalate'), ('chek1', 'Digitoxin'), ('chek1', 'Doxorubicin'), ('chek1', 'Estradiol'), ('chek1', 'Etoposide'), ('chek1', 'Floxuridine'), ('chek1', 'Fluorouracil'), ('chek1', 'Folic Acid'), ('chek1', 'Furazolidone'), ('chek1', 'Gold'), ('chek1', 'Hydrazones'), ('chek1', 'Hydrogen Peroxide'), ('chek1', 'Hydroxyurea'), ('chek1', 'Lead'), ('chek1', 'Lovastatin'), ('chek1', 'Melphalan'), ('chek1', 'Metformin'), ('chek1', 'Methotrexate'), ('chek1', 'Methylnitronitrosoguanidine'), ('chek1', 'Mustard Gas'), ('chek1', 'Nickel'), ('chek1', 'Pesticides'), ('chek1', 'Plant Extracts'), ('chek1', 'Platinum'), ('chek1', 'Polychlorinated Biphenyls'), ('chek1', 'Polyethyleneimine'), ('chek1', 'Quercetin'), ('chek1', 'Rotenone'), ('chek1', 'Silver Nitrate'), ('chek1', 'Soil Pollutants'), ('chek1', 'Sterigmatocystin'), ('chek1', 'Tetrachlorodibenzodioxin'), ('chek1', 'Tobacco Smoke Pollution'), ('chek1', 'Tretinoin'), ('chek1', 'Triiodothyronine'), ('chek1', 'Valproic Acid'), ('chek1', 'Vitallium'), ('chek1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('chek1', 'Zidovudine'), ('chek1', 'Nimustine'), ('chek1', 'Nocodazole'), ('chek1', 'Metribolone'), ('chek1', 'Cyclosporine'), ('chek1', 'Aflatoxin B1'), ('chek1', 'Mitomycin'), ('chek1', 'Monocrotaline'), ('chek1', 'Paclitaxel'), ('chek1', 'Asbestos, Crocidolite'), ('chek1', 'Silicon Compounds'), ('chek1', 'Thapsigargin'), ('chek1', 'Copper Sulfate'), ('chek1', 'Genistein'), ('chek1', 'tert-Butylhydroperoxide'), ('chek1', 'Vitamin K 3'), ('chek1', 'Particulate Matter'), ('chek1', 'Equol'), ('ube2c', 'Sunitinib'), ('ube2c', 'Zoledronic Acid'), ('ube2c', 'Arsenic Trioxide'), ('ube2c', 'Troglitazone'), ('ube2c', 'Leflunomide'), ('ube2c', 'Acetaminophen'), ('ube2c', 'Gemcitabine'), ('ube2c', 'Amsacrine'), ('ube2c', 'Antimony'), ('ube2c', 'Antimony Potassium Tartrate'), ('ube2c', 'Antimycin A'), ('ube2c', 'Azacitidine'), ('ube2c', 'Azathioprine'), ('ube2c', 'Benzo(a)pyrene'), ('ube2c', 'Cadmium'), ('ube2c', 'Calcitriol'), ('ube2c', 'Chromium'), ('ube2c', 'Cisplatin'), ('ube2c', 'Copper'), ('ube2c', 'Curcumin'), ('ube2c', 'Cytarabine'), ('ube2c', 'Demecolcine'), ('ube2c', 'Dibutyl Phthalate'), ('ube2c', 'Dimethyl Sulfoxide'), ('ube2c', 'Doxorubicin'), ('ube2c', 'Drugs, Chinese Herbal'), ('ube2c', 'Estradiol'), ('ube2c', 'Etoposide'), ('ube2c', 'Fluorouracil'), ('ube2c', 'Folic Acid'), ('ube2c', 'Hydrogen Peroxide'), ('ube2c', 'Hydroxyurea'), ('ube2c', 'Ivermectin'), ('ube2c', 'Lipopolysaccharides'), ('ube2c', 'Mercury'), ('ube2c', 'Methotrexate'), ('ube2c', 'Mustard Gas'), ('ube2c', 'Niclosamide'), ('ube2c', 'Nicotine'), ('ube2c', 'Oxygen'), ('ube2c', 'Polychlorinated Biphenyls'), ('ube2c', 'Potassium Dichromate'), ('ube2c', 'Rotenone'), ('ube2c', 'Testosterone'), ('ube2c', 'Tetrachlorodibenzodioxin'), ('ube2c', 'Dronabinol'), ('ube2c', 'Thalidomide'), ('ube2c', 'Tobacco Smoke Pollution'), ('ube2c', 'Tretinoin'), ('ube2c', 'Tubocurarine'), ('ube2c', 'Tunicamycin'), ('ube2c', 'Vincristine'), ('ube2c', 'Zinc'), ('ube2c', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ube2c', '1-Methyl-4-phenylpyridinium'), ('ube2c', 'Cyclosporine'), ('ube2c', 'Fenretinide'), ('ube2c', 'Sodium Selenite'), ('ube2c', 'Cadmium Chloride'), ('ube2c', 'Thapsigargin'), ('ube2c', 'beta-Naphthoflavone'), ('ube2c', 'Copper Sulfate'), ('ube2c', 'Genistein'), ('ube2c', 'tert-Butylhydroperoxide'), ('ube2c', 'Vitamin K 3'), ('ube2c', 'Particulate Matter'), ('ets2', 'Rosiglitazone'), ('ets2', 'Zoledronic Acid'), ('ets2', 'Arsenic Trioxide'), ('ets2', 'Leflunomide'), ('ets2', 'Acetaminophen'), ('ets2', 'Aspirin'), ('ets2', 'Atrazine'), ('ets2', 'Benzo(a)pyrene'), ('ets2', 'Cadmium'), ('ets2', 'Calcitriol'), ('ets2', 'Cisplatin'), ('ets2', 'Curcumin'), ('ets2', 'Dexamethasone'), ('ets2', 'Dimethylnitrosamine'), ('ets2', 'Dioxins'), ('ets2', 'Doxorubicin'), ('ets2', 'Estradiol'), ('ets2', 'Folic Acid'), ('ets2', 'Formaldehyde'), ('ets2', 'Hydrogen Peroxide'), ('ets2', 'Indomethacin'), ('ets2', 'Lead'), ('ets2', 'Lipopolysaccharides'), ('ets2', 'Mercury'), ('ets2', 'Methapyrilene'), ('ets2', 'Nickel'), ('ets2', 'Polychlorinated Biphenyls'), ('ets2', 'Quercetin'), ('ets2', 'Rotenone'), ('ets2', 'Sarin'), ('ets2', 'Tetrachlorodibenzodioxin'), ('ets2', 'Tobacco Smoke Pollution'), ('ets2', 'Tretinoin'), ('ets2', 'Tunicamycin'), ('ets2', 'Valproic Acid'), ('ets2', 'Vitamin E'), ('ets2', 'Zinc'), ('ets2', '1-Methyl-3-isobutylxanthine'), ('ets2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ets2', 'Cyclosporine'), ('ets2', 'Reactive Oxygen Species'), ('ets2', 'Antirheumatic Agents'), ('ets2', 'Cadmium Chloride'), ('ets2', 'Phenol'), ('ets2', 'Genistein'), ('ets2', 'tert-Butylhydroperoxide'), ('ets2', 'Vitamin K 3'), ('ets2', 'Particulate Matter'), ('zfp36l2', 'Zoledronic Acid'), ('zfp36l2', 'Leflunomide'), ('zfp36l2', 'Panobinostat'), ('zfp36l2', 'Acetaminophen'), ('zfp36l2', 'Acetylcysteine'), ('zfp36l2', 'Ethanol'), ('zfp36l2', 'Amphotericin B'), ('zfp36l2', 'Benzo(a)pyrene'), ('zfp36l2', 'Cadmium'), ('zfp36l2', 'Caffeine'), ('zfp36l2', 'Carbamazepine'), ('zfp36l2', 'Cisplatin'), ('zfp36l2', 'Dexamethasone'), ('zfp36l2', 'Doxorubicin'), ('zfp36l2', 'Estradiol'), ('zfp36l2', 'Colforsin'), ('zfp36l2', 'Gasoline'), ('zfp36l2', 'Hydrogen Peroxide'), ('zfp36l2', 'Indomethacin'), ('zfp36l2', 'Piroxicam'), ('zfp36l2', 'Polycyclic Aromatic Hydrocarbons'), ('zfp36l2', 'Ribonucleotides'), ('zfp36l2', 'Silicon Dioxide'), ('zfp36l2', 'Silver'), ('zfp36l2', 'Smoke'), ('zfp36l2', 'Tetrachlorodibenzodioxin'), ('zfp36l2', 'Dronabinol'), ('zfp36l2', 'Valproic Acid'), ('zfp36l2', 'Vinblastine'), ('zfp36l2', '1-Methyl-3-isobutylxanthine'), ('zfp36l2', '8-Bromo Cyclic Adenosine Monophosphate'), ('zfp36l2', 'Cyclosporine'), ('zfp36l2', 'Paclitaxel'), ('zfp36l2', 'Sodium Selenite'), ('zfp36l2', 'Cadmium Chloride'), ('zfp36l2', 'Lactic Acid'), ('zfp36l2', 'Vitamin K 3'), ('zfp36l2', 'Particulate Matter'), ('Sevoflurane', 'smad2'), ('smad2', 'Resveratrol'), ('smad2', 'Sunitinib'), ('smad2', 'Arsenic Trioxide'), ('smad2', 'Troglitazone'), ('smad2', 'Vorinostat'), ('smad2', 'Panobinostat'), ('smad2', 'Acetylcysteine'), ('smad2', 'Air Pollutants'), ('smad2', 'Arsenates'), ('smad2', 'Asbestos'), ('smad2', 'Atrazine'), ('smad2', 'Benzo(a)pyrene'), ('smad2', 'Chelating Agents'), ('smad2', 'Copper'), ('smad2', 'Coumestrol'), ('smad2', 'Dimethyl Sulfoxide'), ('smad2', 'Doxorubicin'), ('smad2', 'Chlorpyrifos'), ('smad2', 'Endosulfan'), ('smad2', 'Etoposide'), ('smad2', 'Glucosamine'), ('smad2', 'Glucose'), ('smad2', 'Heptachlor'), ('smad2', 'Hyaluronic Acid'), ('smad2', 'Hydrogen Peroxide'), ('smad2', 'Ivermectin'), ('smad2', 'Lipopolysaccharides'), ('smad2', 'Melphalan'), ('smad2', 'Mercury'), ('smad2', 'Methyl Methanesulfonate'), ('smad2', 'Methylnitronitrosoguanidine'), ('smad2', 'Mitoxantrone'), ('smad2', 'Niclosamide'), ('smad2', 'Oxygen'), ('smad2', 'Ozone'), ('smad2', 'Paraquat'), ('smad2', 'Phenobarbital'), ('smad2', 'Phenylmercuric Acetate'), ('smad2', 'Phloroglucinol'), ('smad2', 'Progesterone'), ('smad2', 'Quercetin'), ('smad2', 'Silver Nitrate'), ('smad2', 'Tamoxifen'), ('smad2', 'Tetrachlorodibenzodioxin'), ('smad2', 'Theophylline'), ('smad2', 'Tretinoin'), ('smad2', 'Uric Acid'), ('smad2', 'Valproic Acid'), ('smad2', 'Verapamil'), ('smad2', 'Vincristine'), ('smad2', 'Water Pollutants, Chemical'), ('smad2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('smad2', 'Cytochalasin D'), ('smad2', 'Propofol'), ('smad2', 'Amlodipine'), ('smad2', 'Asbestos, Serpentine'), ('smad2', 'Asbestos, Crocidolite'), ('smad2', 'Antirheumatic Agents'), ('smad2', 'Cadmium Chloride'), ('smad2', 'Lactic Acid'), ('smad2', 'Raloxifene Hydrochloride'), ('smad2', 'Soot'), ('Oxaliplatin', 'ccne1'), ('Oxaliplatin', 'txn'), ('ccne1', 'Rosiglitazone'), ('ccne1', 'Sorafenib'), ('ccne1', 'Resveratrol'), ('ccne1', 'Wortmannin'), ('ccne1', 'Pioglitazone'), ('ccne1', 'Arsenic Trioxide'), ('ccne1', 'Fulvestrant'), ('ccne1', 'Lycopene'), ('ccne1', 'Troglitazone'), ('ccne1', 'Vorinostat'), ('ccne1', 'Lapatinib'), ('ccne1', 'Silybin'), ('ccne1', 'Orlistat'), ('ccne1', 'Vemurafenib'), ('ccne1', 'Homoharringtonine'), ('ccne1', '5-Methoxypsoralen'), ('ccne1', 'Acetaminophen'), ('ccne1', 'Acids'), ('ccne1', 'Acrylonitrile'), ('ccne1', 'Amsacrine'), ('ccne1', 'Arsenic'), ('ccne1', 'Aspirin'), ('ccne1', 'Atrazine'), ('ccne1', 'Atropine'), ('ccne1', 'Vehicle Emissions'), ('ccne1', 'Benzo(a)pyrene'), ('ccne1', 'Benzoates'), ('ccne1', 'Berberine'), ('ccne1', 'Butyrates'), ('ccne1', 'Cadmium'), ('ccne1', 'Caffeine'), ('ccne1', 'Camptothecin'), ('ccne1', 'Cannabidiol'), ('ccne1', 'Carbamazepine'), ('ccne1', 'Chelating Agents'), ('ccne1', 'Cholecalciferol'), ('ccne1', 'Ciprofloxacin'), ('ccne1', 'Cisplatin'), ('ccne1', 'Citrinin'), ('ccne1', 'Leucovorin'), ('ccne1', 'Copper'), ('ccne1', 'Coumestrol'), ('ccne1', 'Curcumin'), ('ccne1', 'Daunorubicin'), ('ccne1', 'Deferoxamine'), ('ccne1', 'Demecolcine'), ('ccne1', 'Diclofenac'), ('ccne1', 'Diethylhexyl Phthalate'), ('ccne1', 'Doxorubicin'), ('ccne1', 'Drugs, Chinese Herbal'), ('ccne1', 'Estradiol'), ('ccne1', 'Estriol'), ('ccne1', 'Ethidium'), ('ccne1', 'Fluorouracil'), ('ccne1', 'Fluoxetine'), ('ccne1', 'Folic Acid'), ('ccne1', 'Gallic Acid'), ('ccne1', 'Hexachlorobenzene'), ('ccne1', 'Hexanones'), ('ccne1', 'Hydrocarbons, Chlorinated'), ('ccne1', 'Hydrochloric Acid'), ('ccne1', 'Hydroxyurea'), ('ccne1', 'Malathion'), ('ccne1', 'Metformin'), ('ccne1', 'Nickel'), ('ccne1', 'Niclosamide'), ('ccne1', 'Nicotine'), ('ccne1', 'Oxygen'), ('ccne1', 'Ozone'), ('ccne1', 'Parathion'), ('ccne1', 'Phosphatidylcholines'), ('ccne1', 'Plant Extracts'), ('ccne1', 'Polystyrenes'), ('ccne1', 'Quercetin'), ('ccne1', 'Ribavirin'), ('ccne1', 'Silicon Dioxide'), ('ccne1', 'Silver'), ('ccne1', 'Silver Nitrate'), ('ccne1', 'Silymarin'), ('ccne1', 'Sulindac'), ('ccne1', 'Tamoxifen'), ('ccne1', 'Taurocholic Acid'), ('ccne1', 'Tetracaine'), ('ccne1', 'Tetrachlorodibenzodioxin'), ('ccne1', 'Tetradecanoylphorbol Acetate'), ('ccne1', 'Thiosemicarbazones'), ('ccne1', 'Tobacco Smoke Pollution'), ('ccne1', 'Tretinoin'), ('ccne1', 'Triiodothyronine'), ('ccne1', 'Valproic Acid'), ('ccne1', 'Vincristine'), ('ccne1', 'Vitallium'), ('ccne1', 'Zearalenone'), ('ccne1', 'Zinc'), ('ccne1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ccne1', 'Mifepristone'), ('ccne1', 'Cyclosporine'), ('ccne1', 'Aflatoxin B1'), ('ccne1', 'Paclitaxel'), ('ccne1', 'Amlodipine'), ('ccne1', 'Asbestos, Crocidolite'), ('ccne1', 'gamma-Linolenic Acid'), ('ccne1', 'Sodium Selenite'), ('ccne1', 'Cadmium Chloride'), ('ccne1', 'Copper Sulfate'), ('ccne1', 'Lactic Acid'), ('ccne1', 'Topotecan'), ('ccne1', 'Acrylamide'), ('ccne1', 'tert-Butylhydroperoxide'), ('ccne1', 'Sirolimus'), ('ccne1', 'Vitamin K 3'), ('ccne1', 'gamma-Tocopherol'), ('ccne1', 'Tocopherols'), ('ccne1', 'Flavanones'), ('ccne1', 'Particulate Matter'), ('ccne1', 'Fungal Polysaccharides'), ('txn', 'Resveratrol'), ('txn', 'Sunitinib'), ('txn', 'Arsenic Trioxide'), ('txn', 'Troglitazone'), ('txn', 'Vorinostat'), ('txn', 'Cidofovir'), ('txn', 'Acetaminophen'), ('txn', 'Acetylcysteine'), ('txn', 'Acrolein'), ('txn', 'Adenosine Triphosphate'), ('txn', 'Aerosols'), ('txn', 'Air Pollutants'), ('txn', 'Antimony Potassium Tartrate'), ('txn', 'Arsenic'), ('txn', 'Arsenicals'), ('txn', 'Asbestos'), ('txn', 'Atenolol'), ('txn', 'Auranofin'), ('txn', 'Vehicle Emissions'), ('txn', 'Benzene'), ('txn', 'Benzo(a)pyrene'), ('txn', 'Cacodylic Acid'), ('txn', 'Cadmium'), ('txn', 'Cannabidiol'), ('txn', 'Chenodeoxycholic Acid'), ('txn', 'Chlorogenic Acid'), ('txn', 'Cisplatin'), ('txn', 'Dexamethasone'), ('txn', 'Diamide'), ('txn', 'Bucladesine'), ('txn', 'Clodronic Acid'), ('txn', 'Diclofenac'), ('txn', 'Succimer'), ('txn', 'Dinitrochlorobenzene'), ('txn', 'Doxorubicin'), ('txn', 'Enzyme Inhibitors'), ('txn', 'Estradiol'), ('txn', 'Flame Retardants'), ('txn', 'Formaldehyde'), ('txn', 'Gasoline'), ('txn', 'Glucose'), ('txn', 'Hydrogen Peroxide'), ('txn', 'Ifosfamide'), ('txn', 'Indomethacin'), ('txn', 'Ivermectin'), ('txn', 'Lipopolysaccharides'), ('txn', 'Lithocholic Acid'), ('txn', 'Mechlorethamine'), ('txn', 'Mercuric Chloride'), ('txn', 'Mercury'), ('txn', 'Methamphetamine'), ('txn', 'Methylmercury Compounds'), ('txn', 'Ouabain'), ('txn', 'Oxygen'), ('txn', 'Paraquat'), ('txn', 'Phenylmercuric Acetate'), ('txn', 'Phosphatidylcholines'), ('txn', 'Phosphatidylserines'), ('txn', 'Plant Extracts'), ('txn', 'Polycyclic Aromatic Hydrocarbons'), ('txn', 'Propolis'), ('txn', 'Quinic Acid'), ('txn', 'Ribavirin'), ('txn', 'Ribonucleotides'), ('txn', 'Selegiline'), ('txn', 'Smoke'), ('txn', 'Sodium Dodecyl Sulfate'), ('txn', 'Tetrachlorodibenzodioxin'), ('txn', 'Tetradecanoylphorbol Acetate'), ('txn', 'Tobacco Smoke Pollution'), ('txn', 'Tretinoin'), ('txn', 'Tunicamycin'), ('txn', 'Vitallium'), ('txn', '1-Methyl-3-isobutylxanthine'), ('txn', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('txn', '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine'), ('txn', 'Cytochalasin D'), ('txn', '1-Methyl-4-phenylpyridinium'), ('txn', 'Cyclosporine'), ('txn', 'Aflatoxin B1'), ('txn', 'Fluorescein-5-isothiocyanate'), ('txn', 'Medroxyprogesterone Acetate'), ('txn', 'Reactive Oxygen Species'), ('txn', 'Asbestos, Crocidolite'), ('txn', 'gamma-Linolenic Acid'), ('txn', 'Sodium Selenite'), ('txn', 'Cadmium Chloride'), ('txn', 'Okadaic Acid'), ('txn', 'Copper Sulfate'), ('txn', 'Benzoic Acid'), ('txn', 'Genistein'), ('txn', 'tert-Butylhydroperoxide'), ('txn', 'Salicylic Acid'), ('txn', 'Nanotubes, Carbon'), ('txn', 'Particulate Matter'), ('txn', 'Magnetite Nanoparticles'), ('Rosiglitazone', 'bmi1'), ('Rosiglitazone', 'h2bc5'), ('Rosiglitazone', 'tsc2'), ('bmi1', 'Temozolomide'), ('bmi1', 'Decitabine'), ('bmi1', 'Sunitinib'), ('bmi1', 'Arsenic Trioxide'), ('bmi1', 'Acetaminophen'), ('bmi1', 'Ethanol'), ('bmi1', 'Arsenic'), ('bmi1', 'Cisplatin'), ('bmi1', 'Dexamethasone'), ('bmi1', 'Estradiol'), ('bmi1', 'Gasoline'), ('bmi1', 'Glutathione'), ('bmi1', 'Gold'), ('bmi1', 'Indomethacin'), ('bmi1', 'Lipopolysaccharides'), ('bmi1', 'Malathion'), ('bmi1', 'Nicotine'), ('bmi1', 'Phenobarbital'), ('bmi1', 'Plant Extracts'), ('bmi1', 'Polycyclic Aromatic Hydrocarbons'), ('bmi1', 'Silicon Dioxide'), ('bmi1', 'Silicon'), ('bmi1', 'Smoke'), ('bmi1', 'Tetradecanoylphorbol Acetate'), ('bmi1', 'Tretinoin'), ('bmi1', 'Valproic Acid'), ('bmi1', 'Zinc'), ('bmi1', '1-Methyl-3-isobutylxanthine'), ('bmi1', 'Reactive Oxygen Species'), ('bmi1', '1-Butanol'), ('bmi1', 'Butyric Acid'), ('bmi1', 'Particulate Matter'), ('h2bc5', 'Resveratrol'), ('h2bc5', 'Decitabine'), ('h2bc5', 'Sunitinib'), ('h2bc5', 'Zoledronic Acid'), ('h2bc5', 'Arsenic Trioxide'), ('h2bc5', 'Troglitazone'), ('h2bc5', 'Acetaminophen'), ('h2bc5', 'Antimycin A'), ('h2bc5', 'Ascorbic Acid'), ('h2bc5', 'Azathioprine'), ('h2bc5', 'Benzo(a)pyrene'), ('h2bc5', 'Berberine'), ('h2bc5', 'Calcitriol'), ('h2bc5', 'Cisplatin'), ('h2bc5', 'Copper'), ('h2bc5', 'Coumestrol'), ('h2bc5', 'Curcumin'), ('h2bc5', 'Demecolcine'), ('h2bc5', 'Dexamethasone'), ('h2bc5', 'Doxorubicin'), ('h2bc5', 'Estradiol'), ('h2bc5', 'Formaldehyde'), ('h2bc5', 'Hydrogen Peroxide'), ('h2bc5', 'Indomethacin'), ('h2bc5', 'Methyl Methanesulfonate'), ('h2bc5', 'Mustard Gas'), ('h2bc5', 'Nicotine'), ('h2bc5', 'Plant Extracts'), ('h2bc5', 'Progesterone'), ('h2bc5', 'Quercetin'), ('h2bc5', 'Rotenone'), ('h2bc5', 'Silicon Dioxide'), ('h2bc5', 'T-2 Toxin'), ('h2bc5', 'Testosterone'), ('h2bc5', 'Tetrachlorodibenzodioxin'), ('h2bc5', 'Tretinoin'), ('h2bc5', 'Urethane'), ('h2bc5', 'Valproic Acid'), ('h2bc5', 'Vincristine'), ('h2bc5', 'Zearalenone'), ('h2bc5', '1-Methyl-3-isobutylxanthine'), ('h2bc5', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc5', 'Isotretinoin'), ('h2bc5', 'Cyclosporine'), ('h2bc5', 'Aflatoxin B1'), ('h2bc5', 'Asbestos, Crocidolite'), ('h2bc5', 'Copper Sulfate'), ('h2bc5', 'Lactic Acid'), ('h2bc5', 'Genistein'), ('h2bc5', 'Acrylamide'), ('h2bc5', 'tert-Butylhydroperoxide'), ('h2bc5', 'p-Chloromercuribenzoic Acid'), ('tsc2', 'Resveratrol'), ('tsc2', 'Sunitinib'), ('tsc2', 'Vorinostat'), ('tsc2', 'Acetaminophen'), ('tsc2', 'Acrolein'), ('tsc2', 'Air Pollutants'), ('tsc2', 'Arsenic'), ('tsc2', 'Azacitidine'), ('tsc2', 'Azathioprine'), ('tsc2', 'Caffeine'), ('tsc2', 'Cannabidiol'), ('tsc2', 'Chelating Agents'), ('tsc2', 'Cisplatin'), ('tsc2', 'Copper'), ('tsc2', 'Coumestrol'), ('tsc2', 'Curcumin'), ('tsc2', 'Dieldrin'), ('tsc2', 'Doxorubicin'), ('tsc2', 'Estradiol'), ('tsc2', 'Fluorouracil'), ('tsc2', 'Hydrogen Peroxide'), ('tsc2', 'Ivermectin'), ('tsc2', 'Lead'), ('tsc2', 'Methamphetamine'), ('tsc2', 'Methotrexate'), ('tsc2', 'Ozone'), ('tsc2', 'Quercetin'), ('tsc2', 'Radon'), ('tsc2', 'Selenium'), ('tsc2', 'Smoke'), ('tsc2', 'Testosterone'), ('tsc2', 'Valproic Acid'), ('tsc2', 'Vitamin E'), ('tsc2', 'Zinc'), ('tsc2', 'Aflatoxin B1'), ('tsc2', 'Antirheumatic Agents'), ('tsc2', 'Cadmium Chloride'), ('tsc2', 'Acrylamide'), ('tsc2', 'Sirolimus'), ('tsc2', 'p-Chloromercuribenzoic Acid'), ('tsc2', 'Volatile Organic Compounds'), ('Resveratrol', 'ccna1'), ('Resveratrol', 'h2bc21'), ('Resveratrol', 'h2bc17'), ('Resveratrol', 'h2bc15'), ('Resveratrol', 'mapk11'), ('Resveratrol', 'kdm6b'), ('Resveratrol', 'eed'), ('Resveratrol', 'cdc27'), ('Resveratrol', 'kat5'), ('Resveratrol', 'foxo1'), ('Resveratrol', 'pik3cb'), ('Resveratrol', 'anapc1'), ('Resveratrol', 'dnajc7'), ('Resveratrol', 'ppp1cb'), ('Resveratrol', 'map2k7'), ('Resveratrol', 'ccne2'), ('Resveratrol', 'e2f2'), ('Resveratrol', 'hmga1'), ('Resveratrol', 'akt3'), ('Resveratrol', 'cbx6'), ('Resveratrol', 'vdac3'), ('Resveratrol', 'tgfb3'), ('ccna1', 'Decitabine'), ('ccna1', 'Sunitinib'), ('ccna1', 'Arsenic Trioxide'), ('ccna1', 'Fulvestrant'), ('ccna1', 'Silybin'), ('ccna1', 'Acetylcysteine'), ('ccna1', 'Arsenic'), ('ccna1', 'Atrazine'), ('ccna1', 'Atropine'), ('ccna1', 'Azacitidine'), ('ccna1', 'Benzo(a)pyrene'), ('ccna1', 'Butyrates'), ('ccna1', 'Cadmium'), ('ccna1', 'Calcitriol'), ('ccna1', 'Catechin'), ('ccna1', 'Chelating Agents'), ('ccna1', 'Cisplatin'), ('ccna1', 'Copper'), ('ccna1', 'Diazinon'), ('ccna1', 'Diethylhexyl Phthalate'), ('ccna1', 'Doxorubicin'), ('ccna1', 'Drugs, Chinese Herbal'), ('ccna1', 'Estradiol'), ('ccna1', 'Fluorouracil'), ('ccna1', 'Folic Acid'), ('ccna1', 'Harmine'), ('ccna1', 'Homocysteine'), ('ccna1', 'Hydrochloric Acid'), ('ccna1', 'Hydrogen Peroxide'), ('ccna1', 'Lead'), ('ccna1', 'Lipopolysaccharides'), ('ccna1', 'Methylnitronitrosoguanidine'), ('ccna1', 'Mustard Gas'), ('ccna1', 'Nickel'), ('ccna1', 'Ouabain'), ('ccna1', 'Oxygen'), ('ccna1', 'Parathion'), ('ccna1', 'Progesterone'), ('ccna1', 'Quercetin'), ('ccna1', 'Silymarin'), ('ccna1', 'Tobacco Smoke Pollution'), ('ccna1', 'Tretinoin'), ('ccna1', 'Tunicamycin'), ('ccna1', 'Valproic Acid'), ('ccna1', 'Vanadates'), ('ccna1', 'Zinc'), ('ccna1', '8-Bromo Cyclic Adenosine Monophosphate'), ('ccna1', 'Cyclosporine'), ('ccna1', 'Aflatoxin B1'), ('ccna1', 'Lithium Chloride'), ('ccna1', 'Cadmium Chloride'), ('ccna1', 'Okadaic Acid'), ('ccna1', 'beta-Naphthoflavone'), ('ccna1', 'Nanotubes, Carbon'), ('ccna1', 'Flavanones'), ('h2bc21', 'Sunitinib'), ('h2bc21', 'Zoledronic Acid'), ('h2bc21', 'Troglitazone'), ('h2bc21', 'Vorinostat'), ('h2bc21', 'Acetaminophen'), ('h2bc21', 'Aldehydes'), ('h2bc21', 'Atrazine'), ('h2bc21', 'Azathioprine'), ('h2bc21', 'Benzene'), ('h2bc21', 'Benzo(a)pyrene'), ('h2bc21', 'Copper'), ('h2bc21', 'Coumestrol'), ('h2bc21', 'Demecolcine'), ('h2bc21', 'Doxorubicin'), ('h2bc21', 'Estradiol'), ('h2bc21', 'Formaldehyde'), ('h2bc21', 'Isoflavones'), ('h2bc21', 'Methyl Methanesulfonate'), ('h2bc21', 'Methylcholanthrene'), ('h2bc21', 'N-Nitrosopyrrolidine'), ('h2bc21', 'Niclosamide'), ('h2bc21', 'Oxygen'), ('h2bc21', 'Paraoxon'), ('h2bc21', 'Phenylmercuric Acetate'), ('h2bc21', 'Polychlorinated Biphenyls'), ('h2bc21', 'Rotenone'), ('h2bc21', 'Silicon Dioxide'), ('h2bc21', 'Sodium Dodecyl Sulfate'), ('h2bc21', 'Tetrachlorodibenzodioxin'), ('h2bc21', 'Dronabinol'), ('h2bc21', 'Tretinoin'), ('h2bc21', 'Triclosan'), ('h2bc21', 'Valproic Acid'), ('h2bc21', 'Vincristine'), ('h2bc21', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc21', 'Isotretinoin'), ('h2bc21', '1-Methyl-4-phenylpyridinium'), ('h2bc21', 'Cyclosporine'), ('h2bc21', 'Aflatoxin B1'), ('h2bc21', 'Asbestos, Crocidolite'), ('h2bc21', 'Copper Sulfate'), ('h2bc21', 'Lactic Acid'), ('h2bc21', 'Genistein'), ('h2bc21', 'Acrylamide'), ('h2bc21', 'p-Chloromercuribenzoic Acid'), ('h2bc17', 'Sunitinib'), ('h2bc17', 'Acetaminophen'), ('h2bc17', 'Benzo(a)pyrene'), ('h2bc17', 'Berberine'), ('h2bc17', 'Caffeine'), ('h2bc17', 'Calcitriol'), ('h2bc17', 'Dimethyl Sulfoxide'), ('h2bc17', 'Doxorubicin'), ('h2bc17', 'Enzyme Inhibitors'), ('h2bc17', 'Estradiol'), ('h2bc17', 'Lipopolysaccharides'), ('h2bc17', 'N-Nitrosopyrrolidine'), ('h2bc17', 'Oxygen'), ('h2bc17', 'Plant Extracts'), ('h2bc17', 'Silicon Dioxide'), ('h2bc17', 'Testosterone'), ('h2bc17', 'Valproic Acid'), ('h2bc17', 'Copper Sulfate'), ('h2bc17', 'Vitamin K 3'), ('h2bc17', 'Particulate Matter'), ('h2bc15', 'Sunitinib'), ('h2bc15', 'Acetaminophen'), ('h2bc15', 'Antimycin A'), ('h2bc15', 'Berberine'), ('h2bc15', 'Cisplatin'), ('h2bc15', 'N-Nitrosopyrrolidine'), ('h2bc15', 'Paraquat'), ('h2bc15', 'Plant Extracts'), ('h2bc15', 'Silicon Dioxide'), ('h2bc15', 'Tobacco Smoke Pollution'), ('h2bc15', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc15', 'Aflatoxin B1'), ('h2bc15', 'Sodium Selenite'), ('h2bc15', 'Copper Sulfate'), ('h2bc15', 'Genistein'), ('h2bc15', 'Acrylamide'), ('h2bc15', 'Vitamin K 3'), ('mapk11', 'Sunitinib'), ('mapk11', 'Arsenic Trioxide'), ('mapk11', 'Acrolein'), ('mapk11', 'Air Pollutants'), ('mapk11', 'Aldehydes'), ('mapk11', 'Benzo(a)pyrene'), ('mapk11', 'Cadmium'), ('mapk11', 'Calcitriol'), ('mapk11', 'Cisplatin'), ('mapk11', 'Diazinon'), ('mapk11', 'Ellagic Acid'), ('mapk11', 'Estradiol'), ('mapk11', 'Ethyl Methanesulfonate'), ('mapk11', 'Flurbiprofen'), ('mapk11', 'Formaldehyde'), ('mapk11', 'Hemin'), ('mapk11', 'Ibuprofen'), ('mapk11', 'Methotrexate'), ('mapk11', 'Methyl Methanesulfonate'), ('mapk11', 'Ozone'), ('mapk11', 'Plant Extracts'), ('mapk11', 'Pyrazoles'), ('mapk11', 'Pyrimidines'), ('mapk11', 'Quercetin'), ('mapk11', 'Selenium'), ('mapk11', 'Smoke'), ('mapk11', 'Tamoxifen'), ('mapk11', 'Testosterone'), ('mapk11', 'Tetrachlorodibenzodioxin'), ('mapk11', 'Tobacco Smoke Pollution'), ('mapk11', 'Triclosan'), ('mapk11', 'Valproic Acid'), ('mapk11', 'Vitallium'), ('mapk11', 'Vitamin E'), ('mapk11', 'Cyclosporine'), ('mapk11', 'Aflatoxin B1'), ('mapk11', 'Cadmium Chloride'), ('mapk11', 'Genistein'), ('mapk11', 'Acrylamide'), ('mapk11', 'Volatile Organic Compounds'), ('kdm6b', 'Sunitinib'), ('kdm6b', 'Vorinostat'), ('kdm6b', 'Leflunomide'), ('kdm6b', 'Air Pollutants'), ('kdm6b', 'Berberine'), ('kdm6b', 'Cadmium'), ('kdm6b', 'Cisplatin'), ('kdm6b', 'Doxorubicin'), ('kdm6b', 'Hydrogen Peroxide'), ('kdm6b', 'Lipopolysaccharides'), ('kdm6b', 'Niclosamide'), ('kdm6b', 'Oxygen'), ('kdm6b', 'Ozone'), ('kdm6b', 'Plant Extracts'), ('kdm6b', 'Selenium'), ('kdm6b', 'Silicon Dioxide'), ('kdm6b', 'Theophylline'), ('kdm6b', 'Tobacco Smoke Pollution'), ('kdm6b', 'Tretinoin'), ('kdm6b', 'Urethane'), ('kdm6b', 'Valproic Acid'), ('kdm6b', 'Vitamin E'), ('kdm6b', 'Zinc'), ('kdm6b', 'Cyclosporine'), ('kdm6b', 'Aflatoxin B1'), ('kdm6b', 'Gold Compounds'), ('kdm6b', 'Asbestos, Crocidolite'), ('kdm6b', 'Cadmium Chloride'), ('eed', 'Leflunomide'), ('eed', 'Acetaminophen'), ('eed', 'Amiodarone'), ('eed', 'Benzene'), ('eed', 'Benzo(a)pyrene'), ('eed', 'Copper'), ('eed', 'Coumestrol'), ('eed', 'Disulfiram'), ('eed', 'Formaldehyde'), ('eed', 'Ivermectin'), ('eed', 'Methotrexate'), ('eed', 'Methyl Methanesulfonate'), ('eed', 'Plant Extracts'), ('eed', 'Valproic Acid'), ('eed', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('eed', 'Oxyquinoline'), ('eed', 'Cyclosporine'), ('eed', 'Aflatoxin B1'), ('eed', 'Copper Sulfate'), ('cdc27', 'Arsenic Trioxide'), ('cdc27', 'Vorinostat'), ('cdc27', 'Acetaminophen'), ('cdc27', 'Atrazine'), ('cdc27', 'Caffeine'), ('cdc27', 'Chelating Agents'), ('cdc27', 'Copper'), ('cdc27', 'Coumestrol'), ('cdc27', 'Doxorubicin'), ('cdc27', 'Formaldehyde'), ('cdc27', 'Ivermectin'), ('cdc27', 'Lead'), ('cdc27', 'Methapyrilene'), ('cdc27', 'Methyl Methanesulfonate'), ('cdc27', 'Phenobarbital'), ('cdc27', 'Plant Extracts'), ('cdc27', 'Potassium Dichromate'), ('cdc27', 'Quercetin'), ('cdc27', 'Thimerosal'), ('cdc27', 'Tretinoin'), ('cdc27', 'Valproic Acid'), ('cdc27', 'Vitamin E'), ('cdc27', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cdc27', '1-Methyl-4-phenylpyridinium'), ('cdc27', 'Cyclosporine'), ('cdc27', 'Aflatoxin B1'), ('cdc27', 'Paclitaxel'), ('cdc27', 'Cadmium Chloride'), ('cdc27', 'Zinc Acetate'), ('cdc27', 'tert-Butylhydroperoxide'), ('kat5', 'Decitabine'), ('kat5', 'Sunitinib'), ('kat5', 'Arsenic Trioxide'), ('kat5', 'Vorinostat'), ('kat5', 'Acrolein'), ('kat5', 'Air Pollutants'), ('kat5', 'Benzo(a)pyrene'), ('kat5', 'Cisplatin'), ('kat5', 'Estradiol'), ('kat5', 'Ozone'), ('kat5', 'Pentamidine'), ('kat5', 'Sarin'), ('kat5', 'Selenium'), ('kat5', 'Smoke'), ('kat5', 'Tretinoin'), ('kat5', 'Valproic Acid'), ('kat5', 'Vitamin E'), ('kat5', 'Cyclosporine'), ('kat5', 'Asbestos, Crocidolite'), ('kat5', 'Genistein'), ('kat5', 'Butyric Acid'), ('kat5', 'Volatile Organic Compounds'), ('kat5', 'Equol'), ('foxo1', 'Wortmannin'), ('foxo1', 'Decitabine'), ('foxo1', 'Sunitinib'), ('foxo1', 'Zoledronic Acid'), ('foxo1', 'Arsenic Trioxide'), ('foxo1', 'Fulvestrant'), ('foxo1', 'Vorinostat'), ('foxo1', 'Leflunomide'), ('foxo1', 'Panobinostat'), ('foxo1', 'Acetaminophen'), ('foxo1', 'Acrolein'), ('foxo1', 'Cyclic AMP'), ('foxo1', 'Air Pollutants, Occupational'), ('foxo1', 'Ethanol'), ('foxo1', 'Arsenic'), ('foxo1', 'Asbestos'), ('foxo1', 'Azacitidine'), ('foxo1', 'Azathioprine'), ('foxo1', 'Benzo(a)pyrene'), ('foxo1', 'Berberine'), ('foxo1', 'Cadmium'), ('foxo1', 'Calcitriol'), ('foxo1', 'Cannabidiol'), ('foxo1', 'Carbamazepine'), ('foxo1', 'Chelating Agents'), ('foxo1', 'Cisplatin'), ('foxo1', 'Contrast Media'), ('foxo1', 'Copper'), ('foxo1', 'Curcumin'), ('foxo1', 'Dexamethasone'), ('foxo1', 'Diatrizoate'), ('foxo1', 'Bucladesine'), ('foxo1', 'Diclofenac'), ('foxo1', 'Doxorubicin'), ('foxo1', 'Emodin'), ('foxo1', 'Estradiol'), ('foxo1', 'Etoposide'), ('foxo1', 'Formaldehyde'), ('foxo1', 'Glucose'), ('foxo1', 'Hydrocortisone'), ('foxo1', 'Hydrogen Peroxide'), ('foxo1', 'Indomethacin'), ('foxo1', 'Niacinamide'), ('foxo1', 'Nicotine'), ('foxo1', 'Phenylmercuric Acetate'), ('foxo1', 'Plant Extracts'), ('foxo1', 'Progesterone'), ('foxo1', 'Quercetin'), ('foxo1', 'Carbaryl'), ('foxo1', 'Silicon Dioxide'), ('foxo1', 'Sodium Chloride'), ('foxo1', 'Tamoxifen'), ('foxo1', 'Tobacco Smoke Pollution'), ('foxo1', 'Tretinoin'), ('foxo1', 'Valproic Acid'), ('foxo1', 'Vitamin E'), ('foxo1', 'Zinc'), ('foxo1', '1-Methyl-3-isobutylxanthine'), ('foxo1', '2,4-Dichlorophenoxyacetic Acid'), ('foxo1', '8-Bromo Cyclic Adenosine Monophosphate'), ('foxo1', 'Mifepristone'), ('foxo1', 'Cyclosporine'), ('foxo1', 'Medroxyprogesterone Acetate'), ('foxo1', 'Asbestos, Serpentine'), ('foxo1', 'Asbestos, Crocidolite'), ('foxo1', 'Antirheumatic Agents'), ('foxo1', 'Cadmium Chloride'), ('foxo1', 'Zinc Sulfate'), ('foxo1', 'Copper Sulfate'), ('foxo1', 'Simvastatin'), ('foxo1', 'Sirolimus'), ('foxo1', 'Raloxifene Hydrochloride'), ('foxo1', 'Nanotubes, Carbon'), ('foxo1', 'Protein Kinase Inhibitors'), ('foxo1', 'Particulate Matter'), ('pik3cb', 'Wortmannin'), ('pik3cb', 'Pioglitazone'), ('pik3cb', 'Arsenic Trioxide'), ('pik3cb', 'Fulvestrant'), ('pik3cb', 'Benzo(a)pyrene'), ('pik3cb', 'Cannabidiol'), ('pik3cb', 'Chelating Agents'), ('pik3cb', 'Copper'), ('pik3cb', 'Doxorubicin'), ('pik3cb', 'Lead'), ('pik3cb', 'Metformin'), ('pik3cb', 'Oxygen'), ('pik3cb', 'Ozone'), ('pik3cb', 'T-2 Toxin'), ('pik3cb', 'Tetrachlorodibenzodioxin'), ('pik3cb', 'Tretinoin'), ('pik3cb', 'Valproic Acid'), ('pik3cb', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('pik3cb', 'Cyclosporine'), ('pik3cb', 'Asbestos, Crocidolite'), ('pik3cb', 'Copper Sulfate'), ('anapc1', 'Gemcitabine'), ('anapc1', 'Benzo(a)pyrene'), ('anapc1', 'Caffeine'), ('anapc1', 'Catechin'), ('anapc1', 'Copper'), ('anapc1', 'Dexamethasone'), ('anapc1', 'Doxorubicin'), ('anapc1', 'Estradiol'), ('anapc1', 'Ethyl Methanesulfonate'), ('anapc1', 'Gasoline'), ('anapc1', 'Indomethacin'), ('anapc1', 'Ivermectin'), ('anapc1', 'Methyl Methanesulfonate'), ('anapc1', 'Phenylmercuric Acetate'), ('anapc1', 'Plant Extracts'), ('anapc1', 'Polycyclic Aromatic Hydrocarbons'), ('anapc1', 'Quercetin'), ('anapc1', 'Silicon Dioxide'), ('anapc1', 'Tretinoin'), ('anapc1', 'Valproic Acid'), ('anapc1', 'Zearalenone'), ('anapc1', '1-Methyl-3-isobutylxanthine'), ('anapc1', 'Copper Sulfate'), ('anapc1', 'Genistein'), ('anapc1', '1-Butanol'), ('anapc1', 'Vitamin K 3'), ('anapc1', 'Particulate Matter'), ('dnajc7', 'Arsenic Trioxide'), ('dnajc7', 'Acetaminophen'), ('dnajc7', 'Air Pollutants'), ('dnajc7', 'Vehicle Emissions'), ('dnajc7', 'Benzo(a)pyrene'), ('dnajc7', 'Carbamazepine'), ('dnajc7', 'Demecolcine'), ('dnajc7', 'Diclofenac'), ('dnajc7', 'Enzyme Inhibitors'), ('dnajc7', 'Hydrogen Peroxide'), ('dnajc7', 'Ivermectin'), ('dnajc7', 'Lead'), ('dnajc7', 'Methapyrilene'), ('dnajc7', 'Ozone'), ('dnajc7', 'Plant Extracts'), ('dnajc7', 'Selenium'), ('dnajc7', 'Smoke'), ('dnajc7', 'Tobacco Smoke Pollution'), ('dnajc7', 'Valproic Acid'), ('dnajc7', 'Vanadates'), ('dnajc7', 'Vincristine'), ('dnajc7', 'Vitamin E'), ('dnajc7', 'Antirheumatic Agents'), ('dnajc7', 'Copper Sulfate'), ('dnajc7', 'Lactic Acid'), ('dnajc7', 'Acrylamide'), ('dnajc7', 'Particulate Matter'), ('ppp1cb', 'Arsenic Trioxide'), ('ppp1cb', 'Ethanol'), ('ppp1cb', 'Benzene'), ('ppp1cb', 'Benzo(a)pyrene'), ('ppp1cb', 'Cadmium'), ('ppp1cb', 'Caffeine'), ('ppp1cb', 'Calcitriol'), ('ppp1cb', 'Cannabidiol'), ('ppp1cb', 'Carbamazepine'), ('ppp1cb', 'Dexamethasone'), ('ppp1cb', 'Diclofenac'), ('ppp1cb', 'Diethylstilbestrol'), ('ppp1cb', 'Doxorubicin'), ('ppp1cb', 'Enzyme Inhibitors'), ('ppp1cb', 'Formaldehyde'), ('ppp1cb', 'Gold'), ('ppp1cb', 'Hydrogen Peroxide'), ('ppp1cb', 'Indomethacin'), ('ppp1cb', 'Ivermectin'), ('ppp1cb', 'Methyl Methanesulfonate'), ('ppp1cb', 'Piroxicam'), ('ppp1cb', 'Plant Extracts'), ('ppp1cb', 'Ribonucleotides'), ('ppp1cb', 'Rotenone'), ('ppp1cb', 'Sodium Dodecyl Sulfate'), ('ppp1cb', 'Testosterone'), ('ppp1cb', 'Dronabinol'), ('ppp1cb', 'Tobacco Smoke Pollution'), ('ppp1cb', 'Tretinoin'), ('ppp1cb', 'Valproic Acid'), ('ppp1cb', '1-Methyl-3-isobutylxanthine'), ('ppp1cb', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ppp1cb', 'Cyclosporine'), ('ppp1cb', 'Paclitaxel'), ('ppp1cb', 'Cadmium Chloride'), ('ppp1cb', 'Copper Sulfate'), ('ppp1cb', 'tert-Butylhydroperoxide'), ('ppp1cb', 'Particulate Matter'), ('map2k7', 'Acetaminophen'), ('map2k7', 'Atrazine'), ('map2k7', 'Benzo(a)pyrene'), ('map2k7', 'Caffeine'), ('map2k7', 'Cannabidiol'), ('map2k7', 'Chelating Agents'), ('map2k7', 'Copper'), ('map2k7', 'Diazinon'), ('map2k7', 'Doxorubicin'), ('map2k7', 'Formaldehyde'), ('map2k7', 'Hydrogen Peroxide'), ('map2k7', 'Menthol'), ('map2k7', 'Plant Extracts'), ('map2k7', 'Smoke'), ('map2k7', 'Tetrachlorodibenzodioxin'), ('map2k7', 'Urethane'), ('map2k7', 'Valproic Acid'), ('map2k7', 'Vitamin E'), ('map2k7', 'Aflatoxin B1'), ('map2k7', 'Cadmium Chloride'), ('ccne2', 'Sunitinib'), ('ccne2', 'Zoledronic Acid'), ('ccne2', 'Fulvestrant'), ('ccne2', 'Leflunomide'), ('ccne2', 'Cidofovir'), ('ccne2', '2-Methoxyestradiol'), ('ccne2', 'Acetaminophen'), ('ccne2', 'Adenine'), ('ccne2', 'Air Pollutants'), ('ccne2', 'Amphotericin B'), ('ccne2', 'Arsenic'), ('ccne2', 'Atropine'), ('ccne2', 'Azathioprine'), ('ccne2', 'Benzo(a)pyrene'), ('ccne2', 'Cadmium'), ('ccne2', 'Calcitriol'), ('ccne2', 'Cannabidiol'), ('ccne2', 'Carbamazepine'), ('ccne2', 'Catechin'), ('ccne2', 'Cisplatin'), ('ccne2', 'Coal'), ('ccne2', 'Colchicine'), ('ccne2', 'Coumestrol'), ('ccne2', 'Cytarabine'), ('ccne2', 'Demecolcine'), ('ccne2', 'Diazinon'), ('ccne2', 'Clodronic Acid'), ('ccne2', 'Diclofenac'), ('ccne2', 'Diethylhexyl Phthalate'), ('ccne2', 'Dinitrofluorobenzene'), ('ccne2', 'Endosulfan'), ('ccne2', 'Estradiol'), ('ccne2', 'Ethidium'), ('ccne2', 'Ethyl Methanesulfonate'), ('ccne2', 'Fluorouracil'), ('ccne2', 'Harmine'), ('ccne2', 'Hydrochloric Acid'), ('ccne2', 'Ibuprofen'), ('ccne2', 'Ifosfamide'), ('ccne2', 'Lipopolysaccharides'), ('ccne2', 'Methotrexate'), ('ccne2', 'Methyl Methanesulfonate'), ('ccne2', 'Nickel'), ('ccne2', 'Niclosamide'), ('ccne2', 'Organotin Compounds'), ('ccne2', 'Oxygen'), ('ccne2', 'Parathion'), ('ccne2', 'Quercetin'), ('ccne2', 'Rotenone'), ('ccne2', 'Silicon Dioxide'), ('ccne2', 'Smoke'), ('ccne2', 'Testosterone'), ('ccne2', 'Tetrachlorodibenzodioxin'), ('ccne2', 'Tretinoin'), ('ccne2', 'Urethane'), ('ccne2', 'Valproic Acid'), ('ccne2', 'Vincristine'), ('ccne2', 'Zinc'), ('ccne2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ccne2', 'Oxyquinoline'), ('ccne2', 'Zidovudine'), ('ccne2', 'Cyclosporine'), ('ccne2', 'Aflatoxin B1'), ('ccne2', 'Paclitaxel'), ('ccne2', 'Lithium Chloride'), ('ccne2', 'Cadmium Chloride'), ('ccne2', 'Lamivudine'), ('ccne2', 'Copper Sulfate'), ('ccne2', 'Lactic Acid'), ('ccne2', 'Ritonavir'), ('ccne2', 'tert-Butylhydroperoxide'), ('ccne2', 'Sirolimus'), ('ccne2', 'Raloxifene Hydrochloride'), ('ccne2', 'Nanotubes, Carbon'), ('ccne2', 'Particulate Matter'), ('e2f2', 'Sunitinib'), ('e2f2', 'Zoledronic Acid'), ('e2f2', 'Arsenic Trioxide'), ('e2f2', 'Troglitazone'), ('e2f2', 'Leflunomide'), ('e2f2', 'Cilostazol'), ('e2f2', 'Panobinostat'), ('e2f2', 'Acetaminophen'), ('e2f2', 'Cyclic AMP'), ('e2f2', 'Air Pollutants'), ('e2f2', 'Ethanol'), ('e2f2', 'Amphotericin B'), ('e2f2', 'Arsenic'), ('e2f2', 'Ascorbic Acid'), ('e2f2', 'Atrazine'), ('e2f2', 'Benzo(a)pyrene'), ('e2f2', 'Calcitriol'), ('e2f2', 'Cannabidiol'), ('e2f2', 'Carbamazepine'), ('e2f2', 'Chelating Agents'), ('e2f2', 'Cisplatin'), ('e2f2', 'Copper'), ('e2f2', 'Coumestrol'), ('e2f2', 'Diclofenac'), ('e2f2', 'Estradiol'), ('e2f2', 'Eugenol'), ('e2f2', 'Fluorouracil'), ('e2f2', 'Gasoline'), ('e2f2', 'Harmine'), ('e2f2', 'Hydrogen Peroxide'), ('e2f2', 'Lead'), ('e2f2', 'Lipopolysaccharides'), ('e2f2', 'Niclosamide'), ('e2f2', 'Nicotine'), ('e2f2', 'Oxygen'), ('e2f2', 'Phenylmercuric Acetate'), ('e2f2', 'Polycyclic Aromatic Hydrocarbons'), ('e2f2', 'Quercetin'), ('e2f2', 'Silicon Dioxide'), ('e2f2', 'Silver Nitrate'), ('e2f2', 'Testosterone'), ('e2f2', 'Tetrachlorodibenzodioxin'), ('e2f2', 'Tobacco Smoke Pollution'), ('e2f2', 'Tretinoin'), ('e2f2', 'Triclosan'), ('e2f2', 'Tunicamycin'), ('e2f2', 'Urethane'), ('e2f2', 'Valproic Acid'), ('e2f2', '1-Methyl-4-phenylpyridinium'), ('e2f2', 'Aflatoxin B1'), ('e2f2', 'Antirheumatic Agents'), ('e2f2', 'Thapsigargin'), ('e2f2', 'Ritonavir'), ('e2f2', 'Genistein'), ('e2f2', '1-Butanol'), ('e2f2', 'Acrylamide'), ('e2f2', 'Raloxifene Hydrochloride'), ('e2f2', 'Particulate Matter'), ('hmga1', 'Sunitinib'), ('hmga1', 'Arsenic Trioxide'), ('hmga1', 'Acetaminophen'), ('hmga1', 'Acrolein'), ('hmga1', 'Air Pollutants'), ('hmga1', 'Ethanol'), ('hmga1', 'Antimony'), ('hmga1', 'Antimony Potassium Tartrate'), ('hmga1', 'Azacitidine'), ('hmga1', 'Benzo(a)pyrene'), ('hmga1', 'Cadmium'), ('hmga1', 'Caffeine'), ('hmga1', 'Chromium'), ('hmga1', 'Cisplatin'), ('hmga1', 'Coumestrol'), ('hmga1', 'Dexamethasone'), ('hmga1', 'Dimethylnitrosamine'), ('hmga1', 'Estradiol'), ('hmga1', 'Ethyl Methanesulfonate'), ('hmga1', 'Flame Retardants'), ('hmga1', 'Formaldehyde'), ('hmga1', 'Hydrogen Peroxide'), ('hmga1', 'Indomethacin'), ('hmga1', 'Ivermectin'), ('hmga1', 'Lipopolysaccharides'), ('hmga1', 'Methamphetamine'), ('hmga1', 'Methyl Methanesulfonate'), ('hmga1', 'Nicotine'), ('hmga1', 'Ozone'), ('hmga1', 'Plant Extracts'), ('hmga1', 'Potassium Dichromate'), ('hmga1', 'Progesterone'), ('hmga1', 'Quercetin'), ('hmga1', 'Silicon Dioxide'), ('hmga1', 'Smoke'), ('hmga1', 'T-2 Toxin'), ('hmga1', 'Thimerosal'), ('hmga1', 'Tobacco Smoke Pollution'), ('hmga1', 'Tretinoin'), ('hmga1', 'Valproic Acid'), ('hmga1', '1-Methyl-3-isobutylxanthine'), ('hmga1', '8-Bromo Cyclic Adenosine Monophosphate'), ('hmga1', 'Cyclosporine'), ('hmga1', 'Aflatoxin B1'), ('hmga1', 'Mitomycin'), ('hmga1', 'Asbestos, Crocidolite'), ('hmga1', 'Cadmium Chloride'), ('hmga1', 'Copper Sulfate'), ('hmga1', 'Topotecan'), ('hmga1', 'tert-Butylhydroperoxide'), ('hmga1', 'Volatile Organic Compounds'), ('hmga1', 'Halogenated Diphenyl Ethers'), ('akt3', 'Fulvestrant'), ('akt3', 'Vorinostat'), ('akt3', 'Acetaminophen'), ('akt3', 'Arsenic'), ('akt3', 'Benzo(a)pyrene'), ('akt3', 'Cisplatin'), ('akt3', 'Curcumin'), ('akt3', 'Doxorubicin'), ('akt3', 'Estradiol'), ('akt3', 'Formaldehyde'), ('akt3', 'Insulin'), ('akt3', 'Lead'), ('akt3', 'Menthol'), ('akt3', 'Metformin'), ('akt3', 'Methyl Methanesulfonate'), ('akt3', 'Tetrachlorodibenzodioxin'), ('akt3', 'Thimerosal'), ('akt3', 'Tobacco Smoke Pollution'), ('akt3', 'Tretinoin'), ('akt3', 'Tunicamycin'), ('akt3', 'Valproic Acid'), ('akt3', 'Cyclosporine'), ('akt3', 'Paclitaxel'), ('akt3', 'Cadmium Chloride'), ('akt3', 'Topotecan'), ('akt3', 'Particulate Matter'), ('cbx6', 'Norethindrone Acetate'), ('cbx6', 'Acetaminophen'), ('cbx6', 'Acrolein'), ('cbx6', 'Air Pollutants'), ('cbx6', 'Arbutin'), ('cbx6', 'Atrazine'), ('cbx6', 'Cadmium'), ('cbx6', 'Caffeine'), ('cbx6', 'Cisplatin'), ('cbx6', 'Dieldrin'), ('cbx6', 'Estradiol'), ('cbx6', 'Methyl Methanesulfonate'), ('cbx6', 'Ozone'), ('cbx6', 'Plant Extracts'), ('cbx6', 'Quercetin'), ('cbx6', 'Selenomethionine'), ('cbx6', 'Silicon Dioxide'), ('cbx6', 'Smoke'), ('cbx6', 'Dronabinol'), ('cbx6', 'Tunicamycin'), ('cbx6', 'Urethane'), ('cbx6', 'Valproic Acid'), ('cbx6', 'Vitamin E'), ('cbx6', 'Cyclosporine'), ('cbx6', 'Cadmium Chloride'), ('cbx6', 'Lactic Acid'), ('cbx6', 'Genistein'), ('cbx6', 'Acrylamide'), ('cbx6', 'Volatile Organic Compounds'), ('vdac3', 'Sunitinib'), ('vdac3', 'Vorinostat'), ('vdac3', 'Acetaminophen'), ('vdac3', 'Atrazine'), ('vdac3', 'Benzo(a)pyrene'), ('vdac3', 'Cadmium'), ('vdac3', 'Cisplatin'), ('vdac3', 'Dexamethasone'), ('vdac3', 'Doxorubicin'), ('vdac3', 'Enzyme Inhibitors'), ('vdac3', 'Indomethacin'), ('vdac3', 'Ivermectin'), ('vdac3', 'Methotrexate'), ('vdac3', 'Piroxicam'), ('vdac3', 'Plant Extracts'), ('vdac3', 'Ribonucleotides'), ('vdac3', 'Tunicamycin'), ('vdac3', 'Valproic Acid'), ('vdac3', '1-Methyl-3-isobutylxanthine'), ('vdac3', '1-Methyl-4-phenylpyridinium'), ('vdac3', 'Cyclosporine'), ('vdac3', 'Cadmium Chloride'), ('vdac3', 'Thapsigargin'), ('tgfb3', 'Temozolomide'), ('tgfb3', 'Sunitinib'), ('tgfb3', 'Fulvestrant'), ('tgfb3', 'Acetylcysteine'), ('tgfb3', 'Cyclic AMP'), ('tgfb3', 'Antimycin A'), ('tgfb3', 'Arbutin'), ('tgfb3', 'Arsenic'), ('tgfb3', 'Ascorbic Acid'), ('tgfb3', 'Benzo(a)pyrene'), ('tgfb3', 'Cadmium'), ('tgfb3', 'Calcitriol'), ('tgfb3', 'Chelating Agents'), ('tgfb3', 'Cisplatin'), ('tgfb3', 'Copper'), ('tgfb3', 'Dexamethasone'), ('tgfb3', 'Diazepam'), ('tgfb3', 'Diazinon'), ('tgfb3', 'Diethylstilbestrol'), ('tgfb3', 'Drugs, Chinese Herbal'), ('tgfb3', 'Estradiol'), ('tgfb3', 'Estrogens'), ('tgfb3', 'Fluorides'), ('tgfb3', 'Hydrogen Peroxide'), ('tgfb3', 'Indomethacin'), ('tgfb3', 'Lipopolysaccharides'), ('tgfb3', 'N-Nitrosopyrrolidine'), ('tgfb3', 'Ouabain'), ('tgfb3', 'Phenytoin'), ('tgfb3', 'Phosphorus'), ('tgfb3', 'Progesterone'), ('tgfb3', 'Rotenone'), ('tgfb3', 'Smoke'), ('tgfb3', 'Testosterone'), ('tgfb3', 'Tetrachlorodibenzodioxin'), ('tgfb3', 'Dronabinol'), ('tgfb3', 'Tobacco Smoke Pollution'), ('tgfb3', 'Tretinoin'), ('tgfb3', 'Valproic Acid'), ('tgfb3', 'Vitamin A'), ('tgfb3', 'Water Pollutants, Chemical'), ('tgfb3', 'Zeranol'), ('tgfb3', '1-Methyl-3-isobutylxanthine'), ('tgfb3', '8-Bromo Cyclic Adenosine Monophosphate'), ('tgfb3', '1-Methyl-4-phenylpyridinium'), ('tgfb3', 'Cyclosporine'), ('tgfb3', 'Medroxyprogesterone Acetate'), ('tgfb3', 'Cadmium Chloride'), ('tgfb3', 'Genistein'), ('tgfb3', 'Butyric Acid'), ('tgfb3', 'Raloxifene Hydrochloride'), ('Temozolomide', 'h2bc12'), ('Temozolomide', 'h2aj'), ('Temozolomide', 'rbbp7'), ('Temozolomide', 'cbx2'), ('Temozolomide', 'phc2'), ('Temozolomide', 'slc25a4'), ('Temozolomide', 'cdc16'), ('Temozolomide', 'slc25a6'), ('Temozolomide', 'capn1'), ('Temozolomide', 'capn2'), ('Temozolomide', 'rad9a'), ('h2bc12', 'Zoledronic Acid'), ('h2bc12', 'Troglitazone'), ('h2bc12', 'Panobinostat'), ('h2bc12', 'Acetaminophen'), ('h2bc12', 'Ethanol'), ('h2bc12', 'Aminoglutethimide'), ('h2bc12', 'Benzene'), ('h2bc12', 'Benzo(a)pyrene'), ('h2bc12', 'Berberine'), ('h2bc12', 'Cadmium'), ('h2bc12', 'Cisplatin'), ('h2bc12', 'Copper'), ('h2bc12', 'Coumestrol'), ('h2bc12', 'Demecolcine'), ('h2bc12', 'Disulfiram'), ('h2bc12', 'Doxorubicin'), ('h2bc12', 'Estradiol'), ('h2bc12', 'Fluorouracil'), ('h2bc12', 'Folic Acid'), ('h2bc12', 'Formaldehyde'), ('h2bc12', 'Hydrogen Peroxide'), ('h2bc12', 'Methyl Methanesulfonate'), ('h2bc12', 'Oxygen'), ('h2bc12', 'Silicon Dioxide'), ('h2bc12', 'Dronabinol'), ('h2bc12', 'Tobacco Smoke Pollution'), ('h2bc12', 'Tretinoin'), ('h2bc12', 'Urethane'), ('h2bc12', 'Valproic Acid'), ('h2bc12', 'Vincristine'), ('h2bc12', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc12', 'Isotretinoin'), ('h2bc12', '1-Methyl-4-phenylpyridinium'), ('h2bc12', 'Cyclosporine'), ('h2bc12', 'Aflatoxin B1'), ('h2bc12', 'Tungsten Compounds'), ('h2bc12', 'Zinc Sulfate'), ('h2bc12', 'Copper Sulfate'), ('h2bc12', 'Lactic Acid'), ('h2bc12', 'Acrylamide'), ('h2bc12', 'tert-Butylhydroperoxide'), ('h2aj', 'Vorinostat'), ('h2aj', 'Acetaminophen'), ('h2aj', 'Ethanol'), ('h2aj', 'Amiodarone'), ('h2aj', 'Benzo(a)pyrene'), ('h2aj', 'Benztropine'), ('h2aj', 'Cannabidiol'), ('h2aj', 'Cisplatin'), ('h2aj', 'Clozapine'), ('h2aj', 'Cytarabine'), ('h2aj', 'Dexamethasone'), ('h2aj', 'Diethylhexyl Phthalate'), ('h2aj', 'Formaldehyde'), ('h2aj', 'Gasoline'), ('h2aj', 'Haloperidol'), ('h2aj', 'Hydrogen Peroxide'), ('h2aj', 'Methyl Methanesulfonate'), ('h2aj', 'Nickel'), ('h2aj', 'Polycyclic Aromatic Hydrocarbons'), ('h2aj', 'Silicon Dioxide'), ('h2aj', 'Smoke'), ('h2aj', 'Valproic Acid'), ('h2aj', 'Aflatoxin B1'), ('h2aj', 'Lactic Acid'), ('h2aj', 'Vitamin K 3'), ('h2aj', 'Particulate Matter'), ('rbbp7', 'Fulvestrant'), ('rbbp7', 'Leflunomide'), ('rbbp7', 'Acetaminophen'), ('rbbp7', 'Benzo(a)pyrene'), ('rbbp7', 'Caffeine'), ('rbbp7', 'Carbamazepine'), ('rbbp7', 'Copper'), ('rbbp7', 'Enzyme Inhibitors'), ('rbbp7', 'Estradiol'), ('rbbp7', 'Hydrocortisone'), ('rbbp7', 'Ivermectin'), ('rbbp7', 'Methylcholanthrene'), ('rbbp7', 'Ozone'), ('rbbp7', 'Phenobarbital'), ('rbbp7', 'Promegestone'), ('rbbp7', 'Smoke'), ('rbbp7', 'Uranium'), ('rbbp7', 'Cyclosporine'), ('rbbp7', 'Mitomycin'), ('rbbp7', 'Antirheumatic Agents'), ('rbbp7', 'Copper Sulfate'), ('rbbp7', 'Raloxifene Hydrochloride'), ('cbx2', 'Leflunomide'), ('cbx2', 'Acetaminophen'), ('cbx2', 'Benzo(a)pyrene'), ('cbx2', 'Calcitriol'), ('cbx2', 'Carbamazepine'), ('cbx2', 'Cisplatin'), ('cbx2', 'Copper'), ('cbx2', 'Diethylhexyl Phthalate'), ('cbx2', 'Estradiol'), ('cbx2', 'Lead'), ('cbx2', 'Methotrexate'), ('cbx2', 'Nickel'), ('cbx2', 'Quercetin'), ('cbx2', 'Silver'), ('cbx2', 'Smoke'), ('cbx2', 'Testosterone'), ('cbx2', 'Tobacco Smoke Pollution'), ('cbx2', 'Tretinoin'), ('cbx2', 'Valproic Acid'), ('cbx2', 'Aflatoxin B1'), ('cbx2', 'Antirheumatic Agents'), ('phc2', 'Sunitinib'), ('phc2', 'Norethindrone Acetate'), ('phc2', 'Acetaminophen'), ('phc2', 'Air Pollutants'), ('phc2', 'Arsenic'), ('phc2', 'Benzo(a)pyrene'), ('phc2', 'Carmustine'), ('phc2', 'Dexamethasone'), ('phc2', 'Doxorubicin'), ('phc2', 'Estradiol'), ('phc2', 'Formaldehyde'), ('phc2', 'Hydralazine'), ('phc2', 'Indomethacin'), ('phc2', 'Lead'), ('phc2', 'Ozone'), ('phc2', 'Smoke'), ('phc2', 'Tamoxifen'), ('phc2', 'Tobacco Smoke Pollution'), ('phc2', 'Triclosan'), ('phc2', 'Valproic Acid'), ('phc2', 'Vitamin E'), ('phc2', '1-Methyl-3-isobutylxanthine'), ('phc2', 'Cyclosporine'), ('phc2', 'Aflatoxin B1'), ('phc2', 'Copper Sulfate'), ('phc2', 'Raloxifene Hydrochloride'), ('slc25a4', 'Arsenic Trioxide'), ('slc25a4', 'Fulvestrant'), ('slc25a4', 'Acetaminophen'), ('slc25a4', 'Antimycin A'), ('slc25a4', 'Arsenic'), ('slc25a4', 'Atrazine'), ('slc25a4', 'Cadmium'), ('slc25a4', 'Calcitriol'), ('slc25a4', 'Doxorubicin'), ('slc25a4', 'Estradiol'), ('slc25a4', 'Folic Acid'), ('slc25a4', 'Formaldehyde'), ('slc25a4', 'Ivermectin'), ('slc25a4', 'Lead'), ('slc25a4', 'Lipopolysaccharides'), ('slc25a4', 'Menthol'), ('slc25a4', 'Smoke'), ('slc25a4', 'Testosterone'), ('slc25a4', 'Dronabinol'), ('slc25a4', 'Tretinoin'), ('slc25a4', 'Triclosan'), ('slc25a4', 'Tunicamycin'), ('slc25a4', 'Valproic Acid'), ('slc25a4', 'Vitamin E'), ('slc25a4', 'Cyclosporine'), ('slc25a4', 'Paclitaxel'), ('slc25a4', 'Asbestos, Crocidolite'), ('slc25a4', 'Thapsigargin'), ('slc25a4', 'Okadaic Acid'), ('slc25a4', 'Copper Sulfate'), ('slc25a4', 'Lactic Acid'), ('cdc16', 'Arsenic'), ('cdc16', 'Caffeine'), ('cdc16', 'Carbamazepine'), ('cdc16', 'Chelating Agents'), ('cdc16', 'Copper'), ('cdc16', 'Doxorubicin'), ('cdc16', 'Hydrogen Peroxide'), ('cdc16', 'Ivermectin'), ('cdc16', 'Lead'), ('cdc16', 'Metformin'), ('cdc16', 'Quercetin'), ('cdc16', 'Selenium'), ('cdc16', 'Valproic Acid'), ('cdc16', 'Vitamin E'), ('cdc16', 'Cyclosporine'), ('cdc16', 'Paclitaxel'), ('cdc16', 'Antirheumatic Agents'), ('cdc16', 'Zinc Acetate'), ('cdc16', 'tert-Butylhydroperoxide'), ('slc25a6', 'Acetaminophen'), ('slc25a6', 'Benzene'), ('slc25a6', 'Benztropine'), ('slc25a6', 'Clozapine'), ('slc25a6', 'Dietary Carbohydrates'), ('slc25a6', 'Diuron'), ('slc25a6', 'Dopamine'), ('slc25a6', 'Ivermectin'), ('slc25a6', 'Rotenone'), ('slc25a6', 'Selenium'), ('slc25a6', 'Smoke'), ('slc25a6', 'Tretinoin'), ('slc25a6', 'Uranium'), ('slc25a6', 'Valproic Acid'), ('slc25a6', 'Vanadates'), ('slc25a6', 'Vitamin E'), ('slc25a6', '1-Methyl-4-phenylpyridinium'), ('slc25a6', 'Metribolone'), ('slc25a6', 'Asbestos, Crocidolite'), ('capn1', 'Arsenic Trioxide'), ('capn1', 'Fulvestrant'), ('capn1', 'Acetaminophen'), ('capn1', 'Ethanol'), ('capn1', 'Alprazolam'), ('capn1', 'Arsenic'), ('capn1', 'Aspirin'), ('capn1', 'Benzo(a)pyrene'), ('capn1', 'Caffeine'), ('capn1', 'Calcium'), ('capn1', 'Calcium Carbonate'), ('capn1', 'Cannabidiol'), ('capn1', 'Cantharidin'), ('capn1', 'Chelating Agents'), ('capn1', 'Cisplatin'), ('capn1', 'Copper'), ('capn1', 'Cytarabine'), ('capn1', 'Dexamethasone'), ('capn1', 'Diethylhexyl Phthalate'), ('capn1', 'Diuron'), ('capn1', 'Environmental Pollutants'), ('capn1', 'Estradiol'), ('capn1', 'Furans'), ('capn1', 'Gallic Acid'), ('capn1', 'Glucose'), ('capn1', 'Indomethacin'), ('capn1', 'Ivermectin'), ('capn1', 'Lipopolysaccharides'), ('capn1', 'Menthol'), ('capn1', 'Paraquat'), ('capn1', 'Quercetin'), ('capn1', 'Selenium'), ('capn1', 'Sodium Chloride'), ('capn1', 'Tetrachlorodibenzodioxin'), ('capn1', 'Tobacco Smoke Pollution'), ('capn1', 'Valproic Acid'), ('capn1', '1-Methyl-3-isobutylxanthine'), ('capn1', 'Cyclosporine'), ('capn1', 'Aflatoxin B1'), ('capn1', 'Simvastatin'), ('capn1', 'Genistein'), ('capn1', 'Acrylamide'), ('capn1', 'tert-Butylhydroperoxide'), ('capn1', 'Particulate Matter'), ('capn2', 'Decitabine'), ('capn2', 'Arsenic Trioxide'), ('capn2', 'Vorinostat'), ('capn2', 'Acetaminophen'), ('capn2', 'Aspirin'), ('capn2', 'Benzo(a)pyrene'), ('capn2', 'Cadmium'), ('capn2', 'Caffeine'), ('capn2', 'Calcitriol'), ('capn2', 'Cannabidiol'), ('capn2', 'Cantharidin'), ('capn2', 'Carbamazepine'), ('capn2', 'Cisplatin'), ('capn2', 'Cuprizone'), ('capn2', 'Dexamethasone'), ('capn2', 'Bucladesine'), ('capn2', 'Diethylhexyl Phthalate'), ('capn2', 'Dimethylnitrosamine'), ('capn2', 'Estradiol'), ('capn2', 'Glyburide'), ('capn2', 'Hydrogen Peroxide'), ('capn2', 'Indomethacin'), ('capn2', 'Ivermectin'), ('capn2', 'Lipopolysaccharides'), ('capn2', 'Methapyrilene'), ('capn2', 'Nickel'), ('capn2', 'Phenobarbital'), ('capn2', 'Phenylmercuric Acetate'), ('capn2', 'Plant Extracts'), ('capn2', 'Quercetin'), ('capn2', 'Smoke'), ('capn2', 'Dihydrotestosterone'), ('capn2', 'Tamoxifen'), ('capn2', 'Testosterone'), ('capn2', 'Tobacco Smoke Pollution'), ('capn2', 'Tretinoin'), ('capn2', 'Valproic Acid'), ('capn2', '1-Methyl-3-isobutylxanthine'), ('capn2', '8-Bromo Cyclic Adenosine Monophosphate'), ('capn2', 'Cyclosporine'), ('capn2', 'Aflatoxin B1'), ('capn2', 'Medroxyprogesterone Acetate'), ('capn2', 'Cadmium Chloride'), ('capn2', 'Copper Sulfate'), ('capn2', 'tert-Butylhydroperoxide'), ('capn2', 'Raloxifene Hydrochloride'), ('capn2', 'Vitamin K 3'), ('capn2', 'Particulate Matter'), ('rad9a', 'Arsenic Trioxide'), ('rad9a', 'Acetaminophen'), ('rad9a', 'Acetylcysteine'), ('rad9a', 'Carmustine'), ('rad9a', 'Methapyrilene'), ('rad9a', 'Methyl Methanesulfonate'), ('rad9a', 'Rotenone'), ('rad9a', 'Smoke'), ('rad9a', 'Taurine'), ('rad9a', 'Theophylline'), ('rad9a', 'Tobacco Smoke Pollution'), ('rad9a', 'Tunicamycin'), ('rad9a', 'Valproic Acid'), ('rad9a', 'Aflatoxin B1'), ('Decitabine', 'h3-4'), ('Decitabine', 'h2ac18'), ('Decitabine', 'h1-0'), ('Decitabine', 'hla-g'), ('Decitabine', 'h1-2'), ('Decitabine', 'cdkn2d'), ('h3-4', 'Sunitinib'), ('h3-4', 'Arsenic Trioxide'), ('h3-4', 'Vorinostat'), ('h3-4', 'Alitretinoin'), ('h3-4', 'Panobinostat'), ('h3-4', 'Arsenic'), ('h3-4', 'Arsenicals'), ('h3-4', 'Azacitidine'), ('h3-4', 'Benzo(a)pyrene'), ('h3-4', 'Berberine'), ('h3-4', 'Biguanides'), ('h3-4', 'Butyrates'), ('h3-4', 'Copper'), ('h3-4', 'Dimethyl Sulfoxide'), ('h3-4', 'Disulfiram'), ('h3-4', 'Estradiol'), ('h3-4', 'Homocysteine'), ('h3-4', 'Iron'), ('h3-4', 'Ketoglutaric Acids'), ('h3-4', 'Nickel'), ('h3-4', 'Polyamines'), ('h3-4', 'Quercetin'), ('h3-4', 'Silicon Dioxide'), ('h3-4', 'Tetrachlorodibenzodioxin'), ('h3-4', 'Tretinoin'), ('h3-4', 'Valproic Acid'), ('h3-4', '1-Methyl-4-phenylpyridinium'), ('h3-4', 'Aflatoxin B1'), ('h3-4', 'Sodium Selenite'), ('h3-4', 'Genistein'), ('h3-4', 'tert-Butylhydroperoxide'), ('h3-4', 'Butyric Acid'), ('h2ac18', 'Zoledronic Acid'), ('h2ac18', 'Troglitazone'), ('h2ac18', 'Acetaminophen'), ('h2ac18', 'Air Pollutants'), ('h2ac18', 'Benzene'), ('h2ac18', 'Benzo(a)pyrene'), ('h2ac18', 'Berberine'), ('h2ac18', 'Cadmium'), ('h2ac18', 'Diazinon'), ('h2ac18', 'Doxorubicin'), ('h2ac18', 'Enzyme Inhibitors'), ('h2ac18', 'Hydrogen Peroxide'), ('h2ac18', 'Lipopolysaccharides'), ('h2ac18', 'Mustard Gas'), ('h2ac18', 'Plant Oils'), ('h2ac18', 'Silicon Dioxide'), ('h2ac18', 'Smoke'), ('h2ac18', 'Theophylline'), ('h2ac18', 'Tretinoin'), ('h2ac18', 'Tunicamycin'), ('h2ac18', 'Urethane'), ('h2ac18', 'Valproic Acid'), ('h2ac18', 'Asbestos, Crocidolite'), ('h2ac18', 'Antirheumatic Agents'), ('h2ac18', 'Cadmium Chloride'), ('h2ac18', 'Thapsigargin'), ('h2ac18', 'Lactic Acid'), ('h2ac18', 'Vitamin K 3'), ('h1-0', 'Sunitinib'), ('h1-0', 'Arsenic Trioxide'), ('h1-0', 'Vorinostat'), ('h1-0', 'Acetaminophen'), ('h1-0', 'Ethanol'), ('h1-0', 'Azacitidine'), ('h1-0', 'Benzo(a)pyrene'), ('h1-0', 'Butyrates'), ('h1-0', 'Cadmium'), ('h1-0', 'Carbamazepine'), ('h1-0', 'Cisplatin'), ('h1-0', 'Dexamethasone'), ('h1-0', 'Doxorubicin'), ('h1-0', 'Hydrogen Peroxide'), ('h1-0', 'Indomethacin'), ('h1-0', 'Phenylmercuric Acetate'), ('h1-0', 'Silver'), ('h1-0', 'Smoke'), ('h1-0', 'Tamoxifen'), ('h1-0', 'Thimerosal'), ('h1-0', 'Tobacco Smoke Pollution'), ('h1-0', 'Tretinoin'), ('h1-0', 'Tunicamycin'), ('h1-0', 'Urethane'), ('h1-0', 'Valproic Acid'), ('h1-0', '1-Methyl-3-isobutylxanthine'), ('h1-0', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h1-0', '1-Methyl-4-phenylpyridinium'), ('h1-0', 'Cyclosporine'), ('h1-0', 'Asbestos, Crocidolite'), ('h1-0', 'Sodium Selenite'), ('h1-0', 'Cadmium Chloride'), ('h1-0', 'Copper Sulfate'), ('h1-0', 'Genistein'), ('h1-0', 'Acrylamide'), ('hla-g', 'Arsenic Trioxide'), ('hla-g', 'Fulvestrant'), ('hla-g', 'Vorinostat'), ('hla-g', 'Meropenem'), ('hla-g', 'Angiotensin-Converting Enzyme Inhibitors'), ('hla-g', 'Arsenic'), ('hla-g', 'Aspirin'), ('hla-g', 'Benzo(a)pyrene'), ('hla-g', 'Bumetanide'), ('hla-g', 'Cadmium'), ('hla-g', 'Carbamazepine'), ('hla-g', 'Cefadroxil'), ('hla-g', 'Cefazolin'), ('hla-g', 'Ciprofloxacin'), ('hla-g', 'Cisplatin'), ('hla-g', 'Environmental Pollutants'), ('hla-g', 'Erythromycin'), ('hla-g', 'Estradiol'), ('hla-g', 'Fluorouracil'), ('hla-g', 'Ifosfamide'), ('hla-g', 'Methotrexate'), ('hla-g', 'Omeprazole'), ('hla-g', 'Phenylmercuric Acetate'), ('hla-g', 'Piroxicam'), ('hla-g', 'Progesterone'), ('hla-g', 'Pyrimethamine'), ('hla-g', 'Rifampin'), ('hla-g', 'Selenium'), ('hla-g', 'Sodium Hydroxide'), ('hla-g', 'Sulfamethoxazole'), ('hla-g', 'Tetrachlorodibenzodioxin'), ('hla-g', 'Tretinoin'), ('hla-g', 'Valproic Acid'), ('hla-g', 'Vitamin E'), ('hla-g', 'Zinc'), ('hla-g', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('hla-g', 'Isotretinoin'), ('hla-g', 'Mifepristone'), ('hla-g', 'Cyclosporine'), ('hla-g', 'Lisinopril'), ('hla-g', 'Sodium Selenite'), ('hla-g', 'Antirheumatic Agents'), ('hla-g', 'Ketorolac'), ('h1-2', 'Sunitinib'), ('h1-2', 'Zoledronic Acid'), ('h1-2', 'Arsenic Trioxide'), ('h1-2', 'Troglitazone'), ('h1-2', 'Vorinostat'), ('h1-2', 'Cidofovir'), ('h1-2', 'Norethindrone Acetate'), ('h1-2', 'Acetaminophen'), ('h1-2', 'Air Pollutants'), ('h1-2', 'Ethanol'), ('h1-2', 'Aminoglutethimide'), ('h1-2', 'Antimycin A'), ('h1-2', 'Atrazine'), ('h1-2', 'Benzo(a)pyrene'), ('h1-2', 'Cadmium'), ('h1-2', 'Cisplatin'), ('h1-2', 'Clozapine'), ('h1-2', 'Copper'), ('h1-2', 'Cosmetics'), ('h1-2', 'Coumestrol'), ('h1-2', 'Cytarabine'), ('h1-2', 'Demecolcine'), ('h1-2', 'Doxorubicin'), ('h1-2', 'Endosulfan'), ('h1-2', 'Estradiol'), ('h1-2', 'Ethyl Methanesulfonate'), ('h1-2', 'Flame Retardants'), ('h1-2', 'Hydrogen Peroxide'), ('h1-2', 'Ibuprofen'), ('h1-2', 'Isoflavones'), ('h1-2', 'Ivermectin'), ('h1-2', 'Metformin'), ('h1-2', 'N-Nitrosopyrrolidine'), ('h1-2', 'Oxygen'), ('h1-2', 'Plasticizers'), ('h1-2', 'Fenofibrate'), ('h1-2', 'Progesterone'), ('h1-2', 'Quercetin'), ('h1-2', 'Rotenone'), ('h1-2', 'Silicon Dioxide'), ('h1-2', 'Smoke'), ('h1-2', 'Tetrachlorodibenzodioxin'), ('h1-2', 'Tobacco Smoke Pollution'), ('h1-2', 'Tretinoin'), ('h1-2', 'Valproic Acid'), ('h1-2', 'Vinblastine'), ('h1-2', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h1-2', 'Isotretinoin'), ('h1-2', 'Cyclosporine'), ('h1-2', 'Aflatoxin B1'), ('h1-2', 'Asbestos, Crocidolite'), ('h1-2', 'Lithium Chloride'), ('h1-2', 'Cadmium Chloride'), ('h1-2', 'Thapsigargin'), ('h1-2', 'beta-Naphthoflavone'), ('h1-2', 'Copper Sulfate'), ('h1-2', 'Lactic Acid'), ('h1-2', 'Genistein'), ('h1-2', 'Phytoestrogens'), ('cdkn2d', 'Sunitinib'), ('cdkn2d', 'Arsenic Trioxide'), ('cdkn2d', 'Vorinostat'), ('cdkn2d', 'Norethindrone Acetate'), ('cdkn2d', 'Acetaminophen'), ('cdkn2d', 'Aerosols'), ('cdkn2d', 'Arsenic'), ('cdkn2d', 'Calcitriol'), ('cdkn2d', 'Chelating Agents'), ('cdkn2d', 'Cholecalciferol'), ('cdkn2d', 'Cisplatin'), ('cdkn2d', 'Copper'), ('cdkn2d', 'Dexamethasone'), ('cdkn2d', 'Estradiol'), ('cdkn2d', 'Formaldehyde'), ('cdkn2d', 'Hydrogen Peroxide'), ('cdkn2d', 'Indomethacin'), ('cdkn2d', 'Iron'), ('cdkn2d', 'Lead'), ('cdkn2d', 'Menthol'), ('cdkn2d', 'Methyl Methanesulfonate'), ('cdkn2d', 'Phenylmercuric Acetate'), ('cdkn2d', 'Potassium Dichromate'), ('cdkn2d', 'Retinoids'), ('cdkn2d', 'Smoke'), ('cdkn2d', 'Testosterone'), ('cdkn2d', 'Tobacco Smoke Pollution'), ('cdkn2d', 'Tretinoin'), ('cdkn2d', 'Urethane'), ('cdkn2d', 'Valproic Acid'), ('cdkn2d', '1-Methyl-3-isobutylxanthine'), ('cdkn2d', '1-Methyl-4-phenylpyridinium'), ('cdkn2d', 'Cyclosporine'), ('cdkn2d', 'Levonorgestrel'), ('cdkn2d', 'Reactive Oxygen Species'), ('cdkn2d', 'Antirheumatic Agents'), ('cdkn2d', 'Cadmium Chloride'), ('cdkn2d', 'Copper Sulfate'), ('cdkn2d', 'Lactic Acid'), ('cdkn2d', 'Simvastatin'), ('Sunitinib', 'h2ac20'), ('Sunitinib', 'ubb'), ('Sunitinib', 'h2ac14'), ('Sunitinib', 'h2az2'), ('Sunitinib', 'h2ac7'), ('Sunitinib', 'suz12'), ('Sunitinib', 'cbx4'), ('Sunitinib', 'phc1'), ('Sunitinib', 'mov10'), ('Sunitinib', 'tnrc6b'), ('Sunitinib', 'h1-3'), ('Sunitinib', 'ep400'), ('h2ac20', 'Zoledronic Acid'), ('h2ac20', 'Arsenic Trioxide'), ('h2ac20', 'Acetaminophen'), ('h2ac20', 'Benzo(a)pyrene'), ('h2ac20', 'Benztropine'), ('h2ac20', 'Cannabidiol'), ('h2ac20', 'Cisplatin'), ('h2ac20', 'Clozapine'), ('h2ac20', 'Copper'), ('h2ac20', 'Dexamethasone'), ('h2ac20', 'Disulfiram'), ('h2ac20', 'Doxorubicin'), ('h2ac20', 'Haloperidol'), ('h2ac20', 'Indomethacin'), ('h2ac20', 'Mustard Gas'), ('h2ac20', 'Nickel'), ('h2ac20', 'Quercetin'), ('h2ac20', 'Rotenone'), ('h2ac20', 'Tobacco Smoke Pollution'), ('h2ac20', 'Tunicamycin'), ('h2ac20', 'Valproic Acid'), ('h2ac20', '1-Methyl-3-isobutylxanthine'), ('h2ac20', 'Aflatoxin B1'), ('h2ac20', 'Thapsigargin'), ('h2ac20', 'Copper Sulfate'), ('h2ac20', 'Vitamin K 3'), ('ubb', 'Acetaminophen'), ('ubb', 'Antimycin A'), ('ubb', 'Benzo(a)pyrene'), ('ubb', 'Cadmium'), ('ubb', 'Cannabidiol'), ('ubb', 'Cisplatin'), ('ubb', 'Diuron'), ('ubb', 'Doxorubicin'), ('ubb', 'Estradiol'), ('ubb', 'Gallic Acid'), ('ubb', 'Paraquat'), ('ubb', 'Rotenone'), ('ubb', 'Silicon Dioxide'), ('ubb', 'Tetrachlorodibenzodioxin'), ('ubb', 'Tobacco Smoke Pollution'), ('ubb', 'Cyclosporine'), ('ubb', 'Uranium Compounds'), ('ubb', 'Cadmium Chloride'), ('ubb', 'Copper Sulfate'), ('ubb', 'Acrylamide'), ('ubb', 'Vitamin K 3'), ('ubb', 'Nanotubes, Carbon'), ('ubb', 'Particulate Matter'), ('h2ac14', 'Benzo(a)pyrene'), ('h2ac14', 'Berberine'), ('h2ac14', 'Cannabidiol'), ('h2ac14', 'Dexamethasone'), ('h2ac14', 'Doxorubicin'), ('h2ac14', 'Lucanthone'), ('h2ac14', 'Oxygen'), ('h2ac14', 'Silicon Dioxide'), ('h2ac14', 'Smoke'), ('h2ac14', 'Tobacco Smoke Pollution'), ('h2ac14', 'Aflatoxin B1'), ('h2az2', 'Azathioprine'), ('h2az2', 'Benzo(a)pyrene'), ('h2az2', 'Cadmium'), ('h2az2', 'Carbamazepine'), ('h2az2', 'Catechin'), ('h2az2', 'Copper'), ('h2az2', 'Coumestrol'), ('h2az2', 'Dexamethasone'), ('h2az2', 'Estradiol'), ('h2az2', 'Folic Acid'), ('h2az2', 'Indomethacin'), ('h2az2', 'Ivermectin'), ('h2az2', 'Progesterone'), ('h2az2', 'Valproic Acid'), ('h2az2', '1-Methyl-3-isobutylxanthine'), ('h2az2', '1-Methyl-4-phenylpyridinium'), ('h2az2', 'Cyclosporine'), ('h2az2', 'Sodium Selenite'), ('h2az2', 'Antirheumatic Agents'), ('h2az2', 'Cadmium Chloride'), ('h2az2', 'Zinc Sulfate'), ('h2az2', 'Copper Sulfate'), ('h2az2', 'Topotecan'), ('h2az2', 'tert-Butylhydroperoxide'), ('h2ac7', 'Acetaminophen'), ('h2ac7', 'Vehicle Emissions'), ('h2ac7', 'Benzo(a)pyrene'), ('h2ac7', 'Cisplatin'), ('h2ac7', 'Oxygen'), ('h2ac7', 'Plant Oils'), ('h2ac7', 'Silicon Dioxide'), ('h2ac7', 'Tobacco Smoke Pollution'), ('h2ac7', 'Aflatoxin B1'), ('h2ac7', 'Copper Sulfate'), ('h2ac7', 'Lactic Acid'), ('h2ac7', 'Vitamin K 3'), ('h2ac7', 'Particulate Matter'), ('suz12', 'Acetaminophen'), ('suz12', 'Atrazine'), ('suz12', 'Caffeine'), ('suz12', 'Cisplatin'), ('suz12', 'Curcumin'), ('suz12', 'Demecolcine'), ('suz12', 'Dexamethasone'), ('suz12', 'Hydrogen Peroxide'), ('suz12', 'Indomethacin'), ('suz12', 'Ivermectin'), ('suz12', 'Oils, Volatile'), ('suz12', 'Rotenone'), ('suz12', 'Selenium'), ('suz12', 'Testosterone'), ('suz12', 'Valproic Acid'), ('suz12', 'Vincristine'), ('suz12', 'Vitamin E'), ('suz12', '1-Methyl-3-isobutylxanthine'), ('suz12', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('suz12', 'Aflatoxin M1'), ('cbx4', 'Arsenic Trioxide'), ('cbx4', 'Leflunomide'), ('cbx4', 'Acetaminophen'), ('cbx4', 'Air Pollutants'), ('cbx4', 'Antimycin A'), ('cbx4', 'Arsenic'), ('cbx4', 'Atrazine'), ('cbx4', 'Benzo(a)pyrene'), ('cbx4', 'Caffeine'), ('cbx4', 'Cisplatin'), ('cbx4', 'Coumestrol'), ('cbx4', 'Doxorubicin'), ('cbx4', 'Enzyme Inhibitors'), ('cbx4', 'Ethyl Methanesulfonate'), ('cbx4', 'Formaldehyde'), ('cbx4', 'Gasoline'), ('cbx4', 'Lipopolysaccharides'), ('cbx4', 'Menthol'), ('cbx4', 'Methyl Methanesulfonate'), ('cbx4', 'Niclosamide'), ('cbx4', 'Ozone'), ('cbx4', 'Plant Oils'), ('cbx4', 'Polycyclic Aromatic Hydrocarbons'), ('cbx4', 'Silicon Dioxide'), ('cbx4', 'Tobacco Smoke Pollution'), ('cbx4', 'Tunicamycin'), ('cbx4', 'Urethane'), ('cbx4', 'Valproic Acid'), ('cbx4', 'Zinc'), ('cbx4', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('cbx4', '1-Methyl-4-phenylpyridinium'), ('cbx4', 'Cyclosporine'), ('cbx4', 'Copper Sulfate'), ('cbx4', '1-Butanol'), ('cbx4', 'Acrylamide'), ('cbx4', 'Depsipeptides'), ('cbx4', 'Particulate Matter'), ('phc1', 'Acetaminophen'), ('phc1', 'Air Pollutants, Occupational'), ('phc1', 'Atrazine'), ('phc1', 'Benzo(a)pyrene'), ('phc1', 'Cadmium'), ('phc1', 'Enzyme Inhibitors'), ('phc1', 'Ethyl Methanesulfonate'), ('phc1', 'Hydralazine'), ('phc1', 'Methyl Methanesulfonate'), ('phc1', 'Dronabinol'), ('phc1', 'Tobacco Smoke Pollution'), ('phc1', 'Tretinoin'), ('phc1', 'Valproic Acid'), ('phc1', 'Aflatoxin B1'), ('phc1', 'Antirheumatic Agents'), ('phc1', 'Cadmium Chloride'), ('phc1', 'Copper Sulfate'), ('phc1', 'Acrylamide'), ('mov10', 'Fulvestrant'), ('mov10', 'Acrolein'), ('mov10', 'Air Pollutants'), ('mov10', 'Benzo(a)pyrene'), ('mov10', 'Caffeine'), ('mov10', 'Cisplatin'), ('mov10', 'Ivermectin'), ('mov10', 'Methapyrilene'), ('mov10', 'Oils, Volatile'), ('mov10', 'Ozone'), ('mov10', 'Ribonucleotides'), ('mov10', 'Smoke'), ('mov10', 'Tobacco Smoke Pollution'), ('mov10', 'Tretinoin'), ('mov10', 'Valproic Acid'), ('mov10', 'Zidovudine'), ('mov10', 'Cyclosporine'), ('mov10', 'Aflatoxin B1'), ('mov10', 'Copper Sulfate'), ('mov10', 'Acrylamide'), ('mov10', 'Volatile Organic Compounds'), ('tnrc6b', 'Fulvestrant'), ('tnrc6b', 'Vorinostat'), ('tnrc6b', 'Panobinostat'), ('tnrc6b', 'Acetaminophen'), ('tnrc6b', 'Acrolein'), ('tnrc6b', 'Air Pollutants'), ('tnrc6b', 'Benzo(a)pyrene'), ('tnrc6b', 'Cadmium'), ('tnrc6b', 'Caffeine'), ('tnrc6b', 'Cisplatin'), ('tnrc6b', 'Dexamethasone'), ('tnrc6b', 'Enzyme Inhibitors'), ('tnrc6b', 'Folic Acid'), ('tnrc6b', 'Hydrogen Peroxide'), ('tnrc6b', 'Indomethacin'), ('tnrc6b', 'Melphalan'), ('tnrc6b', 'Methapyrilene'), ('tnrc6b', 'Methotrexate'), ('tnrc6b', 'Ozone'), ('tnrc6b', 'Ribonucleotides'), ('tnrc6b', 'Dronabinol'), ('tnrc6b', 'Valproic Acid'), ('tnrc6b', '1-Methyl-3-isobutylxanthine'), ('tnrc6b', 'Cyclosporine'), ('tnrc6b', 'Aflatoxin B1'), ('tnrc6b', 'Levonorgestrel'), ('tnrc6b', 'Copper Sulfate'), ('tnrc6b', 'Volatile Organic Compounds'), ('h1-3', 'Leflunomide'), ('h1-3', 'Acrolein'), ('h1-3', 'Air Pollutants'), ('h1-3', 'Benzo(a)pyrene'), ('h1-3', 'Cisplatin'), ('h1-3', 'Dimethyl Sulfoxide'), ('h1-3', 'Drugs, Chinese Herbal'), ('h1-3', 'Enzyme Inhibitors'), ('h1-3', 'Estradiol'), ('h1-3', 'Fluorouracil'), ('h1-3', 'Lucanthone'), ('h1-3', 'Methotrexate'), ('h1-3', 'Ozone'), ('h1-3', 'Phenylmercuric Acetate'), ('h1-3', 'Rotenone'), ('h1-3', 'Silicon Dioxide'), ('h1-3', 'Silver Nitrate'), ('h1-3', 'Tetrachlorodibenzodioxin'), ('h1-3', 'Thimerosal'), ('h1-3', 'Tobacco Smoke Pollution'), ('h1-3', 'Tretinoin'), ('h1-3', 'Valproic Acid'), ('h1-3', 'Aflatoxin B1'), ('h1-3', 'Asbestos, Crocidolite'), ('h1-3', 'Copper Sulfate'), ('h1-3', 'Lactic Acid'), ('h1-3', 'Genistein'), ('h1-3', 'Particulate Matter'), ('h1-3', 'Volatile Organic Compounds'), ('ep400', 'Zoledronic Acid'), ('ep400', 'Vorinostat'), ('ep400', 'Cidofovir'), ('ep400', 'Acrolein'), ('ep400', 'Air Pollutants'), ('ep400', 'Benzo(a)pyrene'), ('ep400', 'Cadmium'), ('ep400', 'Caffeine'), ('ep400', 'Cisplatin'), ('ep400', 'Coal'), ('ep400', 'Dexamethasone'), ('ep400', 'Clodronic Acid'), ('ep400', 'Estradiol'), ('ep400', 'Fluorouracil'), ('ep400', 'Formaldehyde'), ('ep400', 'Ifosfamide'), ('ep400', 'Indomethacin'), ('ep400', 'Methapyrilene'), ('ep400', 'Oxygen'), ('ep400', 'Ozone'), ('ep400', 'Quercetin'), ('ep400', 'Smoke'), ('ep400', 'Thimerosal'), ('ep400', '1-Methyl-3-isobutylxanthine'), ('ep400', 'Cyclosporine'), ('ep400', 'Aflatoxin B1'), ('ep400', 'Cadmium Chloride'), ('ep400', 'Copper Sulfate'), ('ep400', 'Lactic Acid'), ('ep400', 'Volatile Organic Compounds'), ('Zoledronic Acid', 'rassf5'), ('rassf5', 'Benzo(a)pyrene'), ('rassf5', 'Cisplatin'), ('rassf5', 'Diazinon'), ('rassf5', 'Doxorubicin'), ('rassf5', 'Estradiol'), ('rassf5', 'Hemin'), ('rassf5', 'Methyl Methanesulfonate'), ('rassf5', 'Nickel'), ('rassf5', 'Silicon Dioxide'), ('rassf5', 'Tretinoin'), ('rassf5', 'Triclosan'), ('rassf5', 'Valproic Acid'), ('rassf5', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('rassf5', '8-Bromo Cyclic Adenosine Monophosphate'), ('rassf5', 'Aflatoxin B1'), ('rassf5', 'Antirheumatic Agents'), ('rassf5', 'Genistein'), ('Arsenic Trioxide', 'ubc'), ('Arsenic Trioxide', 'rps27a'), ('Arsenic Trioxide', 'ube2d1'), ('Arsenic Trioxide', 'gata4'), ('Arsenic Trioxide', 'vdac2'), ('ubc', 'Leflunomide'), ('ubc', 'Aminoglutethimide'), ('ubc', 'Arsenic'), ('ubc', 'Benztropine'), ('ubc', 'Cannabidiol'), ('ubc', 'Chloranil'), ('ubc', 'Cuprizone'), ('ubc', 'Curcumin'), ('ubc', 'Drugs, Chinese Herbal'), ('ubc', 'Estradiol'), ('ubc', 'Haloperidol'), ('ubc', 'Lipopolysaccharides'), ('ubc', 'Naphthoquinones'), ('ubc', 'Silver'), ('ubc', 'Dronabinol'), ('ubc', 'Tobacco Smoke Pollution'), ('ubc', 'Tretinoin'), ('ubc', 'Urethane'), ('ubc', 'Valproic Acid'), ('ubc', 'Vincristine'), ('ubc', 'Zinc'), ('ubc', 'Cyclosporine'), ('ubc', 'Aflatoxin B1'), ('ubc', 'Uranium Compounds'), ('ubc', 'Cadmium Chloride'), ('ubc', 'beta-Naphthoflavone'), ('ubc', 'Copper Sulfate'), ('ubc', 'Acrylamide'), ('ubc', 'Vitamin K 3'), ('rps27a', 'Vorinostat'), ('rps27a', 'Aspirin'), ('rps27a', 'Atrazine'), ('rps27a', 'Vehicle Emissions'), ('rps27a', 'Benztropine'), ('rps27a', 'Caffeine'), ('rps27a', 'Cannabidiol'), ('rps27a', 'Cuprizone'), ('rps27a', 'Enzyme Inhibitors'), ('rps27a', 'Estradiol'), ('rps27a', 'Haloperidol'), ('rps27a', 'Hydralazine'), ('rps27a', 'Ivermectin'), ('rps27a', 'Nicotine'), ('rps27a', 'Potassium Dichromate'), ('rps27a', 'Retinoids'), ('rps27a', 'Rotenone'), ('rps27a', 'Silicon Dioxide'), ('rps27a', 'Tobacco Smoke Pollution'), ('rps27a', 'Tretinoin'), ('rps27a', 'Valproic Acid'), ('rps27a', 'Asbestos, Crocidolite'), ('rps27a', 'Cadmium Chloride'), ('rps27a', 'Lactic Acid'), ('rps27a', 'Particulate Matter'), ('ube2d1', 'Benzo(a)pyrene'), ('ube2d1', 'Cannabidiol'), ('ube2d1', 'Coumestrol'), ('ube2d1', 'Doxorubicin'), ('ube2d1', 'Enzyme Inhibitors'), ('ube2d1', 'Hydrogen Peroxide'), ('ube2d1', 'Nickel'), ('ube2d1', 'Plant Oils'), ('ube2d1', 'Tetrachlorodibenzodioxin'), ('ube2d1', 'Tobacco Smoke Pollution'), ('ube2d1', 'Tretinoin'), ('ube2d1', 'Urethane'), ('ube2d1', 'Valproic Acid'), ('ube2d1', 'Vitamin E'), ('ube2d1', 'Aflatoxin B1'), ('ube2d1', 'Okadaic Acid'), ('ube2d1', 'Copper Sulfate'), ('ube2d1', 'Lactic Acid'), ('ube2d1', 'Nanotubes, Carbon'), ('gata4', 'Fulvestrant'), ('gata4', 'Panobinostat'), ('gata4', 'Arsenic'), ('gata4', 'Benzo(a)pyrene'), ('gata4', 'Cadmium'), ('gata4', 'Carbamazepine'), ('gata4', 'Dexamethasone'), ('gata4', 'Diclofenac'), ('gata4', 'Dimethyl Sulfoxide'), ('gata4', 'Doxorubicin'), ('gata4', 'Fonofos'), ('gata4', 'Malathion'), ('gata4', 'Nicotine'), ('gata4', 'Parathion'), ('gata4', 'Phenylbutyrates'), ('gata4', 'Phenylephrine'), ('gata4', 'Propylthiouracil'), ('gata4', 'Ribavirin'), ('gata4', 'Tretinoin'), ('gata4', 'Triclosan'), ('gata4', 'Valproic Acid'), ('gata4', 'Warfarin'), ('gata4', 'Aflatoxin B1'), ('gata4', 'Monocrotaline'), ('gata4', 'Asbestos, Crocidolite'), ('gata4', 'Permethrin'), ('gata4', 'Particulate Matter'), ('vdac2', 'Fulvestrant'), ('vdac2', 'Acetylcysteine'), ('vdac2', 'Ethanol'), ('vdac2', 'Atrazine'), ('vdac2', 'Vehicle Emissions'), ('vdac2', 'Cadmium'), ('vdac2', 'Deferoxamine'), ('vdac2', 'Dexamethasone'), ('vdac2', 'Dopamine'), ('vdac2', 'Enzyme Inhibitors'), ('vdac2', 'Hydrogen Peroxide'), ('vdac2', 'Indomethacin'), ('vdac2', 'Ivermectin'), ('vdac2', 'Menthol'), ('vdac2', 'Phenobarbital'), ('vdac2', 'Quercetin'), ('vdac2', 'Ribonucleotides'), ('vdac2', 'Rotenone'), ('vdac2', 'Smoke'), ('vdac2', 'T-2 Toxin'), ('vdac2', 'Tobacco Smoke Pollution'), ('vdac2', 'Tretinoin'), ('vdac2', 'Uranium'), ('vdac2', 'Vanadium'), ('vdac2', '1-Methyl-3-isobutylxanthine'), ('vdac2', 'Josamycin'), ('vdac2', '1-Methyl-4-phenylpyridinium'), ('vdac2', 'Reactive Oxygen Species'), ('vdac2', \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\"), ('vdac2', 'Sodium Selenite'), ('vdac2', 'Cadmium Chloride'), ('vdac2', 'tert-Butylhydroperoxide'), ('vdac2', 'Coal Ash'), ('Fulvestrant', 'trpv4'), ('Fulvestrant', 'hipk3'), ('Fulvestrant', 'cacna1d'), ('trpv4', 'Leflunomide'), ('trpv4', 'Acetaminophen'), ('trpv4', 'Vehicle Emissions'), ('trpv4', 'Benzo(a)pyrene'), ('trpv4', 'Calcium'), ('trpv4', 'Cannabidiol'), ('trpv4', 'Dexamethasone'), ('trpv4', 'Estradiol'), ('trpv4', 'Indomethacin'), ('trpv4', 'Methylcholanthrene'), ('trpv4', 'Silicon Dioxide'), ('trpv4', 'Sodium'), ('trpv4', 'Tetrachlorodibenzodioxin'), ('trpv4', 'Tretinoin'), ('trpv4', '1-Methyl-3-isobutylxanthine'), ('trpv4', 'Eicosanoids'), ('trpv4', 'Cyclosporine'), ('trpv4', 'Arachidonic Acid'), ('hipk3', 'Atrazine'), ('hipk3', 'Benzo(a)pyrene'), ('hipk3', 'Cisplatin'), ('hipk3', 'Doxorubicin'), ('hipk3', 'Ethyl Methanesulfonate'), ('hipk3', 'Formaldehyde'), ('hipk3', 'Lead'), ('hipk3', 'Lipopolysaccharides'), ('hipk3', 'Methyl Methanesulfonate'), ('hipk3', 'Silicon Dioxide'), ('hipk3', 'Tobacco Smoke Pollution'), ('hipk3', 'Tretinoin'), ('hipk3', 'Urethane'), ('hipk3', 'Valproic Acid'), ('hipk3', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('hipk3', 'Cyclosporine'), ('hipk3', 'Aflatoxin B1'), ('hipk3', 'Asbestos, Crocidolite'), ('cacna1d', 'Air Pollutants'), ('cacna1d', 'Benzo(a)pyrene'), ('cacna1d', 'Cisplatin'), ('cacna1d', 'Cocaine'), ('cacna1d', 'Diethylhexyl Phthalate'), ('cacna1d', 'Estradiol'), ('cacna1d', 'Menthol'), ('cacna1d', 'Methapyrilene'), ('cacna1d', 'N-Nitrosopyrrolidine'), ('cacna1d', 'Nickel'), ('cacna1d', 'Pesticides'), ('cacna1d', 'Silicon Dioxide'), ('cacna1d', 'Tetrachlorodibenzodioxin'), ('cacna1d', 'Tobacco Smoke Pollution'), ('cacna1d', 'Tretinoin'), ('cacna1d', 'Triclosan'), ('cacna1d', 'Valproic Acid'), ('cacna1d', 'Aflatoxin B1'), ('Vorinostat', 'ehmt1'), ('ehmt1', 'Acrolein'), ('ehmt1', 'Air Pollutants'), ('ehmt1', 'Amiodarone'), ('ehmt1', 'Benzo(a)pyrene'), ('ehmt1', 'Coumestrol'), ('ehmt1', 'Estradiol'), ('ehmt1', 'Hydrogen Peroxide'), ('ehmt1', 'Ivermectin'), ('ehmt1', 'Lead'), ('ehmt1', 'Methapyrilene'), ('ehmt1', 'Ozone'), ('ehmt1', 'Potassium Dichromate'), ('ehmt1', 'Silicon Dioxide'), ('ehmt1', 'Tetrachlorodibenzodioxin'), ('ehmt1', 'Thimerosal'), ('ehmt1', 'Tobacco Smoke Pollution'), ('ehmt1', 'Valproic Acid'), ('ehmt1', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('ehmt1', 'Cyclosporine'), ('ehmt1', 'Aflatoxin B1'), ('ehmt1', 'Copper Sulfate'), ('ehmt1', 'Vitamin K 3'), ('ehmt1', 'Volatile Organic Compounds'), ('Leflunomide', 'h2bc11'), ('Leflunomide', 'tnrc6a'), ('h2bc11', 'Acetaminophen'), ('h2bc11', 'Acrolein'), ('h2bc11', 'Air Pollutants'), ('h2bc11', 'Ethanol'), ('h2bc11', 'Benzo(a)pyrene'), ('h2bc11', 'Berberine'), ('h2bc11', 'Cisplatin'), ('h2bc11', 'Doxorubicin'), ('h2bc11', 'Folic Acid'), ('h2bc11', 'Ivermectin'), ('h2bc11', 'N-Nitrosopyrrolidine'), ('h2bc11', 'Oxygen'), ('h2bc11', 'Ozone'), ('h2bc11', 'Silicon Dioxide'), ('h2bc11', 'Sodium Dodecyl Sulfate'), ('h2bc11', 'Tobacco Smoke Pollution'), ('h2bc11', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('h2bc11', 'Aflatoxin B1'), ('h2bc11', 'Copper Sulfate'), ('h2bc11', 'Lactic Acid'), ('h2bc11', 'Volatile Organic Compounds'), ('tnrc6a', 'Acetaminophen'), ('tnrc6a', 'Amiodarone'), ('tnrc6a', 'Atrazine'), ('tnrc6a', 'Benzo(a)pyrene'), ('tnrc6a', 'Cadmium'), ('tnrc6a', 'Caffeine'), ('tnrc6a', 'Cytarabine'), ('tnrc6a', 'Formaldehyde'), ('tnrc6a', 'Manganese'), ('tnrc6a', 'Methapyrilene'), ('tnrc6a', 'Methotrexate'), ('tnrc6a', 'Methyl Methanesulfonate'), ('tnrc6a', 'Oxygen'), ('tnrc6a', 'Phenylmercuric Acetate'), ('tnrc6a', 'Tobacco Smoke Pollution'), ('tnrc6a', 'Valproic Acid'), ('tnrc6a', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'), ('tnrc6a', 'Cyclosporine'), ('tnrc6a', 'Aflatoxin B1'), ('tnrc6a', 'Antirheumatic Agents'), ('tnrc6a', 'Cadmium Chloride'), ('Panobinostat', 'ventx'), ('ventx', 'Air Pollutants'), ('ventx', 'Benzene'), ('ventx', 'Benzo(a)pyrene'), ('ventx', 'Diethylhexyl Phthalate'), ('ventx', 'Folic Acid'), ('ventx', 'Methapyrilene'), ('ventx', 'Nickel'), ('ventx', 'Ozone'), ('ventx', 'Tretinoin'), ('ventx', 'Valproic Acid'), ('ventx', 'Asbestos, Crocidolite'), ('ventx', 'Asbestos, Amosite'), ('Acetaminophen', 'h2bc4'), ('Acetaminophen', 'h2bc13'), ('Acetaminophen', 'tnrc6c'), ('Acetaminophen', 'slc25a5'), ('Acetaminophen', 'mcu'), ('h2bc4', 'Ethanol'), ('h2bc4', 'Berberine'), ('h2bc4', 'Bilirubin'), ('h2bc4', 'Cisplatin'), ('h2bc4', 'Copper'), ('h2bc4', 'Coumestrol'), ('h2bc4', 'Demecolcine'), ('h2bc4', 'Doxorubicin'), ('h2bc4', 'Estradiol'), ('h2bc4', 'Formaldehyde'), ('h2bc4', 'Hydrogen Peroxide'), ('h2bc4', 'Ivermectin'), ('h2bc4', 'Lucanthone'), ('h2bc4', 'Methyl Methanesulfonate'), ('h2bc4', 'Silicon Dioxide'), ('h2bc4', 'Sodium Dodecyl Sulfate'), ('h2bc4', 'Tobacco Smoke Pollution'), ('h2bc4', 'Urethane'), ('h2bc4', 'Valproic Acid'), ('h2bc4', 'Vincristine'), ('h2bc4', 'Isotretinoin'), ('h2bc4', 'Aflatoxin B1'), ('h2bc4', 'Thapsigargin'), ('h2bc4', 'Copper Sulfate'), ('h2bc4', 'Lactic Acid'), ('h2bc4', 'Vitamin K 3'), ('h2bc13', 'Benzo(a)pyrene'), ('h2bc13', 'Berberine'), ('h2bc13', 'Cisplatin'), ('h2bc13', 'Estradiol'), ('h2bc13', 'N-Nitrosopyrrolidine'), ('h2bc13', 'Oxygen'), ('h2bc13', 'Silicon Dioxide'), ('h2bc13', 'Urethane'), ('h2bc13', 'Zinc'), ('h2bc13', 'Aflatoxin B1'), ('h2bc13', 'Lithium Chloride'), ('h2bc13', 'Copper Sulfate'), ('h2bc13', 'Vitamin K 3'), ('tnrc6c', 'Benzo(a)pyrene'), ('tnrc6c', 'Caffeine'), ('tnrc6c', 'Catechin'), ('tnrc6c', 'Cisplatin'), ('tnrc6c', 'Doxorubicin'), ('tnrc6c', 'Enzyme Inhibitors'), ('tnrc6c', 'Formaldehyde'), ('tnrc6c', 'Phenylmercuric Acetate'), ('tnrc6c', 'Tetrachlorodibenzodioxin'), ('tnrc6c', 'Tobacco Smoke Pollution'), ('tnrc6c', 'Urethane'), ('tnrc6c', 'Valproic Acid'), ('tnrc6c', 'Aflatoxin B1'), ('tnrc6c', 'Copper Sulfate'), ('slc25a5', 'Acrolein'), ('slc25a5', 'Air Pollutants'), ('slc25a5', 'Atractyloside'), ('slc25a5', 'Atrazine'), ('slc25a5', 'Benzo(a)pyrene'), ('slc25a5', 'Bongkrekic Acid'), ('slc25a5', 'Cadmium'), ('slc25a5', 'Dinitrochlorobenzene'), ('slc25a5', 'Dopamine'), ('slc25a5', 'Doxorubicin'), ('slc25a5', 'Fonofos'), ('slc25a5', 'Hydralazine'), ('slc25a5', 'Ivermectin'), ('slc25a5', 'Ozone'), ('slc25a5', 'Parathion'), ('slc25a5', 'Rotenone'), ('slc25a5', 'Smoke'), ('slc25a5', 'Ursodeoxycholic Acid'), ('slc25a5', 'Valproic Acid'), ('slc25a5', '1-Methyl-4-phenylpyridinium'), ('slc25a5', 'Cyclosporine'), ('slc25a5', 'Aflatoxin B1'), ('slc25a5', 'Sodium Selenite'), ('slc25a5', 'Antirheumatic Agents'), ('slc25a5', 'Copper Sulfate'), ('slc25a5', 'Vitamin K 3'), ('slc25a5', 'Volatile Organic Compounds'), ('slc25a5', 'Coal Ash'), ('mcu', 'Acrolein'), ('mcu', 'Air Pollutants'), ('mcu', 'Arsenic'), ('mcu', 'Atrazine'), ('mcu', 'Benzo(a)pyrene'), ('mcu', 'Cadmium'), ('mcu', 'Homocysteine'), ('mcu', 'Ivermectin'), ('mcu', 'Lead'), ('mcu', 'Methapyrilene'), ('mcu', 'Ozone'), ('mcu', 'Silicon Dioxide'), ('mcu', 'Tobacco Smoke Pollution'), ('mcu', 'Tretinoin'), ('mcu', 'Cyclosporine'), ('mcu', 'Aflatoxin B1'), ('mcu', 'Antirheumatic Agents'), ('mcu', 'Cadmium Chloride'), ('mcu', 'Copper Sulfate'), ('mcu', 'Acrylamide'), ('mcu', 'Volatile Organic Compounds'), ('Acrolein', 'fzr1'), ('fzr1', 'Air Pollutants'), ('fzr1', 'Arsenic'), ('fzr1', 'Benzo(a)pyrene'), ('fzr1', 'Chelating Agents'), ('fzr1', 'Copper'), ('fzr1', 'Diazinon'), ('fzr1', 'Estradiol'), ('fzr1', 'Ozone'), ('fzr1', 'Progesterone'), ('fzr1', 'Selenium'), ('fzr1', 'Smoke'), ('fzr1', 'Tetrachlorodibenzodioxin'), ('fzr1', 'Tobacco Smoke Pollution'), ('fzr1', 'Urethane'), ('fzr1', 'Valproic Acid'), ('fzr1', 'Vitamin E'), ('fzr1', 'Zinc Sulfate'), ('fzr1', 'Copper Sulfate'), ('fzr1', 'tert-Butylhydroperoxide'), ('fzr1', 'Volatile Organic Compounds'), ('Air Pollutants', 'tfdp2'), ('tfdp2', 'Air Pollutants, Occupational'), ('tfdp2', 'Amphotericin B'), ('tfdp2', 'Arsenic'), ('tfdp2', 'Benzo(a)pyrene'), ('tfdp2', 'Calcitriol'), ('tfdp2', 'Cisplatin'), ('tfdp2', 'Diethylstilbestrol'), ('tfdp2', 'Ethinyl Estradiol'), ('tfdp2', 'Ethyl Methanesulfonate'), ('tfdp2', 'Formaldehyde'), ('tfdp2', 'Ketoconazole'), ('tfdp2', 'Lead'), ('tfdp2', 'Menthol'), ('tfdp2', 'Methapyrilene'), ('tfdp2', 'Nickel'), ('tfdp2', 'Ozone'), ('tfdp2', 'Phenylmercuric Acetate'), ('tfdp2', 'Quercetin'), ('tfdp2', 'Silver Nitrate'), ('tfdp2', 'Tamoxifen'), ('tfdp2', 'Tetrachlorodibenzodioxin'), ('tfdp2', 'Tobacco Smoke Pollution'), ('tfdp2', 'Tretinoin'), ('tfdp2', 'Urethane'), ('tfdp2', 'Valproic Acid'), ('tfdp2', 'Isotretinoin'), ('tfdp2', 'Aflatoxin B1'), ('tfdp2', 'Cadmium Chloride'), ('tfdp2', 'beta-Naphthoflavone'), ('tfdp2', 'p-Chloromercuribenzoic Acid'), ('Air Pollutants, Occupational', 'h3c15'), ('h3c15', 'Benzo(a)pyrene'), ('h3c15', 'Bilirubin'), ('h3c15', 'Cadmium'), ('h3c15', 'Caffeine'), ('h3c15', 'Doxorubicin'), ('h3c15', 'Ivermectin'), ('h3c15', 'Lucanthone'), ('h3c15', 'Plant Oils'), ('h3c15', 'Silicon Dioxide'), ('h3c15', 'Smoke'), ('h3c15', 'Toluene'), ('h3c15', 'Tretinoin'), ('h3c15', 'Xylenes'), ('uba52', 'Aluminum'), ('uba52', 'Arsenic'), ('uba52', 'Benzo(a)pyrene'), ('uba52', 'Cannabidiol'), ('uba52', 'Copper'), ('uba52', 'Diethylhexyl Phthalate'), ('uba52', 'Diuron'), ('uba52', 'Gallic Acid'), ('uba52', 'Hydralazine'), ('uba52', 'Ivermectin'), ('uba52', 'Lead'), ('uba52', 'Manganese'), ('uba52', 'Potassium Dichromate'), ('uba52', 'Ribonucleotides'), ('uba52', 'Rotenone'), ('uba52', 'Selenium'), ('uba52', 'Smoke'), ('uba52', 'Valproic Acid'), ('uba52', 'Vitamin E'), ('uba52', '1-Methyl-4-phenylpyridinium'), ('uba52', 'Sodium Selenite'), ('uba52', 'Particulate Matter'), ('Arsenic', 'h2bc1'), ('h2bc1', 'Benzo(a)pyrene'), ('h2bc1', 'Methylcholanthrene'), ('h2bc1', 'Valproic Acid'), ('h2bc1', 'Copper Sulfate'), ('h2bc1', 'Nanotubes, Carbon'), ('Benzo(a)pyrene', 'cbx8'), ('cbx8', 'Caffeine'), ('cbx8', 'Cannabidiol'), ('cbx8', 'Dexamethasone'), ('cbx8', 'Folic Acid'), ('cbx8', 'Indomethacin'), ('cbx8', 'Lipopolysaccharides'), ('cbx8', 'Ribonucleotides'), ('cbx8', 'Tobacco Smoke Pollution'), ('cbx8', 'Valproic Acid'), ('cbx8', '1-Methyl-3-isobutylxanthine'), ('cbx8', 'Copper Sulfate'), ('Cannabidiol', 'h4c1'), ('h4c1', 'Cisplatin'), ('h4c1', 'Dinitrochlorobenzene'), ('h4c1', 'Doxorubicin'), ('h4c1', 'Estradiol'), ('h4c1', 'Methyl Methanesulfonate'), ('h4c1', 'Ribonucleotides'), ('h4c1', 'Silicon Dioxide'), ('h4c1', 'Smoke'), ('h4c1', 'Tobacco Smoke Pollution'), ('h4c1', 'Cyclosporine'), ('h4c1', 'Genistein'), ('h4c1', 'Vitamin K 3'), ('Valproic Acid', 'h2ab1')])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "RED_CTD.edges()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "28346683",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "84d181f5",
   "metadata": {},
   "source": [
    "Para visualizar la red usaremos -matplotlib-"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "98cd2961",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw(RED_CTD, with_labels=True)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d63bb66a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "4e8572d1",
   "metadata": {},
   "source": [
    "para ver la red en forma circular"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "5b5d6848",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_circular(RED_CTD, node_size=500, alpha=0.5, with_labels=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "85b67ac2",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "d5bf7134",
   "metadata": {},
   "source": [
    "para ver la red por nodos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "bb82c7d0",
   "metadata": {},
   "outputs": [],
   "source": [
    "pos = nx.spring_layout(RED_CTD)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "bbfa937d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.collections.PathCollection at 0xf832c10>"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAgQAAAGFCAYAAACCBut2AAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjUuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8qNh9FAAAACXBIWXMAAA9hAAAPYQGoP6dpAAEAAElEQVR4nOz9Waxl2Zkmhn1rrT2d6Z47RNwYMyMzSSaLTFYVi8Ui2V1qltStUltooUpQwa4CDMiGYBUMGGgDBmwYkNGw3/RiPRj9oG5ZloCGq0W1SlaxoW632tXdJGtiM0lmVmZyiBwiY7oRdz7zntbgh3+tffYZ77k3bkTcyNwfwbw37jlnT2fvtf71/9//fcwYY1ChQoUKFSpU+FSDP+8DqFChQoUKFSo8f1QBQYUKFSpUqFChCggqVKhQoUKFClVAUKFChQoVKlRAFRBUqFChQoUKFVAFBBUqVKhQoUIFVAFBhQoVKlSoUAGAt8qbtNbY2dlBq9UCY+xpH1OFChUqVKhQ4RxgjEG/38f169fB+fIcwEoBwc7ODl566aVzObgKFSpUqFChwrPF/fv3cfPmzaXvWSkgaLVaxQbX1tae/MgqVKjwQkJpg8NBiv1Biv1+imEqIbWBxxkaoYfLrRCXmyG2miEEr7KJFSo8b/R6Pbz00kvFPL4MKwUErkywtrZWBQQVKnwK0Y1zvPuwi+/fOcROJ8YwU3Cq54yxid/rPke7HuC1S02s1XwYY4qgoRl62F6LsN0KcekJggalDQ4GKfb6KfZ6CQalwOS89lGhwicJq5T7VwoIKlSo8MnBKpPpViMAADzqJviXP9vFj+930EtyBIJjsx5gsxGgVfNRD0Qx0KS5wqNugg/2hzgaHiNTjxAIjkvNENutEOPxiEFwoBF62KgF8D2OOJXItYEvODbqPq62I3x2u4Vr7WhiUj9NYNIIBK6v1/D1V7fwpRtttGv+M73OFSq8aKgCggoVPuFwAcBHB0O8+fER3n3YxeEwQ640BGeIPIHQ5wgEh9QG/USin+TIlEKSa6RSI/Q4Io9jxBg6cY47h0P4gqMVebjWriHJFXa6CUaZhMcZtpoBBGdIMo1ekiPyOV7ZaiCVGncOBtjtJeglErky4AwIBEfocTA78QvGUAsErrcjfPHaGr7x2iX0khw/+PgIB4MUoSew1QxwtV2bmwFQ2mCYSdw9HOH2bh+XmiF+4/XL+ObrlxF64ll/BRUqvBBgq7gd9no9tNttdLvdqmRQocIFw6IVfyYVDgYZ7h6NcGd/gL1+ikxqMAaEHofgDIwxMAAeZ1DGQCoDYwwypdFPJLQB6oHAet3Hej0At8t8bQxypdEd5eiMMuTaoBF4aEUCBgzGAIyB9gHgyAYgnNF+YOg1TzBoDShj0AgEtpohfMEQ5wq9WCLJNaTWUFrD4xxX2hG+eHUNG41gIjtx0vXZ76foxjneuL6G3/rl67i11Xi6X0qFChcEp5m/qwxBhQovKBalz5U2OBxm2O+nGGUKaa5gAEQ+pe+boQdPjNuP4kxir5+in0hwBniCQyoN367apTY4GGSIM4WtZojIF+CMIckUjkYZ0lxDa4001+jGDKHHwe2qXWuDVNKkbgwABjQCD83QG5cQBL1vkCr00yECwWEMBR2Z0khyDWMMOFOIc4XdboKNRoCtRoCbG3Vst0KEPq36jTEYZQrDVGKYSmRKQxvAJRH+1c/38cO7R/irr13ClXZU8Q4qVCihCggqVHjBkOQK33t/H9+5vT+TPu8nOX6+20c3zuFxDsYUfI/blbjBXj/F8SjDei1Au+5jlCrs9RNIbbAWeVDGoBvn0DZv6AuOwOPwtMEwU0g7MS61QgySHPv9DEobCA74ngBgoDSQK42GR0PLMFdQNhjQBmAAhqkEA3EIGAOMAVKpkUoFqQxiptCMPHBGq3tfMHAwKEPvTXKF3V6CzijDx4dDhJ7A5SZxGrpxjjTXyJWGS326oCTOFXKpoAzww7vHuLlRw42NOjw7+Ve8gwqfdlQlgwoVLiAWlQE6owzvPOhit5/gcivESxv1YrX/uJvgvZ0uklzD48DBMIMxhmrzdjluDE3YbmUsNdXwQ09AaYN+miNXBgwoVtaRL2gbMIhzjUQpKEUyp5wDnDEwMFrxM5qA3aDiVvqAZTkbA2UDg3ogEHgcmdQFl4Ax2m+ZHMgBaABSUfaD/k7bEIJBaVMEG4HH0Qg9bDUC1AMPw1SiE2fF9j3OoG1QAQDX1mt4/UoLt7bqgAEOBxkedWP0U4maL/D6lRa+dH0N6/WgyiBUeCFxmvm7CggqVLhAWMai78Y57h+NkEiNQFBaPhQc63UfjAG7vRScMdQDjoNBBj0VDJSRSY1unAMAar6AMgaZ1JDKoPx2W+6H4PS7Ko0WovQ+VvyHfnFBwaJ5U1uOAUBcglDw4t9aaySKduxxQBnqHjCl45nerMs0MEb75IwCFMEYQl9AcAZtDH3eXk+pDHyPoxFwtCIfvuDIFXEjtKGsQq4N1kIP19cjNEIfdV+gXffx2qUm2jUP2qAqO1S40Kg4BBUqvGBYVgYQnOHe4RA/fdTDKFNgAGIloQxlEna6MaQyNkBg2OvTxFcPRDFJluHS7sbQyrqfSrtyNsWKn95nigBA6tlj1gbwBCsmZzdpq1KGwH1+emp0kzsAGGXAQEEOYzTBuhKDUgDDeHtuW+V/c6CYfLXNFoyPwSCRGh5nxXmNj98glgr9BNjtZQgEw5V2hK1mWLxXKo1uLLHfz8DAsNOJcTTMkMlHCDyOS80Al1tREfhUZYcKLzKqgKBCheeMu4dD/NFbO/jJox7aNR+f3W4VE5xUGu886OLH9zvIlUYgGDxPQNgVsDHUJqgoz45U6mL13U8MBjZNHngCnNOKOZEKw1RR2t3Orm4Cdft1wYDB5ORbhgGtsh0/0U3ii95fzMdT7zEAMmWgNAU7as7r0/stQwNg2oyDgqk3aAPkyiD0GHwxfo9WBkYDYJQBybTBTidBnClsNAJIZSC1xiCRGKQSdw6GWK/72GoECH2BNNfoJRKRn+P1Ky2s14Oq3bHCC40qIKhQ4RmhzAt43I3xqJvgJ496eOt+B2musNUMkOQKwyxHM/Shtcad/SE+OBhCKoNW6BXsfYckV8iVgc8BpYFU2RQ/A9zMmysKFDzBiskRALgZp9ldXR/GQAHQczIC82AwP3sw733GoOADzL0+JxYvF0MZANrMbIPbgEeDiIsGHIIBmSKiI7e8B8YYuO1q2O2lOBpm8K0uA/EWqFBxNKSuilogsFbz0QwF9vsZ+skx3rjextV2hLXIx1rkF+2Of/ijh/jZ437V7ljhwqMKCCpUeMoo8wI+PhzicTfF4TBFL87RTyQMaBW/10/BbNufxxkyqaDsTN2cEwxobZDYlj8F6u8vp+o9m/7nBpYjMJl6LyZmM/6RrxgInBVPc/PzAoqCV1AKCrjjGdjrqZRBqjUYLKkRVLaQWhG/weNFNkZqINMaLDeIcwVfcKxFHjKp8c7DDoB1XG1HACjbcrUdYaPu4yePetjpxvjdr76ML7+0/hSvQoUKZ0dFKqxQ4SmhzAvY7aXoxhm6cU4tcQboJjlgiMXvJhxlgDijfnuUGPoUJFDgwDlNUJnUGKWqINm5ydbV2N0E54h4n1ZwAJi6Do4QWS5xuK4JR55koFJCIPhEKUVqoB5wRL5HHRu2HME5hy8Ybm3VEXqCyIm2JMEZBYahJ/A3vnAF33htqyIfVngmqEiFFSo8Z5R5AYIB3TjD4TBD5Ak0Qw+7vQTGEMPf1daZ7bnLlQYs4c9NTJnUyF2rHdfQ2kCWZvl5Nfcyce/TDA2ATQVF87IJGpOlEnf9MqURgFmvBAoKhilpJmhQCaafasBQQHE4zIqWTnf9GQN8zsA4w53DIf7pu48Q+QKt0MMrlxp4ZauO7VZUdSlUeK6oAoIKFc4RSht85/YevvXmfRz0UzAAj3oJcQAiEuI5HmUYpgqRzyc6ALQ26NqeeWCWHOdW/tmTFNs/pVjlik13LwA2IDNAYgw4TJFp0AbIlJpp0VQKkFqh5nM0I99mIhhyrZFkClmuoLTBIMmxWQ+Qa4O37ncmOhbWIq/qUqjwXFAFBBUqnAMcT+CP3n6If/3RIVJFNekyRyAbUn97nCnbXicKhr4TyykL9MCS8KZb+Co8HSzrpij0GNy/YbM1NiCQupSZMUAiNfxcoeYLpFIhkZTVYWAQnCGVGqNc4eZGHYHHMUoVeolE4OVoRV7VpVDhuaDiEFRYGfNY8kfDDKOMJr1G6GGzHuDaWoSr67VPReqzzBO4dzTE3cOYrH0DD497iRUHEtYwyGCYSqTWYAgljQBLkgcw7tk3GAcEVSxwcVC+mzmb+t5K/ybtg9LvfKzZ4LoXWpGHrWaIQHDEmcIgzeEJjpc26rjUCJAqUnH8ysvr+O0v36i6FCqcGhWHoMK5YhFLPsmpjlqAOdtajs1GiGtrEV651PjEpj7LPIFm6CGVBr7gWK9RMCC1QeRxJPl4hUiOf7bdjZOiX/kSTgcAT5n0X+GMcOWFclnH2P+416QmCeiiq8GgiAA5Y5AgDYlBIhF4Ap4gRcZhptCLu1ir+ahZI6kHxyO8db+D/+jfeA3/xmcvPeOzrfBpQZUhqLAQy1jyvuCoBQK+4DOWuHFme+M9jnbkYb3mY3st+kSlPt+638G33ryHzijHrc06HnRi/PRRD+s1H71E4mCQwuNspgyQSl3o/jvGOlBlAF40zOMbnPR+zsksytggUBsKGDzBIBhDK/KLoIDaI6ltUXCGUSrRTyXqvoff/bWX8L/6q698Ip6jCk8fVYagwhNBaYO37h/jv//RQ/z0UQ8aBr1RjkGmEHkczchD6An4gk3o5HPGEHoCoSegjcEoVTgcZmCMwRf5J0ag5a37HfzB9+8iUxqf224ikxp3D0eI7ADdjXMYQ65+2lC6uCzJC2ag9XJVvwoXG6t+b+XygtKAcnoHQKEU6XEOpQ1GmUQr8gEweJxhlGvsdBK0ax4AhsgT6CU5/p9/cgcf7Q/x+998Da9dbp73qVX4FKMKCCoUKBPjfnDnCKNMQTCgnylobaz5i0Y/lRCMIfA41mo+GoEoHPccOGNoRh4ixXE4yDBMJT633XzhBVruHg7xrTfvIVMaL2/WwRjDbj/FKJPYbAToJxJxRs6EAK3+YCgYyKQuWOtVIPDpgMEkz8D9zcaFVklSF0RDJHnhB0HCUwpJTiUFAAUX5X98ZwdvP+zg937tZfz7X77xiSvHVXg+qAKCTzmUNnhwPMI//8lj/MkHh3jQGeFokFn9e45BKuExoFbzJix0lTFIpcJuj9Ta2jUf63V/xkDGExybDfKp//luH1+60cYoU/iD798FgBcqKEhyhW+/vYPOKMfntptgjAyBHhyNYAwwSiUedWLEuQIDEcqk0sVkUGkCfDox3T7q4P6cK1NoGmRKwRcMPmfwPQ6tqZ8h8nihrBhp6lTZ7cb4+9/9EH/+4SF+5ys3PjHluArPD1VA8AlHuTNgr5dgkEq7WlU4GGT42aMe3t8boBvnYACGtmNAKqAT50XLnNQGgScQCGJLe4zB4+SmlyuNg0GKOJPYaoaI/MlBiTGGdo2Cgp/s9PCVlzfQTXJ868172Kj7L0z54Hvv7+O9nR5e2aLMQJor3D0a4aODAbQGDozGIFUklwsDifGg/8nts6jwpJjuIpGKOhAEo6DSwCCWGqENEJQ2ZOWsGXKp8OP7x9jtJXjz7jF+96svVWWECmdGFRB8QlHuDNjpxBhmZHertMHhMMN+P8UglUhyBc6ARiCgwCA4R82nzABnVMt0jOk8lYg5rVac3C5jQOBxeJrY0WknxnYrQjOavLVcUHA0zPH+Xh+/8vIG7hwM8e23d/D733ztwq9sunGO79zeR7vmQ3CGj/YH+PhwiONhhlRq1AMBmdF7yyliJ5vrDHaAqlxQYTmc7oEjHRoA+Sgv/BfKhk1KMwAKd3KF3V6CP/ngAL/71Zfw21UZocIZUAUEnzCUOwMOBilCT2CrGeBqu4Z+Qmn7bpwXPdI1nzoFhmmOVBmbDdDUSWA186l1igIDrQ1GmUKuNOqBRzVy0EDlRFh2+wmARUGBh71+intHI9zarOO9nR6+e3sfv/nFq8/8Wp0G7z7s4mCQ4nIzxA/vHmN/kCLyBGqBwDBTEIwVDnoTWQE2/kfFHaiwKqbbT4sgQRsYS0QUoOeyEQgk0iAQDN1Rhr/33Q/xZx8e4He+crMqI1Q4FfjJb6nwouDu4RB//7sf4Q9/9BC5MvjsdguvXGqgFfnY76f44d1jHPQz1HyBQSoBkLEOpSUpGwAAo0xB6dnJi3T06X25MugnObKS9y1jKER49voJklzNHKMnOEJP4O7hCACwVvPwndv76Mb5U7km5wGlDf7iziFGmcKP73dwMEixXvPRjLwiE5DZNO/cYKBChVNCY/b5KyshkqkSiRaBMXiCuhK2WyEagYfbuwP8g7+4i7//3Y9w93D4jI++wouKKiD4hOCt+x3859/9ED99TDVu178MAI+7Cd552EEmFeo+x14vwSinSX+UUX9zJslQx9glrrGkQTWHEUUWvZQxGLjPll4LPQGpDQ4HaeHWV0YjFBhlErv9FNutCAeDDO8+7D61a/OkOBikeO9hF4+6MXKlsdkIiq4Kd73SXBXGOFUwUOFpwAkhuf9LQ7oWvTiHVOSP8KiXwsAgUxrdOMc7D2hceOt+53kffoUXAFXJ4BOAt+538P/+/l30kxzrNR87nRiZZbcnucSd/SFSRfXIR1mCxHrCK00BgFTGlgPGbm/ONpec3viM/LDLFihNcryc+UX5gDEg8jiGmUJnlGOzEUx81nETHh6PcHOjhsDj+P6dQ3zjta0LKXP89v0O3t8boOZTN0VZe4ExRuxwqccruot3ChU+IXAeCuVSwijXhRz28TBDkpMOSHeUY5RKDDKF//pP7+B//euvvlBdPRWePaqA4AXHuw+7+H/88W086MTgsOI39jWlNfb7KVLrk8sY1SAFA3xBpEBtGJRWVLM04wFHaxsUaCA1uigtlOGCAqnGoipuruScTFy6cY61yJvRKagFwvbsK2w1A+x0YhwOUmyvRU/vYp0BSa7wT959hExpXGtHE8EAMA6KlDGFP8E8lLkFFSo8CebdR8oaYeVKIzQcgjFoZrDbT5ApjZ1OjP/7P/8Z/s7fegOfu9J61odc4QVBVTJ4QZHkCv/knR38J//DX+K9nS5gDKJAYKMR4FIzRDP00EskMmXgc4bQI3lU0hAgN7Zc2fYlt1E2VlADxpOYNkAm1dyBiAEFp2CaMxBYIaNhNssl8AVHrg0GqUQj8DDMFHb76fldoHPC997fx0cHQ9QDbyYYAOgclaZsTPUwVXie0PbZHqWKiL9SI841+omENgY/fdzH//Ufv4f39/rP+1ArXFBUY9gLCEce/C++dwcHgwzX12vYaIQIPTJCGaQSD49HGCQkKuRZiWFlDDiHFTgh34Hc+rYyGyw4uJZCh1xjgitQBrPmLc7AZ/rvvTjHtGUGZ87IRUJw+n2vl5znZXpiuFbDyOOFze00nEYDgHHAUKUCKjxHuGwVPeZkoHQwyBBnCj+6e4y//Q9/hD/80QPs9pK5HKEKn15UJYMXDM5Uh0oBGuu1AL7gyCS1CnaTHJ1hhkyR9CkXrHjotTbgjNksACskUklGdf7A4LgEACmqCWYKrkAZ3JYOMmUQlWoLXnFsBoE3+7lcjvc7L5PwPOFaDdfrAQ6H2dL3OiKhu14VjaDC84IxQJLrosRnYMCUAkBjwQd7A/yn//Sn+MUbbXzpRvsT60Za4fSoAoIXCGVTnVboYZRJhB7Hw06GNKeAIM5JKU9pmpXykni+tgLq3GYEXBZAGzJemZMRB4CiNm5AJEPO+YxEsSs1ZFIh9HixLcEYMqOJnOjxmc+4LgTGGKS6OGa/rtUw9AT0kiW/tIpyiloziKxZLboqPEeU2xO5feQ8TsRgbQwySUTg9/cH4Izh9m4fl5rhJ8qNtMLZUAUELwg+2h/gv/qzO+iOMkS+wI/vHaOXkJogY4BvBYU4Y+DcrgpKNruur1lbfQHGTLGCcFO7yx7OiwvcylcbCjICgZmaOmeUPteGJkn3OYDITtMw9jMAHeM08fB54mCQ4lEnxmYzQJyRN4E2ZiYQypSG4Pb6AGCWA27MZIBVxQgVniUcv9Vl9zRQCBlxbqAN0BlmeNxL8Nc+dxlHw+wT40Za4eyoAoILjm6c40d3j/H3vvsh7h+P4Fnmfj+VJGUK4gckuYI2gGCA4cQHYHZ+ZXY2d7arbqBwHQX0npPNdzicXKqBZIA/VTpwXQlKm5n2wUW1Sr9URmgEF2dlstdPMcwUrrZr4IzBF4wY3FOrJzpXDsa0vZ5mLF1cusBLGhAqVDh3lLME090vZLdMmb67h0NcboX4pZvr2Kj7L7wbaYUnQxUQXFCUJYjf2+nhUTdGI/DQTXIoA3iM3NCIN2QgNQMD8QFyRStUaAPO2eSK33YS2Az3eJwwk8HC3PKBld8FqMTgcTPZk29/qjmRxfSftKHPNgIPStPvF6nlcK+XwBgKbOqBQCvy0I3zmYDAWAKXxxmUdudlr2XFJajwnKHhKobj6JRZwovPGVINvLfTw2cvN1EPPXxuu4m7R6MX0o20wpPj4uRoKxQoSxAPU4lMKdR8CgaMMfC45QDY9yv7wHOGgjTo2gWd+NAM2HiymlrMUpCwZDlL7zcLa+Vzdzc1M5JXAkMz9DDMJBqBwJVWuHinzxhO2hmga3pjo16UQ8pgjNkMAgfn4/N0D1ZleVzhecMAyCRZJse5QpKTF8koUxAc6CcSf/mgA4Du51ubdaRK41tv3qtkjz9lqAKCC4ZpCWLGGPqJRD+lYCD0OMrrTsoOmKJzwKEoDxhAzvElKN7ktoPJ9yybx9zH5IJgY97fpksIcabQijzUAoFD2zq51bw4AYHUk9mPK60Q9cDDKJ3shHDnFXgCDBQYAABc2xeqoKDC84cBSR1LTf9XBohzjV5CjqdvPejiJztdpLkqgoLOKMe3395BKi9W90+Fp4cqILhAcF0Ecabwue0mAo/j3uEQw5Q8BYi9P6kXQCl+Mz81Xc4CLFDKY1OZgokswRK4UsX8bZYDFvrplwiD2gYxNzbqJI8sNb7+6sWSLfasNoJD6Avc2qojkWqiGyIQVLbxrb4Ds39zGLd+VahwMeAWCy6jCNAz+L0PDvBP3n2E27t9KGMm3EgrfDpQBQQXBHcPh/jWm/eQKY2XNykzMMoUHvUSSKUR2WAAmGKvL5IPLP1e/ueC6sH4dSz6x3ycVB5QtuOgPEkOU4V64OFKK8ReP8GlZoAv3WifvLNniGY4S6+5tVXHditEN5ZFsOALasE0jCHyOCkWMobQozYvJxDztEKdpxlCnde2L06YVwGYzAZyBipBAjDa4GiQ4S8+OsSffXCAOFcvhBtphfNDFRBcACS5wrff3kFnlBfBAEBGJf1E2vp0qRwwHRCY2XLBBKayAPN8jecN2gvjAeY6FzCTrQBQtBwCgLT6A64jQSqNVCrc2qoDAHqxxG+8fvnCiaJsr5FvQbk7wuMcr19pIfI5ulZ90RcMoc8paPMFfMGKckMgyMTJtYKe98ToBnNXRDrL9vkJActkgWoMt8JceT+oBpuLBvfsurHDAKgHAsYAH+4N8b33D2AMLrwbaYXzQ/WMXgB8733qJLhVCgYAYKcTQ+lZhT9ReoANZtP2Bd3QTPxxaTngNAHBJBlx/C7XneBS/063YM06BBpj0I0ltlshXt6s4+7RCG9cX8M3X7+8YE/PD+QrLzDM5MTf1+sB3rjeLoybAKAV+VbDwaAeeIWTJCzZMPQoQ+IJdqoHzk26Hqf/z3vNCUyZ8t8x+X1yLJ68FwUSwu5XcDb3PnCBhAsm3H6nt03HziAEgycY/FMGRm4bi6SjK5wdrtwIAGDjzEE9oHv1YJDizY+PMMwkvn/nsJI5/hSgajt8znB6+e2aj9Aft7RpY7DXT6ya4FRAwJ3g0OKSwTwJ3aKtELZ9cOpFbqhNqYyJFsRi7JjlCLhjditigER7fMHRCIQNBnJEPsfntlt42ImxXvfxW798/UIqo11qhri+XsPdwxHWosnsxdV2BGAd7+10cTTM0Qg5mTUpg8DjaIQeBqks9BgYY/AYTWqaU1uommJxTpM6i4nWTvgAINi4s8O1hzoVRTb1OYOxCqV73U2q7rMeZxNtqY7bAfdZzCeIMvu602cAqGvEmHFbKrPnO2MIxRgYM5O+GaVrUAYHKe1xS3RhxmCBnUaFM8JplxAniEp8AeOIfI4k1zgaZjAgjZCL6EZa4XxRBQTPGU4v/7Pbk5ako0xhlOuJ9LsDZ6yw3Z2nF+BWjzNtgcz1JE8SCOe9DtCAXNYlcJNM+YNsapIJPFHYLCttsNEMitW04AxvXF9DN8kRCo7f++rLF1YRTXCGr7+6RQSrOUJLV9sRIp/j9m4fe/0UgeAYpBIep6CgCQ/DVEIqCpJcYCfshJhKDeNmbtDk7HGGVJLapGc9KLQxpC5pvzCPkwaEg5tYBScVSu2CQEaZJM/K1Rq7D8ZI515wIPAoeDOwAkuM2kBJ/prKHpnU4wDD7ofb7ZaDCc4EMkniWAbzg4HyirS8Tc7pvlOm9LdSUOvuO9pvFRScJ4rvpHS9AfruIp8jzjW6cY739wZ40InnBgRKGxwMUuz1U+z1EgxSCanpvm+GHrbXImy3QlxqhheKOFxhFlVA8BxR1sufflCGqSxEbqbBGBB6AsNUgtbr81ZxNOROiwxNDLJzooKJ1RojuVNVykSU682s2I81TuJUNzeGnA8bgUAzFDgaUmbg9StN9BKJ9bqP3/vqy/jlCy568qUbbVxqhtjvpzYrMIn1eoCvvLyBu0cj3DkYYphJ9BOJeijgC45W5GOUSeTKakTw8ZUTjCG3q3Gfk8gUlYfGifdA8LEUNGcFP0FwTiJUBgg8IjUqbZBJhdhO4DVfIPJFkaFIi/5zA2EnV2WjOGXoe22EXrG9gQ1m3P3jc4a1mg/BKFjNFdWDymULUmw0NpChicat7gHblWKjUTfhaw0YjaKkxUo/fUHXRJXaajljEDA4SyNcKf761KN4zg3GgSmbzAgxS5SNc4X9fop/8dNdfOXljeL1bpzj3YddfP/OIXY6MYaZGgd8jE383ggErq/XKiOlC44qIHiOKOvlT2OYSaoFz5UMBALBEHMGrXXxIE8QC219d1pCF5gqHUxv2L7oBmVjxttxQwWVyydXFdoAdZ86IVKpIBgQ+QK9ROJSM8RWI8Ao03jj+toLo5Xervn4jdcv4w9/9BAb9cmSjoMnOD5zuYmb6zV8eDDEW/eOkWQanGvKCNgVeq4MjDLFyt0XHKFPcsgGxPA2hkhdAAkjSRBpse55CH1yjQw9huvrNQDA4YDklRmjwMAA8DwB2HvBreIB+i4MAN8GHalUNLHb0oHnCUhtIK3jZOjTRABDgUkr8opgpRWRVHYqXYnB2MkfxUDfS/Iiw2FKOhjuFmUug+GNMxjc3ktKU1aECTovqQykLllr2/LWdJnFoZr4T4bLIhlDQdk4IJscETine3WUKbx599iqdfJCRfVgkCL0BLaaAa62a3MzAEqTzfndw1FlpHTBUQUEzxFlvfxp5JJWgoCeKyXMOUXvw1QvmNnpPW6iKb9cHjAXyRQz0ETghI9ga41u8ipDapq4Ao9hlEloA7QiD0JwrEUe2pGPzUbwQg4C33z9Mn72uI+fPOrhc9vNhQFa6At88doa1us+3r7XQWInb20c18MgUxqZ1IXlNIEjUxqJ1EXw4HGOtZqPXNFqP/AoGHDyzpENTK61azgeZTgcZhhlCnVf4PJaAI9zHA8zDDNFhD4GpLZ0sWHFnzKpsVE3kMogt+ndyOfwOBHKpDI4GmUYpJLuA4zvFcYYaoGHwNOIM43UHrvv8YKDEAiOxOgJaefIF1BaF9dL2ICJAUglXQOn8VCUMWxmxOMUsORazw1SyyiCD0wGvxUIrPgPwcASUdn8scDxRHZ7Cf74p7t4cBzjJ496aNd8fHa7dWIZQHCGtcjHWuRDaYP9floZKV1QVAHBc0RZL38ayhh4glLLyhh4c57UyKe6rbQTzPQ0y0CrMGmmSgeWK1AmJk4PEoCVQeYMBhq+oMFbKlr1SbvaTXJtt8txPJIQDNhoBLi+XsO1tQivXGq80GnC0BP4rV++jp1ujLtHo5lOkGlcb9fAX2Z4b6eLJNdYr3kTLo7GZgsyRXbVShsMkhy5Nqj5wgYA5J1gDNVmu7GELxiur0dohp7NOGjEmYIBBQatyIPSGsNUIc41fI8jUBqDVBUBW933wRl1fdzcIE0FwRnuHo3w8cEQ/UQildIO4B5e2qihM8rhC45OnCHOFRgMOOfQ9p4LfYHLrQCNkAb7VCoKcHINT5DtdeRxXGtH8DjHg+OYOg6m7vlaIBB6HJkyGGUSSa4puLCBkAFlDQRjCHwOjzN7/WjCMqAgJ1eTXTeLfuc2UjgtHeGTkH1YtABgtpQ1+34qCXUTif/yTz7CSxsNvHKpPjdjVoYxBqNMYZhKK8GurU4H7e/PPzrEh/sD/IffeAVfubWxdFsVng2qgOA5oqyXPw23enLpXY/PPnyMAY3QR64y5NpAY9ael2q7RESb4ROAondVqu068qCr8TqyWSvyixWsVJomHcEhONAIPAjOcG09wtde2cIb19Zwdb2GK60QW8+QSPS0yE23thr43a++jD/4/t2VgoJpwmHoCTRCYa2qKZMSeLzovNhqhvilG+tYr/vY7ad4eDxCL5G2jg/qcmAGh4MMx6McgcdR8wXaNR83Nuq40goR+gLaGAwSiYNhit1eijRSCAXDpRbxH1JJq2vfZnLuHo1rvlfbETbqCqkkR8fQF9jtJRjlCi3O0Ah9pDlp4edSU4bKF4WUtruXGYC67+FKy8PNjTpCj+PjwyH2+im0UZBaI/DmDzucM0ScIfQC8u3Q7n420OCoBxzrNR+N0CvuvcfdBMNMoeaTKNTxKCPuAzCZKjAUONQDgThXRQvdIgXPMlymody18aJi+q5lsEERc2PF/PvaGCBOJY5HDN94bWtpMJDmCnv9FA+OR+gnsiiLuf0Vl9AY3D+iMsLv/drL+O0v33ghFw2fJFQBwXPEtF5+Gc4WeK3mY7enFqb2PcHQjDx04rwgCE2/jTMquhZBQek1V8vVBRHMfQaQytigw4Nn04aCMWSSVg2t0MPNzTo+c7nxXMsBz4Lc5FzfvvXmPby/N8CtzeUrpDLh8O7hCEfDDB5nqAVEONTatWEKfOl6G1faEZQ2WK/7kCpCPZCoBQKfudzAa5eaGGUKj7sJ7h4Ni7JMIBjiqYndneM3Xt2cOEelDQ4HKXZtsDTMSILZs22h22sRrrRCrNcDdEYZdvspvv32Q/zrO0e4shZRi6HH0PAFuO1wiTOFzGaMOCNCaSP00Ag91ANR3NubjQB3j0Z452EXuaIsgif4/LZEAABlxPxQFKTC9ZqPK2shPD6pdrDVDJF24iLYYWCIfDo+qcdERgYg8qkllDOGYUaZEK0pUKK9zke5IsdKf5vGstcuKty5MTgRrdn35JIyPZ4lqI4yhWY0+9xIpXHvaISPD4cY2XJVLRBoRt7MQgWgNtdMKhwOMvz9736IH949wr/3S9dfuLLiJwlVQPAcMa2XX0Yj8MDAUPdJ5S+3in/zEPkCdUnuZUq53vfJ91D6H0U2oLxXlyngltDl6sXaGISW6S7tJCuVRq6B7WaAf+sXtvE337j63MoBZYvoZ0Fu+vJL5Bn/7bd38N5OD2s1D9utaOGqqkw4LK/8DwYZcqnRqvnYagToxBk6cVZM5q8uKbOsOrFPZ2YEJ/7B9loEnCAT7d6310tw/2iEz19dO/HaLIO7DnGmkEkNzoA018gXeWGA7tPtuo8vXGsjzRV2ugk6o3wiqOKMshTbaxF2uwmGuYQxGoCwga4BOHlNUGBBHRJuEqSOi1L3hg2mlR5nyty1E7b9wbXiKsu9mOArlCKC6fO6kMFC6WCMIbLpTKuoMRjmCgyUYVHa2O6mSXRHGX72uI/9QYrIE9hsBHODgDLo+/NwfZ0Mzj7cH+Ifvfmg4hY8R1QBwXPEPL18B0qLMmgA67UA+4MUnm3tm4dW5EEbmiSVNtaKly3PBoAmfeYoxhaCAZvNAO1aAMAgk7SqU9rAExxfvdbG3/n3vohblxrPra/47uEQf/TWzjMnN93aauA//muvFYHIB3sDhB7HZjMoSifT8ARfuPJ3ry+bzKfPYdWJHXiyMkpZvvk8vmfOKeDZbATIFfEgMqXt/WisxDOtVEepxFde3igIt69eahRBVT+RGKSlrAhospKKpnqmqZwVBB4CQcHxMFNo2uyF1gZpKNAZkdJk6NPf4kxCg0EbyhhwRuTIeecuKGqBbcQoShTT7xRF6e2JL9+5oDg+U9IVAd1XZb8RhySnIC4QDIJzMiObEjh53E0sZ0ZhveZPcGZWOibGsF730YlzMAb85FEPO90Yv/vVl4vMXIVngyogeI5YNuDWAyKWdeMc7Tr1s1OtVCzQJmBohqIgrWljCoa3m/BdLZRbirYniAWvbSeCS1bUfFGQ15g9lu1WAN8TuNaO8Lf/+ueea/T+1v0OvvXmPXRGOV7ZOpncNA+CM1s39089AEW+wG9+8Sq+9urWRKnicTdZWqpYtvI/b5xHGaUs3zyt1ngWCMbsJDTmUcy7i1KpYIyHVmmfoS/w8mYdNzdqiDOFQSoxzCRyaQruhNR9AEQu9AVH4LFixeuyCRv1cYvvWiSx26fvLPIFPG71F0CTZcDZwkCIMYbQE+BMI5FmbjeDI+q6rgj6nBWQOtslPB+UMhiuW8P32MxiQ2tTnFvke7Y9lK63w+NugncedqC0wWYjWMqtWQZPcISewE43wV99bROP+yn+4Pt3AaAKCp4hqoDgOWLZgMsZw42NOg6HHQDlWqlC6M0PCjwxls01Vm1E2ZY3MzUCuRWNYKQz72SHI58mrsutqKgJ1wNRpAL/l1+/depg4DzJfs4iOpUK19oROnGOYTdGLk3hrOh7DI1gXMtelroMfYHPbTdx92h06gGoXfPx65+9hG+8tnWmNP7TwHmWUZbJN58FvrfauY8yWmk6TYYyOBvzFMq4sz/Abt/HZp1KMN1YIs6pPOHZ9tnp829GHowJ8biXoJdQOaIR+liLDHqJpJKAMhB8fo8+QGU/f0o90WOA73Hktu4OxgpNEUfUzaSeICg+i1LCdNlC2GCAMxStrGVkitpABSe+CgUHY2ny7ijDeztdKG3Qtn4lT4JGKHA0zLA3yHDLep1868172Kj7VfngGaEKCJ4jThpwr7RC1AMPo1ShGVG9erefLA0KyrK5GgwBBwAaEDUAmHF/dz0gJTtZdBJ4aEYefu2VzWLVneYKd49GZ1IXPG+y393DIf7BX3yMx90EudK4vTuwbWbj1PG4pku14VbkTTDx54Ex9kQD0GnT+E8LT6OMsky++bRwvBhXHpgHbYhEeHNjeSfHNDKbk+ecYbMRYi3yMcwU+klOCo3aYJQqKJ1O3ieMYaMRIMlJdnkt8rFW8xBnCvePRkWrnKGDszdZqR3HpgEib6zo2QhFIcqFOYEIL7IW9LwqbSbaJct8hPPuaigHA679mGSzJ9P8xhgkORE1a75XZA8Yo+BAKo2f7/aR5OqJMgNlOEnsh8cj3Nyo4dZmHe/vDfDtt3fw+998rSIaPgNUAcFzxEl6+aEvcGurjp8+6iFSHM3IAxBhr58gzhUij8/lFJD8rFdIzHJGKnIuZQtYmVrBkEhaxWw1QuRa45WtBkKf2N17/QS9WJ5aXfBpkP26owz/2T//OX58vwNf8BKDmS9kMOeKdNgPhx3UAw+3tuq4tVWfGfyAcVDwog5AT6uM8rd+8Xoh37y9Fo77ym26/jRZGceLyZVeeG2HqbQlqvBUx154OFh4gqNdI2GsYSYxTBVev9ICZ+OAxB1z0x7X/eN4oiNkey3C4SCBMYAQ3JbhrCoonA8AkEFjsxHgM5ebuHMwQC8hmWjOiLhIkst0XI63I0oTLGdswriKs7GhEze2O+hUV2MxaH+l62SVCKcfS6UpyAo8yhq6KoHLQt47GmGvn2L9HDIDZdQCgX4iEWcKjdDDrc063tvp4bu39/GbX7x6bvupMB9VQPCccZJe/q2tOg4HKfb7GTYbPpqRB0/UCtlaRwaafiY9wWckZkliyFibWqoPNgKBrUaAYaZwqRlgs+HjzsEQmdS41AzwO1+5cao2oKexSgWA/+yf38aff3SEzbqPVs1ficEcegKhR/35o1Thp496OBykeP1KC+v1WbloFxS8aAPQD+8e47/+0zvopzlakY+PD0dzJ+qadbCbJxQT2IG+ZtP07cjDR/tD/N1/8T7aNR/v7w2KdDcMJkirq2ZlyryYefeTVKR6+MVra6cOaDibP2kyRmTD7VaIz19tLb1vpjtCyJfCRy/OkWUKvmA27c8K0a/Q6h/8wtU1fOlGG9faNbx1/9iWjRR6tjxAMSgRehkDQo/cMaUy9toHRWBsbK3elfnK1/isYBjbVVulYvicwYDNdBcYS05msFkdhkKBsma7nj4+HCLyxKkJhCfBFxyDlDgijdBD6Aus1Tx85/Y+vvbqVqVT8JRRBQTPGSfp5Xuc4/UrLfQT0hFv13xEvsC1dg3dOC8U5FytVLBxy6GTmA09UsaLbVsiOA1G9UAg8Dj2BhkEpxagYarwylb9TOS3p7FKfedhB7ky+GBvgM16gHb99AMCZ6TVECmO/X6GfnKMN6635wZgqw5AF8HhrRvn+OOf7uK//NM76FmNeYMYwKw8tdS6cF4UfEwgc+9zde1MqkKBMOAM3UQiyzU0AG10Qb6LfIFW5KMRjCeFk7IyZV7MdNnAiTRtt0Lc2qqf+lrMY8i7Y5La4MZG/cQgEphPXtzrU/tlZ5Qj8ATqARHgfEGT4+EwQ8MGUlfbEb6MDby300Wcc7RrAXZ7CVJrOlWPPLQiD5FH3hJHwxTGUIBAhGBeXBtjKAOjNamQOmEkrc2pSImCjQMmbVDIQRPZcbK7wBhL6gSpdPq21VlaGe31eoBeIjHKqFRw3nDnPczGrY3brQgf7A3w7sMufv2zl859nxXGqAKCC4CT9PLX6wHeuN7GOw87RVDAOdU+W5GHYaZoFSM1smn2oIM1n7nUDPH5Ky3UAxqQdvsJtoXAv/2FK/j6a1tnJr85sl+m9FLN/1UR+rSa/IuPDpFkCp5gaNWe7Hb1BMdmw0c3zvHOww6A9blBwbIB6CI4vLmSzL/42R5+cPcYwyTH9lpUOBU6OPGj4zhFJksCQr7Aes2jLIkBOnGGfkaSwy433I9zkDo1tbo2A89OThqCcyQ5mSP5gqNtt7VKVmaaFwOMg4HIF/j8lZb18DgdGqFHqntTgcYwVagHHq6csgRRJi9eWYvwhatrhcgUOVhqsqi2pYoyyfFqm76L93a6eNRJ4AsOGKARebjejsBL5xcIPsELCj2GUWaouI+x0FLdrtSHKU3Gq6YM3GOs7eTvCXoOnMtl3R8Hh9RVQCVEV2oBrOGUAeq+wM31Gh52Yiti9PQIsrkcn6BTbP3+nUN847WtykL5KaIKCC4AVtHLp4lrHe/tdHE0zNG2GvnlWmnR2y11IUBE2gOkxlbzBb726hY2GkFBFvyFq2tPbEV893CIb715D5nSePkEWd8ydFnrfKomnSmFuwcjCKtZn0pqJ5vHhj4NGGNo1ygoeG+ni8jnM+WDeQPQsxZBWoRySWaQ5tBa4/p6bSZ1m+QKB4O0UIxrhMJ6VxCB7WCQoR/nMGCFCp1zq8ykRiol2Q4zSi3HuUK75iPOAaUdB2C8rThT2GqGxffDYAlzRuPjgxHuH8W4vh5hsxEi8jkedWLLbufoJaQa+KXrbbTnlHJWgZMzLvMTqASh8IUzlCCmMU9kqp9IjKyU8+NuYtVCxwHhrc06rrcjxLlGL8mx10uw10+x1aAWXgATvKBRJuFbUbHMZnPq1uOBzJ8UtKa6v54iIS6KD7QhMSXBgcBjxQpcGtJucPyAzPpqNAKBrWaIfpJjmNE2siI7QCXLfiKL0tLTgAvsythqBtjpxDgcpETerfBUUAUEFwSr6OWvqpHfKC2G3OqrEXr4pRvrWKv5eNSNz0QWnIckV/j22zvojPKVMwNpriYG1elOAWUMOqPc9pMzSrcyYL+frJz6XQYXFBwNc9ze7eMrtzbmSOKOB6A4V89FBGka5ZLMtXaIN++OUPO9mWBgkFCaW2ozQzx194nOFY6sME/Z2jiTuvAlCDxa2UptYLTGIGW40opwOEwLUmvgcXjaYJgppJ0YW40AYAz9JEea64KIl2uNbpxhrRYg9DlGucLx4RA+ZyTz/NIGrszJ1qyKaX4C3ffyzCWIRZguKdze7aNd8/E3vnAF2gp3TbeaDlKJdx928c/ee4wf3j3Cw24CjzsdA5rMa4GASg1iqRHZDIsTaRqk0pITXfcBZQ3yEgeElEVL+gIAGB8TLbUhgqPHDQyoDTLwBRLnbyEYNpsh2nXi57h7QGtSJ418gc9cbpI7ptJFdudpwAAzz3gj8PC4m2C3XwUETxNVQHCBsIpe/kka+eUHSdp6buhx0sPPFT7YG5yJLLgI33t/H+/t9PDK1smZAan0RNp1UafA0TAFQBNVJsn1jgM4GNCS5fyCAg97/RR3D0f4zOXmxOtuAPreBwd48+7RcxNBcpguyTw4jufWcQfJWGxnkYhVZmWuuZ1JRpkilUDGCllaZ0sMhsIOeZhKxJHC9fVZUmvkcfRTiY8PR9YKm7JXgQ1WjRHkhCgVthoBmDF43EuhtIHWBu/vD5BpvbAL5CQwxnDT8hOU1ugnEpFP/JuzbO8kOKGjeuDh937t5aW17bJexcPOCP/Te4/xJx8c4niUFe6TzZB0F45HGR53ExyPMnRGGQaS5I6cSiDnDDWfI/R5wcbXVmrZ44zInnCGZQblhXZulRUFt/eGoezkWm2SCwJYkyMDJFKDM1ZwQe4djuZO2OeNac0KwSmzsddLnmtr7ycdVUBwwbCKXv6i9KWTc3XEIKkM1mo+LrUihD4/93p2N87xndv7aNdmyZDT6Iwy/Hy3j/3+cq1zCmJkQX6DbZf0bLsaBQUMl1vhE5cPnDra3cMRbq7XJs5BcIbjYYb/z48f4FIzPDdexFlEkKZLMgDw4Hg0U8dNcoU9Gwws0qmQSheTvscAcOqDH6SyUK3zxJTkNehaZVJjv5+gXfMmSK20gtVQ1gRAadfbPnkAHmcYZgr3j0e4sV7Dr7xcw+Egg9IaSusTu0BOwnYrRM3n2OtlaEYCb9xon2k7q2Kvn+BSM8CXVpygBGd4ebOB/81f+wz+5199eYaL0rfiSFfbEZQxOB5mNnXOwI2B71G7rQHZjjtHVNeyXG4f9MCKFkltfyqrRhZ6ApdbEdo1v+icmIbPGXKtwQFcadfwhatrEJwXeg9PC9oYy7+ZPzUNM/VU9/9pRxUQXECsqpdfTl9O2N7mCleDEG9cb+NXX9nAjfX6U1HKe/dhFweDFJ/dbi1931jrXJ+odT7MFHKlUfNtc6Rd4TCgqBH3khy50thuRU+cunTqaLv9tJhsAQpgHhyPcKVdOxUv4iScVgRpXklmmMqZOq62pkdSL84MOH96DQoG3DkJzii9DyoxzDtTFxRIpbHfT3Fzs46NRgDOgEe9xK5eLVNeG3QTSdsqHYhg1IHBGcPNjRo+f3VtQge/GYoTu0BOQuAJaCPxC1dbuPoUU8tprtCLJX7nK2ez7F2mcvm4G+Nf3d7H2g0PrdDDQ5sxcNkYboNlX3DkUmO3lxSWzswGcwyTBk0aDDWPoeYLKGPQT3K0Ig+MzT6LxpCTpTYGG/UAv/ryRsHtmNZ7OG/kSsO3nTrToBbSC2IK8QlFFRBcUJxVL3/a9vZpQWmDv7hziNATS4OMSa3z5SImxhj04hy8NFmVU540yLFCbXG3nwB4sqBgWh2N20Hn9m4fuTLYrJ+v8AowXwTJ43xuG+NPH3Xxo3sdvLrVwChTqAcCQ7siL593N84xzJSdhOfvN8mVrSNPyfAaUN+7va5czN+A+14GqaQWPMFxYEtWjYYPbT9PpkUGocfRjHwIRiUE16Y3SCUedmK8stXA1XaEms/xc8uLCQSRGpd1gUyjLKL1zc9dQj+R2LHPyXl/dwDdp3ePRnjj+hq++frlJ9rWtMplkiv8F9/7CO2aXwSAn782v9TmCw5uyZQPO7HtfiDraDDyTDB2H3WfShyMMXjGIM41Dgcprq3XZsqMR6MMmdK4uhbh5kZ9gtuxSO/hvBBnRF6dR1o0xpy77kGFSVQBwQXHRdTLB4CDQYpHnRibzcUp2c4ptc5zRb3w5Yd++iOCUX3UFxxSa+z1E3ii9kTlg2l1tLtWha0WiDO1wK0CFxS8db+Dv/edDyG1mWljlNrg54/70DZQ8gVHK/KKNLEbyKXS6MSZrSHPv8ZaG6TSTARbDq4jhTPYdP/sdQdQWnkyHA5TcDAYjMsTgo07NHypYcDmZoQaoUea9f0UL23W0ba8mHtHI3x8OEQqJUaZxo/vH+Pr3tbcfnfXxXE4yGZEtB53E/zn3/1wITn3SeCCgfW6j9/65evnrmY5j5NzUokQANZqHgyo1TOFtqJUHKHHi6yCA2MMkccxzBQ6owybjbAwiOolOWq+h//ZG9t443ob/9NPHk+oqC7SezgPrKIZ0XiK3Q0VqoDghcFF0ct32OsTqczZ007DrbKTXJ+YGXAg1rRBwMqD1+R7GAOMpsEj9ATiXM1d6ZwGZXU0jzPcPRwh8gQSqRAsWC0/KaTSeNiJ8fHhALd3+/jFG5QiL7cx3jsaIfB4MSE60Z/jUYYkJ0e/dt23ZRYqFSyCayvzpsZzAwo87KKSvASMXWUuAGfAKCVtiLXInxs8+IIhzjWGmUK7xqc+TynvBzYrA1BbbDP0cHO9hv1BhsNBgv1+ij/+6S5e2qqj7gmEfjlQpIzYPBGtVTp2zgIXDISC4/e++vK5G+6cxMk5yfERxuBwmOFhJ7EtqeQLobkBM2zie+KcQTCGw6HVL5HkfvrZy0387q+9hL/xhStIco0f3TueUFFdpPdwHlimGUEtsKzqMHjKqAKCCmfCXi+ZcJCb1hS4fzjC/eMYoeAY5RIcNAj5nEMIqn8GNoXsButM6cIe10G40gHGK1SABojAQ2mlk59ZOa2sjpZKjVEmsV73kUo146p3HuiOMvzscR/7gxSBEDDQVohpXOLRxuChJQ4yoJC5dfr5aa7wsBPjYJgWRFKldZG2d+9jjH5JJV3b6dl7rM1PEwaz5kJFl8Ec5Ip0LoRZPCE4/f5+kmMt8mYm5Hog0IlzvL83wOEgte2netw2xzmagcAwU9jvJbjcDOEJH5+/sobXr7bw6qXG0ozYKh07p8GTmHytilU5OYscH8vH+uA4xgd7g0KLQptZMp4jHDYDgW+8tol/90vX8PXXxuqcoSdmVFTn6T2cB07SjBhmEo1AnFpgqsLpUAUEp8BFkKu9KHB9ytOaAkmuMcoljkckmlOeVhhzamnkrubZ9LJre1JzrN2EFWopJjeL8cRBq81uTBPPk9QYM6mxO6QecaWpLHHeAUGZROfS6Z1RNsFhAMgCuDPKoYzBg+MYSa4gNa0Ec6mRawNtNOJcFdeGmjLYTFnAEf1oZUecCSdx7YIJxy1jDIV2wFxiIig4EYxMgrQVkpoHT3CkuUauDIJSG5nW1MK420sxspr11H7qzaw6+wl1P3zmShPDROGD/T46cYaaz/H6lebS52yVjp1l0Magn0g8OKb23qtrEV7ZbODjwyEOrEDOeT3vq3JyVkHoC3xmu4nXLjcwTKmscjQad4M4gmgz9JApjS9eXcP/+d/9QqFFUca0iupJfhRnwSqaEYeDDK9s1bHVrAKCp4kqIFgBF0Gu9qIhzhX2+ikedkhhjTNaOQ4zjdgatLjaJcPYGU4bWulqrWA8Dp0bxDlJ4DJghrHk0svlmjkwSTYMBEecq7np6VXBQIQmx94fZTRh11esWZpyhmSBcdAwk/hgb2AJlkFx7wjO8Kgb4wd3jqxKIJVBnHCQq+8DdI9RGxnV/nWxfydPS8IzHqNAldk2QGkMmM0GZNLYvvVSCr58LvZ85kUETkHO42SbvcwWWTAgN0QydJNNWUHRGKAWeEtbA10XSJxpvHKpcWqRp1U7dsoYpRL3jkf4aH+IYSrhCYZLjRBSG7z1oANz//yf91U4OacFYwzNyEcz8nEL869RL8nRi3N0RtncdPw8FdWbC/wozoKxbPVizQjns/H1VyvZ4qeNKiBYgosiV3vRcPdwiO/e3seD4xiXmyHqAQ3ao0zBldw9O5E7uDYozqiPWmuDNCclwlogbMqeWp1I1IY+yxgNSsNUju3nMTlXudVxL56fnl4FbuWbK4N6SAHIzY2Ta89prrDbS3DncIjuKEeSKyhDknH0WRo0pTYYZRJgDK3QQ5xTe+UoVcXqf7+fgdnAatryloHO0Rd0XaU2c9ne2gZd2gYIvrDZFStqAwCGOQljXZz7+FoywJrnTN+xxhrreHxcj1Zm3lGMt2VApaAGZhUUE+gZidppTHeBnEXkadWOHak0DgYpDocZpDJohh5+6WYbL23UUZ+TKTrP5/0kTs7TwioKgNOcjKsteubLfhRngQsGBGdLNSNOq/dQ4eyoAoIFeBo2vudNQnoecPK5u72EVs+M0uBukDcAVKawjJzPQNeKWzlVlVDaOBAMg1Sjn5DUsltVBoIh5mQdW/jIT23TCedMp6dPA2U0DKgHux4IbJfqldMciSRTeNxN8LiXYJRLwJBKnLDKfNrW4qWin2Umf5yqqUmYfnI2Zvy7c3TZFTo+QMlxH/b06+W/O6laWsHPBhdusnaBxcRqb95GMc4OlBnrJ8zn9DltFioorvL56S4Q4GwiTyf1/r91vwMGhs9faeHmRt326S++l87zeZ/m5DwrrKoAWOZk3DuOcWO9hvf3BogUP1OZzgmQRT7HGzfaCzUjnlTvocLpUAUEc/A0bHzPIld70TgL0/K5ux8cYLebwMCgVjLGKa/kl4ExUsVzSnmhxyE4TaaDVKIJCgo4pzapUaacCdzM+QrGkBmNrJSeXhVOHU0w8rZPpcYXLblpnu9CKhWOR2ToA9AqlnOAG8BwgIFW+E7ExbXzMQarFle6BiDdeWWAUT6e7DnsnMxK19JMztPL5lIO8r1XBtBq/vfhMivK0PGB26DA6hJMf0pajke58WKVCT2VCl1r/DOtoLhKMqfcBVLmdJxW5MlhumPnrfsd/PlHBzAAvvbq5nN53h0n53lhFQXAMifjLx90UPMFOqMMW83wVIZmw1QhlQrbrXCpKuV56j1UWA1VQDCFk2x8lzn0+R5JbjZCD/WATIfOspK5iJyFafncx10KUMDGLnkAxunyFQMUly1Q2iDJFQDqpTeGrF458+FZVzZyPdRWYtcUhDpX7s4UZRemuxdOglNH8znVj1+73MCN9Qgf7g9mxGByleNwSHbCgQ1giMhP90GSj7kD1JfPkWtH1pu/fzknSJh5q1keAEy9tQhEnOGN4wXMXBNWOO1S0MLt36aCAbcNziev60mXmL5HyojMU1BcJZAtd4FMY57I02nS9edp260tebMdefhof4j/9J/+FF97dQufudw4MYCX+umIKK2CsgLgKouQ3/7ydbx+pYl/8s5j/PDeER52YlxqhjP22w7alqfijEpj9cDDF66tLfWteNp6DxXmowoISlhm43uSQ58brBkYfMHQijzc2CDJ4NAXK61kLipnwcnnHg8zXF+v4VE3wV8+6NA1MLrgBwjG5nYKnAQXFOTSQMMAmhWGOqNMohX5RTpVaQMJAOnsikZpg8NBhlGqJroXTkppOnW0QSbhexzX2hHeetCd8V3Y6yfY6cTQBgi9sW48ME7RG9DqHLAr7zl8gDKm/+4+q0tvYKz07xUxHRQANOELPjnxlDkZjqjIyi+447FdCvN0IZZBasoYrYXeZJeIPSb/FOnmfDpyKo6BgoL3dnr47u19/OYXr660vbPadk9j0dgwyqg19NVLDdQDsTSA9/g40H/WMMYgUxp/+sHBqRYhf+sXr+EL19fw7R8/xNEwQ2hLhsDUmMgYfE4Oo+UxcdnxPE29hwqLUQUEFotsfFd16HNw0XA3znE47KAeeIVT2LKVzEXmLPyz9x7hu7f3oYzB3cMRjocZ+qkEQCQ8ZVRJH4BWyIzxorVtFTDQ5JBKDQUDz9AgmVnvAtdf7wIPYNaEB7CkO8GQSoXdHnUvtGs+1q2t6zScOppndRHWawa3dwczvgtHwxQ7nRjGBgPlLSltCtMXsp1lxbaXBQPLLgabWNmfdgOYSPi7wVnbF8oUi6IHxIy5B5yNAxNg3MHgC+pYcNsHsLDlEKBgiHwpxIyCosuqrap8R8e2+EKEvsBazcN3bu/ja69unZgpO4tt9zROGhuMMTgaZsiVxme32wDYwgB+nnb/s4BU5IXw/333MSKfn2kR8ltfvo73dno4HGZoRx4MWMFJcVnTpm0tPakr4VnoPVRYjCogsPje+/t492EX22sh9vsphqlEJybVr35C9e1W5CH0xNJ0NGfkcx5aT/NRqiZc3OatZC4KZ2EaSa7wz957jL/7Lz/EKJNohh58j0OBhGU8ztBNcsBYchIAY0haOJOadNM5mztxzwNjgOCA1LSa5dxp46tiRS48jprvIc4kpJpkvNM27D65gDGwDokp4kxiqznrkNiLySjpWjvCzfU6/rsf3Ucj9CbUFUcZae/rOcGANuNgwJH1imPB6YMBDRtUnOGzM7BRQXlbhRBRiUBY1nlgZjIAccRD192gtC62Q9/X4m82kcZes9n7WVphG39FJUiDky13t1sRPtgb4N2H3aV2xMDpbLvnYRX3TrLY9guL7dcuNxcG8J+/0rItos+OWNgZZfjp4z4edhNcaoZnXoS8db+LG+tUDnnYSU6t9wBM+lG8cX3tE0PCftFQBQQA7h+P8N/84D4edWPcOxpRvStX6MV5YQebK41BKgujllXS0ZwxNCMPkeITLm7llcydg+G51TCB5ezr05AUHxyP8Edv7eC77+9jlElcbUfwOEc3ziGtGyFpolPPPjfjtkIOA2ZToLky0GbSmnUZyFFPIVMGulQylpaNR6YuDCLyEVszl/LENE1YCzwOT1NLY9qJC4dE5w9wPMrxV17bxO985Sb+2zfvgzNWnBtAqfKdTozccgbKp2AwWSaY9Qg4xRdX3q5ZjZR54nYwux3qKBgTAwvS49SxamPJjpr8D+qBh1zr0us0cS2apI2hgJJsrGdf0wZYW8Hfogz/hO4R56Pw/TuH+MZri3vWT2PbPQ+nce8ki22Ojw+HuFGy2J4O4D/YHyDNFYaZxFr09Nn07hz6icR6RCXM0wYi5XO4ezRCK/LwlZfXce9otJLewzI/iooz8HzwqQ4IXM3+v/nBfbz7sIt2zaN+YwZ04hyBNQcpO+8pY0rpaIb1WoD2gnS0gyc4Nhs+unGOdx528Mb1Ng4GGf74p7v4wd2jJ65hTmOafe1xoBvLleuDnDPs98m8RmvSmPeste20G6Ej++WKtNAZg12SmkJzQGkDbRQCwRcOOu7aKm1mSHYAkGsDwWBbCzUEZwg9Dk8Qiz23QkBuW+VLyTnZvia5wqNujGbqweMMuTL4q69t4f/yt76Af/iD+0gyjatrIXqJhBuTj0YZ+gmJ00wfurT+ANPKgO4YzloSdhP5uWQJgIkSBGAn+1KWwJUNinZHBpsJIOfERujBEwzajJ8DY1f+i25ZKh0RgWz62mSKfBhWNapxXSCN4OThaqsZYKcT43CwuK9+VYngeVjVvdMFw7nSyKXGQSLxg4+PcLkVFkJVjnz8ue0mPj4cFu27v/LyxqmP66znEHgM6/XVBbjmobwI+WBvgN/68g0wYGWH1nl+FBWeDz61AYGr2b+308WjboK1mo+NRkBKav3UtkhN+rkzRoI75XT0/iDFaEE6ugyXPuzGOX76qIdLzRD/7Zv3sV4L8PrVJ88MzNvfjXaEv7hzhP/kf3gX22sR6v7J9cGPD4Z4+0EHUmu0awH6SY6tpjPXme9GWA889JO8qPFPHseYJZ4pjQCTQYEBrf6lNuOBApOrW/e7Y/UbyycYpqR3EHokbJRKDWNIRXEujKH2vlTi5a0GXr3UwN/+65/Dj+93KH18qY56KPD2A1Jh09rgcJACmE2N0zHYNPuc725MOT0bzpteNlE2wBTHgI2zBAzjNkiPAc2SHoSTkZbagHO21PgptSWjaKoF1BnubDSDlfvXXRfIKnX2k4R2nkQieBX3TqnI0KkXk2mQE27KpMZHB0N0RhnAWMGZaUUebm7UcW0twsEgw0cH5LuweUaJ3pMUM7UB3t/rE9Ez8nA8ylcS4DoJ5UXI//jODv633/wMvvHa6xfKobXCyfhUBgTlmv12K8S9oxEaoSgmAKnNRNp4Hpaloxd/hoKCo2GOe0dDxLnG575w/sEAMK5xHg/J2/zmeg2vXFpekxskOT4+HFq98hBHwwwdK597qcnsSn/SjRCgkkoj9DBIJbHRbQBQJrWhFBSETBTs99yussuTkkOZIe+2Q3X6ScXDOFNgDGhFPq6vR5A2cHEiP46IGHgcHgd2eykyqfF7v/Yy1uvBRPr4cjOELzgOBylSqTFIFRhIYAhsXBpwOv7zxjGXln8SzEv3n2kbZn5woa3ugNtH+Vob0DWr+WJC04EzKhFkWqPuiRmBIifGRCU3DaO1DQzo+nNGJNFGILBeX30l6LpAaiusYk8S2jmrRPBJ7p1ak+peJ86QK7ovPMERMF6MFUoZtCL6bCoV4lyhc5ThzsEQkS9wqekjlwY/+PgIf/0LV07VgZFaKfEHRafD2CjKBYPaGHRHxJlphh7SXKMRTgpwPQnmtYBeJIfWCifjUxcQTPcd7/VT5MqgGZHJzDBTiLzlwUAZLh2dSoXdfgLg5KCgEXLcOSATHXnWQvMSlGucm40Aca5w73iEl5Y4vkml8fPdPpJcFTr7HicJ4VGmsNOJSWIY81fEgcfRhIdhKsltz9AqeZyWBsBIbdCl/HOlrXofs2lqM1E/d8p+AA1oyhiIslkS7KrVkD5/KhVyadCMPDTmjHFOHW29HqAV+eiMsiJ9/NJGHfePRnhwPMIgyXE0yidKAlpNNv6Nv7X5EcFz6iCbwaJ2RQ3ATL04DrYWE/jc5O6siLU2yKxYk9KUVXHdDMagEG8ytiThcYaNegCtDfgKhELXBXJjo34q3fxFQjtnlQi+ezTCXj/F+pzMQNmfwbPjwUymDEAiqQ3RBU/FLWKATp7jaJgBMDiOc2TvPsKXX9rA9gktelJp3Dsa4ePD4Xj/C4yijoYpNIAoEEikRjeRAAI87MS4tVWHWCYvuiLO2gJa4WLgUxUQzOs7HmYSBsZG+NQ6NN0idRIYo7R1KhX2+gk8UVtaPkilKUoOi0xFzop5Nc4GZzgaZtjrp3hpc76b2L05A56yPICaT+2Ax8NsaeM5CZP4GKY54twUqcpypsDp+ks70RbmRyXJXpfS5gz2Oo4Ff+bV7B3xU2uD+8ejohvEkQ0FZ1BWxnd7jdTR4lzhX/58D5FPPgwPO3ExoG41ycjmYJDRMXM2Ub4wtp0Q9vfyedB7nqxc4PC0Y4ry9hnoGoYeL76fiW4DQ1yNyBMwniHNCKORSAXtSieglksfVpBJkVcFlYVsyU1wHFvnvWXtoA7DVKEeeKeyvS0L7UzjLBLBaa5w93CEyJslEU/7M0yPHcaQ4FYqx90ojdBDwGY7lbT1u5BK42EnhtIGazUfr2w15k7YZRvtRZ0ODi4YJgEuIu5u1H3UAw8/edTDwSDF56+00F5iNLUqXAvov/r5Pl691ECc6wuhtFrhZHxqAoJFfcdO7GSYKdszfUa3PBsUxDk51V1br819OB0xzxcMqaRJ5/Wzn9YEFtU4nWPgA2sQMz0QpbnCx4fDmQFvTDKjiSLJFXKpIX1RmA9NwxMMa7UABhmSXEMpA84tcY1Nb7eczhyvZl0de0zks5a9ViVPagMGU2QVpG3VImKiRpK7NkVWlA18wXGpSZmBfiKRSo2fPe5RTRdEbmqW2kpbkY8Dyx8osxSn+Q2wx260GVsKn/aLe4pwZZbyMbnf3TftUtoMsOluBhiDVGlEmhcpbsYYrqxFGKY5HndTGNA5e4IV/AwGmvCkNsgVXToX/Dl/ilXaQQGaxFKp8AUrI70qjDEL+QlnkQje7RNPaLMxOVku8mcoH/8oU0UJgYPuQ2/B5Mc5QyP0AZAK6ihTaCyYsOfZaC+DG98ijyOVFPhestddKo39fop+IvHG9Tautp9sgZLmClmu8cOdY9w7GqJphcWAxSJHFanwYuBTExAs6jtWljI9zZ4/CxgDIo9jmCl0Rzk2GrPRtiPm+R6Z8RwO0/mSsqfEvBrnBNNZaTw4JgOXeuBNyCwf2XTn9IBXPiTGqHUwU6pQD1x0yIzBBiTSEv1ozWz0WEoXsCQ2Ozg43X9hgwdtzIR8LmMkAx15HJnSRJiyfe7jwMIUaokkkcrR9D3UfAGpSSRmt3dQaBUM0hxKA81QoJ8a9EttpS67UKR2y99RKaBx/zaGLIYFx4WKCIpsCzARkLk5iYHMo9wkxc3Ys8DjDKNcQWuDyCcSGAwwKFQibTbNUGcIx3jSV9a5UmoSNKoH3oSD5Un8G3LCk9huhbi1NT+rtQyLOhhOKxGsjcHD4xFlDkufS3LKBs7zZwCIRDhMJTQAjzveycmlJNfVkVtBrmboYaPuT0zYAEpZwODE83GLEAbq8GCMvBxcEEZdUEHRBQWsnykomC5fJDnZif/izfW5fIhPizvsi4RPRUCwrO9Y2BXnNHv+rOB2JduJM7Qib2ab1B5HxDzOGZKcVhGNJ1QqK9c43YPWT3KkuS7scHOlcedgWBDFnMxy1wZD03XdaRU6zmnFniuDOJMIfTHh5OcCG1dnjjwOpTQM5+Cwznp2teS4Am6gyJUuyIIA5k6qjFkhINtNIBgNtjXb2lYEVnaCaoV0/XuWZMUZ6RikOWlKuImxZvuky22lSW7JjvZYNBu36s0cmgtISp0HFw0aRDAsHxplwyiAKpdiyHBKQ2qNmifgBQKhz9FPcgwSWmGv1Tz04xy5NDZYtLVzziiTZNPjtUDMXT0Di/k3zhY38jlev9JaqHc/D8pO+IvKcKeVCB5lNKmVCY2T5OP5wYDLRHhTi4xV7g1HkO0nOfpJDs4Y2jUPw0zhh3ePoI0pFDhXCW5yRWULajPk2F6LZjo2yl1Q7+10UfP5qcoH88oXudJIc00LoDlj66fBHfZFw6ciIFjWd+x7i9nzZ0UgOOJcYZgptGuTD0Jm2b+MsWJiHE65uJ0WrsYZCI5ekqMbjydAYjpTqn2UEXPcZS6ckuIgkWAMyFSMds3Dep1qkS5wKDP1AUBrjX5qEOd6Mofu3mj/zex5Km0KPQLOXRuiXdG7AbrENShS2lOxgdYGfbvyZAzgnE+0xZUxyhT2Bqk1OuLFwC1txoQ6GigYTHIKyBgbt5WS2dKYy8DgshiLJxMbizxxh8F5wSUrptsNAVJcbNcCED+DatxkhUzLWG3Jno3Iw195bQvHoxw/vndsrx2z97GTqKUyQ64NhKHS2UY9wNEwg2+zLYswzb8RPEIqiXT6xo32Qie8RRhmEo1ALOQcnFYieJjKgnTs0I3zEvl48v3SZq8AClinJ+xVhxgSWRIFsbebSPiC4WiYIlfASxs1jDK1sJvGtwZfBqSpkkqN9ZqHS61oIb9p3AVFHUq/emtjJaLhovLFIpfKRed73kqrFU6PT3xAcFLfcSPwxla15xQQMEb/78U51qY81Z35j7H7E4IVA8hZsdtP0Y0zKG1KTOf5nRKqtDpy7H4haDXviHRxprBl2++ErcML0Cpe2py/MQaGAz5jJWfD8f6MTbU7cbtc0yQj3NsYsdyNGbPSWSkCYKXB1GUfknwsmys4K9LT08gk8QikMoi8ycBmlElLQuTQmlz4Bqmyynu8yDLkyhQxjgaKEkKZIe5cAsvLbhcUXASUORnTh8QZK+k1MHgC404PMAQedQOkUuOHd48L6eAt2x/vRLm0MdjtpZBGY70WoOaP5YhHmbL16uXpXxcUDDOJB8cxrrYj/OLNdVw9A9n2cJDhla16cZzT2F6LiiB1FSKbIx27zJVUGp04m0s+dhoAGrOZAXf9l3k/lOHGEN+jgOCVrQZ+8qiHYaahtMZHBwMKSOZM2MaW2xgjUq7gZLZ2fYVOjXlyy8swSWKeLF8sc6lchLO4w1Y4P3ziA4KT+o7dyvB8eOFj+IJbVT1SA3Nw6Upn7uIxhuwJWg+1Mfj54x66oxycs7lM5zKmJ6tMWlMezhBwNlHXvdwiS9NRJm1/+XiS5Nxua8EAwxgxALigurRLv2vLIHSH6IKB8qSq7QDsNi21tsRBFAJF5Zr09Pm4dK3glJGJDGUHKJVN26FSB31GaYNBquBxXQyYypLkDOj4XXeB4xc4yWK447/g8Oy1k7akUQ84OOOFCQ0FhQI1n77veuDhtctNxJnC+7t9MM7wlZfX0a4HM0Y1nVGG27t97PVTcMbgCXptreZjt6dmlCOn4bguLnC5shadKRhQtvT39VdnZYudbPfhgILndx52EHhioW25w7TD4tCSBGtzVtnu/nKcgclzHAeVp4EvOOKMuEZUPqDAWWkg10AwZwE/HYgsM4Wah0Vyy9PoriDUBCx2qVyEaaXVRe6wFc4fn/iA4KS+43ogEHocveR8R3XBGDJDZL7yKrboblAakScgBDv1A1vG3cMRHh7HYEuyAmVMv6ym9s35uM1wr58SsSxTNNBzgDGOzDaw61Kqcjlocncp7LLEsCnS1KCsAehNjrkujSnq1MLWnKMFNWmpzDhdyxmMGZeDmKEBWxsDJcfHTkc3jkfcYM61zeaY8TEZAGmuEXjM1tvteRT/KV/Xk67J00VBIrTHPeG6aGj1PlYCNoAizYAuo/vxxkYdN9bpmblzOADAcGurMXdyWK8H+MrLG4Xz39GQVtCBICGo6WcAsK2bhlbc2tDEd7kVQnCOg0GGNFfFvrQpqe9lErk0RUBdnsy7cYZLzQBfKongdOMc7z7sFjK6g1Rht5dilCo0QlES75lvW17YQWNMzit/9w5aG6Ryvoy1O4dl3g+LkNtOhb1eAsaA9bpPmgY5lR43G0HhBMktL8mVyVzJ4OFxjH4i8agTn6io6tAIvaWtyvN0S+bBHdtpMU/kqCIaPn188gOCE/qOXRp0r5+uOLmtBredTOoJkRyXdgbI3MXVZM+CzijDew+7UMag5YmVSh7TKct5z6prMxymCv1cATCWD8Ah4FQCx0TCky6a0xhwjHSNcqeBKeruutSCoLSBZqQfQCQrMddGt3we43KA7U+wZQmX3UhtNoQx4gUYhqKHnpT6xqx4x/FwE7tbvWqgyOhMGBqVDssA0Oq8c06nRClYmT4Oj9M3Op1NMqWg6cFxjG6coxF4dI04laZeXqBj4QmOz1xu4uZ6Dbv9FA+tYp4nhHWUnJS1ZqD7KPIFWtHYKEwb2w3ST3GlFU5si7Iypvh8eTKn78rgt3/5OoCxT8l3bu/jYJBO2PrWA5Kn3ij17S+yLS/nDudJdztkVsRqTgXLZpeWez/Mg1QGHdsdIG2nhzveyOeIc12QCxeBgYido0ytrKgKnNyqPE+3ZB5cqeksqESOnj0+8QHBKn3Hl5sBblvlvHk16SfB9Ao8EBzKGESCenA7sV6qCb8Irs1wmK8mpuQOY/r8Fj2rSgOZpHqoYOOWKUp7Aq78rGF5AUswWcum/xqXFCiz8u3fbHIAxmhoEAFueTBA5MhUUnAlrQIi1cRRtEBpg8l0bum7cV0KSgMed90SDIzZTALDuOOgFCTM++ocf+J5oTjOBa8Tf4IUBqOJgICO+0orQrvuY5hK/PxxH5wDa5GPh3ZyWDbAh77Ay5t13NyoYZhK7PdTvPOgg06cw+O8EHoK7Hdalkd2xlWjVOLPPtiHL8g4y+NEbmyGwpZspssB1EdfCwTe2enh7/zRuwXnZKMRzNj6brdC1ANRZAlca66b1LU2OB5m2O8nhVCTsQGDMgYBm812ZFIXJNppEJl2uffDNDJJGgyhx0lZMFcTMtkuYO0nszylaTgPitMoqgKUPe0ncqYLapFuySKc5FK5DE7kyLnDVjoFTxef+IBglb7jdj1APfSQZGdTKlyG6RU41eANmmFQqNudpcPAtRlGHrXRnYQixTr1AM8jObnVtgFDIFwrHbHQPcHsSk6XDIlOuF7lVb+Z+BPAaEVuNOkU+MKSAA0p49HnNLpJjsibLBfQpKaR5EQiBIh/UL7k2gAyU+NGCHuCE5LK40OBgYEyDB6jFjVtOyRcgMHKaXgDMDvYj68dBRXlFezzwKI7gsGpPTJkdsJxRMhEks+Ac+90K1qpqA3QgMoKJ92vaa4mVvbUjUCmUz7ngKZsjWthLMdnUhukuYI0BpEVicoY6SHMsx43xqCfkC7GV29tYJAq/OjeEQaZwq2NOq6tRzPZwdAXuLFew9sPujgckk+FnhPEGWPQGeW240Sh5ouiw2XiWhtn+DR7LYwNpGv+cm5PGVIZaosFkQLdNtwxOcVOpamEQaUTMv4qlwvcPR4IZ9ttTqWo6guOQSJnuqD2+vN1S6ZxGpfKZdhuRfhgb4B3H3bx65+99ETbqrAcn/iAYJW+40boYb3moWMMEqkX9k2fBeXtEAuZJFs94aRd+akDgrKU6kJnvyk4zoI/tUqZbi0EyuQoq7zHiHkOO9kJTvVWaVdTRiwPCZwOggNjxNB3k1a5bcoFLFJTjdQNbtp2UJCapIDUGqk0BUfAER3Lq1dXpy6jcCg0rgwyfq/LEkhNVsvCZQmK8sjsuUkDCG1KQYo9R3cMS67L08KyfQo7wXNOgQ9Lc3DGoTS1+q3V/OLYXYtsPRRIc4XDYYa7hyP8wrXW3Jo+DNCJUxwPqUQQehz1kBQgm6FXqPq5WnCcScRSQSkAzJaitC7aP+uBmLg/p63H2zUfDKSb8KXrbQwzhbcfHENpg1YgcO9ohJ1OjJc267i8FqIReIg8jv1BigfHcaGX0Ag8BHxWShgAAqFxPMrRi3MMXTeKLXW4t7u22ulPG1Cg4Au2Ut3enecoI5Mwp86ZKRL3yqzAmNRjsSxlyKKbW+6He448wdEMqBzjMgTKZshWUVQFxgZi5S4oYwwezBFqmofTuFQug7AZpe/fOcQ3XpsljFY4P3ziA4JVbsZ6ILAW+UitGA2l6s4nKHArcCe2Ugs8fGY7wof7QwxTiY16cGov8rKUaiJPDgjcZLY2p95Xbi30GE28idQTxCnOiJ0eeqJIqwo+Vrdz/553uZxqoMGkWl75V7eidgGIa82kfdjUPGfghmx149yRHBl1DKg5wQAm6//AuCXQlSsAm/K3nAiGcQbH2Lq04AxaLi8BkOJiuaY9ub95eB4Bg7M1BuiagxlLTqN0d+QL7PVSdP0crcgvxIWo1u8hjXO8/aCDvV5iJ6dxTV8qjZ6VhBaMVqW5LfMIxmx6OsJePykMsKTNVHg+g7IpewM7KDFT7H9G+ApE7nyQxGiGHn7l5XUcjVL8+F6n0DBwGGYavZ0u2scBBCfvEqkN2pGPa+0I+/0UUmuIBa2RniAjp0xSux/AisDUdbq4YIjxqfvPdtPUA2/lscQF48xmqOhcqdyV5DTBcsvO1YxBKxL+4aVxBvb6DFOJ/UEGnwgbyKRBMxRFN9IyRdUyyl1Q84SaFuE0LpUnYasZYKcT43Aw39a6wvngEx8QrNJ3zBnDjY06DocZLjVD7A/SJw4KyjV7FwwITiuZ9bqPnU6C41GGX7xxOi/yaSnVVaLlzJrMzJNzdSl61y+eKVr1l1v63CpZG4OGJShJO2iFHmmhy1JGwUHpsaELK/5jrw/c5EsTZ+RxSAPkdkAPfXJkK5+dsxzWdnKggITBGI3pcETrsXNiOX1fTk87wp1gxrLwTWlf47TsKpO2mfrdoKRTcAEwr4Thrr9v7at9waAssXCUKXv+Tv9ek0HOKIPSGjc26mhG5BcxSCX2YrLJbtt69uRqnhdGRuvKx8NOjEzSypnbDF5usyzMUNZFa0CnckalkMo3xmpRkJ/An314WJxfI/CoPbWYIClFPkilvYcpwO0lOeKczJpGuVz4vDNGtf9M0jGRJgEQZ2TtHPnCft9udc6KYACg7OMi349puGCcAkkGwTkGqSQzNFDwKgQ5pLpynYHLCLgnYDZDlhvASG1LG7ro1FmmqFq+R8pdAiTUpE/kH5zVpXIRGoGHx90Eu/0qIHiaOF8G3QXEditEIxAnimNcaYWoB2QZeqUVFcIt+oyyc65mzxlIsU1w/NKNdVxpRwh9gXbNKyRJT4PpCN2l2BetRLWd1NZrwdyHnjFKE2tDDzGZ2MymPzmH5RBwtCLfpvFpcG1GXlFCcBOoNiiCgZmYxa2m7UDmcUadB7YbpBX5tiNhPLCXgwuXvXDZimkaw0x6/4TxSNugxJUwjEHh/wCM9Q/mYdmml9055oTXnwYcB4IxFN+Ru96OrOdxSm/XfG7vB4PDYVbUtEOP02rVtqIOUondXgJtTFEnd6vbyJIGjSENgI8PhjgYZIg8URDhckUTqyOtajMmbbryjidYkfZmoHR4LRAQnENaQukgVUUmaVoqmIFhlEkkUqMeCtRDDzWfAvVBJsEZGS5NP+9aj1UclabuGA0S2XLlgEEqMcqoAyJV1jvEBrKLVDQXwQXjAH0/qVSk/lh6Hh3xEjATDpvz7kP3ffrcBcIGUms7huSFDPkiq2h3HOUJfWjvg5Mm+bO4VC6DUzTd6yXnsr0K8/GJDwguNUNcX6/haJAtfV/oC9zaqiORCpHPcX29hob1DU+tdv5pkNsWt2GqcLkV4qu3NnDFGoakuUIj8PGrL2/gcS89keNQhpNSdYFAUEr5T2OaKLYIjYC4Ba5kMu9hdyswZbMHtcBD5BORyR1PaEeeXBExbLxCd6s1jJX/gIk6pDbAes1D4IlC0tmNctpMZhq4re0bu+IBJgfEafvhmbOxLwpWkke2M7Q2lFZXmvbj/n/WoOAioSiXlDIngVXCm4ZLzbvUvpuohODFynKY5EVbbziH/U/bsfvg5JkxSiVpXQQC7chDIHgRDKjSvQG4SZFS4q6Pv2Enc+kY/y6FDhIN6sY5ZCnFLRXxdtw95Qi4zBIUSaGT/uZzhsSqXI5SiV4iiTcw1U5ozLgtjzPLGzHjoNXpKkzzdU76bohEa4Nq+zw7xUMXgLjnk7Nxa+38Yt3kd+lz933Slc2VwSCRBTFx2RhU7o5wz+EyOJfKW1v1U7lUroJlwUuFJ8cnPiAQnOHrr24hlapI4y3Cra06tlshurFE6HFca9dwqRkW2YIkVzM+8WU4lnScUQtcK/Lwxetr+NVbG4VRiDEGd49G+MWbbfzv/vpnsV73cfdotHJQMC2l6lL+0/7vboDxOOksLIvoPcGxXgus8dL8VkRml5Uu8FBaoxWRgtgV65zmc47Api7Lg7zjEJRr7I4w5dLVNV/gUitCM6QgTGsNGNfuVUr/l7oDOGM2jVs6b0x6Ccw7F5dm5ZwVE5+DWvDZRUHBVHJiKdwk/DxQvv6Cj/kai267zAbCzAVNzE1IGoFV4XzcJ4OfRcGAsZNkatUjXcmnF+foJxKZrX/DpvE9TsfGXSaAWR6JYFiLPKxFPjijLJmxr2u7H5cyJ4e9vDDAKktVcwZ7b41P2glxMUb3TWRtvgeZgrSeF0Iw+N7Y8tuVCMrQoOP27fGmUqOfyKIF1qkoxrYcM0zpZ5yrYtUvlS6uEXEv6H4vd0C4DMzEF7vCTeVKHy4rwOwZOFfGfI6SlrbE2zLpWZsTsmLmyVwqTzqH6XGuwvniE88hAIAv3WgTN6CfLrX19Di5q/WTY3TjHO2aj81GgLWInMZ6MQ00TqlvHgSjuuh2K8S/+fltrJX6Zl0wsF73Czev3/3qy/iD79/F3aMRbm2ezCeYlgF1Kf+yRKwLBhhj2F5iZlJGu+7jcJgiyeX85noAttGgSO2u1XxbH+ZYi7zCVW2nExdtT67O6QZE54zXCL0iQ8DsIC+1wVYzRNqJEduFgLRdBPMU4JidqMoaCZgqFxTlCuO+A/opSoEAYwzM1lsnxloz2bLKGQPjJZKb/fuqQ9QzLxEse40B0LMTGzBWfHQBDGPUFgrQir3m0wSW5JqU86a+F6dx4IJwqU0hMGUAGG0w0LLQiWBwqX3LbLcRZeDxgtDqCIZl4yDYCcJ91gWimdKQlrPjOCmuk0HbEkWZ6OaEuAapRD+lgKcZkgaC0qbIOJTPUmrinriASZuxsRCAoisgG+mi3XBZzK9t4OuIrC4z4Foa3Xc2fX+Crb6q45wjgEYiibMRCkCBFjuDVGLTmyQXzuuCspW8uXgSl8pVYIw5F0faCovxqQgI2jUfv/H6Zfzhjx5ioz5rgVzGej3AG9fbeOdhpwgKvKlJz7X/uPo1Y64Vj0MwKhN88fra3GAgFBy/99WXC21uZ9zxrTfv4f29AW5tLk+zlaVUHSjlzwsRl0TSz1UUyRw4o0m6b9OIc7sG7Io9cwPF1KAaeDS4cM7Q8CeZ1UobHI+IeLYW+XPT1FqTGtv2WoR7h0NIZWDYOMVdjKjFBDA+RuoLYDMT3MQ7XDBQ1FTdKyjUE7kNKjgfE9gmMhPMCjXpyQDiNJM9B4m1MNBKctXPctBxabvcd6taYDxQF5doQTRgbDkE3E1ybOb18qpaGVXsy5Ekh5ZwOD3BGUMrdLcKdxOYMWaiC8SR3cqLPZfpYXaSZXZCpAmXuiEyZSaMgxy5FIb0J9x3qDSgGAUlDBSAMJgieOynFIwEYqwNkNv6v9aA4aYQTdLGTJBLRa4Q58QR8AUr3AATq53g2xW71BRYGZuyCgQvEf9mr5u7D7T9j2SskH02ZmmMfipSsuAcodBIFV2fwGNQEjgapli3+hMOo4zcC8tdUMGCCblMnD6LS6UzhhqmpHvgSi/cfk+N0LPBaBUQPE18KgICAPjm65fxs8d9/ORRD5/bbi59iCiLsI73dro4GuZo14iF6ya9RUQhY0h2dXttMl2W5qrIDPzeV1/GL0+5d335pXVs1H18++0dvLfTw1rNw3ZrVlAFoMloegLxBAUru70EnDO0Qm9lzfKJ7XBOXQNazw8KSgS/jeYsSXGR1rsj6YW242JRY4Q2hmrDdt/KTMQApQ3O/ELyumJyYnbH4bZhYFUQgYnyUbnM4AI8n7NiciEG+TgQc74KcMepZ/UOFoGBJnV3ZTkfT4zzgguXPqf92nY+W2PmbuVuVgsG3GtFUIBZwmdZgwJ24nWTrms1JU4NkWbdd+Vq9W6V6yY/V2KbEOUpZRyK4y2fg5kM2lyqn2mGsCS4o7UuiIflpJ3B2DejKA3BBiaYNLMKPTqnYUopqUAwSE3XoRaQ+VH5OYw8Dm0yZJI6Fjz7xXFOMtu5HpcIXGADwLY2zpZWXJmx+K7t902kVhTdFB6ngN+U7gd3XU8RDwDAhLAYCbeRlXlnlBdiQy4QurkxmbVshF7ReVB2gOzGEpHP8caN9qmMqdJcYa+f4kEhTz0OkO1tUZxsIjX++Ke7qAcevnSjXakWPgV8agKC0BP4rV++jp1uvFJ6/mo7QuTzwsUt9AQa4aQTWhnjdJnA56+0IDiH0gZ7/QS9WOKN62tFmWAebm018B//tdcK/fUP9gYIPY7NZmBbqWi/ZRlQp78+yqhP2fU7X2tH4GdI1zE7kEe+h2EqZ1sJDTGsN2oe1ueQFOdpvbtWKo8z3NiI0Lde8tPiTyQ/LDFIqccbNnAor8JnaqfjH0RGKzG0uR2kp0WR3Oq6DDP1u5tYfcHhWQGfsSojrCETCjtnNlWML0/sRFwcX0NXhggdIVNSX7sb+MdByBjus1oDOTSE4JZX4VbH47TxKpODyyywqffP06DwbP86YDkbBlA2+jHMWItj4gIYGHicj4macEqhkwGdU3+cuOhFNmH8HWg9bhWmy2sAKxusjUHmtjMdCJnx+ZW3w+yBMJsxkMogU/Q6g2Wyc8oyxblCYNX/yuCcWcv0nGSytQ2AbFCUWYOj6e9cG3o+AjEmCWptLAGRkTiU1IU/hoGBEyD1GAUtUrPi/nGlOHd8Llvi3EPtJS1KCi7b4s7GGR9xxiDtZzujDGu2BXGYStQDge2pLgFqTx2Lqg1TsrjeboV4/Upr5cyAVBr3jkb4+HA4tmwPSMRq3hgb5woslTge5fgHf/ExLjVD/Mbrl/HN1y9XpkfniE9NQADg1DX7RS5uNZuiL6dAXbrsi1fXwDjDnYMhMqlxqRngd75yY6UbN/IFfvOLV/G1V7cmHNoed5NiMuolklrAbITuC471mo+bG3WEHsc7D7voJXKpHekiuMGFard+seIb10kNIs4XkhTLWu/GjNsCG4EoMhaB4Eg78UTft7T1aKldqpZDaYZBpsBLqfGJbIHdfVkQaIIQCJq43MDo6rzAbPZiHqj320o1M5dZYCUOBXEbalYTfxrlzeoy4cC+agwQWjMfx82QU4EAfXbyGKl5RdN5Mzo5Zhafx1yUgixZipbmaVA4tTqX5aG9E5yDpNsCB6ANBX+i+JyZKEs4/snU4UwEDO73TGkE4MX2y9c+U+POn5Nuc22KCgkMjOUZUBBQvme0MqWgkp7peuARGa+cJfCFdQCl3xOpIUuln3JmgP7NwEFqjpmygZ9d3dd9sho+HuU23mHFNXHXwt1rnu3ocTHtmC9EGZtl94ArwbjvhjFm1Thpn57gGGUkOb1R85HkCm9cb8+UL0OPI/A49vspIl+gHnj4wrU13Nqqr8wZ6I4y/OxxH/sDkl7fLJlMLUJqXRVfv9qCMcB+P8Uf/ughfva4v3ShVeF0+FQFBMDpa/aLXNwGqSoi/1Eq4XscL23U0M8kNAxe2arj669unSm11a75+PXPXsI3XtvC4SDFbj/FXi/BMCO5UakM1iIPl1th4eHuJv83DPDOQzKTqQdj45Z5fIdgSvO8rGngCepPT2x3BTkFMmzUg4UlE0ciS6UqWq82msFEbTLyBbZbEXb7CREfbY+4MgYNbyxV61KSGuMVlxvMXVp5GVy3hGNqM/vH6Ql20WYYg+26YEXwVw5EpAZ8TiWQvJz+Hr+lIIhN7MsQD2SQSMSZtOnz5adTnjCN3bcjBZaNo1aN/8oTl7RBAGNsQoPCAFYARxerdrd9xyUosiSlEggZ/dD2XKtf2QtonluhKW0TsNkdRn93nQ7uQ67d0H3wpFMel0jcRD8uKbjjc62OBi5tTxyRXGkM0hyCU3uikytmzOkxULDcCAR6Shfb0JqyJzPX3QCKGwSMISwFGk5+e+J9lmzpkm2ZNV4TNlvlkBekSiK8zrse7r4rfzeebddUhhYAlxohPbeadCdczf7nj3vjshHo2qxFPgZpji9db+Oa1VVZFY+7Cd7b6SLJiZ+wCklwRuSIUQZ3o+7jJ4962OnG+N2vvlyM7RXOjk9dQACcrmbvUHZxizOFXpJjp0M+45+/0sTXXt3Erc0GttciXGmF2GqGxfaUJmGWPTuxD1KST/U46Xxvr0XYboW4VPoMQJPJ9lpEylzW453IeaQpP0+xa6PuY7sV4b2dLh51lK1bzj+nabOYsqaBZ1OMbuADAxq+oNXMMJtb5xsk1FoWet6EAc00nIztw84Io4zY7IKNAxLAkifthOrU4RhYqd48ThfrUorUlRkMxul6GvQnWx9Pgvs8DdaKrk1p9eYmmJGc7TFwk+e0mU2RwjWAgl2dalO0rE2vnKe36fgE2kxmRk4F+6Exv4LIZb4Ymx5pmw1wRDrP2k8uOr5y6yYDs0RQA6nscdsvxwUQSw5rouYPmwLXmiZGrYGcmeI6TFVq5m/TYOJ7LwdWBZG09Lpzu3QBifNCmZYr5pyhFXhIcmqpZIyhHjAkufVisL2ajuxKmRwSiQ59gahEjpvls5jiO3IZGm27HVwQU9zf88i/U3D3Xfm7yZUB19R5oA2KdP3hIMWXbrTxH/zKTSv1TO2XniURb69FqPkC/68//QhK49TBwDsPO1DaYLMRrJzBXCRyFPoCn9tu4u7RCH/w/bsAUAUFT4hPZUAArF6zL0Npg2EmcTjIkEmNV7YaS+tY3TifSP0PMzURaZd/bwQC19drJ2YVnK7C7d3+hBzzdE2uGdI5JDkFBYGYDAyMmTaL4WjXPPgeQyY1BBMTKf+2CPCVl9ex1QxLTGBTrOQDwbDbT7HbS7DdCk982D0xll4mE5TZ4yPyniFyFcY69sXgBvo7paonCXIMthbPpoyVsNpEWmbyu/JHAF4cb9lUaWa1i8m2xsntjgmIDDSgG714si3DZXjG12A8IZazCIs3MLnSdwJPqVTgTBSBU15KxxPLmwHgRebH7c+dw/R+abJmxbWX2hRZhOnrNY3pdlBuDCQmiZdu+8UJTZ3f1J+mLwGASS7JdHChjA0S7N+cj0auDPpJXrThEWeHFgf0vYyDRkc8nbwLHM9AT2g3uOCXMRQaCeWAkgJd+qw7fsFOmRGyAV1xnxoXkGprHCYLXsJvfuEq/p03ri7d5r/1+e2VurYcuqMM7+10obQ5VTnTiRx94dra3P0wxnBrs467RyN868172Kj7VfngCfCpDQiA1Wr28ybuk8oBSa6KQONgQITErWaAq+3a0kDj7uEIt3f7JxJmpnUVFtXktKY6aCfOrCEQlUCEXf0TWUkU9eH9fgbGqF6nNPWBb9qshSc4rqxRenCRO2OmNA4G6YkPu9YGh4MUBsBa5KGfSnDG0I9lQZTKFbng0WqMPsOLGdpmCGzQQLLJ2qoLTq4CHSlx1UCgDIPxJAwbFAhDdVyxZEU/3dZYnLcxxcTmJnDKgjhuwMnHw9yEOhUAoXysCz7sDpeXJzpGKevcBnfOA8IFHEGJKxMIbs2QSihWrJMEP3c8DvTdlGbgqWtHq/E5x88msyHMjOvsrPTh02R/puGIeMVhmXEZQcMRR+lepA4FWQhrpVKhYUtzmaLJVVgZb+ea6QIvmuSdtsa4ldBqcNE52ayYVJPtxQVhEGSlzIBif2UCIyY+4/gHy69Nrg0+PhzBFwyt0Medg0HRcr0Ip+nakkrj57t9JJYHsGowsKrIkQsK3t8b4Ntv7+D3v/laRTQ8Iz7VAYHDspr9dLpsuhwwjbuHQ/zRWzv4yaMe2jUfn91unWhAJDjV5dYiH0qbEwkzZV2FTGq8v9efW5PjnGGjEaC1srCSQW7bqSLrGQ8AnTjHZ7abJ64EFvUoT6MTZ0WatZfYnneP+AKyxHnQZpxO1XC8gLFIkS+IIAUG5GpyMpleJZ52snCTNdVex5MxlXqon1uV5JSLlRvm67ybUjAw/RmGeQoK8+FW+O6YfM4KDoObzGZ2X5oQ3FdEpDK6dsYK/0hdaq0EJsok9FlS4Su73xkDyAV5ezP1U03/oQSXHp/ZxtRkNkHWs1fxvLTryofnriXX4/IZgwtWafLvJzlGVkpX2dW1MoCxRFxtV+GsEDBiNohjhXpnrjQy61haD0Tp2o7PupxVcl+H4AwhG4snuayJu6+cTsaqYKDWxn6a4x/+4B7e2enhd796E3/jC1fmTq6n6dq6dzTCXj/F+ikyA6cVOXJBwXs7PXz39j5+84vLMxwV5oOZFTRze70e2u02ut0u1tbWnsVxvZB4634H33rzHjqj/ESy4kkoaxfMI8ykUuH/9o9/gu/c3kMjEFivnxx5u9phbiVjneIeke+IT+ALht1egn4icb1dgzLA5VaAX3l5o5A5XSQcMsoU3t3pLmUNZ1Lho4MhkkwVq5fA40UK1U3EmaTOA+eG51bXDNQy5Xu8mLxcu2PgcdvpcObLPoFiLpxagYaCzJhc0AKMA4h5E5sT4imvAt0Kvyj5rFg2cMflVphugpr+aGE1PZUZoOOhwECQIAK1v9kJxB2TL+b73eeKlO7KKMoGC67XSueEcbDiJmMDzKxuy3VzIpudYidnAE2UJFvticmVuTthV/5ijK5PIKgzQlpdAq3HAaD7GXjEH3KT7ShTqPkc3SS3AkljHoMLJN314fZZddsqux8Cs9fsJPjcqhhaE6mata2u+R5+4/VL+A//yisL0/Bv3e/gD75/F6nSc4OCNFf40w8PoDVWFkkrd2394s31U+kaPOrGCATH//Fv/kKlU2Bxmvm7yhCcE9yDkSl9YgptFZxEmHncTdBLchs5r7avsrBSY4kJ2fX1Oj7aH+D+8QjX2hFakY83Pz5aKhziJsSuVSOcxyAephL3jka2bRLjuqkhJboyjP0fBQDEL5CaJv5cG+hcIfAEGEj0xW3rnGIBAJaXYE+uHDYXK/JSOYK052mC0oYUFt3BlAfoReuc09wt5fo+TUTjHUysckvHzKaOA3psDFW+ZpxhYTDgeunnHlNpQ2f5Dhx50B3rxHZLUAaFqNGpWi3PCPoaiceiDHUSSFuH0oZKAsa4/A7leiKf2pIdOz7JVBFAOwtmGAqkLzVDJFIVCp+RJ5DKfCY49LgrX2LMXWHjANmz3JZsTnC4DKTXYX0ecg3OgcATiARHP8nwj/9yBx/sDfC//xuv4yu3NmY+f1LX1l4/xShTheDRSXgSkSMA2G5F+GBvgHcfdvHrn710qs9WqAKCc8FH+wP8V392B91Rhlbk4/buoLA/9j0SMnHtgafxBl9EmElyhW+/vQOlDb7+2ibefdgtan7LAhGXIVgmvRwIDo/DthZJ7PZTaGMQeGKpcIg2ZPt6OMiw26UMQ7vmk4CRAR73Euz1kmJCcSz30OOzK2rQqii3bVKSU287iSZxZIpU1IgwySwLnRXmTOcJV1+ePFea2D3bMkYDMw30xaRr5vMW5m3PYfr9jv0+/Xa30nQtWNOB2bxdzD2OOcg1IDO63oE3Dgyck990kOG+x2kxpSeBwfxAzO1zuozwLKDNWJAJQNEmSSWCSWLIMJOFLLJgrFgZUyaLpJ05p3LZMBsi8oQ1YzJFKceAHESl1kXrLO2YSjxmijDigo9x3mIx3P3igkZnGGQASAkM09wSSymb+IOPj/B/+Edv4T/69Vfx21++MbPyXtS1xRnw4Hg04Wq6+PqaM4sclSE4LXi+f+cQ33ht68RybYVJVCWDJ0A3zvGju8f4e9/9EPePR+T9bl+brhH7gqEVebixUceVVniqcoIxBu/vDfDFa2v4/W++hu/e3sd/98MH2F4LIZXBg+MRCSHZtqhAcJv+pxIAkRbHHIJ5VskODGXZVepSWK/7eGnjZOMld00ed2PSwdcGoeDIlC7ElIoUO5utUU+fc2qJbm4ScEELYzSI5WpcJxWsRCBkJ08aiybOZRClyQ8AfEHcBbc9V+YsM+KXpc7dhMo5K1TrysfkzmVeCt59FpifInavm6nPFpO4/Ydjm7v3OrhJ2bctdoUokcFEmURMnXMZTzppzwuongfm3SvTbaLzsmVO9tgF3KFHNuNxTk6oNZ8Mldx334w81AMPo1TiYScuuADTrYVKG/geh29vAG2IyFz+XhZGBWYyGGQYixMZWzaq+RyhLwp1SBoziAD8jde28Fu/fH0u4XmSTJ3BGIMP9wdohAKRP7v2dEqrsTU2qwcebm3VTyVyNA+9JEc/zvF/+pu/MLc1+9OGqmTwlFG+8d/b6eFRN8blZohoQQbA3fjdOMfhsHPqG79MmPnvf/QA/7+f7uFRN8a9o1GRwuecQWYGe/20qC0L7lKMAGCKboGAzWoTONGSOLe2r1YjoRX6iHON/UGKzfqsf8E0GgGJC1GNnOFwmEFqY41gSO+dYXkw4M7Z42NFOcacgIuygkocnBmMbKmhnMk2pYFx3kRJ28dEfX1m//anG/gNxnK0zkgnt332hd6BSxyz+ZP0PGibAp93XAZ2JTp1IvOu2vS5GswqN4qSwZB7j+t5d59npX9oAKmiiMEFEuVJ0GVyTspOnBUXIRhwmMmwzMlcAK7DZMx7YQaF58MwlYX3QM3n2GyE2KgH6IyyQqmwGVJAfzQk4u3Ca1AKHsuZsWXBQDlIZqWfLvBw20hyPfU9k1tlN87x5x9RJ9Zb9zv4X3z1pQluwXTX1rf/cgfxDilZDqya50TgxBh8ztCu+WdaKC1CI/DwuJtgt59WAcEpUQUEp0S5i6Dmc2RKYasRor6gFQ+gQTj0BEKP3NNGqcJPH/VwOEhXTo0JzjBIcvzdf/khMqmwUfdRD72JFL5uGXTiDN1YIskV4lRBaefMRkprruUQGJPdZGlA4QxohMKaHNlWKqs10InzEz0dPMGxXgvwqBsXrWyAJeAxWnWG/myZYO45M4BjLEzE7UBblrQtDzCCzQ8C5k3Oy/JibvJ06zKXpVCaXPvcCsttQpnxxHoaFBNoOQDAZFAwr8Tg3hN6lJbO5LgrY95RzAsG3AkUPAh37cx431NvnUvWnA5CPolY5bzK2UAXwFLARM9AIDiEYFBKIzfEtakHHiKfCMGDVKET59hsBvAFQxQIDDNJgdmc1kJXHJBqyp75FMHARNBZ+rvLaIzjdQbNgVwqDBKJ+0cj7A9S/OXDDv72X38dv/bK5sS+XNfWKJXY7ca42q5hmEnbwWQl120ptRl6qJ2ylHoShCUi7/WSQtCtwmqoAoJToNxF8MpWHXv9FEmuVybMADQoNyMPkeLY72foJ8d443rbOizOh9MZ2Osl6MU51moeNuawAjln2GyEEJzjUScuWokAIuT1U4lRJhG4wMAeT+RTANCNM8v4J4nWgDN43KCfSHRHGV6/2kI/UQs9HRwin2qfY1McFOnpVeqJDowxcE6Kd6qkaGMMkCxonZxWBwQAZtnozj4YGNf5TSmFag8TwloiFlLJGH9GLyi+z6TzsbxcULwRpYnY/iwIknM+7AZ9V9Jxk/lJGQldmvjHxzz+xHmv7j9tcJmiibbIOUEs5wxCA6nS2OnEhUX55VaAOwcj7PVSXF+vkfkXiMchtZloLQQo8DCGiKHFd7ZiMMAwVTYo3Wvc3riOo+A6gbSmskEuNY6GGYKUYbeb4Pcfvol/+xcu4/e+9gpubtQm1FZHuULkC1x5Tqv0YTbrMVJhOaqAYEVMdxEAqxNm5sETHJsNH904xzsPOwDW5wYFZe3vZuThYJAVLUbzavqDVOJgkMITDPXAg4Gz56VWpkxqGG3QqvtYq/nwBYdgRPrTBjMuhJwz1AKOONN4cBTjxnoNkcdxMEzR71khIcYgLNPZGKAzykCzFo0yvschQJwAqQ18nEx8otq2mVz5jmOCuTOXNijMkMqg/u8xF4HZTAWzx+tY627CdGTLs06OJwYC5eO1O57gPUzt29X8DcYKewbjLgG5hFnuCjxOL6CcKShnJc6TFPhphLvlyjLE5RW7MVbYyrb31X1SAt3tJwAoKFiLaDzYbPgTLqOBxwtfCecUaWBsZmpy/wXM7H3oeCJ66m/F8drnwrXUSitYNX1fSAPInP6ajnL8ox/t4J+8u4tXLzXwq7c28O988Sq+dKNtnS7Pb+V/GjDGCrJkhdVRBQQr4O7hEN968x4ypfGy7bUdphL9RKIWnL3mxRjVz7pxjvd2uoh8PlE+mNb+HmZqglAXeJMPW5Ir7PVIZbEsjVqu1dcD0jAY5QqtyEdgvQmGmULkTXILtC0ZpJL+vz/I0IlzrNd9+LZXXWlTpEW5tYv1BMel0MPRMB2vbDiH0Bq5MZDWOnUeDCb7qomcNVsPd++d+azt354mYrHSdVCaOACudl/OAJSNe54Fyip5DuV9Oz4I4FZx1L0S+Rye4Mikoj53ZopJvazNX6wM7WSgNABuvexLO3LKfBXOhiJYm/cCbBZHA8ZoNEMf3AoLpVJhr5/AEzVcaYcYZhL7/QyR7wjBFORSa6Egx0Rri5mpqa6aOaWl4vdywDn1+jTnRpnJjop5cHoVRhtIQzoK7+8OcPdwiO/e3sevvbKJtZo/ESA9SxhjVjJOqjCJKiA4Aa7FrzPKJ/QFhin15K8qtrEILig4Gua4vdvHV25twON8rva3czYzxgqglFwHnRwwWQjzhZE51Z7HAxFjETpxZt3P3MRjrMPhOFXJGRB5tJTV2mBzLRpzFyxpcpBIIjVyhlwqhB6H4OStLpVbLRhrIDO7ktdmbKrDypO6XdqXV7HeArlfNzAbTRMn/c3MkPfmraAw599PA/Mmf7c6mx6HtTuh0oc8QYRPgNwAfYFC1XF6EmCYtVBWGmB8PIFNBw8Vzoa5j1ypFOS+yjiTRcAeegJxTi6m19ZrWK9Ru682Br6t4+eKLKnpHqG2unog0E9koYo4fRwMbMJrYzrr5LJhZbEsGFr9rwLHNeGcwTcuW6HBILDbT/Gvbu9jLfLBGHC9HaF9hhbCJ0XjCRZrn1ZUIdQJ+N771EkwrcI1tAzg8yDDUFDgYa+f4u7haEL7u6wtoGwKzoBWB2V04vIqf/kxuaBAaoPHvQSZHK/YpdLoJxKjjPqQPQ47GFEwEHkcw0yhYwWIgDFp0hO8SG8PM4XUurO1Ih++YBMEw+nWR2eb7Bz3CrthzNY/RXlZvwDGkIAQacqPU+Pcdl9Q6ny83ef1ILhzLLfzleEmEa1pIte2vpspg1Rqa11MwVGhRFjatuCsUNpjpddzfToBmxcZzyLzsXAfbPyie08qDXqJhLQBfvmZatd9NAIK9qQt4fFSGcvJS1PL7eR36DgLrAjUx8cw3Wo4w1Ex5MC5KlzZgvbLCpdRDaAZCgxTice9GLu9GD/4+AiPu8kptv5kcONk1WFwejzzDMFZrYCfB7pxju/c3ke7NuvoNT0hPyk8QWQ+FxDM0/4uP8C6NHs4da/yKv8kuIHoeJQXqw8nTawxVkYrw5jxhNqNc6xFXpGWM8agZ+VG3WSuFBESG6GHVuRDpBJ9u33KdvDChMldT5cVGNfSxyZGgUdGR9IKEy3DolVvORXq0uuO9LiIMHjeWHTk8/4+LyhS2qAXZ9bbgf5qjO1XN5OeCcB4xchgWybNifHUC4Vl8aGb/GyS6amdtws4Z/6IyXKMy9jEGYmDNUIPkS21deMcrVDA8ziu1n18uD9Arg1Cn2OUKmSahKG0IPMvradKFfahmSY2TuslTAcDDIuFqk465/F+6N5LJUk3r0Ue+kmOODfY7SUw6GART+q8McwkGoGYsUuucDKeWUDwNKyAnzbefdjFwSDFZ7dbM69NZXHPBY1Q4GCQ4uePc+u7Prlunajvl57oofVqr/mnW+caoDDdSXJVGLVQZWD27AqSk+CIc4VhptCu0T6dn4AnOHKpCx0BZYjo2Aw91EOBXNOgARha9RpdSAEzezzl/TFYDXlb8ta26L6sy2/RS2Xb4fIY6oh6FxHTh+UmFMCej101cgCwLV3OdlgbgNkb1U0eF/Q0nwiLOjKA2Tr60woMJp6WOeWo6d+VMTAS6KgckcdRCwRSpTHKKTO3VvOxXg8wzCQG6dj3gzHiE1DGyI2ZU/sund/0xH9ewUBxIqXsB23bILHlwlbkIR3kVoqYeFI1nz/18sHhIMMrW3VsNZ8sIHiRFq/nhaceEDxtK+CnBaUN/uLOIUJPzD1OZzxynuCMjGoGqcRWc/ahKR9HwRS3K3O+YBJfBlerV9pgkEgrtbp4O+7PlJoEtUBGXsFvUMYgYBxZ8X4GYdnQw1SiFXm2JZFGrHogkEhSWBOc9AYYaNR2A7cyZtxa5Qag8s9TwMnsPqtMwNNAOVPgfhrAkiStxXApWJWf0CignDlZliyat3J39fLzvCwGKGyaF2V6iufHvs/9O5W6YOTvdmOsNwJkUiPOFXKpEQoOyWjLjFGWq1wumFaYXHqcLii2z9iTGIE5fovBOAhhsJ4ITKLmCzRDjl6i0I1z+ILj57t9/OqtDTLWegpQtpPq66+eXbb4RVy8nheeakDwLKyAnxYOBikedWJszpmYgdWtfgGs6DLIyVrW1oWVHsvCOvhFen7cb19emZ8Wri7pyEeRYHODATdmiNJrxHAfdztkluE3swKxQYFjIjdCYY1YnH88LMEKAJjtMtCFSVA55ctKRX9HoDvVeGYmz+dFQ7mFcFocyf1ezoJ8UsGmfl/2fRaBJGaDAzb1tye9LxbFmeVgoLzjMunTPTTDTCHXKYaJhNLElK/5xDFoBNTBM0glZKbOdLxun5zNJ+WeBuX7rfw3Y0iZcJSpQghtmCnUM1nwpF673HyynS/AXj/BpWaAL51BkOhFXbyeJ55aQDAt4nMWSUrBGa62I2zUffzkUQ873XiuFfDTwF4/xTBTuNquzX29EXr2YTYLiYVS6ZU9BFwvf5zJYsVd7iIAKAjhACRMEZDkVkkwOAO5sUhdFoc1fxtF8FJ6KARjyIwmwRWPT5zbLOuZwYMpgpfQY0glWaN61ipWW6KhVOPUKFt8SONt4+SBfNXV5EWHm7xWWeG+wKd5IgxWFH4qvX/6d0sbmfue88RMMFDepw3sOagNVjDAaIM4I3LtditEN86R5FSXv7oWIc4lckWtu1qejhjqgiMhqF3waZ6zu1fd+GIA7PczNAIPHx8OcWO9ttKcoI3BKFNku27VDhcZx+VSoxdL/M5XZg2YpjFdDvj4cIh//fERHnUStGserrVrWKv5qAdiYcb0oixezxNPJSB41lbATwOun39RRqMRevAFR670TDSoNel+d+IMuWXaL/IQAMap8SRTSHJiHh8NsxlJT18wCMGR56rIFmTWy+As19hlCNwTPO2gVpyPvQ7lY3G/OtOb6brkNIiJbJBKg1YowCAt+3++aU5ZpMftj2NSrW1VuAHqkzBJumvySTiXJ8FpFreL7panXTlaFgxMvM+moZXtJGGgyaafSOTawOfAVj3A0SjDKFNUw4486ERCSlOQYgEU3iWL7g+DkzUGzgPu3IUlDUub1XrYGWGzGWKvn+KlzfrCz6e5wm4/xcPjkbVdd04hk4uAsnGcAfC1VzbxzdcvL9zuvHLA8TDDg+MRcmVQs5LRj7oJfEE8iJsbdWyf4LPwPBev54lzDwjmificBxZZAT8tDFK59PV6INCKPHStvr9DkiscDNLiwZ1W/psHxgDPZggEp/a8ruUFbDVDRPZGZLa8QIpn9FlHLHKpfycU5FJ3bqXtzI7Kmuja1iEFrB+9/b2oCVoik7Q9/XGuioecav7ziU2FkA4mB2NKUxJHwmkKuHp+sfrF1IdcuteU3QxPVy540YOBMl+A81ldgVU//yJfg7Ni0aR8mut3FjgFytPAPbceZwgEo84bQ3yh42EGZagziHMSBOOwz3eJ92NslmHZ+T0rCo07BKdVkGsgVcB+L8WP7x3j5kZtZn6QSuPu0Qh3D0cYZbKQSG9G8/1PtBVqetiJwRjw4DjGd2/vz6TtF5UDGGO4ezhEI/QmWrxnDekEXtlq4NZWfSn/4XksXs8T5xoQLBLxOS+4oOD9vQG+/fYOfv+brz21Ws1JspuMMdzcqONw2CnKBiTMk0BqUzy4p4F7iDmjtr9hppCW9M61IdfAjVqAONNoRtyqFupC0GfZQODS/qEn4Nv2PRhbmzekDCj12JClzFbOtYbMJssCxgAjT0LW/Al+gbN8nU44GJDcbq5QtDa6iR5YMIiy0g8zDlZOdV1P9/YLh1ISB8bY66vNyoSwF/38zxtPs/3QQYPIg6sOgeVj0jZb0I68woOEAViL/GJMoTGCjWWrDeAEuC5MWay0ImCMQbCx3PL94xF+fL+Dr7y8Uby9M8rw890+9vspIk9gsxGcqPPCgEKv5Y1rbXDOZtL2i7hsnVGGnz7qTYi/OcwzpPvJox4OBik+f6W1tFPiWS9ezxPnGhA4EZ9Xts4vMzCNshXwd2/v4ze/ePWp7MfjYzbpImy3QtQDgZG19tztU5lhlazAPBS7Ywycc9R8UhR0eucGQDP0cX09wm0rXHQ8ypBKXXgqMD5/YeImE2fDCmYKUpGxK85cGTDLZGZgYLZ9zRckozq9rUxrdBMJdRwjsrO7sSsa4VYx9kIobSakVhlQlFwcK74YP1YYsC/KmPesMJ4sSMr2aa9wP7F4xuUWU7rfF2UMzNQkzhmw2QggOMNujxYYzFBg4GzDBWcIfVGoiWqYiUzSRbw9nH0255QZ/PG9Y1xuBnhps1HybNFYr/krkaSlXcFHvsCXrrdxxWoclNP2v/LSBn58/3iGyyaVtmOoxmbDXzpfccbQCAUEB+4fx3jYiXHdcgw4I25XIxxzGRhjz3Txep44t4BgmYjPeSP0BdZqHr5zex9fe3XrqbR6NJfYGZeP45WtBt5+0MEoVTAwhVPgWVB8zoxTgU5m+HEvRiP08Es317FR8/Hewy6ORzlp3TNSo1u6bbt9zhyTn8yOnKa/gXMDHAsDaW2V7gSbuy3BSLnQ2BJHrjSEUEVk7dQcJ4SHME5ZuiyEx8Z1zwuzurmgcGWaF7hz8pmiXLZ6FpmBabj2ZDNVt3L/LMp7pc94nKOX5BhmCspKE2vDkOYKqdRjC3ND3KPCrZM9n3NcFeTOaRAIAcU00lzjTz44xF/9DHB7t289W5ZPzgCNG8NUIpUa261wZsXu0vZv3e/gzz88xK3NOn75pfWJ7d49Gs0Vf5vGDDFck27K8TCbmOvcAmeac/AsFq/niXNrBnUiPpefkTrUdivCwSDDuw+7T2f7axEYYycq4t1Yr8EYIM5VqX3ubKAHmpbLLgXPbASa5LrwVf/x/Q4EZxOeBSdlMyb2AxT9/kCJoMPKqWljRVD4wowDQAFDYIVVtAH6sUQmNQIxVhV0wQDVwFmhr+50ENyAeFEHsouGKhg4HRzn4lnfXy7AJSOgsQ4GMBmgu3+X4cy9Qo/cEQUn91LfZi61MUinzI0uigJl8SzPGzgsUagWCLTrHjpxhj/+6S56cY7I5wuPXxuSNj8eZTgaZhCc4YvX1vCrtzbmpu97cU7eLkrjYJihG4+l1tNc4e7hCJGVW5+7Pzvp3z8eYbeXIJUKQjDUAnKlDDyOVGo0Qw+XmiE2GgFCn6Mb53j7QQd/+uEBPtofwBOsWLyWj+Gi4lwCgpNEfJ4G3ET0/TuHT8VRa7sVomEZp8vgyCyU3tdPlMoVpcFh7HBHE2rNJwXAH9w5RK40rqxFuNKugVsS4mknicl2QwszDgYA2+a4JM1ZbkUUnNJqGigUvUJPIFe6CACcDwNgyU+GshDu6+OYbQerUOFJ8TzvJ8oCjO/zicDErfCnJnJpDEapBMyY+AsbBDRDj8zDLIHkQieh542FNl3CGEMz9BF5pF662QiQSZqEDwYpDgYpDu3Pg0GK42GG1JYTfvnmOn79M5fw2uXmXIKf84JJpca1doQ0p/KAswvf7acYZRL1cP7VS3KFnW6M/UEKY2hsj3xRWFK7zK3UZCjnOGShJ7BeD7DZCKA18JNHPfzw7jFCwZ/q4vU8cS4lg5NEfJ4WtpoBdjoxDgfpuRtZXGqGuL5ew93DEdai+SWJNFf4+HCIVuijFfrY7VMkedaygWPuO7MQY0jmlzGGjbqP/X6KROoie9EMPVxrR/j4YIhcGnCPrbRfbcY+55MpfCofuLrYsuBOG1PwFhwCweFb7sAwlZMWx1OZDGPGZiplFnw5xVuhwpPiInRYzMt+MWBCYKoMN9kzGHA99iZQtiXZGRzpBZ+/KNAGYNM6LS41AnJ95BzgigzQvnBtjfQGUolMmWKiDQSbqdEvw71SOYBzPmEc9+qlBh4ej2bGLodVieGMTZpSbTbGcx9n1BYaKY79fop+IrFRD/D9O4f4xmtnV1B8FjiXgOAkEZ+nhUbg4XE3wW7//AMCwRm+/upWUdua9yXu9am9cMyGjbDXTxDn6kxdBgx0Mzn2fWLJgpeaIfpJXqyyyx4CrcjH1XYNO52YavjW4GjRng3sgMOIBV1mILl/Bh6f6Boof9a1N0pF12SUqYnWxsDjhbBKrhR8wYr0J8DmZlDmJCoqVDgXXNR7aZmqYfmYaVJ1QYX5/7P357+WZVd6IPbtvc90hzfFiykjMjMyyWRSxUGsYrGKLZXEkqVWtweg/EPBrbIE2DBsNdoNt3/yrwb8D7hhwEDDQtsy7IYLLthlQ2xAsFuW1CyWpGKLLCVFJovMTDIzMjMi472IN93xDHvwD2uvfc697943xBvivcjzJV7kG+4994x7r73Wt74POjchkL+q5EEGZ0cgG0GBY3KhQ66pBKqlw4fPxviN1zfQOwF36yjwIq1ZDmgax613Ywxzjc4Ca+RRrk9FDJ83ejOORKWmpfEEasrC7oxLPDnIMcgr/Lu/dgdfvbd2ZYOC8wkIjhHxuSgoX0/bHuTAc0hVHoev3V/DzX6Kp8PikEuXcw6fzkWa/SxCpDrYGVGApKRAok7OK9DWkda/sZhWFv1UYbOfYlqSkVAWK5TGzngIAMSqHeYaRaWhHdXtuT7Jk3X4DN+eyJmBGRa0/7+1gGo8LyycxBM7GztVxlLrYgPMCaDWRYRzUBoi41z1QaxFixeJwOdpfO/m/s7PatNFcf51VwUOJJGshM90CN8uacm3JE4EHIiAvDsucGvlbAu75iKtiV6qsDsu8eneFJVx6GezpYa8Mtj2wcBpMryRF5CikoRb2vptrMPepMR//H/7EX7rjU38d752F9/+wsUQ4s+CcwkIjhPxuWiMy9M4eZ8ca50Yv/v2Lfzxnz/CRne2e2JSmoWRZhYrvLLWwf60wsG0wrQyQakwsIPn4Bz1+U8rg26iIKVEL1a4u57BWof9aRmsjSPMeggAtO31boRnI4uOEtAWKLWhCbyxFHFwM33L/D8lKCtQeZKSthaRVICg4EJ729UmISpWYrYkgEYGAXWPfGUc0qgOPK7ioNWixVXDcc9J08siWHyETMLVAztzMkfIGIcspva8WAHT0mFnVJ4pIFi0SGNI34n16e6YjKNKWqQY64KybGEsOjHpDpDo0/KogInk44JUFImATWPi/CIMdOjIS4O9SYV/9atn+OHDXXzhVh9/51uv4m/92p0r05J4LgHBcSI+FwkhBPS8Afw54jtv38LPnwzxs88GM2JLdCNY9LPDp1BKgRu9BKtZNNOyUrrF++m8wuBaJ8ZvPriBQht8sD2Ctc5bG1MKCzjsIcBY7yYhk9CJJdIorpULfeqq0hbW1iqHlaHfx0oSYQYyaAVUPgjgTgDpxYssuBXxMJmHy4ORktDWwDgaCCbVVRyiWrR4OXDdgu1JqSGEROwnQZ689yblUW87wXYXL9IANkxz2BoUcM5hVNTmUKWm8VQKYOSzmJEvfybqcOlXG4dRQR4TzYAskstJ2ALkIQFQS3usJD7YHuI//Sfv40cP9/A/+itvXAnxonMJCE4i4nNRcM49l9PfSZFGCr/3jXt4fDDFw90JHng5Zu6xX0RMYXdDriN1YoXIe5hbOEhQS17sWfyFdujEEt9+cxMbvQTaUlng6bDAuNCz7Ur+/9VcECSFwGY/RbE/RaEt0qgWMKF9ovdEiiJlJhZKiaAzoKRAAmpxLLSDapQdnGc7c3bgqPDP+QBkvjzQlgtatDg7rjPnRgnPKxAOdq42WZzRfnHRIo0zrAdTTWVL4xBJIPMt29ZSO2Psx0oe57QhDlQuyYwti4nMWGqLQV55ETc6HvjtLPOCYfCCaZBrvLbRQTehMsZ/9bMtfLI3xX/8N9564TLH5xIQnETE5yLRWxARnicebPbwd771Ov7wBw9DUFAuyEqc1t0wVhZKSfQShV9/fQMbvu4VSYm376xgd1xiXBhkyeGAZ1GrZRYr3F7NfN+s9boIdINytoCFiayDFzMSwNyNLBozt/O9iPxp1Ip4dDZILxHO4W2cxqmuRYsWZ8NVCsRJ+VTAOir1sj8LsHhMOwrONZwQC41P96cY5NqXQWmcG+YViooWQl3fug3U5YDSOFhbL4pIPAmQCkHvYVLS4ilWkhwXmaOF2bICe8EshRCIJZVmiRge49ZKiv1JiZ9/NsD//p+9j//kb37phQYF5zKTN0V8LpNYaHyp4rw7DBaBL9If/fBjvL89onZA/zeKQqug1ncSd8PKWgxz7XtaM4wL7Wv39HCsdxM8uNHF4/0ptHGI5GxZZlms0U8jYDXD9iDHtLIzZig87/OD18+iIHikBD2sHOgogWC0xKZC8RGdE8wf0D4KZyxq+2qDgRYtLg/z7cUvErwPPE9QBjSe+d1xKCqD7WGBT4MTog2T/7gwnuxsQ8YhVgJSRodKK84BhTYLa/4A+y8A0rd/j0tDPAh5OBiY2fAy+PcKYIYYvt5NsD8p8cH2CP+nP/0V/lf/3pdfWPngfAKChojPsp79i8C41OglCncuSR3x119bx0Y3xnd//Bj/5GdbmFYGk1Jjd1ye2N2QywnaOqx3Y2x4EYu/+GyAnVGBt++sYN0rb2WxwmonJhJMY3IHjjZN6acRovW624FYvZZIhZZqXr00QuJlhyclaaUzp0BKSoEB9JDGopYznu8qmDk2EF9BitqZELjeKc4WLV4GXKWgoPILnCRW0MZhUtKqPo2OLv1qY/Hx7gQf7Yzr8TZR6GcRZT4db1sgrxykFHTMjgKPqW/nFqjbp5t+K0shBJyrVSGVAxnCzaEuqtYlVvaJoYWVQ6WpNDEpNCalCboK690EO6MCP38yxP/733yK//nfeOuFEA3PJSA4iYjPRWBnVOKNzS42+5cTEABUPvj7f/0LKCqD/8ePPsXDnQmsc+h6nsDijACtsrUn7MVK4mY/xnq3dvMiEYsSw3wPX723hrtrGUpjkcUKN/vpzOR+VIsnBxzGOmQxKQVOSotcky56EgOdJAodAvQah1xbGM8pYG8DgLQe2H55nqTIGQdOn+XaQsDBWAvj2om/RYurgkXtjC8KFoB2QOzFzUptASGwcYSD4MGkxM+fDPF0tNwJkbOfRUVdZ5GoV/EOlMmlDC59Jns/iGMoaNqQ+ySAIAgl3WEivYCox/qgvYJaARaUgRVGwDiHT/Ym6KcRVrIYvYRUDnfGJf7kvWf46r21F+J9cC4BwUlEfM4bxpIP9rffvHzlpyxWePNWH1IAq1lEqXZtA+t0HgJEzstiFS7+PBEyUhI3ejEOphV+8mgfwHro969bGUvsT6mGlVeGyDC+pj/PX+BWQeOorQbem8AYYJhrjIUJBENA1CYrztvrgiQ7m4xdJcTScz0tNbU0utpFsUWLFlcHTQ2DFw3riESY+HHQOoeVBR1bABpOiOZIJ0Qh4IOL2WAAqIXTlCP+wiCvwkLnaII0fHZ19nXGAQp1UMCvM1YE50l+vfAZVyVF8IZxmmaKvDKYlDSOr3UiZLHEQV7in/xs68KM+47CubEBjxLxuQhsD3Pc7Cf42gUIEh2HhztjfP/9p2ESJ81+ij5LY8lF0MtuSi/MwxbCR7VnCiGw1qGg4N3HB7jRi2sinhS40SMHrcFE4kYvRVFRm83Yp5+4RVD5PtxICvRjiZUsRuGtktNIobKWWhB9W2GkyECFPouUEo3FiZUWrXWYVnUQ0qJFi6uJq/R4WguUoMk2knJhOfLJQY6fPNr3TojJkeNnURGRO5GLx1ma1IlcOKkMpqX2r1u+TfaaAL9KNMoAgOde1YspiMMaBlw+4IUWwPL0tEjkrO6zUUk6NAL4cGeMnz46wO+8dfOoU3juOLeA4CgRn/NGURkMphq//837lx5B5ZXBd3/8GHlpcXc1xSDXyOIISURs2bNSQTgo2B1X2PY9s01U2uLuWobfevMGng5y/OyzIcYFcTdi74q2KAjZ8ymuSAlESqETKzhPIhzl9GB0Y4W8Iv0Aay2ck6Fbgh4C572+KVsgfTvCqDB1Ty6u1qDTokWLqwnr/3EAupnC44MpXt/shsn0YFLi3ccHQaPlOJviaWm8W9+ycqo3JoolKl9acM4hdlioH8CcqTAEN1q/nZtVZOU/L2xD97+fl4MPKrFCIIkEIuvCwg7I8a9+dfneB+faL7hMxOc84ZzDw90JvnpvFd95+9a5b/84fP/9p3j38QBv3Oyimyr8+NP9kA04L1BQEGFrkBPvoE/bt14++P5GF8+GJX722RB5ZXB/vXOsFkPCqapG7UsIbj2kVX5emWDrqR0wLgyUbBTP/BPFOgPWOa+tUKOtFrRo0eKkYPnlyHsCTEqDXhoFx8K8MsdmBgBqYTTOkd7LkvGYDdkiKZFFVHJmXkESHbZ55zEOWBxicJaA/z5PNKSsgZdwF1763b/WeJljJjWy+FsnlphUFvuTEv/m490LMe47Cueq6MMiPuvdGA93J+cuVsTBwHo3xu99496lszAPphW+995TrHUoA3J7JUU3UZgU5y+dHCmJbhIh1w5TT5IZFwbdJAIc8JNH+6iMxY1eciJhJuYazGfluAUxUgKVsRgWxAWQABEMPfdACXqQ4KicoM3hYKBFixYtTgsSZ7M4mJQYexl8diw8LjMA0Bg1mFaQAsjiaNZiml8DmsAT71OQxSoIrGnjUGmSMa5sLSrHUu6hTbqx0XlyppKNripXG8Bpyz8jtENWXjI5rwwOphUGOakeWt9G3/HdXx9sj/HOp/vPf2KfA+cu8cciPqmS5xoUcDCQKok/+NbrL6RP86ePDvBsVOCWb3NMY4U3NnvItbkQ+eTVTgQhgP1x6ftqDW71Y7y/PTxRGq2JWAmk3jipCeP5DpXxYkKeIZvEChvdBP0sRuR1DKbaUFTte3faYKBFixZngQAtRrSxYWW8yLHwKFSGVvvMhWq2TTOsdb6UWmdH00hR9wGAwpDWQKUtKmv9ZF53W/HrmvyB2eMQoYSgrQ8EwGRGBNXY4EYr6LilqO3iD/IKUy/WFCmJXFv84598hkJfjFfPIlyI5u+vv7aOv/vtB+gmikR8qrMdUFEZvL89QjdR+HvffoBvvAAlJ2Md/uzDHaSRmqnpPNjs4vZKioNpde4ZESUlemmEUaGxNy5xs5dgXBrklTlVMABQGWIliynibexn5TW+2QFRsuaAT7tlsQyZGMW1LrnYxrhFixYtTgPudDKWJuRnozI4FnbTk2WAK1OLq0kpkEXSj3P0d16hs46Lc8C0NAsnWiVF6KZaWCbA4ewDT6LzfAIOBg6VLzyXQQpBInaSuF1w7MdQwTogUQIfPhvjT957eqLzcB64MM3hpojPu48HWO1EuL2SnYogYazD9jDHYKrx1Xur+L1v3HthCk7PRgU+25/iRn+2V1ZJiS/fWcEw1ziYVqeeqI/DRifG3riEdg69NKKSyXN+Ri9RiJUMToncKglH5QHheQpSer/yiiycxyUpKiZKhppbGw+0aNHiLJAAUiWh/eq9MhbbwwKAW+hYuAylH494TGT9FRYp0tYhVsToZyEklh+OJLUQWsf6AkeLvi2EoKzqPBYGAyABI+YNNDZB2QNHGQ/rLJQUSCOJ77339NJaEC/OFQi1iM/vf/M+EiXxwfYIHz0bY5BXS3WrjXUY5BU+fDbGB9sjJEri9795H//hd77wQt2gtockDNRLDsdQa90EX723BuWJMedZJim0QRYr9JIITwb5idNoixD5XlftNRzGDdtq4ZW+nGPXLoFJZYK1tfKRdaHtIR5CixYtWpwW0jsKykYr3yCvsDepFjoWLsP8XCIE0E2o3Mouht0kIo6UNyYiciGl5nklD3iitHOnWvDMT2UcaHAwQCRsF4TdrGWZd+IscGbB8Xt9CziVD4BnoxI/fXRwij16fly4K1EWK/ztr9zFb7+5iZ8+OsAPPtzB4/0pnhzkYeIUQsx830sU3tjs4ttvbuJr99cuvbVwEbYH+ZEKgaS9sI53Hx9gd1xi7QgBjZNAG4uDKYlnvHU7RSQFPtge4rUb3efeJkAeCZNCY2dcASCZYSt8jcwfH6evppWB9FEqQLrfbTDQokWL8wCP+VwWdaC27rwywejtNNtpgkWArDOIlIRxLiyAooZbqxKsWUBjIfm3EOfgNEMdt1xTKaCe02hcbZQvwGqHLBhHv+CWxVCy8MHEZwc5VtIYP/jwcloQL82mcK0T43feuol/5wub2BkV2BoW2B7kGJdEyIu869/t1Qx3VlJs9tNLVyA8CqPGanoZ7q5l6MQSv9gaYntYII2IA3CalkTrb9xCW9xeSfHlOyv47CDHpDTI4gjDXJ+pLCEFPyj0AEgpAOs8wxVBSaviB8LfyKR+eDWkT1u0aPF8uCrPL+uVVKzgJwVKUAZyf1qhm5DXykkF3ZqwlqTY00his5/gYFL5LgQxEwzQe6mGz4ZsUhDx0DgXugxOAgEqu0ofCLCZXFPCgIMBDjz4DxzQWJ8t4AClEytYB+xOCnyyN7mUFsRL9y1WktwJb69mwCWrDBrr8GxUYNsHI6NCQ1tKH/XTiPZrJcXNBcGItnX/PllietvNUqPSpO+vhEAcCby60UU/jfDZwRS74zKYcHDr3zysv/lYlKKbKHzllVU82OxCSerWyCuNr7+6hl89HZ2Jq8Bs3m6iUHi1QhbsIGtjluF0/iamm5T9v1u0aHE9caWeX1qHYFpqVFqG9mZriVj36d4k9PZHUqCbROgkJKg2HyTwWM1Ca8Y69BKFzX6KRElMCuNt38mTYJ4wSNoFwtfua+l1IlifPFNg/QqqmREQ4R/UZMK5uaWpC8OlBecoWOolCvuTCgITbA1fwoDgReBgWs2UK8alObJccW+9c6hcQSYcBh/vTvAo2G66cLs0I28BgVhREMAp+mlFioDzESN/HyuJ9U6MVzeoa6Gp9FhUFqVxeGOzh14S+bJEhbVOdOqyxLgke9BuQt0Sw1wDom6LAeCVCWsxpFK3KoQtWlx3XKVnt7nyprZDh1hKGGtD67N1DlYDcMDBVENKIJYSaSyRxQrrHfKFAajTwDmHJFLY6CdY78aQQmB3XKI0Futdco3NNbUUMsuf9qXmDVTGQYp65xads/ksC3cUOEemTfxzM+rgAEGJxd0LYVuCGxjpQ3bHJfpphO1hgQ+fjfH1C15Ev9QBQV4ZfP/9p/jee0/xbFQgjRQ2+wnurnUWliOMdRiXGg93Jnhva4ib/RS/+/YtfPvNTby/NcR7WyMkkWzYbh694h8X1HnQTRRe3ehgo5sgrwxKU3sdJEqgl0bopVGwwjx0HNqECfvuWoYslngvlCUUeqk6UVmCBTwE4PcBuNFLUGiLYU7ZEiWEz4b4iNXWamJXJt/YokWLlwICpEFQGgfVmIhp8eFX6L7Gbi1QWItC0+Jqd1QijiRW0ghpJLHeTWbMj5iHFfmxs5MopJFEaYisTWXQ2To+UKf2hSCTJJZuaWoSzONQO+KiYEAe38Hg/OulFOilCtY5DHMN6xzeezIEvnHcGT0bXtqA4OHOGP/oncf42WcDrHVivHV75VhOgpICq1mM1SyGsQ5PhwX+r3/2EP/nf/kRpqWGcyQGxKmpSVmFWhGbCsVKIvFfaZcu6KQw+NWzMW6vaLx9ZwXrR9h8zoPlLbsN1u16N8E3X9/Aw90JHu5MTlyWmJQao0J7MRAZImltLH75dIzSi3KQnKZPX/n3X6l0Y4sWLZ4bVymuZxEfAMEy3QGAEIgVIDz1PggC+fo8lxLgHEZFhTRSMNbOZEw5G9ppZFulFIgcUKLOzIqwLxaxkjPqrQKCyNRHqLAtPZcNDoGSjU4uzPKzAISAhIOHyPvRCEGfP60M/s0nexfuJvxSBgTvfLKPP/rhx9ifVHhjs/tcRkt80p8NC+yOS/RScjR8tDelSfqI1kIS8JFY9SmtfhYhMxJPhyWG+R6+em/txI6Q41IjVjJYdTIiJfHFW328ut7B1rAIZYxR0SiHoFGWEBSJKylweyVFP63LDUmkcHc1w9aQOim0l2JudhTwDTx/1M2oukWLFlcfV+lZdUu+r4yFsDRuRZJcBYW3aneoWw27KUkVjwta7ERSYLOfzcgZN9dH3G5tnQ8GRPOzJfoptStOCoPSWDTyFKc7JuYQiNo4iRePR50ILs2yxwwrKk5Ki4c7Y3y2P8WrZ+w0OwovXUDwzif7+MMfPERp7JkMlpq2myuZwtNhiWllEEmBlU6MRMiF6R/nqAZfaIOtAftcx1jvxrjRI2vjnzzaB7B+oqBgZ1Ris5dg2WOcxgqv3+ji1Y0OpiXpBjDRkcsScSTQSyLsjkv88uloYYZirRtjUmrsT6rQn1toE2p9svHgWNdmDFq0uK64ShkCBvOTQroevGJ2KI2DhICSRAAXvj3PWIdJobGSxVjtRNgdV3i4O4FxwHonCXLGjFLb0C02323AE7X2wmvGcwqMXbAKOukx+Q/wtAgAjXFzwQDK46qUVNI9yDWyiBaDSSQwKjT+P+8+wf/sr3/h+XboBHipAoKHO2P80Q8/RmksXr/Rfe5ggG0388qgqCwmlUGsBKwjJ0BnHUS0eNtUdxKIJNkLV8bi2ajAtNTY7KdY61BQ8O7jA2SxPLJ8YLyA0Nfur+HdxwdH7rMUNRdhEaxzeDLIUVQWe5NyYalj1e9bMzvGDyZnTKylMsJVG1BatGhxOkifpr5K2iLclgd49r3v3bNwMIZIfyxRDFB74KiosJrFWEkVhoXGo70JtKEsbiKYT1DrEMx3GTh4tUNHHQ7SEw7TSJCZm/d6WaRGuAxS1HwAPq6jVlHO1ceeegMm6+2QS22gvJ39n37wDP+Db712Ydo8L01AkFcG3/3xY+xPqjNlBth2c39Skg2wdUEDO5KCCC2lxro6vu1PCBAJ0TqMS4Nif4rbKxnWOjF2xxXe2xrimw82yEVwAbaHOW72E3zrjRv42WeD56ofFZUJJYVPdicY5BrjcvHnKSGCZWflHxA6EG6HOazK1aJFi+sBJsrB8cRDWc5paV+4URkTl0kLhVoAjddCaYr6ABTACOsgPAmRvFgqdBOJLJaYlhZbgymyOALHFJOSygTzmYHahdAhUSI4IAb4BZ6SApW2KE4YPZkl3QaLwHoFyl8THuJrKWOLyhpkkcTuhFQLf+etmyfaj9PipQkIvv/+U7z7eIA3NhdnBo7TDugltLreOpji490Jcm/I1IlVKA0oJdFNFMalCb7dJwH5XCsqIwxz3EGGtQ61kjzcmeCLt/qH3lNUBoOpxu9/8z6+cLOHXqIwLjVWs5NFhtrYQDqclFRbSyKJOJIzBEUGlzpQ0c2pvZymAChKBpbXv1q0aHEt0CStSUEpAqUE7BVJE0jUZkRH7VEzUACAXFs/nsP7IjhYp9FPI+SVCXLFzZnBWLI5to5If02C4TyIiC1QmpOzCY4NBhokSg4G5hd81O1FvgfjQqOozIWqFr4UAcHBtML33nuKtU58iEDYXCEfpx0gBZkYFdogiSQ6PsJsoptEKLXFtLLI4pOv2JkcUmiD7WGOe+sdpJHCw50JXl3vzOw3Wz1/9d4qvvP2LURS4t56Bw93JicKCPYnJX6xNcTTYYEsUrjRSyCFwN6khMgXKy5yqSOJJSqvXMi9uQ7E9m22Hl6N4aNFixYnRfOZ1cbBWEMa/u5q8AocaGWtTxGcNEnN2jhYUf9SW2BcVKh811RzLOdggFP1kVzMCQv75jOkSiJ0RZx452Y2dLh9MUgmA4AXwBOh68CTJ72Q3EFOmeWLUi18KQKCnz46wLNRgbdur4TfLVohH6cdsDMqSKgH1BoioJHFs9oAQpBr4P60wjCvgqc2KW3RhWT7TNa0br43jRSmlcHOqMCdtQz7kwpbwwKve+YoBwPr3Ri/9417wXr4229u4r2t4bFlgycHuec/2JmeXICUCPkmW1buYOEMri/O37ziigweLVq0eH5YgDJ/DQfgq/Bcn/bzZ0iIftK3jQl7WBhEkjqpGNbVnAEAtX/Lss9wDtpR9iKLFabl4S6sI3cOdVlgHjWPw8F4VSMaf71QnKP9S7gd0jr88ukYn+xN2oBgEYx1+LMPd5BGKkyUy1bIR0EA2J9UAMiH2jmHSUlkkm5CDoPWR5Wk3CcwrSxKzRO0Z+j5m4CiTkrTJ0oGuUohyJd7XFJJIJICj/YmeHWjAwHg4e4EqZL4g2+9PuPu+LX7a7jZT/F0WMx0JzRLIY/2pvjVs5GX7owwLDQSVeuBs0aBcSS4sQhKUlCjff1OiQXthy8IV2HAatHiZcT5J58vD9yqRyRp4VfxNFJYR8JC1mcJIMQMP6rp33Jouw3eVKwEugl5C+RVo/sKC0SJPDjomgcvuOYtkOd9DVhRMfMcMyEENnopdscl/vkvtvGbD26c7kSdANc+IHg2KvDZ/hQ3+sTWP2qFfBTyymBcalrZ+8lbOrKnHEwrSClgrK+zO+qG5RS6dQ6REl77GsHlShuHyhjk0iKNRMg2SK+cdTCtcGclxTDX2B+XeDYusd6N8Qffeh3feG19Zv/WOjF+9+1b+OM/f4SNLpUNmqWQSWmwNylhHUmAFrqE3z1izMbUYxsrgdJYRHKxNoMUlNkwtr5xnUMgHTF7VjR+dxlog4EWLc4fzZR783fX7VnjscjBNYIC+p1xCLLCxguvAdTex/4tjOBQ6FsFlRToxvXYbbz3DZshcRLgqPPFm+cgoKmKeOi1or4iPP5q4zAoNBJJLYiRknjnk/3gaXOeuPYBwfawwLg0uLvWmdEOuNE7nfnPINewFkjj2ZDNWoPKcAmhwdRFLUBhHLWkSB9tKj+pSsVR5uFsQ6IkppVBoQ0mlcUHT8f4q1/cxO99495MZqCJ77x9Cz99dIDvf/AsmCFFUiCNFLQpoaRAf4734JyD8VHtpDS+FdIgUQJySXcDPzCC/xUu1L6YPXuZuI4DVIsWVx3NsawZ4J9kkruq0BaQYoERm3DoRNSW6FBPzhaANfZwdlcdzu4C8I6JErpRazlqYUSZYpxqLuKghLvUBMgF0knSt0ljiYNJdSHdBtc/IBiQut4wp95+Y92pnQBZ1SrIR4JX9/ZQnUhwVOCjTnjDDeMlNfPKQgq6oWIvPalEnW0Y5hrdJIJSlLp6OiLzit98sI7/8DtfCJyBRXhykGNYaGwPc0hBioNKSuyOS0wqiyw6TIwRQiAS8LoItH+VcdidVMhi5e06EUgs2rNu2XBkUe/tZQ4U13VgatHiqqNR4j70oIU0PK7f87eoNbrUDnC07O8mksZZn/08Cf+LwTywvLKQ7viOg0DKPuG+u8Y2E1/ipWvhoKT0/jUSG53kQroNrn1AMCo0jHV4b2uIvLKnzgwAJHZRGguJ2b7U+UiZV8hNVq4xDlbUK2oONCvtoI3xNxftj3MOlQMGeYVOrNBLyJTj9c0e3r6zemQw0JRj/q0Hm/jF1gDDnNpq2MBj3lazCeI/eGatpf2otA6lDqB2OZzv+32R9cXrNhi1aHGdwIsB4HDwbUFBQXjt5e3WucM4oDAWnVhirZMcazJ0FBJFizwr6PwcRS4U8AqER5QJGMxZEIKCgeA+ax2UEuglMpSwH2x28Xh/eu7dBtc+INDWYWdc4mBaYf2UmQFGZWxosSu0CfWjZdc5pNr8xVNShPKB49y6qB+0WAkobmvxFz1StMKfVsYTSJYnnhbJMSeRxLuPD/DZQY5SG3STxZfS+XJBri2sdzGMYyqwGUeBglK0/5EUFBDp2cj3RQwEbWagRYuLhwNC692i543HQSVqBv+LFjF6XjhH2dyzBAMA6RyksULlreOXISSTj0kTNLMCpBrbXETSVydWUEpCCMryDqYa/VRja3i+AcHJGHdXGKU2oZvgpATCw9uwsNYz693xaTKHwy/gIEF60iArZFkve8ks1W4aeVtLBBJgrs3SfV8mx3x3LcM3X9+AEHWGY144SBsqpUxKA3jiYyRFMF8S8JGztlCShDG0Jwmc9aE5K9pgoEWLy8Nxzxun4ZeNC9ehS8EBmFS1+dtZ0IkVpDza16U5j8wXF5zPxvJCVEB4h8NGMACak2IlgrmdBY3To0Lj6TDH9iA/87E0ce0zBM9GJUpt0Ukk2ff6tkDjGlr9fgLk9rv5LEKuDbRvXl3WLzqPo9LpFBzQqtt6GeBBXmG9k5B0phCh9bAyFisZuSLO4zg55iSizgEpyPjioKyCOYbzEz2AUE7gVQCpEvrMhm9tcajlPRkSL241IOb+f11XJS1aXGfwwjaS9AwuS49flwC+Mg6Fdsjis4UwypO5J6U5dOzz2RaaB+qWQjf3WlpEwvMF6v1iG/puUhPFtbHIYoVurPBsVOLpqDjTcczjWgcExjr86ukYlbF4tD8NcsTLMG9LzNoCw1yH1MxJb+yQAToqZcRMVktZgmFeYb1L9Sv2RphW5JewKO1zlBxzURn88ukI28OCVvpeWZBNPUJED3oIOFBgTkMkBdIkAkCmH3llw/E32cfMq7gscBDCpCYm/rRo0eLFgCc0oJ7smsJlzpGC30kkh180HEi9MI3SEykTstX9IvJhoiQmqLsNwiLGj1nNMstMkDBH3rRwsAbQcLVUMWis7qVREE3i87vaidHLIuxMSnz0bHxu5wa4xgFBXhn8lz9+hB99vItcG1jnkMZqqS2xdRRdjQuNg2kF5f0FAFoZi+eceI6LM2kipqAg1xbjkoiAAHELRgURGO+spDPvWybHrI3Fx7sTfLQzxtYgx7Q0kFKEOpSUpD7WJDgyrYFvzDShG41TU9o4lFofyZm4jIecB5krPaK0aPE5RDMzoARmmO0k+iMgpJcPvuJBQa5pEdTPDk9/TfE5Fmer2eVupj1xfsIIixhXr/ytI3dY4YMmAWIiLpo3KLhyML5sK73uAX9saSxiJdFLVNC8+XBn/Fymd8twLQOChztj/KN3HuNf/WoHxgJrWezFdg6fFGbXF9qEkwvA9/HrUAO6SG8PDgrIv9sQQcT7epMSlj1kg7xIjvlgUuLnT4bYGubQmsglxjkIS4EAAFR+0lcN166gfgUqYYwLg1JbrGYxuXgZe+gGfRGr8kP74P+5yoNLixafF4SFwdyDKgSNK8ovMK4iIXh+n4Y5dVhxbZ5asg0KTe3jnFEVAESYV2aDIO3qbABv3zZeGcrWaIgSLQEHA84TziNFgcfEl5WzWMFYh41+EvhmSSQxzPW5dhpcu4Cg2X633omwHUvEKsLWIJ9poVnErucolm/byjgvQ/x84PTOiV4LSjNpS9HpaieGdVQj6qcx9idluKiL5JhZgXGYV6i0xVRTZ4QEQkqJLUM5eqz3k35SIHILaXk77E1KpJEi1S0BSOdbjUSdCgQu5+FeFjFfB7JSixYvOzj9rS1lGqWc9UNxc/+/6nAABtMqpOZp4qXx+CghIcq00hiaRBJdJbE/qWbGKiYTcjAALB/f4KhkwB1rsZK1RbMfk0tjUWiLtU6Mda9SS4q09Lrz7DS4Vl0G3H43LQ2+dLsfCBi9RCFWEpVv3VvGrg8pabCmAAUKz0tYO+1kxeYb3GpYVBaJkljJImwNa3LIIjnmnzzax8Af01STCBELHwF082lrw2cs34daeMM4YFQaaB8wCdTRrPIPxnE3iJj7el4sm/yvywDTosXLgGXP8vwEZxqZOxFqk/zzRe/l2SFA4/7+tMLupEJhqNOKM7dNMIdCe38BCOoYW8lipJEMmWkOBHj7nFjgzIGxbubLWnLelZ7blkWKSO9zOyqo0ADtM8wAZbiTSCGJ5Ll2GlybDMGi9jvjnJeZlFjrxHg2KmAri6kvBURSLL05mSQCXG6KSwq6uaYVTcSvrGXoJIou6v01ALNyzAeTEu8+PsCo0JgUBg4OnVgG4gmD01NHiRPN7gflupjA50JdDGE7zv/9KAQSov+ZU2gnOZ/8vqZkaosWLV4smoum+d/x9855DRMeb/y4RsqnV+9Jnj8W1eBdAVTuMBY43DPg3yPYrE552Xc6bgnfwWV5S7PvYS8YWvWLmYUPqyEuEy1yoCBCCKCfxXDOYXuYI1IdTCuD9U6MRFG32nnhWgQEy9rvlG/tA4D1LqXdD6aVlw5e7GDF4HrNWW5d5+oLJiiUO7InlT/MOqphpbHCahbj6bDAz58Mg6MhyzE75/CLrSGGeYVpScFAGtVZAdWITJur/BOjEQkZz4pt7OaJyEH8eSFwOO0JFWCrBD+gnPL9LVq0ODc0V7lAozbefDYbC4dQVnS0KEmURKEvf6F1WthGvR5wyGLKMi/rKODurMPS8BQolDh8rNZShlWxjP0p9s/5jIQUQC+NkEQSzi8kn40KpJHCqxtdWlgeIWp3WlyLgGBZ+13c8PAttQ1kkEXTIkeDfBNrW7Nhn3cOYvYoz/YcEQrUNw4FHf6zGhOs8e/ZHZeYlAb/33c/w4fPRri33oHxbYof707wZJCj8oxXzgww2KrYWgoexCmPZD6Q5/MRCC4n2Yb//1EP/9w4MlNvnK+xXSS5s0WLFicHp705GGiOl5zZc42VMbUou5nn+6qiKbSkhERpHDqxQLLE8O0oxKoxJos6gOJzFJ9iodbkKJCYXd12KASQRRKDaYUbPYnbKyk+2hk/tyDfIlz5gGBZ+x0A9JIIAsC01HgyyFFqiziSKLSF0Y6IMAAcRNDpB+CJHOdPhGHBH8CFaHq+h58nRSmAm70Ut1czPBsVuLvWwUonxsOdCX71dITdSYlISmhrA2dgvrYlfeRaadIQEMfcF5yloMrV4X0L54PPzwlPjAAWZidsfboPHX/4TMfHcrl6By1atDgaHLyzi6vxqqvN57T5yMYR9eYba650YN9cxAif8teGutGyU6YonSPOGm8v2BtbF86Bto5aDo8oDbCqLZdru7H0lsvHHQUWito9L658QLCo/Q4gYZ6DaYW9SYnPDgxK7XybCK2TK+NQgS8AnTwmFUopQmR7VizbCt8MPFk22+cEKA2VRvUMnsYSq1mM1SzGtDL4bJBjrygh/OvYi5u/Qt0fmOmXdQtuuvksxXH73gwWzpL2m1c6nE9HNvfhqvcut2jxeULI5vmUAM2TAhqLM4fMK6i88ul1eZhDxkOQDH66wDF2GVhbBoJaFDlDIgXLD9flZGMtAEGLMR7r3OznR1IgSxTSSC7UFXAOyLXFaieGkhJPDnIIIT4/5kaL2u+0sXi4M8YHT0cYTivklUWurW+1o9lQgkQgjJ2dhMOK9RKXoi78U194B6pdsS6AEAK9hjlREkkY4yCl8HbFBtOKiCPzq/Yw0YPrXnXZAqJOPzFE+OfoDMC5nKEGP+A4XJPxo0WLzwV4ouLxi1j29lDJAPDdSIJ6+pUUMJb646/6M+0AGGvhFAn9aK/2qo6JCJyjVkBjHbqJQlEJlNoGTRfrB1w2KtKWxnvqLKgXaFxa5nnBeC2Eylikc+RFkqI3iKTAzT6Z4n24M8Zbt/qHRO3OgisdEMy3320PcrzzyT6eDPIQiRnnTzLIhpjT3YHJiQVkj0u+U7m+xi2BSpDBEEXUFrEUQb0QgL+xjE/PufAwJs0e1QABay0qruU1yhYzr3pBZL357EiLFi2uFxyIoyXkbNZPhsmMspj9NPJdRg7Tisavqw5t6dhYe0UvUf1j0mTlTeRiJXCjn6KbKHyyN0GsJGkDKCpZC9CK31ga47Wh91Cr+NGlA+O1aqaSPG/SmHx6OBvApYSdUYn1BzE2+5+TgIDb7272U/zo4S7efTxAqS31bMYKEkClDSpRT3jz7lMhQzC3Kr7sW9WChIFiJb2AEkWH09JgrROj06gDjfMKhbbQ1itc+RYZbS2UPFxXkhIQ/ild1Pb3osUmjgoKrlF2sUWLzxWaz6UFoBppAx6XrE9PJlE9LglBsvCV0Ze/06cElTocpJSorENekqLtIighkEVqxgtnXFCLexZLjAsDgNwJaUVvw2cIgaD/ctS+sICeA2V3x6XGpCTdg7trWVg4KilQGos3b/bPTbYYuOoBwSDHuND40w+e4eHOGEIIrHZqDX7jiRtcHphJjTfOEXcWCNBr+XdnDWAXBR7HQQqvBuijbW0d7m90wzE9Ocjxi61hUF0MYkqCTZJssC6u90NACBeO81BGBJS6P9Qyc4r9fi5wKePol7Ro0eIaQAgg9kRnoB4/aLKrO72u0zMtQFmCOAK6MYkNdRN1YrfcsuEoa33JthMrkpVvnIkmH+O50Tix05Iyxmud853Cr3RA8O5nA7y3NcSkNIiURGeOdck3XyQAjVmCRhPNFaqxdPNKKWDN2W9eXpGfBMZHjVmsQrmjl8ahBsSKhNo4REqibPSXMoPVeLWsZqtLnbo7xp50QVBwUTirxkOLFi0uB3Ke9OzHk+ZYwqRBrn0b6+C4ROtqx9jrBCmANKJ0/LS0MMriRi/BRi85/s0e2lqvA0CKs8xp48BAWxe4CaQVc7QQ0Xy3QS9WoWSwNcwBZMhiiUIb3OwncGeKMA7jygYE73yyjz/5xTbGhUbknQnnJzPjZx0bNKA8FkVior6pKShwQb73edFkii4Ck294X4gLQBEnkxwfbHaRxiooEhrrfI2oqiNw3p7giNbNqDDyTWaP0adYQC04F8ycavf8UtAtWrR4MeBhgR355tPmDn6s9AOmbbzJWsBKBHl4hnUC5RXmETCzX8YkplRZh1GhkUxKdLwc/iJDIuu5BJPSYFRoCEFEvzSS+NWzMYxxoVsh9rL5hbG+tdrBHTFALlNETCOFQhtsDabopjHur2dYyeJzFSUCrmhAwDLFe9PK12cW92OGdjrrT6SoOwvEkvQMT7K+W+RMkH6DTY1v/ozZb2Y/O68MummEu2sZHmx2oY3FL7aGyCuDG70EO+NyRhTEoTYSEb50YJxDFH6HQKZkvsCy2+R5Hs/59sFlaLMCLVpcPzDvimV2zTGiZIcyAYK6v6wVULJWiX1BPOYTIxDPhUCsqGVyo5tgrRNjmGuMGp0SzfKqAHHB1jvUJr4zKrDeifHZwRSxN4Ixvlsh8AcETeqdRPlS9+kVERMlMSw0pNT44u0+ng2LcxUlAq5gQMAyxU+HBSpD7YTL9PmdI4MIngiFEIB0h4OCJbXscykXYHGZ4vDO1t+WxuF2GuHLd1YQSYlfPR1he0g3FZsPhf/7B1TyjeM/i9mwYv5AOGtwTpMzBz3UY3vEobXBQIsW1xaNxT+A5fyoeX2VmWACDpUhO/dmSfM6gIOhwlj89pubyCuDcaExLjRK3+0lhUCiBHpphF4aoZsofPRsjL1Jif1phXFp0E0UtJUYFRqmOUb7eUz5r9PCOYfSWKSey7A/qQCcrygRcAUDApYpziIFa8mpkKOoReAWQ/47WRwT2bCptX0R4BXxSS4v7wa3Qd5dy7DeTVBUBh/tjJFFqva5VrU4RqwErGbhIQ4KRPBi4P5VoFnnuxgsyhRE4vBg0qJFi+uDReTi5kJnfgwN5GxH5GjWKaCVLa1+rWaBnuuiQEor88G0wqTUWMli9NLjp8deGsE6h8G0ovKDFEikQB8RxoUmPpjvaXxe/hYLIEWS2g6dAz56NsbdtexcRYmAKxYQsEzxahbho50x0kgSW9PRxMNwoTfflwsAOFGHrpyuuuhadnP7/PGLogOepFnnOpLApDTevarApKRSASNWEpEQqLzqYuIJhhwUQAg4S+fBeUEN5hc8z8O3aEBoHmPoUBCzmQfmRxzHXWjRosXVRfPZ5wVL+FowMLDAqgWNTVKQIA8bvfE2tG9JPGp8eZFoejMY5xBHdBy7oxIrWXyibfTSCMY4lNrOBBBJJCFFjEmpUWpLInTGYQpTd70JHFkqcF4qWluHXqKw2U+RxQrWOWwPCmx0zbmKEgFXLCBgmeJX1joY5hr9LEKuLfLKIJKUMSiNRenNfiqvnBXKA8DC1PVF35DNcoRw9UQJ1BM0Z4k6MclSHkwrjAuNT/cmnoxT3wmxIgnLSWXgQDdLDEkPnQOED4gqQ6UEJgCdNhvCkT7LIh9XEpiPcJmL0aJFi+uNmbLnEeNI8yVc+3Y+ne5ETfTm1zgsFoe7CmAfgsiv1LJYodAWu+MSD272TrSNzHcScMthE1IAcSRRagNjgVGpIVATL5tZb9YpSJQkQSPHBkcSN/sx1rtJmCOkEKisRaEt1rsn74g4Ca5MQNCUKWb5xn6WYCWLMS40Jr6Ww46GUpLQj8HsBLxoUly0eL+oGzQEB41aG2sORFKgn8YoNB3fs1GJYa5nRIkYvURhd0xtikwknNf7r6yDdM+fklNechQ43lxo2WqhRYsWLxZnHdfCJN+YyI+CDSUCh1K7mXGBsrWzpcurumZwIBVBISSkpBbEQluMypMLKtFilThfvOp3jn6fa5IxdhDIIoEslmHFH+YIH1A5B2jtUHgZ/m6icHslRT+NDhEHraMyRBop7E/Kl9PLoClTvDMsKLIUApHwRkWGaiiRbEZWtPYPdfxj6uccrTaJhheNSCKQBOniCpSGbp69SekDH7oM2liMS4NhXmHqFbOaMsRcCmnu90VM0sd1KlzVFGCLFp83nGBRv/A9M2MIaml1YDaVvmi7zBdyzBvwKQB2UeUSo8PV5w8YR0HBahYH8vppJJfHhYZSJN3MJPhJqSl7KzzXwgp0EoUsVsj8yn9Zp4EMiz+SL85ihUgd/szVLEIaK2wNi5czIGCZ4rtrHXxmpgCAUaGxPSzCRLisHWOZQt8icE38PLHoweF9Ng6QDljJIiQNd0MBOj6e73cnBQ6m2mtlUwA0s625ZcBRD+xR+8nZlOb54giVOQ5hu0eVEFq0aHElcNLnMYwj8zygxjaUf8FR5UM2j6NMgbv2HCLrMOM8e5pV1rjQkEJgo5vgs4Mprf4dgk4MdxokfpUvhIDy5YEj98k6jEuDYn+K2yvZzKKx0BZfeWUVlbHYHuTA/bXTH/QSvGiZ+4DtQQ7n6ORZR/bGW97EiCfTkGrxYCLdaSfGZs3/LBBz30tBGYFY1hLJUszWihhSUGRaGYvHB1M8G5V0/IIlQEkfmyfpmbScqD9v2X4t+pOY/4OPTi1qbXL2Pm/LAy1aXH2c9DGdyQD433GAwOOJc5gZY5dtO1LEeXJLypVhm+LqaxEAdNzsJgtgZuF2HFhNlt0Mte+MY24FBRvLW+eXQXoxPusctoY5aSI4h4NphdsrKR5sdgEA49Ics6XT4coEBKOirtvklcbBtIJzpPgkpUA3iUhZsHHDesPjc7/reLI9yWb5tc16PD0kpH/NilXUgmLDRKukxKQ02B+XmJQGmb8JxyUpYPNDl0ayZv6eYpKm9NPsBbY+kzJP+iHCIFl1wqfQBPwgcvKPbNGixRXEicZIUQcMR2VbBYiIp60jHpdkYnL9mpCxvSaLCgfq+mJy9knaDRnW0ar96bAgvwPJBG0H7TxBPH4+rQAhSMyIutFyPB0VyGKFL99ZgZISQoiXV6mQdZ61sdgaFCGNw6vryAtCNAUfAIp2L6pOdVx9jn9v/Mwq4KCkbxtsSguDbo5JadBJKC1nrMXeRMMC6McSxlLQAKAWs/DfJ57sEiZv/vyjUvrzRJ+5feYAw7k6myHgz6UAlJfcZLJhqW2rNdCixTWB8hO8bUzO85oCi/riF+kONMGLCAXMdEYJPzDVZUj6f1Pi+CqjMi6k/2+cwsvAOYdBTuN2N4kQK4thXqGyVDboJmqphs5JQEGBDJ/xrQc3sOY7C5xz565UeGUyBJG3+H24OyH/AnU48Z14z20AKCqL0tgLCwZYCngRN4AhG1+UIeC0m51JvYkGOXJcaAhBGRElaNIFiIhi3WwwwIiVQBKJMLGzGBPX+xfu/9zX/N+a204jhZv9BGmsECnhfydDO2QkBWKfqWjRosWLAY81R0GANFuC2mmDdzXfpeQaA0RzVX/ckCpweFwhUpzwYkS1It91yTJyliCJBDZPERDsTyuU2iJreBek3gqatQXOAmsdppVFFikkkURezZYIzlup8MqM8f00QmUsHu5MKNKSMijwNRHUr+AubMW6jGMQam6oa3JJJIIYh5KiwVQlvQQOWJhFyh0TALDRJaniaWVQeUWrZbdPoiTSSMxkLc56+KwumkSSAg3r0E8jzO+F81oHUtaiJC1atLhc8GLgWAgi+3FNe9kkz9vjhc9pxhR3HgPQFYNxlN3tnrBkUFQGe+MS0gdfPHknkcTrN7pY68TINZEAT1s+cY5aznNt0UsU7m90sNaJ8dHOGEVlvAiUeHmVCm+vZhjkpB19oxdjVGgUmgSJGKW2GBe0ko59RuGy2lo4GHBhgufgQAQdbxFeR96LVEsySBSJETlHrSZ5ZbHejdFNI4hRiWllPPnw6H2IlYSDRWXq437ewxcg0mIviWCcw86oRCQleilxNmyjLEPlBbe0m+IlGxdatLhSWNQdsOx1DrVYWJNwLRqvOWvVOZRK7WExnrAvfmy8biiNRV6aEwUF295vJ5YikBJ7icKNXgIlJWIpYR0wKipMCg0pKdsaKRnKsc1yAhtLVZ5rFiuBG/0Ua92YfBQiid1xie1hgbVujF6iXl6lws1eglGuATgoKbHaibE1MKH2VWobiIdSkEEQ+3hfdNdL0C7wYMJeTRAEKuODAn+BuaeUTSliSO+KSCpU6504eBZo62bbXpaAU3qJEii1O9NxO79BGmi8fbLvfY2URKlJ9KgZBNEN2zgvx0QDbaDQosXZcVJC8bIsAOO8fQXm+QEz03+DyHRdxgEegt/5dB/31jq40U/QS6KFLYLaWPzy6QiVcWHBdKOXIFISO+MSRWXJ6hiAFBJSWmgvcexAwYMSApESM6UFJQSySGG1QxN+kyPApZhP9ybQJsMbN3vY7L+kAcE8eolCrEQQewiEOyGCrn9opbnAO67J0A3ZAVBkRxeciB3W2RlXwvq9tNoutKUAwDkIuEZry8miaAcEzoT09Sn7HE83ny4lAO2Aobf45JvNWOfPOUILzaLaYqgNipqwtGinr8tg0KLFywbODHCZc55DcJGfx7+4Ts9/Fkm8ttHFq+sd3N/o4snBFE8OqB0e8Jlf/32pHfYnJW6tpOgmET7YHmBYGGhTUfu5kkg8r4KgfJumgzaU5WV5YukoW7vRS5BGNO8tIyJ2E4XBtEIvifDtNzefyznxKFyZgGBnTIYSxciQNKOSWO8k2B7mXiuaOg20N9EI6ZZL6m1plgqa14BW/YtdCeffr72CRxopr5DliCk6l6I/9NlgbQIXIkrufz1NlqSZNhSgoICVuhLvYc5BAccaxjpYuEOrFClnz0uLFi0uDyddB/HCKXCZTvi+5wUnBoLmyTUZHzhg6qcKSgr8vd9+HUoKbA0LbA9yjEsDbSwiJdFLFAa5xnd//Aj31jt478kQhXaQwhzZVSAEGxkppN47iQ2Mcm0xmFbY7EsIsTxbHCuJZ0WBLFH42jkKEjGuTECwPcixkkWYVhEmhUE/i7DWjbEzLjAuDK2oHWAsR6C0Qr9oDkEj8wWA23ka7Tb+W/LKXuBK6NPyqRIotEMSCcRKBmKhA9CJFSalCSn6+c9nJzEl6b2ltjPthxCzD/0iHKon+n+kD+O1tVBShkyBNt6wBA7GcxaaAUXkSZ8cMS/NErxgXKMxqUWLQ2CxM1pQ1L8/zT1t3GEO1EViJii4BqDxjDKm48JgXBo8G5f4+v01Iu0tmHj/6V9sYVoa/PiTfeSVxc1+ir1JeepxUAjqIIuayoSrWeimmwcZ/Dl88WYPa52TOTKeBleGMz4qNGIl8MZmD7mmaIxT4lLS5E8pFmLNGutg7OUM9vwZ3tYaxjN4LShAqawLrM/Y13ysQ9h/IgPWqTvefw4KspjSRPNKjM5nEYL8ZSShTc34n8dxF5P3gb3MnQOcv3v5s5g8GPlzHjc+iPeNsyTUKnr8eXuRuAr70KLF84JcTetgX4m6xXkRjpqLLrpk0ARnFK/D80d+M9RWvTetUGpDksBH4N3HB/hkb4LKWNzoxdjsJ+glCvlzdBQArEwoSZlwkM8I9TFIqZB8DN681T/9h5xkPy5kq88BFiZ6sNnF7ZU02ANbRz4AAEIbX9N847yC0JNsy/oMhbUUdQdWqLYojEWhDR1HY0usr8D61oCAtjYEBQBNsPNKjNq3DElRZx94JT/D4G3efOJoXQKgznA4EAmSI3npSYW6sU9SAJW1swIkopZjbvY4z3/YVTc1adHiqkLAq4yKOsNlXP1/Yw8/X83xa16hdP7vl4XrMgTQeG6hJGAMpe6PkgR+uDPGv/zlDqxzWOvEQX9hs58ikgKFNs8VFAivTOucw/Ygn9EcYNniLJa4t965sGt5ZQICnjiVlPjynRWksQrGRmkkESsZHopAXDliAnweHJXqCatj1Ct9gVlio7Uk61n5pzWStOqvOQ+0DW3cofSdkiRxaTwBUQgqJfBqXQgEdyzhd0CIBW2AR5wTNeMUORvB8++NRSgDSClgjCdLCvJoCBkOz6CNPfeAt3cZXR8tWrzMaJLy5uEW/3rm9/Mr82bZ7LoIBV0mnACM4fS9wu6EsgSLkFcG3/3xY0wrQ+NzYzzNYoXbKxmEOHtQoK3DzqjwGXEKBpQU+Or9NXTnug/OE1cmIGjWTNa6Cb54qxc0oQtNq2++mecJbucBh+Nr8Pw6fuAcqO6kbSNrIWgVbkGtkTxpOkeBgPV9pkOfASm1xaQ0XotAYLUTo5uo0JJoHU3MnDWYCUaWpQ2XrBDmVbPmgwc6t85nPxzZcPq/xYrUCllCmksKzfPn0AYDLVqcBfw8WrdYKfU4OBwOGmZ+bqOBGQgAojGe91KFaWkwrRaPZN9//ynefTzAvbVsIXmwn0W4s5JBesG55+oEEwJZJDEuDXZGBXbHFWIl8fVX13HXCxGdt0Ih48qQCm+v0gnmenkvibCSRZiUBoNp1ah/s1/0xRJkeMKdKU/468+9+PPZAuFJeM55Nqli8SRHalY+PS8EHW+sJB7vT7HWickYQ0nESqDQFs9GBXZGpZ90ufVvthzBYsaHiCyNffY/AqCSgPBpFeHf7+buaeeASltYL6CRRBJlZRFJIkJGSqDnmbSshlYZi8FUt8FAixZnxEUsdprbvm6tgBeJ5vjIY/i0NDDOLcwQHEwrfO+9p1jrxKGcY507tNDqZxEi1cHOqMC4NMH++LRkQ+scno1KfPlOH1+5t4b1bnJhCoWMqxMQrKToJQrjUmM1izEuNJJIovJsd21tXQeXAtL51exzzEInYZ6LxucYT7QDFtfuELbHxMK6vu4gPAHSlw1AQUJeGbxxs4dhXgUlKkYWK9zspxhMK2hfhmAeQvOmqmv/9QHNlzbmVQetc7CGXmB8qsPB8xlE/eZuopDFKsgqKwmUBkiVDPLMSrCoBhAp+nuLFi2uJi5as+W6gQMBB5JvT5XEgRfHW5RK+emjAzwbFXjr9gryylC3mLYQQgSpetMYpzuxghSikQEmfYJl3CsuxWqvN8MKt6+sd7DuDY3Gpb4QhULGlQkIbvZT3Fvv4OHOBKtZjNJQKr00JPM7zHVIwczLYp50gl+0il4GclGkYERw2t5PoEz4UVKGFj7iEoiFaXjl0+vaOECSlsAg13h/awjtV9hpNJsCIs0BkhJmUyTnvCZAKBbOpgjrTAWVB4inQOcr8j4LRGakG66TkFhGXpnQIwvAaz7UE7+zRJyMvEbBpDSN4IQ5DwKJcm1Q0KLFFYVozICh9Ppid+mFg4+/GyukscS4MIiUQBrNztjGOvzZhztIIxWUBZ0DPt6dQAqx0HeHUZd3BSptUR6xP0qQORIrFY4KjScHOR5s9iCFwM6oxBub3XNXKGRcmYBASYFvv7mJ97aGgVg3KQ3SSNYtd36VrS3Vt5syusuCAp4kn6d2ZiwgpKtX0K6+uJFspOtBmYDmHsxoFfjjq4yDNkA3keinCg7UbmmdwytrnZnPLn3TMbsfFlKgmgtomod1uG7o0KwHhNKGACzohqc6VJ36D1kEVtHynQ7GEyxiKTDVFtIHAAB1PdhwXgSoaNKiRYurhqbUcPuM1oilQCdRgbgtnO/qauDZqMBn+1OsdSL86ukIH+2MMchLlNqimyokUh276jfWQkmBfhIhjWUoe3MpPFYSiS8b8/jaSRQthkuDLFYotb0QhULGlQkIAOBr99dws5/i6bDAMNcw1oW+fp7QIknp+AIWzjrMz5Ezme9zOGfGHibKOUeTJtfkeKUcOAVCUG+rqAMDti41IKdGIQTWOzEmhcbuqESiZIg0naNAgdUJK2PJ8AJ+FS8Oxzc0qdf7R2Ik9Ngr1XBJ9N0BSSTDvqWRogwEamJhURnkFZE5+TWrWYRRoVFZBw6gjRUQwkFChM6DFi1atLguyGIVur6UEFACKOasdLeHBZ6OCkxLg51xiSxSuLvagbbTkIVdBCGASAhEUnmtF4thoWGdwmY/RRYfTQ6MlcSoMBgVGoO8ws1+ciEKhYwrFRCsdWL87tu38P/80afYHVNihU80p7OJbU+iRfOqgcDsxLikFBT+dBSOSqnNZ4f4Zwt44iCtrkn1zwX9AepX9aQ96zDINbQl2cqPdyczspfT0oQswfzNtuiQpBCArI9doA5kpCMvRiLBIJBcGIkSmHqugRCoxY+EQCQAI4kXIaVA10esoRMBLrReCn/8Jzm/LVq0eHlxnegKPBSWxno7e3mIVPhnv9rBL5+OkUUS6504tP2tdWI8GxWIrAsl1mUQghZiM6qEKxn62fJpmA3yDiYlHAR+/5v3L0ShMHzehW35OfGdt28Fsp0S9WSrZO3Ix/LFi9o+aBKm7134ZxbOLY0T6tcs+B2XC1hTYP6LTyav0I0lTYLSkONhGgkkSsBY4OmowNYgR2UsuokKZMVuomZa+kK9CjSZs67Bov2TQgTNAv47SxoX2gayShqJmZtXSmpz0ZasmZmkmEYSK1kysz3iNURwLGLkGteByxgLMhgtWrRocRXBLdbGOqx3kiCNz3jnk33807/YgrG1oyFj3dsQn0ahkFQJFakSDnPv8ns0Hh/k+Oq9VXzn7VunPLrT4coFBGmk8JsPNshlD7UhEE923Mt/1IQjfcqeJzIWzAEOr+5Pg2NLEM0AwX+kbUgbSzYOAmUJspiY/P00QqKIjZqXJshWzgQbjUnW+mBj0bFwPYq5E5wksZbSYFLiUJqKdRXYRAoAskRhJYtDx0Tzs5JIoptEtR7Dgh05j3JNixYtrg/4kZfXbEHA5kK9RKGb0oKMSYUPd8b4ox9+jNIsNi56XoVCIWiuc85hezirStiEcw6TUqMTS/zeN+4dIp+fN65cQABQeeD1Gz2kEYlEcI0miWRD7ve49EzdEhcm58bFkvL0B+9c/XUcmkGBlxLAuCBp41hysFCXBPoZTbCDvPKKjXWJBKi7KsJE73gCX5wCEYLIMmlUt7iwxsCoMJiU9dcwrzDOq3C+OHkwrahdRvkOC95fgIKOSFG9jeSkG/txwnPUokWLlwc8NjVVWa86BEhATgpgs59iWvmFWqSCKuH+pMLNfgptHUaFxt6kxLNRgafDAs9GBaaVwUoWh46t0wYFTVXCJlihUAqJ33nrFh5s9s7/BMzhSnEIGKNCY6Mb42v31/Cjh7t0kSIZeAQnBbP7nZ+wggWon6lPO2e5BT8s3SU32wpobM3yz2KFQlvklUVPCk9CJOEKbQGFxkPV2AgTX0Kw4Wi7kLU4BpMGhQDiiIMKASmIy0DGTNTmyP7eeUUcAyYsakukQu27DXjbB1ONjldRNF7kKI2lZ9Citkk+5Xlt0aLF9YcFD1VHt+FdJTj/bz8lcbhRoXGjmyCJFb7//lO888k+OrHCB8/G2BmVGEyrpduyjtqzS0PZhpPICwuBoEp4MKmw0SO9AW2s9y5QeP1Ggq+8sno+B3wMrmRAwEZHf+nuCh4fTLE3rnyNpvYAOKTOtwQzE6QUIZ1uAWhtoZ/zvuW3MR+hSaKpV/X1JM6/59clETkgFtoijSTyyoYuCkCEAILpgBx5z7RaijooIAvtmlsQS+k7FGouAnMDCk1dC0LIwCtQTN70K38iIFLk3EvIZXFSGZS58yUEFzIfUghAAaa6HoNAixYtLgY8JF+XkUCAmPzaWozyCt2ENAAqY/HHP/oEn+5PAdAErSRN3ovIg9xeKADklcXepEIaKfQzdUjJcB7Sz0v70xL9NEKuDQptcXslxVu3+ng2Li9MmfDQvlzKp5wSbHSUxgpfvrOCfqaw0Y39TeaNfpaly+GDAC8ZTHMW8Q8SRf9XklLd53XTOtS6427+93OZCGo9of1bySKvZGVJycoTCLsJ2SFDCN+rGo48bIPB91qz/k9pMIvS1KUWkkamyR7gjAW9wccgqDz5MZIC/SzyUtLAtLLBl8EYjoI9YdJnOvLKttLFLVp83iGwdFy+ilCSFAWnvnz6+kYX2jr84588xl88GSKJJG70EtzopYilXDrGsfhbL42w0Y19Fthgb0yeNXoJ5wug8VwKgXFh8GSQQ0mBr7yySly6SF6oMuE8rmSGoGl09GCzG+o1G50ExhZEkHNmZrJkNAmiwhMR59sTjaWJ7yImMM4WgDMZc393INEh4/UU7q138Gh/inHpfHeBhbYSkZKIrYMxDtpRK+NMJsLVn8E/8u8tavGkWNYiF3zcnGHhAILtjK2vc5TaojIsVuQfcEf9tFr6IMKymuPx54P3r0WLFi83rovtuWzMEbESGBUG9zsxIIhI6JzDahZhNaMWv1gBaSyRVwaRPJrYJ6XAShahE1MpoPQdCEe1JZJCocRqFuGvfuEmMm9etDOaXqgy4TyuZEAwa3REdsjDXONZUSCWEp1MIq8kxqWuSwehti5mmP7z5EOeFIHn65lvlgaOe9H86yTqidtYh71JifVuDCUoZa+Ng7aAsdqXDoj8SJbEswJJISjAbPeBEqSBHcnFQRDg/Q/gSzOA5xLQZ3DLY2VI52E1TZAogdI4EinSFtWStsdluCZjRIsWLT4HEKBx0lgaCyuv0ppGEv/20wMkkUAkJDqNhakQAitZ7GXb3bGkdoBatFczGToI1rukX8AdYvMKhda54IcA+DH7gpUJ53ElSwZNoyOA7JC/em+N5H8tUVc6icJqFlPfPYR3CiR7Xu7dXyRaFIIB1G2Jp8Fxr+eugvnXcdYgZBBAtaZfPh1hb1KRSpYEIln7DghJZEO+F4IGQmO7UgCRDyioHiZmpC8XHzdrOtTnwPqb3Hip4kgCkRKYlJTuymKJ1SzGRi/BahYHzsH8Mc7/ug0GWrRocdXAJV4paK7oJAqfHeTQ1uG1jS6MQ1DJZfQSRYZG5uSjGpPIhQCGuUbHG9fdWklxs59io5tQ27kv61bGYuzbzreH+YUrE87jSgYEbHS0O6ptIO6uZfjCzf6Mz3QSydArf5RgD0ClBard86QlLmyyWsa0ZxIev8Y4EgJiR8dYSSgl0UkU1joxVtII3ZR0CiJZKwx2YolM1RePiZFMOpzlLMwe97yIkGuUXUh5kLaT+AALANXAPB+BI+llx70oKGjRokWLqwAeuaytyd23V1JU2mJSaNzsJ+jEKgQLTURKYq0TBS+dk+K49sKwb16AblxoFJXBYKrxu2/fulBlwkP7cGmfdAqw0VGhTdAdAID7Gx1sdBN0Y4lcWxSazCJWshjdRAFC+LS7O0Tm4579mRXx3OdyKukiJjQOEprZA6or0Q1T2VohkFmnSSTRiRX6WYT1bhJUCKUUiCNVG2Sgrt0F9v/ccTNPIOxPIy5wjeCAgwHuxuDuhIkvzzhHN6xxi88Ttx61aNGixVWDa3zFEri/3oE2tDCLlMSDzd6RC8X1btJQJjxlpsC3F+5PlrcuAtQF9nB3cinKhPO4kgEBMGt0xOilEbqJwmY/w61+CilIPKfQBrEnZPTSKNTBtaHVceFZ8cZSZBj0/CNZGyH5/zeljy8Ch24hJ4KmAOtnL9JbSCKJfhpBgLgGPDnPCy9ZO7viD94G89uc2xHn4G0/1Uy9ilshK+OQVwZ5ZVAYS+ULWWcEmltvg4IWLT6/uA7PvgD5EGSxwt6khHUOm70EDza7MwZ585hVJjxdUMALvYNpBW2WUNqdw9NRgfVufCnKhPO4MqRCYx2ejQpsDwtsD3KMCo1YSfzbT/cwmJZY7yboJAorWYSDKQk4rGQRxqXBYFrNkDGYQxDEiHyLXawoCEgjhUgJlNr699E+1GJAIhQULrIGzpkK+myq3wvhlhJIkkhCihiTUqM0FtorbAkpYIwLdTHSGFAwzjsrOlIoaGYo6oyCj5YVlSMWcWWYpDn15BjWg/CnaobYSccCaj+yLYegRYvPG67yMy8Ea64IZHGESaExKTXiSOLVjS52RqRCOMh14FVxqTb21sRZrHB7NcPWIA86MichGQKUfZ1WBuPSYK0zu/J0jrRebimJP/jW65eiTDiPFx4QHEwr/PTRAX7w4Q4e708x9ixOACFV/ecf73niBRlCDHONbqKQRAprHcoMVIZsgjkw4ElKAtj3EVkniWYmPIe5iSz0oswKCvlfXciNztGokPA9vJglG8whUlQiGeYVKmNCu4GSAtIRIdA6QBsDbWcn/kWgWllNPFS+HXL+/lY+ImZZYulfI1wdaATRKJDaIsSskFKLFi0+P7ioMfN5IUFjnZJUN46UwNawgLEOkQQ+2hnjo50JxgVpB1SNVbwAjXlpTLy1XqJwZzXD9iAPSrrHuR0CCL40g2mFVa/1ArAyoYYSAv/ur93BN15bv5iTcAxeWECQVwbff/8pvvfeUzwbFUgjhc1+grtrnZkV8itrGX70cA+lJmvKcWExKjSmOxq3+hnWujGkEEgiWv335to1S02qUYlnejbB9XbuOGBWHF18PLeK4WlhAZ8doM+uLKCOyRQ5IKzoWaSpyU0wthZF4pQ+PwzMCyi1bUTMCI5fXDaJlJwJS1yTtNnofAiZB38uOZ65SoNBixYtLg+hi+sKDQKUCZWBu7UzKlBoG7IAvZQWmZnnqHUac4bzi628IgGj2BMM765l2BuXGJeGdF/U4e62eURKBq2XSJHHTaENbvZTpFGGb39h8+JPxrJ9exEf+nBnjH/0zmP87LMB1jox3rq9sjRNvu5bDn/yaB95ZXHDaz1vDQpsDXNMSo3NfnrIwY9RGQvrHJK5i+Rc3YcfB/U+mgxpAp2Nby/6vjaOLoZSQKGNT0Mtfi1ZQLtgRsR+Dc73sTJpRkrfkihlaDXkTWo/uQsH2LlQ3jgHYwDjbJB75pV/00sBIG6CggvBkwv7eH1ESlq0+LyCn+PzflTDwuAKgTOhAgKVdbCgzEASS9xezZDFNB3GinxzjHOI/CAshEAkgEiq0Ln1bFSilyhsdBN0EoODqca0In5VpOQhQbywHwByY7EzLhArco79tVdWcaOXYFLoS1MlXIRLDwje+WQff/TDj7E/qfDGZhfpkom8ibtrGYB1vPv4ALvjCitZhLwyGBVkFUy6zxn62eHDKY31pYH6wlhLdpeUWSCmPt8sbr4gfsFofgrrAvCKf5mZUxC28CUojsa5XCCln7gdaRkYRzwCzn6QfDKlwywAsYDf4gBYQ8TMWImQCbDwgk4NnWTOPthGUNCWClq0uPrw5XT6v2t0QJ1xu1dRxpxt45VP2691aAJOlEIvqech5poVerEqofAZ6cg6jEuDQue4vZrhtY0YY+8eW1QWlVvcBi9Ai640kvja/XXcWUmRxgofPhtfqirhIlxqQPDOJ/v4wx88RGksvnS7f2IiBkBBQRZLvLc1xPawQBZHyLWFtYCxFlvDHMDhoKDZtugcBQjGOvQShU4SYXuQozSUNkqUJEnjS1zaNkMPC6CoSC5Y2+XkQiZPNv+qjUXhiYWw3Frj4Ez9iIdV/vw+LCISNl5bzs3uzXjgULfCkuNs0aLF1YII/9S/EO5qTubnhVjJQAKUQsA4YK0TzTgTCiGw2omxNTBHmuhJKdCJJQptsTXIcWc1w1onnuW0+fmEWr9JcC5REsO8whdu9vH6jS6AF6NKuAiXFhA83Bnjj374MUpj8fqN7qmCAcZ6N8E3X9/Aw90JHu5MMK0khrkmQQdjsT3MEanOTPmAL8bU+1THSuBGP8VaN4Y2DrtKQFvqSIikQAyq7wSyHy7+AWnQF6hLwDqMCw0l4mBG1EQzFec8GbAy9WTMcscAi2u4GcGi+fzHopt+UeAws8/zu+XaYKBFi+uEw5yql/cZZpXXSAokkYKxFqU2yCKJ9W5y6PU9bzBXGYtkiRAbQMFDGlFQsD3IEa3T/BM4bUvel1dm5ly/CFXCRbiUgCCvDL7748fYn1SnzgzMI1ISX7zVx6vrHWwNC/ziyQCP96dea1/j490JbnSTEPlOSuMzAhFWO/GMT3WsSEGq1NaT8JwPGryu9CXlvZVPt3P/vgRpDQzzCj0va9kEBwSsfa0bEQsLEEnBHQezLohNQ6SwPb/NoOJ1gn2eDyKOCyBatGhxdTA/xb3MwYBA7aAbSRk0ADoxKcMusieOlMR6J8HTUYHIuiM7CDgomFYWO6MCr6x3jrU8pu4ueg2rEv7+N+9fqirhIlxKQPD995/i3ccDvLH5fJmBRUhjhddvdPHqRgdbBzn+4skAW4MClbHopQr31rtIlMD+tMLHuxPcXkkPfTanhsaFhgMRRdKISB55paGNufjsAKch5kh5Qjg4CIwKjT5mgwLh+Q5a18JDQF3Lb3ZNsKJgSA/6D5CNz2qWLE4K5//hz3lZB5MWLV42HCoVvMTPr0Td7SC9m6yxwI1eggc3unh8kC9971qXNF/GpZnpOFgEIURDibDEjfl2twWIIwpSXpQq4SJcuFLhwbTC9957irVOfCIC4WkhhcAr6x1850u38Ntv3sCNXoK9SQUpgM2VFHfXMkRSHrrhrSP3Pu1Jh5GkzEAvjXyanq6+xOyzc96wvkVwJoXv/+FaEnsJMIy1wV97ft9E0ywh/A5o/pqFhoDl9bGTgDMLL3PNsUWLlw1iLhh4WZ/f0IGFWmOm0A6JkvjNBzfw6kaXSsJHeAvUqoTm2K4JKQUiKXAw1cuVCFEbyfVihYe7kxemSrgIF54h+OmjAzwbFXjr9sqFfg6XEl5ZzfDOJ/tII4XhtMLOuPTKfgaJqgMDajeUuNFLcLOf4skBkQunFdWVCl1nB+rwgHDe0TTzB5q1fe0A6YWCjCWBppUshrG2Fgia6/XnzAFnBma231gFKK/iGN53hmN6WVcWLVq89HiJgwGGEICzXt/FOHQSiW+8tobXb3Qx9mq4lbFLJ+MsVri9kmFrmPt28KMzBbESmFZ2oRIhozLUzr03rbCWxS9MlXARLjQgMNbhzz7cOaSPf5HophFeWe/g/kaGv/fbD7A1LPB//NNf4bP9HJv9hFoNlUAvjYI3gnUOP3q4h0f7U4jKKxvamskfboALTK3NBwXWEbnQutpLYOqtiMN75vdnSRdB83eqmRlwuNBjatGixdVDMDN7sbtx4RBAcGkVINL4G5s9fOUeEfe6DSn8o1bn1LmWYXuYhwXjMk4B8beAYT6rRNjEKNdwANa7Mf7ubz14YaqEi3ChAcGzUYHP9qe40T/M4rxIbPYTPDnIoaTAr7+2jv/hb72O/+LPPloqgKSEwJfvrGBrQMpVxkv8hTjgkiZNDgoArwBoASNqTYJxaUggQwpUmO1xbfIGjtpX64mGfBpe9kGhRYvPC06a6fu8PPPcKdaJZVBd/corq4gkrdyFEORfMN4PbYHL0M8iRKqDnVGBcWmCv8Git0RKkg6BcUiihv6NcxjlFYa5xl976yb+g998DVIK/NO/2MKooMVeJAX6aYTbqxlur6S42U8vtQ3xQgOC7SGdvLtrnYv8mEPoJRGeHOTYGha4vZrNOCeSyNFhTCtyriL1P0ltIS/gyeGPjPxNoA17BRBnQCmHyojFwQCWP+ySXwhf928zAy1avBRgIjFHBLyAEQ2xMMZZyoPXAUysbpKeqc3Q4f5G59D4f3slRTdRmBRmobBdE1ms8MpaBwfTCvvTEtPKNFQJa/8XJYDKOZTahJb3keeBGWvQS2IM8gr/2X/9S1LR9a67Qojg4yOEQC9RuLfewbff3MTX7q9dSgfCxQYEgzxMspcJ5VtMtgc54E/k7759C3/854+w0T1MbtyflPjp4wMikfSo1eRFK+3xjSaF8/LLrB4ISDFb/xeNiX5+txvVjobcMNpSQYsW1xjNiV1i1piNlUybpOP5jqKXDRwISEm0amNdaONWUqCbKPylu6uHUvhprPDGZg8/+2yAzMgZgaJFkFIsdNotXc3GsM6hqCw+2pn4TKwA89TzykKbCj95dIA0kujECqudGK9udHHbKxbC7/+41Hi4M8F7W0Pc7Kf43bdv4Ttv37pQ8uGFBgSjQl/k5o/FuDTh+++8fQs/fzLEzz4bzGghjIsK//rDXXw2yCFBqnxFZV+4DrdxDjGIpKKkxLS0Mz4BMyTEJTVBGih8NoAHiBAVLHhDixYtrgWaj65xgLOuoUFSdwA51DonL+vjzjoDPLZZz71iMaJ+EmGlE+H2Eo+AB5tdPBsVeDoscKOXnKg1PlLykNNuXpFs8bSigCxRArdWMygBDHKN/QnJ7r++2UUkSeumMhYH0wo74310EwpOHmx2oaTEahZjNYthrMPTYYE//vNH+PmTIX7vG/cujIR4oQGBtu7cdAdOCyHETOtHGin83jfu4fHBFA93J7i/luGTvSl+/Ok+dkYlkkjAQUBbi0gJRIrsfl+UQY82QCksBKgjoMkGThTxCEpjD030zf2V0tsUo2E+5OoMQYsWLa43JLxbqi8DSuFCCcFh1mOEtUdetkefxj4XWqC5XLKSRSgqA20d3tjsLW17V1Liy3dWMMw1DqYV1jrxiect9jXg0kDptWykADZ6KWIlySK5NMhiiXvrncBhkEIgjRTSiIjtk8LgZ58N8GxU4Mt3VrDmFRSVFLi7lmGjG+Nnnw3w+GCKv/Ot1/HrF0BGvFAdAlaHehFwzh1K/zzY7OHvfOt1VNrin/18G//2030Mc41OrJAohbyijAK7CEpBboEvAg7UM1toGxQTOSsghEAcUXorixWkXOJH4BOGwtsZh22/xKuFFi0+L+B0eCzryd44BOXSRInZziMBREpggRr6tQcfI5cONroxbnQTWAf0UoUHm90j37/mXXWVFDiYVqeat0aFxuP9KSYldSAk3iuh0AZbBznyyiCNJe6udpa68koh0M8irHdiPB0W+OHDPTyZE01KY4Uv3e5jUhr84Q8e4p1P9k+8jyfFhQYE/fSFuCsHNB2smtDWYlQaFJqIhLESmJQa1tED1px4najrcC8CSh7WQCh1rUUgBZD42b55C0sxGyTI+aDgIne6RYsWFw4WGOOAv9k5xK3LbFXerBS+0AHtnCFAXWKxJGJfJIBOEuFmP0XhTevurGZQ8vip7u5ahq/fX0esJHbH5ZHiQoxRobE1yGGdQyeu2xGNdRhOK+TaIFYCa50ElbGhNPFsVGBvXGJcaLKs9wFI5LVxKmPxk0f7h4ICIQQe3OiiMBZ/9MOP8XBnfPqTdgQuNCC4vZpBCDHjOHgZML5UcXt1llHKbovdJMLfePsWlBTQ3sKyNJbqUP613N7HEfZlPkPNB1jbZmag/n2pLSrv3MgtMGFfBRb2yUohEC3JJrRo0eJ6QYA7hrhmLpBGAllE45a21KHUHOS1cbAvmRqRpKEPSSTRSWN0YuoqSCKJ7gIvmKNwdy3Dtx5s4NZKiv1phWFeLVUyzCsTiPPsoAiQkmxeGeTaAo4k6PcmJZ6OCuyOS+xNSuyO6edH+1N8sjvBp3tTHEwraB/ErHWIO/Du4wMcTMqZz+WgYH9S4bs/foxCm0W791y42IBgJUUvURiXl0suHJcavUThToNEMu+2mMYKK2mEG90k1OKNf7CaIj4vYvJsBgTA4s4BAVoBsG6ClIJKB/yeBV7cXHho44EWLa4/qPRH/fNJJJFFErEksfUkqrMGaSyRxaS1H/v69ssC4klQF0EvjeCcgwS1CH79/jqySKLSp1uQrnlX3a+8sgolBXbHJfYnJanX+uDAWoedUQFtKRgAaHE5KQ12RiUq46B8y2Piuwm6Sf3ViRXSSCKSxFsbTCt8vDvG+9sjfLI7wajQ6CYK09LgF1tDmLkojoOCdx8P8CfvPT2fk4kLJhXe7Ke4t97Bw50JVrPLc3HaGZV4Y7OLzT4FBIvcFseFhrZAJ6kvDDkHOnAHiUNtI3xZOY6ZlN5c94DA7DfKdxCUxkJa8vcWilJo2jpY62YCGu42aNGixfWGAKDUrDgOtxvWnUkGxpdBlSSfFmsdhoXGuDAnHtOOWpy8SHDWtJ9GiKTAqDCIlMCDm138pburWO3EePfxPvLq9AvSSEl84VYf99c72B4W+HRvgmGug8rgKK8wKgyUBMaFC1kabcg8SfrShZKzCzBrnXfmNeF61XDIjcGkNNgdl2FuerhjsNaJ8eW7qzP7mMYKq50I33vvKX77zc1z0Sm40IBASYFvv7mJ97aGIbV90TCWLIG//eZm+LxFbovjkhwOh7lBJAWyuGZ7GsttJIdzaxfN1A1nyNU/u7nfSf9L6YUsjAWccOilCqV21CUhBbRzqLSdyXq8RIuDFi0+t3Cg9L+EDWOalKCVZywxzIkTlUWSMp/G1YJFOCxsxttc1IDU1Dm5CiAyJWAtLX6KymAK8qb59dfW8ZV7pEZorMONXgopxXPPP2ms8Jp31Z2UBuNCY39S4t8+GiCLqPvLGAvjEEq43N0x8W3vQtTctGBKJ3wH2AxHjL5zvtwzrThocPhvPtwFALx1uz/Dh7i9kuGD7RF++ugAv/PWzec8ozUu3O2wqRJ4Gdge5rjZT/C1+2sAlrstVtqF4IG7EfjCAVSjB4ipy46HF92t18wONIVE+IapzZZEUC8E6OGIpIC1CFafDhSNAr5bQiKkEPmLP+6iHR1fBrTnp8VVgwNQGBrHslhhLYvRSRRlDTUZo/XSCAIChXY4mFY4mFaYzq2Ym4sFHm+aX9zafFUQFBgFlUwsyM74v/XlW/jLr66Htr5xqfHKaoZ7a50zzz9C0LlkN91hXsF4CfhISRLgEzWZO4sUYt++DlCWelSYMK9wJ9uicUX4bhABeOMlMmD6t58e4EcP92Y4BUpSuegHH+6cC1fvwgMCVgk8mFYoqvMjPyxCURkMphq/+/atkD5ht8Vbc6IUxmcCjPcJYJTaYlRQWihSAsJLUl4GQ5/FRJofMM8nAGoSEYRAFktEkkoelSUuRGVsSElRdwGVE5T/Xkn6PmxbXK1U4FUEB05t8NTiqoADe+McppUOq8/cr0z7aYTK1OTjytiZEmLzPuaOBR7mZtr4ZD3RNbsVml+XBbKpp/Grl1C7+Honxl/54k28dmNWrGdnVOKNmz38e1+9cy7zz/6kxA8f7uLnWwMAQDeJEEkZ2tU5UIm95TIvOInnVUsql8aiqOyRariUBaEzO/HeCdY5bC9oSdzsJ3i8P8XO6OyL7gsPCABSCfzqvVU83J1cmC6Bcw4Pdyf46r1VfOftWwCOdltUDeEifki0cRh7dcVQ+/F/m2/bO080HyqHWlyj+XN4rc9iRIoeiLVOjFgJGL8N41wYGGRDvWvRhwrRCEJOiEu5Ya4gwjURlz8ItmixDLzKrAxlAIZ5BQdKnxea6tH8eBvnvJ7+EdlODgxE/RrnuENJhDbouuXx8hYTyqfZnXWBJ5HFEm/c7OHuXEdZs3T8N758+8zzz5ODHD96uIetgwISAh3f0h7a1T1vC6DzXGjqMiiNC8JQzOFiJ9tJabyYkfVqh7RI5RIvBwXWIaghkjLibEtiLyEZ5a1zyMJfyvjOKoHr3fhCggIOBta7MX7vG/eC1vNRbotxJGZU/ZzDIS0CTvlWvAAAiBVJREFUYDZill4W9DwhMRudz082Er7bgfdbUYpICeEnfGLYMrdBs4jRknQUQ2C2b/mkeMk6lk4F7u1uBmwtWrwoOEekZw76K0OLgURJlMYi9x1I1te1jW2Ypc1tKxCOm9lJDgp8Tds6F3qULruEEDWO0Tgi7N1aSbDejdFPD5PpmqXjs84/Tw5y/OTRPipj0UtpblGCygCVcVASKIyFMbPnhb0kmqWB+U/WlgTouI280JTdLTzBHQ6hE4FF6uZbEme8e86IS1vwsUpgquS5BgUcDKRK4g++9fqMxjO7LfaSw9zJXhLN1OH54ja1CACEkgE9fA7nUKaZhZj9fn4Sb9b9+eHkO41LHZGS6CZRXUNyXPc7emfbBsQWLa43HGqtkkjSGLU3Kb3egIODmxEn4u8XDfwhOznHOKy7GLjN0b/eHXZTvAg0idzM3n91I8ONXupVW2fHsUWl4+edf/YnJd59fABjaSIujYVxDqUm8yFtLaalhTauzpqgXmzymH3cIqIpuSxAE3ypLXJN0stSUBdcUZmgU5BXsy2JTe+e58WlZoB//bV1/N1vP0A3UXh/e3Tmmk5RGby/PUI3Ufh7336Ab8xpOx/lttjzrSrOEfku1+aQuh/AP4uZVM55YeF0PBcU8M2kfLqOH8JmjQlA8POW/skXgh/uYwpV54DPa1jxeT3uFlcDocYf0vwCpV9BA1QylKLmQc2UB4+4eTkTNp8tAGYzEhcVCzRX1UpQNpfF19Z9ibTQPmMhxMyCb1HpmHHa+Ucbi/e2hsgri16iMMg1ng5LTEuDg7xCqR20RXBVtI1yQHCnxcnPE2d8WFuCxeWYA2Jds3OBgoLtYYGHO5ND3j3Pi0vXFv7119ax0Y3x3R8/xruPB1jtRLi9kp2qJcRYh+1hjsFU46v3Vpe6Px3ltkhCFgqDvKI6j0VghDZhfduHQx2pnheaHQTLYJx/KJQAC1KxqmLeuKGnlaVMQiRQVg5CUq3NApBYYjJ1TgfzeU2ff16Pu8XVQJPgZy2gG3ekQ91l1IRtvGcpj6DxWuHqAKDOlD7/PjdX+8vGPrYKhkDoGEgiQSQ+JYKrYBoJxFIEifxlpeMmTjP/PNydYGtQQAD4dH/q6/g05nIZhhZmFIyd16LRWADShWCOCYrWAYOcfBaEEIiURBpJfLQzxu2V7Fjr5pPghZgNPNjs4e//9S/g++8/xffee4oPtkdII4kb/QQ9L+YwD/aH3hmVKLXFzX6C3//m/SP9oY9yW5RC4NWNLh7v58grvbDmbqxDycRDXMwE0FzAN+tMzc+LPLFEW+eJgxRFwgcExrFcc50WVIJWCJWlFYN0nNKqj5ISitcH89dgJpNyym1dtiXsRd0/LT6f4OecFFYXv8a45ZMuxwr8HACL70/n/2kOo89zH4f733OlQkp9bgedA7QDpKMFmpTUwpfFKrw2UhJFZTHKNTb7KTqJOrJ0PI+TzD9FZfD+1hDDvIK21IkWK+lX6zacW24P5GM5SyW8ueg0FqRR0Mj+OOOQVwb7kwobPeLF9dIIu+MSg7xa6t1zGrww96EsVvjbX7mL335zEz99dIAffLiDx/tTPDnIQ5pbCDHzfS9ReGOzi2+/uYmv3V87VpnpOLfFVzc6+POPBaalRTwXXbECIOB9Aaw7sk3keeGWfN8MDipDMbVzgFRAKui2Eb6V0Bg7Q1yxfpCIfcqwNLaO9huSxi/K2vl5wA9Kc2L11ZylDyGfD7lg8uc0K6XoLh7ccnSdznmLqwuuTR93O81M5AteTB0EdRkSOLxNBxo75tuTTxLk8gpaQMA4N8NjYCLjosBeSrIvTpQ85MuiBFA6coK9v9FFpW3IDPzBt14/VDpehOPmn4e7EzzcnUCCPBIMAFgaU3MhIJ2bMZ6jjMyxH3ssmEfAUvrN9nD+/dNhgU5CQRKXiffGZVDmPQterB0hSKfgd966iX/nC5vYGRXYGhbYHuQYlwbakGhQL1G4vZrhzkqKzX564vLCcW6LG90Eq1mMUa4RqzqJRZOwrVv34FNCl0yt5QfOOk8YcvRgdRMJJSXGhaZ6leX0kn+fcDM3ahZLr8DYDBougCB5QZBA4FbwABJKnEsGxWZKVAhiKXuDSMqyXKIkNQ9+833cn+eOjRZnw1yJ/+gX8rjQ+BXmvuegYNnreEExv+mj0EynO5+hTJSsFVZ9G2Tzc5UUiJUIYkiLTNqoXk7+Lc45fLQzObJ0fBQWzT//8pfP8JNPD9CJyHmQeyscHPYnJY2d/nwIv1A7r2xjyMgAgd/GXQRMJK+Mxc6owCvrHUifuRgXmuyuz4gXHhAwlCR3wturGeBVBs+KptvioiBCCIF76xmeHOQ+RePCzcaiPs13XVbad/6BDCtLQdEqpc8EpIgxLDQq40sIri4JBEEi5ygFB3JBY4nNZjAwX6pofvZJ9vWo1571nInwj/9ZzAYFyx4B0TgQXv1I4VcrfI0v4WI2I/taOhahzfQkq7wWLeZx0nsmPCONSXcmw4b6HpSi/n5p+eCECJmBRoqCF1ZSAE4ICEeaq8Y6WJApEYuoWRDRO41mMwTOAZW15N8iiD/w3/v6rSNLxycBzz/TyuBnnw0AQeqH08qi1NYb3zlMCh3GTnPiqOx0mAnEfPkEqMeNSAmMS4MDXzqojEOkJMpzGNCuTEBwEWi6LS4zV+qnEUlDWgvj/ARq6xYSBifaLzooaNb0mp9lfJag64MBgG6MNJKoNMkSWecgQhaDhgIhBCLQ5FdZh04soK2Y4Q/Mp95J/ex8jkcIiqSfZzXMD8B8FmDZ98uCGeuaeg/i3Cfho+6JRRkBFn5xoHppixYXBRf+IfDz6Bo/8/PwvM/8fJDBwQCl0ekvrN+vrQUvs3hy444vbWdNf7QhI6aZcq4fn7uJwt/+tTv4X/zNL52LqQ9Ared//Oef4hdPBhjmGmPBInASiZAoNPlGiEvgXs0uzugCNQMjJQX2pyV6Kfnv3OjG56JU+FIHBCdxW1RSop9F5H5oHCpHKXg1l35pPkDL0tRnhcDsQzm/+k29fek8lJcuZpVC6xmpVWNjzpcIDjTxDTqxhIBAYaxX2bIhgldKIHFupoVpGY47DzwQiBOcs/mJ1eF0JJ2Zh8jNbi+szB2VVM7rAi4LWhieMHxoZ7gLpMX1xWmzaS8K80FzoohsvExHYFFN/ySIJNBPY5TaBIE351fWxtbjl/Cpb84G1GRBWuCwwdy0MoiVxEY39nwpsnvvxAq3VjJ8/dX1cwsGAOD/9eef4B//5Iln8gPdNJoxdppWJnQXXAZ42GDZY+Xb5IWgFsxpZbA7rrDaibHaic9Fh+ClDghO4rYoBbUgRlLgYFqhqljX082nCAIuKkswv835n6eVRVxodGIVosWadAlE/uFSQqCXqjChcpuKcw5jr4u9msXQ1kHnlPdKlEQSKeSV8eJMAsYZGLM8LT+fsp+p7Tdfc8zJap5PjsPmA5GjqmPzKVD+XXMedvClAudC++Z5gFdgRx0iv6bJaWjud4vri7Myyy8dfmIxbnmwH4LnxoM5/9L5YDuWwEYvQawkYiUwKjQsa8BYaodeyaKFnICZ7TaDBSlgjMNaJ0GsaHzupRH+8v11Wh2fA6ue8acfPMM//JcfIa8Meok65PuQVyboFkhcHv+nuRBVfvzi7LWDw2Ba4ev3V2EczkWH4KWXpj/ObZH8xAU2+ymSSFK6y/d+WucWdim8iOef682DXJNjWWlCtNiEdRxpK3Ri5fUWInQTBSUlXXAHFNpQrc7R499LI3Riqtdxmk9AHLpB+GYMLY4zf6xr483fHyfOEUmBVIlAbGqWTJqfwYPUojhNyVkDKqAOLvh74c+jkoBCLd18ViwaLI/6Ox2jOxRQtbieuC7XUPkyFZvthIl/wWtnMqJzWPR6JWUIjJJIop9GEPCiOs4hiw53Cxy/vxS45JXB7rhErCT+8v113FwhhcLbc/4Fz4t3PtnHP/jeBxhMNVayCJOKXAnHBXlBDHONYaFDR8YLg/9s5Rd3zo/1t1YyOOfORYfgpQ8IjnNb7PkbN4kk1jqJJ+s572fQDAxOthq8KAhBKTlKXVkM8gq74xKFtqFjgPcvjdShB9lxEOBtN/PKIq80Im+fmfgHNotk3Q7kJ9+5Et7S/at/qOvkPOAsutEESHApjWTI3jRX+2Tb7A1VRF1C4GOdyQz4HzjtyOUX19hWGgmohtW1c+frXsj2p4tOkcNhw5jA2Tinz29xuXiR48FpwM8fr/ibz8XM3+fex+PAouNrvjeNKDM5KnRtGx9RKVbwf567c1poY7E3KXFrJcW3HmzgzlqGcanRSxTurJy9ze6nj/bxv/v//QLvPh4gLw2eDAqMck1eEJXBpNAY+XKyBaXvX0R3kPU+FDyuFppa5buJCgJ111qH4DLxnbdv4edPhvjZZwN86XZ/ZlXdS6MgOMEra2OJhZ8owMK7WPm684tqFTNuNo2uLULdHwCMNX7yJleyeXBdTggB64U1OonCWjfC3pjkOGmiog8hAg29VwiBSFKKsTmR0R9x5Ig4/2feMyVpspeSjFhYdCmSdZbA+TdIH5o5UQ9Q9XZooInZqho41B7K54XOm6s7F1z9d64SPe/grhqfYR1Jms6fB/6sppjMotMnGr+/6pPN5x3XoXU08u6oxJan382X10L2DfXzPaMXgNmSlwANiZESkKAUv7HkFitFHH7uZxH6aRSc/aQgYSHV4A40wf332ndCCSFwb62D33ywAeVVC3dGJd7Y7J6p7z6vDP7Zz7fwD/7kV3i0RyqEaSx9xpiE3iIlUFScLfUkyef+xLPBgbItSSRR+ZbLO6sZqTZOq3PLmHwuAgJ2u3p8MMXD3Qke3OiGoKCbKKxkEQ6mVbgJukmMSalRGe6dFbACmOrZm+OYufBCwc9SqOPxqh7AsNDIQnsi/Z4nXSmonTICTfrWVt5hi9p4AB88OAfn04rWO3pJgCZlYCZjshQLVvI8GcdKYjWLYZ3DYGpnnBfD6xyCYRMPWOTpIAIRMvLBHHz5w829p95XEQKe5qDXHBnPShhltUi4w0qIQhCpyoEyPKEc4r8JA86SEWf+ei/7XYsWi2DnguTmc8bPKIsPNXkR/Fxy6y5vRUkBBSCNJSpNg4+S1M47KakzgCetfhpBG4txaTCYVii1RemWT61K0MJstROj0AY3V9IQDDRtjU8jd9/Ew50x/tE7j/HPf7GNZ6MCm/0ET4cFEiVCyZNaDG3wKXjRzxhlqun4m+c1rwyGhcGtleRcMiafi4AAqN2u/vAHD2eCAiFIwnhnvB9q55ESWMnITSpYiLrZVR5PWC+kfIB6MnE+a2HBcsWUZhtoi0lpyCrZP6hSEGeCrUyNdsg6MXqpwLT0ZEI/Y0eWlMA4vch8lSbRqDkhzSuOze+vkvVkF3n9cSUFJrmGEAKZkmHCNn5i5wlUGxeEOeA/S3tSlGC2tCWPdCmI0MRKhCxGZKyFFHVyfmFa/yzBQIjM6mvDDSGVrZUv00ghEvR6KWZbiRwAId2htCSXGpYxwl/0YNWCwGqai5QxXySMczD68Oo2BAKNn0XjF83noRk/S79I0pbGE2upbElZMipHCiHw2noniMNFSmKtI7GaRagMScKzaQ+XJ0mUiFbpnPF7NqoXKsCsrfHz4J1P9vFHP/wYT4cFCm2w3klQWQteQkxLg0lFDoMcDFwVcAm3n0ThvAqQv8E3Xlt7OZQKLxO/7iUt/+iHH+P97REe3OgijRVur6ToJgq74zK8VghKqacRCT5MSl0LP8z+79IRonQfGfBKXkkRbJ2tVwEDSJGx0AY7I0vpJkFBD+txd2IFbawXuBB+AhdIlECuZ/3TmwuN+YdlPvXYTDlKIWBAmYbVTowkkpiWDctpDrKEgLN1UBaCHl/y4GDBOUqhrXViVMZCG4ssVtifVnQuBHyrkvNeD6AcgQMEK7DM7fxZruehYBG1OmGiBPm4Wy8K1fj7fOth4IqgllVe1p3YvC4tXixCXMeTG+og8UVfI4Haka+ZBWtO9uGeBWZ2uGmGxG6rkZRwEBDCIVYSzjlMSgdnLBxoUo8U8ZEO7YsQSCLiLZ0UrMDHtsa//837z9Vu+M4n+/jDHzxEaSz6icK40OilEQbTCnllMC21t5J2M2Pbi75+jMRrNkwqHVR8OZt7loxJE5+rgABY7nb1xmYPT4fFoa4CKQVSIVBoktQ0c6F/cxKcT6tdJJoTBd8GpaHe3U6ikEiJLBKojMHuuKD6oXVEuPNv4Ak2EUA3iTDMq5n2TIfZ9OE8mGwYsgeYLSdI0OTr/GSupEAnJoeuZZbT/P6kQYxstiKF1zmHvCI1MW0dtgY5cs8Opushwnsj4Uk51i1lCT9vbXA2jYqZzw4ZD/+5XO5wjkovvCvSa73TPUSBQ2gnbWyfMwXPIyDTZhIuFrOBMintHVeCuqySzyEjIQ7YMZsFCJko3i/HRFkRjOI4U8cZgRCsChoHeolElijkFZUI1jrPT5m1vrzXSyMcZWt8EjzcGeOPfvgxxoVGpAT+9Ud7GBUag1xjUtBiL2RdcXWCOQYv3NJIYVqZcG4LbfF69/kzJvP43AUEwGK3q1hRR8JgWqGTuJk0lfUkFyUAA3imJz3t1lLQwGS1s9ahTwNe4TfJQNPKhjoTHwH7Mig5R+RpTPasGDYqdHi98ce0rO9W29mJZv74jSP+AUCs49urKYa59pyGxZbT1u/7cbrcxmcdYiWRRnRsw5zsrvna8aQaKwkRAdPSE5Xm66lnuFhhYEU9qc/8TdT2peEa+N9HilKUFEg6GK/r3gyEEr8C43vOApDGHQpuuHTUxHFStC3OD81nwPlgQILGi/mTz/dM8/m7rH2bBz+v4W8CSH2kX2ob8tQOXvAMbAkPRLGCtQ6dJMJ6V2EwLcMCSQpgMK2wmkWHWqNPisrUTPrjbI2PQq1AOESpDYa5wajQlKXwzw2XLHgcvWzfmuMQ+TYRLhsMphU6MZV//9pbN89NoOlzGRAAi92uhrnBJ3tTHEyrmZvOeKfDyE9Uxjr6v+N+cr+aE7MR92WAbY4dAPjWGOscYkGWyQXT3R0pF8aqEezM6SwkkURqFIZ5nXYHjjZ1av6lmW4Mg57HWifGrX5Kq3hjUWgzk173uwPrgG58fM8ylwi41phGEnvGXwk+PNAkzeUDVnPkvzn/zVmuF2dRaDtsgzILfoghEDIYm/0Ed1YzHEyrkN3g8gKLo0ohsNaJUXo+iBR0LJEUEHo28LMNEiijFUK8fHCpp3lvLyKYApc/VnCtfh4c0PIjVxmLxKf904gEy0a5JhIvEEoCr6xl6MRReAY7icLWIEehLZSkrobKOCTR8wUEk9JgLYvwdFQgi9SxtsbLwAqE2lr0kgi9VGGQM9+oqjlZfJ6uaPjMw3CsJIrK4OmwxM1egv/2V++e22d8bgMCRtPtanuQ43/93Z/inY/3EUcCWaSI+FZRS14vURCAX0W7cIHCwHvJDzjQSI2DIlxrqeVNMVkHdRrMOiL8ZDE5jsGTKhmlpok68kQhqmEffjyaq+Kjjpf2CXAQKLRBXlmsdxJsDXJoM6sc6UAp/VgJZPHRKwCWYSaOQS2PyuRJfg0wa7DCymdJJGEtBUtnvV4OCLLM1Lc9u0WaGOjzWVCk8kzpJJLoxIr2xx8Dmb8IGEspQiXpfFRzHI9YSVhnwuc1bZzb8sDlgsmEQP1MKAGsdRIkSmBYaBSVCbbkPDFf9jXi1ftR4Hun9JLmSlKJz/laexIR4e/WSoq1TjLz3n4aAasZtgc5KkP3c+lb5U4L61zIUPTS6MS2xvNoKhDeWc0QKYm9cQnnHKalDhLLLEJHbdmn/pgLRe0tQ3eMBFAYi9ha/OaDG3hlvXN+n3VuW7rmUFLglfUO/id/9U28dbuPjW4CJWmF1omVF8ghOc1uEsErcgKoI7cXcR8Z3zEQmLr+iS917djIXwDdWIUvKzABCiAm/7iglLsKuX/CwkHEr3pl4zXzkTb/JfKT8vYwRxZLpLGsW/TAqyrnZaSjhauYJijTIYMQR2UcKk0TPQSCl4MUs5oMobXRt5fy5Lp4v0+OJklw/st47gIHC3zORoXG/qTA44MptLFII4lI0nnJK5roma0u/HmRwpcewORDCmyqRjAQTJye81haHI95EZ9mYCz9M5hFEvfWM7x6o4uVNAolIlYLfFHZm4XJvnppHLQ8+Jn0uUfEknlSDv00wno3WbAhCgrurXe8/C9J6863PB4H6xyeDgsYS2S5/+g7X3yuYOCdT/bxn//JLzEuNO6uZUHJT1sbWq0BGi+Mrdv6rlI8IEELCTguO1KQBdBi9t//6t1zIRMyPvcZgnl87f4a3rrdx964xO6kxPawwLTUM+E819sPptULT8uGFCXqOrNzXDposJ9F3Q5lQdkA6fv5nQMmPloWglYHXO8GXLD5FKhliOfbDJurUyXrVTHrGShPTNodl+jGCvvCExhFncbvpdEhTsE8KAPicLMfhwe89PKokaQBl7kVkZrNgISeatCNr4RAhQaZ6IzXci6OCuDUcOV3LJKUnfjl9hhCCCIVGu9A6YMGB2CYawhhKHjxAWmhbc0f8NdrxiuiEWQ1cZn66y875jNjIRiQ5Cey0olhrMPeuMQr6x3cWklxMK2gfanxJKZhLwJ1SUNA+IlR+wFOW8/FgcN6J57hWM0jixVeWeuQPgiA3XGJSFJJIVZy4Xutc6iMxbSkkqKxDr/3jVfwn/zNt57L1vhXT0f4h//iV/hoZwwBgb1JFTqp9qclppX1gV09kF21axLGk7Bos5hWls6lN3g6LzIhow0I5sBSx3/854/w1VdWcbNf4J1P9lEaDVnVKluxkj6Vq194ejak712d4uebiZm6JMlcy5FaQStlByLdsAgTP8RSNvSyJa+mBT1UHAU1MgzN4KNZphB+pT4uNbpJhHFJHudkOe28BCcFWMelFp1zyLVFL1EzKxTeZ/70WNG+EeGzQdLzX9YCUHMr6ROUe86SiucJnAiV9DvtgG4sgneGsYBUpNHA6pmlDwCsoyzBakdglGtU1sFY6wdYBM2IZTsY7gm0JMPnBa/uJejaNWJtWv17fY3Ed9GMS4P9SYUbvQS3VjJ8djCFEwKJcigW6AJcBjjzfFwWjgPNytBEnWuD9W6MG90E08qg69PryyAltQ2/dqOL9W6CR3sTDHONUVGXuZrPkxACsc/IOgC//cYN/C//1pdOHQwcTCv8+cM9/IM/+SU+2hljXBA35yCvUPkSIQuXOb8TUuBEbqyXDSH8OMxBmaPM02YvwdNxibdv98/V7RFoA4KFmJc61sbix58eAKDJc+wjTWPPXoM+F/DE5urVqEBtmWksGoZFHv5FealDZMzdBUCd3mYCEb8viSQi50KNkLc53zoIx6lt4evdVLNLY+r/dQBiSaWMeIncchPOUfAQSTKiaq4yuGxifFCzmtEKpqk2SR0W9HnOb2/RKu+IU/x81zqcz3oyURJB2lhrCxmpsOpvBkbsMcGaC6WxiJXCZj/Bk0FORlaSBo1YSTg/4C3az3BP+NbIqk0XnBoOdB9JAMardxrfKRPJ2aBW+ozOgWfa3+wnGOQVJqUG9/BLd3WDMwdfu7YWg6nGaifGX/niTfQThR8+3MPBtMJaJz4yKHAgldjXb3Tx6kYH05LY/eNSo9I1ZyaOSD+llyg8HRXopRH+g2+9dqpgIK9M6Bp79/EAnx1MSTLZmxIZr3cihcDU1p421FFwNa8BfJnRAqHzar0bI9cOK2mEr55zdgBoA4KFmJc6Zh6BEC6wxBMlIJTyqlYvbl9d+Kfxs/+/taTxH0XC6+s7OFPXyKQAptrC2TplLmXNyF+mNy6FQKJoUgvEQ//BzOTnTEQSCd/fLGilURmSiJYC9ze6yGIi+bAtM2uJzxyjDwZYr7tJOqRAw0Abh24aQXoPdSHQUJs0wRiESitk4ARXmxEtK/00yqsnuhbzp6s54HMw0NxW6R1T0kiimywumQjhAzHrMCo0ijHdg6mSQfGNN3pU4OKAF3qvXndwmYyzcMzboQyBhPFEOOUnHvasp57xGDf7KbYGtOJutibqKzIbhXvdB8vSl/MiCfzVL97AfU9e++q9Nfzk0f6JgoLYdxhITw7spYunHNYZeJ5uApYi/tlnA3RiidIYbPZSDIoKuZdkZ/GzpnZLM7t5FUHjCZVB+xlpMQymGhu9BDd6MdbPOTsAtAHBUjSljh/tUysim0uwgh5Aq1M2GXpR6dhln2dBXQUskStBKWkW4ejECrk2sH5QS3z3wUlIabTyZ9Mj4gcw4U0KWoFyyYJNJoVvhUy9s+JGlwaTLCKFwYNpdcgAhcsEkaRgoJ9GM/VG7QWP+qnC3bUMj/amNIj542iqTRbaQFsBCUdywtYt5Q08z/UUOMxDcI2/sdLbfK2SernVkfwJax1KQ4TDQrsZjoQAneeTzPWhdHGK43penKXEchXhgKBW2uSdOB8IlMTJ9YRPgcSvcLkff70bY1pq7E1KXyZyM6Je/BnnhRPzRho3Kbf+cjq9Eyts9hLc7NfGOXfXMgDrePfxAXbHJdY6NZ+HYX1JoZccP8UUlQk6A6ftJmAp4v1JhTc2u9geFsgrCrD3x6SL0MxwNruALrvt86SQoIWZ9dywKJJIlcCoJOGXX3tlFaNCn5v9cxNtQHAEfv21dby3NcT/4XsfeF+Aw5KbM/3yojGRXJGbzcE7JTYGMt6vXFsYQz/H6vi0/SIIIRAJqq9WoKACDoiVC+UKJeH7mmUg9rBJSRorSClwo5dgNYuCAUpRGUwM1cVp9Uw2n9SvX9cb7290Ma003t8a+Z5pSa2Tss4iSCmQSeqpHpcam90EB7meUWasTM29aJ6n01zD+UG9+d6mSBAj8tkJJwQmhcZqJ1mQHUHDU8MGTwqABt3Uk7ScA2VCFswAzckr9hkcFpUS/kDbxMHJIQW1IHPJQPt2UKDm8mjrUBUaQhAZrNQp0lhhs08EQwgHBa9oiIsZK/h+nt/20qyiA7iQFiuBlTTG7dUUpaHMVHN1f3ctQyeW+MXWENvDAmkk0UujUMqrjEXsORXLYKzD9jDHYKrx1Xur+L1v3DtVZoCliAttcG8tw96kwk8eHQQp4pIkP2G9ymIzQzB3Cq4UpPTkcC+73lUShXGQAF7d6IZswXmYGc2jDQiOwDuf7OOHH+3ii7f6SCOJj3enyCuDdEZWtx7Blwl/vGjMrGb8z6xyxRNBZRwELOJIPlfLmvAzi3PEMr6zmlE3wbTEwdSrHxoLJSWs1jDWYVIZpPHcxB1LWBsFYZSNXoyNTurJP3W9sZ9G6CQKUghsDXII3yC12omxNTALr4VxDrGUWOsmWOnE+PAZZRmYbyFE3c//PIMFv2+GLAWq85MKGq0KK69IGHnyGQAUmjgW3cYAys5x7D/B6pjSX1BrXchaUcupgIY7dL1Detv/3oSMTb2TEhcTxM5PSNc5a8DXspMQV0Abi8TLg3MPO59j5qpQG6nF44MpXlnrIIsVlbJGBfFGZDNVf7717GXbYS5Jk98iJAeLdB9t9mLcXKHy3LNRgTGnPxpY6yb45usb+Hh3go92xjPdBOPCYKMbo5PM8gCMdRiXGjujEqW2uNlP8PvfvI/vvH3rVJyBhztj/Bd/9hGeHOQotcF7WyNMK4Nnw4L8QnxwYy1gnZ25Jlf9/mPl0qBX4YB+qiBlhI1uci72z8vQBgRLwNrXpbH4tVdW8eBGF5NyG4O8nElrA3Pp5SsYFDRXBLxr2jpEiupt/GdaJdfM9dOATDZIEIlX89OSnAxXsgjGks+CNkR804Z6ja2tyX288l/v0sr/zko6EzAsQy8ltbTKUAcCM/TnszmVscgiVjeUuNlP8eneJOg4SMFT9ukhgZBy5fcrgVoEykN7LVsp+T1UeimNpQApklBKotQW40J74iClnuZ9GkjAiEysYiVqcinq0kUza1Ff48UlIWaWn2XQjP2qmdtT57Fo1XoR6fLnQfOczO+f8N8QgZO6bayjVT4L28xXfCiAoL+NS4PH+1PcXsmoPCQlCkvpOV69CgE4e7aWxOPOJQe/ytcFA2kN8Nk8sta9vTpL3K2WEB0iJfGFW33cX+9ge1jg070JBtMKg7zCeifC+1vDIB4GwJcRFN7Y7OLbb27ia/fXTs2UP5iU+E//yXv484/3ECsi1NLiAHhKJxSpEtDOoXI28ITMGc/tZYH5V1zqXevEuLOWUcDlx4HzMjOaRxsQLEBeGXz3x4+xP6nwpdt9uomzGF9/dQ3vPjpApCTGhQ4tYfPp5bP2s18EeCDmOjYAVH6C4b/zhKEtWSEz7yAMWAu2y7oAgUiI2lOgCR5UY6/Ot4cSnVjhjc0eIiUXrvxPim6isJKRLsR6N8FaJ8azUYHIS/sCXOulDAJPqGudGDsjhUlpaOXur+XzrmIXkZPc3OwbZK7hJ3bnoKTESqQwyCuMSoM0cpj43kSuf5LQkZsJNvmaaGsRSQWWlFlU+uB6Mg+IS0/vEWWvZZMNt7PyOVB+9bnofHAmhq8HT7RX4ZlZRDKrV/y0goYg/4ksVp6kScFYXjnIJa14AhToWuewNczRiRSco/c5V3uGzH/2acFBKbA8sONFy0zrnQOkksgiiVfWMqzNiQ7R/Xf0jqWxwmu+m+CjZ2NU1uG/+7W7cBDBma+XKNxezXBnJcVmP32uCe3hzhj/2//qF/jBh7vY6CZY6dRlilGuZ91TXV0yvSol3NOglyriWPlFkQApFN5ZPX/9AUYbECzA99+n1pU3NrszD/iDzS52RgWeDkvcX8+gLfB0mOOZnxSdm41Ar1p6lFYhFK2zyE1z/5oBTWkof+kXp5Cy7jwAaFVRaRsGMCmoJp7FVO+fB58b6mmm1UisBNa7Ce5vnE16UwrqWNgZ78M6F8hb49L47hD4lj0R1A0BBP2DXBu42vLhudC0lyXtBiahWSSQtYOkH5yaRlNCAGks0bFkQz3MdU0a9Ntn5vf8ECp86YACslnb1hlS2fzNuCxNED5vwSrZb2NRkMCbZ4VItpA9dD79sTtRGz5dhYSaAA5xKfiYI9/WKf2KWvv7WEqa6DkoqKxDhGX9+QJppFBog4O88uUrAalIbrvyUuEn3deF12buRcsCOyUBJSXYsCiOFHqpCqTdeTjgxAF6qS1K4/D737yPv/2V89PYB6iE+3/5Vx/ihx/voRMrWJDQGWdld8dl6GCqTK3fAVyNe+wk4GumJMuTU6mzMja4Tv7u27fOXX+A0QYEcziYVvjee0+x1okPpasjKfH2nRUM8z0Mco21ToxuEiFWVZC8nLEEvWKwPGKDHtyT7Ce/xhgXWve4lh1EiyQgpCRylVwsLsTkw0jS6igvDaaVwTuf7CNW4syM2TsrKbpJhElh0M8ibPZTFPtTFJraEI11uNFPZ9jQHH3rM16wMHGIBo9AcABAUqOpUDOqkeysBtSDeRqRaQkHC5R6p/KC8aO6mF9V+UChNBYSwk9gDS6Ew8LyD6eJF2HRaopXkkdNRByAUH95/fn8Wsd/95kbJSitexWyA/OraQqCgVjO6nAIIRB5HkjkHNIoRuTDCE5JqwVBAZcE0kgh1zRexP4eiJSAcUQi43Nx3Ck5dEmPCPDmAzklaMKpDAUGGz1qiTzKQyQ+gUHRWS2Kj8KffvAM//mf/BK/fDrCcFrRM5LX++Scw6gwMI4cX4HZe/MK3GLHQoCe3SQiF0luYXUOpN3igN94bf3cz20TrZfBHH766ADPRgVuLWFwrncTfPXeWhAdqQxrYnurYMHa/Ze62ydG0Nhf8oRwRqC58uPfAQgMamtJiyGJJKSUtZfCCdKAQohQqxQC+P4Hz/DZwfRMx5XGCg82u15zgJwQb69kEEJgVGh0E4W17mxUba3DqKhmJq3TXjb2DuABl+Wfw/Z8B0Bl6myMAII6Ifz3AGVcjKMSyFoWo5dSKyJfMwc/6fgv5l/wficRZXHSSAVBI8BPysvKGTO/ODq1uiz9HPgpgtPL9INq3jeN92lXlz84PrtKA7bijA3zTeb+zqqfxlEHwY0eBZrcaUApajf3nvr/sb9fKv8QamNhLXEQgkx140NF4yuStXJopER4NmeuxYKT2RyPckMZQCkE7q6muLfeWRoMnLR9kIOB57UoXoa8MvjDH3yE/81/+VP8YmuAidcr6SYRuokKXxnLk/L+4OouzBaBrq2gritBwai2rHdBXR6v3+jiv//r98/t3C5CGxA0YKzDn324g9S7HC7D3bUMX7+/jsoT45xziCMZyEU8GEqxeHV2VdFcsQoxa1wUK9LcZ1jQoMK1SHYbPCq1yLVL1uOflga3VxLkpcY///k2fvbowEfCz/ckP9js4vZKioMpbaOX0mARK0nkrrkR4skgx/6kmrlGy7gSixD5CY18BuDtsGcnWg4SjXVBOlXKOsPCQRTrDHCKlzouiBux1omJbCjq9lAmUyWKzKKUEEgU1Rw5xdsM5BZlo134hz5zGRHwKPCq38cAYYK3PjKaTxjxuaaOMJqU1BUYhfjcZhER1GK5WJSLwW2kTF69s5IhjVRo3dWuLvPQ9uuNCSmpz9yR2mmwSxazwQcHVFJQ9og9QvgepdSy8F++XIU6OGh+zfMiIkHPy521zpHP7EnaBzkYSJV8boviRXi4M8Z/9l9/gH/4Lx4iLw1ur2SQgibN+V3Oq5OXXK4alB8D0kjMLMR4ATAsNLpxhP/pX/vCuZ3bZWhLBg08GxX4bH+KG/3FTl5NdGIZrGm1dUEas2mjqUS9UrgO0WpzggAak4nDjMIhwzjS0OfVaLMdswme7AptwspWW4f9aQWAVPj2JhX+9JfP8MunI9xcSfHqBk3uJ+kyYDRLOvuTCgA5s339/hp2x+VMv/Qw13g6LCAAZBEpTlqHWaOgJeCVWjMtLISA8Ixt40dkHmg5g6CtQxrLsApvBlF8bnggaG6XJitqE42XRJhW1JOya6xQlTwcpDTRTOufFdbVpEGgnvAtGp0koMlIO2/KJdyVeDbo2pMIzEkCQuF5EpW/rylL0MHOqMAg19DWek0ImqJnrL59ScU4Cqq5rMOrQQ4UpRBIpWjUwakHZj5nQQGCaGSq3KFnOdwbXmp5vZv6DhV7SFSoialXWZxvH2ScRVRoEYx1eDYq8P33n+G7P36Ej3cnGOYVVrMY+9MKpbHoSAnn6BywTfKoqGoO1Jn24MVg0XjirEWlgW4i8Hd+6zX8zls3L34/LvwTrhG2hwXGpcHdtaNJbtpY/GJrCOcc3tjs4rNBjmejkhjWnvjhHNVJuXbO7V5XHe4E3zdhHIIyWDLXd+VcLapD4iAsuEGD0o1ujI1eik2kWO9U+GRvip1xBSGAnXGJbkJdCA82u1BLuAnzWO8m+NLtPv6bj3YRSYnfeG0Nd9c70MaGfuktf720pf0WfsJlkuVR14lWZbMP7/zfAT/ZSVe3XPmJOpbSKy3Sp1D6r5bEhi8xHNrufKSw6LMFe1fUtWgm+DXJVSe5rs8D57zTJGc9nAvXfYY8KCjw4vmSV7sX+Xw0t9+MqZo1e21pgksidaLMnpQ0oVdeDYpd/rpJhb1JgUlpUGoaBzhwVj4TIKWEdT47AJ9lcXXZMVa02MhiRZodpSbiaFNQasExwgcH9S98h4A/z3EksZJFuL2SopNIPB2Vh0SFGCx3fn+je+hvZxUVmsfBtMJPHx3gBx/u4KePDvDe1giVtZiWVDvnYKCsyPCrGXSyrsd1BRNXGQ61JXMkHf7WX7qN//FffeNS9qUNCBrYHuSBgX8UPt6dYHtYYL0TQymJu6sZCm09656WPtqn03lLvCJ4GeFAJMVc28DqnxfVYWIWT7ixqqVdAWClE+OBFHi8P8Wo0LjRS6GNw88+G+DZqMCX76wcaoeaBw9S08rid9++hWGuMSg0NrwA0hdu9XFnNcO/+OAZtmzhU/mA8VPFUVKvfB2VPJ5xHdJ9DpB+21wjtM55NUXtvRtoBcgiNZw+nkezb3xZMMJZGjKPaqZ6WLbp+e9D/sRlb21O6jw4p5FC5ZUpOZxT4vJUEZslME7xL2uF5N9rCzhtkCh57DjAf60aG5VSYKOXYCWLMCo0ngxypIqcPZkYpv3KfIav4egZYRfVRInQMhspcg6MSoNBQR0KZN0rwN0E8+AMgfVlCyVI3tsB6KcRSmPxG3fXcWtcHhIVYovicWHQTaKgiHdeokJNNE2Jno0KaOPw6f4U3URCCoWyMaa4AihhUVnyX+ED52Dzeg+vzBVyoWQoYLHRS/H3//oXLpQ30EQbEDQwKg73z8+jqAw+2hkji1RItUVKYqOb4NmoQEdJ9ESEUtda+4DPFlj30prLWFCUn3tzIXZO5J7g8DpLAUKiJOK5VGUvjXBnNcOkJHniQpOK4OP9KQbTCl+7v+511GscNUg9Ocjx3R8/xruPB1jtRLi9kmFrkGNSGi89Sztm/ENYSoHclw6aKW7Ar3rF8szADHgFHFbp8KZNlD1K/XZir/VQ+sxEs344D+5KcEv+zvuYKIGpZ5Az2LmSa86Lyj8nOKRjMyd83LTadogVvBWw8UEJdU3wKpfB6fL5LoZFaLbBCtAqaj7AEahLF81Jk8s0nJIPZNK5g6O229l20YXH7Dcyz00BvBeHFHh9o4vfeH0dhbbYG5cYFga74wJPBjkkgGGhw7OQxRJKHjb34n3spgoQfpzi0sAxF5K6XwRWOzFib7bUTRQKQx4h86JCw1xjlGtoS1oYr2508NHOOBzvWUWFmmiaEq11Yryx2cOPP92HtQ43egk+3ZuG66gNKXmSdwl5ssDV4+l1HVYFaJyo/LhIHhjSKyw6/LW3buELt/qXtj9tQNCAtkd7fANUVpiUBjd6s6vV2d53IiZlsZpJmStPJLrO6a2jYH35YFrZsCIWAlC+vskrtMinQ+MFZj79jFYvX7jZQxzJ4KO+N6nwpx88xWs3utjoJidSPnuw2cPf/+tfCCuQv/hsgF8+pVKPdQ6ZmuU8dGIFAZKabQqzCZwsGAir6EZ6Ho4mRSW9bKoFisqhl0hYV2sIeCYg5uvNDB4stHGQSxYLPFFmkUKpddgX50tZvFqcv/3OuroS4R+EoIBY9NZ3oXiCZBrhySBvHqonWQJw3uyHf+c3F9ojBQKZkt7qA8ZGEMJYlsXhTIFtnIQQjDTPg3/roXbRJQfvFvxd++6jr7yyio0erbC5FDkqNP7lB8+Qa4PS0OQ3rdio66iQj+5R9gNRUgalQQ4QQgDkHCyIWNr3tszaOiKf+tZHliNuigpNSoNRXuH97RG+eq+D3/3STWTemvisokJNzJsSpbHCr56OsD0ssJZFmJQGk0IDAsGboNnBg8Y4ep2H08i3KXVihSymu55Klw5rWYy//qWLazFcuD+X+mlXHJGsJTYXwTmHT/cmwVe7CSnETO87E+yabnt5pb1nwPW+iY9C87iMc7DaNWpkNKArKWYUA5tgq9LtYY5vf2Gz9lHPK3y4M4EUAr/x2jrurnVONEhlscLf/spd/Pabm/i//+uP8dHOiIRgDEkpz0MpCWkcfbHee1jB1kHIoeNuTLYCs6vO+XOSCOD+RjfYPjc5Blx/n4cQtHJo6ubPn3N+XxYrTCuDvKI9YiZ6qRevZo+7F8OEv+SFy1a0zc6K1YyGmm6iQvaIXgNkERlfMcckLw3p0QOQnphovHYB69FX2obU6vyO8cQR/sKr6eZrUF+n8MhzkOLqwCF4RSw4bg62jHHYm5Seu0GT8qTUuLmSYrOfeF2GegusrLm/WwKggHG1E2N7QOWuzAdRy851N4kwzKtASq3jQ+H3y0GDft/zwQAwK90NHJYjFkKgmyg8HRV4++4K/qPvfPFCWO1sSlQaG5Rgi8rgl0/p2dwaFhgXGuOKMoS6MfNzKc7/eK3BV1j5jiB2jO3EZJx1eyXDmzcvtqtgHm1A0MBRrTUAMCkNhrleyrjl3vetYT4TFLDbXqJiABraM4kq7Q4powHX/0bneZQGbPqByFUOaUQDVG/JOQQoiBrmGtPSBA/1Xhrh9mqG97dHKLTFv//VO6eqq/V9Z8H/v703+5Esy8/DvrPcJfZcqrL2pffp6dlnOEMNxRlZsmADEkhQFEBRMgxJgGn6yW/2k/1H6MmAIEMw4KEImDRE+8GCIAEciqKas5BDdc/0dPd0d1Z37ZVL7Hc75/jhd86598aSldld1ZVVfT+guqojIyJv3Ii4v+37fd8LZ7rYm5LNslMCc7yR0Moqa23w4cEM2pAgi5vxu2TR6HpwqVbIrl3NGcDsOqGylZmypLF+TIJWnDGkh3OSTjYGCliZbBpTSscaEJHNBbxqpHIJAWPW2jqnYEz8DfrZOnLhUTiqFlxH9XSBNtfEmQgEw+G8QDeSKOw8XRuAc+PlrP3rYAzDeQZl+ScuYXK/y/FzuNuzqxwngz1flsy4asPCVP52Ak7VHxib1VXXRQVnZSVuq3KtqUqdpKRHwuzx5JpU5cJ5gdff20cvljVvDqes+f6DKWBHGN1IQm7QlsI0U2U3ZEW2Ja3C5iQtvFsnvW7jNSsCQcHdjTVd8uIScWpV10/M41ofrKLqEXN1i5RgC6Xxlx8e0oiAu+0sOmgNN/5h3ufhab8+AuV1QhvAaI20oPd0sxtAaWCjLXF1u/1YHA2PQpMQVLDTJyEb9yVbxDQl175uvP600c9iS25TtWzfuflNtaFWkaSkwFWWjvj0tH/gXfXlLriMlfPcea7QX+GfXkUgOCapWrJcZYzh2lYbb94a4ftv3z+2NOpwnuOP37qH/++N20hyhXFaIMmcIiDzF/95pjDlBaJAYNAKrRSq1RkQ1Kb2u90oZ9F+5Qu0XumOlf62lTLTEIx2qF3FFgfU4bixN6UqEpQwuRiwuK5JfFWrMGlKXwP32ZmkBYkSCaqi3cjGJWb+3yjfoGN3B7CcRCwmJP5g3N+MRiSR4JimpT9GyBk4CzDLCiQ5Bdy4srLqRkqZKnxwZvacOlIexd5yZc83PuxrVAZ+hbR6nI6AVn2Me121DoKBX4nMlAHXZUK22GQhhU6DUNKKZRwInOvFaEfUDRnOc+xND9EOJa5tt2n/v0fKgGNrkQyUWwrOIXSea2+itjiyCiVHFxKTJEdelB0jwRnaAZ2/6v0XpbvpM1P+/FGvD67CKo+Yw1mGt+6M8fadMQCDtj3uqS5KDo5LrJ/2C+MKGFAC3I8lLm606Dsccmy1I1zZfDyOhkehSQgq2OlF6IQC06xAP14myxB7++Es824s/U7y1Aae0LZEQ8GRcG115xkYM/7ixBmwxlTsqUM1LrggpAy14fenGbQx1qWQW1JVWQ1xRqObVZarga02//AvbmKea2qPatKA6Nouwk4vwpluhFxp/Js3b+OPfnIbb90ZYW9KK1a5JdUxVyFpQDGq3nPNkGvq2zjxmFw7AR1WmSev+gwwBCCpYmOzBUdQFIyY4pkqV6YAqgw3OyFuHSY2iGPtuibjpLWQ+QoZ9Ds0SUYrXSovxoHAoEW/r7BbL7XWOBba5WtQfZWLycCqr4F/35njNLiuhka7onbnmPPGkBZF1UFUMOa9M7RdtXNVMOnTlxbPgf1epVaKe/H1lDPn6mjFnk9j6h2CCqoJRTVZcAkFA3z1KjhDrgySooBgDGe7AdoRdQIiKRBJAW0MZqnCz26PsDdJ8fK5Hs4PqHConkbOGbY6EfpxgGmmME5ypLlGblavLYeB8J4ioSQfkcVixnWpFqW7A8ke+frgUVj0iLkzTPDmrSEmNilqBdJfA3Knz8BLz4tnAS4Zd9oiytC1q207PoIzvHq+j3FaPDZHw6PQJAQVnOmSjOfu3mxlQpCdQAqrzPZzDOd57YIXCoZ5XragYUrClCn0M7mJ4F6S0TR6SQtaaRKcWaITzVE7lTZndcaZ5gp3xyluHswwSgoczDI8mKTY7oTlrj9KkmEkOd67P8WN/ZmvGiPruOYCbZXU6DgAWhtkGtbpkSHTZAdtgJqXg2/ZL4DbjoG2rQQncxsHJEOcqWWOAKkpMrQCjnmuUSjaOReM1XT07QtEIMp1MqOdBLD9nSDpbLov/dWNA8zSAllRttQdx+GoMVXVPa9GlMTq1+6ex20CCEZJHq2OLbPnGaMEb8P6hozmOZnjGO03Lzhj0IySgExpv8pLO/3MjgVWRwvbXKhtE7jHAGWS5SRiVz3eQS+8fl25k7LvQcBJUXCSFbh9OMd2xR+AM4ZuLBErjvvjDOPkAGd7kWf+L/JCpOAYtDj6sUSuyNwmsxLHjpPAbaEhGMM0KzBKCqSFriVWAJAUZAvupLtJNMlgOMvxbjF5JOuD6+CEht57MMX/+foNJLnCe8ZgNM9x83BOoxWbmAhtMLer20mu7FimPO9PewfVdarcJgEDoBVgDMMsLbDdjfCFiwNoGJzpho/N0fAoNAlBBYIzfOu5bbx9d7xybKDN+gvhKlC2H6IfS0wz5S94BgAYUKhSyIUBXqQEgJc+XppzPsVwalzGVn1JrrDRCsA4McbvjmiuP2gFfkWsUBq7+zPs7s0wywq/K92PJRiAl8/1ahdSpQ1+emuIH904wDzXaAccZ7oRtDGY5xSg3IXSBQwAfq7KhZvF2v1tTjPOQHKEkjJ6pY9e92IwMIzsciXnFU1y+nl13dIZPXUjiX5L4v44q7TEy3l2rYpkFAjSokrOI9JdJ6A9dmOINJnZABGHAqkNqFWWPT3fem0Cs3A/zsrPI1u4n7tN2kRGG3K/nGVq2ZSpgkDSe14NfvfHqa8cIzB0IkqWZqkCd1sEldHKugrS3c6ZW1Wsg5IpHDsJX/w1GrDqfzRScs6H45SC86KDoBQcW50Aw3mODx5MEEuBWHIM5zkGK4i2zAbMUHIcVbfHIXWEqteZzGjPbRCcYX9KJMbCFjYv7XTxNz937hOvD65CVWjo1uEcu/sz3NiboRMJ3B7OfZcQcJbrBiKn5FmvWCWtfn+edpSbMnYEyBjO9CJ8/eom4kDgg70ZfvNrlx6bo+FRaBKCBXzh0gBnuhHuj9OlnffqitJJsJjtZ0pjmhZ4MEnpAscsqcgGRp0qPzOlrNI89aOE6uthjIFxck88tBdCCmLEhH4wScEYcDDN8KMbB7g/ThFLga1OWBvXjJOCNAUqF9y37ozw4xsHUNpgsyWhDakeAqUHvHMT9JXy4rEy60VhDDJF73luL6Id+z4puy7oOAWOJ+EYw7NMWcEaO3s2xlf9oSd6GQznOT2n4Lg3Ti0ZLKTPSUGraEcmH7biaIWixlchxriE0jlmmUIk7e8OuOUkLFfQi3BcEF7pitBzm7UiP66VX2iDUND2gDFq5RdnMUGqBr95rpBaRboz3QhbnRDDeY6PDmb+vTS6VNM7CrySODjOB+zWgV7zOo4Lya1kt30+2mChpEUpjTvDOc4PWrWkgDGGQSvARwekyrnZiTDLirVJwbGPpXad0TboApc3W+jFgU0kyZTtxZ0u/uf/+lXPZ3lUWBQaiqTAZieAMbSa3Y8D3Dqce6JsVYxHKYMCz0bxU0W1C+cIk7nPoGnU+Y1rm+jFgV33fPRukcdFkxAsYNAK8N2Xz+IPfnwTm+26BXIoPtmXp3rB60YSkWB4/8EM3LaLnXAN59pWPcaT3lx792n8svjLW6WsJPlWY+feBbqg7YNQckhtcDDL8dPbI2y2Q5zrR0skxEBwTJIC0wrx8N17Y/zwg30obaiDYC+sUhuMEiKEhoJD2AzdeYz7w2LOvdCOBBhDKIDMGOQaMEZD69w7krn7SV7yC9zvbIeUsDjnO8emjuzal0sGBGe4vt3Fm7eH0MYgsBLN3M4Y3Tmqjv8FY1BaoxUE2O7SDvvMimAFlWNgDOjFEsUsxyxXEIwhYLSHntq9bl65WjFYWWaUBD5TSWiqe9/rPoeMlcp9nBlMksJe+JcfsZggVcEBpIVCL5YwoLbzxG4mxJKDSbqwznIFYQAw482lqnBB3/+/cbd+cjBQNZsrbdX9qh0m69eQKdw+nOPKVrvmKGgAa17FcTjP8eVLA/z87hj70wyDh5BuHwalDcZJgV4c4AsXBzhXKWyUNnj33gR/83PnHnkysCg09OJOD4KT2+g0pe2s++MEe9PMb/YEnEFr5d+Rp/H69jBUv7suAZKCkxV2rrDdjdCN5GNxizwpmoRgBb7z8lm8dWeMn94eeTYsQNUhvan1veKPA6oYGS5ttvBgkvr9Y2bbsmDOyKSspAQvGdRPE8ove92YxY0PlF1D4yyAFIx20I0BN8A8L5DkAboLF0gXyKdWXXJvkuIHH+yjWEgGAGoVB4IhKQwO5xmJ9IAqErbCzcglA8JmCS5hUAbQyqDQBc32XV/f5mxuNugqY7ca5rYCNEh/QWlKBuJA4NXzfXx0OIPWRBgcJUUZcKslvPtdADJDa3DbrQCDVoDNdngkM70fS+vdYMCZQWE3FVywrPIhytY//TKnsa7trHzdZ88lE+7fTv42s4S3WabAmWO/0/2qCZJDoTQmaYG7Y5KxJU0C+qVZoZHlCspqFCySzY76Wjzqr0y1c0JjmFLuuNphKmzCe/twjmtnOv664RLZL14a4E/eeYC74wTfuLaJn98d10y4TnKd0Ya+R2mhsdOLVsp93xsnj2U+vUpoyIG2swy0VrgzSkm+2/JyiBdC9zsOyfVpg/ucVJVGO5FEJAUMDJIcuLQR48bB/LGuex4XTUKwApEU+LUvX8StIc2+rtl9WceKz+2F7OPCVYdxwPHFS5v40Y0DHExzJIVlpxu6uObKrlbZx7mtBGPKdi7w9GTVi8fp2ssuMM2yAq1AYJKRYFA3klCGWNBSrPZszxTxDH7wwT6mKVWUNdEeYxn7ufaSuYYZ79AI1JM7AyLqKU3tS8D4L7WLy47N7meBpt4uTrhGJCn4dUJBZC9l0AooATqc5/6CfXec4r37Ey+CkyuaQQuGytyd+ddCXQ0KuKOEyKqDlsRGO1zLTKfVPIbckFytFUeDZOXWBGPMPzccz8MAabFMuFv1uXPvIWeo+QBwzvw2x8wKDjkyqTblXrzWdF4OZ5kXjIoDjjiUCIS1hy6UT+RO8pl/HMmAS9wdydRY0mNV7pgxIngWmsx5ouEcFzfaNRXDs70YV7eIyPzSThdfu7rpTbhW+QssgoyyNGYZraa2Q4HPX+ivNARLc4XRvHjk8+kf7R7gX/7p+xinOXpxgA/2Zr77E0iGw1lOQkMZ+TBIRolAsZjQPS0XshNAcoYoKIWtnMkdY0CSaWtGRsTix7XueRI0CcEaXNvu4Le+cRXfe33XJwVOYWw4zz92QlBtFb92aYCdfoxXzvXwxq0hGARG8wIkUVOSvdyqE1iZFDw1WUAVlZGBAwNdTLmgajJXNGuPBIMUHBK0krY3SXFho+7d7ro1v7g/we1hgjior1xVDZYAW8EaR+YxEMya2aC6nkYriYstTI2yQ0PEOuNHDm6+LiuExFlGaoiBpI0Hbeh4Cq3xuXN9PHe2g71Jhh/tHmCeacQBzX4ntpqqKtW54zXGrZZJSDt2yJXBg0mGeUatx0Vy3jQtcDjPa10AzoAw4BjEEtqQqp7boDF2xOE6BYsfs6qGARZ+7hICbezoxb3dhhIDyWg9b5zkdjxECVOSq3IkoJ3AV0TbOVmBvABmebl58KRhUI6WAPfdLJOCqtwxJQUGuQLujzP0Y4m0MNjpRbi23QYAfOnyJu6OMrxxa4S/9vz2Wn+Bauu5+u9A0KbGUZbhTnToUc6nh/Mc/+5nd/Ev/vR9jOY5IslhMF86xoNZhsNpaU+sUG5pVO93Gt7bR47FHM4WFkppm8wH+KXrm/j1r1x6op0BhyYhOAJfsdna7//wBt65N8G1rTYub7axNz38WGODQmkM5wXigOO1SwOc79Ns79p2Gw8mKe6PU1zZinFj31hmNrWoXTegKjvrvkjuwlsVAzqtWFkBMGJpw87WlBVtioKgFGyRHNNM4XCW1zwkXKB85/4ExhhElZloVmivhiftHpw2JBzDgVL21RIEXZVX3Sz1QdSUoxpXQQsGv1++auvAGIOkMJhnCqHkeO1iH99+4QxuDxOMkgJ/9dEQ792fYJIW6MfSJzJOlraw0smOl8g5rN552XJ3nBSpDaaZQno496z2UDLrE099jl4sMUnsOqPdfsg1mSH14oAEm5IceWXNaxVIv6H8f15JNNzFjsYEzJIFTYWbQfoDha1o6fdq3B3NkVo1wEFL+nW9JKdtg+po4LR0xbQBWOUa4JICbRPFqtwxYwxSUDfrw/05Lm+18cq5nq/gQ8lxbbuNO6MEH+xNcX27s+QvMLVz+EyVa4ehVSzsRBLtsC5EVIVLBh7VfNoRB//9W/fwg90DTJMcO/2YfCsqx6A1STqP53lNkdW9dy659FbYzxiIQFgx0wJ1H9NcISvo+/Fb37iC//67LzwxzsAimoTgIfjKlQ1stgPvmtcKyJVslqojFQuroNke7d7v9CK8fK6HjcpsT3COV871LGte40w3wt1RgsgGwrltobu1PWY5zXlloPs0NA2ofV3ft3b/UoYYBvRz0mpw4DZwD+c5+rGsEa6maYGDee4FagDUAmF1j19wBlUYasXb1cdAOPGbuulU7drKylE+rZ7SBVkbg34c+KTAkf/89oLRmGakbPmPv/0c/s6XLmI4z/Gv//Imfu/Pb2A0L8CMQbqw8yY4Q1FoaEXt9yis2+EugnMipaaFxt1RAvRjwAB3x2Tn3QoElHaOisRqJtZ+4fUx/PmpdAeOeh+ZPbeSuzVOY7XYydGQ5IVVrVKunlDODIazDAcz2gBph9KPPjgjItreJPVtZcmt+dEpWMH1n1kNMG5qnQLHKShUXeeC+CZkEb7ZCpZm+1e32z54VMeUblRZ3aQ5CR61HHGVODhJc2itcXGjtUSCdF2fw1nuO0aLHSfyqvhEh3OqQQlASV4G6DVLy+v56tUN/NO//ulZGx8HTUJwDCy65kVS4Nbh3O93HzXbcxbI7VDiVTvbk3yZ3Ttoh3jt4gD/+eYhskIjlORqFgiOTlfiYJb5mSRdgOiimin91LgnHnWYWqMUF8Ky62RoBVymmcKgxT1rfX+aQWuDyEqyFsp4oqEj8jg4oRwyoHH8DGbXPY0PdOsaP4705JjCylZrrtNQe60GmKQ0031xp4f/8IsHnsj1szsjXNlq03oao8+CqlQSgjEUmiRvtcGRyUB5bAyRpKTg9uHcH28khW1lGy8dTElB4DkHDyYpJglVcZKzpdmu/x2Vc+N4DGXMI+Km5ESWdUYtLtdx/h1OyyOUHDPrJ3HFrsW5oDJJC9w8mFGyAlg3QeMT4dMA141TBhCVz6vrKjn1TPeZISdD2nDZn+VIc1Vr7XdCiSgQ+Buv7OCHu/u+I7mq/X9cPGo54ipx8MIgwg93Z2gFZYLuRljDeY4Hk5RcGXXFU2LFcz4rnYFaumv/JxCUHAaSI7JCWrOswKAlcW27i9/46uUnojVwFJqE4Jiouub9xY0D/G9//At8eDBDKxerZ3uMVmoGraBmbHIUSPdgA2/eGmKc5JgXGhsxyfFmhUamSYKWW7ljwRlCUBB4Gr5Y7vwshjZjALd45Ix4tCUl+cdaEtfIdglyReS4uXVEE3ZNbpYV3mJ5aXzHKODlyl3AjRdpqYnzrDrIynMYQ9UhZ2a1gJUmUSADgy9c2sDXrm7inXsT/OGPPwIYaPTRDvAeGAbtYO3oqRcHK+Wv155fu8J3MCc54A17ngpt0AkFNtsh9mcZCk2qd91IIpKUHLVDCWG7JbNMIbUW1rRxQZ0F3ymxr7FQGnzBCZAxBsmoXao4fBfLiQlxxjBohcgK2jpwOxwuqCQ5renNM2W5DoKY6MacGtaZ45wwe0gaqCRG8CRJZ2vtCKitUCArNMZJjrvjFFe32v4xglOiutEK8LvfecF3JPstiZ1efCIJ20chR+wUBu+NU9wbkcTwf3j3AZQxuNiP8cHeDKN5gZ1ehEJpL4g0zciUzABAZQR3Ot65xw+/acNoJMBAGxWRLWgE59juxvj2C9tPTGvgKDQJwQkxaAX4G6/s4OpWG//s37+Dg1mGfhzQWo2d7QWSoRNKdCOJ1poOwjqcH8SIJcOfvb+Heab9DLwVCrDcAIKq2UIbal1zIBCAWpb9P51YEWyN/Q9npO7nVtwWL4JScE88nNnZvDOHYQyY2xU1uUKRrnwOBm2Yl5tVZmGFzFbqMFjfKUDJX1CV9owx8N4BnDE8d6aDr1zZgDNl+v47D8AY8M3rWyTOgqN9MY6Sv65K8FaRFhpaaRiQWl4nCnCmG2CjHULbFbh5RpoMWhvflm+FxE3Q2iBhysvJruqaHNUa9/dhDMySIGE0cg0MWgLn+i1khcI0K9AJBXJNq6C9mFbsHoxTzOyWgRTckuYYdHG6xLnKsVBJxGSM+c+yAY2uIslJNMpyP5yPxs2DGS5vtpbe/2mmljqS796bIJIcW90QnVCuTA6UJu+PvUmGrNAfW454UWFwmilM0xzv3Z9C2fHT4TTD/ixHobS3YXafk6zQ3ociLTQ4N16v4VmHtEQZJ4vuupBO1Mzpl7xwtvNEtQaOQpMQfEw8f7aLf/zt5/C913eRKo2Xz3Q+tsJYFcYYHCYFvnhxA3/rlQj/9md3cXM4BwdDoYFOJBBJCjxZYVd3TlUz9WgsHqOpVH2hoNa7VvVA6yAYQ2a0d//b7oS4P8l8RZZYmd4jq2jA2h4rGlPAVcHM/w7HJ6gR2WoVYDk6UHbXPFfaz7o7kcRGK8CXL2/UVr9GSe7PwHF9MdbJX2cr5AuNre5ptMQQCIELgwhxQF9zLoi0N0kLZIXG4TzHNFNe/4KOy3EruGXHG+sf4AyF1rfGF49FG9L351xAaYWAccSS4/44LZ0PGfOjIGXHJEYbW13Zc8CcJfTp+YRXA78BAA2vaeFWETkjo7NgYb4uOavZezs48Sqg3pGsBug7w6QcrbFlD4/r221867ntE8sRr1IY3O6GONON8JOPDhEHElsder5ZplCMU6QFkUOBuj9HIHiZJIFhlSjVswYnSqaNqX03tAa4ZDjTDTFNSar9v/3l66dio2AVmoTgE2DVFsKjnvn9yktn8c+//wt8dDjHJM0xsTayAH0Jua2otS6Q2z177hg8KPfDnzRWxeiq+p3grEZMWnXILuiMkwIb7cC657kAS8RAuaJaXYTblU+MXiLQMXss3FB27xODFQdkACS5RsA5Ykn+CoUmjYMvXtqoEcfujlOfYNwbpyf2xVglf51bbwJXraa520WX4IxMbdLCoOrTtdEOsTfJyCcA8IEZoNeZFspf0NwWQ2HFY7QxYKa0Xa62xqW90Y0TctvhiQOBjXaAWaYwtqZUuSKzI3oO+nM4y2iVU2svLV09z+YUBRU/+mKwGyv070C4FVQ6/prDZAWCMeS2W1NNCIwxS+S8QSvAr7x4Br/8/Db2Jinu2hb+NFMolCYBrJBstM/1Imx3oxM75K1TGASAX9yf4N44RTciPY3RPLejgXI1Gqjs1wNQWnneAIc5Fdefxw1tL7TGAKJiPy44w3aHunOcA//gm1fxtWubT/pw16JJCD4hFrcQHvXM76+/eAbdSOJf/eAG3rw1xN44QzsSNTa74AyTeYEH0wyCO0Z22cqkCvbJdhCq9Z0T8gGcRr7BwnVw7bjYrbVd3+6Q1r3dW0ytrfBxzzq3UsMu4PsWsDteOzf3bWHXgXGJlk0kQsFwZYtav059cFEuVhuDmwczkiwGw0cHM2y2w4/1flTlr+vnxeCjgzlJP9ukiDNgnOQ15UbnujfLFOa5Qq8SkNy2xKLWA3UL4I2dXIsYdqSQFRqmQiwzoNHP+UELm20iC/ZbGrOUggtxIeoVpRPWgaFORv21laOdylvwROG7F5yBG2eExbH4tVcrPsicr7f37oSrCwrBGVl792PgEaoMHqUwmOYKHzyYIis0bie57xalivglTgLcXWcc3KqswbNDGlwH503AOV0vpGTe7wSgEVCuDDbaAb5wtotf/8qlJ3zER6NJCB4BHvfMzyUd//dffIT/96/uIMkLnB/ES0pkwySjtSw7z2R2+EsseOM94z9tuGTAJyk22LokwJhVM+jl5zGGVni2uyGubbfx7r2Jr0QWA9nD4K5fbo9em7IlXiPJ2f/4W+1fypCeAQBMUwVlzFq5WFcdt+zFfpwU2HjE7GIyQ9K1ClMKToqFyiCU9QDcCuj+JKRDAdp3G1ZI3DNG61JEfrPdHdi/NRAF3DvVCc5wfhCjV2lNSM7RjSXujVNPAPUbC7BJhTErHQmd+Y07DhdsniRcIKx24sxiVgmsTGyd9kXV3ps4LRT0Py385YeH+N7ru8iU9hLtjlQ6TQv8/M4I7z+YQhsNyck4KytUZRuIUFVTfdLvy6eNcuuGxnTdmPRTiEtE4mcv7nQQSo6/+6ULp26rYBFNQvCI8Lhnfte2O/jd776InV6E//0/foCbhwl6kUQ7IlnT0P4pGLVrpWXF0ay7VLnTj7BbUK3YjlO9uXGGX1djjEhpki051i0GBdfO5pzh0kYLgpeeARpqbSBbB1fJMpSbDTTzqzjirek4VOfHua2Y18nFAqWWeze2a3VJ4ROPR+GLAVCipIxBWDkJgpGrmhPKAcougOAc5/oRDme599FwvI2jjsa+bZRogpYBCxCPQBsglGzJ8tehFUoInoMzei8jKbxgi7JlpVzxJrqOhPvJk2YTeE6J7Rxxm5VqAIv1fTUhcP8OBIfWqjZbdyTLc73o8R68xe7eFL//wxvIlMbVrTayQuPuOMVNq4w4SgrcHydWKIxkr4uMpKN99W/bZOoUJGiPG+uub96HwdB3KlcagjHEUoAHDGd7IWIp8dqlJ+dgeBI0CcEjxuOc+cWBwD/81nVc3e7in3//F7g9SpDmGpNUIS+s3a6hGW5qaC3OifpEksRttCEp0aOMao6LKs9L2FmwNnXzJXe7u4g44iAA6+xI65mFfZB7aPWclLNthkEsfHXtW3PGeALTceEubAwAB/MiO7W2+BH9TtcWH8QBXtrp4vmz3bX3nWZFGThQdkoehS+GQ2YX/utjDxodZUrDUZgc4xmG+ATtUPrVxkJZL42TsBsMnau00NhoBV5lcPVdKdna7ES0Vpsrn4gY+wFZ1xk6VajyG9zpWpOlVF9P1d0xyVUtEdybZLi+3cZ29/EkBNU1wo8OZvh/fnILHx3MsNOL8WfvPcDBlEYCTu1zltLqahQISixVmZQ5ae/TIBL1acGg7CZWP49EIAXOdiP04gCh5HbExrA3TdEKJTa7T9bB8CRoEoLHhMc18wNKXsHv/WAX90YpttohUqXws9tjTNMCwrKYGcggRvCSRc4MEEkKRNIQGe8kX2qGUq/eBXnGAGZbvZwBpkJ0czr/2gZEHxTt3L4VWDMY2zI2dm7vEgK3PSA5w9luRMHNVp+dSKIVCNvqPOFJrB67Ozdr2uKuEnRdA6qKaC7YjaTl369HvmJfjnF8Yl+MKlbNqh2qktfzTHnBFOc+SKuNGe6OUmjAyya7EcoiXHel3NKgbtei18TScdjPjBQMFzdaPhEpiZGrUzo/n3Y/ZHhiypxrX539jCzeo3o6Ft0dAzvGUZrGN996bvvEhMCHYdUa4d1hgpuHcwSC4cMDKxvNLNFWcCSFIhKc3ZQwhpJ39302xgCfoWTAYyERgCGC6GYnxBWrLOkwmmfQBtjpRU/cwfAkaBKCpxSryIxfuDjAG7eG2OqEmGUK90YJMmUQs7qSWiiFd9UDaMYMBrs+xmyluPoLL7ibuZc/r2bO1AKn+bVrT7vrZGCf34AuMIGggOTm9wYU2CSnxCEtiEXfCQW2u5FvL7uEwJlNuYvoSWpbg/K4FmPYYlu8vJWQK7pYbrZDGjM8pIRVpp4yuHP1SXwxll7PEYfgjk9bgumWFShyoNXGyBolpX5lytCDygN2bwArRy2h5CR8FK0XWCqPkY5DaVPTWLg7SmqM9GVyaKX8fsLt6bWv0I2ZLHynq5IAa0PujmUSRZ/jx2FJvG6NcLMd4qODGdqhxMR2Afqx9BoarntYnnFOHAH7va69uM8YbD7rCx/GGALJsdUJa8lAkhfYn+Z45XwP/+Tbzz1xB8OToEkInmIskhn3JvRlPpxl2GiHtSqM9tKpt8k5BcRM0ZpeHArPLWCM2oRZoXxL0AVIwUoeRLlWBL9rbAxV9mTVaufL1nUPtuJWhkFrEu5ph9KvbjkFQW0MGCdVr0AwbHUjr+Z3MMuw0QrQtuQ8xhgub7bx/oOpF9U5boXFbJm5ripdBzc7bYcCnUjicJ4/NBAKmwRVn4Mzhp1ehHYoTuSLsQ5HHYI7vmmq0A4lOrH0HgJVhIJbwiH3RE3vbVAhqgrbRXEXRdI+OM4xlsERKDUWskJhlhXl52hhVOO6H1VioatcP+nY6yTw3IFVWMhGqxtAAAXbwI4Lc6URcPKUeByWxEetEX64P8P+NEOaa5+IT9MChbZeFKoU7DIAtB1F0eceYDDP/ObAOri3WHKSCc/s++g2Q7QxmCYF9mYZXtzp4n/5u5/HSzu9J3rMJ0WTEDzlWCQz/t6f7+LHNw5RqJTm85IjUhqzXGOW0Zc94BztgFTiOqGAtEIiSa4wzwsoe5V1bTGGMhmg20uPexcgSaqT1SSD6csDGHAEto3gZt2BoC+UXWf2BD3BDDqRwEY79McGlGS4y5v11hwFVYlxQpLFfM0cehFuUOK6IseFOzfb3cgfWyiOfnwgl38eCoYoELi+3cFPb48QK760g34SiCNeA+fU9UkLhVcv9Gk/fsX9ylVG2gA5Sfv6OPd191k8VMFJeTGUHJ1ILiQidB9yQ6yTPQ0jN9BPKydYd4ppu6AkPQKlmyZnVqtBG2x2Q0jBMZllGLQCxAHHL+5PH6kl8Y93D/B//KcPcG+cYhBLDOdkIMXt9/6tO2MMrbR1VcOC2dfhJKbhxLmqrxOf2eYAANgVXPqcus9mP5ZQxmAyy7x/x8vnuvhf/85rT10yADQJwTMDR2b86tUN/LN/9w7+6uYQ2+0AuS6D6SwtMEoLqv4NcDjNMEkVQmF8dRNJSe5/lqiX5JqqMAOfBABlJ1kwIJCrpXSNIbnZUFAWnRYGUcwxaIWQgtUuSFobuoi15FLQB6iKaYcCOwss7CgQuLrVxv1JCg6rnLfCx2AJjuNwgkGDtrPUfovcAl2F9TAnuk4offUL+9vcY6rW14utx5PABfPq5pszcQo4w9Dqzl/bbuPG/mzlcwRWErkqNPQwVJnzDz1Ge5/F3MGAHCgdAXZVcpEpXepCWLjW7afRJVh3Njz/BJUOCOi8OG5IUmh0QhJocmObSxstfHgwP7El8aLHwMRW97nS+KuPDvFnv9hDWijEgcDdEfPHZgDkhcLtYeK/z1IwL6bkDK14VcPkY56rpxnM/tEoP6fVc8FgN3q0lTu3q72DFult7HQj/JNfeQ4vnXv6kgGgSQieObRDid/+5lUMv/8LzDKFl8/Wg6s2BvNMYZIWuDdO8PbdCQqlSS9BMN82lhwoNAnb3DycW11y5lnGkpEfe67M2mRA2ZGCFByposp/FQvdGIP9aYbLm7EXP6kqDlJ1q/H5C/2VSpAv7nTx1p0Rkpxa184HYW1310ZNvmJvfB2Moe5GIDkuWfJcWpBb30MTgkgiEMwz/KuPqVpfD+c5Bq3gYyUFq4K5si8vyRVaocTL53qQnNcSlOq4w1U/aaEg+TEDVIU5/zC4inkxvCpNBjBVqkL9tZUrmoudEGdD/akHL89zZKV+gj005bZnBLPnkmG7G4EzIvu2Q4G0IHOp4xLOVpED3Xdsb5Li9uEcB7McYEBMovrot4Jal+39BxPvPsnt90QbA8k58Vxs5qDMZ3ssANB1y4kOGTsejSVHHAhkijxFzvVi/PJzWwgEx/1Jis1O+EhcJZ8kmoTgGcS17Q5+6xtX8b3Xd2ve6gBdQJ2/+rl+jLPdGP/55iGUNkvBKOTUGm+FArt7MyQ57SEzkKJaFHBMEtqxr1blVAVR4I3sGs6gFWBjhbOfMcYr/H31ygbevT/B/XGGrU7g+QrDee6r21XoxRIXBi3s7k194F2XFFS7FoZzyvQfEvsc4Ypz4NKghZYlg80yVeM0rIMjPw7nOQyw9Jiq9fXHTQpWBfPcXv1DyfHapQE2rGBSNUGpVqaMURC5O1IrA/MqLDLnj4ZBZE2THFyXpReReuKq7oTrGlTNlsqDrq+1Pg4I7uy5Sx4BEQPpNRmUVtuulRwHtMnjxIbigOzM51mBzU6IwTEtideRA88PWpgkOd66M8bBLEOhQSZKkkOD1nTvjpT/7jEGShhgTXhA7ifa0DimPK/lOf4sdggcfJfN/jvgzBuAtTiZVX3lygY0gPuTDK9dHHwsV8nThiYheEZxXJ+FquXy/jTHoCWXZtntUOLioIWPDmfQhgIcDOn408ofaeZzexXRoAy7Hwc404tqVUoVLtgLzvCFiwNsdSO8zBnGyQGG1uZ4lBSIA4FXzvVWiv4AFMhe3Olib5oizSkI5lYprGq8U+1atEOBQhtMU+UJc6ugDZEvOQMubbSw1Q397as4DavAGcOlzTYeTA4BrH5M/X3IfAvyuFgM5lpTV+VsL8KXrmzifEUBr5qgLLaqO6HwycKiPPIiqsz54yQwSa6x3Y28mBNnDNO0QC+WCITA7t6UtDoWMjTOiKiq9PJ7VR0bPI4gxu3v51a62VQG6ZyVBFFHHHVmT6797kSalNa4M0rQCiR+9aUz+HtfvfzQ4HEUOfDOkCyJE2v/XWgSl3JdPMmFV/a8O0q8z4WBJQxWxn9m4e/Ff39W4RI9Gm8SxykSDK1AgAtyE70Qxx/LVfK0okkInmEc12fh/CBGHHC8fXeMe2OqQjqR8O3YaVog16V/gDZERlT2gjNNCxzOaO+Wc4Z2JHG2G6IbybWBolB6pfb/RqVavj1M0ItpnXJRDngRO70IW50Qk6TAJCWNeG2Z046V7grTTkRJD2cGCde2FV1/PndxV1ZJ8dJGC1udkr+wjtOwDud6kU9M1j3m/CBGK+D4uX8faLRw3JXETiggOcMsK6C0QTeW+GvPby/J4boEZdXKoxQcG60Q9ycppG19r0OVOf8wuNn55873cWN/hlmqEAfcj4Kk4Lg7SjDLipW+EnEgkNnPXlmd25/XluROrp9/VCLh9BjAFpwwUfInpKCfF4oqbc45upHAVicC58D+NCUjo1Din/zKdfz9r19+aPA4ymPgzjDxXb1+LPHRYbJgUmX8lkihNZKsQFY5KTVZh8fcXXkaUZ1qMZCOiDYGrYCjFRLp9csXB/jtb147savkaUeTEDzjOK7PwkY7xNeubmJ3f4YPHkxxb5SisM5z/Vh6ad5JUviAFVodAXdtnmcKoeC4sBEjXHPBcwlGWui12v+b7QCDVkDqd+0QG+2Hf+GqjP1z/RiHM3L045whLxQyTcGiU7Gj5ZwhkgyzzHg+gTGA0qXnQ78lcWmjHBMAD+c0rEM/fvjrGNj34cb+DB/sTbE/zSBtu5LWOZcDtDZEKptlCoIzJLlBK5T4+tWNtdr45+x2xqqVx0E7wCwrMM2UFX5afvwic/5hcCuPVzZbYAz42a0RZhl5clzbbqNQBhvtEPO8WNmdCAVtzGSF8kmMO6zFhO/jJAWlp8VCpez+n7luBEVQ9/scIXauaF0mDgTaoUAoOWZZQR0qMLy808PvfOcF/MqLZx56LD/aPcC//NP3MU5z9OIAH+zNPFcjVwrv359CaRLoujfOME0LSA4/KqsaUBVqWZG02hF4UgJPpxWBADphADDj3SqV0dhuRfjq1Q0M5wW+eGmA//FvvWTdVp8tPHuvqMESTuqzcH4QY7OtkBY0H44C2p0mMyEy8EhzjQfTFMW8QDeS+MKlATZaIW7sT211a2pdBhewyJ5XrNT+r7o+fvuFM/j6tU38aPfg2C6SVcb++UGMw1mOvWmGgnO0ONkrM2Mwz5V/jLED07QwYGRqbzUSBLY7Iba6YS0IH4fTUL3vLFOYJDneuTfBTi+CgcGfvbeHq5stdOMAnUh6PoEzlSHvA40z3ciTDYez3LcwgXpVy0Ckwo1WgM+d6+GNWyMIznD9zHo55SgQuLbdxs9WrDxyRiS49HBe8xyonrMqc/5hqK48uq2Qd+9NME0LvLzTpbVDDjx/toP9aYp5rmoVL0DJWyw5CqX9BgwqSQHnrKaQWQ10SzySyr+5O6clAcYnFpIDzvDHaSOU3QtazXT+ILEgsumFASXDoaAxx/4sw7l+jN/+pYfzBYbzHP/uZ3fxL/70fYzmOSLJYTD3ryFXBvvT1I7qAM4y0mgwBhnqyYx7OQ/bwGiSgRIM8CNGwTjaMUcvlsgK7fkC17ZD/MNvXn0mkwEAYOYYRuOj0QiDwQDD4RD9fv/TOK4GjxFKm2P5LGy0QxzOsrX3a4cSe9MUb90Z4c6w/PmDSYo9K37CGEkltwKBfivA5c02dnqRr6xXuT5+9+WzfiZXJ1VlD3WRPJik+E/v72OaEfcgkjQvV1pjmpLlb6GM7wIYewyzrABnNE7Yaod+rFCFSwYCwfGNa5trxxhprrxm/GieY5jkEIzh+bMdAAzv3Z9AGYN2ICAEh+XXQ5vSyAeoBH3LfXCBf9AK0I2l96dwJNFWwHHjYA6tS6Lbta31HIdCa/x496BG4qxikhS4O04sOdQaERlrMsVIfnidb0H1nO1Pc5zthfjatU0IxrC7P0NuVSjjUPhjLLTGDz/Yxzt3J1b8SS4lIuMk9wqWjKEmLGUMlkyyHDwZ0P7YEec4q+zhV+7LbGLIKrmCU290PvedkLpN5/oRXrs4wGaHPg9H2ZkvQmmDjw5m+Lc/vYPvv/MAP787RpIVGLRDRJIjkgKCM8zSAvcmKWYZMdxJ36DU8XBdkkpe86mKNj1t4AvvubA8lX5L4kw3QiA4AsGoy8iAq1sddCOJf/Sta0/dFsFJ4neTEDT4xFiVYIznOW4NE+zuTzHPiOgWSOYvtouujxc3Wke6Pq5bu8KK50tzhTvDBBudEF+82Eccytq65TQr/FyQM4ZAMiSZwu4e7edvtJeDY5UA+aVLG57zUEWhtG/1zzIFwSiIRFLgS1c2PLHvzjDBX310iOE8Q5Ir252gqn2zHWCzEy6NBnyXJVV+3XGzE2KzHcAuv2E4pxbzb/3SVcAY/KsffIhxSlbLGvaiJymQuc7EaJ7jR7sHyJVeud0wSWg9lV5HyZw/t8bRcNU5CwTH169tohUI7O7PsGEZ9gbA917fRaq0TwoOZxn+7Bd7uDtKIDgQB/WkoFAG4yT3rXFH6nP3cRsugGPTl450VXCbqDpug8sjBCeTq14kUWgiy7oWPAM52gWCoxcH2OwEuL7dsZ0idmRiuwj3ef43b97BD3f3qZOlNJJc05qlfUFaG2RK22RR+8AFEIcjrfhkcOYEquyWz5HvzmcTLglw3QDXoOyEEgbA2V6ETZvoF0pjb5phqxPilfO9p3alsEkIGpwaHLcbcVzXx+M+34cHc/xfP/4Qh7N87YbFIkrmtq5tW6wjQFYxnGV4684Y9ycpYikQSoZxQsS51y4Naiz/g2mG19/fw4f7MxjAi8M4oaZ2JHCmG9VImYXSmGYKozlVyJnS0NoglBzdUCBTGoJzbLTDWnJ0OMt8N4L7cQPtyPdiiUubbcAAP787Wrl6CtDq2/1xguG8QGCNiXoP4UNUE6jXLg7AGFZWzFXynHuf7gwT/Pn7e9ibZpArkoKs0JikpEypbaeHKvlS/MmBrwiQHLQWyO0qo0sMnZ1vGBA5EyA+SWrFubglN260A5zrxXYThPlzfZzEttrxevfeBLeHNBLYaAW4PUq8Tbl7ndO0QGEMjLYbMoz5UQYRfEuFxGZL4GhUP9VSkI6K0vT960YSaaFxcaNl1TI17gxpK+TvfOk8fuMYWyGnFU1C0KABaG3rYRsWizicZX7bgsR2aO1wHQESqK+A9WKJtDBIC4WdXoSXz/X8/n+aK7x1Z+zvC9AqkzOTcW1tbVXQOpFE184wZ5mijQnASkRzMJCSJMCw2Qn8rnsJ519BPhVxILwgUq405vY526HEIJbYn2XIClNLhhwJNMmVr0zdat06omOhNA5nOYSgTkInlEdWzKvep/vjFD/4YJ8UKBlqCQ1QBksa+xABTBvSDAgEuXsWVuTKwSUOTjOAwRFL6XgCQc51geBIc4VxWiDJFFoh8R7+2vPb+OKlDRgYzHN94sS2ukZYKI2bdo130AowSgrcHSWexOmSHoA+C5ky0HZM4rQO3AYkx+rVwQZ1VC3aQ9uFYQAlt3ZL5PwgRl4YjNMCnUjgn377On7z61ee6pXCJiFo0MDipBwEpQ2GSYa3bo9xZ5gAAC4MYrx6oYdeHC49htr/B0gL7RXf2qHEte02rm23ITn3o4Sf3h7h3oiesx0KS6g0fmzggpcxxvvPO5CDJPNX/Gpwg61ed/oxzvQiH6C1MZilCrO8QMg5cm2QFTS+kYJIe46sZgyx/KVgGM5yUFVtrCsmx3YnxE4/gmAMSaFxMKVxh3dFpANHUpB75qAV4IWzHbx8rndkxXzU+yQFwy/uTXBjf+Y3D6pchkwpTFNFapm8lE92nRanFVGOA2B39XmtK2AMEAUc3ZA6MpkqV2s/f6GPv//1K/jq1c2PvV6mtMEfv30Pv//DD/FgnCKUHDf2ZtCGVkNDwfFgkiFXpChZKI1xUhAPhAEGpHjofByU+uwqCZ4EjifAOfMqnq7TIqxnA33OaBQWCI5zvQgawIV+fOytkNOOJiFo0GABJ+EguNbvFy4OAABv3BqufMw0LfDegym0bbW7Fvy5CmnSjRJuDecYzQtwDsRyeZWPSI8Fkrxi7GN/RrwLy4i3TpKuyqVOA/O7+te320srkqOkwINJ6iWCldE2CSh/P4k2kehPyJknpDkthEDyimkVdR4cWTQtFIZJgazQiAOB57bb+Mb1LbxyroeXzvVwrv/wzsy692mUFLg3SvDRwRwTq1EgOKx7J5EqOS+tst3aSK5JmIoxSgKcT0ShtNf+V5oSo3YoSM6ZAa2Aqv1vPbeNX35+G8+d6ZzI5GnVa/nXP7mJP39vH5nSiAOOw3mONNc1/4l5VkAIjlgyZIqSMWlJk0obpIW2stxNF+A4qBJGI0ldLEcgzhVpCgxaoX0PaBvopZ0u+RH0I/zDX3r6yIPr0CQEDRqswcfhNKx6zCwt8Cfv3sedYYKXdrroxgFaoai1z90oYZYp6yS5eq+/sCuZuSLimjEGuS7FbzijAOha4u1QgsFQggIK0MqQiFIYMJzvxWiHEkmuME5zFJqEajUYJGPY6UeIJAXyJFdICo1pUiAp6Bg4gF5L4sIghuRkhV3tBChNxzvLChSKkpNuJHB5s42NdgitDRKlkeXkUDhoBXjpXA+vnu/h+pkudnoRzjyEM7J4zu9PUvz8zhhv3Bzi9nCOTGm7AlhKBmdKeQttyWk99nw/wnYnghTMGvxQktAKBa5tdXBxEKNnNf9PymdZh2q348b+DLt7UwhOVs+jeWF5JtyPQNJcYZTkYGDIbTuDoVwxrZIeGxwPdP7IUEtYwyatDXJtEEuO58500bLrvqN5jkyR8NpXrmw8ExLEVTQJQYMGjxn/9qd38Ac/vrmkIudQVZPTxuDBJKsFAQc/Cwcg7UQgtTR5RwHUhtr2UlCFq3S5nri4c69tAuEugk6DPbRzdffcg1aItFCYZZSoKFtNM5CojzE0U++EgrT34wCFMTic5RjOieUvOavZZ7cjIuPliipwx+DPLfktlBxnexGubbVxZat9rFHCIpQ2uDdK8PbdMd69P/XqhgxAK5TY6YY424/RjyQK8/Fm/Z8EVZ5AJxL46GCGvQkx1ZU2+PBg5omDtEFAHI3Mlv7NKODkcB20xa5aJBk45zCmdHJkMLi02cagFSC3o5lxUuDV8z38N7987ZmRIK7iJPH72VRXaNDgMWI4z/HHb9/HoBWsTAaGswxv3hqSfHAk8eHBfEloB6gTx6T9kWvlc9suBpwojYYx1Mp363bCjhFY9XntjFQrg1CS8uIkIcVGaU16UmUwmhfWMKh0YHScAuOOQxuMkhyH89wLSBlDYwcpyDh6kioUOkehNfSIIRIM5wbx0uqk4zMcznIAM4yTAm/fHeNMNzpyPW8RgjNc2GjhwkYL333lGG/Wp4hFueGbh3M8mGTYsJsb04yMwGLJMc8UkkJBa3hSKTjAmpHAsVDVEABQ66Aw0ChIG0DbNdnA8m8458gtB0baz/t3Xz6L/+m/+hzOHlOG/FlGkxA0aHBCvHFziAeTFC/uLHueF0qTuEyuqEWckOpgayFxKKwHBODYz8xX1dVkwEEb2khwuvP+grgQdN2F0bHsA2GVInPSvHP3NoD3eWCwbo6aBHc8GU8DQhA/IS/I7VFwbueyxNMnTQdtL84GqQLujBJIwWtSzZwxdGOJOOAYzolv8OqFPnJl8Ac/vom37oyf6lbtX354iO+9votMaby000VWaHywN0UsXQfFYDTPYYzBJKXEwBFFDQBV1HkjDY6G+/wvCgwZQ9LnZ7qld4gj6U4zhcsbLVzebKEdChzMc2y2Q/wP332hSQYsmoSgQYMTQGmD//T+nleQW8SN/RnujVNs2Db4aJ57cpODkzR2YwJHanQbg2whyLvb3XDPrcwZQ3NRwZ0HAyqPo/s4Mlo1iageddXUyRGu/O9g8Ktu7kGCUWJyOM8BO8N3a34GgFIaSWaw+2CKq9ttDFr1NU0pOLY6AYbzHG/eGuKLlzZwfbuNn94e4dZwjt/6xlXv1Pm0YHdvit//4Q1kSuOqFVi6NyZVwS2rXkgBqfBunFUXTve+NMnA8eFs2J1qo7PHlpzh6oLuCKllZnjhbAdfv7YJbtUyB3GA3/6lq09tEvo4cHx/1QYNGuDBJMXtw7m3Qa4izVWtKsyVQVboJQnkJCfym0sGAJKZ1TC1YF1NBoDKfLQSoB2xXq2gArkgU22nLu6sEw+B+fvVfmbscRn4pKOwvzBXRNBilWSHWrUcoSBy3I39GUZJvnRcjDEMWgGUNnjz1hDznBjes0zhe6/v4i8/PFx6zGlFkiv80U9u4XCW+2TAGJIjlpz5sclwnmNudYalYPUEEaZJBk4ABkpMnbRzWMlqu7GsGWM5gSxnoV4og3fuTdAOxVMpQ/y40SQEDRqcAPfGKaaZQmeFuYmrCtsRVSeZ0t6lzkFrg7SojwWMJd9RVV7eVk0Gqq1+f5u90a0pLv58Ea6Kr0LreuJR7Wa4X++emzOGwhLhXAfBjTmq4JxU4HJl8NH+zPMk6sdCSUGSa7x9dwxlDK5ttZEqjd//4Q3s7k2PeCWnB3/yzn28eWtU84yYZQrjpPAs9iRXeDBJyQdBsFrSR6twn/phPxXg9g+r/HEg8yhKrKorsludqPYdcmqZr57vY5YrfLA3w+cv9PG733mhSQZWoEkIGjQ4Ae6NyOxncVywqirM7ZW+JrtrLWp5rUKkx7PKc1WNaaqPX8WLd5X9Q6vMFTNqDVRGFWsfBm1nEMa4TQZG3QZTChtVQRK7tFN/Zzj3yoxVUFIgcW+cYndvBsbIjOlwluOPfnILabH8mNOEdeRS51YZCNok2LMaEIKxpfevWHHuGlTMqCr/785dIDgM7DZLoQFDPhutUKBjk7BCaexNUhgDnOlEGKcFQsHxm1+7hN/5zvPNmGANGg5BgwYnwKpqF1iuCgHUZHMBCvRZoWudALq9/lxeXwdlkP6kIeOoxztyVvWGpcTBAKayI29gbFJgvKFQIOrhTjDnjkgX5wsbrSWZYymo7bu7N8PljRbZMm+18eatEb7/9n387c+f/7gv+bFjHbl0mhbedOlglmGaKUjBVnweSmJnMzMoq1ONcmRV47twEs3qxQJZQWJNwtqakzQ3w4EVfSqURr8V4PkTqGU2aBKCBg1OBLqAL5fSrirsxuVXalWgL7TxDmu1+xlaHzSmYn98jDX5k8SRI+9bYRuuut/iBdobClUIkZLXzw2JBtE4Y5IWOJxl2Ooss7k7kcD+lGy2HSGs35L447fv45vPbZ/Ki/hR5NLMtlwKpXE4p/W2YsVYgEY9BpwzcNaIDwF10qvrenHAGjrRTwtNzqBneyHaocT+NEMUcPRbAYrC4OIgxleubOC/eGUHVzbbj01z4llEkxA0aHACSM5WtnirVaHDsjyxWWL5A3VSmQu8x8IjDCCLF+Kj7udGBe5BrmOgDPN6Cg6cw65S0rphPw6WSJZuvHDzYIbLm9RF2OnFePfeBG/cHJ5KPfmjyKVuw2Nq1SdbgYAy9fHH4trnZzlc+SRz4XYO23ViZTelFTLEgUAsaWxwf0IJ10s7vaYT8AjQJAQNGpwA3Wj1VyZbwQxbrEqUXTRnS/wD93ddR+BheJRcNJ8QHCPJKJMXAwbmuwSFNl5TwcHvi3PiVEwzhUFrmbrUCgXGSYF5ptCJyHgqlByvv7+HX35++9RVeI5cen7QWvoZtwGsunLqiKV+/dM43gjd/lkZGywSKgVznAD6brhtmUhyDFoByXQzIMk1BGP43PkuwDiU1tif5bjQ5/iNr17Gr750pukEPAI0CUGDBifATj/2hjPVi4+rCqtw7nvGlNKqq0rBukbBoz/mY2MFd+DIu1deDwU5lyKUYNZv1kkqj5Mc/VgujV0CwTFJFSZp4S2at7shbh3OsTdJsdOPP8kre+RYRy4FYA2k6iunwuoOlJ8FGqUwmxu5LsGzmhMIVpJfWeW2SDqvAQalNDQYBtYkLA5KgqA2OV690McLZ7tIc4Xd/RlePtfFP/jG1WZb4BGi2TJo0OAE2OlF6IQC06xOLuQrVvpCwb3tKkBBYFXEZ2DHDgblJsKJD/2hOMmkYt19Vx6XDYRScKS59uJHVXDbZaie104oMc0U7o7TYx7Zp4d15FIA6EQShTZQWvvOgBPPcSuarrtTT56ezdGBZE5AqHx91QSo0AaFIvOtdihwZatMBmh1sMBOL8KVzTZuD+fN6uBjRJMQNGhwApzpRri40cL+JKvdHorlr1IgqO1d+PVDtnIW4ISGFjcLniYwK3KwMiGw5DmqEo1fx1yFvCifQFi+xr1R8hiO+JNhHbkUgO9wKFMRbWJAJEUpT7xwnhhjeFa73dqUWgGC2+0Te3uhNDhjaIUcrYBjpxchlGUycDjLwa3D5/sPps3q4GNGMzJo0OAEEJzhW89tk5hOZWzQiSQ5BRrjiYWMMfRbAe6OlG8Vryqtn8YEYBWoc7BiLsKIZ+AUETOlsepS7s7fIqbZ6dMjWEcuBYB2KBAJvrRmGAqGOWfQerU2oRN7etpkCdZ1txhoJMAZeWJwVvbCcmVoI8cAuVJIC4NQcm97rY3BPFfgjOGVcz28drHfEAY/BTQJQYMGJ8QXLg1wphvh/jjF+QHNtjuRRCA4cqVrrn2dUPjbBXOMabNEvHO8hFXwSoHAqnB7qrC6Q1BPevS61wks6RQwxnyH5TRhHbkUoGPeaAe4M0rKRBCk4BhLjtmaBIcxBmYFqp6WnIBV/iyOQTqRRDcSS2ZdWaERSobLGy1wBuxPSd76+nYbgRRIC4X9aYbLm238+lcu4VdfbAiDnxaahKBBgxNi0Arw3ZfP4g9+fBObbVKpa4cCvVhiOM9rCYEUxJZ+MEkRVOyFF4l3kjufgIVf5pIBO204TbFxVWdj8TZjxQtq8s1HlMDBwt6iMWZpTfE0YB251GGjHUBwcrCsauvHgUCuNJJ89TlwGwqnISHgQKlNUTkm18kAaFTmAr4xxipx0risGy1rNGhN2yhnunR+hvMcUcDxxcsbONuNcG+cYDQH/stXzz3V7pdPK07fN61Bg6cA33n5LF672Mfu/sxX/Jc32yi0WQp4G+0AnVAgU6SsplcEdcFWfxkN6OLLuWu3fvoBY11dtijEy1bc5pKfamBY7AIAlCQwxlZ6RHRCsXTbk8Y6cqlDJ5Roh4I+D5WOCGM0Dydm/XJH5bRwCZj7T4UX4gmBlhwYCo5AEFmSxj20LRJLjlYgkBYaSa5QaOPXLJNCoxMKdCOJ/WkOyTmeP9vFPFN4996k4Qg8YTQdggYNPgYiKfBrX76IW8M5dvdnuLbVxk4vQjsUmKWqpljIGcN2N0JaaGijkGPF2IAxCA5otbCmCJQa+Jap7VYc181tT3L7w+63Phmo/9B1AhZjvdZk6FMNcnxFxMuVRsBZrRWvLHHvtK0cAiW5dHdvhn68PNPuRNIGfoVZptAKhD83UhCbPp9rzzmpnhHOGYSu+1mcFNUqHlidRFalglehZrddIUdWya/OadMYWLMhhn4ssdOLMcsVRvMcWaGRauUNvArFcPMwQT+W2O6GiCXHxY1WwxE4BWgSggYNPiaubXfwW9+4iu+9vuuTguvbHfz09gix4rVWdxwI7PRi3B7NkRYKymBJ1U9yMmypstAFr1/YOWcwerXM7VGFpV9XfNh9FjICR4RcfNy6FTm2kCQYAKHkvqXsKstFzDOFQSuoeUFMswKdUOBcb1nu+EljHbnUoRNJa8/LKSAWCpEsk4I4EJjnipJEbZOC6vvM6nbUVRznvVyF6lv7sASx7Oy4ro/xplZCOOMqjUKRFHccCK84ud2NEEiOgeToxxJprvBgkiEtNDY6AXZ6MV670MfXr23i0mYb53pRwxE4JWgSggYNPgG+Yvegf/+HN/DOvQkub8R4MCHC4VYnrHUBurHEBbRwY3+KpNBk77rQShecjIIM3P72clveBYvF29cx1F2gZw8bNSwuB1T/sfDAxZBOo416pauNNaSxCYCyASVYSAi0VTm8tNmuvd69SYbr26RFfxqxilzqUOWU7PRi3B0ntaTAjQ6UJkKdqthfu785W90lWEwI1gX35XEElgie7ok4o8RNco6sUMitzLbWAGPGjze4MZCCtiiqRNpZRh2ATigwSQsv5a20wTxTaIcCf/2lM/i1L19qugCnGE1C0KDBJ8RXrmxgsx3gj35yC2/eGmGzHWI4zzGc5xi0gqWk4PqZDnYfTDEvNESFNEejAAbBjFcBXBwtuAtzNQg4FTh/sV8I/MdxTPRBxqyp/LH6Oekx9BPJWc2LXhugHTCf9BRKIw7EkiviNFVoh7LWCVCalP6+9dzpky12WEUudXCckr3pIfotgXOIcW+cYJ4rxJKDc4ZQkFOfsWMDxzeg7gt1DDiWk79VwlDCJo/KbSmYZda/G0UJu/oI0HsGRl2bnlWQNEYiUxqzrPDW1lrTCuFOP0IvDjx/QGmDQ/s5v7bVQRxwZMqg0BqTpECmND7/Yh9/76uX8OUrm6f2vWxAaBKCBg0eAa5td/Df/erz+JN37uOP376P/VmGmwdz5EpjqxNCVCwO26HEte0OdveoU5Dkym4aMLQjgVwZKKWhjIEGVWWwwj9O9TAUzKu8AWV3YPFyy4FagiA5BZhVHQbPWeA2oLjIw+oJweI1ne7C4OK8MQaFnSlXFee0AXpxPUEqFLXTX73QrwXUe+MEZ7ohvnBpcJzT/8TwnZfP4q07Y/z09ggv7XRrr22RUyJFC3sT8kBwnRO3hig5vf/KdkuctPGSgBHKdr5Tx3R3cZ8NKXhpGGQMlB1JGBjEgUArEDAAkqxAWhhwBstxoEeRiBJHwAOMkxxJAUQBw/l+hI126Ds8k7RAWmjs9CK8cq6HbhxgmhXYm2RAAby408V3Xz6L77x8trZ50+D0okkIGjR4RIgDgb/9+fP45nPbeOPmEP/6Jzfxg/f38dHBHK1A2E2B8gLeb4fAPLeELABg9mKvoVFe/JVrCxgyCXIM9kxpTBIFbbRvLVfbxAzwz+MMdqj6NEskM7NwH8MAY9nhq4iG1U4A4LgO1grZUCLSDssgkyuDQPDaxkBVlvbadtvfnuYKo3mB3/zapVPfWl5FLnWvOQpEjVMSBwIXBi0c2u7RPFd+AyPXGoHgkFbi2LHyldYotBu3UEIXSUEBllFCNcuU7yy4gC+4I3IyJDl5RAjGaU2QM+o8SAHODQQHcm2gckpMDBiU1sSNEALn2wKvXOhjNMtxMMswtb8vlBxne9QxuDNKwMYpOqHA9e12QxB8SsHMOrmtCkajEQaDAYbDIfr9/qdxXA0aPPVQ2uAnHx7gD//iJn56e4RQcnRDCSk4AkkrdrNM4Rf3J0hymrNqA6SFwp4lYUlOwbRK3ooDAWGD7ygpoG01masyMagW8QykFFedPesKi91Vmy5hcXCWs7WK1JRrkLBVv7Dtb6CUqO1G0u/fa03rZme6IbY6kX1ug+E8RyA4vn5tExvt0N/+zr0JPn+hj9/5zvNPTWX5lx8e4nuv7yJVupYUKK3xo92DJU5JYZ0fRzYxcDP3ql6D66pwRm6QrhPTCniNe5IWGqN5DsFJEInXnoM+TwykmpnkCoklM3IG9FvU/k8LjXmuvAiU4ABn3CY1bR/YBWfoRWQ+dLYXIRREnu2EAjv9uCEInkKcJH43HYIGDR4TBGf42rUtfP7iwI8SHkwyRJJjqxuiY/fRN9sB3r47xr1xikgKDFoBAsFw8yCBNgbdSKDfCiE5wzgpkBUamXETYoNcG1K4YwySlRsIHHaObAClTH3uj1JT3liy39qtgcooIhDU1ta6XDN0nIDCdgY6lWSgunteDfpDG8BeuzSo3b67P8NGO8CvffniU5MMAMvk0mtbbUSBgOAcr5zrYZwUNU4JCVYRCz9XdD4eWMleaTUKlDIIJMfZboSNdoC00H7kIDmz550Sw3YowRnZBDuOgk8GGMO5Xox2JDBNCswk8QV2uhECKfzqYyAYBKPtgTvDBHEo8M3rW3j+bLcJ+J8RNB2CBg0+JQznOd64OcTr7+/h1uEc00z5lrs2wP1xggeTDJnSNF8OqHILBffVpTGkA58WCvNcYZ4qjNMc2gAbrQCbnRAwwP4swzRV0NaGF3Bqh8wHgG4sfduebquPAoyt/jkDMptQxJJDa4NUlVwGzpgVpaH9ekeSNMbYSpTh4kYLcSBQKI3hvEAccLx2aYDzVmPAJQOR4PhH37r21LrY7e5NPbm036J9fMEZ7gwT/Oebh1DaLBFNHSZJgbujOdKCBKy6kcR2N/I8DIC6LYfzDMN5gVxpFIosli/0YwSS+4SBM7qv4AybnQicUbeH+CttXNtuQ/L6tofSxioFFnjtYr9RCnxGcJL43SQEDRp8ynAGLnfHKe6NEkwz5S/sDBSg338wweEsx63hHB/uz5ArTVWgrcwYSBWuF0tstEN8uD+DNmWw0ZqqzsN5hnmmkBW6phpYreLTXGOU5KV0MnPzau6JbpQcwNrUOhIizQ8CzhAHNCOvJhRpoak67cdohwLTVCEtFHZ6EV4+1/OdAedvv9EOngl/+yRXKztCk3mBn90ZIclJc6HcLiEHyHmmMM+JZAljsNmJ0IvlSmXHJC9wf5whVxqdSPptBW2A0TzDLFPgnMZS/Vhisx3i8hbt/FfJm0obTwTM7FinIQI+W2gSggYNnnJUk4Y3bh7iP7y7hxv7U3RCiTOdEL1WYNXwKAivq0ALpTFJC9wbpZhmNKcOBEcoGJbZ/ro2xzZWjIaBOgFgJJwEYyAEseRJz18jlML+f8kZEJxhq03Hsqo6fdYr0lUdoWla4NYwwXieQ9ouELNJVS+m2fx2O8CdcYrdvRlmWQHJGVrWJAsAphV2/0s7XQjO8WCa4u4oRZordEKBl851sdmOcGc4xzgtasZZrtPk/t0JRaMU+AyjSQgaNHjGsK7qdDwEALgzTPDmrSGSXKMXEwltlikobdAOBM72IqSFws0D2odnVowmEkQe03a2P0vJjS9XCmAMkSTWeiQ5zg8iXBq0kSqNB+PEz8Zdl8OGGcQBRz8OvECPU6STgn/mKtLFjtDhPMcbNw/xzr0JZplCL5I4vxFjuxPVRJvSXOHuOMVH+7OV7P4z3ciPedYF9aO6UQ0v4LOBJiFo0OAZxVE8BMYYpmmOW4cJRmmBthQ40wtxdauDnUqr2AWamwczjJOCVOkcl0EbjJKcWs5Ol74f4/p2BxcGca3dbIzBJCnwYJLi5mGCgxkF+VbA0Y0l4kAgkrw2A28q0hIPey+rl+aG3d/g46JJCBo0eMZxVOUXCoaPDub42e0RJmmBOBBL3QSAZtfzTGGU5NifZjiY5sgKhUE7wKsX+rg0aOHDgxkOZxlmuV4ZrBYD/Ocv9JEr3VSkJ0BTxTd4nGgSggYNGhy7Am1azg0aPLt45DoE7sIxGo0++dE1aNDgUwED8MWdEJ8/cx77kxT3Jinuj1MyorFBvR0St2CnG2HLBfV8jlE+988TA7jWY7jWa635TRmmk+zTeEkNGjQ4IVzcPkbtf7yEYDweAwCuXLnyCQ6rQYMGDRo0aPAkMB6PMRgc7Q1yrJGB1hq3bt1Cr9dbKajRoEGDBg0aNDh9MMZgPB7j4sWL4HzRuLyOYyUEDRo0aNCgQYNnG0enCw0aNGjQoEGDzwSahKBBgwYNGjRo0CQEDRo0aNCgQYMmIWjQoEGDBg0aoEkIGjRo0KBBgwZoEoIGDRo0aNCgAZqEoEGDBg0aNGgA4P8HHm9VjiXmwjgAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_networkx_nodes(RED_CTD, pos, node_size=500, alpha=0.5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7c29f349",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "5bc68c78",
   "metadata": {},
   "source": [
    "para ver la red por aristas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "6d3d59b1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.collections.LineCollection at 0xf5b2340>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_networkx_edges(RED_CTD, pos)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a884cb16",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "e97b0d2e",
   "metadata": {},
   "source": [
    "Para ver la red de forma spectral, este plot nos permite ver la alta condensación de la red."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "241bd73d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_spectral(RED_CTD, node_size=500, alpha=0.5, with_labels=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "52503a5f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "58566e82",
   "metadata": {},
   "source": [
    "### Analizar la red"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "86f616c6",
   "metadata": {},
   "source": [
    "edge-label, par ver los datos de las interacciones."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "defa8207",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{('tp53',\n",
       "  'Calcimycin'): Text(0.1426088404841721, 0.20665549859404564, \"{'Interaction': 'Calcimycin results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pemetrexed'): Text(-0.16800626693293452, 0.35732729732990265, \"{'Interaction': 'TP53 protein affects the susceptibility to Pemetrexed', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Celecoxib'): Text(0.023997160140424967, 0.11701086908578873, \"{'Interaction': 'TP53 results in increased susceptibility to Celecoxib', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Sildenafil Citrate'): Text(-0.11859336076304317, 0.5999709367752075, \"{'Interaction': 'TP53 protein inhibits the reaction [Sildenafil Citrate results in increased susceptibility to Doxorubicin]', 'InteractionActions': 'decreases^reaction|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Emtricitabine'): Text(-0.11689213244244456, 0.46279749274253845, \"{'Interaction': '[Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tenofovir'): Text(-0.10469176946207881, 0.383121594786644, \"{'Interaction': 'Tenofovir results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Rivastigmine'): Text(0.04020896600559354, 0.6543318927288055, \"{'Interaction': 'Rivastigmine metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Fingolimod Hydrochloride'): Text(-0.08398946700617671, 0.25783268362283707, \"{'Interaction': 'RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Imatinib Mesylate'): Text(0.003663222538307309, 0.12128487601876259, \"{'Interaction': 'Imatinib Mesylate results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Atorvastatin'): Text(0.027600495610386133, 0.12351349741220474, \"{'Interaction': 'Atorvastatin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Bortezomib'): Text(-0.01988836145028472, 0.1771208606660366, \"{'Interaction': '[Vorinostat co-treated with Bortezomib] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Erlotinib Hydrochloride'): Text(-0.00569289131090045, 0.10468265041708946, \"{'Interaction': 'Resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased expression of TP53 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Dasatinib'): Text(-0.05419341800734401, 0.13905053585767746, \"{'Interaction': 'Dasatinib results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Bendamustine Hydrochloride'): Text(-0.01119666313752532, 0.6541770994663239, \"{'Interaction': 'Bendamustine Hydrochloride results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Polychlorinated Dibenzodioxins'): Text(0.06513072224333882, 0.6447026133537292, \"{'Interaction': '[Polychlorinated Dibenzodioxins co-treated with Dibenzofurans, Polychlorinated] results in increased expression of TP53 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dibenzofurans, Polychlorinated'): Text(-0.050899460446089506, 0.4690188765525818, \"{'Interaction': '[Polychlorinated Dibenzodioxins co-treated with Dibenzofurans, Polychlorinated] results in increased expression of TP53 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Antineoplastic Agents, Immunological'): Text(0.10552158625796437, 0.2988166809082031, \"{'Interaction': 'Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Docetaxel'): Text(0.022853576112538576, 0.1308048591017723, \"{'Interaction': '[TP53 protein mutant form results in decreased susceptibility to Docetaxel] which results in increased cleavage of SREBF2 protein', 'InteractionActions': 'decreases^response to substance|increases^cleavage'}\"),\n",
       " ('tp53',\n",
       "  'Clopidogrel'): Text(0.2609950643964112, 0.2658628672361374, \"{'Interaction': 'Clopidogrel results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Irinotecan'): Text(0.029141536448150873, 0.20856666192412376, \"{'Interaction': 'TP53 results in increased susceptibility to Irinotecan', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Sevoflurane'): Text(-0.022077505942434072, 0.27258262783288956, \"{'Interaction': 'Sevoflurane results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Oxaliplatin'): Text(-0.03188627166673541, 0.12739723548293114, \"{'Interaction': 'TP53 protein results in increased susceptibility to Oxaliplatin', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Olanzapine'): Text(-0.21903089759871364, 0.35882313549518585, \"{'Interaction': 'Olanzapine results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Rosiglitazone'): Text(0.0038416164461523294, 0.15402542846277356, \"{'Interaction': '[Rosiglitazone results in increased expression of TP53 protein] promotes the reaction [Rosiglitazone results in decreased expression of CHRNA4 protein]', 'InteractionActions': 'decreases^expression|increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Gefitinib'): Text(0.003463153028860688, 0.1142701543867588, \"{'Interaction': '[TP53 protein results in decreased expression of AURKA protein] which results in increased susceptibility to Gefitinib', 'InteractionActions': 'decreases^expression|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Sorafenib'): Text(-0.032176058273762465, 0.10708791762590408, \"{'Interaction': 'Sorafenib promotes the reaction [GSK3B protein results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'increases^phosphorylation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Resveratrol'): Text(-0.05423051444813609, 0.16658771876245737, \"{'Interaction': 'YARS1 protein affects the reaction [Resveratrol results in increased acetylation of TP53 protein]', 'InteractionActions': 'affects^reaction|increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Wortmannin'): Text(-0.026974066626280546, 0.13765414617955685, \"{'Interaction': 'Wortmannin results in decreased phosphorylation of TP53 protein', 'InteractionActions': 'decreases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Temozolomide'): Text(-0.05722943274304271, 0.1677761059254408, \"{'Interaction': 'TP53 protein results in increased susceptibility to [Temozolomide co-treated with O(6)-benzylguanine]', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Decitabine'): Text(-0.023613035213202238, 0.1776437908411026, \"{'Interaction': 'TP53 protein promotes the reaction [Decitabine results in increased expression of CDKN1A protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Zoledronic Acid'): Text(-0.029778465162962675, 0.16442062286660075, \"{'Interaction': 'Zoledronic Acid results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Limonene'): Text(0.0011662277393043041, 0.6093467175960541, \"{'Interaction': 'Limonene results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Arsenic Trioxide'): Text(-0.054442796390503645, 0.18536996468901634, \"{'Interaction': 'TP53 protein promotes the reaction [Arsenic Trioxide results in increased expression of RB1 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Fulvestrant'): Text(-0.05355164734646678, 0.18061600625514984, \"{'Interaction': 'Fulvestrant results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Lycopene'): Text(-0.09633428929373622, 0.14289554208517075, \"{'Interaction': 'Lycopene results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Troglitazone'): Text(-0.01659876247867942, 0.15630216826684773, \"{'Interaction': 'Troglitazone results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Artesunate'): Text(-0.06269793538376689, 0.3437291383743286, \"{'Interaction': 'Artesunate results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vorinostat'): Text(-0.04304040549322963, 0.19580266252160072, \"{'Interaction': 'Vorinostat results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Silybin'): Text(-4.0222425013780594e-05, 0.1269998550415039, \"{'Interaction': 'Silybin results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Cidofovir'): Text(-0.11369444755837321, 0.3490447551012039, \"{'Interaction': 'Cidofovir results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cilostazol'): Text(-0.051415238063782454, 0.08668332546949387, \"{'Interaction': 'Cilostazol results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Simendan'): Text(0.06674721883609891, 0.6170615255832672, \"{'Interaction': 'Simendan affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Meglumine Antimoniate'): Text(0.1419365298934281, 0.6242092251777649, \"{'Interaction': 'Meglumine Antimoniate results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Roscovitine'): Text(-0.04831773741170764, 0.29991720616817474, \"{'Interaction': 'Roscovitine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'O-(Chloroacetylcarbamoyl)fumagillol'): Text(-0.19715670822188258, 0.26494549959897995, \"{'Interaction': 'O-(Chloroacetylcarbamoyl)fumagillol results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Bexarotene'): Text(0.031171355862170458, 0.3297128826379776, \"{'Interaction': 'Bexarotene results in increased phosphorylation of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Tirapazamine'): Text(-0.08681129245087504, 0.46395716071128845, \"{'Interaction': 'TP53 results in increased susceptibility to Tirapazamine', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Panobinostat'): Text(-0.059106293600052595, 0.14907199703156948, \"{'Interaction': 'Panobinostat results in increased acetylation of TP53 protein', 'InteractionActions': 'increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Ciclopirox'): Text(0.21434833528473973, 0.3040117025375366, \"{'Interaction': 'Ciclopirox affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Axitinib'): Text(0.1954078865237534, 0.32316266000270844, \"{'Interaction': 'Axitinib affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Homoharringtonine'): Text(-0.013163318391889334, 0.10008582100272179, \"{'Interaction': 'Homoharringtonine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Clofarabine'): Text(-0.09028826234862208, 0.29866963624954224, \"{'Interaction': 'TP53 protein affects the susceptibility to [Resveratrol co-treated with Clofarabine]', 'InteractionActions': 'affects^cotreatment|affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  '5-Methoxypsoralen'): Text(-0.18747090874239802, 0.22100798413157463, \"{'Interaction': '5-Methoxypsoralen results in increased expression of and results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Acetaminophen'): Text(-0.06901178089901805, 0.20420974865555763, \"{'Interaction': 'Acetaminophen results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Gemcitabine'): Text(0.016816783230751753, 0.14635508228093386, \"{'Interaction': '[TFAP2A protein co-treated with TP53 gene mutant form] results in decreased susceptibility to Gemcitabine', 'InteractionActions': 'affects^cotreatment|decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Matrines'): Text(-0.21997087774798274, 0.2228536754846573, \"{'Interaction': 'Matrines results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Betulinic Acid'): Text(-0.05393443210050464, 0.11065598204731941, \"{'Interaction': 'Betulinic Acid results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Acetylcysteine'): Text(-0.03234875528141856, 0.1532630268484354, \"{'Interaction': 'Acetylcysteine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Acridine Orange'): Text(-0.06298187701031566, 0.6380753815174103, \"{'Interaction': 'Acridine Orange results in increased stability of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Acrolein'): Text(-0.03742833016440272, 0.2120518609881401, \"{'Interaction': '[TP53 protein affects the susceptibility to Acrolein] which affects the localization of CCNB1 protein', 'InteractionActions': 'affects^localization|affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Acrylonitrile'): Text(0.059949774760752916, 0.21716197580099106, \"{'Interaction': 'Acrylonitrile results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Adenosine Triphosphate'): Text(0.04300889791920781, 0.1438399124890566, \"{'Interaction': 'TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate]', 'InteractionActions': 'decreases^abundance|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Aflatoxins'): Text(0.17417869390919805, 0.5955012738704681, \"{'Interaction': 'Aflatoxins results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Air Pollutants'): Text(-0.05707826046273112, 0.1973896622657776, \"{'Interaction': 'Air Pollutants results in increased mutagenesis of TP53 exon', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Air Pollutants, Occupational'): Text(-0.12243303237482905, 0.13908066600561142, \"{'Interaction': 'Air Pollutants, Occupational results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Albuterol'): Text(0.1130545032210648, 0.13438800908625126, \"{'Interaction': 'Albuterol results in increased expression of TP53', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ethanol'): Text(-0.01215045666322112, 0.19865138083696365, \"{'Interaction': 'Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Aldehydes'): Text(0.12336031766608357, 0.2662294879555702, \"{'Interaction': 'Aldehydes results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Allergens'): Text(0.07441920461133122, 0.20834245905280113, \"{'Interaction': 'Allergens results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'alpha-Chlorohydrin'): Text(-0.20200015185400844, 0.33489806950092316, \"{'Interaction': 'alpha-Chlorohydrin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Aluminum Oxide'): Text(0.1253569913096726, 0.15235880389809608, \"{'Interaction': 'Aluminum Oxide analog results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Amides'): Text(0.11652949871495366, 0.6079841554164886, \"{'Interaction': 'Amides results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Amidines'): Text(0.08061666460707784, 0.6128836274147034, \"{'Interaction': 'Amidines analog results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Aminacrine'): Text(0.15178478183224797, 0.43803030252456665, \"{'Interaction': 'Aminacrine results in increased stability of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Aminolevulinic Acid'): Text(0.1991818738169968, 0.41665318608283997, \"{'Interaction': 'Aminolevulinic Acid analog results in increased expression of TP53', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Aminopterin'): Text(0.03599119605496526, 0.6538819968700409, \"{'Interaction': 'Aminopterin metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Amiodarone'): Text(0.00040751323103904724, 0.21378373727202415, \"{'Interaction': 'Amiodarone results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ammonium Chloride'): Text(0.09920569183304906, 0.6230622828006744, \"{'Interaction': 'NR1I2 protein affects the reaction [Ammonium Chloride affects the expression of and affects the phosphorylation of TP53 protein]', 'InteractionActions': 'affects^expression|affects^phosphorylation|affects^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Amodiaquine'): Text(0.07737227948382497, 0.14684166200459003, \"{'Interaction': 'Amodiaquine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Amsacrine'): Text(-0.08182106493040919, 0.32525965571403503, \"{'Interaction': 'Amsacrine results in increased stability of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Androgens'): Text(0.1279836636967957, 0.34954194724559784, \"{'Interaction': 'TP53 protein inhibits the reaction [Androgens results in increased expression of NKX3-1 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Antineoplastic Agents'): Text(0.20377035858109593, 0.31554488837718964, \"{'Interaction': 'TP53 protein promotes the reaction [Methotrexate results in increased susceptibility to Antineoplastic Agents]', 'InteractionActions': 'increases^reaction|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Arecoline'): Text(0.01173579366877675, 0.07357744127511978, \"{'Interaction': 'Arecoline results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Armin'): Text(-0.0576935145072639, 0.6231399774551392, \"{'Interaction': 'Armin metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Arsenic'): Text(-0.0670105624012649, 0.17763108946383, \"{'Interaction': 'YTHDF2 protein affects the reaction [FTO protein affects the reaction [APOBEC3B protein affects the reaction [Arsenic results in increased mutagenesis of TP53 gene]]]', 'InteractionActions': 'affects^reaction|increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Asbestos'): Text(0.058937807101756334, 0.16427988139912486, \"{'Interaction': 'TP53 gene SNP affects the susceptibility to Asbestos', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Ascorbic Acid'): Text(0.009017053991556168, 0.16467465739697218, \"{'Interaction': 'nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Aspirin'): Text(-0.030596434604376554, 0.16297302418388426, \"{'Interaction': 'Aspirin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Atrazine'): Text(-0.07140832720324397, 0.2109181098639965, \"{'Interaction': 'kolaviron inhibits the reaction [Atrazine results in decreased expression of TP53 protein]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Atropine'): Text(-0.1021314668469131, 0.32356874644756317, \"{'Interaction': 'Atropine inhibits the reaction [Parathion results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vehicle Emissions'): Text(-0.003646537195891142, 0.19498763605952263, \"{'Interaction': 'Vehicle Emissions results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Azacitidine'): Text(-0.029583833646029234, 0.1441590115427971, \"{'Interaction': 'Azacitidine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Azathioprine'): Text(0.0030840192921459675, 0.16959438379853964, \"{'Interaction': 'Azathioprine results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Azinphosmethyl'): Text(0.1367436689324677, 0.5790343284606934, \"{'Interaction': 'Azinphosmethyl metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Benomyl'): Text(0.044547554571181536, 0.47388458251953125, \"{'Interaction': 'Benomyl affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Benzalkonium Compounds'): Text(0.20031941356137395, 0.20832547545433044, \"{'Interaction': 'Benzalkonium Compounds results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Benzene'): Text(-0.006791634950786829, 0.1751834051683545, \"{'Interaction': 'TP53 SNP affects the susceptibility to Benzene', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Hexachlorocyclohexane'): Text(0.03630202682688832, 0.2735787257552147, \"{'Interaction': '[Hexachlorocyclohexane co-treated with Estradiol] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Benzo(a)pyrene'): Text(-0.07444367138668895, 0.20580077171325684, \"{'Interaction': 'Wortmannin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Berberine'): Text(-0.08953234134241939, 0.18612409755587578, \"{'Interaction': 'Berberine results in increased phosphorylation of and results in increased acetylation of TP53 protein', 'InteractionActions': 'increases^acetylation|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Bile Acids and Salts'): Text(0.08357710810378194, 0.11833817139267921, \"{'Interaction': 'Bile Acids and Salts results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dicumarol'): Text(0.0791025129146874, 0.22830002009868622, \"{'Interaction': 'Dicumarol results in increased degradation of TP53 protein', 'InteractionActions': 'increases^degradation'}\"),\n",
       " ('tp53',\n",
       "  'Bithionol'): Text(0.19425803842023015, 0.5962660908699036, \"{'Interaction': 'Bithionol affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Bleomycin'): Text(0.12799460859969258, 0.18560984544456005, \"{'Interaction': 'TP53 protein results in increased susceptibility to Bleomycin', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Busulfan'): Text(0.06148843141272664, 0.1980418600142002, \"{'Interaction': 'Busulfan results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cacodylic Acid'): Text(0.03600795613601804, 0.18084210716187954, \"{'Interaction': '[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TP53 mRNA', 'InteractionActions': 'affects^cotreatment|affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cadmium'): Text(-0.0654643434099853, 0.19128717109560966, \"{'Interaction': 'TP53 protein affects the susceptibility to Cadmium', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Caffeine'): Text(-0.08411933062598109, 0.21002919226884842, '{\\'Interaction\\': \"SIRT3 protein promotes the reaction [Caffeine inhibits the reaction [2,2\\'-azobis(2-amidinopropane) results in increased phosphorylation of TP53 protein]]\", \\'InteractionActions\\': \\'decreases^reaction|increases^phosphorylation|increases^reaction\\'}'),\n",
       " ('tp53',\n",
       "  'Calcitriol'): Text(-0.02701831189915538, 0.17233520932495594, \"{'Interaction': 'Calcitriol results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Calcium'): Text(0.07115924777463078, 0.17088768538087606, \"{'Interaction': 'TP53 protein affects the localization of Calcium', 'InteractionActions': 'affects^localization'}\"),\n",
       " ('tp53',\n",
       "  'Camptothecin'): Text(0.005541238497244194, 0.16194299433846027, \"{'Interaction': 'TP53 protein results in increased susceptibility to Camptothecin', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cannabidiol'): Text(-0.04092403454706073, 0.2034940868616104, \"{'Interaction': '[Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in increased expression of TP53 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Capsaicin'): Text(-0.009627392049878836, 0.13522709533572197, \"{'Interaction': 'Tunicamycin promotes the reaction [Capsaicin results in increased degradation of TP53 protein]', 'InteractionActions': 'increases^degradation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Carbamates'): Text(0.17084239842370152, 0.26649659872055054, \"{'Interaction': 'Carbamates analog results in increased phosphorylation of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Carbamazepine'): Text(-0.04854756547138095, 0.17802027985453606, \"{'Interaction': 'Carbamazepine affects the expression of TP53 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Carbenoxolone'): Text(-0.22553692338988185, 0.3531685322523117, \"{'Interaction': 'Carbenoxolone affects the expression of TP53 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Carbofuran'): Text(-0.14564191875979304, 0.43423083424568176, \"{'Interaction': 'Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of TP53 gene', 'InteractionActions': 'decreases^stability|increases^degradation|increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Carmustine'): Text(0.014245748985558748, 0.18741650506854057, \"{'Interaction': 'TP53 results in increased susceptibility to Carmustine', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Catechin'): Text(-0.01474324008449912, 0.20542573556303978, \"{'Interaction': 'Catechin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cefotaxime'): Text(0.07315465481951833, 0.6233433187007904, \"{'Interaction': 'Cefotaxime results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cephalothin'): Text(0.13241319777444005, 0.6396653652191162, \"{'Interaction': 'Cephalothin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ceramides'): Text(0.06452053459361196, 0.2980455905199051, \"{'Interaction': '[UGCG protein results in decreased abundance of Ceramides] which results in decreased phosphorylation of TP53 protein', 'InteractionActions': 'decreases^abundance|decreases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Cerium'): Text(0.12212511571124196, 0.46559861302375793, \"{'Interaction': 'Cerium results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Chelating Agents'): Text(-0.0315111237578094, 0.1721075801178813, \"{'Interaction': '[Chelating Agents binds to Copper] which results in increased expression of TP53 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Chlorambucil'): Text(-0.03236082149669528, 0.3503209948539734, \"{'Interaction': '[Theophylline co-treated with Chlorambucil] results in increased expression of TP53', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Chlorfenvinphos'): Text(0.17336613358929753, 0.6139644086360931, \"{'Interaction': 'Chlorfenvinphos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Chlorine'): Text(0.2578248721547425, 0.2894154191017151, \"{'Interaction': 'Chlorine results in increased expression of TP53 protein modified form', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Chloroform'): Text(0.1576782655902207, 0.38236279785633087, \"{'Interaction': 'Chloroform results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Chloroquine'): Text(0.03872244851663709, 0.1447421619668603, \"{'Interaction': 'Chloroquine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Cholestanols'): Text(0.05293065728619695, 0.6488790512084961, \"{'Interaction': 'Cholestanols inhibits the reaction [Paclitaxel results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cholesterol'): Text(-0.13549911556765437, 0.2781838998198509, \"{'Interaction': '[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of TP53 mRNA', 'InteractionActions': 'affects^binding|affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Chromium'): Text(0.07493167044594884, 0.19358856603503227, \"{'Interaction': 'TP53 mutant form inhibits the reaction [CDKN1A gene mutant form results in increased susceptibility to Chromium]', 'InteractionActions': 'decreases^reaction|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cisplatin'): Text(-0.06566720781847835, 0.19886046275496483, \"{'Interaction': 'Y 27632 inhibits the reaction [Cisplatin results in increased expression of TP53 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Citrinin'): Text(0.04618520336225629, 0.21101702749729156, \"{'Interaction': 'Citrinin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Clotrimazole'): Text(-0.15514371870085597, 0.15936432569287717, \"{'Interaction': 'Clotrimazole results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Clozapine'): Text(-0.16427745996043086, 0.30694109201431274, \"{'Interaction': 'CSF3 protein inhibits the reaction [Clozapine results in increased expression of TP53 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cobalt'): Text(0.0666123223491013, 0.15208957437425852, \"{'Interaction': '[tungsten carbide co-treated with Cobalt] results in increased expression of and results in increased stability of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Colchicine'): Text(-0.14730463502928615, 0.2417757287621498, \"{'Interaction': 'TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein]', 'InteractionActions': 'affects^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Copper'): Text(-0.057466070633381605, 0.17993434704840183, \"{'Interaction': 'Tretinoin inhibits the reaction [[Copper binds to Isatin binds to trimethylenediamine] which results in increased expression of TP53 protein]', 'InteractionActions': 'affects^binding|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Coumaphos'): Text(-0.07660566596314311, 0.6420798301696777, \"{'Interaction': 'Coumaphos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Curcumin'): Text(-0.021635729353874922, 0.1796584501862526, \"{'Interaction': '[Vitamin E co-treated with Curcumin] results in decreased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cycloheximide'): Text(0.004516012966632843, 0.10830311849713326, \"{'Interaction': 'TP53 mutant form results in increased susceptibility to Cycloheximide', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cyclophosphamide'): Text(-0.1555626350454986, 0.2415371537208557, \"{'Interaction': 'TP53 protein promotes the reaction [Methotrexate results in increased susceptibility to Cyclophosphamide metabolite]', 'InteractionActions': 'increases^reaction|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cytarabine'): Text(0.014255431946367025, 0.2627548649907112, \"{'Interaction': 'TP53 gene mutant form results in increased susceptibility to Cytarabine', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cytochalasin B'): Text(0.07941669644787908, 0.26110775768756866, \"{'Interaction': 'Cytochalasin B results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dactinomycin'): Text(0.04545389907434583, 0.15949787909630686, \"{'Interaction': '[TNF protein co-treated with Dactinomycin] results in decreased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Daunorubicin'): Text(0.005303702550008893, 0.12985218316316605, \"{'Interaction': 'Daunorubicin results in increased phosphorylation of and results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Dichlorodiphenyl Dichloroethylene'): Text(0.03596520097926259, 0.230510912835598, \"{'Interaction': 'Dichlorodiphenyl Dichloroethylene results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Deferoxamine'): Text(-0.03362008137628436, 0.1261453479528427, \"{'Interaction': 'TP53 protein results in decreased susceptibility to Deferoxamine', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Dehydroepiandrosterone'): Text(-0.0810849922709167, 0.31912581622600555, \"{'Interaction': 'Dehydroepiandrosterone results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Deoxyglucose'): Text(0.04852652223780751, 0.2640397474169731, \"{'Interaction': 'TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate]', 'InteractionActions': 'decreases^abundance|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Dequalinium'): Text(-0.0327708306722343, 0.6296373903751373, \"{'Interaction': 'Dequalinium results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dexamethasone'): Text(-0.03796920878812671, 0.19844363629817963, \"{'Interaction': 'Dexamethasone results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Diamide'): Text(-0.1664799707941711, 0.3284865468740463, \"{'Interaction': 'Diamide results in increased glutathionylation of TP53 protein', 'InteractionActions': 'increases^glutathionylation'}\"),\n",
       " ('tp53',\n",
       "  'Dianhydrogalactitol'): Text(-0.003241035621613264, 0.37280720472335815, \"{'Interaction': 'Dianhydrogalactitol results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Diazinon'): Text(-0.11790380207821727, 0.15816942090168595, \"{'Interaction': '[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dibutyl Phthalate'): Text(0.033705220092087984, 0.11618474498391151, \"{'Interaction': 'Dibutyl Phthalate results in increased methylation of TP53 promoter', 'InteractionActions': 'increases^methylation'}\"),\n",
       " ('tp53',\n",
       "  'Bucladesine'): Text(0.040719196666032076, 0.17196478974074125, \"{'Interaction': '[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Clodronic Acid'): Text(-0.13234060583636165, 0.33880047500133514, \"{'Interaction': 'Clodronic Acid affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Dichlorophen'): Text(0.2171654743142426, 0.5728276371955872, \"{'Interaction': 'Dichlorophen affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Dichlororibofuranosylbenzimidazole'): Text(-0.11930183647200465, 0.46187251806259155, \"{'Interaction': 'Dichlororibofuranosylbenzimidazole results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Diclofenac'): Text(-0.015692639630287886, 0.14930614363402128, \"{'Interaction': 'Diclofenac results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dieldrin'): Text(0.009317158255726099, 0.24305666238069534, \"{'Interaction': 'TP53 gene mutant form results in decreased susceptibility to Dieldrin', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Dienestrol'): Text(-0.028292767237871885, 0.6191372275352478, \"{'Interaction': 'Dienestrol affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ditiocarb'): Text(0.009179433574900031, 0.6330510675907135, \"{'Interaction': 'Ditiocarb results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Diethylhexyl Phthalate'): Text(-0.04049756331369281, 0.16229873965494335, \"{'Interaction': 'Diethylhexyl Phthalate results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Diethylnitrosamine'): Text(0.09447024436667562, 0.4103439152240753, \"{'Interaction': 'Diethylnitrosamine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Diethylstilbestrol'): Text(0.0027372867334634066, 0.22083137929439545, \"{'Interaction': 'Diethylstilbestrol results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Digitoxin'): Text(0.022779388818889856, 0.2118961103260517, \"{'Interaction': 'Digitoxin results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dimethylformamide'): Text(0.19473036052659154, 0.27453386038541794, \"{'Interaction': 'Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Dioxins'): Text(0.02670614281669259, 0.33728282153606415, \"{'Interaction': 'Dioxins results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Diphenoxylate'): Text(-0.06369462935253978, 0.6077251732349396, \"{'Interaction': 'Diphenoxylate affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Dipyridamole'): Text(0.13603634061291814, 0.22519558668136597, \"{'Interaction': 'Dipyridamole metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Disulfoton'): Text(-0.049971922766417265, 0.6130441427230835, \"{'Interaction': 'Disulfoton metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Dithiothreitol'): Text(0.005583621037658304, 0.2717497944831848, \"{'Interaction': 'Dithiothreitol inhibits the reaction [Glutathione results in increased glutathionylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^glutathionylation'}\"),\n",
       " ('tp53',\n",
       "  'Docosahexaenoic Acids'): Text(0.08756315382197499, 0.18921724148094654, \"{'Interaction': 'OSGIN1 protein promotes the reaction [Docosahexaenoic Acids affects the localization of TP53 protein]', 'InteractionActions': 'affects^localization|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Dopamine'): Text(-0.039410106372088194, 0.2785887271165848, \"{'Interaction': '[Dopamine results in increased expression of HIF1A protein] which results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Doxorubicin'): Text(-0.06443614093586802, 0.19506026059389114, \"{'Interaction': 'zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]', 'InteractionActions': 'decreases^reaction|increases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Drugs, Chinese Herbal'): Text(-0.0224771979264915, 0.16107858408940956, \"{'Interaction': 'Drugs, Chinese Herbal results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pentetic Acid'): Text(-0.01872198609635234, 0.6424525678157806, \"{'Interaction': 'Pentetic Acid inhibits the reaction [pyrithione zinc results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Chlorpyrifos'): Text(0.04412536742165685, 0.13936226069927216, \"{'Interaction': 'Cycloheximide promotes the reaction [Chlorpyrifos results in decreased expression of TP53 protein]', 'InteractionActions': 'decreases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Dust'): Text(0.06491597788408399, 0.15685816924087703, \"{'Interaction': 'Dust results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fonofos'): Text(-0.16646042047068477, 0.37317509949207306, \"{'Interaction': 'Fonofos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Edetic Acid'): Text(0.2711983066983521, 0.2643894627690315, \"{'Interaction': 'Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]]', 'InteractionActions': 'affects^binding|decreases^activity|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Ellagic Acid'): Text(-0.11200049100443721, 0.12546201422810555, \"{'Interaction': 'pifithrin inhibits the reaction [Ellagic Acid promotes the reaction [Quercetin results in increased phosphorylation of TP53 protein]]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Endosulfan'): Text(0.010732690338045359, 0.16272006975486875, \"{'Interaction': 'Endosulfan results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Enzyme Inhibitors'): Text(-0.07994997827336192, 0.22578492015600204, \"{'Interaction': '[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TP53 protein', 'InteractionActions': 'decreases^activity|increases^O-linked glycosylation'}\"),\n",
       " ('tp53',\n",
       "  'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester'): Text(0.0021527206990867853, 0.6601696312427521, \"{'Interaction': 'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Erythrosine'): Text(-0.21047052321955562, 0.2986346334218979, \"{'Interaction': 'Erythrosine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Estradiol'): Text(-0.06216174690052867, 0.19298634678125381, \"{'Interaction': '[Parathion co-treated with Estradiol] results in increased expression of TP53 protein mutant form', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Estrogens'): Text(-0.16723045287653804, 0.17277460172772408, \"{'Interaction': 'Estrogens results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ethacridine'): Text(0.22087271930649877, 0.5575505495071411, \"{'Interaction': 'Ethacridine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ethacrynic Acid'): Text(0.06076688366010785, 0.22510843724012375, \"{'Interaction': 'Ethacrynic Acid affects the localization of TP53 protein', 'InteractionActions': 'affects^localization'}\"),\n",
       " ('tp53',\n",
       "  'Ethidium'): Text(-0.2024333286099136, 0.28635963797569275, \"{'Interaction': 'Ethidium affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ethinyl Estradiol'): Text(-0.040871146600693464, 0.28313200175762177, \"{'Interaction': 'Ethinyl Estradiol affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Amifostine'): Text(0.003941278904676437, 0.3406737148761749, \"{'Interaction': 'TP53 protein promotes the reaction [Amifostine results in decreased phosphorylation of CDK1 protein]', 'InteractionActions': 'decreases^phosphorylation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Ethylenebis(dithiocarbamates)'): Text(0.05300022708252072, 0.6138812899589539, \"{'Interaction': 'Ethylenebis(dithiocarbamates) results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ethylnitrosourea'): Text(0.06129387440159917, 0.40777787566185, \"{'Interaction': '[Ethylnitrosourea results in increased mutagenesis of TP53 gene] which results in decreased activity of TP53 protein', 'InteractionActions': 'decreases^activity|increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Etoposide'): Text(0.0029162766877561808, 0.17324662022292614, \"{'Interaction': 'UF010 compound promotes the reaction [Etoposide results in increased expression of and results in increased acetylation of TP53 protein]', 'InteractionActions': 'increases^acetylation|increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Eugenol'): Text(0.0011908826418220997, 0.29218198359012604, \"{'Interaction': 'Eugenol results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Fenbendazole'): Text(0.1453798753209412, 0.21565765514969826, \"{'Interaction': 'Fenbendazole results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fenitrothion'): Text(0.22060665907338262, 0.5570743083953857, \"{'Interaction': 'Fenitrothion metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Fenthion'): Text(-0.011376769747585058, 0.3394651859998703, \"{'Interaction': 'Fenthion metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ferric Compounds'): Text(-0.061123895924538374, 0.3909023255109787, \"{'Interaction': 'Ferric Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fish Oils'): Text(0.09493972780182958, 0.26059313118457794, \"{'Interaction': '[Fish Oils results in increased abundance of Eicosapentaenoic Acid] which results in increased expression of TP53 protein', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Flame Retardants'): Text(0.00865430710837245, 0.2547828480601311, \"{'Interaction': 'Flame Retardants results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Flavonoids'): Text(0.10123812081292272, 0.3719300627708435, \"{'Interaction': 'Flavonoids results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Flucytosine'): Text(0.0005108998157083988, 0.503565102815628, \"{'Interaction': 'Flucytosine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Floxuridine'): Text(-0.06624983577057719, 0.4188894033432007, \"{'Interaction': 'Floxuridine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fluorometholone'): Text(0.10046696336939931, 0.1163758747279644, \"{'Interaction': 'Fluorometholone inhibits the reaction [Glucose results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fluorouracil'): Text(-0.02946048555895686, 0.1744346348568797, \"{'Interaction': 'TP53 results in increased susceptibility to [Poly I-C co-treated with Fluorouracil]', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Fluoxetine'): Text(0.02829261915758252, 0.22652732580900192, \"{'Interaction': 'Fluoxetine results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Flurbiprofen'): Text(-0.036530624609440565, 0.08084161579608917, \"{'Interaction': 'TP53 protein results in increased susceptibility to Flurbiprofen', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Folic Acid'): Text(-0.045449729543179274, 0.17557706404477358, \"{'Interaction': 'U 0126 inhibits the reaction [Folic Acid results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Formaldehyde'): Text(-0.0407753954641521, 0.19993559271097183, \"{'Interaction': 'Formaldehyde results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Colforsin'): Text(0.09068300249055028, 0.16414833907037973, \"{'Interaction': 'Colforsin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tegafur'): Text(-0.03529598144814372, 0.6100974678993225, \"{'Interaction': 'TP53 protein affects the susceptibility to [Uracil co-treated with Tegafur]', 'InteractionActions': 'affects^cotreatment|affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Galactose'): Text(0.1461525154300034, 0.2488235980272293, \"{'Interaction': 'Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Gallic Acid'): Text(0.009163195500150323, 0.1945958398282528, \"{'Interaction': '[Paclitaxel co-treated with Gallic Acid] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Gentamicins'): Text(0.15408893348649144, 0.28648997843265533, \"{'Interaction': 'Gentamicins results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Gentian Violet'): Text(-0.19352875230833888, 0.2906334102153778, \"{'Interaction': 'pifithrin inhibits the reaction [Gentian Violet promotes the reaction [TP53 protein results in increased expression of BBC3 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Glyburide'): Text(-0.12421534536406398, 0.49782127141952515, \"{'Interaction': 'Glyburide results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Gliclazide'): Text(-0.054411962162703276, 0.650725930929184, \"{'Interaction': 'Gliclazide results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Glucose'): Text(-0.008269139099866152, 0.13499305956065655, '{\\'Interaction\\': \"[Tretinoin results in increased uptake of Glucose] inhibits the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N\\')copper(II) results in increased expression of TP53 protein]\", \\'InteractionActions\\': \\'decreases^reaction|increases^expression|increases^uptake\\'}'),\n",
       " ('tp53',\n",
       "  'Glucosides'): Text(0.11958275409415364, 0.5877167284488678, \"{'Interaction': 'Glucosides inhibits the reaction [Paclitaxel results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Glutaral'): Text(0.2695615333504975, 0.28554244339466095, \"{'Interaction': 'Glutaral results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Glutathione'): Text(0.026966397184878588, 0.14167531207203865, \"{'Interaction': 'TP53 protein results in decreased abundance of Glutathione', 'InteractionActions': 'decreases^abundance'}\"),\n",
       " ('tp53',\n",
       "  'Glycerol'): Text(0.17965007247403264, 0.231406532227993, \"{'Interaction': 'Glycerol results in increased activity of TP53 protein mutant form', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Heparin'): Text(0.08446200611069798, 0.1512260576710105, \"{'Interaction': 'Heparin analog results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Heptachlor'): Text(0.08248328091576695, 0.18381194025278091, \"{'Interaction': 'Heptachlor results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Heterocyclic Compounds, 3-Ring'): Text(0.023040388245135546, 0.38143396377563477, \"{'Interaction': 'Heterocyclic Compounds, 3-Ring results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Hexachlorophene'): Text(-0.20142408786341548, 0.3193272203207016, \"{'Interaction': 'Hexachlorophene affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Homocysteine'): Text(0.018364602234214544, 0.2343175932765007, \"{'Interaction': 'Homocysteine affects the expression of TP53 protein', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Hycanthone'): Text(0.16107012750580907, 0.6018748879432678, \"{'Interaction': 'Hycanthone affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Hydralazine'): Text(-0.08509483514353633, 0.23880686610937119, \"{'Interaction': 'Hydralazine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Hydrazones'): Text(-0.1706688362173736, 0.26025518774986267, \"{'Interaction': 'Hydrazones results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Hydrogen Peroxide'): Text(-0.048207908403128386, 0.19089209660887718, \"{'Interaction': 'TP53 protein results in increased susceptibility to Hydrogen Peroxide', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Hydroxamic Acids'): Text(-0.026166788768023252, 0.05318838357925415, \"{'Interaction': 'Hydroxamic Acids analog results in increased acetylation of TP53 protein', 'InteractionActions': 'increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Hydroxyurea'): Text(-0.08064336655661464, 0.24073553085327148, \"{'Interaction': 'Hydroxyurea results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Hymecromone'): Text(-0.012937699910253286, 0.6266933977603912, \"{'Interaction': 'Hymecromone metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ibuprofen'): Text(0.03526264848187566, 0.16527713742107153, \"{'Interaction': 'Ibuprofen affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ifosfamide'): Text(-0.1276276963762939, 0.3272392004728317, \"{'Interaction': 'Ifosfamide affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Indomethacin'): Text(-0.03329092962667346, 0.2139280140399933, \"{'Interaction': 'Indomethacin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Clioquinol'): Text(0.07013611169531941, 0.15055944491177797, \"{'Interaction': 'Clioquinol results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Iohexol'): Text(0.17753674509003758, 0.23992273956537247, \"{'Interaction': 'Iohexol results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Iopamidol'): Text(0.14070065738633275, 0.3460555523633957, \"{'Interaction': 'Iopamidol results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Isatin'): Text(-0.08899328438565135, 0.4644884765148163, \"{'Interaction': 'Tretinoin inhibits the reaction [[Copper binds to Isatin binds to trimethylenediamine] which results in increased expression of TP53 protein]', 'InteractionActions': 'affects^binding|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Isoproterenol'): Text(0.13737805606797338, 0.11872784420847893, \"{'Interaction': 'Isoproterenol results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ivermectin'): Text(-0.07239340571686625, 0.21293571218848228, \"{'Interaction': 'Ivermectin inhibits the reaction [geranylgeranic acid affects the localization of TP53 protein mutant form]', 'InteractionActions': 'affects^localization|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Ketamine'): Text(0.2612786334939301, 0.2722072899341583, \"{'Interaction': 'Ketamine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Lead'): Text(-0.06698970822617412, 0.18791343830525875, \"{'Interaction': 'titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA]', 'InteractionActions': 'decreases^reaction|increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Levamisole'): Text(0.14310454251244664, 0.3577999174594879, \"{'Interaction': 'Levamisole results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Lithium'): Text(0.1066310522146523, 0.24516364932060242, \"{'Interaction': 'Lithium inhibits the reaction [sodium arsenite results in increased expression of and affects the localization of TP53 protein]', 'InteractionActions': 'affects^localization|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Lovastatin'): Text(-0.00913764676079154, 0.08900915086269379, \"{'Interaction': 'Lovastatin results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Magnesium Oxide'): Text(-0.03695292351767421, 0.6513121426105499, \"{'Interaction': '[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Malathion'): Text(0.07381347985938191, 0.1804460659623146, \"{'Interaction': 'Malathion results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Malondialdehyde'): Text(-0.1989354002289474, 0.16546879010275006, \"{'Interaction': 'Malondialdehyde results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Mannitol'): Text(0.1554690790362656, 0.3221791386604309, \"{'Interaction': 'Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Mechlorethamine'): Text(0.06339847715571523, 0.25001373142004013, \"{'Interaction': 'Mechlorethamine results in increased stability of TP53 protein', 'InteractionActions': 'increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Melatonin'): Text(0.003604527562856674, 0.10846203565597534, \"{'Interaction': 'Melatonin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Melphalan'): Text(-0.09326144633814692, 0.1923782415688038, \"{'Interaction': 'Melphalan affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Menthol'): Text(-0.06607133476063609, 0.20311525091528893, \"{'Interaction': 'Menthol results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Metformin'): Text(-0.018986485432833433, 0.1506525157019496, \"{'Interaction': 'Metformin results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Methotrexate'): Text(-0.0557658183388412, 0.1865928377956152, \"{'Interaction': 'TP53 protein results in increased susceptibility to Methotrexate', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Methoxsalen'): Text(0.1074392986483872, 0.2104218825697899, \"{'Interaction': 'Methoxsalen results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Methoxychlor'): Text(0.06219828175380826, 0.14184096828103065, \"{'Interaction': 'Methoxychlor results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Methyl Methanesulfonate'): Text(-0.07581831095740199, 0.19842695444822311, \"{'Interaction': 'TP53 protein affects the reaction [Methyl Methanesulfonate results in increased expression of CDKN1A mRNA]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Methyl Parathion'): Text(0.12725153984501958, 0.29122714698314667, \"{'Interaction': 'Methyl Parathion results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Methylene Blue'): Text(0.023534676525741816, 0.6195581555366516, \"{'Interaction': 'Methylene Blue affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Methylmercury Compounds'): Text(0.07685206504538655, 0.18405171111226082, \"{'Interaction': 'Methylmercury Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Methylnitronitrosoguanidine'): Text(0.04133452521637082, 0.2073812149465084, \"{'Interaction': 'TP53 protein results in increased susceptibility to Methylnitronitrosoguanidine', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Methylnitrosourea'): Text(0.026323134545236826, 0.3462013304233551, \"{'Interaction': 'TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein]', 'InteractionActions': 'decreases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Mevinphos'): Text(0.03530123317614198, 0.6049378216266632, \"{'Interaction': 'Mevinphos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Mitotane'): Text(0.12227259995415807, 0.30892471969127655, \"{'Interaction': '[Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Mitoxantrone'): Text(-0.029118299018591642, 0.3245365470647812, \"{'Interaction': 'Mitoxantrone affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Molybdenum'): Text(0.0248566553927958, 0.6396285593509674, \"{'Interaction': 'Molybdenum analog results in increased expression of and results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Morphine'): Text(0.10841723205521703, 0.16003510949667543, \"{'Interaction': 'Naloxone inhibits the reaction [Morphine results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Mustard Compounds'): Text(0.20148832025006413, 0.5849294662475586, \"{'Interaction': 'Mustard Compounds results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Mustard Gas'): Text(0.0028521441854536533, 0.19365858286619186, \"{'Interaction': 'Wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Mycophenolic Acid'): Text(0.07599510671570897, 0.10301394015550613, \"{'Interaction': 'Mycophenolic Acid affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'NAD'): Text(-0.21903402684256434, 0.310218021273613, \"{'Interaction': '[[Resveratrol results in increased activity of and results in increased phosphorylation of SIRT1 protein] which co-treated with NAD] results in decreased acetylation of TP53 protein', 'InteractionActions': 'affects^cotreatment|decreases^acetylation|increases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'NADP'): Text(0.18324536504223943, 0.6043964624404907, \"{'Interaction': 'NADP promotes the reaction [sodium bichromate results in increased expression of TP53 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Naloxone'): Text(0.21649443032220006, 0.203571405261755, \"{'Interaction': 'Naloxone inhibits the reaction [Morphine results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Naphthalenes'): Text(-0.11337062297388911, 0.6176078915596008, \"{'Interaction': 'Naphthalenes results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Nickel'): Text(-0.05781880347058177, 0.16116212017368525, \"{'Interaction': 'TP53 protein affects the reaction [Nickel results in increased expression of MDM2 mRNA]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Niclosamide'): Text(-0.017152938526123762, 0.12974026799201965, \"{'Interaction': 'TP53 protein results in decreased susceptibility to Niclosamide', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Niacinamide'): Text(0.022582671139389277, 0.11545347794890404, \"{'Interaction': 'Niacinamide results in increased phosphorylation of and results in increased acetylation of TP53 protein', 'InteractionActions': 'increases^acetylation|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Nicotine'): Text(-0.013970672618597746, 0.1667810846120119, \"{'Interaction': 'TP53 protein affects the reaction [Nicotine results in increased phosphorylation of MAPK8 protein]', 'InteractionActions': 'affects^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Nifedipine'): Text(0.04286670358851552, 0.27488885819911957, \"{'Interaction': 'Nifedipine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ninhydrin'): Text(-0.02911747945472598, 0.6554984152317047, \"{'Interaction': 'Ninhydrin affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Nitric Oxide'): Text(-0.22134536085650325, 0.28709742426872253, \"{'Interaction': 'Wortmannin inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Nitrofurazone'): Text(-0.047674066852778196, 0.6325020492076874, \"{'Interaction': 'Nitrofurazone results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Nitrogen Mustard Compounds'): Text(0.1641957056708634, 0.43308404088020325, \"{'Interaction': 'Nitrogen Mustard Compounds results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Nitrogen Oxides'): Text(0.14738376857712865, 0.2298184186220169, \"{'Interaction': 'Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Nitroprusside'): Text(0.03928392427042127, 0.24214093387126923, \"{'Interaction': 'Nitroprusside results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Nitrovin'): Text(0.1542156976647675, 0.588232159614563, \"{'Interaction': 'Nitrovin affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Masoprocol'): Text(0.01592980371788144, 0.09325440973043442, \"{'Interaction': 'MYC affects the reaction [Masoprocol results in increased expression of TP53 protein]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Norethindrone'): Text(0.16792694153264165, 0.24744262546300888, \"{'Interaction': 'Norethindrone results in increased expression of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Noscapine'): Text(-0.06883468804880977, 0.46837037801742554, \"{'Interaction': 'Noscapine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'o-Phthalaldehyde'): Text(0.06670774193480611, 0.6019530892372131, \"{'Interaction': 'o-Phthalaldehyde affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Organometallic Compounds'): Text(-0.03401955170556903, 0.5014421045780182, \"{'Interaction': 'Organometallic Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ouabain'): Text(0.02086338447406888, 0.15521370386704803, \"{'Interaction': 'Ouabain results in decreased expression of and results in increased phosphorylation of TP53 protein', 'InteractionActions': 'decreases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Oxalates'): Text(0.11569548072293401, 0.6336323618888855, \"{'Interaction': '[TP53 gene polymorphism results in increased susceptibility to [Smoke results in increased abundance of Oxalates]] which results in increased expression of MUC5AC mRNA', 'InteractionActions': 'increases^abundance|increases^expression|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Oxygen'): Text(-0.05072341440245509, 0.18567613884806633, \"{'Interaction': 'TP53 protein mutant form results in increased susceptibility to Oxygen deficiency', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Ozone'): Text(-0.05806054500862956, 0.18352829664945602, \"{'Interaction': 'Ozone affects the expression of TP53 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Palmitates'): Text(0.1603070986457169, 0.19969656690955162, \"{'Interaction': 'SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Palmitates results in increased acetylation of TP53 protein]]', 'InteractionActions': 'decreases^reaction|increases^acetylation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Paraquat'): Text(-0.010685242246836424, 0.1912755500525236, \"{'Interaction': 'Paraquat results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Parathion'): Text(-0.13792560575529933, 0.22506941109895706, \"{'Interaction': 'Parathion results in increased expression of TP53 protein mutant form', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Patulin'): Text(-0.017156959977000952, 0.29728278517723083, \"{'Interaction': 'Patulin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Penicillamine'): Text(0.022104619536548853, 0.49346762895584106, \"{'Interaction': 'Penicillamine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pentachlorophenol'): Text(0.14518531085923314, 0.1602667610059143, \"{'Interaction': 'Pentachlorophenol affects the expression of TP53 protein', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pentamidine'): Text(-0.14580265758559108, 0.11647568643093109, \"{'Interaction': 'Pentamidine inhibits the reaction [KAT5 protein results in increased acetylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Pergolide'): Text(0.10205255122855306, 0.35835446417331696, \"{'Interaction': 'Pergolide inhibits the reaction [[Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of MSH2 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pesticides'): Text(-0.0992347034625709, 0.10707428306341171, \"{'Interaction': 'Pesticides results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Phenindione'): Text(-0.0915169077925384, 0.6303408145904541, \"{'Interaction': 'Phenindione results in increased degradation of TP53 protein', 'InteractionActions': 'increases^degradation'}\"),\n",
       " ('tp53',\n",
       "  'Phenylmercuric Acetate'): Text(-0.08259471086785197, 0.21588997542858124, \"{'Interaction': 'Phenylmercuric Acetate affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Phenytoin'): Text(0.06817027227953076, 0.22423531860113144, \"{'Interaction': 'Phenytoin results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Phloretin'): Text(-0.07018243847414851, 0.05480439215898514, \"{'Interaction': '[Ruthenium binds to Phloretin] which results in increased expression of TP53 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Phorate'): Text(0.012802284210920334, 0.6486799418926239, \"{'Interaction': 'Phorate metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Phosmet'): Text(0.1839519334025681, 0.5868058502674103, \"{'Interaction': 'Phosmet metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Phosphamidon'): Text(0.2026255768723786, 0.5782102346420288, \"{'Interaction': 'Phosphamidon metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Phosphatidylcholines'): Text(-0.1700183260254562, 0.21305593103170395, \"{'Interaction': 'Phosphatidylcholines inhibits the reaction [rubitecan results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Organophosphates'): Text(-0.10467087803408504, 0.46182188391685486, \"{'Interaction': 'Organophosphates results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Leptophos'): Text(-0.014482613187283278, 0.6094694137573242, \"{'Interaction': 'Leptophos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Phycocyanin'): Text(0.10334770800545812, 0.6090863049030304, \"{'Interaction': 'Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Phytic Acid'): Text(0.018716698046773672, 0.27676746994256973, \"{'Interaction': 'Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Piroxicam'): Text(-0.011390104424208403, 0.24182242900133133, \"{'Interaction': 'Piroxicam promotes the reaction [Cisplatin results in increased expression of TP53 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Plant Extracts'): Text(-0.04233669815585017, 0.16499364376068115, \"{'Interaction': 'Plant Extracts results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Plant Oils'): Text(-0.15728069422766566, 0.2567957639694214, \"{'Interaction': 'Plant Oils results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Poly I-C'): Text(0.10487273754552007, 0.10984576120972633, \"{'Interaction': 'TP53 results in increased susceptibility to [Poly I-C co-treated with Fluorouracil]', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Polychlorinated Biphenyls'): Text(0.004462234093807638, 0.16469514090567827, \"{'Interaction': 'Polychlorinated Biphenyls results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Polycyclic Aromatic Hydrocarbons'): Text(-0.001709007192403078, 0.17501540202647448, \"{'Interaction': 'Polycyclic Aromatic Hydrocarbons results in decreased methylation of TP53 promoter', 'InteractionActions': 'decreases^methylation'}\"),\n",
       " ('tp53',\n",
       "  'Polyethyleneimine'): Text(0.1244111624546349, 0.1403880063444376, \"{'Interaction': '[Niclosamide binds to Polyethyleneimine] which results in increased expression of TP53 mRNA', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Polymyxin B'): Text(0.15491803409531713, 0.18222657963633537, \"{'Interaction': 'TP53 protein promotes the reaction [Polymyxin B results in increased expression of TFRC protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Polysaccharides'): Text(0.11847179802134633, 0.2136673890054226, \"{'Interaction': 'Polysaccharides results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Potassium Dichromate'): Text(-0.010580738540738821, 0.1662549525499344, \"{'Interaction': 'Potassium Dichromate results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Povidone'): Text(0.00448152597527951, 0.39637719094753265, \"{'Interaction': '[Silver co-treated with Povidone] results in decreased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fenofibrate'): Text(0.04278655769303441, 0.12731630727648735, \"{'Interaction': 'Fenofibrate affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Proflavine'): Text(0.11430103005841374, 0.6410383582115173, \"{'Interaction': 'Proflavine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Progestins'): Text(-0.2221435564570129, 0.26903776079416275, \"{'Interaction': 'TP53 protein inhibits the reaction [Progestins results in increased expression of VEGFA mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Progesterone'): Text(-0.02367709344252944, 0.1737613556906581, \"{'Interaction': 'TP53 protein results in increased susceptibility to Progesterone', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Pyrogallol'): Text(0.16429053666070104, 0.620229572057724, \"{'Interaction': 'SB 203580 inhibits the reaction [Pyrogallol results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Pyrroles'): Text(0.09807365061715245, 0.6459997892379761, \"{'Interaction': 'Pyrroles analog results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Quartz'): Text(0.0339338188059628, 0.0790930911898613, \"{'Interaction': 'Quartz results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Quercetin'): Text(-0.05108154146000743, 0.17609351314604282, \"{'Interaction': 'TP53 protein affects the reaction [Quercetin results in increased expression of MIR34A mRNA]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Quinacrine'): Text(0.04784169839695096, 0.27199947088956833, \"{'Interaction': 'Quinacrine results in increased stability of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Razoxane'): Text(-0.11382830468937755, 0.370329812169075, \"{'Interaction': 'Razoxane affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Retinoids'): Text(-0.043158910702914, 0.12399464100599289, \"{'Interaction': 'Retinoids results in increased phosphorylation of and results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Ribavirin'): Text(-0.15260642347857356, 0.1855902187526226, \"{'Interaction': 'Ribavirin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Riboflavin'): Text(0.12851877184584737, 0.26009899377822876, \"{'Interaction': 'Riboflavin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ribonucleotides'): Text(-0.11898407666012645, 0.27808497846126556, \"{'Interaction': 'TP53 protein binds to Ribonucleotides', 'InteractionActions': 'affects^binding'}\"),\n",
       " ('tp53',\n",
       "  'Rotenone'): Text(-0.04199711559340358, 0.20198872685432434, \"{'Interaction': 'Rotenone results in increased expression of TP53 protein modified form', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ruthenium'): Text(-0.1791309374384582, 0.2931198328733444, \"{'Interaction': 'Ruthenium results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Rutin'): Text(0.1754833203740418, 0.19602597132325172, \"{'Interaction': 'Rutin inhibits the reaction [Cisplatin results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Selenium'): Text(-0.08602669415995479, 0.18396616354584694, \"{'Interaction': 'Selenium results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Selenomethionine'): Text(0.07286154897883534, 0.2628084197640419, \"{'Interaction': 'Selenomethionine results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Silicon Dioxide'): Text(-0.05929015902802348, 0.2027159333229065, \"{'Interaction': 'SIRT1 protein inhibits the reaction [Silicon Dioxide results in increased acetylation of and results in increased phosphorylation of and affects the localization of TP53 protein]', 'InteractionActions': 'affects^localization|decreases^reaction|increases^acetylation|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Silver'): Text(-0.0026442534290254116, 0.194042406976223, \"{'Interaction': 'Silver results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Silver Nitrate'): Text(-0.010623493697494268, 0.2429419606924057, \"{'Interaction': 'Silver Nitrate analog results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Skatole'): Text(0.12377669336274266, 0.5923669636249542, \"{'Interaction': 'Skatole results in increased phosphorylation of and affects the localization of TP53 protein', 'InteractionActions': 'affects^localization|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Smoke'): Text(-0.07905044732615352, 0.18956002593040466, \"{'Interaction': '[TP53 protein polymorphism results in increased susceptibility to Smoke] which results in increased expression of MUC5AC mRNA', 'InteractionActions': 'increases^expression|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Sodium Chloride'): Text(0.10050666751340032, 0.17833606339991093, \"{'Interaction': 'Sodium Chloride results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Sodium Fluoride'): Text(-0.010003769304603338, 0.10125834122300148, \"{'Interaction': 'Sodium Fluoride results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Stilbenes'): Text(-0.10450887260958552, 0.09497150033712387, \"{'Interaction': '[Stilbenes results in increased expression of TP53 protein] which results in increased expression of BAX protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Sulindac'): Text(0.0019154828041791916, 0.1362333633005619, \"{'Interaction': 'Sulindac results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Suramin'): Text(0.1548480880446732, 0.1973107047379017, \"{'Interaction': 'Suramin results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein]', 'InteractionActions': 'decreases^acetylation|decreases^activity'}\"),\n",
       " ('tp53',\n",
       "  'T-2 Toxin'): Text(0.0022628854494541883, 0.31068676710128784, \"{'Interaction': 'T-2 Toxin results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tamoxifen'): Text(-0.025371949654072523, 0.1482712347060442, \"{'Interaction': 'TP53 protein results in increased susceptibility to Tamoxifen', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Tea'): Text(-0.09561576275154948, 0.6149857640266418, \"{'Interaction': 'Tea results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Testosterone'): Text(-0.04201372666284442, 0.17851903848350048, \"{'Interaction': '[Testosterone co-treated with gingerol] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tetrachlorodibenzodioxin'): Text(-0.04385152040049434, 0.1984466165304184, \"{'Interaction': 'Tetrachlorodibenzodioxin results in decreased susceptibility to [nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of TP53 protein modified form]]', 'InteractionActions': 'decreases^response to substance|increases^expression|increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Tetrachloroethylene'): Text(-0.03808563156053424, 0.35252906382083893, \"{'Interaction': 'Tetrachloroethylene results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tetrachlorvinphos'): Text(0.08282949449494481, 0.6480622291564941, \"{'Interaction': 'Tetrachlorvinphos metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Tetradecanoylphorbol Acetate'): Text(-0.019984524231404066, 0.12928772903978825, \"{'Interaction': 'Tetradecanoylphorbol Acetate results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Thalidomide'): Text(0.029933248180896044, 0.13287951797246933, \"{'Interaction': 'Thalidomide analog results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Theophylline'): Text(-0.019046447705477476, 0.09449452906847, \"{'Interaction': 'Theophylline results in decreased expression of TP53', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Thimerosal'): Text(-0.019266329240053892, 0.16461927676573396, \"{'Interaction': 'Thimerosal affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Thiocarbamates'): Text(0.17377937259152532, 0.5715107321739197, \"{'Interaction': 'Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Thioguanine'): Text(0.1518556815572083, 0.6253954768180847, \"{'Interaction': 'Thioguanine results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Thioinosine'): Text(0.0379701410420239, 0.6293958127498627, \"{'Interaction': 'Thioinosine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Thioridazine'): Text(-0.1885223942808807, 0.20269611850380898, \"{'Interaction': 'Thioridazine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Thiosemicarbazones'): Text(0.016581779811531305, 0.25795282423496246, \"{'Interaction': '[Thiosemicarbazones binds to Copper] which results in decreased activity of TP53 protein', 'InteractionActions': 'affects^binding|decreases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Thiostrepton'): Text(0.1123942625708878, 0.23947925120592117, \"{'Interaction': 'Thiostrepton results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Thiourea'): Text(0.25370072247460485, 0.2861727476119995, \"{'Interaction': 'Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tobacco Smoke Pollution'): Text(-0.06598928896710277, 0.2004747986793518, \"{'Interaction': 'Tobacco Smoke Pollution results in increased mutagenesis of TP53 gene', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Toluene'): Text(-0.11159081337973475, 0.08092887699604034, \"{'Interaction': 'Toluene results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Tosylphenylalanyl Chloromethyl Ketone'): Text(0.07105131866410375, 0.11584296450018883, \"{'Interaction': 'TP53 protein results in increased susceptibility to Tosylphenylalanyl Chloromethyl Ketone', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Tretinoin'): Text(-0.06586630968376994, 0.1899582650512457, \"{'Interaction': 'Vorinostat inhibits the reaction [Tretinoin inhibits the reaction [Cisplatin results in increased acetylation of TP53 protein]]', 'InteractionActions': 'decreases^reaction|increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Triamterene'): Text(0.09194621117785573, 0.5923906564712524, \"{'Interaction': 'Triamterene metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Trichlorfon'): Text(0.06606172444298863, 0.6399513781070709, \"{'Interaction': 'Trichlorfon results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Trichloroethylene'): Text(-0.029254458379000425, 0.04860227555036545, \"{'Interaction': 'Trichloroethylene results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Trientine'): Text(0.09246098669245839, 0.6039087176322937, \"{'Interaction': 'Trientine results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Trifluridine'): Text(-0.07466288236901164, 0.6229366064071655, \"{'Interaction': 'Trifluridine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Tritolyl Phosphates'): Text(0.18688854994252324, 0.5704002976417542, \"{'Interaction': 'Tritolyl Phosphates binds to TP53 gene', 'InteractionActions': 'affects^binding'}\"),\n",
       " ('tp53',\n",
       "  'Tunicamycin'): Text(-0.07356544164940715, 0.1929609440267086, \"{'Interaction': 'Tunicamycin promotes the reaction [Capsaicin results in increased degradation of TP53 protein]', 'InteractionActions': 'increases^degradation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Uracil'): Text(-0.09919846383854747, 0.6035561859607697, \"{'Interaction': 'TP53 protein affects the susceptibility to [Uracil co-treated with Tegafur]', 'InteractionActions': 'affects^cotreatment|affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Uridine'): Text(-0.16439649043604732, 0.4254615902900696, \"{'Interaction': 'Uridine inhibits the reaction [celastrol results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ursodeoxycholic Acid'): Text(0.027784849051386118, 0.20313968509435654, \"{'Interaction': 'Ursodeoxycholic Acid results in increased ubiquitination of TP53 protein', 'InteractionActions': 'increases^ubiquitination'}\"),\n",
       " ('tp53',\n",
       "  'Valproic Acid'): Text(-0.08205297915264964, 0.20551489293575287, \"{'Interaction': 'Valproic Acid results in increased methylation of TP53 gene', 'InteractionActions': 'increases^methylation'}\"),\n",
       " ('tp53',\n",
       "  'Vanadium'): Text(0.0643416908569634, 0.22223640978336334, \"{'Interaction': 'Vanadium results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Vinblastine'): Text(-0.10087041882798076, 0.133902657777071, \"{'Interaction': 'TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein]', 'InteractionActions': 'affects^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Vincristine'): Text(-0.04374731285497546, 0.22871088236570358, \"{'Interaction': 'Vincristine results in increased glutathionylation of TP53 protein', 'InteractionActions': 'increases^glutathionylation'}\"),\n",
       " ('tp53',\n",
       "  'Vinyl Chloride'): Text(-0.0955416145734489, 0.41714292764663696, \"{'Interaction': 'XRCC1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene]', 'InteractionActions': 'increases^mutagenesis|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Viper Venoms'): Text(0.08544820221140981, 0.3634148985147476, \"{'Interaction': 'Viper Venoms results in increased expression of and affects the localization of TP53 protein', 'InteractionActions': 'affects^localization|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vitamin D'): Text(-0.04467458976432681, 0.3137092590332031, \"{'Interaction': 'Vitamin D results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vitamin E'): Text(-0.05272112740203738, 0.20599450916051865, \"{'Interaction': 'Vitamin E results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Warfarin'): Text(0.15988848032429814, 0.17386060860008, \"{'Interaction': 'Warfarin results in increased degradation of TP53 protein', 'InteractionActions': 'increases^degradation'}\"),\n",
       " ('tp53',\n",
       "  'Water Pollutants'): Text(0.16018546046689153, 0.2916489541530609, \"{'Interaction': '[Water Pollutants results in increased abundance of naphthenic acid] which results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zearalenone'): Text(0.007073490298353136, 0.2226906269788742, \"{'Interaction': 'Zearalenone results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zinc'): Text(-0.03864271147176623, 0.17741873115301132, \"{'Interaction': 'Zinc results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zinc Oxide'): Text(0.13114597322419286, 0.15810268139466643, \"{'Interaction': 'Zinc Oxide results in increased phosphorylation of and results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  '2-Acetylaminofluorene'): Text(0.046570074278861284, 0.32155822217464447, \"{'Interaction': '2-Acetylaminofluorene results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  '2-Naphthylamine'): Text(-0.039108510594815016, 0.5140966773033142, \"{'Interaction': '2-Naphthylamine results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  '2,6-Dichloroindophenol'): Text(-0.16288728592917323, 0.3652607351541519, \"{'Interaction': '[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased phosphorylation of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  \"3,3'-Dichlorobenzidine\"): Text(0.019389455672353506, 0.657300740480423, '{\\'Interaction\\': \"3,3\\'-Dichlorobenzidine affects the activity of TP53 protein\", \\'InteractionActions\\': \\'affects^activity\\'}'),\n",
       " ('tp53',\n",
       "  '4-Nitroquinoline-1-oxide'): Text(0.14491768600419164, 0.2773643285036087, \"{'Interaction': '4-Nitroquinoline-1-oxide results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Eicosapentaenoic Acid'): Text(0.16934307338669896, 0.20908046513795853, \"{'Interaction': '[Fish Oils results in increased abundance of Eicosapentaenoic Acid] which results in increased expression of TP53 protein', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Mercaptopurine'): Text(0.13929905416443944, 0.33135953545570374, \"{'Interaction': 'Mercaptopurine affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'): Text(-0.05016562668606639, 0.2054145596921444, \"{'Interaction': 'TP53 protein promotes the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRCA1 protein]', 'InteractionActions': 'decreases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  '8-Bromo Cyclic Adenosine Monophosphate'): Text(-0.008238525595515966, 0.14260716922581196, \"{'Interaction': '8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  '9,10-Dimethyl-1,2-benzanthracene'): Text(-0.10250690905377269, 0.3162314295768738, \"{'Interaction': '[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form', 'InteractionActions': 'increases^expression|increases^metabolic processing'}\"),\n",
       " ('tp53',\n",
       "  'Zidovudine'): Text(0.005285081046167761, 0.1821067687124014, \"{'Interaction': 'Zidovudine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Epirubicin'): Text(0.16905607702210546, 0.1701729167252779, \"{'Interaction': 'Epirubicin results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Octreotide'): Text(0.010854102671146393, 0.6149026453495026, \"{'Interaction': 'Octreotide results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Nimustine'): Text(0.09539148630574346, 0.26539725810289383, \"{'Interaction': 'TP53 protein affects the susceptibility to Nimustine', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Hazardous Substances'): Text(0.14480156125500798, 0.5997600853443146, \"{'Interaction': 'Hazardous Substances results in increased mutagenesis of TP53 exon', 'InteractionActions': 'increases^mutagenesis'}\"),\n",
       " ('tp53',\n",
       "  'Fatty Acids, Omega-3'): Text(-0.20716192899271846, 0.37804603576660156, \"{'Interaction': 'TP53 protein affects the susceptibility to Fatty Acids, Omega-3', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  '1-Methyl-4-phenylpyridinium'): Text(-0.04106440348550677, 0.17804977670311928, \"{'Interaction': 'U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of TP53 mRNA]', 'InteractionActions': 'affects^expression|affects^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Nocodazole'): Text(0.07404356868937612, 0.24237355589866638, \"{'Interaction': 'TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein]', 'InteractionActions': 'affects^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Metribolone'): Text(0.018889281433075666, 0.12628169730305672, \"{'Interaction': 'TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Propofol'): Text(0.03751711593940854, 0.10879185795783997, \"{'Interaction': 'Propofol results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Albendazole'): Text(0.16215040208771825, 0.5759629905223846, \"{'Interaction': 'Albendazole affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Ganciclovir'): Text(-0.05348613811656833, 0.49950286746025085, \"{'Interaction': 'Ganciclovir results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cysteine Proteinase Inhibitors'): Text(0.08109836699441075, 0.39678090810775757, \"{'Interaction': '[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased phosphorylation of TP53 protein', 'InteractionActions': 'decreases^activity|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Carboplatin'): Text(0.12172847660258412, 0.21533550322055817, \"{'Interaction': '[Paclitaxel co-treated with Carboplatin] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cyclosporine'): Text(-0.056650306563824415, 0.20609208568930626, \"{'Interaction': 'Cyclosporine results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Terfenadine'): Text(0.025083762127906084, 0.05427800118923187, \"{'Interaction': 'Terfenadine results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Aflatoxin B1'): Text(-0.08012795774266124, 0.19663437455892563, \"{'Interaction': '[Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA]', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Mitomycin'): Text(0.014860705938190222, 0.14288343861699104, \"{'Interaction': 'TP53 protein affects the susceptibility to Mitomycin', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Monocrotaline'): Text(-0.04643160430714488, 0.28543660044670105, \"{'Interaction': '[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression|increases^metabolic processing'}\"),\n",
       " ('tp53',\n",
       "  'Arachidonic Acid'): Text(0.07485442282631993, 0.20373132452368736, \"{'Interaction': '[TP53 protein results in increased expression of ALOX5 mRNA] which results in increased metabolism of Arachidonic Acid', 'InteractionActions': 'increases^expression|increases^metabolic processing'}\"),\n",
       " ('tp53',\n",
       "  'Pravastatin'): Text(-0.10352774290367961, 0.09316670149564743, \"{'Interaction': '[Pravastatin results in increased phosphorylation of MDM2 protein] which results in increased degradation of TP53 protein', 'InteractionActions': 'increases^degradation|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Paclitaxel'): Text(-0.01993655553087592, 0.15728787891566753, \"{'Interaction': 'TP53 protein results in decreased susceptibility to Paclitaxel', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Medroxyprogesterone Acetate'): Text(0.021927714813500643, 0.18535324186086655, \"{'Interaction': '[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Goserelin'): Text(0.05299486638978124, 0.6347299218177795, \"{'Interaction': 'Goserelin results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fenretinide'): Text(0.015985519159585238, 0.18659272603690624, \"{'Interaction': 'Fenretinide results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Cladribine'): Text(-0.17156748054549098, 0.3199450820684433, \"{'Interaction': 'Cladribine metabolite affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Reactive Oxygen Species'): Text(0.007975888438522816, 0.18194733187556267, \"{'Interaction': 'TP53 protein results in increased abundance of Reactive Oxygen Species', 'InteractionActions': 'increases^abundance'}\"),\n",
       " ('tp53',\n",
       "  'Asbestos, Serpentine'): Text(0.03411683114245534, 0.09985208511352539, \"{'Interaction': 'Wortmannin inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Asbestos, Amphibole'): Text(0.06047646375373006, 0.19138124585151672, \"{'Interaction': 'Asbestos, Amphibole results in increased phosphorylation of and results in increased stability of TP53 protein', 'InteractionActions': 'increases^phosphorylation|increases^stability'}\"),\n",
       " ('tp53',\n",
       "  'Asbestos, Crocidolite'): Text(-0.04576070932671428, 0.17674299329519272, \"{'Interaction': 'Asbestos, Crocidolite results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Asbestos, Amosite'): Text(-0.15539928851649165, 0.41418060660362244, \"{'Interaction': 'TP53 protein results in increased susceptibility to Asbestos, Amosite', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Platinum Compounds'): Text(0.19930386962369084, 0.562262624502182, \"{'Interaction': 'TP53 gene mutant form results in decreased susceptibility to Platinum Compounds', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\"): Text(-0.13293814240023494, 0.45854300260543823, '{\\'Interaction\\': \"4,4\\'-Diisothiocyanostilbene-2,2\\'-Disulfonic Acid inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein]\", \\'InteractionActions\\': \\'decreases^reaction|increases^expression\\'}'),\n",
       " ('tp53',\n",
       "  'Isocyanates'): Text(0.17545748176053166, 0.26226645708084106, \"{'Interaction': 'Isocyanates results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zinc Compounds'): Text(-0.03339960379526019, 0.39677420258522034, \"{'Interaction': 'Zinc Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vanadium Compounds'): Text(0.09061015816405416, 0.6375063061714172, \"{'Interaction': 'Vanadium Compounds results in increased expression of and results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Ruthenium Compounds'): Text(-0.015396855305880308, 0.499828964471817, \"{'Interaction': 'Ruthenium Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Lithium Chloride'): Text(-0.13172159669920802, 0.16900575812906027, \"{'Interaction': 'Lithium Chloride results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Silver Compounds'): Text(0.035643421579152346, 0.14834918454289436, \"{'Interaction': 'Silver Compounds results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Sodium Selenite'): Text(-0.03460109932348132, 0.19940659403800964, \"{'Interaction': 'TP53 protein affects the susceptibility to Sodium Selenite', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Cadmium Chloride'): Text(-0.0561589184217155, 0.19354305416345596, \"{'Interaction': 'TP53 protein affects the susceptibility to Cadmium Chloride', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Thapsigargin'): Text(-0.013632505666464567, 0.20748110115528107, \"{'Interaction': 'Thapsigargin results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zinc Sulfate'): Text(0.020045974757522345, 0.17281128652393818, \"{'Interaction': 'Zinc Sulfate results in increased phosphorylation of and results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Oleic Acid'): Text(-0.01089812396094203, 0.07211509346961975, \"{'Interaction': '[Palmitic Acid co-treated with Oleic Acid] results in increased expression of TP53 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Palmitic Acid'): Text(0.007571727270260453, 0.10535760596394539, \"{'Interaction': 'SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased acetylation of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Staurosporine'): Text(0.055506978649646044, 0.17740320041775703, \"{'Interaction': 'Staurosporine promotes the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]', 'InteractionActions': 'increases^activity|increases^localization|increases^phosphorylation|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Okadaic Acid'): Text(0.002103038365021348, 0.18388880975544453, \"{'Interaction': 'Okadaic Acid results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'beta-Naphthoflavone'): Text(0.024437297601252794, 0.23188234865665436, \"{'Interaction': '[beta-Naphthoflavone binds to and results in increased activity of AHR protein] results in decreased susceptibility to [1-nitropyrene results in increased expression of TP53 protein]', 'InteractionActions': 'affects^binding|decreases^response to substance|increases^activity|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Copper Sulfate'): Text(-0.07629975257441401, 0.21352087333798409, \"{'Interaction': 'Copper Sulfate results in increased phosphorylation of and results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Buthionine Sulfoximine'): Text(0.08189491601660848, 0.22968649864196777, \"{'Interaction': '[Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [Benzo(a)pyrene results in increased activity of TP53 protein]', 'InteractionActions': 'decreases^abundance|decreases^reaction|increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Acetic Acid'): Text(0.14311437727883458, 0.6097342669963837, \"{'Interaction': 'Acetic Acid results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Zinc Acetate'): Text(-0.09875620482489467, 0.1481708651408553, \"{'Interaction': 'nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|decreases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Ritonavir'): Text(-0.0224752607755363, 0.11070417612791061, \"{'Interaction': 'Ritonavir results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Glycyrrhizic Acid'): Text(0.07854319782927632, 0.11027699708938599, \"{'Interaction': 'Glycyrrhizic Acid results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Topotecan'): Text(-0.07142620859667659, 0.275173619389534, \"{'Interaction': '[TP63 protein alternative form co-treated with TP53 protein] promotes the reaction [[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with Topotecan] results in increased expression of BAX protein]', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Glutathione Disulfide'): Text(-0.07074827281758189, 0.46916016936302185, \"{'Interaction': 'Glutathione Disulfide results in increased glutathionylation of TP53 protein', 'InteractionActions': 'increases^glutathionylation'}\"),\n",
       " ('tp53',\n",
       "  'Sodium Azide'): Text(-0.0838836538605392, 0.3709074407815933, \"{'Interaction': 'Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of TP53 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Budesonide'): Text(0.25498322071507573, 0.2847120016813278, \"{'Interaction': 'Budesonide results in decreased expression of TP53 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Simvastatin'): Text(0.011135883163660765, 0.15311733214184642, \"{'Interaction': 'Simvastatin results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Genistein'): Text(-0.04550030408427119, 0.1703510507941246, \"{'Interaction': 'TP53 protein results in increased susceptibility to Genistein', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Nitric Oxide Donors'): Text(-0.0974695342592895, 0.6302236020565033, \"{'Interaction': '[Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Acrylamide'): Text(-0.06694463966414332, 0.22615422308444977, \"{'Interaction': 'Acrylamide results in increased phosphorylation of and results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression|increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'tert-Butylhydroperoxide'): Text(-0.030567124020308256, 0.183471092954278, \"{'Interaction': 'tert-Butylhydroperoxide results in increased glutathionylation of TP53 protein', 'InteractionActions': 'increases^glutathionylation'}\"),\n",
       " ('tp53',\n",
       "  'Sirolimus'): Text(-0.009248854126781225, 0.133575776591897, \"{'Interaction': 'Sirolimus results in decreased phosphorylation of TP53 protein', 'InteractionActions': 'decreases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Butyric Acid'): Text(-0.017335205804556608, 0.11225948110222816, \"{'Interaction': 'Butyric Acid results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  '3-Hydroxybutyric Acid'): Text(-0.1849130648188293, 0.42862069606781006, \"{'Interaction': '3-Hydroxybutyric Acid inhibits the reaction [ERCC6 gene mutant form results in increased acetylation of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^acetylation'}\"),\n",
       " ('tp53',\n",
       "  'Sodium Benzoate'): Text(0.12728520901873708, 0.6209613382816315, \"{'Interaction': 'Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Raloxifene Hydrochloride'): Text(-0.022027674596756697, 0.14412709325551987, \"{'Interaction': 'Raloxifene Hydrochloride results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Vitamin K 3'): Text(-0.05375533131882548, 0.21578554809093475, \"{'Interaction': 'Vitamin K 3 results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'alpha-Tocopherol'): Text(0.09380872966721654, 0.13371901400387287, \"{'Interaction': 'alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Tocopherols'): Text(-0.17963897762820125, 0.17554551921784878, \"{'Interaction': 'Tocopherols results in increased activity of TP53 protein', 'InteractionActions': 'increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'S-Nitrosoglutathione'): Text(0.08158959867432714, 0.37957747280597687, \"{'Interaction': '[S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]', 'InteractionActions': 'decreases^expression|decreases^reaction|increases^nitrosation'}\"),\n",
       " ('tp53',\n",
       "  'S-Nitroso-N-Acetylpenicillamine'): Text(-0.0009942390024662018, 0.641666442155838, \"{'Interaction': 'S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('tp53',\n",
       "  'Plant Preparations'): Text(0.19519225182011724, 0.18845983035862446, \"{'Interaction': 'Plant Preparations results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Aristolochic Acids'): Text(0.07178314449265599, 0.1352110058069229, \"{'Interaction': 'Aristolochic Acids results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Nanotubes, Carbon'): Text(-0.009716104250401258, 0.1838992740958929, \"{'Interaction': 'Nanotubes, Carbon results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Linoleic Acids, Conjugated'): Text(0.2707928759045899, 0.27099204808473587, \"{'Interaction': 'Linoleic Acids, Conjugated results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Proanthocyanidins'): Text(-0.07860122201964259, 0.6101559996604919, \"{'Interaction': 'Proanthocyanidins results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Flavanones'): Text(0.037107369396835566, 0.18074955977499485, \"{'Interaction': 'TP53 protein results in decreased susceptibility to Flavanones', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('tp53',\n",
       "  'Chalcones'): Text(-0.18348583159968257, 0.4030817598104477, \"{'Interaction': 'Chalcones analog results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Apigenin'): Text(0.0720374402590096, 0.16837493609637022, \"{'Interaction': 'TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Hydrolyzable Tannins'): Text(0.12938198866322637, 0.17514880653470755, \"{'Interaction': 'Hydrolyzable Tannins affects the activity of TP53 protein', 'InteractionActions': 'affects^activity'}\"),\n",
       " ('tp53',\n",
       "  'Betalains'): Text(-0.20778302429243922, 0.22683458030223846, \"{'Interaction': 'Betalains results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Ferrosoferric Oxide'): Text(0.12227743538096547, 0.15815586457028985, \"{'Interaction': '[Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of TP53 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Particulate Matter'): Text(-0.04749317793175578, 0.17992812767624855, \"{'Interaction': '[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of TP53 protein', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Soot'): Text(-0.018762208055704832, 0.09520024806261063, \"{'Interaction': 'Soot results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Halogenated Diphenyl Ethers'): Text(-0.1079956772737205, 0.13594949804246426, \"{'Interaction': 'Halogenated Diphenyl Ethers results in decreased expression of TP53 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Iron Compounds'): Text(0.13978775264695287, 0.19982535392045975, \"{'Interaction': 'Iron Compounds results in increased expression of TP53 protein modified form', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Magnetite Nanoparticles'): Text(0.08835546346381307, 0.147736351005733, \"{'Interaction': '[Daunorubicin co-treated with Magnetite Nanoparticles] results in increased activity of TP53 protein', 'InteractionActions': 'affects^cotreatment|increases^activity'}\"),\n",
       " ('tp53',\n",
       "  'Polyphenols'): Text(0.04841121705248952, 0.12513889372348785, \"{'Interaction': 'Polyphenols results in increased expression of TP53 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Fungal Polysaccharides'): Text(-0.18071369407698512, 0.20030757784843445, \"{'Interaction': 'Fungal Polysaccharides results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('tp53',\n",
       "  'Phytochemicals'): Text(0.14800773980095983, 0.15231839567422867, \"{'Interaction': 'Phytochemicals results in increased phosphorylation of TP53 protein', 'InteractionActions': 'increases^phosphorylation'}\"),\n",
       " ('tp53',\n",
       "  'Selenium Oxides'): Text(0.07059017242863774, 0.6577831208705902, \"{'Interaction': 'Selenium Oxides results in increased expression of TP53 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('Calcimycin',\n",
       "  'il6'): Text(0.24297502636909485, -0.07355054840445518, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^secretion'}\"),\n",
       " ('Calcimycin',\n",
       "  'mapk3'): Text(0.2219473272562027, 0.010588038712739944, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein', 'InteractionActions': 'affects^cotreatment|increases^phosphorylation'}\"),\n",
       " ('Calcimycin',\n",
       "  'rela'): Text(0.2185213416814804, 0.04787823453079909, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein', 'InteractionActions': 'affects^cotreatment|affects^localization'}\"),\n",
       " ('Calcimycin',\n",
       "  'mapk8'): Text(0.10364192724227905, 0.009147629141807556, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('Calcimycin',\n",
       "  'mapk1'): Text(0.21680868417024612, 0.01805865205824375, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein', 'InteractionActions': 'affects^cotreatment|increases^phosphorylation'}\"),\n",
       " ('Calcimycin',\n",
       "  'sp1'): Text(0.10902979969978333, 0.10901855304837227, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of SP1 protein', 'InteractionActions': 'affects^cotreatment|affects^localization'}\"),\n",
       " ('il6',\n",
       "  'Aripiprazole'): Text(0.20277447998523712, -0.08500761538743973, \"{'Interaction': 'Aripiprazole promotes the reaction [Ozone results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Fluticasone'): Text(0.2732354998588562, -0.18688120692968369, \"{'Interaction': 'TNF protein inhibits the reaction [Fluticasone inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Celecoxib'): Text(0.12436334602534771, -0.1631951779127121, \"{'Interaction': '[Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Atorvastatin'): Text(0.12796668149530888, -0.15669254958629608, \"{'Interaction': 'Mevalonic Acid inhibits the reaction [Atorvastatin results in decreased expression of IL6 mRNA]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Bortezomib'): Text(0.08047782443463802, -0.10308518633246422, \"{'Interaction': '[Dexamethasone co-treated with Bortezomib] results in decreased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Erlotinib Hydrochloride'): Text(0.0946732945740223, -0.17552339658141136, \"{'Interaction': 'Interleukin 1 Receptor Antagonist Protein inhibits the reaction [Erlotinib Hydrochloride results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Dasatinib'): Text(0.046172767877578735, -0.14115551114082336, \"{'Interaction': 'Dasatinib results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Atazanavir Sulfate'): Text(0.001533225178718567, -0.2919468358159065, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sugars'): Text(0.4275563806295395, -0.4640248343348503, \"{'Interaction': '[Biological Factors binds to Sugars] which results in increased expression of IL6 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Docetaxel'): Text(0.12321976199746132, -0.14940118789672852, \"{'Interaction': 'Docetaxel results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Clopidogrel'): Text(0.3613612502813339, -0.014343179762363434, \"{'Interaction': 'IL6 protein results in increased susceptibility to Clopidogrel', 'InteractionActions': 'increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Irinotecan'): Text(0.12950772233307362, -0.07163938507437706, \"{'Interaction': 'IL6 protein results in decreased susceptibility to Irinotecan', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Rosiglitazone'): Text(0.10420780233107507, -0.12618061853572726, \"{'Interaction': 'Rosiglitazone results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sorafenib'): Text(0.06819012761116028, -0.17311812937259674, \"{'Interaction': 'Sorafenib inhibits the reaction [Oleic Acid results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Resveratrol'): Text(0.04613567143678665, -0.11361832823604345, \"{'Interaction': '[TNF protein co-treated with Resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]', 'InteractionActions': 'affects^binding|affects^cotreatment|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Wortmannin'): Text(0.0733921192586422, -0.14255190081894398, \"{'Interaction': 'Wortmannin inhibits the reaction [IL6 protein results in increased expression of VEGFA mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Temozolomide'): Text(0.043136753141880035, -0.11242994107306004, \"{'Interaction': 'Temozolomide results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Decitabine'): Text(0.0767531506717205, -0.10256225615739822, \"{'Interaction': 'IL6 protein inhibits the reaction [Decitabine results in increased expression of MIR99A mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sunitinib'): Text(0.03613927960395813, -0.08218876644968987, \"{'Interaction': 'temsirolimus inhibits the reaction [Sunitinib results in increased expression of and results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Zoledronic Acid'): Text(0.07058772072196007, -0.11578542413190007, \"{'Interaction': 'Zoledronic Acid results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Arsenic Trioxide'): Text(0.0459233894944191, -0.09483608230948448, \"{'Interaction': 'MIR491 mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of IL6 mRNA]', 'InteractionActions': 'decreases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Donepezil'): Text(0.5087419599294662, -0.3795987591147423, \"{'Interaction': 'Donepezil affects the secretion of IL6 protein', 'InteractionActions': 'affects^secretion'}\"),\n",
       " ('il6',\n",
       "  'Fulvestrant'): Text(0.04681453853845596, -0.09959004074335098, \"{'Interaction': 'Fulvestrant results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Pamidronate'): Text(0.37890060245990753, -0.330419160425663, \"{'Interaction': 'Pamidronate results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Imiquimod'): Text(0.18454283475875854, -0.32341449707746506, \"{'Interaction': 'Imiquimod results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Troglitazone'): Text(0.08376742340624332, -0.1239038787316531, \"{'Interaction': 'Troglitazone results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Bosentan'): Text(0.25790150463581085, -0.3509790077805519, \"{'Interaction': 'Bosentan results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Telmisartan'): Text(0.28656022250652313, -0.2390221282839775, \"{'Interaction': 'Telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Vorinostat'): Text(0.057325780391693115, -0.0844033844769001, \"{'Interaction': 'Vorinostat results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Verteporfin'): Text(0.36269788444042206, -0.4937836155295372, \"{'Interaction': 'Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Silybin'): Text(0.10032596345990896, -0.15320619195699692, \"{'Interaction': 'Silybin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Orlistat'): Text(0.0831589475274086, -0.22012070566415787, \"{'Interaction': 'Orlistat inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cilostazol'): Text(0.04895094782114029, -0.19352272152900696, \"{'Interaction': 'zinc protoporphyrin inhibits the reaction [Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aluminum Chloride'): Text(0.28216665983200073, -0.3385036513209343, \"{'Interaction': 'Aluminum Chloride results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Eptifibatide'): Text(0.4882100373506546, -0.3869467005133629, \"{'Interaction': 'Eptifibatide results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  '17 alpha-Hydroxyprogesterone Caproate'): Text(0.5025808364152908, -0.35272782295942307, \"{'Interaction': '17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [lipoteichoic acid results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Tigecycline'): Text(0.4928172081708908, -0.4179736003279686, \"{'Interaction': 'Tigecycline inhibits the reaction [enterotoxin F, Staphylococcal results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Acetaldehyde'): Text(0.14168789982795715, -0.18397141247987747, \"{'Interaction': 'Acetaldehyde results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Acetaminophen'): Text(0.031354404985904694, -0.07599629834294319, \"{'Interaction': '[Lipopolysaccharides co-treated with Acetaminophen] affects the secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|affects^secretion'}\"),\n",
       " ('il6',\n",
       "  'Acetates'): Text(0.4720596820116043, -0.4278470203280449, \"{'Interaction': '[Hyaluronic Acid metabolite binds to Acetates] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^binding|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Gemcitabine'): Text(0.1171829691156745, -0.13385096471756697, \"{'Interaction': 'Gemcitabine results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Acetylcysteine'): Text(0.06801743060350418, -0.12694302015006542, \"{'Interaction': 'Acetylcysteine results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Acetylmuramyl-Alanyl-Isoglutamine'): Text(0.4117373377084732, -0.27134474366903305, \"{'Interaction': 'Acetylmuramyl-Alanyl-Isoglutamine analog results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Acids'): Text(0.14249584823846817, -0.23939143121242523, \"{'Interaction': 'SN50 peptide inhibits the reaction [Acids results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Acrolein'): Text(0.06293785572052002, -0.06815418601036072, \"{'Interaction': 'ST2825 inhibits the reaction [Acrolein results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Adenosine Triphosphate'): Text(0.14337508380413055, -0.13636613450944424, \"{'Interaction': 'Suramin inhibits the reaction [Adenosine Triphosphate results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aerosols'): Text(0.05526415631175041, -0.20767215639352798, \"{'Interaction': 'CAV protein promotes the reaction [Aerosols results in increased expression of IL6 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Agglutinins'): Text(0.3984449952840805, -0.498228095471859, \"{'Interaction': 'Agglutinins results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Air Pollutants'): Text(0.04328792542219162, -0.08281638473272324, \"{'Interaction': '[TAB2 mRNA affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased expression of IL6 mRNA', 'InteractionActions': 'affects^response to substance|increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Air Pollutants, Occupational'): Text(-0.02206684648990631, -0.1411253809928894, \"{'Interaction': 'Air Pollutants, Occupational results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Albuterol'): Text(0.21342068910598755, -0.14581803791224957, \"{'Interaction': '[Theophylline co-treated with Albuterol] inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ethanol'): Text(0.08821572922170162, -0.08155466616153717, \"{'Interaction': 'TLR3 protein affects the reaction [Ethanol results in increased expression of and results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^reaction|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Aldehydes'): Text(0.22372650355100632, -0.013976559042930603, \"{'Interaction': 'Aldehydes results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aldosterone'): Text(0.20354577898979187, -0.28314199298620224, \"{'Interaction': 'Aldosterone results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Allantoin'): Text(0.170209638774395, -0.47161921113729477, \"{'Interaction': 'Allantoin results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Alloys'): Text(0.4037870019674301, -0.513206921517849, \"{'Interaction': 'Alloys results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aluminum'): Text(0.0876583494246006, -0.3957422897219658, \"{'Interaction': '[Zinc co-treated with Copper co-treated with Aluminum] results in increased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aluminum Oxide'): Text(0.22572317719459534, -0.12784724310040474, \"{'Interaction': 'Aluminum Oxide results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Amino Acids, Peptides, and Proteins'): Text(0.09151925798505545, -0.3263116255402565, \"{'Interaction': 'dulaglutide inhibits the reaction [Amino Acids, Peptides, and Proteins metabolite results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Amiodarone'): Text(0.10077369911596179, -0.06642230972647667, \"{'Interaction': 'Prednisolone inhibits the reaction [Amiodarone results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Amphotericin B'): Text(-0.018787086009979248, -0.22737080603837967, \"{'Interaction': 'Amphotericin B analog results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Anthralin'): Text(0.4620848745107651, -0.4494943246245384, \"{'Interaction': 'Anthralin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Anti-Inflammatory Agents'): Text(0.3148649036884308, -0.517228327691555, \"{'Interaction': '[Anti-Inflammatory Agents binds to and results in decreased activity of GPR4 protein] inhibits the reaction [[Biological Factors binds to Sugars] which results in increased expression of IL6 protein]', 'InteractionActions': 'affects^binding|decreases^activity|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Antigens, Bacterial'): Text(0.2756752073764801, -0.5566516742110252, \"{'Interaction': 'Protein Kinase Inhibitors inhibits the reaction [Antigens, Bacterial results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Antioxidants'): Text(0.3568558841943741, -0.5160721763968468, \"{'Interaction': '[Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Apomorphine'): Text(0.21805930882692337, -0.3785087689757347, \"{'Interaction': 'Apomorphine inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Arecoline'): Text(0.1121019795536995, -0.20662860572338104, \"{'Interaction': 'Arecoline results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Arsenic'): Text(0.03335562348365784, -0.10257495753467083, \"{'Interaction': '[Palmitic Acid co-treated with Arsenic] affects the expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Arsenicals'): Text(0.1158230034634471, -0.19733025878667831, \"{'Interaction': 'Arsenicals results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Asbestos'): Text(0.15930399298667908, -0.11592616559937596, \"{'Interaction': 'Asbestos results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ascorbic Acid'): Text(0.10938323987647891, -0.11553138960152864, \"{'Interaction': 'Ascorbic Acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aspartame'): Text(0.10713517741532996, -0.26249464601278305, \"{'Interaction': 'Aspartame results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Aspirin'): Text(0.06976975128054619, -0.11723302281461656, \"{'Interaction': 'IL6 protein inhibits the reaction [Aspirin results in decreased expression of STAT3 protein modified form]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Auranofin'): Text(0.20233166217803955, -0.18228218331933022, \"{'Interaction': '[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein', 'InteractionActions': 'affects^cotreatment|decreases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Vehicle Emissions'): Text(0.0967196486890316, -0.0852184109389782, \"{'Interaction': 'Vehicle Emissions results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride'): Text(0.4483676105737686, -0.4756799563765526, \"{'Interaction': 'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride promotes the reaction [Ozone results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Azacitidine'): Text(0.07078235223889351, -0.13604703545570374, \"{'Interaction': 'Azacitidine affects the secretion of IL6 protein', 'InteractionActions': 'affects^secretion'}\"),\n",
       " ('il6',\n",
       "  'Azathioprine'): Text(0.10345020517706871, -0.11061166319996119, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Azathioprine', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Aziridines'): Text(0.43469594419002533, -0.43457283824682236, \"{'Interaction': 'NR3C1 protein promotes the reaction [Aziridines analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Barium Sulfate'): Text(0.29818645119667053, -0.5217494890093803, \"{'Interaction': 'Barium Sulfate results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'BCG Vaccine'): Text(0.34976592659950256, -0.4873531088232994, \"{'Interaction': 'hydroxyflutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Beclomethasone'): Text(0.32730840146541595, -0.32531262189149857, \"{'Interaction': 'Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Benzalkonium Compounds'): Text(0.3006855994462967, -0.07188057154417038, \"{'Interaction': 'Benzalkonium Compounds results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Benzbromarone'): Text(0.43111710250377655, -0.4477199539542198, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Benzbromarone', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Benzene'): Text(0.09357455093413591, -0.10502264183014631, \"{'Interaction': 'Benzene results in increased methylation of IL6 promoter', 'InteractionActions': 'increases^methylation'}\"),\n",
       " ('il6',\n",
       "  'Benzo(a)pyrene'): Text(0.025922514498233795, -0.07440527528524399, \"{'Interaction': 'SOCS3 protein affects the reaction [Benzo(a)pyrene results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Benzoates'): Text(0.007486402988433838, -0.30019544810056686, \"{'Interaction': 'Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^activity'}\"),\n",
       " ('il6',\n",
       "  'Benzofurans'): Text(0.2695119380950928, -0.22196274995803833, \"{'Interaction': 'Benzofurans analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Benzoyl Peroxide'): Text(0.2604268044233322, -0.2763087823987007, \"{'Interaction': 'Benzoyl Peroxide results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Berberine'): Text(0.010833844542503357, -0.09408194944262505, \"{'Interaction': 'MIR142 affects the reaction [Berberine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of IL6 protein]]', 'InteractionActions': 'affects^reaction|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Bezafibrate'): Text(0.11598724499344826, -0.3093796893954277, \"{'Interaction': 'Bezafibrate inhibits the reaction [IL6 protein results in increased expression of SPP1 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Bile Acids and Salts'): Text(0.18394329398870468, -0.1618678756058216, \"{'Interaction': 'Bile Acids and Salts results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Bilirubin'): Text(0.11209073197096586, -0.08412711694836617, \"{'Interaction': 'Bilirubin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Biological Factors'): Text(0.08054381795227528, -0.3975684866309166, \"{'Interaction': 'Biological Factors results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Bleomycin'): Text(0.22836079448461533, -0.09459620155394077, \"{'Interaction': 'Bleomycin results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Butyrates'): Text(0.05462059751152992, -0.19545108824968338, \"{'Interaction': '[Butyrates results in increased acylation of Hyaluronic Acid metabolite] inhibits the reaction [[Hyaluronic Acid metabolite binds to Acetates] which results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^binding|decreases^reaction|increases^acylation|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Cadmium'): Text(0.03490184247493744, -0.08891887590289116, \"{'Interaction': 'Cadmium results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ceruletide'): Text(0.2841430753469467, -0.5356905981898308, \"{'Interaction': 'PTHLH protein promotes the reaction [Ceruletide results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Calcitriol'): Text(0.07334787398576736, -0.10787083767354488, \"{'Interaction': 'Calcitriol results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Calcium'): Text(0.17152543365955353, -0.10931836161762476, \"{'Interaction': 'Edetic Acid inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Cannabidiol'): Text(0.059442151337862015, -0.07671196013689041, \"{'Interaction': 'Cannabidiol results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cannabinoids'): Text(0.023780889809131622, -0.3103926554322243, \"{'Interaction': '[Plant Extracts results in increased abundance of Cannabinoids] inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Capsaicin'): Text(0.09073879383504391, -0.14497895166277885, \"{'Interaction': 'TRPV1 protein promotes the reaction [Capsaicin results in increased expression of IL6 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Carbamates'): Text(0.27120858430862427, -0.013709448277950287, \"{'Interaction': 'Carbamates results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Carbamazepine'): Text(0.051818620413541794, -0.10218576714396477, \"{'Interaction': 'Carbamazepine results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Carbon'): Text(0.2619532495737076, -0.3510625883936882, \"{'Interaction': '[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^abundance|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Carbon Monoxide'): Text(0.11355900065973401, -0.2977174147963524, \"{'Interaction': 'IL6 gene SNP affects the reaction [Carbon Monoxide results in increased expression of IL6 protein]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Carbon Tetrachloride'): Text(0.18634510040283203, -0.29042836278676987, \"{'Interaction': '[Dexamethasone co-treated with IL6 protein] results in decreased susceptibility to Carbon Tetrachloride', 'InteractionActions': 'affects^cotreatment|decreases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Carmustine'): Text(0.11461193487048149, -0.09278954192996025, \"{'Interaction': 'IL6 mRNA affects the susceptibility to Carmustine', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Carnosine'): Text(0.4859107881784439, -0.3536643460392952, \"{'Interaction': 'Carnosine inhibits the reaction [Glucose results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Catechin'): Text(0.08562294580042362, -0.07478031143546104, \"{'Interaction': '[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with Catechin analog] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Chelating Agents'): Text(0.06885506212711334, -0.10809846688061953, \"{'Interaction': '[Chelating Agents binds to Copper] which results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^binding|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chenodeoxycholic Acid'): Text(0.029527224600315094, -0.2331506609916687, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chlorine'): Text(0.3581910580396652, 0.009209372103214264, \"{'Interaction': 'Chlorine results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Chloroquine'): Text(0.13908863440155983, -0.13546388503164053, \"{'Interaction': 'Chloroquine results in increased expression of IL6', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chlorpromazine'): Text(0.18509626388549805, -0.1949562057852745, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Chlorpromazine', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Cholecalciferol'): Text(0.02049657702445984, -0.22304655611515045, \"{'Interaction': 'Cholecalciferol results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chromium'): Text(0.17529785633087158, -0.08661748096346855, \"{'Interaction': 'Chromium results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Chromium Alloys'): Text(0.32207024097442627, -0.3332167789340019, \"{'Interaction': 'Chromium Alloys results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ciprofloxacin'): Text(0.14654907956719398, -0.1198893058754038, \"{'Interaction': 'Ciprofloxacin inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cisplatin'): Text(0.0346989780664444, -0.081345584243536, \"{'Interaction': 'IL6 protein results in decreased susceptibility to Cisplatin', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Leucovorin'): Text(0.024731218814849854, -0.2667003497481346, \"{'Interaction': 'Leucovorin inhibits the reaction [Methotrexate results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Clomipramine'): Text(0.3763911873102188, -0.48428674787282944, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Cloxacillin'): Text(0.45901502668857574, -0.46558868139982224, \"{'Interaction': '[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]', 'InteractionActions': 'affects^cotreatment|increases^activity|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Coal'): Text(0.04471466690301895, -0.2631535455584526, \"{'Interaction': '[Coal results in increased abundance of Arsenic] which results in increased expression of IL6 protein', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cobalt'): Text(0.16697850823402405, -0.1281164726242423, \"{'Interaction': '[tungsten carbide co-treated with Cobalt] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cocaine'): Text(0.15205754712224007, -0.22517111897468567, \"{'Interaction': 'Cocaine results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Copper'): Text(0.04290011525154114, -0.10027169995009899, \"{'Interaction': '[Zinc co-treated with Copper co-treated with Aluminum] results in increased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cortisone'): Text(0.48405779898166656, -0.3720955476164818, \"{'Interaction': 'perfluorooctane sulfonic acid inhibits the reaction [Cortisone results in decreased expression of IL6]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Curcumin'): Text(0.07873045653104782, -0.10054759681224823, \"{'Interaction': 'tin protoporphyrin IX inhibits the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Cycloheximide'): Text(0.10488219885155559, -0.17190292850136757, \"{'Interaction': 'Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased secretion of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Cytarabine'): Text(0.11462161783128977, -0.017451182007789612, \"{'Interaction': 'Cytarabine results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dactinomycin'): Text(0.14582008495926857, -0.12070816790219396, \"{'Interaction': 'Dactinomycin results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'DDT'): Text(0.09932807460427284, -0.21059361100196838, \"{'Interaction': 'DDT results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Deferoxamine'): Text(0.06674610450863838, -0.1540606990456581, \"{'Interaction': 'Deferoxamine inhibits the reaction [Coal Ash results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Demecolcine'): Text(0.06269681826233864, -0.03315693140029907, \"{'Interaction': 'Demecolcine results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Demeclocycline'): Text(0.3879193812608719, -0.5230602845549583, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Demeclocycline', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Deoxycholic Acid'): Text(0.12039324175566435, -0.20825497061014175, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Desipramine'): Text(0.23786096274852753, -0.2717824652791023, \"{'Interaction': 'Desipramine inhibits the reaction [TNF protein results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dexamethasone'): Text(0.062396977096796036, -0.0817624107003212, \"{'Interaction': 'NR3C1 protein promotes the reaction [Dexamethasone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Diacetyl'): Text(0.26482953131198883, -0.14204520918428898, \"{'Interaction': 'Diacetyl results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Diazoxide'): Text(0.20601916313171387, -0.30897488445043564, \"{'Interaction': 'Diazoxide results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Dibutyl Phthalate'): Text(0.13407140597701073, -0.1640213020145893, \"{'Interaction': 'Dibutyl Phthalate results in increased secretion of IL6', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Bucladesine'): Text(0.14108538255095482, -0.10824125725775957, \"{'Interaction': 'Bucladesine promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Diclofenac'): Text(0.08467354625463486, -0.13089990336447954, \"{'Interaction': 'lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Diclofenac results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dietary Carbohydrates'): Text(0.008277371525764465, -0.3937145695090294, \"{'Interaction': 'Dietary Carbohydrates results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Diethylhexyl Phthalate'): Text(0.059868622571229935, -0.11790730734355748, \"{'Interaction': 'prolinedithiocarbamate inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Diethylstilbestrol'): Text(0.10310347261838615, -0.05937466770410538, \"{'Interaction': '[Lipopolysaccharides co-treated with Diethylstilbestrol] results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Dihydroxyacetone'): Text(0.2103678062558174, -0.12178396945819259, \"{'Interaction': 'Dihydroxyacetone results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dimethyl Sulfoxide'): Text(0.0360315665602684, -0.18258891999721527, \"{'Interaction': 'Dimethyl Sulfoxide results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Dinitrochlorobenzene'): Text(0.13761671632528305, -0.07242640480399132, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Dinitrochlorobenzene] results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Diphenhydramine'): Text(0.14960747584700584, -0.4268660768866539, \"{'Interaction': 'Diphenhydramine inhibits the reaction [Histamine results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Disulfiram'): Text(0.062024395912885666, -0.16841057687997818, \"{'Interaction': 'Disulfiram inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Diuron'): Text(0.07892479002475739, -0.01697089523077011, \"{'Interaction': 'Diuron metabolite results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dobutamine'): Text(0.20866818726062775, -0.3283177986741066, \"{'Interaction': 'Dobutamine results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Docosahexaenoic Acids'): Text(0.18792933970689774, -0.09098880551755428, \"{'Interaction': '[Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Domperidone'): Text(0.19800201058387756, -0.4661869928240776, \"{'Interaction': 'Domperidone results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Doxorubicin'): Text(0.03593004494905472, -0.08514578640460968, \"{'Interaction': 'IL6 protein inhibits the reaction [Doxorubicin results in increased expression of BAX protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Doxycycline'): Text(0.3413105010986328, -0.054292336106300354, \"{'Interaction': 'Doxycycline inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Drugs, Chinese Herbal'): Text(0.07788898795843124, -0.11912746290909126, \"{'Interaction': 'Drugs, Chinese Herbal results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chlorpyrifos'): Text(0.1444915533065796, -0.14084378629922867, \"{'Interaction': 'TNF protein inhibits the reaction [Chlorpyrifos results in decreased expression of IL6 mRNA]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Dust'): Text(0.16528216376900673, -0.12334787775762379, \"{'Interaction': 'Dust results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Dydrogesterone'): Text(0.47662799060344696, -0.44523491710424423, \"{'Interaction': 'Mifepristone inhibits the reaction [Dydrogesterone results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Edetic Acid'): Text(0.37156449258327484, -0.0158165842294693, \"{'Interaction': 'Edetic Acid inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Egtazic Acid'): Text(0.19455286115407944, -0.2687888666987419, \"{'Interaction': 'Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Emodin'): Text(0.0828696433454752, -0.20713969320058823, \"{'Interaction': 'Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Enalapril'): Text(0.29162684082984924, -0.5531119629740715, \"{'Interaction': 'IL6 gene polymorphism affects the susceptibility to Enalapril', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Endosulfan'): Text(0.1110988762229681, -0.11748597724363208, \"{'Interaction': 'MIR22 mRNA affects the reaction [Endosulfan results in increased expression of IL6 mRNA]', 'InteractionActions': 'affects^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Endotoxins'): Text(0.32587379217147827, -0.5063057169318199, \"{'Interaction': 'zileuton inhibits the reaction [Endotoxins results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Environmental Pollutants'): Text(0.12765108421444893, 0.015403412282466888, \"{'Interaction': 'Environmental Pollutants results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Epinephrine'): Text(0.14489027857780457, -0.30967531353235245, \"{'Interaction': 'Epinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Erythromycin'): Text(0.2165016531944275, 0.03545772284269333, \"{'Interaction': '[TNF protein co-treated with IL6 protein co-treated with IL1B protein] inhibits the reaction [Erythromycin results in increased activity of CASP3 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^activity'}\"),\n",
       " ('il6',\n",
       "  'Estradiol'): Text(0.038204438984394073, -0.08721970021724701, \"{'Interaction': '[[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the expression of ALB protein', 'InteractionActions': 'affects^cotreatment|affects^expression|affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Estriol'): Text(0.2597547173500061, -0.2925925478339195, \"{'Interaction': 'Estriol results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Fatty Acids, Nonesterified'): Text(0.18403364717960358, -0.4632992371916771, \"{'Interaction': 'MIR26A1 mRNA inhibits the reaction [Fatty Acids, Nonesterified affects the expression of IL6 mRNA]', 'InteractionActions': 'affects^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Fenbendazole'): Text(0.24574606120586395, -0.06454839184880257, \"{'Interaction': 'Fenbendazole results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Flame Retardants'): Text(0.10902049299329519, -0.02542319893836975, \"{'Interaction': 'Flame Retardants results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Flavoring Agents'): Text(0.42127959430217743, -0.4974735900759697, \"{'Interaction': '[Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Floxacillin'): Text(0.37837548553943634, -0.49695830792188644, \"{'Interaction': '[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein]', 'InteractionActions': 'affects^cotreatment|increases^activity|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Fluorometholone'): Text(0.20083314925432205, -0.16383017227053642, \"{'Interaction': 'Fluorometholone inhibits the reaction [Glucose results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Fluorouracil'): Text(0.07090570032596588, -0.10577141214162111, \"{'Interaction': 'SB 203580 inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Folic Acid'): Text(0.05491645634174347, -0.10462898295372725, \"{'Interaction': 'Folic Acid results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Formaldehyde'): Text(0.059590790420770645, -0.08027045428752899, \"{'Interaction': 'Formaldehyde results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Colforsin'): Text(0.19104918837547302, -0.11605770792812109, \"{'Interaction': 'Colforsin promotes the reaction [TNF protein results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Furosemide'): Text(0.5137804299592972, -0.34366054087877274, \"{'Interaction': 'Furosemide results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Gadolinium'): Text(0.2847030609846115, -0.25307079404592514, \"{'Interaction': '[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Galactose'): Text(0.24651870131492615, -0.031382448971271515, \"{'Interaction': 'ginsenoside Rh2 inhibits the reaction [Galactose results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Gallic Acid'): Text(0.10952938138507307, -0.08561020717024803, \"{'Interaction': 'Gallic Acid inhibits the reaction [TNF protein results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Glucosamine'): Text(0.15766745805740356, -0.21679989993572235, \"{'Interaction': 'Glucosamine inhibits the reaction [TNF results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glucose'): Text(0.09209704678505659, -0.14521298743784428, \"{'Interaction': 'Resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glutaral'): Text(0.3699277192354202, 0.005336396396160126, \"{'Interaction': 'Glutaral affects the expression of IL6 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Glutathione'): Text(0.12733258306980133, -0.13853073492646217, \"{'Interaction': 'Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Glycerol'): Text(0.2800162583589554, -0.04879951477050781, \"{'Interaction': '[Nicotine co-treated with Propylene Glycol co-treated with Glycerol] results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nitroglycerin'): Text(0.4054201692342758, -0.4600088521838188, \"{'Interaction': 'Nitroglycerin results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glycochenodeoxycholic Acid'): Text(0.09719836991280317, -0.2508143410086632, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glycocholic Acid'): Text(0.029974214732646942, -0.269633986055851, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glycodeoxycholic Acid'): Text(0.02769874781370163, -0.2684912905097008, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glyoxal'): Text(0.4643338471651077, -0.3795153722167015, \"{'Interaction': 'Glyoxal analog affects the expression of IL6 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Gold'): Text(0.1149934520944953, -0.13122894521802664, \"{'Interaction': '[Thioctic Acid binds to Gold] which results in increased expression of IL6 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Gold Sodium Thiomalate'): Text(0.4498983174562454, -0.43482475727796555, \"{'Interaction': 'Gold Sodium Thiomalate results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Hemagglutinins'): Text(0.3994920402765274, -0.48319851607084274, \"{'Interaction': 'lead acetate promotes the reaction [Hemagglutinins results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Heparin'): Text(0.18482819199562073, -0.12897998932749033, \"{'Interaction': 'Heparin results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Hesperidin'): Text(0.005337372422218323, -0.2500560060143471, \"{'Interaction': 'Hesperidin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Histamine'): Text(0.16472821310162544, -0.20455357432365417, \"{'Interaction': 'TNF protein promotes the reaction [Histamine results in increased expression of IL6 protein]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Hyaluronic Acid'): Text(0.1601630412042141, -0.2214888259768486, \"{'Interaction': '[Hyaluronic Acid metabolite binds to Acetates] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^binding|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Hydralazine'): Text(0.015271350741386414, -0.04139918088912964, \"{'Interaction': 'Hydralazine results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Hydrocarbons'): Text(0.3436158448457718, -0.5417798087000847, \"{'Interaction': '[Particulate Matter co-treated with Hydrocarbons] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Hydrocortisone'): Text(0.010087385773658752, -0.21959353238344193, \"{'Interaction': 'Hydrocortisone results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Hydrogen Peroxide'): Text(0.05215827748179436, -0.08931395038962364, \"{'Interaction': 'tetramethylthiourea inhibits the reaction [Hydrogen Peroxide results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Hydroxamic Acids'): Text(0.07419939711689949, -0.22701766341924667, \"{'Interaction': 'Hydroxamic Acids analog inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Hydroxychloroquine'): Text(0.2483125478029251, -0.21060467511415482, \"{'Interaction': 'Hydroxychloroquine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ibuprofen'): Text(0.1356288343667984, -0.1149289095774293, \"{'Interaction': 'Ibuprofen results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Indomethacin'): Text(0.06707525625824928, -0.06627803295850754, \"{'Interaction': '[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Indoprofen'): Text(0.3468973934650421, -0.2832435891032219, \"{'Interaction': 'Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Iron'): Text(0.08809811621904373, -0.20382308959960938, \"{'Interaction': '[IL6 protein results in increased expression of HAMP protein] which results in decreased secretion of Iron', 'InteractionActions': 'decreases^secretion|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Isoniazid'): Text(0.19112970679998398, -0.30370157212018967, \"{'Interaction': 'Isoniazid results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Isoproterenol'): Text(0.23774424195289612, -0.1614782027900219, \"{'Interaction': 'Isoproterenol results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ketamine'): Text(0.36164481937885284, -0.007998757064342499, \"{'Interaction': 'Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ketanserin'): Text(0.357610359787941, -0.2680078372359276, \"{'Interaction': 'Ketanserin inhibits the reaction [Serotonin results in increased expression of and results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Kynurenic Acid'): Text(0.3936410993337631, -0.47322841733694077, \"{'Interaction': 'Kynurenic Acid results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Latex'): Text(0.21012327075004578, -0.2288440242409706, \"{'Interaction': 'Latex analog results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Lidocaine'): Text(0.4728510230779648, -0.36498289555311203, \"{'Interaction': 'Lidocaine results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Lipids'): Text(0.15429935231804848, -0.4684985801577568, \"{'Interaction': '[[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Lipids', 'InteractionActions': 'affects^abundance|affects^cotreatment|affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Thioctic Acid'): Text(0.07560480013489723, -0.288271464407444, \"{'Interaction': '[Thioctic Acid binds to Gold] which results in increased expression of IL6 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Lipopolysaccharides'): Text(0.04402395710349083, -0.1149505851790309, \"{'Interaction': 'Zymosan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Lucanthone'): Text(0.004046790301799774, -0.013254567980766296, \"{'Interaction': 'Lucanthone results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Malathion'): Text(0.17417966574430466, -0.09975998103618622, \"{'Interaction': 'Malathion results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Manganese'): Text(0.10325572220608592, -0.19277971982955933, \"{'Interaction': 'Manganese results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mefenamic Acid'): Text(0.4927864521741867, -0.33900516480207443, \"{'Interaction': 'Mefenamic Acid results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Melatonin'): Text(0.10397071344777942, -0.17174401134252548, \"{'Interaction': 'Melatonin results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Menthol'): Text(0.03429485112428665, -0.0770907960832119, \"{'Interaction': 'Menthol results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mercuric Chloride'): Text(0.15577231347560883, -0.1949419006705284, \"{'Interaction': 'Mercuric Chloride results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mercury'): Text(0.18668698519468307, -0.06872996315360069, \"{'Interaction': 'Mercury results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Metformin'): Text(0.08137970045208931, -0.12955353129655123, \"{'Interaction': 'Metformin results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methimazole'): Text(0.21502765268087387, -0.3253871724009514, \"{'Interaction': 'Methimazole results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methotrexate'): Text(0.04460036754608154, -0.09361320920288563, \"{'Interaction': 'SB 203580 affects the reaction [Methotrexate results in decreased expression of IL6 protein]', 'InteractionActions': 'affects^reaction|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methyl Methanesulfonate'): Text(0.024547874927520752, -0.08177909255027771, \"{'Interaction': 'Methyl Methanesulfonate results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methyl Parathion'): Text(0.22761772572994232, 0.011021099984645844, \"{'Interaction': 'Methyl Parathion results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methylcholanthrene'): Text(0.08538689836859703, -0.01887870579957962, \"{'Interaction': 'Methylcholanthrene results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methylmercury Compounds'): Text(0.1772182509303093, -0.09615433588624, \"{'Interaction': 'Methylmercury Compounds affects the expression of IL6', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Methylprednisolone'): Text(0.3871520310640335, -0.4594218358397484, \"{'Interaction': 'Methylprednisolone results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methylthiouracil'): Text(0.26405397057533264, -0.2451445385813713, \"{'Interaction': 'Methylthiouracil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Mevalonic Acid'): Text(0.18428809195756912, -0.24099675565958023, \"{'Interaction': 'Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of IL6 mRNA]', 'InteractionActions': 'decreases^expression|decreases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Mexiletine'): Text(0.3152589350938797, -0.5330556854605675, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Mexiletine', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Monensin'): Text(0.4947957247495651, -0.40850313752889633, \"{'Interaction': 'Monensin results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Morphine'): Text(0.20878341794013977, -0.12017093750182539, \"{'Interaction': 'Morphine results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mustard Gas'): Text(0.1032183300703764, -0.08654746413230896, \"{'Interaction': 'tofacitinib inhibits the reaction [Mustard Gas results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mycophenolic Acid'): Text(0.1763612926006317, -0.1771921068429947, \"{'Interaction': 'Mycophenolic Acid results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'N-Formylmethionine Leucyl-Phenylalanine'): Text(0.16300706565380096, -0.28620704263448715, \"{'Interaction': 'nimesulide inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Nafcillin'): Text(0.4381355494260788, -0.41099485009908676, \"{'Interaction': '[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]', 'InteractionActions': 'affects^cotreatment|increases^activity|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Naloxone'): Text(0.3168606162071228, -0.07663464173674583, \"{'Interaction': 'Naloxone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Naphthoquinones'): Text(-0.027669623494148254, -0.15540893003344536, \"{'Interaction': 'Naphthoquinones results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Niacin'): Text(0.2213776633143425, -0.266561396420002, \"{'Interaction': '[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Nickel'): Text(0.04254738241434097, -0.11904392682481557, \"{'Interaction': 'Resveratrol inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Niclosamide'): Text(0.08321324735879898, -0.15046577900648117, \"{'Interaction': 'Niclosamide inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^activity|increases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Niacinamide'): Text(0.12294885702431202, -0.1647525690495968, \"{'Interaction': 'Niacinamide results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Nicotine'): Text(0.086395513266325, -0.11342496238648891, \"{'Interaction': 'SIRT1 protein inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL6 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Nitrogen'): Text(0.1653975434601307, -0.2929047867655754, \"{'Interaction': '[Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^binding|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nitrogen Dioxide'): Text(0.31774111092090607, 0.01783127337694168, \"{'Interaction': 'Nitrogen Dioxide results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nitrogen Oxides'): Text(0.2477499544620514, -0.05038762837648392, \"{'Interaction': '[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides]] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^abundance|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Norepinephrine'): Text(0.3169521540403366, -0.1601129099726677, \"{'Interaction': 'sulforaphane inhibits the reaction [Norepinephrine results in increased expression of and results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nortriptyline'): Text(0.4072161763906479, -0.4978594407439232, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Nortriptyline', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Oligoribonucleotides'): Text(0.5160465687513351, -0.3671802058815956, \"{'Interaction': 'Oligoribonucleotides results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ouabain'): Text(0.12122957035899162, -0.1249923431314528, \"{'Interaction': 'Ouabain results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ovalbumin'): Text(0.3855547457933426, -0.5089285895228386, \"{'Interaction': 'Ovalbumin results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Oxazolone'): Text(0.1027408002410084, -0.4118417724967003, \"{'Interaction': 'Oxazolone results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Oxygen'): Text(0.04964277148246765, -0.0945299081504345, \"{'Interaction': 'Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Oxymetholone'): Text(0.4916002005338669, -0.38879238814115524, \"{'Interaction': 'Oxymetholone results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ozone'): Text(0.04230564087629318, -0.0966777503490448, \"{'Interaction': '[Vehicle Emissions results in increased abundance of Ozone] which results in increased secretion of IL6 protein', 'InteractionActions': 'increases^abundance|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Palmitates'): Text(0.26067328453063965, -0.0805094800889492, \"{'Interaction': 'Sodium Salicylate inhibits the reaction [Palmitates results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Pantothenic Acid'): Text(0.2724030464887619, -0.5410920307040215, \"{'Interaction': 'Pantothenic Acid results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Paraquat'): Text(0.08968094363808632, -0.08893049694597721, \"{'Interaction': 'TNFAIP6 protein inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Pentachlorophenol'): Text(0.24555149674415588, -0.11993928599258652, \"{'Interaction': 'Pentachlorophenol results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Peptidoglycan'): Text(0.2879372537136078, -0.2320306897163391, \"{'Interaction': 'Peptidoglycan results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Perfume'): Text(0.18351545184850693, -0.46976881474256516, \"{'Interaction': 'Perfume results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Pesticides'): Text(0.0011314824223518372, -0.1731317639350891, \"{'Interaction': 'Pesticides results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Phenobarbital'): Text(0.1171844583004713, -0.06411175429821014, \"{'Interaction': 'Phenobarbital affects the expression of IL6 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Phenylbutyrates'): Text(0.1151349013671279, -0.28320369869470596, \"{'Interaction': 'Phenylbutyrates inhibits the reaction [Acrolein results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Phenylmercuric Acetate'): Text(0.01777147501707077, -0.06431607156991959, \"{'Interaction': 'Phenylmercuric Acetate results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Phloretin'): Text(0.03018374741077423, -0.22540165483951569, \"{'Interaction': 'Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Phosphorus'): Text(0.1232357770204544, -0.3255171999335289, \"{'Interaction': '[Phosphorus co-treated with paricalcitol] affects the expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Piroxicam'): Text(0.08897608146071434, -0.038383617997169495, \"{'Interaction': 'Piroxicam results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Plant Extracts'): Text(0.05802948772907257, -0.11521240323781967, \"{'Interaction': 'tin protoporphyrin IX inhibits the reaction [Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Platelet Activating Factor'): Text(0.47681771218776703, -0.40780549496412277, \"{'Interaction': 'PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Poly I-C'): Text(0.2052389234304428, -0.1703602857887745, \"{'Interaction': 'Vehicle Emissions promotes the reaction [Poly I-C results in increased expression of IL6]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Polychlorinated Biphenyls'): Text(0.10482841997873038, -0.11551090609282255, \"{'Interaction': 'Polychlorinated Biphenyls results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Polycyclic Aromatic Hydrocarbons'): Text(0.09865717869251966, -0.10519064497202635, \"{'Interaction': 'Polycyclic Aromatic Hydrocarbons results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Polydeoxyribonucleotides'): Text(0.4110862463712692, -0.46288856118917465, \"{'Interaction': 'Polydeoxyribonucleotides inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Polyethylene Glycols'): Text(0.2762115150690079, -0.3248462602496147, \"{'Interaction': '[Polyethylene Glycols binds to Gold] which results in increased expression of IL6 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Polyethyleneimine'): Text(0.22477734833955765, -0.13981804065406322, \"{'Interaction': '[Polyethyleneimine binds to Gold] which results in increased expression of IL6 protein', 'InteractionActions': 'affects^binding|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Polymyxin B'): Text(0.25528421998023987, -0.09797946736216545, \"{'Interaction': 'Polymyxin B inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Polyphosphates'): Text(0.33928030729293823, -0.2148933932185173, \"{'Interaction': 'scolymoside inhibits the reaction [Polyphosphates results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Polyribonucleotides'): Text(0.11392718506976962, -0.2755037769675255, \"{'Interaction': 'SKP2 protein promotes the reaction [[Polyribonucleotides results in increased expression of MIR337 mRNA] inhibits the reaction [IL1B protein results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Polystyrenes'): Text(0.15281149372458458, -0.2308214083313942, \"{'Interaction': 'Polystyrenes results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Potassium Dichromate'): Text(0.08978544734418392, -0.11395109444856644, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Potassium Dichromate] results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Prednisolone'): Text(0.23944617807865143, -0.4475051686167717, \"{'Interaction': 'Prednisolone results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Fenofibrate'): Text(0.14315274357795715, -0.15288973972201347, \"{'Interaction': 'IL6 promoter polymorphism affects the susceptibility to Fenofibrate', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Progesterone'): Text(0.0766890924423933, -0.10644469130784273, \"{'Interaction': '[[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the expression of ALB protein', 'InteractionActions': 'affects^cotreatment|affects^expression|affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Propanil'): Text(0.4546138495206833, -0.4167557582259178, \"{'Interaction': 'Propanil promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Prostaglandins E'): Text(0.4340047091245651, -0.47672977298498154, \"{'Interaction': 'Prostaglandins E results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Proteoglycans'): Text(0.5227020531892776, -0.3538433387875557, \"{'Interaction': 'Proteoglycans inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Pyruvaldehyde'): Text(0.14801615849137306, -0.29434118419885635, \"{'Interaction': 'Pyruvaldehyde analog affects the expression of IL6 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  'Quartz'): Text(0.13430000469088554, -0.20111295580863953, \"{'Interaction': 'Quartz results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Quercetin'): Text(0.049284644424915314, -0.104112533852458, \"{'Interaction': '[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Quinazolines'): Text(0.20734911412000656, -0.2500966414809227, \"{'Interaction': 'Quinazolines inhibits the reaction [IL33 protein results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Quinine'): Text(0.5111722201108932, -0.3298454210162163, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Quinine', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Radon'): Text(0.1573142483830452, -0.0012776628136634827, \"{'Interaction': 'IL6 promoter SNP affects the susceptibility to Radon', 'InteractionActions': 'affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Batroxobin'): Text(0.501444861292839, -0.3217451050877571, \"{'Interaction': 'Batroxobin analog results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Riboflavin'): Text(0.2288849577307701, -0.020107053220272064, \"{'Interaction': '[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Rifampin'): Text(0.12234552018344402, -0.01379704475402832, \"{'Interaction': 'Rifampin results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone'): Text(0.5067033618688583, -0.39558037370443344, \"{'Interaction': '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Rotenone'): Text(0.058369070291519165, -0.07821732014417648, \"{'Interaction': 'Rotenone results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ruthenium Red'): Text(0.33936507999897003, -0.29378119856119156, \"{'Interaction': 'Ruthenium Red inhibits the reaction [Capsaicin results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Rutin'): Text(0.27584950625896454, -0.0841800756752491, \"{'Interaction': 'Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Sulfasalazine'): Text(0.35200750827789307, -0.14512282237410545, \"{'Interaction': 'Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Saponins'): Text(0.08188717439770699, -0.2602092996239662, \"{'Interaction': 'Saponins inhibits the reaction [Hydrogen Peroxide results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Selenium'): Text(0.014339491724967957, -0.09623988345265388, \"{'Interaction': '[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Serotonin'): Text(0.2179667204618454, -0.2600991055369377, \"{'Interaction': 'Serotonin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sesquiterpenes'): Text(0.3962012678384781, -0.2863405719399452, \"{'Interaction': 'Sesquiterpenes analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Silicon Dioxide'): Text(0.04107602685689926, -0.07749011367559433, \"{'Interaction': 'Triiodothyronine inhibits the reaction [Silicon Dioxide results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Silver'): Text(0.09772193245589733, -0.08616364002227783, \"{'Interaction': 'Silver results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Silymarin'): Text(0.017584174871444702, -0.21358880400657654, \"{'Interaction': 'Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Smoke'): Text(0.021315738558769226, -0.09064602106809616, \"{'Interaction': 'Smoke results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sodium Chloride'): Text(0.20087285339832306, -0.1018699835985899, \"{'Interaction': 'Sodium Chloride results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sodium Dodecyl Sulfate'): Text(0.15016113221645355, -0.07190798223018646, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Sodium Dodecyl Sulfate] results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Gold Sodium Thiosulfate'): Text(0.3483751267194748, -0.5278905555605888, \"{'Interaction': 'Gold Sodium Thiosulfate results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Sodium Nitrite'): Text(0.4740486890077591, -0.40190356224775314, \"{'Interaction': 'Sodium Nitrite results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Sodium Salicylate'): Text(0.2725123167037964, -0.19814997911453247, \"{'Interaction': 'Sodium Salicylate inhibits the reaction [Palmitates results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Spironolactone'): Text(0.08823844790458679, -0.42463313788175583, \"{'Interaction': 'Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dihydrotestosterone'): Text(0.06786011531949043, -0.1905185505747795, \"{'Interaction': 'hydroxyflutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [BCG Vaccine results in increased expression of IL6 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Staphylococcal Protein A'): Text(0.25901253521442413, -0.5502940639853477, \"{'Interaction': 'Staphylococcal Protein A results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sulfadiazine'): Text(0.03613611310720444, -0.40623190253973007, \"{'Interaction': '[Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sulfur Dioxide'): Text(0.41836927831172943, -0.481515608727932, \"{'Interaction': 'Sulfur Dioxide results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Suramin'): Text(0.25521427392959595, -0.08289534226059914, \"{'Interaction': 'Suramin inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Talc'): Text(0.44311918318271637, -0.4583873972296715, \"{'Interaction': 'Talc analog results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Tamoxifen'): Text(0.07499423623085022, -0.13193481229245663, \"{'Interaction': '[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Taurocholic Acid'): Text(0.14030715450644493, -0.24079973995685577, \"{'Interaction': '[TNF protein co-treated with IL6 protein co-treated with IL1B protein] results in decreased import of Taurocholic Acid', 'InteractionActions': 'affects^cotreatment|decreases^import'}\"),\n",
       " ('il6',\n",
       "  'Testosterone'): Text(0.05835245922207832, -0.10168700851500034, \"{'Interaction': 'Testosterone results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Tetrachlorodibenzodioxin'): Text(0.056514665484428406, -0.08175943046808243, \"{'Interaction': 'Tetrachlorodibenzodioxin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Tetradecanoylphorbol Acetate'): Text(0.08038166165351868, -0.15091831795871258, \"{'Interaction': 'withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Thalidomide'): Text(0.1302994340658188, -0.1473265290260315, \"{'Interaction': 'Thalidomide results in decreased activity of IL6 protein', 'InteractionActions': 'decreases^activity'}\"),\n",
       " ('il6',\n",
       "  'Theophylline'): Text(0.08131973817944527, -0.18571151793003082, \"{'Interaction': 'Theophylline results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Thimerosal'): Text(0.08109985664486885, -0.11558677023276687, \"{'Interaction': 'Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Thioacetamide'): Text(0.18940840661525726, -0.23759669065475464, \"{'Interaction': 'Thioacetamide results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Thiophenes'): Text(0.019918493926525116, -0.27177322655916214, \"{'Interaction': 'Thiophenes inhibits the reaction [KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Thiourea'): Text(0.3540669083595276, 0.005966700613498688, \"{'Interaction': 'Thiourea inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Tin Fluorides'): Text(0.33053378760814667, -0.5416867062449455, \"{'Interaction': 'Tin Fluorides inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt'): Text(0.18929854035377502, -0.1968643143773079, \"{'Interaction': '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Titanium'): Text(0.2131575345993042, -0.46004318445920944, \"{'Interaction': 'Titanium results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Tobacco Smoke Pollution'): Text(0.03437689691781998, -0.07973124831914902, \"{'Interaction': 'Tobacco Smoke Pollution results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Toluene'): Text(-0.011224627494812012, -0.19927717000246048, \"{'Interaction': 'Toluene affects the methylation of IL6 promoter', 'InteractionActions': 'affects^methylation'}\"),\n",
       " ('il6',\n",
       "  'Toluene 2,4-Diisocyanate'): Text(0.23967798054218292, -0.26747243851423264, \"{'Interaction': 'Toluene 2,4-Diisocyanate results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Tosylphenylalanyl Chloromethyl Ketone'): Text(0.1714175045490265, -0.164363082498312, \"{'Interaction': 'Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^activity|increases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Tretinoin'): Text(0.0344998762011528, -0.09024778194725513, \"{'Interaction': 'Tretinoin results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Trichloroacetic Acid'): Text(0.4574231654405594, -0.4479493424296379, \"{'Interaction': 'Trichloroacetic Acid results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Trichloroethylene'): Text(0.07111172750592232, -0.23160377144813538, \"{'Interaction': 'Trichloroethylene results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Triclosan'): Text(0.008489325642585754, -0.16750936955213547, \"{'Interaction': 'Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Triiodothyronine'): Text(0.03649405390024185, -0.22495175898075104, \"{'Interaction': 'Triiodothyronine inhibits the reaction [Silicon Dioxide results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Trimethoprim'): Text(0.43367861211299896, -0.49139615148305893, \"{'Interaction': '[Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Triterpenes'): Text(0.33557745814323425, -0.22287505120038986, \"{'Interaction': 'Triterpenes inhibits the reaction [TGFBI protein results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ubiquinone'): Text(0.485380157828331, -0.4327419027686119, \"{'Interaction': '[Ubiquinone co-treated with Niacin co-treated with Riboflavin] promotes the reaction [Tamoxifen results in decreased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Urethane'): Text(0.0056540146470069885, -0.10570847149938345, \"{'Interaction': 'Urethane results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Uric Acid'): Text(0.12308762408792973, -0.3969498798251152, \"{'Interaction': '[Uric Acid co-treated with TGFB1 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^cotreatment|increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Uridine Triphosphate'): Text(0.3175859600305557, -0.2290566861629486, \"{'Interaction': 'Uridine Triphosphate results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ursodeoxycholic Acid'): Text(0.12815103493630886, -0.07706636190414429, \"{'Interaction': 'Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased secretion of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Valproic Acid'): Text(0.018313206732273102, -0.07469115406274796, \"{'Interaction': 'Valproic Acid results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Vanadates'): Text(0.06394315510988235, -0.21393341571092606, \"{'Interaction': 'Vanadates results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Vanadium'): Text(0.16470787674188614, -0.05796963721513748, \"{'Interaction': 'Vanadium results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Verapamil'): Text(0.20167901366949081, -0.27852895110845566, \"{'Interaction': 'Verapamil inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Vinblastine'): Text(-0.0005042329430580139, -0.14630338922142982, \"{'Interaction': 'Vinblastine results in increased stability of IL6 mRNA', 'InteractionActions': 'increases^stability'}\"),\n",
       " ('il6',\n",
       "  'Vincristine'): Text(0.05661887302994728, -0.05149516463279724, \"{'Interaction': 'Vincristine results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Vitamin E'): Text(0.04764505848288536, -0.07421153783798218, \"{'Interaction': 'Vitamin E results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Water Pollutants'): Text(0.26055164635181427, 0.011442907154560089, \"{'Interaction': 'Water Pollutants results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Zearalenone'): Text(0.10743967618327588, -0.05751542001962662, \"{'Interaction': '[Zearalenone co-treated with deoxynivalenol] results in increased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Zinc'): Text(0.06172347441315651, -0.1027873158454895, \"{'Interaction': 'Zinc results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Zinc Oxide'): Text(0.2315121591091156, -0.12210336560383439, \"{'Interaction': 'Zinc Oxide analog results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ziram'): Text(0.2866617441177368, -0.30167534202337265, \"{'Interaction': 'Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Zymosan'): Text(0.5264027565717697, -0.3335321918129921, \"{'Interaction': 'Zymosan results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  '1-Methyl-3-isobutylxanthine'): Text(0.06616008281707764, -0.07295175641775131, \"{'Interaction': '[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  '1,2-Dipalmitoylphosphatidylcholine'): Text(0.49968720972537994, -0.3671729788184166, \"{'Interaction': '1,2-Dipalmitoylphosphatidylcholine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  \"2,2'-Dipyridyl\"): Text(0.35255223512649536, -0.29756154865026474, '{\\'Interaction\\': \"2,2\\'-Dipyridyl inhibits the reaction [sodium arsenite results in increased expression of IL6 mRNA]\", \\'InteractionActions\\': \\'decreases^reaction|increases^expression\\'}'),\n",
       " ('il6',\n",
       "  'Eicosapentaenoic Acid'): Text(0.2697092592716217, -0.0711255818605423, \"{'Interaction': '[Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'): Text(0.050200559198856354, -0.07479148730635643, \"{'Interaction': '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of IL6 mRNA', 'InteractionActions': 'affects^expression'}\"),\n",
       " ('il6',\n",
       "  '8-Bromo Cyclic Adenosine Monophosphate'): Text(0.09212766028940678, -0.13759887777268887, \"{'Interaction': '[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Zidovudine'): Text(0.1056512669310905, -0.09809927828609943, \"{'Interaction': 'Zidovudine results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Dinoprostone'): Text(0.13316446542739868, -0.2441396564245224, \"{'Interaction': '[IL4 protein co-treated with CSF2 protein co-treated with TNF protein co-treated with Dinoprostone co-treated with IL1B protein co-treated with IL6 protein] results in increased expression of MUC1 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Epirubicin'): Text(0.2694222629070282, -0.11003313027322292, \"{'Interaction': 'Epirubicin results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Isotretinoin'): Text(0.08187004178762436, 0.005548156797885895, \"{'Interaction': 'Isotretinoin results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Roxithromycin'): Text(0.30233629047870636, -0.35605020076036453, \"{'Interaction': 'Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cytochalasin D'): Text(0.21972838789224625, -0.07410010695457458, \"{'Interaction': 'Cytochalasin D results in increased stability of IL6 mRNA', 'InteractionActions': 'increases^stability'}\"),\n",
       " ('il6',\n",
       "  '1-Methyl-4-phenylpyridinium'): Text(0.05930178239941597, -0.10215627029538155, \"{'Interaction': 'UCA1 affects the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of IL6 protein]', 'InteractionActions': 'affects^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Mifepristone'): Text(0.08532403223216534, -0.15597297623753548, \"{'Interaction': 'Mifepristone results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Metribolone'): Text(0.11925546731799841, -0.1539243496954441, \"{'Interaction': 'IL6 protein inhibits the reaction [Metribolone results in increased activity of AR protein]', 'InteractionActions': 'decreases^reaction|increases^activity'}\"),\n",
       " ('il6',\n",
       "  'Propofol'): Text(0.13788330182433128, -0.17141418904066086, \"{'Interaction': 'Propofol results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Ionomycin'): Text(0.12479826994240284, -0.2560649737715721, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Carboplatin'): Text(0.22209466248750687, -0.06487054377794266, \"{'Interaction': 'IL6 protein results in decreased susceptibility to Carboplatin', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Iloprost'): Text(0.3541552424430847, -0.27502238005399704, \"{'Interaction': 'Iloprost results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cyclosporine'): Text(0.04371587932109833, -0.07411396130919456, \"{'Interaction': '[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Crack Cocaine'): Text(0.2985793650150299, -0.2863188907504082, \"{'Interaction': 'Crack Cocaine results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Terfenadine'): Text(0.12544994801282883, -0.22592804580926895, \"{'Interaction': 'Terfenadine inhibits the reaction [IL4 protein results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Aflatoxin B1'): Text(0.020238228142261505, -0.0835716724395752, \"{'Interaction': '[Zearalenone co-treated with Aflatoxin B1] results in decreased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Mitomycin'): Text(0.11522689182311296, -0.13732260838150978, \"{'Interaction': 'Mitomycin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Arachidonic Acid'): Text(0.17522060871124268, -0.07647472247481346, \"{'Interaction': 'Arachidonic Acid results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Pravastatin'): Text(-0.0031615570187568665, -0.1870393455028534, \"{'Interaction': 'Pravastatin inhibits the reaction [Ritonavir results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Paclitaxel'): Text(0.08042963035404682, -0.12291816808283329, \"{'Interaction': 'Paclitaxel results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Medroxyprogesterone Acetate'): Text(0.12229390069842339, -0.09485280513763428, \"{'Interaction': '[Polyphenols co-treated with Antioxidants co-treated with Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Medroxyprogesterone Acetate co-treated with Celecoxib] results in decreased expression of IL6', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Procaterol'): Text(0.5310313850641251, -0.3177078887820244, \"{'Interaction': 'Procaterol promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Clarithromycin'): Text(0.31218191981315613, -0.3444056883454323, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clarithromycin', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Bisoprolol'): Text(0.42838265001773834, -0.4230821952223778, \"{'Interaction': 'Bisoprolol results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  '8-Hydroxy-2-(di-n-propylamino)tetralin'): Text(0.45902545750141144, -0.4187033399939537, \"{'Interaction': '8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Reactive Oxygen Species'): Text(0.10834207432344556, -0.09825871512293816, \"{'Interaction': '[[Testosterone co-treated with Estradiol co-treated with Progesterone] affects the susceptibility to [IL6 protein co-treated with IL1B protein co-treated with TNF protein]] which affects the abundance of Reactive Oxygen Species', 'InteractionActions': 'affects^abundance|affects^cotreatment|affects^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Gold Compounds'): Text(0.10526751494035125, -0.21513070166110992, \"{'Interaction': 'Gold Compounds results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Asbestos, Serpentine'): Text(0.13448301702737808, -0.18035396188497543, \"{'Interaction': 'IL1RN protein inhibits the reaction [[Asbestos, Serpentine results in increased secretion of IL1B protein] which results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Asbestos, Amphibole'): Text(0.1608426496386528, -0.0888248011469841, \"{'Interaction': 'Asbestos, Amphibole results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Asbestos, Crocidolite'): Text(0.054605476558208466, -0.1034630537033081, \"{'Interaction': 'TNF protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of IL6 protein]', 'InteractionActions': 'increases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Durapatite'): Text(0.5179731696844101, -0.3138531222939491, \"{'Interaction': 'Durapatite results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Isocyanates'): Text(0.2758236676454544, -0.01793958991765976, \"{'Interaction': 'Isocyanates analog results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Leukotriene D4'): Text(0.22460684925317764, -0.4509035274386406, \"{'Interaction': 'zileuton inhibits the reaction [Leukotriene D4 results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Silver Compounds'): Text(0.1360096074640751, -0.13185686245560646, \"{'Interaction': '[Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of IL6 protein', 'InteractionActions': 'affects^binding|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Sodium Selenite'): Text(0.06576508656144142, -0.08079945296049118, \"{'Interaction': 'Sodium Selenite results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Stavudine'): Text(0.1778446063399315, -0.4155960902571678, \"{'Interaction': 'Stavudine results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Antirheumatic Agents'): Text(0.030151717364788055, -0.07663493975996971, \"{'Interaction': 'Antirheumatic Agents results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Cadmium Chloride'): Text(0.044207267463207245, -0.08666299283504486, \"{'Interaction': 'U 0126 inhibits the reaction [Cadmium Chloride results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Saquinavir'): Text(0.37329457700252533, -0.527992270886898, \"{'Interaction': 'Saquinavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Thapsigargin'): Text(0.08673368021845818, -0.07272494584321976, \"{'Interaction': 'Thapsigargin results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Zinc Sulfate'): Text(0.12041216064244509, -0.10739476047456264, \"{'Interaction': 'Zinc Sulfate results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Oleic Acid'): Text(0.08946806192398071, -0.20809095352888107, \"{'Interaction': 'Sorafenib inhibits the reaction [Oleic Acid results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Palmitic Acid'): Text(0.1079379131551832, -0.17484844103455544, '{\\'Interaction\\': \"tin protoporphyrin IX inhibits the reaction [3,3\\',4,5\\'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]]\", \\'InteractionActions\\': \\'decreases^reaction|increases^secretion\\'}'),\n",
       " ('il6',\n",
       "  'Okadaic Acid'): Text(0.10246922424994409, -0.0963172372430563, \"{'Interaction': 'Okadaic Acid results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'beta-Naphthoflavone'): Text(0.12480348348617554, -0.048323698341846466, \"{'Interaction': 'beta-Naphthoflavone results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Zinc Acetate'): Text(0.0016099810600280762, -0.1320351818576455, \"{'Interaction': 'Zinc Acetate results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ritonavir'): Text(0.07789092510938644, -0.1695018708705902, \"{'Interaction': 'Ritonavir results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Indinavir'): Text(0.3320031017065048, -0.5253187343478203, \"{'Interaction': 'Indinavir results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Glycyrrhizic Acid'): Text(0.17890938371419907, -0.16992904990911484, \"{'Interaction': 'Glycyrrhizic Acid inhibits the reaction [Histamine results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Riluzole'): Text(0.3403141051530838, -0.5128472968935966, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Riluzole', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Gadolinium DTPA'): Text(0.20411910116672516, -0.46433984488248825, \"{'Interaction': 'Gadolinium DTPA results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Linoleic Acid'): Text(0.3923726826906204, -0.3130955621600151, \"{'Interaction': 'Linoleic Acid results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Losartan'): Text(0.13252299092710018, -0.2619621828198433, \"{'Interaction': 'Losartan results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Benzoic Acid'): Text(-0.0026989951729774475, -0.26030025631189346, \"{'Interaction': 'Benzoic Acid analog inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]', 'InteractionActions': 'decreases^reaction|increases^phosphorylation'}\"),\n",
       " ('il6',\n",
       "  'Budesonide'): Text(0.3553494065999985, 0.004505954682826996, \"{'Interaction': 'Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Simvastatin'): Text(0.11150206904858351, -0.1270887148566544, \"{'Interaction': 'Simvastatin results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nevirapine'): Text(0.3213118314743042, -0.5504172965884209, \"{'Interaction': 'Nevirapine results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Genistein'): Text(0.05486588180065155, -0.10985499620437622, \"{'Interaction': 'Genistein results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  '2-Propanol'): Text(0.28469277918338776, -0.20991045981645584, \"{'Interaction': '[Tetradecanoylphorbol Acetate co-treated with 2-Propanol] results in increased expression of and results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^expression|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Nelfinavir'): Text(0.0705549456179142, -0.3519965186715126, \"{'Interaction': 'Nelfinavir results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Polymethyl Methacrylate'): Text(0.16740352660417557, -0.4697355255484581, \"{'Interaction': 'Polymethyl Methacrylate results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Propylene Glycol'): Text(0.305819034576416, -0.5497355982661247, \"{'Interaction': '[Nicotine co-treated with Propylene Glycol co-treated with Glycerol] results in increased secretion of IL6 protein', 'InteractionActions': 'affects^cotreatment|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Styrene'): Text(0.10816077538765967, -0.3180510178208351, \"{'Interaction': 'Styrene results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Milrinone'): Text(0.37261317670345306, -0.47181086987257004, \"{'Interaction': 'Milrinone promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'tert-Butylhydroperoxide'): Text(0.06979906186461449, -0.09673495404422283, \"{'Interaction': 'tert-Butylhydroperoxide results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Sirolimus'): Text(0.09111733175814152, -0.1466302704066038, \"{'Interaction': '[TGFB1 protein modified form co-treated with Sirolimus] results in decreased expression of IL6 protein', 'InteractionActions': 'affects^cotreatment|decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Brefeldin A'): Text(0.4123517721891403, -0.4342579171061516, \"{'Interaction': 'Brefeldin A results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Butyric Acid'): Text(0.08303098008036613, -0.16794656589627266, \"{'Interaction': 'Butyric Acid results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Methylmethacrylate'): Text(0.4132133573293686, -0.44637157768011093, \"{'Interaction': 'Methylmethacrylate results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Raloxifene Hydrochloride'): Text(0.07833851128816605, -0.13607895374298096, \"{'Interaction': 'Raloxifene Hydrochloride results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Rolipram'): Text(0.36015503108501434, -0.5371678695082664, \"{'Interaction': 'Rolipram promotes the reaction [TNF protein results in increased expression of IL6 mRNA]', 'InteractionActions': 'increases^expression|increases^reaction'}\"),\n",
       " ('il6',\n",
       "  'Perindopril'): Text(0.5163633674383163, -0.29988007992506027, \"{'Interaction': 'Perindopril results in decreased expression of IL6 protein', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Polyethylene'): Text(0.28916411101818085, -0.36843863874673843, \"{'Interaction': 'Polyethylene results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Diphtheria-Tetanus-acellular Pertussis Vaccines'): Text(0.3461051732301712, -0.5012217685580254, \"{'Interaction': 'Diphtheria-Tetanus-acellular Pertussis Vaccines results in increased expression of IL6 protein', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Vitamin K 3'): Text(0.04661085456609726, -0.06442049890756607, \"{'Interaction': '[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3', 'InteractionActions': 'affects^cotreatment|increases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'alpha-Tocopherol'): Text(0.19417491555213928, -0.14648703299462795, '{\\'Interaction\\': \"alpha-Tocopherol inhibits the reaction [2,2\\',4,4\\'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of IL6 protein]\", \\'InteractionActions\\': \\'decreases^reaction|increases^expression|increases^secretion\\'}'),\n",
       " ('il6',\n",
       "  'Plant Preparations'): Text(0.29555843770504, -0.09174621663987637, \"{'Interaction': 'Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Pertussis Toxin'): Text(0.16353479772806168, -0.2791772857308388, \"{'Interaction': 'Pertussis Toxin inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Fullerenes'): Text(0.1737392321228981, -0.24615494161844254, \"{'Interaction': 'Fullerenes analog results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Nanotubes, Carbon'): Text(0.09065008163452148, -0.09630677290260792, \"{'Interaction': 'TNF protein inhibits the reaction [Nanotubes, Carbon analog results in decreased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Antigens, Dermatophagoides'): Text(0.29961270093917847, -0.5359509214758873, \"{'Interaction': '[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of IL6 mRNA', 'InteractionActions': 'affects^cotreatment|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Linoleic Acids, Conjugated'): Text(0.37115906178951263, -0.009213998913764954, \"{'Interaction': 'Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL6 mRNA]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Apigenin'): Text(0.17240362614393234, -0.1118311109021306, \"{'Interaction': 'TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Luteolin'): Text(0.11903238203376532, -0.1873062625527382, \"{'Interaction': 'Luteolin inhibits the reaction [nickel chloride results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Hydrolyzable Tannins'): Text(0.2297481745481491, -0.10505724046379328, \"{'Interaction': 'Hydrolyzable Tannins inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of IL6 mRNA]', 'InteractionActions': 'affects^cotreatment|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Protein Kinase Inhibitors'): Text(0.1905738189816475, -0.18292175978422165, \"{'Interaction': '[Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of IL6 protein]', 'InteractionActions': 'decreases^activity|decreases^reaction|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Chitosan'): Text(0.09869509236887097, -0.29068031162023544, \"{'Interaction': 'Chitosan results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Phytoestrogens'): Text(0.18032431602478027, 0.0036793872714042664, \"{'Interaction': 'Phytoestrogens results in decreased expression of IL6 mRNA', 'InteractionActions': 'decreases^expression'}\"),\n",
       " ('il6',\n",
       "  'Antigens, Plant'): Text(0.5296077281236649, -0.295387901365757, \"{'Interaction': 'zopolrestat inhibits the reaction [Antigens, Plant results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Ferrosoferric Oxide'): Text(0.22264362126588821, -0.12205018242821097, \"{'Interaction': 'Ferrosoferric Oxide results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Particulate Matter'): Text(0.05287300795316696, -0.10027791932225227, \"{'Interaction': '[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of IL6 mRNA', 'InteractionActions': 'increases^abundance|increases^expression'}\"),\n",
       " ('il6',\n",
       "  'Oseltamivir'): Text(0.46276791393756866, -0.39320214837789536, \"{'Interaction': 'IL6 protein results in decreased susceptibility to Oseltamivir', 'InteractionActions': 'decreases^response to substance'}\"),\n",
       " ('il6',\n",
       "  'Soot'): Text(0.08160397782921791, -0.1850057989358902, \"{'Interaction': 'Soot results in increased secretion of IL6 protein', 'InteractionActions': 'increases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Interleukin 1 Receptor Antagonist Protein'): Text(0.44850264489650726, -0.39773034304380417, \"{'Interaction': 'Interleukin 1 Receptor Antagonist Protein results in decreased secretion of IL6 protein', 'InteractionActions': 'decreases^secretion'}\"),\n",
       " ('il6',\n",
       "  'Diketopiperazines'): Text(0.33395977318286896, -0.23340287059545517, \"{'Interaction': 'Diketopiperazines inhibits the reaction [Polyphosphates results in increased secretion of IL6 protein]', 'InteractionActions': 'decreases^reaction|increases^secretion'}\"),\n",
       " ...}"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nx.draw_networkx_edge_labels(RED_CTD, pos)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "437b3ca0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "a982be55",
   "metadata": {},
   "source": [
    "Numero de nodos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "6426b2b7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1446"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "RED_CTD.number_of_nodes()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "00d9f75d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "859c7e46",
   "metadata": {},
   "source": [
    "numero de aristas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "326be937",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "11670"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "RED_CTD.number_of_edges()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "573f68ca",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "7d590208",
   "metadata": {},
   "source": [
    "Tamaño de la red"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "d55a9a4e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "11670"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "RED_CTD.size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "52c2e382",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "42ae2952",
   "metadata": {},
   "source": [
    "Grado de conexión de los nodos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "54a5fc01",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DegreeView({'tp53': 514, 'Calcimycin': 7, 'il6': 491, 'mapk3': 469, 'rela': 319, 'mapk8': 193, 'mapk1': 474, 'sp1': 106, 'cdkn1a': 345, 'Aripiprazole': 6, 'nfkb1': 210, 'cebpb': 112, 'mapkapk2': 46, 'ets1': 61, 'Risedronic Acid': 2, 'Fluticasone': 4, 'stat3': 175, 'Salmeterol Xinafoate': 3, 'myc': 229, 'Everolimus': 8, 'ccnd1': 271, 'rb1': 159, 'ccna2': 144, 'akt1': 297, 'sirt1': 122, 'mtor': 145, 'eif4ebp1': 88, 'Pemetrexed': 3, 'Dutasteride': 1, 'Interferon beta-1b': 1, 'Celecoxib': 20, 'jun': 253, 'cdk2': 137, 'ccnb1': 163, 'cdk4': 110, 'h2ax': 200, 'mapk14': 128, 'cdkn1b': 161, 'map2k1': 94, 'Varenicline': 2, 'Sildenafil Citrate': 1, 'Emtricitabine': 2, 'Tenofovir': 3, 'Valsartan': 4, 'tgfb1': 231, 'serpine1': 165, 'Formoterol Fumarate': 2, 'Rivastigmine': 1, 'Fingolimod Hydrochloride': 6, 'Imatinib Mesylate': 19, 'cdk1': 152, 'pten': 109, 'raf1': 73, 'Atorvastatin': 14, 'mdm2': 118, 'pik3ca': 58, 'Bortezomib': 37, 'atm': 116, 'e2f1': 89, 'rnf2': 18, 'ehmt2': 32, 'phc3': 23, 'tfdp1': 51, 'vdac1': 52, 'map2k6': 74, 'anapc11': 20, 'mapk9': 124, 'map2k4': 47, 'cdkn2a': 96, 'Capecitabine': 3, 'rbbp4': 32, 'Erlotinib Hydrochloride': 19, 'foxo3': 77, 'cdk6': 82, 'Dasatinib': 28, 'ezh2': 60, 'h2bc3': 25, 'h2bc14': 22, 'h2bc9': 32, 'cdc25a': 64, 'hmga2': 58, 'h1-5': 36, 'h1-1': 13, 'h1-4': 26, 'Atazanavir Sulfate': 5, 'mapkapk3': 38, 'Liraglutide': 1, 'Bendamustine Hydrochloride': 1, 'Dimethyl Fumarate': 1, 'Febuxostat': 1, 'ring1': 14, 'Venlafaxine Hydrochloride': 1, 'Mastic Resin': 1, 'fos': 237, 'Acebutolol': 3, 'Polychlorinated Dibenzodioxins': 1, 'Dibenzofurans, Polychlorinated': 2, 'Sugars': 1, 'Peanut Oil': 3, 'Antineoplastic Agents, Immunological': 4, 'Janus Kinase Inhibitors': 1, 'Docetaxel': 17, 'Clopidogrel': 2, 'Irinotecan': 24, 'h2ac6': 52, 'chek2': 86, 'chek1': 92, 'ube2c': 67, 'ets2': 49, 'zfp36l2': 39, 'Sevoflurane': 7, 'smad2': 63, 'Oxaliplatin': 20, 'ccne1': 117, 'txn': 97, 'Olanzapine': 2, 'Rosiglitazone': 26, 'bmi1': 33, 'h2bc5': 53, 'tsc2': 42, 'Gefitinib': 18, 'Sorafenib': 26, 'Resveratrol': 74, 'ccna1': 56, 'h2bc21': 46, 'h2bc17': 21, 'h2bc15': 18, 'mapk11': 41, 'kdm6b': 29, 'eed': 20, 'cdc27': 31, 'kat5': 24, 'foxo1': 76, 'pik3cb': 22, 'anapc1': 28, 'dnajc7': 28, 'ppp1cb': 39, 'map2k7': 21, 'ccne2': 76, 'e2f2': 59, 'hmga1': 53, 'akt3': 27, 'cbx6': 30, 'vdac3': 24, 'tgfb3': 52, 'Interferon alpha-2': 1, 'Wortmannin': 31, 'Temozolomide': 41, 'h2bc12': 42, 'h2aj': 27, 'rbbp7': 23, 'cbx2': 22, 'phc2': 27, 'slc25a4': 32, 'cdc16': 20, 'slc25a6': 20, 'capn1': 45, 'capn2': 49, 'rad9a': 15, 'Pioglitazone': 17, 'Gabapentin': 1, 'Decitabine': 44, 'h3-4': 33, 'h2ac18': 29, 'h1-0': 36, 'hla-g': 44, 'h1-2': 60, 'cdkn2d': 41, 'Sunitinib': 72, 'h2ac20': 27, 'ubb': 24, 'h2ac14': 12, 'h2az2': 25, 'h2ac7': 14, 'suz12': 21, 'cbx4': 38, 'phc1': 19, 'mov10': 22, 'tnrc6b': 29, 'h1-3': 30, 'ep400': 31, 'Zoledronic Acid': 36, 'rassf5': 18, 'Limonene': 1, 'Vinorelbine': 2, 'Arsenic Trioxide': 88, 'ubc': 30, 'rps27a': 26, 'ube2d1': 20, 'gata4': 28, 'vdac2': 34, 'Meloxicam': 4, 'Carvedilol': 3, 'Donepezil': 1, 'Moxifloxacin': 3, 'Fulvestrant': 55, 'trpv4': 19, 'hipk3': 19, 'cacna1d': 19, 'Pamidronate': 2, 'Imiquimod': 5, 'Lycopene': 18, 'Rimonabant': 8, 'Troglitazone': 43, 'Letrozole': 6, 'Terbinafine': 2, 'Bosentan': 3, 'Artesunate': 6, 'Telmisartan': 5, 'Vorinostat': 54, 'ehmt1': 24, 'Leflunomide': 36, 'h2bc11': 22, 'tnrc6a': 22, 'Fluvastatin': 2, 'Lapatinib': 15, 'Verteporfin': 1, 'Silybin': 19, 'Orlistat': 15, 'Cidofovir': 7, 'Irbesartan': 2, 'Cilostazol': 11, 'Aluminum Chloride': 3, 'Nabumetone': 1, 'Simendan': 1, 'Vemurafenib': 15, 'Meglumine Antimoniate': 1, 'Tropisetron': 1, 'Eptifibatide': 1, 'Deferiprone': 3, 'Eplerenone': 2, 'Roscovitine': 8, 'Crizotinib': 5, 'Edaravone': 1, 'Alitretinoin': 9, 'Norethindrone Acetate': 8, '2-Methoxyestradiol': 10, 'Deferasirox': 1, 'Eucalyptol': 4, 'Fomepizole': 1, 'Trabectedin': 4, 'Aprepitant': 2, 'O-(Chloroacetylcarbamoyl)fumagillol': 4, 'Bexarotene': 6, 'Tirapazamine': 2, '17 alpha-Hydroxyprogesterone Caproate': 1, 'Afatinib': 4, 'Meropenem': 1, 'Dronedarone': 5, 'Panobinostat': 25, 'ventx': 13, 'Ciclopirox': 3, 'Axitinib': 3, 'Homoharringtonine': 13, 'Clofarabine': 9, '5-Methoxypsoralen': 6, 'Tigecycline': 1, 'Acetaldehyde': 14, 'Ado-Trastuzumab Emtansine': 3, 'Sand': 1, 'Acetaminophen': 102, 'h2bc4': 27, 'h2bc13': 14, 'tnrc6c': 15, 'slc25a5': 29, 'mcu': 22, 'Acetates': 1, 'Gemcitabine': 21, 'Matrines': 4, 'Betulinic Acid': 14, 'Acetone': 1, 'Acetylcysteine': 50, 'Acetylmuramyl-Alanyl-Isoglutamine': 2, 'Acids': 8, 'Aconitine': 4, 'Acridine Orange': 1, 'Acrolein': 42, 'fzr1': 21, 'Acrylonitrile': 9, 'Adenine': 4, 'Adenosine': 5, 'Cyclic AMP': 7, 'Adenosine Diphosphate': 5, 'Adenosine Monophosphate': 1, 'Adenosine Triphosphate': 13, 'Aerosols': 14, 'Aflatoxins': 1, 'Agglutinins': 1, 'Agmatine': 1, 'Air Pollutants': 59, 'tfdp2': 31, 'Air Pollutants, Occupational': 12, 'h3c15': 14, 'Albuterol': 7, 'Ethanol': 38, 'Alcohols': 3, 'Aldehydes': 4, 'Aldosterone': 5, 'Allantoin': 2, 'Allergens': 9, 'Allethrins': 3, 'Allopurinol': 5, 'Alloxan': 1, 'Alloys': 1, 'alpha-Chlorohydrin': 3, 'Alprazolam': 1, 'Alprenolol': 2, 'uba52': 22, 'Aluminum': 3, 'Aluminum Oxide': 6, 'Amides': 1, 'Amidines': 1, 'Amiloride': 7, 'Aminacrine': 2, 'Amino Acids': 4, 'Amino Acids, Peptides, and Proteins': 4, 'Aminoglutethimide': 3, 'Aminolevulinic Acid': 2, 'Aminooxyacetic Acid': 1, 'Aminopterin': 1, 'Amiodarone': 17, 'Ammonium Chloride': 1, 'Amodiaquine': 8, 'Amphetamine': 2, 'Amphotericin B': 6, 'Amsacrine': 7, 'Amygdalin': 1, 'Androgens': 2, 'Androstenedione': 1, 'Anethole Trithione': 2, 'Angiotensin-Converting Enzyme Inhibitors': 1, 'Aniline Compounds': 2, 'Anisomycin': 8, 'Anthocyanins': 8, 'Anthralin': 1, 'Anthraquinones': 4, 'Anti-Inflammatory Agents': 1, 'Antifungal Agents': 2, 'Antigens, Bacterial': 1, 'Antigens, Viral': 1, 'Antimony': 3, 'Antimony Potassium Tartrate': 9, 'Antimony Sodium Gluconate': 1, 'Antimycin A': 34, 'Antineoplastic Agents': 3, 'Antioxidants': 1, 'Apomorphine': 2, 'Arachidonic Acids': 2, 'Arbutin': 7, 'Arecoline': 9, 'Armin': 1, 'Arsenates': 7, 'Arsenic': 68, 'h2bc1': 6, 'Arsenicals': 9, 'Asbestos': 12, 'Ascorbic Acid': 26, 'Aspartame': 7, 'Aspirin': 41, 'Atenolol': 3, 'Atractyloside': 1, 'Atrazine': 47, 'Atropine': 6, 'Auranofin': 6, 'Vehicle Emissions': 34, 'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride': 1, 'Azacitidine': 29, 'Azathioprine': 29, 'Azinphosmethyl': 1, 'Aziridines': 1, 'Barium Sulfate': 1, '3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester': 1, 'BCG Vaccine': 1, 'Beclomethasone': 2, 'Bee Venoms': 6, 'Benomyl': 2, 'Benzalkonium Compounds': 3, 'Benzamides': 1, 'Benzbromarone': 1, 'Benzene': 29, 'Hexachlorocyclohexane': 8, 'Benzo(a)pyrene': 130, 'cbx8': 12, 'Benzoates': 5, 'Benzofurans': 5, 'Benzophenoneidum': 1, 'Benzoyl Peroxide': 3, 'Benztropine': 6, 'Berberine': 34, 'beta-Endorphin': 2, 'Bezafibrate': 5, 'Bibenzyls': 1, 'Biguanides': 1, 'Bile Acids and Salts': 7, 'Bilirubin': 11, 'Biliverdine': 2, 'Biological Factors': 3, 'Biological Products': 4, 'Biphenyl Compounds': 1, 'Dicumarol': 11, 'Bithionol': 1, 'Bleomycin': 6, 'Bongkrekic Acid': 1, 'Boron': 1, 'Bumetanide': 1, 'Bungarotoxins': 5, 'Bupivacaine': 2, 'Buprenorphine': 2, 'Busulfan': 12, 'Butylated Hydroxyanisole': 8, 'Butylated Hydroxytoluene': 2, 'Butyrates': 22, 'Butyrophenones': 1, 'Cacodylic Acid': 15, 'Cadmium': 72, 'Ceruletide': 1, 'Caffeine': 63, 'Calcifediol': 6, 'Calcitriol': 49, 'Calcium': 10, 'Calcium Carbonate': 1, 'Calcium Chloride': 2, 'Calcium Oxalate': 1, 'Camptothecin': 25, 'Cannabidiol': 66, 'h4c1': 13, 'Cannabinoids': 5, 'Cantharidin': 11, 'Capsaicin': 33, 'Carbachol': 2, 'Carbamates': 4, 'Carbamazepine': 48, 'Carbenoxolone': 2, 'Carbidopa': 2, 'Carbocysteine': 1, 'Carbofuran': 2, 'Carbon': 3, 'Carbon Monoxide': 5, 'Carbon Tetrachloride': 4, 'Carbonyl Cyanide m-Chlorophenyl Hydrazone': 1, 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone': 5, 'Carmustine': 16, 'Carnosine': 1, 'Carrageenan': 1, 'Catechin': 27, 'Estrogens, Catechol': 2, 'Cefadroxil': 1, 'Cefazolin': 1, 'Cefotaxime': 1, 'Cephalothin': 1, 'Ceramides': 6, 'Cerium': 2, 'Cetylpyridinium': 1, 'Chalcone': 1, 'Chelating Agents': 53, 'Chenodeoxycholic Acid': 10, 'Chitin': 1, 'Chlorambucil': 6, 'Chloramphenicol': 3, 'Chloranil': 1, 'Chlordan': 3, 'Chlorfenvinphos': 1, 'Chlorides': 1, 'Chlorine': 2, 'Chloroform': 3, 'Chlorogenic Acid': 3, 'Chloroquine': 15, 'Chlorpromazine': 7, 'Chlorpropamide': 1, 'Cholecalciferol': 13, 'Cholera Toxin': 1, 'Cholestanols': 1, 'Cholesterol': 5, 'Cholic Acids': 3, 'Choline': 3, 'Chondroitin Sulfates': 2, 'Chromium': 11, 'Chromium Alloys': 2, 'Chromones': 2, 'Cimetidine': 2, 'Ciprofloxacin': 10, 'Cisplatin': 104, 'Citrinin': 13, 'Leucovorin': 6, 'Clofibrate': 8, 'Clofibric Acid': 1, 'Clomiphene': 1, 'Clomipramine': 1, 'Clonidine': 2, 'Clorgyline': 1, 'Clotrimazole': 8, 'Cloxacillin': 1, 'Clozapine': 8, 'Coal': 6, 'Coal Tar': 1, 'Cobalt': 8, 'Cocaine': 8, 'Colchicine': 10, 'Colistin': 2, 'Contrast Media': 4, 'Copper': 78, 'Cortisone': 1, 'Cosmetics': 2, 'Cotinine': 5, 'Coumaphos': 1, 'Coumarins': 2, 'Coumestrol': 42, 'Cuprizone': 4, 'Curcumin': 49, 'Cycloheximide': 21, 'Cyclophosphamide': 7, 'Cysteine': 3, 'Cytarabine': 13, 'Cytochalasin B': 7, 'Dacarbazine': 2, 'Dactinomycin': 16, 'Danazol': 2, 'Dapsone': 3, 'Daunorubicin': 18, 'Dichlorodiphenyl Dichloroethylene': 10, 'DDT': 16, 'Deferoxamine': 23, 'Dehydroepiandrosterone': 6, 'Demecolcine': 24, 'Demeclocycline': 1, 'Deoxycholic Acid': 13, 'Deoxyglucose': 9, 'Dequalinium': 1, 'Desipramine': 5, 'Dexamethasone': 64, 'Diacetyl': 6, 'Diamide': 4, 'Dianhydrogalactitol': 5, 'Diatrizoate': 9, 'Diazepam': 3, 'Diazinon': 19, 'Diazoxide': 3, 'Dibutyl Phthalate': 14, 'Bucladesine': 16, 'Clodronic Acid': 6, 'Dichlorophen': 1, 'Dichlororibofuranosylbenzimidazole': 2, 'Diclofenac': 38, 'Dieldrin': 13, 'Dienestrol': 1, 'Dietary Carbohydrates': 2, 'Dietary Fats': 3, 'Ditiocarb': 1, 'Diethylhexyl Phthalate': 41, 'Diethylnitrosamine': 3, 'Diethylstilbestrol': 14, 'Diflunisal': 1, 'Digitoxin': 14, 'Dihydro-beta-Erythroidine': 2, 'Dihydroxyacetone': 9, 'Diltiazem': 2, 'Dimercaprol': 1, 'Succimer': 2, 'Dimethoate': 1, 'Dimethyl Sulfoxide': 17, 'Dimethyldithiocarbamate': 1, 'Dimethylformamide': 4, 'Dimethylnitrosamine': 5, 'Dinitrochlorobenzene': 15, 'Dinitrofluorobenzene': 8, 'Diosgenin': 7, 'Dioxins': 5, 'Diphenhydramine': 2, 'Diphenoxylate': 1, 'Diphtheria Toxin': 3, 'Dipyridamole': 4, 'Diquat': 2, 'Cromolyn Sodium': 3, 'Disulfiram': 20, 'Disulfoton': 1, 'Dithiothreitol': 7, 'Diuron': 10, 'Dobutamine': 4, 'Docosahexaenoic Acids': 9, 'Domperidone': 2, 'Dopamine': 11, 'Doxorubicin': 100, 'Doxycycline': 2, 'Drugs, Chinese Herbal': 36, 'Pentetic Acid': 1, 'Chlorpyrifos': 14, 'Dust': 13, 'Dydrogesterone': 1, 'Fonofos': 4, 'Ecdysterone': 1, 'Edetic Acid': 2, 'Egtazic Acid': 6, 'Ellagic Acid': 11, 'Emetine': 4, 'Emodin': 14, 'Enalapril': 1, 'Endosulfan': 24, 'Endotoxins': 1, 'Environmental Pollutants': 5, 'Enzyme Inhibitors': 33, 'Ephedrine': 1, 'Epichlorohydrin': 1, 'Epinephrine': 5, 'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester': 1, 'Epoxy Compounds': 2, 'Erythromycin': 3, 'Erythropoietin': 2, 'Erythrosine': 3, 'Estradiol': 104, 'Estriol': 3, 'Estrogens, Conjugated (USP)': 1, 'Estrogens': 8, 'Estrone': 3, 'Ethacridine': 1, 'Ethacrynic Acid': 9, 'Ethidium': 4, 'Ethinyl Estradiol': 11, 'Amifostine': 6, 'Ethyl Methanesulfonate': 25, 'Ethylenebis(dithiocarbamates)': 1, 'Ethylmaleimide': 2, 'Ethylnitrosourea': 3, 'Etoposide': 32, 'Eugenol': 8, 'Farnesol': 5, 'Fatty Acids, Nonesterified': 2, 'Fenbendazole': 5, 'Fenitrothion': 1, 'Fenoterol': 2, 'Fentanyl': 2, 'Fenthion': 5, 'Ferric Compounds': 3, 'Ficusin': 2, 'Filipin': 1, 'Fish Oils': 7, 'Flame Retardants': 12, 'Flavonoids': 3, 'Flavoring Agents': 1, 'Flecainide': 1, 'Floxacillin': 1, 'Flucytosine': 2, 'Fluorides': 5, 'Fluorocarbons': 1, 'Floxuridine': 3, 'Fluorometholone': 5, 'Fluorouracil': 49, 'Fluoxetine': 11, 'Flurbiprofen': 9, 'Flutamide': 2, 'Folic Acid': 46, 'Formaldehyde': 58, 'Colforsin': 8, 'Fructose': 2, 'Tegafur': 1, 'Furans': 1, 'Furazolidone': 6, 'Furosemide': 1, 'Fusaric Acid': 1, 'Gadolinium': 4, 'Galactosamine': 2, 'Galactose': 4, 'Gallic Acid': 21, 'Gasoline': 17, 'Gentamicins': 5, 'Gentian Violet': 4, 'Glyburide': 2, 'Gliclazide': 1, 'Gliotoxin': 2, 'Glucocorticoids': 4, 'Glucosamine': 11, 'Glucose': 29, 'Glucosides': 1, 'Glutamine': 1, 'Glutaral': 2, 'Glutathione': 21, 'Glycerol': 3, 'Nitroglycerin': 1, 'Glycochenodeoxycholic Acid': 9, 'Glycocholic Acid': 7, 'Glycodeoxycholic Acid': 7, 'Glyoxal': 1, 'Gold': 19, 'Gold Sodium Thiomalate': 1, 'Gossypol': 3, 'Graphite': 1, 'Guanosine': 4, 'Cyclic GMP': 2, 'Guanosine Diphosphate': 1, 'Guanosine Triphosphate': 1, 'Haloperidol': 4, 'Harmaline': 2, 'Harmine': 8, 'Hemagglutinins': 1, 'Heme': 2, 'Hemin': 12, 'Hemocyanins': 1, 'Heparin': 11, 'Heptachlor': 9, 'Hesperidin': 8, 'Heterocyclic Compounds': 1, 'Heterocyclic Compounds, 3-Ring': 4, 'Hexachlorobenzene': 8, 'Hexachlorophene': 3, 'Hexanones': 6, 'Hexestrol': 1, 'Histamine': 10, 'Homocysteine': 11, 'Humic Substances': 3, 'Hyaluronic Acid': 10, 'Hycanthone': 1, 'Hydralazine': 13, 'Hydrazones': 6, 'Hydrocarbons': 1, 'Hydrocarbons, Chlorinated': 7, 'Hydrochloric Acid': 5, 'Hydrocortisone': 8, 'Hydrogen': 2, 'Hydrogen Peroxide': 77, 'Hydrogen Sulfide': 2, 'Hydroxamic Acids': 6, 'Hydroxychloroquine': 4, 'Hydroxyurea': 17, 'Hymecromone': 1, 'Hypochlorous Acid': 4, 'Ibuprofen': 14, 'Ifosfamide': 8, 'Immunologic Factors': 3, 'Indican': 1, 'Indoles': 1, 'Indomethacin': 51, 'Indoprofen': 3, 'Inosine': 1, 'Inosine Diphosphate': 1, 'Insulin': 2, 'Iodoacetamide': 1, 'Clioquinol': 10, 'Iohexol': 5, 'Iopamidol': 3, 'Iron': 12, 'Iron-Dextran Complex': 3, 'Isatin': 2, 'Isoflavones': 11, 'Isoniazid': 4, 'Isopropyl Thiogalactoside': 1, 'Isoproterenol': 6, 'Ivermectin': 60, 'Ketamine': 2, 'Ketanserin': 3, 'Ketoconazole': 3, 'Ketoglutaric Acids': 2, 'Kynurenic Acid': 1, 'Labetalol': 2, 'Latex': 5, 'Lead': 44, 'Leukotriene B4': 1, 'Levamisole': 3, 'Levodopa': 2, 'Lidocaine': 1, 'Lipids': 2, 'Thioctic Acid': 5, 'Lipopolysaccharides': 53, 'Cholesterol, HDL': 4, 'Cholesterol, LDL': 2, 'Lithium': 7, 'Lithocholic Acid': 7, 'Lobeline': 3, 'Lomustine': 1, 'Loperamide': 5, 'Lovastatin': 14, 'Lucanthone': 14, 'Magnesium': 1, 'Magnesium Oxide': 1, 'Malathion': 9, 'Maleates': 4, 'Maleic Anhydrides': 1, 'Malondialdehyde': 4, 'Maneb': 3, 'Manganese': 15, 'Mannitol': 3, 'Mebendazole': 7, 'Mecamylamine': 2, 'Mechlorethamine': 10, 'Mefenamic Acid': 1, 'Melarsoprol': 2, 'Melatonin': 19, 'Melitten': 10, 'Melphalan': 10, 'Memantine': 3, 'Menthol': 28, 'Mercaptoethanol': 2, 'Mercuric Chloride': 12, 'Mercury': 8, 'Mestranol': 1, 'Metformin': 35, 'Methadone': 2, 'Methamphetamine': 12, 'Methapyrilene': 24, 'Methimazole': 4, 'Methionine': 2, 'Methohexital': 3, 'Methotrexate': 50, 'Methoxsalen': 6, 'Methoxychlor': 9, 'Methyl Methanesulfonate': 51, 'Methyl Parathion': 4, 'Methylcholanthrene': 10, 'Methylene Blue': 1, 'Methylmercury Compounds': 10, 'Methylnitronitrosoguanidine': 15, 'Methylnitrosourea': 5, 'Methylphenidate': 1, 'Methylprednisolone': 1, 'Methyltestosterone': 1, 'Methylthiouracil': 5, 'Mevalonic Acid': 7, 'Mevinphos': 1, 'Mexiletine': 1, 'Miconazole': 1, 'Mimosine': 3, 'Minocycline': 3, 'Plicamycin': 3, 'Mitotane': 3, 'Mitoxantrone': 7, 'Molybdenum': 1, 'Monensin': 1, 'Monocrotophos': 1, 'Morphine': 9, 'Morpholines': 1, 'Mustard Compounds': 1, 'Mustard Gas': 27, 'Mycophenolic Acid': 10, 'N-Formylmethionine Leucyl-Phenylalanine': 6, 'N-Nitrosopyrrolidine': 18, 'NAD': 3, 'NADP': 1, 'Nafcillin': 1, 'Naloxone': 4, 'Naphthalenes': 1, 'Naphthoquinones': 10, 'Naphthyridines': 1, 'Naproxen': 3, 'Neomycin': 2, 'Neurotensin': 3, 'Niacin': 6, 'Nicardipine': 2, 'Nickel': 48, 'Niclosamide': 32, 'Niacinamide': 10, 'Nicotinamide Mononucleotide': 1, 'Nicotine': 46, 'Nicotinic Acids': 2, 'Nifedipine': 6, 'Nimodipine': 1, 'Ninhydrin': 1, 'Nitric Oxide': 4, 'Nitrobenzoates': 1, 'Nitrofurantoin': 1, 'Nitrofurazone': 1, 'Nitrogen': 5, 'Nitrogen Dioxide': 2, 'Nitrogen Mustard Compounds': 2, 'Nitrogen Oxides': 4, 'Nitroprusside': 10, 'Nitrosourea Compounds': 2, 'Nitrous Oxide': 1, 'Nitrovin': 1, 'Masoprocol': 13, 'Norepinephrine': 5, 'Norethindrone': 3, 'Nortriptyline': 1, 'Noscapine': 2, 'Novobiocin': 1, 'Nystatin': 1, 'o-Phthalaldehyde': 1, 'Oils, Volatile': 2, 'Oleanolic Acid': 15, 'Oligomycins': 7, 'Oligonucleotides': 1, 'Oligopeptides': 4, 'Oligoribonucleotides': 1, 'Oligosaccharides': 3, 'Omeprazole': 4, 'Organometallic Compounds': 2, 'Organotin Compounds': 10, 'Orotic Acid': 2, 'Ouabain': 21, 'Ovalbumin': 1, 'Oxalates': 1, 'Oxazolone': 2, 'Oxotremorine': 1, 'Oxprenolol': 2, 'Oxygen': 65, 'Oxymetholone': 1, 'Oxypurinol': 1, 'Ozone': 61, '4-Aminobenzoic Acid': 1, 'Palmitates': 4, 'Pantothenic Acid': 1, 'Paraoxon': 3, 'Paraquat': 29, 'Parathion': 13, 'Paromomycin': 1, 'Patulin': 5, 'Penicillamine': 2, 'Pentachlorophenol': 7, 'Pentamidine': 4, 'Pentobarbital': 3, 'Pentosan Sulfuric Polyester': 1, 'Pentoxifylline': 10, 'Peptides': 1, 'Peptidoglycan': 5, 'Perfume': 2, 'Pergolide': 4, 'Perhexiline': 2, 'Pesticides': 11, 'Phenanthrolines': 2, 'Phenformin': 2, 'Phenindione': 1, 'Phenobarbital': 19, 'Phenols': 2, 'Phenolsulfonphthalein': 1, 'Phentolamine': 2, 'Phenylbutazone': 3, 'Phenylbutyrates': 5, 'Phenylephrine': 5, 'Phenylmercuric Acetate': 28, 'Phenylthiourea': 2, 'Phenytoin': 9, 'Phloretin': 5, 'Phloroglucinol': 3, 'Eosine I Bluish': 2, 'Phorate': 1, 'Phosmet': 1, 'Phosphamidon': 1, 'Phosphates': 6, 'Phosphatidic Acids': 1, 'Phosphatidylcholines': 8, 'Phosphatidylinositols': 2, 'Phosphatidylserines': 2, 'Organophosphates': 2, 'Phosphorus': 4, 'Leptophos': 1, 'Phycocyanin': 1, 'Phytic Acid': 6, 'Vitamin K 1': 4, 'Pilocarpine': 1, 'Pindolol': 2, 'Piroxicam': 20, 'Plant Extracts': 56, 'Plant Oils': 13, 'Plasticizers': 2, 'Platelet Activating Factor': 1, 'Platinum': 4, 'Poly I-C': 6, 'Polyamines': 1, 'Polychlorinated Biphenyls': 21, 'Polycyclic Aromatic Hydrocarbons': 27, 'Polydeoxyribonucleotides': 1, 'Polyethylene Glycols': 2, 'Polyethyleneimine': 6, 'Polymyxin B': 5, 'Polyphosphates': 4, 'Polyribonucleotides': 6, 'Polysaccharides': 7, 'Polystyrenes': 8, 'Potassium Dichromate': 28, 'Povidone': 4, 'Practolol': 2, 'Prednisolone': 2, 'Prednisone': 5, 'Proadifen': 1, 'Probenecid': 3, 'Probucol': 1, 'Procainamide': 1, 'Procaine': 3, 'Fenofibrate': 11, 'Prodigiosin': 5, 'Proflavine': 1, 'Progestins': 3, 'Progesterone': 33, 'Promegestone': 7, 'Promethazine': 1, 'Propanil': 1, 'Propolis': 4, 'Propranolol': 4, 'Propyl Gallate': 1, 'Propylthiouracil': 1, 'Prostaglandins E': 1, 'Epoprostenol': 2, 'Protein Synthesis Inhibitors': 1, 'Proteoglycans': 1, 'Pyocyanine': 4, 'Pyrazoles': 2, 'Pyrethrins': 2, 'Pyridazines': 2, 'Pyrilamine': 2, 'Pyrimethamine': 3, 'Pyrimidines': 4, 'Pyrogallol': 1, 'Pyrones': 1, 'Pyrroles': 1, 'Pyruvaldehyde': 6, 'Quartz': 7, 'Quercetin': 75, 'Quinacrine': 7, 'Quinazolines': 6, 'Quinic Acid': 1, 'Quinidine': 1, 'Quinine': 1, 'Quinolines': 2, 'Radon': 4, 'Ranitidine': 2, 'Razoxane': 3, 'Batroxobin': 1, 'Reserpine': 2, 'Retinoids': 11, 'Ribavirin': 11, 'Riboflavin': 4, 'Ribonucleotides': 18, 'Rifampin': 7, '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone': 1, 'Rotenone': 50, 'Ruthenium': 5, 'Ruthenium Red': 3, 'Rutin': 6, 'S-Adenosylmethionine': 4, 'Sulfasalazine': 3, 'Saponins': 8, 'Sarin': 3, 'Secobarbital': 3, 'Selegiline': 7, 'Selenium': 31, 'Selenomethionine': 8, 'Serine': 1, 'Serotonin': 5, 'Sesquiterpenes': 2, 'Carbaryl': 2, 'Shikimic Acid': 3, 'Silicon Dioxide': 75, 'Silicon': 1, 'Silver': 27, 'Silver Nitrate': 20, 'Silymarin': 11, 'Simazine': 3, 'Skatole': 1, 'Smoke': 67, 'Sodium': 1, 'Sodium Chloride': 8, 'Sodium Dodecyl Sulfate': 14, 'Sodium Fluoride': 13, 'Gold Sodium Thiosulfate': 1, 'Sodium Hydroxide': 1, 'Sodium Nitrite': 1, 'Sodium Salicylate': 4, 'Soil Pollutants': 3, 'Sorbitol': 7, 'Spermine': 1, 'Spiro Compounds': 2, 'Spironolactone': 2, 'Dihydrotestosterone': 20, 'Staphylococcal Protein A': 1, 'Sterigmatocystin': 6, 'Stilbenes': 8, 'Streptozocin': 7, 'Sucrose': 3, 'Sulfadiazine': 2, 'Sulfamethoxazole': 1, 'Sulfates': 7, 'Sulfonamides': 2, 'Sulfonylurea Compounds': 1, 'Sulfur Dioxide': 1, 'Sulindac': 25, 'Superoxides': 4, 'Suramin': 5, 'T-2 Toxin': 12, 'Tacrine': 1, 'Talc': 1, 'Tamoxifen': 45, 'Tartrazine': 4, 'Taurine': 5, 'Taurocholic Acid': 8, 'Taurodeoxycholic Acid': 1, 'Taurolithocholic Acid': 2, 'Tea': 1, 'Teniposide': 2, 'Terbutaline': 3, 'Testosterone': 39, 'Tetracaine': 5, 'Tetrachlorodibenzodioxin': 69, 'Tetrachloroethylene': 4, 'Tetrachlorvinphos': 1, 'Tetracycline': 2, 'Tetradecanoylphorbol Acetate': 36, 'Dronabinol': 31, 'Tetrodotoxin': 2, 'Thalidomide': 20, 'Theophylline': 14, 'Thiamylal': 3, 'Thimerosal': 28, 'Thioacetamide': 4, 'Thiocarbamates': 1, 'Thioguanine': 1, 'Thioinosine': 1, 'Thiopental': 1, 'Thiophenes': 6, 'Thioridazine': 7, 'Thiosemicarbazones': 9, 'Thiostrepton': 6, 'Thiourea': 2, 'Thiram': 3, 'Threonine': 1, 'Thymidine': 1, 'Thyroxine': 6, 'Timolol': 2, 'Tin Fluorides': 1, '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt': 10, 'Titanium': 2, 'Tobacco Smoke Pollution': 102, 'Toluene': 4, 'Toluene 2,4-Diisocyanate': 5, 'Tosyllysine Chloromethyl Ketone': 2, 'Tosylphenylalanyl Chloromethyl Ketone': 8, 'Toxaphene': 2, 'Tretinoin': 98, 'Triamcinolone Acetonide': 1, 'Triamterene': 1, 'Triazoles': 2, 'Trichlorfon': 1, 'Trichloroacetic Acid': 1, 'Trichloroethylene': 8, 'Triclosan': 21, 'Trientine': 1, 'Trifluoperazine': 6, 'Trifluridine': 1, 'Triglycerides': 2, 'Triiodothyronine': 11, 'Trimethoprim': 1, 'Trinitrotoluene': 1, 'Triterpenes': 4, 'Tritolyl Phosphates': 1, 'Tubocurarine': 5, 'Tunicamycin': 36, 'Ubiquinone': 1, 'Uracil': 1, 'Uranium': 4, 'Urea': 2, 'Urethane': 46, 'Uric Acid': 3, 'Uridine': 2, 'Uridine Diphosphate': 3, 'Uridine Triphosphate': 4, 'Ursodeoxycholic Acid': 12, 'Valproic Acid': 129, 'h2ab1': 1, 'Vanadates': 14, 'Vanadium': 8, 'Vanillic Acid': 2, 'Vecuronium Bromide': 2, 'Verapamil': 6, 'Vinblastine': 14, 'Vincristine': 32, 'Vinyl Chloride': 3, 'Viper Venoms': 4, 'Vitallium': 18, 'Vitamin A': 3, 'Vitamin B 12': 2, 'Vitamin D': 5, 'Vitamin E': 35, 'Vitamin U': 2, 'Warfarin': 4, 'Water Pollutants': 4, 'Water Pollutants, Chemical': 2, 'Lutein': 2, 'Xylenes': 1, 'Zearalenone': 11, 'Zeranol': 4, 'Zinc': 42, 'Zinc Oxide': 7, 'Zineb': 1, 'Ziram': 4, 'Zymosan': 1, '1-Methyl-3-isobutylxanthine': 42, '1-Naphthylisothiocyanate': 3, '1,2-Dipalmitoylphosphatidylcholine': 1, '2-Acetylaminofluorene': 5, '2-Naphthylamine': 2, \"2,2'-Dipyridyl\": 2, '2,4-Dichlorophenoxyacetic Acid': 1, '2,6-Dichloroindophenol': 3, \"3,3'-Dichlorobenzidine\": 1, '4-Nitroquinoline-1-oxide': 3, 'Eicosapentaenoic Acid': 4, 'Mercaptopurine': 4, '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide': 61, '8-Bromo Cyclic Adenosine Monophosphate': 20, 'Oxyquinoline': 5, '9,10-Dimethyl-1,2-benzanthracene': 6, 'Zidovudine': 21, 'Dinoprostone': 9, 'Dinoprost': 1, 'Phorbol 12,13-Dibutyrate': 3, 'Thiorphan': 5, 'Gemfibrozil': 2, 'Epirubicin': 5, 'Octreotide': 1, 'Citalopram': 1, 'Quinolones': 2, 'Nimustine': 8, 'Hazardous Substances': 1, 'Isotretinoin': 12, 'Fatty Acids, Omega-3': 2, 'Josamycin': 3, 'Roxithromycin': 2, '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine': 4, 'Magnesium Chloride': 1, 'Cytochalasin D': 4, '24,25-Dihydroxyvitamin D 3': 1, '1-Methyl-4-phenylpyridinium': 53, 'Mifepristone': 23, 'Famotidine': 3, 'Nocodazole': 11, 'Metribolone': 13, 'Propofol': 11, 'Ionomycin': 9, 'Albendazole': 1, 'Ganciclovir': 2, 'Eicosanoids': 1, 'Cysteine Proteinase Inhibitors': 3, 'Carboplatin': 7, 'N-Methylaspartate': 4, 'Dextran Sulfate': 1, 'Iloprost': 3, 'Dizocilpine Maleate': 3, 'Tacrolimus': 1, 'Organoselenium Compounds': 4, 'Cyclosporine': 92, 'Crack Cocaine': 3, 'Aphidicolin': 3, 'Terfenadine': 5, 'Aflatoxin B1': 95, 'Aflatoxin M1': 11, 'Oxidopamine': 8, 'Bupropion': 3, 'Fluorescein-5-isothiocyanate': 5, 'Mitomycin': 25, 'Monocrotaline': 11, 'Arachidonic Acid': 9, 'Leuprolide': 1, 'Levonorgestrel': 4, 'Pravastatin': 6, 'Paclitaxel': 42, 'Foscarnet': 1, 'Acitretin': 4, 'Ramipril': 1, 'Medroxyprogesterone Acetate': 15, 'Dimaprit': 3, 'Procaterol': 1, 'Goserelin': 1, 'Selenocysteine': 2, 'Clarithromycin': 2, 'Doxazosin': 3, 'Bisoprolol': 1, 'Xamoterol': 2, 'Amlodipine': 8, 'Fenretinide': 23, 'Photosensitizing Agents': 1, 'Cladribine': 4, '8-Hydroxy-2-(di-n-propylamino)tetralin': 1, 'Paroxetine': 1, 'Reactive Oxygen Species': 25, 'Bisphenol A-Glycidyl Methacrylate': 2, 'Adenovirus E1A Proteins': 1, 'Gold Compounds': 9, 'Asbestos, Serpentine': 16, 'Asbestos, Amphibole': 12, 'Asbestos, Crocidolite': 59, 'Asbestos, Amosite': 3, 'Silicon Compounds': 3, 'Hydroxyl Radical': 1, 'Platinum Compounds': 1, 'Lisinopril': 1, \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\": 3, 'Isothiocyanates': 2, 'Durapatite': 1, 'Isocyanates': 4, 'Azithromycin': 1, 'gamma-Linolenic Acid': 7, 'Zinc Compounds': 3, 'Vanadium Compounds': 1, 'Tungsten Compounds': 2, 'Uranium Compounds': 2, 'Ruthenium Compounds': 2, 'Leukotriene D4': 2, 'Lithium Chloride': 17, 'Silver Compounds': 18, 'Sodium Selenite': 41, 'Superantigens': 1, 'Stavudine': 2, 'Antirheumatic Agents': 39, 'Excitatory Amino Acid Agonists': 2, 'Excitatory Amino Acid Antagonists': 2, 'Hexamethonium': 4, 'N-Methyl-3,4-methylenedioxyamphetamine': 1, 'Antineoplastic Agents, Alkylating': 1, 'beta Carotene': 5, 'Metals, Heavy': 2, 'Cadmium Chloride': 87, 'Quinpirole': 2, 'Saquinavir': 1, 'Lamivudine': 7, 'Phosphatidylinositol 4,5-Diphosphate': 1, 'Thapsigargin': 30, 'Zinc Sulfate': 22, 'Pyruvic Acid': 1, 'Oleic Acid': 9, '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine': 4, 'Palmitic Acid': 19, 'Staurosporine': 11, 'Okadaic Acid': 23, 'beta-Naphthoflavone': 13, 'Copper Sulfate': 90, 'Buthionine Sulfoximine': 10, 'Acetic Acid': 1, 'Citric Acid': 3, 'Lactic Acid': 34, 'Zinc Acetate': 14, '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid': 4, 'Ritonavir': 20, 'Indinavir': 1, 'Glycyrrhizic Acid': 6, 'Topotecan': 15, 'Riluzole': 1, 'Gadolinium DTPA': 2, 'Linoleic Acid': 2, '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid': 3, 'Phenol': 6, 'Succinic Acid': 4, 'Glutathione Disulfide': 2, 'Losartan': 7, 'Sodium Azide': 4, 'Oxalic Acid': 1, 'Benzoic Acid': 6, 'Budesonide': 2, 'Xanthine': 1, 'Simvastatin': 29, 'Nevirapine': 1, 'Genistein': 58, '2-Propanol': 4, 'Nelfinavir': 3, 'Polymethyl Methacrylate': 2, 'Propylene Glycol': 1, '1-Butanol': 14, 'Nitric Oxide Donors': 1, 'Styrene': 4, 'Milrinone': 1, 'Acrylamide': 35, 'Chlorodiphenyl (54% Chlorine)': 6, 'tert-Butylhydroperoxide': 50, 'Sirolimus': 35, 'Brefeldin A': 1, 'Butyric Acid': 19, '3-Hydroxybutyric Acid': 2, 'Salicylic Acid': 1, 'Sodium Benzoate': 1, 'p-Chloromercuribenzoic Acid': 12, 'Sertraline': 9, 'Oligoribonucleotides, Antisense': 2, 'Methylmethacrylate': 1, 'Enzyme Activators': 1, 'Selective Estrogen Receptor Modulators': 2, 'Raloxifene Hydrochloride': 34, 'Rolipram': 1, 'Ketorolac': 1, 'Perindopril': 1, 'Polyethylene': 2, 'Shiga Toxin': 4, 'Shiga Toxin 2': 2, 'Diphtheria-Tetanus-acellular Pertussis Vaccines': 1, 'Vitamin K 2': 5, 'Vitamin K 3': 47, 'alpha-Tocopherol': 11, 'gamma-Tocopherol': 5, 'Tocopherols': 7, 'Permethrin': 4, 'Singlet Oxygen': 1, 'S-Nitrosoglutathione': 4, 'S-Nitroso-N-Acetylpenicillamine': 1, 'Plant Preparations': 5, 'F2-Isoprostanes': 1, 'Peroxynitrous Acid': 2, 'Aristolochic Acids': 8, 'Ginsenosides': 1, 'Diarylheptanoids': 1, 'Pertussis Toxin': 7, 'Fullerenes': 8, 'Nanotubes, Carbon': 29, 'Antigens, Dermatophagoides': 1, 'Fatty Acids, Omega-6': 1, 'Tetrahydroisoquinolines': 3, 'Linoleic Acids, Conjugated': 2, 'Proanthocyanidins': 1, 'Flavonols': 2, 'Flavanones': 13, 'PQQ Cofactor': 2, 'Diterpenes, Clerodane': 1, 'Chalcones': 2, 'Apigenin': 13, 'Luteolin': 19, 'Hydrolyzable Tannins': 7, 'Protein Kinase Inhibitors': 11, 'Depsipeptides': 2, 'Chitosan': 6, 'Phytoestrogens': 5, 'Betalains': 5, 'Aptamers, Nucleotide': 1, 'Antigens, Plant': 1, 'Ferrosoferric Oxide': 8, 'Particulate Matter': 67, 'Benzophenanthridines': 7, 'Oseltamivir': 1, 'Soot': 14, 'Interleukin 1 Receptor Antagonist Protein': 1, 'Oncostatin M': 1, 'Diketopiperazines': 4, 'Volatile Organic Compounds': 28, 'Halogenated Diphenyl Ethers': 9, 'Histone Deacetylase Inhibitors': 2, 'Coordination Complexes': 2, 'Iron Compounds': 5, 'Magnetite Nanoparticles': 9, 'Vaccines, Virus-Like Particle': 2, 'Polyphenols': 14, 'Coal Ash': 5, 'Equol': 6, 'Lopinavir': 2, 'Matrix Metalloproteinase Inhibitors': 2, 'Fungal Polysaccharides': 7, 'Oxaloacetic Acid': 1, 'Organothiophosphates': 2, 'Phytochemicals': 7, 'Selenic Acid': 4, 'Selenium Oxides': 1, 'Levofloxacin': 1, 'Neurokinin-1 Receptor Antagonists': 1, 'Frankincense': 3})"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nx.degree(RED_CTD)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "03e9b873",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "e94915af",
   "metadata": {},
   "source": [
    "Calcular el grado de cada nodo en un directorio/diccionario"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b16c8685",
   "metadata": {},
   "outputs": [],
   "source": [
    "grado = dict(RED_CTD.degree())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "934f375a",
   "metadata": {},
   "source": [
    "Encontrar el nodo con mayor conexión (grado mayor)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "d6fe0084",
   "metadata": {},
   "outputs": [],
   "source": [
    "nodo_mayor_conexion = max(grado, key=grado.get)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7bf1e074",
   "metadata": {},
   "source": [
    "Encontrar el nodo con menor conexión (grado menor)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "87674428",
   "metadata": {},
   "outputs": [],
   "source": [
    "nodo_menor_conexion = min(grado, key=grado.get)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "256eea87",
   "metadata": {},
   "source": [
    "Imprimir el resultado de los nodos con mayor y menor grado de conexión de la red"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "7a313862",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "El nodo con mayor conexión es tp53 con un grado de 514\n",
      "El nodo con menor conexión es Dutasteride con un grado de 1\n"
     ]
    }
   ],
   "source": [
    "print(f\"El nodo con mayor conexión es {nodo_mayor_conexion} con un grado de {grado[nodo_mayor_conexion]}\")\n",
    "print(f\"El nodo con menor conexión es {nodo_menor_conexion} con un grado de {grado[nodo_menor_conexion]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bcba26b5",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "4c587374",
   "metadata": {},
   "source": [
    "Obtener el Top 10 de los nodos mas conectados de la red"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "95756253",
   "metadata": {},
   "outputs": [],
   "source": [
    "grado = dict(RED_CTD.degree())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "f63d9150",
   "metadata": {},
   "outputs": [],
   "source": [
    "top_10_conectados = sorted(grado.items(), key=lambda x: x[1], reverse=True)[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "151bb815",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Los top 10 de los nodos más conectados son:\n",
      "tp53 con un grado de 514\n",
      "il6 con un grado de 491\n",
      "mapk1 con un grado de 474\n",
      "mapk3 con un grado de 469\n",
      "cdkn1a con un grado de 345\n",
      "rela con un grado de 319\n",
      "akt1 con un grado de 297\n",
      "ccnd1 con un grado de 271\n",
      "jun con un grado de 253\n",
      "fos con un grado de 237\n"
     ]
    }
   ],
   "source": [
    "print(f\"Los top 10 de los nodos más conectados son:\")\n",
    "for nodo, grado in top_10_conectados:\n",
    "    print(f\"{nodo} con un grado de {grado}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "68303fcb",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "73807326",
   "metadata": {},
   "source": [
    "Obtener el Top 10 de los nodos menos conectados de la red"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1d020752",
   "metadata": {},
   "outputs": [],
   "source": [
    "grado = dict(RED_CTD.degree())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "fbe5d592",
   "metadata": {},
   "outputs": [],
   "source": [
    "top_10_menos_conectados = sorted(grado.items(), key=lambda x: x[1])[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "96018179",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Los top 10 de los nodos menos conectados son:\n",
      "Dutasteride con un grado de 1\n",
      "Interferon beta-1b con un grado de 1\n",
      "Sildenafil Citrate con un grado de 1\n",
      "Rivastigmine con un grado de 1\n",
      "Liraglutide con un grado de 1\n",
      "Bendamustine Hydrochloride con un grado de 1\n",
      "Dimethyl Fumarate con un grado de 1\n",
      "Febuxostat con un grado de 1\n",
      "Venlafaxine Hydrochloride con un grado de 1\n",
      "Mastic Resin con un grado de 1\n"
     ]
    }
   ],
   "source": [
    "print(f\"Los top 10 de los nodos menos conectados son:\")\n",
    "for nodo, grado in top_10_menos_conectados:\n",
    "    print(f\"{nodo} con un grado de {grado}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a642333f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "1b96f44f",
   "metadata": {},
   "source": [
    "Obtener el top 75 de los nodos mas conectados"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "28ab0da9",
   "metadata": {},
   "outputs": [],
   "source": [
    "grado = dict(RED_CTD.degree())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "b5c58297",
   "metadata": {},
   "outputs": [],
   "source": [
    "top_75_mas_conectados = sorted(grado.items(), key=lambda x: x[1], reverse=True)[:75]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "2ab7f564",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Los top 75 de los nodos más conectados son:\n",
      "tp53 con un grado de 514\n",
      "il6 con un grado de 491\n",
      "mapk1 con un grado de 474\n",
      "mapk3 con un grado de 469\n",
      "cdkn1a con un grado de 345\n",
      "rela con un grado de 319\n",
      "akt1 con un grado de 297\n",
      "ccnd1 con un grado de 271\n",
      "jun con un grado de 253\n",
      "fos con un grado de 237\n",
      "tgfb1 con un grado de 231\n",
      "myc con un grado de 229\n",
      "nfkb1 con un grado de 210\n",
      "h2ax con un grado de 200\n",
      "mapk8 con un grado de 193\n",
      "stat3 con un grado de 175\n",
      "serpine1 con un grado de 165\n",
      "ccnb1 con un grado de 163\n",
      "cdkn1b con un grado de 161\n",
      "rb1 con un grado de 159\n",
      "cdk1 con un grado de 152\n",
      "mtor con un grado de 145\n",
      "ccna2 con un grado de 144\n",
      "cdk2 con un grado de 137\n",
      "Benzo(a)pyrene con un grado de 130\n",
      "Valproic Acid con un grado de 129\n",
      "mapk14 con un grado de 128\n",
      "mapk9 con un grado de 124\n",
      "sirt1 con un grado de 122\n",
      "mdm2 con un grado de 118\n",
      "ccne1 con un grado de 117\n",
      "atm con un grado de 116\n",
      "cebpb con un grado de 112\n",
      "cdk4 con un grado de 110\n",
      "pten con un grado de 109\n",
      "sp1 con un grado de 106\n",
      "Cisplatin con un grado de 104\n",
      "Estradiol con un grado de 104\n",
      "Acetaminophen con un grado de 102\n",
      "Tobacco Smoke Pollution con un grado de 102\n",
      "Doxorubicin con un grado de 100\n",
      "Tretinoin con un grado de 98\n",
      "txn con un grado de 97\n",
      "cdkn2a con un grado de 96\n",
      "Aflatoxin B1 con un grado de 95\n",
      "map2k1 con un grado de 94\n",
      "chek1 con un grado de 92\n",
      "Cyclosporine con un grado de 92\n",
      "Copper Sulfate con un grado de 90\n",
      "e2f1 con un grado de 89\n",
      "eif4ebp1 con un grado de 88\n",
      "Arsenic Trioxide con un grado de 88\n",
      "Cadmium Chloride con un grado de 87\n",
      "chek2 con un grado de 86\n",
      "cdk6 con un grado de 82\n",
      "Copper con un grado de 78\n",
      "foxo3 con un grado de 77\n",
      "Hydrogen Peroxide con un grado de 77\n",
      "foxo1 con un grado de 76\n",
      "ccne2 con un grado de 76\n",
      "Quercetin con un grado de 75\n",
      "Silicon Dioxide con un grado de 75\n",
      "map2k6 con un grado de 74\n",
      "Resveratrol con un grado de 74\n",
      "raf1 con un grado de 73\n",
      "Sunitinib con un grado de 72\n",
      "Cadmium con un grado de 72\n",
      "Tetrachlorodibenzodioxin con un grado de 69\n",
      "Arsenic con un grado de 68\n",
      "ube2c con un grado de 67\n",
      "Smoke con un grado de 67\n",
      "Particulate Matter con un grado de 67\n",
      "Cannabidiol con un grado de 66\n",
      "Oxygen con un grado de 65\n",
      "cdc25a con un grado de 64\n"
     ]
    }
   ],
   "source": [
    "print(f\"Los top 75 de los nodos más conectados son:\")\n",
    "for nodo, grado in top_75_mas_conectados:\n",
    "    print(f\"{nodo} con un grado de {grado}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "50db7d85",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "35b362a6",
   "metadata": {},
   "source": [
    "Para hacer una gráfica de barras hay que separar los nombres de los nodos y sus grados en dos listas separadas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "de7101e9",
   "metadata": {},
   "outputs": [],
   "source": [
    "nodos = [nodo for nodo, grado in top_75_mas_conectados]\n",
    "grados = [grado for nodo, grado in top_75_mas_conectados]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "18e98528",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(12, 8))\n",
    "plt.barh(nodos, grados)\n",
    "plt.xlabel('Grado')\n",
    "plt.ylabel('Nodo')\n",
    "plt.title('Top 75 nodos más conectados')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3e841583",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "34aba50c",
   "metadata": {},
   "source": [
    "Generar una variable que nos permita ver en un plot el comportamiento de los nodos."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "10c01f63",
   "metadata": {},
   "outputs": [],
   "source": [
    "Hist_degree = nx.degree(RED_CTD)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "bf1b4d17",
   "metadata": {},
   "outputs": [],
   "source": [
    "grados_dict = dict(Hist_degree)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "a7474089",
   "metadata": {},
   "outputs": [],
   "source": [
    "valores, frecuencias = zip(*grados_dict.items())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "5a2ac874",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.bar(valores, frecuencias)\n",
    "plt.ylabel('Grados')\n",
    "plt.xlabel('Frecuencias')\n",
    "plt.title('Histograma de frecuencias de los grados de los nodos en la red')\n",
    "plt.gca().xaxis.set_major_locator(plt.MultipleLocator(100))\n",
    "plt.xticks(rotation=90)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "75ddd58d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DegreeView({'tp53': 514, 'Calcimycin': 7, 'il6': 491, 'mapk3': 469, 'rela': 319, 'mapk8': 193, 'mapk1': 474, 'sp1': 106, 'cdkn1a': 345, 'Aripiprazole': 6, 'nfkb1': 210, 'cebpb': 112, 'mapkapk2': 46, 'ets1': 61, 'Risedronic Acid': 2, 'Fluticasone': 4, 'stat3': 175, 'Salmeterol Xinafoate': 3, 'myc': 229, 'Everolimus': 8, 'ccnd1': 271, 'rb1': 159, 'ccna2': 144, 'akt1': 297, 'sirt1': 122, 'mtor': 145, 'eif4ebp1': 88, 'Pemetrexed': 3, 'Dutasteride': 1, 'Interferon beta-1b': 1, 'Celecoxib': 20, 'jun': 253, 'cdk2': 137, 'ccnb1': 163, 'cdk4': 110, 'h2ax': 200, 'mapk14': 128, 'cdkn1b': 161, 'map2k1': 94, 'Varenicline': 2, 'Sildenafil Citrate': 1, 'Emtricitabine': 2, 'Tenofovir': 3, 'Valsartan': 4, 'tgfb1': 231, 'serpine1': 165, 'Formoterol Fumarate': 2, 'Rivastigmine': 1, 'Fingolimod Hydrochloride': 6, 'Imatinib Mesylate': 19, 'cdk1': 152, 'pten': 109, 'raf1': 73, 'Atorvastatin': 14, 'mdm2': 118, 'pik3ca': 58, 'Bortezomib': 37, 'atm': 116, 'e2f1': 89, 'rnf2': 18, 'ehmt2': 32, 'phc3': 23, 'tfdp1': 51, 'vdac1': 52, 'map2k6': 74, 'anapc11': 20, 'mapk9': 124, 'map2k4': 47, 'cdkn2a': 96, 'Capecitabine': 3, 'rbbp4': 32, 'Erlotinib Hydrochloride': 19, 'foxo3': 77, 'cdk6': 82, 'Dasatinib': 28, 'ezh2': 60, 'h2bc3': 25, 'h2bc14': 22, 'h2bc9': 32, 'cdc25a': 64, 'hmga2': 58, 'h1-5': 36, 'h1-1': 13, 'h1-4': 26, 'Atazanavir Sulfate': 5, 'mapkapk3': 38, 'Liraglutide': 1, 'Bendamustine Hydrochloride': 1, 'Dimethyl Fumarate': 1, 'Febuxostat': 1, 'ring1': 14, 'Venlafaxine Hydrochloride': 1, 'Mastic Resin': 1, 'fos': 237, 'Acebutolol': 3, 'Polychlorinated Dibenzodioxins': 1, 'Dibenzofurans, Polychlorinated': 2, 'Sugars': 1, 'Peanut Oil': 3, 'Antineoplastic Agents, Immunological': 4, 'Janus Kinase Inhibitors': 1, 'Docetaxel': 17, 'Clopidogrel': 2, 'Irinotecan': 24, 'h2ac6': 52, 'chek2': 86, 'chek1': 92, 'ube2c': 67, 'ets2': 49, 'zfp36l2': 39, 'Sevoflurane': 7, 'smad2': 63, 'Oxaliplatin': 20, 'ccne1': 117, 'txn': 97, 'Olanzapine': 2, 'Rosiglitazone': 26, 'bmi1': 33, 'h2bc5': 53, 'tsc2': 42, 'Gefitinib': 18, 'Sorafenib': 26, 'Resveratrol': 74, 'ccna1': 56, 'h2bc21': 46, 'h2bc17': 21, 'h2bc15': 18, 'mapk11': 41, 'kdm6b': 29, 'eed': 20, 'cdc27': 31, 'kat5': 24, 'foxo1': 76, 'pik3cb': 22, 'anapc1': 28, 'dnajc7': 28, 'ppp1cb': 39, 'map2k7': 21, 'ccne2': 76, 'e2f2': 59, 'hmga1': 53, 'akt3': 27, 'cbx6': 30, 'vdac3': 24, 'tgfb3': 52, 'Interferon alpha-2': 1, 'Wortmannin': 31, 'Temozolomide': 41, 'h2bc12': 42, 'h2aj': 27, 'rbbp7': 23, 'cbx2': 22, 'phc2': 27, 'slc25a4': 32, 'cdc16': 20, 'slc25a6': 20, 'capn1': 45, 'capn2': 49, 'rad9a': 15, 'Pioglitazone': 17, 'Gabapentin': 1, 'Decitabine': 44, 'h3-4': 33, 'h2ac18': 29, 'h1-0': 36, 'hla-g': 44, 'h1-2': 60, 'cdkn2d': 41, 'Sunitinib': 72, 'h2ac20': 27, 'ubb': 24, 'h2ac14': 12, 'h2az2': 25, 'h2ac7': 14, 'suz12': 21, 'cbx4': 38, 'phc1': 19, 'mov10': 22, 'tnrc6b': 29, 'h1-3': 30, 'ep400': 31, 'Zoledronic Acid': 36, 'rassf5': 18, 'Limonene': 1, 'Vinorelbine': 2, 'Arsenic Trioxide': 88, 'ubc': 30, 'rps27a': 26, 'ube2d1': 20, 'gata4': 28, 'vdac2': 34, 'Meloxicam': 4, 'Carvedilol': 3, 'Donepezil': 1, 'Moxifloxacin': 3, 'Fulvestrant': 55, 'trpv4': 19, 'hipk3': 19, 'cacna1d': 19, 'Pamidronate': 2, 'Imiquimod': 5, 'Lycopene': 18, 'Rimonabant': 8, 'Troglitazone': 43, 'Letrozole': 6, 'Terbinafine': 2, 'Bosentan': 3, 'Artesunate': 6, 'Telmisartan': 5, 'Vorinostat': 54, 'ehmt1': 24, 'Leflunomide': 36, 'h2bc11': 22, 'tnrc6a': 22, 'Fluvastatin': 2, 'Lapatinib': 15, 'Verteporfin': 1, 'Silybin': 19, 'Orlistat': 15, 'Cidofovir': 7, 'Irbesartan': 2, 'Cilostazol': 11, 'Aluminum Chloride': 3, 'Nabumetone': 1, 'Simendan': 1, 'Vemurafenib': 15, 'Meglumine Antimoniate': 1, 'Tropisetron': 1, 'Eptifibatide': 1, 'Deferiprone': 3, 'Eplerenone': 2, 'Roscovitine': 8, 'Crizotinib': 5, 'Edaravone': 1, 'Alitretinoin': 9, 'Norethindrone Acetate': 8, '2-Methoxyestradiol': 10, 'Deferasirox': 1, 'Eucalyptol': 4, 'Fomepizole': 1, 'Trabectedin': 4, 'Aprepitant': 2, 'O-(Chloroacetylcarbamoyl)fumagillol': 4, 'Bexarotene': 6, 'Tirapazamine': 2, '17 alpha-Hydroxyprogesterone Caproate': 1, 'Afatinib': 4, 'Meropenem': 1, 'Dronedarone': 5, 'Panobinostat': 25, 'ventx': 13, 'Ciclopirox': 3, 'Axitinib': 3, 'Homoharringtonine': 13, 'Clofarabine': 9, '5-Methoxypsoralen': 6, 'Tigecycline': 1, 'Acetaldehyde': 14, 'Ado-Trastuzumab Emtansine': 3, 'Sand': 1, 'Acetaminophen': 102, 'h2bc4': 27, 'h2bc13': 14, 'tnrc6c': 15, 'slc25a5': 29, 'mcu': 22, 'Acetates': 1, 'Gemcitabine': 21, 'Matrines': 4, 'Betulinic Acid': 14, 'Acetone': 1, 'Acetylcysteine': 50, 'Acetylmuramyl-Alanyl-Isoglutamine': 2, 'Acids': 8, 'Aconitine': 4, 'Acridine Orange': 1, 'Acrolein': 42, 'fzr1': 21, 'Acrylonitrile': 9, 'Adenine': 4, 'Adenosine': 5, 'Cyclic AMP': 7, 'Adenosine Diphosphate': 5, 'Adenosine Monophosphate': 1, 'Adenosine Triphosphate': 13, 'Aerosols': 14, 'Aflatoxins': 1, 'Agglutinins': 1, 'Agmatine': 1, 'Air Pollutants': 59, 'tfdp2': 31, 'Air Pollutants, Occupational': 12, 'h3c15': 14, 'Albuterol': 7, 'Ethanol': 38, 'Alcohols': 3, 'Aldehydes': 4, 'Aldosterone': 5, 'Allantoin': 2, 'Allergens': 9, 'Allethrins': 3, 'Allopurinol': 5, 'Alloxan': 1, 'Alloys': 1, 'alpha-Chlorohydrin': 3, 'Alprazolam': 1, 'Alprenolol': 2, 'uba52': 22, 'Aluminum': 3, 'Aluminum Oxide': 6, 'Amides': 1, 'Amidines': 1, 'Amiloride': 7, 'Aminacrine': 2, 'Amino Acids': 4, 'Amino Acids, Peptides, and Proteins': 4, 'Aminoglutethimide': 3, 'Aminolevulinic Acid': 2, 'Aminooxyacetic Acid': 1, 'Aminopterin': 1, 'Amiodarone': 17, 'Ammonium Chloride': 1, 'Amodiaquine': 8, 'Amphetamine': 2, 'Amphotericin B': 6, 'Amsacrine': 7, 'Amygdalin': 1, 'Androgens': 2, 'Androstenedione': 1, 'Anethole Trithione': 2, 'Angiotensin-Converting Enzyme Inhibitors': 1, 'Aniline Compounds': 2, 'Anisomycin': 8, 'Anthocyanins': 8, 'Anthralin': 1, 'Anthraquinones': 4, 'Anti-Inflammatory Agents': 1, 'Antifungal Agents': 2, 'Antigens, Bacterial': 1, 'Antigens, Viral': 1, 'Antimony': 3, 'Antimony Potassium Tartrate': 9, 'Antimony Sodium Gluconate': 1, 'Antimycin A': 34, 'Antineoplastic Agents': 3, 'Antioxidants': 1, 'Apomorphine': 2, 'Arachidonic Acids': 2, 'Arbutin': 7, 'Arecoline': 9, 'Armin': 1, 'Arsenates': 7, 'Arsenic': 68, 'h2bc1': 6, 'Arsenicals': 9, 'Asbestos': 12, 'Ascorbic Acid': 26, 'Aspartame': 7, 'Aspirin': 41, 'Atenolol': 3, 'Atractyloside': 1, 'Atrazine': 47, 'Atropine': 6, 'Auranofin': 6, 'Vehicle Emissions': 34, 'trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride': 1, 'Azacitidine': 29, 'Azathioprine': 29, 'Azinphosmethyl': 1, 'Aziridines': 1, 'Barium Sulfate': 1, '3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester': 1, 'BCG Vaccine': 1, 'Beclomethasone': 2, 'Bee Venoms': 6, 'Benomyl': 2, 'Benzalkonium Compounds': 3, 'Benzamides': 1, 'Benzbromarone': 1, 'Benzene': 29, 'Hexachlorocyclohexane': 8, 'Benzo(a)pyrene': 130, 'cbx8': 12, 'Benzoates': 5, 'Benzofurans': 5, 'Benzophenoneidum': 1, 'Benzoyl Peroxide': 3, 'Benztropine': 6, 'Berberine': 34, 'beta-Endorphin': 2, 'Bezafibrate': 5, 'Bibenzyls': 1, 'Biguanides': 1, 'Bile Acids and Salts': 7, 'Bilirubin': 11, 'Biliverdine': 2, 'Biological Factors': 3, 'Biological Products': 4, 'Biphenyl Compounds': 1, 'Dicumarol': 11, 'Bithionol': 1, 'Bleomycin': 6, 'Bongkrekic Acid': 1, 'Boron': 1, 'Bumetanide': 1, 'Bungarotoxins': 5, 'Bupivacaine': 2, 'Buprenorphine': 2, 'Busulfan': 12, 'Butylated Hydroxyanisole': 8, 'Butylated Hydroxytoluene': 2, 'Butyrates': 22, 'Butyrophenones': 1, 'Cacodylic Acid': 15, 'Cadmium': 72, 'Ceruletide': 1, 'Caffeine': 63, 'Calcifediol': 6, 'Calcitriol': 49, 'Calcium': 10, 'Calcium Carbonate': 1, 'Calcium Chloride': 2, 'Calcium Oxalate': 1, 'Camptothecin': 25, 'Cannabidiol': 66, 'h4c1': 13, 'Cannabinoids': 5, 'Cantharidin': 11, 'Capsaicin': 33, 'Carbachol': 2, 'Carbamates': 4, 'Carbamazepine': 48, 'Carbenoxolone': 2, 'Carbidopa': 2, 'Carbocysteine': 1, 'Carbofuran': 2, 'Carbon': 3, 'Carbon Monoxide': 5, 'Carbon Tetrachloride': 4, 'Carbonyl Cyanide m-Chlorophenyl Hydrazone': 1, 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone': 5, 'Carmustine': 16, 'Carnosine': 1, 'Carrageenan': 1, 'Catechin': 27, 'Estrogens, Catechol': 2, 'Cefadroxil': 1, 'Cefazolin': 1, 'Cefotaxime': 1, 'Cephalothin': 1, 'Ceramides': 6, 'Cerium': 2, 'Cetylpyridinium': 1, 'Chalcone': 1, 'Chelating Agents': 53, 'Chenodeoxycholic Acid': 10, 'Chitin': 1, 'Chlorambucil': 6, 'Chloramphenicol': 3, 'Chloranil': 1, 'Chlordan': 3, 'Chlorfenvinphos': 1, 'Chlorides': 1, 'Chlorine': 2, 'Chloroform': 3, 'Chlorogenic Acid': 3, 'Chloroquine': 15, 'Chlorpromazine': 7, 'Chlorpropamide': 1, 'Cholecalciferol': 13, 'Cholera Toxin': 1, 'Cholestanols': 1, 'Cholesterol': 5, 'Cholic Acids': 3, 'Choline': 3, 'Chondroitin Sulfates': 2, 'Chromium': 11, 'Chromium Alloys': 2, 'Chromones': 2, 'Cimetidine': 2, 'Ciprofloxacin': 10, 'Cisplatin': 104, 'Citrinin': 13, 'Leucovorin': 6, 'Clofibrate': 8, 'Clofibric Acid': 1, 'Clomiphene': 1, 'Clomipramine': 1, 'Clonidine': 2, 'Clorgyline': 1, 'Clotrimazole': 8, 'Cloxacillin': 1, 'Clozapine': 8, 'Coal': 6, 'Coal Tar': 1, 'Cobalt': 8, 'Cocaine': 8, 'Colchicine': 10, 'Colistin': 2, 'Contrast Media': 4, 'Copper': 78, 'Cortisone': 1, 'Cosmetics': 2, 'Cotinine': 5, 'Coumaphos': 1, 'Coumarins': 2, 'Coumestrol': 42, 'Cuprizone': 4, 'Curcumin': 49, 'Cycloheximide': 21, 'Cyclophosphamide': 7, 'Cysteine': 3, 'Cytarabine': 13, 'Cytochalasin B': 7, 'Dacarbazine': 2, 'Dactinomycin': 16, 'Danazol': 2, 'Dapsone': 3, 'Daunorubicin': 18, 'Dichlorodiphenyl Dichloroethylene': 10, 'DDT': 16, 'Deferoxamine': 23, 'Dehydroepiandrosterone': 6, 'Demecolcine': 24, 'Demeclocycline': 1, 'Deoxycholic Acid': 13, 'Deoxyglucose': 9, 'Dequalinium': 1, 'Desipramine': 5, 'Dexamethasone': 64, 'Diacetyl': 6, 'Diamide': 4, 'Dianhydrogalactitol': 5, 'Diatrizoate': 9, 'Diazepam': 3, 'Diazinon': 19, 'Diazoxide': 3, 'Dibutyl Phthalate': 14, 'Bucladesine': 16, 'Clodronic Acid': 6, 'Dichlorophen': 1, 'Dichlororibofuranosylbenzimidazole': 2, 'Diclofenac': 38, 'Dieldrin': 13, 'Dienestrol': 1, 'Dietary Carbohydrates': 2, 'Dietary Fats': 3, 'Ditiocarb': 1, 'Diethylhexyl Phthalate': 41, 'Diethylnitrosamine': 3, 'Diethylstilbestrol': 14, 'Diflunisal': 1, 'Digitoxin': 14, 'Dihydro-beta-Erythroidine': 2, 'Dihydroxyacetone': 9, 'Diltiazem': 2, 'Dimercaprol': 1, 'Succimer': 2, 'Dimethoate': 1, 'Dimethyl Sulfoxide': 17, 'Dimethyldithiocarbamate': 1, 'Dimethylformamide': 4, 'Dimethylnitrosamine': 5, 'Dinitrochlorobenzene': 15, 'Dinitrofluorobenzene': 8, 'Diosgenin': 7, 'Dioxins': 5, 'Diphenhydramine': 2, 'Diphenoxylate': 1, 'Diphtheria Toxin': 3, 'Dipyridamole': 4, 'Diquat': 2, 'Cromolyn Sodium': 3, 'Disulfiram': 20, 'Disulfoton': 1, 'Dithiothreitol': 7, 'Diuron': 10, 'Dobutamine': 4, 'Docosahexaenoic Acids': 9, 'Domperidone': 2, 'Dopamine': 11, 'Doxorubicin': 100, 'Doxycycline': 2, 'Drugs, Chinese Herbal': 36, 'Pentetic Acid': 1, 'Chlorpyrifos': 14, 'Dust': 13, 'Dydrogesterone': 1, 'Fonofos': 4, 'Ecdysterone': 1, 'Edetic Acid': 2, 'Egtazic Acid': 6, 'Ellagic Acid': 11, 'Emetine': 4, 'Emodin': 14, 'Enalapril': 1, 'Endosulfan': 24, 'Endotoxins': 1, 'Environmental Pollutants': 5, 'Enzyme Inhibitors': 33, 'Ephedrine': 1, 'Epichlorohydrin': 1, 'Epinephrine': 5, 'Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester': 1, 'Epoxy Compounds': 2, 'Erythromycin': 3, 'Erythropoietin': 2, 'Erythrosine': 3, 'Estradiol': 104, 'Estriol': 3, 'Estrogens, Conjugated (USP)': 1, 'Estrogens': 8, 'Estrone': 3, 'Ethacridine': 1, 'Ethacrynic Acid': 9, 'Ethidium': 4, 'Ethinyl Estradiol': 11, 'Amifostine': 6, 'Ethyl Methanesulfonate': 25, 'Ethylenebis(dithiocarbamates)': 1, 'Ethylmaleimide': 2, 'Ethylnitrosourea': 3, 'Etoposide': 32, 'Eugenol': 8, 'Farnesol': 5, 'Fatty Acids, Nonesterified': 2, 'Fenbendazole': 5, 'Fenitrothion': 1, 'Fenoterol': 2, 'Fentanyl': 2, 'Fenthion': 5, 'Ferric Compounds': 3, 'Ficusin': 2, 'Filipin': 1, 'Fish Oils': 7, 'Flame Retardants': 12, 'Flavonoids': 3, 'Flavoring Agents': 1, 'Flecainide': 1, 'Floxacillin': 1, 'Flucytosine': 2, 'Fluorides': 5, 'Fluorocarbons': 1, 'Floxuridine': 3, 'Fluorometholone': 5, 'Fluorouracil': 49, 'Fluoxetine': 11, 'Flurbiprofen': 9, 'Flutamide': 2, 'Folic Acid': 46, 'Formaldehyde': 58, 'Colforsin': 8, 'Fructose': 2, 'Tegafur': 1, 'Furans': 1, 'Furazolidone': 6, 'Furosemide': 1, 'Fusaric Acid': 1, 'Gadolinium': 4, 'Galactosamine': 2, 'Galactose': 4, 'Gallic Acid': 21, 'Gasoline': 17, 'Gentamicins': 5, 'Gentian Violet': 4, 'Glyburide': 2, 'Gliclazide': 1, 'Gliotoxin': 2, 'Glucocorticoids': 4, 'Glucosamine': 11, 'Glucose': 29, 'Glucosides': 1, 'Glutamine': 1, 'Glutaral': 2, 'Glutathione': 21, 'Glycerol': 3, 'Nitroglycerin': 1, 'Glycochenodeoxycholic Acid': 9, 'Glycocholic Acid': 7, 'Glycodeoxycholic Acid': 7, 'Glyoxal': 1, 'Gold': 19, 'Gold Sodium Thiomalate': 1, 'Gossypol': 3, 'Graphite': 1, 'Guanosine': 4, 'Cyclic GMP': 2, 'Guanosine Diphosphate': 1, 'Guanosine Triphosphate': 1, 'Haloperidol': 4, 'Harmaline': 2, 'Harmine': 8, 'Hemagglutinins': 1, 'Heme': 2, 'Hemin': 12, 'Hemocyanins': 1, 'Heparin': 11, 'Heptachlor': 9, 'Hesperidin': 8, 'Heterocyclic Compounds': 1, 'Heterocyclic Compounds, 3-Ring': 4, 'Hexachlorobenzene': 8, 'Hexachlorophene': 3, 'Hexanones': 6, 'Hexestrol': 1, 'Histamine': 10, 'Homocysteine': 11, 'Humic Substances': 3, 'Hyaluronic Acid': 10, 'Hycanthone': 1, 'Hydralazine': 13, 'Hydrazones': 6, 'Hydrocarbons': 1, 'Hydrocarbons, Chlorinated': 7, 'Hydrochloric Acid': 5, 'Hydrocortisone': 8, 'Hydrogen': 2, 'Hydrogen Peroxide': 77, 'Hydrogen Sulfide': 2, 'Hydroxamic Acids': 6, 'Hydroxychloroquine': 4, 'Hydroxyurea': 17, 'Hymecromone': 1, 'Hypochlorous Acid': 4, 'Ibuprofen': 14, 'Ifosfamide': 8, 'Immunologic Factors': 3, 'Indican': 1, 'Indoles': 1, 'Indomethacin': 51, 'Indoprofen': 3, 'Inosine': 1, 'Inosine Diphosphate': 1, 'Insulin': 2, 'Iodoacetamide': 1, 'Clioquinol': 10, 'Iohexol': 5, 'Iopamidol': 3, 'Iron': 12, 'Iron-Dextran Complex': 3, 'Isatin': 2, 'Isoflavones': 11, 'Isoniazid': 4, 'Isopropyl Thiogalactoside': 1, 'Isoproterenol': 6, 'Ivermectin': 60, 'Ketamine': 2, 'Ketanserin': 3, 'Ketoconazole': 3, 'Ketoglutaric Acids': 2, 'Kynurenic Acid': 1, 'Labetalol': 2, 'Latex': 5, 'Lead': 44, 'Leukotriene B4': 1, 'Levamisole': 3, 'Levodopa': 2, 'Lidocaine': 1, 'Lipids': 2, 'Thioctic Acid': 5, 'Lipopolysaccharides': 53, 'Cholesterol, HDL': 4, 'Cholesterol, LDL': 2, 'Lithium': 7, 'Lithocholic Acid': 7, 'Lobeline': 3, 'Lomustine': 1, 'Loperamide': 5, 'Lovastatin': 14, 'Lucanthone': 14, 'Magnesium': 1, 'Magnesium Oxide': 1, 'Malathion': 9, 'Maleates': 4, 'Maleic Anhydrides': 1, 'Malondialdehyde': 4, 'Maneb': 3, 'Manganese': 15, 'Mannitol': 3, 'Mebendazole': 7, 'Mecamylamine': 2, 'Mechlorethamine': 10, 'Mefenamic Acid': 1, 'Melarsoprol': 2, 'Melatonin': 19, 'Melitten': 10, 'Melphalan': 10, 'Memantine': 3, 'Menthol': 28, 'Mercaptoethanol': 2, 'Mercuric Chloride': 12, 'Mercury': 8, 'Mestranol': 1, 'Metformin': 35, 'Methadone': 2, 'Methamphetamine': 12, 'Methapyrilene': 24, 'Methimazole': 4, 'Methionine': 2, 'Methohexital': 3, 'Methotrexate': 50, 'Methoxsalen': 6, 'Methoxychlor': 9, 'Methyl Methanesulfonate': 51, 'Methyl Parathion': 4, 'Methylcholanthrene': 10, 'Methylene Blue': 1, 'Methylmercury Compounds': 10, 'Methylnitronitrosoguanidine': 15, 'Methylnitrosourea': 5, 'Methylphenidate': 1, 'Methylprednisolone': 1, 'Methyltestosterone': 1, 'Methylthiouracil': 5, 'Mevalonic Acid': 7, 'Mevinphos': 1, 'Mexiletine': 1, 'Miconazole': 1, 'Mimosine': 3, 'Minocycline': 3, 'Plicamycin': 3, 'Mitotane': 3, 'Mitoxantrone': 7, 'Molybdenum': 1, 'Monensin': 1, 'Monocrotophos': 1, 'Morphine': 9, 'Morpholines': 1, 'Mustard Compounds': 1, 'Mustard Gas': 27, 'Mycophenolic Acid': 10, 'N-Formylmethionine Leucyl-Phenylalanine': 6, 'N-Nitrosopyrrolidine': 18, 'NAD': 3, 'NADP': 1, 'Nafcillin': 1, 'Naloxone': 4, 'Naphthalenes': 1, 'Naphthoquinones': 10, 'Naphthyridines': 1, 'Naproxen': 3, 'Neomycin': 2, 'Neurotensin': 3, 'Niacin': 6, 'Nicardipine': 2, 'Nickel': 48, 'Niclosamide': 32, 'Niacinamide': 10, 'Nicotinamide Mononucleotide': 1, 'Nicotine': 46, 'Nicotinic Acids': 2, 'Nifedipine': 6, 'Nimodipine': 1, 'Ninhydrin': 1, 'Nitric Oxide': 4, 'Nitrobenzoates': 1, 'Nitrofurantoin': 1, 'Nitrofurazone': 1, 'Nitrogen': 5, 'Nitrogen Dioxide': 2, 'Nitrogen Mustard Compounds': 2, 'Nitrogen Oxides': 4, 'Nitroprusside': 10, 'Nitrosourea Compounds': 2, 'Nitrous Oxide': 1, 'Nitrovin': 1, 'Masoprocol': 13, 'Norepinephrine': 5, 'Norethindrone': 3, 'Nortriptyline': 1, 'Noscapine': 2, 'Novobiocin': 1, 'Nystatin': 1, 'o-Phthalaldehyde': 1, 'Oils, Volatile': 2, 'Oleanolic Acid': 15, 'Oligomycins': 7, 'Oligonucleotides': 1, 'Oligopeptides': 4, 'Oligoribonucleotides': 1, 'Oligosaccharides': 3, 'Omeprazole': 4, 'Organometallic Compounds': 2, 'Organotin Compounds': 10, 'Orotic Acid': 2, 'Ouabain': 21, 'Ovalbumin': 1, 'Oxalates': 1, 'Oxazolone': 2, 'Oxotremorine': 1, 'Oxprenolol': 2, 'Oxygen': 65, 'Oxymetholone': 1, 'Oxypurinol': 1, 'Ozone': 61, '4-Aminobenzoic Acid': 1, 'Palmitates': 4, 'Pantothenic Acid': 1, 'Paraoxon': 3, 'Paraquat': 29, 'Parathion': 13, 'Paromomycin': 1, 'Patulin': 5, 'Penicillamine': 2, 'Pentachlorophenol': 7, 'Pentamidine': 4, 'Pentobarbital': 3, 'Pentosan Sulfuric Polyester': 1, 'Pentoxifylline': 10, 'Peptides': 1, 'Peptidoglycan': 5, 'Perfume': 2, 'Pergolide': 4, 'Perhexiline': 2, 'Pesticides': 11, 'Phenanthrolines': 2, 'Phenformin': 2, 'Phenindione': 1, 'Phenobarbital': 19, 'Phenols': 2, 'Phenolsulfonphthalein': 1, 'Phentolamine': 2, 'Phenylbutazone': 3, 'Phenylbutyrates': 5, 'Phenylephrine': 5, 'Phenylmercuric Acetate': 28, 'Phenylthiourea': 2, 'Phenytoin': 9, 'Phloretin': 5, 'Phloroglucinol': 3, 'Eosine I Bluish': 2, 'Phorate': 1, 'Phosmet': 1, 'Phosphamidon': 1, 'Phosphates': 6, 'Phosphatidic Acids': 1, 'Phosphatidylcholines': 8, 'Phosphatidylinositols': 2, 'Phosphatidylserines': 2, 'Organophosphates': 2, 'Phosphorus': 4, 'Leptophos': 1, 'Phycocyanin': 1, 'Phytic Acid': 6, 'Vitamin K 1': 4, 'Pilocarpine': 1, 'Pindolol': 2, 'Piroxicam': 20, 'Plant Extracts': 56, 'Plant Oils': 13, 'Plasticizers': 2, 'Platelet Activating Factor': 1, 'Platinum': 4, 'Poly I-C': 6, 'Polyamines': 1, 'Polychlorinated Biphenyls': 21, 'Polycyclic Aromatic Hydrocarbons': 27, 'Polydeoxyribonucleotides': 1, 'Polyethylene Glycols': 2, 'Polyethyleneimine': 6, 'Polymyxin B': 5, 'Polyphosphates': 4, 'Polyribonucleotides': 6, 'Polysaccharides': 7, 'Polystyrenes': 8, 'Potassium Dichromate': 28, 'Povidone': 4, 'Practolol': 2, 'Prednisolone': 2, 'Prednisone': 5, 'Proadifen': 1, 'Probenecid': 3, 'Probucol': 1, 'Procainamide': 1, 'Procaine': 3, 'Fenofibrate': 11, 'Prodigiosin': 5, 'Proflavine': 1, 'Progestins': 3, 'Progesterone': 33, 'Promegestone': 7, 'Promethazine': 1, 'Propanil': 1, 'Propolis': 4, 'Propranolol': 4, 'Propyl Gallate': 1, 'Propylthiouracil': 1, 'Prostaglandins E': 1, 'Epoprostenol': 2, 'Protein Synthesis Inhibitors': 1, 'Proteoglycans': 1, 'Pyocyanine': 4, 'Pyrazoles': 2, 'Pyrethrins': 2, 'Pyridazines': 2, 'Pyrilamine': 2, 'Pyrimethamine': 3, 'Pyrimidines': 4, 'Pyrogallol': 1, 'Pyrones': 1, 'Pyrroles': 1, 'Pyruvaldehyde': 6, 'Quartz': 7, 'Quercetin': 75, 'Quinacrine': 7, 'Quinazolines': 6, 'Quinic Acid': 1, 'Quinidine': 1, 'Quinine': 1, 'Quinolines': 2, 'Radon': 4, 'Ranitidine': 2, 'Razoxane': 3, 'Batroxobin': 1, 'Reserpine': 2, 'Retinoids': 11, 'Ribavirin': 11, 'Riboflavin': 4, 'Ribonucleotides': 18, 'Rifampin': 7, '4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone': 1, 'Rotenone': 50, 'Ruthenium': 5, 'Ruthenium Red': 3, 'Rutin': 6, 'S-Adenosylmethionine': 4, 'Sulfasalazine': 3, 'Saponins': 8, 'Sarin': 3, 'Secobarbital': 3, 'Selegiline': 7, 'Selenium': 31, 'Selenomethionine': 8, 'Serine': 1, 'Serotonin': 5, 'Sesquiterpenes': 2, 'Carbaryl': 2, 'Shikimic Acid': 3, 'Silicon Dioxide': 75, 'Silicon': 1, 'Silver': 27, 'Silver Nitrate': 20, 'Silymarin': 11, 'Simazine': 3, 'Skatole': 1, 'Smoke': 67, 'Sodium': 1, 'Sodium Chloride': 8, 'Sodium Dodecyl Sulfate': 14, 'Sodium Fluoride': 13, 'Gold Sodium Thiosulfate': 1, 'Sodium Hydroxide': 1, 'Sodium Nitrite': 1, 'Sodium Salicylate': 4, 'Soil Pollutants': 3, 'Sorbitol': 7, 'Spermine': 1, 'Spiro Compounds': 2, 'Spironolactone': 2, 'Dihydrotestosterone': 20, 'Staphylococcal Protein A': 1, 'Sterigmatocystin': 6, 'Stilbenes': 8, 'Streptozocin': 7, 'Sucrose': 3, 'Sulfadiazine': 2, 'Sulfamethoxazole': 1, 'Sulfates': 7, 'Sulfonamides': 2, 'Sulfonylurea Compounds': 1, 'Sulfur Dioxide': 1, 'Sulindac': 25, 'Superoxides': 4, 'Suramin': 5, 'T-2 Toxin': 12, 'Tacrine': 1, 'Talc': 1, 'Tamoxifen': 45, 'Tartrazine': 4, 'Taurine': 5, 'Taurocholic Acid': 8, 'Taurodeoxycholic Acid': 1, 'Taurolithocholic Acid': 2, 'Tea': 1, 'Teniposide': 2, 'Terbutaline': 3, 'Testosterone': 39, 'Tetracaine': 5, 'Tetrachlorodibenzodioxin': 69, 'Tetrachloroethylene': 4, 'Tetrachlorvinphos': 1, 'Tetracycline': 2, 'Tetradecanoylphorbol Acetate': 36, 'Dronabinol': 31, 'Tetrodotoxin': 2, 'Thalidomide': 20, 'Theophylline': 14, 'Thiamylal': 3, 'Thimerosal': 28, 'Thioacetamide': 4, 'Thiocarbamates': 1, 'Thioguanine': 1, 'Thioinosine': 1, 'Thiopental': 1, 'Thiophenes': 6, 'Thioridazine': 7, 'Thiosemicarbazones': 9, 'Thiostrepton': 6, 'Thiourea': 2, 'Thiram': 3, 'Threonine': 1, 'Thymidine': 1, 'Thyroxine': 6, 'Timolol': 2, 'Tin Fluorides': 1, '1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt': 10, 'Titanium': 2, 'Tobacco Smoke Pollution': 102, 'Toluene': 4, 'Toluene 2,4-Diisocyanate': 5, 'Tosyllysine Chloromethyl Ketone': 2, 'Tosylphenylalanyl Chloromethyl Ketone': 8, 'Toxaphene': 2, 'Tretinoin': 98, 'Triamcinolone Acetonide': 1, 'Triamterene': 1, 'Triazoles': 2, 'Trichlorfon': 1, 'Trichloroacetic Acid': 1, 'Trichloroethylene': 8, 'Triclosan': 21, 'Trientine': 1, 'Trifluoperazine': 6, 'Trifluridine': 1, 'Triglycerides': 2, 'Triiodothyronine': 11, 'Trimethoprim': 1, 'Trinitrotoluene': 1, 'Triterpenes': 4, 'Tritolyl Phosphates': 1, 'Tubocurarine': 5, 'Tunicamycin': 36, 'Ubiquinone': 1, 'Uracil': 1, 'Uranium': 4, 'Urea': 2, 'Urethane': 46, 'Uric Acid': 3, 'Uridine': 2, 'Uridine Diphosphate': 3, 'Uridine Triphosphate': 4, 'Ursodeoxycholic Acid': 12, 'Valproic Acid': 129, 'h2ab1': 1, 'Vanadates': 14, 'Vanadium': 8, 'Vanillic Acid': 2, 'Vecuronium Bromide': 2, 'Verapamil': 6, 'Vinblastine': 14, 'Vincristine': 32, 'Vinyl Chloride': 3, 'Viper Venoms': 4, 'Vitallium': 18, 'Vitamin A': 3, 'Vitamin B 12': 2, 'Vitamin D': 5, 'Vitamin E': 35, 'Vitamin U': 2, 'Warfarin': 4, 'Water Pollutants': 4, 'Water Pollutants, Chemical': 2, 'Lutein': 2, 'Xylenes': 1, 'Zearalenone': 11, 'Zeranol': 4, 'Zinc': 42, 'Zinc Oxide': 7, 'Zineb': 1, 'Ziram': 4, 'Zymosan': 1, '1-Methyl-3-isobutylxanthine': 42, '1-Naphthylisothiocyanate': 3, '1,2-Dipalmitoylphosphatidylcholine': 1, '2-Acetylaminofluorene': 5, '2-Naphthylamine': 2, \"2,2'-Dipyridyl\": 2, '2,4-Dichlorophenoxyacetic Acid': 1, '2,6-Dichloroindophenol': 3, \"3,3'-Dichlorobenzidine\": 1, '4-Nitroquinoline-1-oxide': 3, 'Eicosapentaenoic Acid': 4, 'Mercaptopurine': 4, '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide': 61, '8-Bromo Cyclic Adenosine Monophosphate': 20, 'Oxyquinoline': 5, '9,10-Dimethyl-1,2-benzanthracene': 6, 'Zidovudine': 21, 'Dinoprostone': 9, 'Dinoprost': 1, 'Phorbol 12,13-Dibutyrate': 3, 'Thiorphan': 5, 'Gemfibrozil': 2, 'Epirubicin': 5, 'Octreotide': 1, 'Citalopram': 1, 'Quinolones': 2, 'Nimustine': 8, 'Hazardous Substances': 1, 'Isotretinoin': 12, 'Fatty Acids, Omega-3': 2, 'Josamycin': 3, 'Roxithromycin': 2, '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine': 4, 'Magnesium Chloride': 1, 'Cytochalasin D': 4, '24,25-Dihydroxyvitamin D 3': 1, '1-Methyl-4-phenylpyridinium': 53, 'Mifepristone': 23, 'Famotidine': 3, 'Nocodazole': 11, 'Metribolone': 13, 'Propofol': 11, 'Ionomycin': 9, 'Albendazole': 1, 'Ganciclovir': 2, 'Eicosanoids': 1, 'Cysteine Proteinase Inhibitors': 3, 'Carboplatin': 7, 'N-Methylaspartate': 4, 'Dextran Sulfate': 1, 'Iloprost': 3, 'Dizocilpine Maleate': 3, 'Tacrolimus': 1, 'Organoselenium Compounds': 4, 'Cyclosporine': 92, 'Crack Cocaine': 3, 'Aphidicolin': 3, 'Terfenadine': 5, 'Aflatoxin B1': 95, 'Aflatoxin M1': 11, 'Oxidopamine': 8, 'Bupropion': 3, 'Fluorescein-5-isothiocyanate': 5, 'Mitomycin': 25, 'Monocrotaline': 11, 'Arachidonic Acid': 9, 'Leuprolide': 1, 'Levonorgestrel': 4, 'Pravastatin': 6, 'Paclitaxel': 42, 'Foscarnet': 1, 'Acitretin': 4, 'Ramipril': 1, 'Medroxyprogesterone Acetate': 15, 'Dimaprit': 3, 'Procaterol': 1, 'Goserelin': 1, 'Selenocysteine': 2, 'Clarithromycin': 2, 'Doxazosin': 3, 'Bisoprolol': 1, 'Xamoterol': 2, 'Amlodipine': 8, 'Fenretinide': 23, 'Photosensitizing Agents': 1, 'Cladribine': 4, '8-Hydroxy-2-(di-n-propylamino)tetralin': 1, 'Paroxetine': 1, 'Reactive Oxygen Species': 25, 'Bisphenol A-Glycidyl Methacrylate': 2, 'Adenovirus E1A Proteins': 1, 'Gold Compounds': 9, 'Asbestos, Serpentine': 16, 'Asbestos, Amphibole': 12, 'Asbestos, Crocidolite': 59, 'Asbestos, Amosite': 3, 'Silicon Compounds': 3, 'Hydroxyl Radical': 1, 'Platinum Compounds': 1, 'Lisinopril': 1, \"4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid\": 3, 'Isothiocyanates': 2, 'Durapatite': 1, 'Isocyanates': 4, 'Azithromycin': 1, 'gamma-Linolenic Acid': 7, 'Zinc Compounds': 3, 'Vanadium Compounds': 1, 'Tungsten Compounds': 2, 'Uranium Compounds': 2, 'Ruthenium Compounds': 2, 'Leukotriene D4': 2, 'Lithium Chloride': 17, 'Silver Compounds': 18, 'Sodium Selenite': 41, 'Superantigens': 1, 'Stavudine': 2, 'Antirheumatic Agents': 39, 'Excitatory Amino Acid Agonists': 2, 'Excitatory Amino Acid Antagonists': 2, 'Hexamethonium': 4, 'N-Methyl-3,4-methylenedioxyamphetamine': 1, 'Antineoplastic Agents, Alkylating': 1, 'beta Carotene': 5, 'Metals, Heavy': 2, 'Cadmium Chloride': 87, 'Quinpirole': 2, 'Saquinavir': 1, 'Lamivudine': 7, 'Phosphatidylinositol 4,5-Diphosphate': 1, 'Thapsigargin': 30, 'Zinc Sulfate': 22, 'Pyruvic Acid': 1, 'Oleic Acid': 9, '1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine': 4, 'Palmitic Acid': 19, 'Staurosporine': 11, 'Okadaic Acid': 23, 'beta-Naphthoflavone': 13, 'Copper Sulfate': 90, 'Buthionine Sulfoximine': 10, 'Acetic Acid': 1, 'Citric Acid': 3, 'Lactic Acid': 34, 'Zinc Acetate': 14, '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid': 4, 'Ritonavir': 20, 'Indinavir': 1, 'Glycyrrhizic Acid': 6, 'Topotecan': 15, 'Riluzole': 1, 'Gadolinium DTPA': 2, 'Linoleic Acid': 2, '15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid': 3, 'Phenol': 6, 'Succinic Acid': 4, 'Glutathione Disulfide': 2, 'Losartan': 7, 'Sodium Azide': 4, 'Oxalic Acid': 1, 'Benzoic Acid': 6, 'Budesonide': 2, 'Xanthine': 1, 'Simvastatin': 29, 'Nevirapine': 1, 'Genistein': 58, '2-Propanol': 4, 'Nelfinavir': 3, 'Polymethyl Methacrylate': 2, 'Propylene Glycol': 1, '1-Butanol': 14, 'Nitric Oxide Donors': 1, 'Styrene': 4, 'Milrinone': 1, 'Acrylamide': 35, 'Chlorodiphenyl (54% Chlorine)': 6, 'tert-Butylhydroperoxide': 50, 'Sirolimus': 35, 'Brefeldin A': 1, 'Butyric Acid': 19, '3-Hydroxybutyric Acid': 2, 'Salicylic Acid': 1, 'Sodium Benzoate': 1, 'p-Chloromercuribenzoic Acid': 12, 'Sertraline': 9, 'Oligoribonucleotides, Antisense': 2, 'Methylmethacrylate': 1, 'Enzyme Activators': 1, 'Selective Estrogen Receptor Modulators': 2, 'Raloxifene Hydrochloride': 34, 'Rolipram': 1, 'Ketorolac': 1, 'Perindopril': 1, 'Polyethylene': 2, 'Shiga Toxin': 4, 'Shiga Toxin 2': 2, 'Diphtheria-Tetanus-acellular Pertussis Vaccines': 1, 'Vitamin K 2': 5, 'Vitamin K 3': 47, 'alpha-Tocopherol': 11, 'gamma-Tocopherol': 5, 'Tocopherols': 7, 'Permethrin': 4, 'Singlet Oxygen': 1, 'S-Nitrosoglutathione': 4, 'S-Nitroso-N-Acetylpenicillamine': 1, 'Plant Preparations': 5, 'F2-Isoprostanes': 1, 'Peroxynitrous Acid': 2, 'Aristolochic Acids': 8, 'Ginsenosides': 1, 'Diarylheptanoids': 1, 'Pertussis Toxin': 7, 'Fullerenes': 8, 'Nanotubes, Carbon': 29, 'Antigens, Dermatophagoides': 1, 'Fatty Acids, Omega-6': 1, 'Tetrahydroisoquinolines': 3, 'Linoleic Acids, Conjugated': 2, 'Proanthocyanidins': 1, 'Flavonols': 2, 'Flavanones': 13, 'PQQ Cofactor': 2, 'Diterpenes, Clerodane': 1, 'Chalcones': 2, 'Apigenin': 13, 'Luteolin': 19, 'Hydrolyzable Tannins': 7, 'Protein Kinase Inhibitors': 11, 'Depsipeptides': 2, 'Chitosan': 6, 'Phytoestrogens': 5, 'Betalains': 5, 'Aptamers, Nucleotide': 1, 'Antigens, Plant': 1, 'Ferrosoferric Oxide': 8, 'Particulate Matter': 67, 'Benzophenanthridines': 7, 'Oseltamivir': 1, 'Soot': 14, 'Interleukin 1 Receptor Antagonist Protein': 1, 'Oncostatin M': 1, 'Diketopiperazines': 4, 'Volatile Organic Compounds': 28, 'Halogenated Diphenyl Ethers': 9, 'Histone Deacetylase Inhibitors': 2, 'Coordination Complexes': 2, 'Iron Compounds': 5, 'Magnetite Nanoparticles': 9, 'Vaccines, Virus-Like Particle': 2, 'Polyphenols': 14, 'Coal Ash': 5, 'Equol': 6, 'Lopinavir': 2, 'Matrix Metalloproteinase Inhibitors': 2, 'Fungal Polysaccharides': 7, 'Oxaloacetic Acid': 1, 'Organothiophosphates': 2, 'Phytochemicals': 7, 'Selenic Acid': 4, 'Selenium Oxides': 1, 'Levofloxacin': 1, 'Neurokinin-1 Receptor Antagonists': 1, 'Frankincense': 3})"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Hist_degree "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d89b2f58",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "fbf415ee",
   "metadata": {},
   "source": [
    "Ordenar los grados"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "e8086e6b",
   "metadata": {},
   "outputs": [],
   "source": [
    "Orden_degree = sorted(grados_dict.items(), key=lambda x: x[1], reverse=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "3c53eb50",
   "metadata": {},
   "outputs": [],
   "source": [
    "xOrden_degree = list(map(str, Orden_degree))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "00370b56",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\"('tp53', 514)\",\n",
       " \"('il6', 491)\",\n",
       " \"('mapk1', 474)\",\n",
       " \"('mapk3', 469)\",\n",
       " \"('cdkn1a', 345)\",\n",
       " \"('rela', 319)\",\n",
       " \"('akt1', 297)\",\n",
       " \"('ccnd1', 271)\",\n",
       " \"('jun', 253)\",\n",
       " \"('fos', 237)\",\n",
       " \"('tgfb1', 231)\",\n",
       " \"('myc', 229)\",\n",
       " \"('nfkb1', 210)\",\n",
       " \"('h2ax', 200)\",\n",
       " \"('mapk8', 193)\",\n",
       " \"('stat3', 175)\",\n",
       " \"('serpine1', 165)\",\n",
       " \"('ccnb1', 163)\",\n",
       " \"('cdkn1b', 161)\",\n",
       " \"('rb1', 159)\",\n",
       " \"('cdk1', 152)\",\n",
       " \"('mtor', 145)\",\n",
       " \"('ccna2', 144)\",\n",
       " \"('cdk2', 137)\",\n",
       " \"('Benzo(a)pyrene', 130)\",\n",
       " \"('Valproic Acid', 129)\",\n",
       " \"('mapk14', 128)\",\n",
       " \"('mapk9', 124)\",\n",
       " \"('sirt1', 122)\",\n",
       " \"('mdm2', 118)\",\n",
       " \"('ccne1', 117)\",\n",
       " \"('atm', 116)\",\n",
       " \"('cebpb', 112)\",\n",
       " \"('cdk4', 110)\",\n",
       " \"('pten', 109)\",\n",
       " \"('sp1', 106)\",\n",
       " \"('Cisplatin', 104)\",\n",
       " \"('Estradiol', 104)\",\n",
       " \"('Acetaminophen', 102)\",\n",
       " \"('Tobacco Smoke Pollution', 102)\",\n",
       " \"('Doxorubicin', 100)\",\n",
       " \"('Tretinoin', 98)\",\n",
       " \"('txn', 97)\",\n",
       " \"('cdkn2a', 96)\",\n",
       " \"('Aflatoxin B1', 95)\",\n",
       " \"('map2k1', 94)\",\n",
       " \"('chek1', 92)\",\n",
       " \"('Cyclosporine', 92)\",\n",
       " \"('Copper Sulfate', 90)\",\n",
       " \"('e2f1', 89)\",\n",
       " \"('eif4ebp1', 88)\",\n",
       " \"('Arsenic Trioxide', 88)\",\n",
       " \"('Cadmium Chloride', 87)\",\n",
       " \"('chek2', 86)\",\n",
       " \"('cdk6', 82)\",\n",
       " \"('Copper', 78)\",\n",
       " \"('foxo3', 77)\",\n",
       " \"('Hydrogen Peroxide', 77)\",\n",
       " \"('foxo1', 76)\",\n",
       " \"('ccne2', 76)\",\n",
       " \"('Quercetin', 75)\",\n",
       " \"('Silicon Dioxide', 75)\",\n",
       " \"('map2k6', 74)\",\n",
       " \"('Resveratrol', 74)\",\n",
       " \"('raf1', 73)\",\n",
       " \"('Sunitinib', 72)\",\n",
       " \"('Cadmium', 72)\",\n",
       " \"('Tetrachlorodibenzodioxin', 69)\",\n",
       " \"('Arsenic', 68)\",\n",
       " \"('ube2c', 67)\",\n",
       " \"('Smoke', 67)\",\n",
       " \"('Particulate Matter', 67)\",\n",
       " \"('Cannabidiol', 66)\",\n",
       " \"('Oxygen', 65)\",\n",
       " \"('cdc25a', 64)\",\n",
       " \"('Dexamethasone', 64)\",\n",
       " \"('smad2', 63)\",\n",
       " \"('Caffeine', 63)\",\n",
       " \"('ets1', 61)\",\n",
       " \"('Ozone', 61)\",\n",
       " \"('7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide', 61)\",\n",
       " \"('ezh2', 60)\",\n",
       " \"('h1-2', 60)\",\n",
       " \"('Ivermectin', 60)\",\n",
       " \"('e2f2', 59)\",\n",
       " \"('Air Pollutants', 59)\",\n",
       " \"('Asbestos, Crocidolite', 59)\",\n",
       " \"('pik3ca', 58)\",\n",
       " \"('hmga2', 58)\",\n",
       " \"('Formaldehyde', 58)\",\n",
       " \"('Genistein', 58)\",\n",
       " \"('ccna1', 56)\",\n",
       " \"('Plant Extracts', 56)\",\n",
       " \"('Fulvestrant', 55)\",\n",
       " \"('Vorinostat', 54)\",\n",
       " \"('h2bc5', 53)\",\n",
       " \"('hmga1', 53)\",\n",
       " \"('Chelating Agents', 53)\",\n",
       " \"('Lipopolysaccharides', 53)\",\n",
       " \"('1-Methyl-4-phenylpyridinium', 53)\",\n",
       " \"('vdac1', 52)\",\n",
       " \"('h2ac6', 52)\",\n",
       " \"('tgfb3', 52)\",\n",
       " \"('tfdp1', 51)\",\n",
       " \"('Indomethacin', 51)\",\n",
       " \"('Methyl Methanesulfonate', 51)\",\n",
       " \"('Acetylcysteine', 50)\",\n",
       " \"('Methotrexate', 50)\",\n",
       " \"('Rotenone', 50)\",\n",
       " \"('tert-Butylhydroperoxide', 50)\",\n",
       " \"('ets2', 49)\",\n",
       " \"('capn2', 49)\",\n",
       " \"('Calcitriol', 49)\",\n",
       " \"('Curcumin', 49)\",\n",
       " \"('Fluorouracil', 49)\",\n",
       " \"('Carbamazepine', 48)\",\n",
       " \"('Nickel', 48)\",\n",
       " \"('map2k4', 47)\",\n",
       " \"('Atrazine', 47)\",\n",
       " \"('Vitamin K 3', 47)\",\n",
       " \"('mapkapk2', 46)\",\n",
       " \"('h2bc21', 46)\",\n",
       " \"('Folic Acid', 46)\",\n",
       " \"('Nicotine', 46)\",\n",
       " \"('Urethane', 46)\",\n",
       " \"('capn1', 45)\",\n",
       " \"('Tamoxifen', 45)\",\n",
       " \"('Decitabine', 44)\",\n",
       " \"('hla-g', 44)\",\n",
       " \"('Lead', 44)\",\n",
       " \"('Troglitazone', 43)\",\n",
       " \"('tsc2', 42)\",\n",
       " \"('h2bc12', 42)\",\n",
       " \"('Acrolein', 42)\",\n",
       " \"('Coumestrol', 42)\",\n",
       " \"('Zinc', 42)\",\n",
       " \"('1-Methyl-3-isobutylxanthine', 42)\",\n",
       " \"('Paclitaxel', 42)\",\n",
       " \"('mapk11', 41)\",\n",
       " \"('Temozolomide', 41)\",\n",
       " \"('cdkn2d', 41)\",\n",
       " \"('Aspirin', 41)\",\n",
       " \"('Diethylhexyl Phthalate', 41)\",\n",
       " \"('Sodium Selenite', 41)\",\n",
       " \"('zfp36l2', 39)\",\n",
       " \"('ppp1cb', 39)\",\n",
       " \"('Testosterone', 39)\",\n",
       " \"('Antirheumatic Agents', 39)\",\n",
       " \"('mapkapk3', 38)\",\n",
       " \"('cbx4', 38)\",\n",
       " \"('Ethanol', 38)\",\n",
       " \"('Diclofenac', 38)\",\n",
       " \"('Bortezomib', 37)\",\n",
       " \"('h1-5', 36)\",\n",
       " \"('h1-0', 36)\",\n",
       " \"('Zoledronic Acid', 36)\",\n",
       " \"('Leflunomide', 36)\",\n",
       " \"('Drugs, Chinese Herbal', 36)\",\n",
       " \"('Tetradecanoylphorbol Acetate', 36)\",\n",
       " \"('Tunicamycin', 36)\",\n",
       " \"('Metformin', 35)\",\n",
       " \"('Vitamin E', 35)\",\n",
       " \"('Acrylamide', 35)\",\n",
       " \"('Sirolimus', 35)\",\n",
       " \"('vdac2', 34)\",\n",
       " \"('Antimycin A', 34)\",\n",
       " \"('Vehicle Emissions', 34)\",\n",
       " \"('Berberine', 34)\",\n",
       " \"('Lactic Acid', 34)\",\n",
       " \"('Raloxifene Hydrochloride', 34)\",\n",
       " \"('bmi1', 33)\",\n",
       " \"('h3-4', 33)\",\n",
       " \"('Capsaicin', 33)\",\n",
       " \"('Enzyme Inhibitors', 33)\",\n",
       " \"('Progesterone', 33)\",\n",
       " \"('ehmt2', 32)\",\n",
       " \"('rbbp4', 32)\",\n",
       " \"('h2bc9', 32)\",\n",
       " \"('slc25a4', 32)\",\n",
       " \"('Etoposide', 32)\",\n",
       " \"('Niclosamide', 32)\",\n",
       " \"('Vincristine', 32)\",\n",
       " \"('cdc27', 31)\",\n",
       " \"('Wortmannin', 31)\",\n",
       " \"('ep400', 31)\",\n",
       " \"('tfdp2', 31)\",\n",
       " \"('Selenium', 31)\",\n",
       " \"('Dronabinol', 31)\",\n",
       " \"('cbx6', 30)\",\n",
       " \"('h1-3', 30)\",\n",
       " \"('ubc', 30)\",\n",
       " \"('Thapsigargin', 30)\",\n",
       " \"('kdm6b', 29)\",\n",
       " \"('h2ac18', 29)\",\n",
       " \"('tnrc6b', 29)\",\n",
       " \"('slc25a5', 29)\",\n",
       " \"('Azacitidine', 29)\",\n",
       " \"('Azathioprine', 29)\",\n",
       " \"('Benzene', 29)\",\n",
       " \"('Glucose', 29)\",\n",
       " \"('Paraquat', 29)\",\n",
       " \"('Simvastatin', 29)\",\n",
       " \"('Nanotubes, Carbon', 29)\",\n",
       " \"('Dasatinib', 28)\",\n",
       " \"('anapc1', 28)\",\n",
       " \"('dnajc7', 28)\",\n",
       " \"('gata4', 28)\",\n",
       " \"('Menthol', 28)\",\n",
       " \"('Phenylmercuric Acetate', 28)\",\n",
       " \"('Potassium Dichromate', 28)\",\n",
       " \"('Thimerosal', 28)\",\n",
       " \"('Volatile Organic Compounds', 28)\",\n",
       " \"('akt3', 27)\",\n",
       " \"('h2aj', 27)\",\n",
       " \"('phc2', 27)\",\n",
       " \"('h2ac20', 27)\",\n",
       " \"('h2bc4', 27)\",\n",
       " \"('Catechin', 27)\",\n",
       " \"('Mustard Gas', 27)\",\n",
       " \"('Polycyclic Aromatic Hydrocarbons', 27)\",\n",
       " \"('Silver', 27)\",\n",
       " \"('h1-4', 26)\",\n",
       " \"('Rosiglitazone', 26)\",\n",
       " \"('Sorafenib', 26)\",\n",
       " \"('rps27a', 26)\",\n",
       " \"('Ascorbic Acid', 26)\",\n",
       " \"('h2bc3', 25)\",\n",
       " \"('h2az2', 25)\",\n",
       " \"('Panobinostat', 25)\",\n",
       " \"('Camptothecin', 25)\",\n",
       " \"('Ethyl Methanesulfonate', 25)\",\n",
       " \"('Sulindac', 25)\",\n",
       " \"('Mitomycin', 25)\",\n",
       " \"('Reactive Oxygen Species', 25)\",\n",
       " \"('Irinotecan', 24)\",\n",
       " \"('kat5', 24)\",\n",
       " \"('vdac3', 24)\",\n",
       " \"('ubb', 24)\",\n",
       " \"('ehmt1', 24)\",\n",
       " \"('Demecolcine', 24)\",\n",
       " \"('Endosulfan', 24)\",\n",
       " \"('Methapyrilene', 24)\",\n",
       " \"('phc3', 23)\",\n",
       " \"('rbbp7', 23)\",\n",
       " \"('Deferoxamine', 23)\",\n",
       " \"('Mifepristone', 23)\",\n",
       " \"('Fenretinide', 23)\",\n",
       " \"('Okadaic Acid', 23)\",\n",
       " \"('h2bc14', 22)\",\n",
       " \"('pik3cb', 22)\",\n",
       " \"('cbx2', 22)\",\n",
       " \"('mov10', 22)\",\n",
       " \"('h2bc11', 22)\",\n",
       " \"('tnrc6a', 22)\",\n",
       " \"('mcu', 22)\",\n",
       " \"('uba52', 22)\",\n",
       " \"('Butyrates', 22)\",\n",
       " \"('Zinc Sulfate', 22)\",\n",
       " \"('h2bc17', 21)\",\n",
       " \"('map2k7', 21)\",\n",
       " \"('suz12', 21)\",\n",
       " \"('Gemcitabine', 21)\",\n",
       " \"('fzr1', 21)\",\n",
       " \"('Cycloheximide', 21)\",\n",
       " \"('Gallic Acid', 21)\",\n",
       " \"('Glutathione', 21)\",\n",
       " \"('Ouabain', 21)\",\n",
       " \"('Polychlorinated Biphenyls', 21)\",\n",
       " \"('Triclosan', 21)\",\n",
       " \"('Zidovudine', 21)\",\n",
       " \"('Celecoxib', 20)\",\n",
       " \"('anapc11', 20)\",\n",
       " \"('Oxaliplatin', 20)\",\n",
       " \"('eed', 20)\",\n",
       " \"('cdc16', 20)\",\n",
       " \"('slc25a6', 20)\",\n",
       " \"('ube2d1', 20)\",\n",
       " \"('Disulfiram', 20)\",\n",
       " \"('Piroxicam', 20)\",\n",
       " \"('Silver Nitrate', 20)\",\n",
       " \"('Dihydrotestosterone', 20)\",\n",
       " \"('Thalidomide', 20)\",\n",
       " \"('8-Bromo Cyclic Adenosine Monophosphate', 20)\",\n",
       " \"('Ritonavir', 20)\",\n",
       " \"('Imatinib Mesylate', 19)\",\n",
       " \"('Erlotinib Hydrochloride', 19)\",\n",
       " \"('phc1', 19)\",\n",
       " \"('trpv4', 19)\",\n",
       " \"('hipk3', 19)\",\n",
       " \"('cacna1d', 19)\",\n",
       " \"('Silybin', 19)\",\n",
       " \"('Diazinon', 19)\",\n",
       " \"('Gold', 19)\",\n",
       " \"('Melatonin', 19)\",\n",
       " \"('Phenobarbital', 19)\",\n",
       " \"('Palmitic Acid', 19)\",\n",
       " \"('Butyric Acid', 19)\",\n",
       " \"('Luteolin', 19)\",\n",
       " \"('rnf2', 18)\",\n",
       " \"('Gefitinib', 18)\",\n",
       " \"('h2bc15', 18)\",\n",
       " \"('rassf5', 18)\",\n",
       " \"('Lycopene', 18)\",\n",
       " \"('Daunorubicin', 18)\",\n",
       " \"('N-Nitrosopyrrolidine', 18)\",\n",
       " \"('Ribonucleotides', 18)\",\n",
       " \"('Vitallium', 18)\",\n",
       " \"('Silver Compounds', 18)\",\n",
       " \"('Docetaxel', 17)\",\n",
       " \"('Pioglitazone', 17)\",\n",
       " \"('Amiodarone', 17)\",\n",
       " \"('Dimethyl Sulfoxide', 17)\",\n",
       " \"('Gasoline', 17)\",\n",
       " \"('Hydroxyurea', 17)\",\n",
       " \"('Lithium Chloride', 17)\",\n",
       " \"('Carmustine', 16)\",\n",
       " \"('Dactinomycin', 16)\",\n",
       " \"('DDT', 16)\",\n",
       " \"('Bucladesine', 16)\",\n",
       " \"('Asbestos, Serpentine', 16)\",\n",
       " \"('rad9a', 15)\",\n",
       " \"('Lapatinib', 15)\",\n",
       " \"('Orlistat', 15)\",\n",
       " \"('Vemurafenib', 15)\",\n",
       " \"('tnrc6c', 15)\",\n",
       " \"('Cacodylic Acid', 15)\",\n",
       " \"('Chloroquine', 15)\",\n",
       " \"('Dinitrochlorobenzene', 15)\",\n",
       " \"('Manganese', 15)\",\n",
       " \"('Methylnitronitrosoguanidine', 15)\",\n",
       " \"('Oleanolic Acid', 15)\",\n",
       " \"('Medroxyprogesterone Acetate', 15)\",\n",
       " \"('Topotecan', 15)\",\n",
       " \"('Atorvastatin', 14)\",\n",
       " \"('ring1', 14)\",\n",
       " \"('h2ac7', 14)\",\n",
       " \"('Acetaldehyde', 14)\",\n",
       " \"('h2bc13', 14)\",\n",
       " \"('Betulinic Acid', 14)\",\n",
       " \"('Aerosols', 14)\",\n",
       " \"('h3c15', 14)\",\n",
       " \"('Dibutyl Phthalate', 14)\",\n",
       " \"('Diethylstilbestrol', 14)\",\n",
       " \"('Digitoxin', 14)\",\n",
       " \"('Chlorpyrifos', 14)\",\n",
       " \"('Emodin', 14)\",\n",
       " \"('Ibuprofen', 14)\",\n",
       " \"('Lovastatin', 14)\",\n",
       " \"('Lucanthone', 14)\",\n",
       " \"('Sodium Dodecyl Sulfate', 14)\",\n",
       " \"('Theophylline', 14)\",\n",
       " \"('Vanadates', 14)\",\n",
       " \"('Vinblastine', 14)\",\n",
       " \"('Zinc Acetate', 14)\",\n",
       " \"('1-Butanol', 14)\",\n",
       " \"('Soot', 14)\",\n",
       " \"('Polyphenols', 14)\",\n",
       " \"('h1-1', 13)\",\n",
       " \"('ventx', 13)\",\n",
       " \"('Homoharringtonine', 13)\",\n",
       " \"('Adenosine Triphosphate', 13)\",\n",
       " \"('h4c1', 13)\",\n",
       " \"('Cholecalciferol', 13)\",\n",
       " \"('Citrinin', 13)\",\n",
       " \"('Cytarabine', 13)\",\n",
       " \"('Deoxycholic Acid', 13)\",\n",
       " \"('Dieldrin', 13)\",\n",
       " \"('Dust', 13)\",\n",
       " \"('Hydralazine', 13)\",\n",
       " \"('Masoprocol', 13)\",\n",
       " \"('Parathion', 13)\",\n",
       " \"('Plant Oils', 13)\",\n",
       " \"('Sodium Fluoride', 13)\",\n",
       " \"('Metribolone', 13)\",\n",
       " \"('beta-Naphthoflavone', 13)\",\n",
       " \"('Flavanones', 13)\",\n",
       " \"('Apigenin', 13)\",\n",
       " \"('h2ac14', 12)\",\n",
       " \"('Air Pollutants, Occupational', 12)\",\n",
       " \"('Asbestos', 12)\",\n",
       " \"('cbx8', 12)\",\n",
       " \"('Busulfan', 12)\",\n",
       " \"('Flame Retardants', 12)\",\n",
       " \"('Hemin', 12)\",\n",
       " \"('Iron', 12)\",\n",
       " \"('Mercuric Chloride', 12)\",\n",
       " \"('Methamphetamine', 12)\",\n",
       " \"('T-2 Toxin', 12)\",\n",
       " \"('Ursodeoxycholic Acid', 12)\",\n",
       " \"('Isotretinoin', 12)\",\n",
       " \"('Asbestos, Amphibole', 12)\",\n",
       " \"('p-Chloromercuribenzoic Acid', 12)\",\n",
       " \"('Cilostazol', 11)\",\n",
       " \"('Bilirubin', 11)\",\n",
       " \"('Dicumarol', 11)\",\n",
       " \"('Cantharidin', 11)\",\n",
       " \"('Chromium', 11)\",\n",
       " \"('Dopamine', 11)\",\n",
       " \"('Ellagic Acid', 11)\",\n",
       " \"('Ethinyl Estradiol', 11)\",\n",
       " \"('Fluoxetine', 11)\",\n",
       " \"('Glucosamine', 11)\",\n",
       " \"('Heparin', 11)\",\n",
       " \"('Homocysteine', 11)\",\n",
       " \"('Isoflavones', 11)\",\n",
       " \"('Pesticides', 11)\",\n",
       " \"('Fenofibrate', 11)\",\n",
       " \"('Retinoids', 11)\",\n",
       " \"('Ribavirin', 11)\",\n",
       " \"('Silymarin', 11)\",\n",
       " \"('Triiodothyronine', 11)\",\n",
       " \"('Zearalenone', 11)\",\n",
       " \"('Nocodazole', 11)\",\n",
       " \"('Propofol', 11)\",\n",
       " \"('Aflatoxin M1', 11)\",\n",
       " \"('Monocrotaline', 11)\",\n",
       " \"('Staurosporine', 11)\",\n",
       " \"('alpha-Tocopherol', 11)\",\n",
       " \"('Protein Kinase Inhibitors', 11)\",\n",
       " \"('2-Methoxyestradiol', 10)\",\n",
       " \"('Calcium', 10)\",\n",
       " \"('Chenodeoxycholic Acid', 10)\",\n",
       " \"('Ciprofloxacin', 10)\",\n",
       " \"('Colchicine', 10)\",\n",
       " \"('Dichlorodiphenyl Dichloroethylene', 10)\",\n",
       " \"('Diuron', 10)\",\n",
       " \"('Histamine', 10)\",\n",
       " \"('Hyaluronic Acid', 10)\",\n",
       " \"('Clioquinol', 10)\",\n",
       " \"('Mechlorethamine', 10)\",\n",
       " \"('Melitten', 10)\",\n",
       " \"('Melphalan', 10)\",\n",
       " \"('Methylcholanthrene', 10)\",\n",
       " \"('Methylmercury Compounds', 10)\",\n",
       " \"('Mycophenolic Acid', 10)\",\n",
       " \"('Naphthoquinones', 10)\",\n",
       " \"('Niacinamide', 10)\",\n",
       " \"('Nitroprusside', 10)\",\n",
       " \"('Organotin Compounds', 10)\",\n",
       " \"('Pentoxifylline', 10)\",\n",
       " \"('1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt', 10)\",\n",
       " \"('Buthionine Sulfoximine', 10)\",\n",
       " \"('Alitretinoin', 9)\",\n",
       " \"('Clofarabine', 9)\",\n",
       " \"('Acrylonitrile', 9)\",\n",
       " \"('Allergens', 9)\",\n",
       " \"('Antimony Potassium Tartrate', 9)\",\n",
       " \"('Arecoline', 9)\",\n",
       " \"('Arsenicals', 9)\",\n",
       " \"('Deoxyglucose', 9)\",\n",
       " \"('Diatrizoate', 9)\",\n",
       " \"('Dihydroxyacetone', 9)\",\n",
       " \"('Docosahexaenoic Acids', 9)\",\n",
       " \"('Ethacrynic Acid', 9)\",\n",
       " \"('Flurbiprofen', 9)\",\n",
       " \"('Glycochenodeoxycholic Acid', 9)\",\n",
       " \"('Heptachlor', 9)\",\n",
       " \"('Malathion', 9)\",\n",
       " \"('Methoxychlor', 9)\",\n",
       " \"('Morphine', 9)\",\n",
       " \"('Phenytoin', 9)\",\n",
       " \"('Thiosemicarbazones', 9)\",\n",
       " \"('Dinoprostone', 9)\",\n",
       " \"('Ionomycin', 9)\",\n",
       " \"('Arachidonic Acid', 9)\",\n",
       " \"('Gold Compounds', 9)\",\n",
       " \"('Oleic Acid', 9)\",\n",
       " \"('Sertraline', 9)\",\n",
       " \"('Halogenated Diphenyl Ethers', 9)\",\n",
       " \"('Magnetite Nanoparticles', 9)\",\n",
       " \"('Everolimus', 8)\",\n",
       " \"('Rimonabant', 8)\",\n",
       " \"('Roscovitine', 8)\",\n",
       " \"('Norethindrone Acetate', 8)\",\n",
       " \"('Acids', 8)\",\n",
       " \"('Amodiaquine', 8)\",\n",
       " \"('Anisomycin', 8)\",\n",
       " \"('Anthocyanins', 8)\",\n",
       " \"('Hexachlorocyclohexane', 8)\",\n",
       " \"('Butylated Hydroxyanisole', 8)\",\n",
       " \"('Clofibrate', 8)\",\n",
       " \"('Clotrimazole', 8)\",\n",
       " \"('Clozapine', 8)\",\n",
       " \"('Cobalt', 8)\",\n",
       " \"('Cocaine', 8)\",\n",
       " \"('Dinitrofluorobenzene', 8)\",\n",
       " \"('Estrogens', 8)\",\n",
       " \"('Eugenol', 8)\",\n",
       " \"('Colforsin', 8)\",\n",
       " \"('Harmine', 8)\",\n",
       " \"('Hesperidin', 8)\",\n",
       " \"('Hexachlorobenzene', 8)\",\n",
       " \"('Hydrocortisone', 8)\",\n",
       " \"('Ifosfamide', 8)\",\n",
       " \"('Mercury', 8)\",\n",
       " \"('Phosphatidylcholines', 8)\",\n",
       " \"('Polystyrenes', 8)\",\n",
       " \"('Saponins', 8)\",\n",
       " \"('Selenomethionine', 8)\",\n",
       " \"('Sodium Chloride', 8)\",\n",
       " \"('Stilbenes', 8)\",\n",
       " \"('Taurocholic Acid', 8)\",\n",
       " \"('Tosylphenylalanyl Chloromethyl Ketone', 8)\",\n",
       " \"('Trichloroethylene', 8)\",\n",
       " \"('Vanadium', 8)\",\n",
       " \"('Nimustine', 8)\",\n",
       " \"('Oxidopamine', 8)\",\n",
       " \"('Amlodipine', 8)\",\n",
       " \"('Aristolochic Acids', 8)\",\n",
       " \"('Fullerenes', 8)\",\n",
       " \"('Ferrosoferric Oxide', 8)\",\n",
       " \"('Calcimycin', 7)\",\n",
       " \"('Sevoflurane', 7)\",\n",
       " \"('Cidofovir', 7)\",\n",
       " \"('Cyclic AMP', 7)\",\n",
       " \"('Albuterol', 7)\",\n",
       " \"('Amiloride', 7)\",\n",
       " \"('Amsacrine', 7)\",\n",
       " \"('Arbutin', 7)\",\n",
       " \"('Arsenates', 7)\",\n",
       " \"('Aspartame', 7)\",\n",
       " \"('Bile Acids and Salts', 7)\",\n",
       " \"('Chlorpromazine', 7)\",\n",
       " \"('Cyclophosphamide', 7)\",\n",
       " \"('Cytochalasin B', 7)\",\n",
       " \"('Diosgenin', 7)\",\n",
       " \"('Dithiothreitol', 7)\",\n",
       " \"('Fish Oils', 7)\",\n",
       " \"('Glycocholic Acid', 7)\",\n",
       " \"('Glycodeoxycholic Acid', 7)\",\n",
       " \"('Hydrocarbons, Chlorinated', 7)\",\n",
       " \"('Lithium', 7)\",\n",
       " \"('Lithocholic Acid', 7)\",\n",
       " \"('Mebendazole', 7)\",\n",
       " \"('Mevalonic Acid', 7)\",\n",
       " \"('Mitoxantrone', 7)\",\n",
       " \"('Oligomycins', 7)\",\n",
       " \"('Pentachlorophenol', 7)\",\n",
       " \"('Polysaccharides', 7)\",\n",
       " \"('Promegestone', 7)\",\n",
       " \"('Quartz', 7)\",\n",
       " \"('Quinacrine', 7)\",\n",
       " \"('Rifampin', 7)\",\n",
       " \"('Selegiline', 7)\",\n",
       " \"('Sorbitol', 7)\",\n",
       " \"('Streptozocin', 7)\",\n",
       " \"('Sulfates', 7)\",\n",
       " \"('Thioridazine', 7)\",\n",
       " \"('Zinc Oxide', 7)\",\n",
       " \"('Carboplatin', 7)\",\n",
       " \"('gamma-Linolenic Acid', 7)\",\n",
       " \"('Lamivudine', 7)\",\n",
       " \"('Losartan', 7)\",\n",
       " \"('Tocopherols', 7)\",\n",
       " \"('Pertussis Toxin', 7)\",\n",
       " \"('Hydrolyzable Tannins', 7)\",\n",
       " \"('Benzophenanthridines', 7)\",\n",
       " \"('Fungal Polysaccharides', 7)\",\n",
       " \"('Phytochemicals', 7)\",\n",
       " \"('Aripiprazole', 6)\",\n",
       " \"('Fingolimod Hydrochloride', 6)\",\n",
       " \"('Letrozole', 6)\",\n",
       " \"('Artesunate', 6)\",\n",
       " \"('Bexarotene', 6)\",\n",
       " \"('5-Methoxypsoralen', 6)\",\n",
       " \"('Aluminum Oxide', 6)\",\n",
       " \"('Amphotericin B', 6)\",\n",
       " \"('h2bc1', 6)\",\n",
       " \"('Atropine', 6)\",\n",
       " \"('Auranofin', 6)\",\n",
       " \"('Bee Venoms', 6)\",\n",
       " \"('Benztropine', 6)\",\n",
       " \"('Bleomycin', 6)\",\n",
       " \"('Calcifediol', 6)\",\n",
       " \"('Ceramides', 6)\",\n",
       " \"('Chlorambucil', 6)\",\n",
       " \"('Leucovorin', 6)\",\n",
       " \"('Coal', 6)\",\n",
       " \"('Dehydroepiandrosterone', 6)\",\n",
       " \"('Diacetyl', 6)\",\n",
       " \"('Clodronic Acid', 6)\",\n",
       " \"('Egtazic Acid', 6)\",\n",
       " \"('Amifostine', 6)\",\n",
       " \"('Furazolidone', 6)\",\n",
       " \"('Hexanones', 6)\",\n",
       " \"('Hydrazones', 6)\",\n",
       " \"('Hydroxamic Acids', 6)\",\n",
       " \"('Isoproterenol', 6)\",\n",
       " \"('Methoxsalen', 6)\",\n",
       " \"('N-Formylmethionine Leucyl-Phenylalanine', 6)\",\n",
       " \"('Niacin', 6)\",\n",
       " \"('Nifedipine', 6)\",\n",
       " \"('Phosphates', 6)\",\n",
       " \"('Phytic Acid', 6)\",\n",
       " \"('Poly I-C', 6)\",\n",
       " \"('Polyethyleneimine', 6)\",\n",
       " \"('Polyribonucleotides', 6)\",\n",
       " \"('Pyruvaldehyde', 6)\",\n",
       " \"('Quinazolines', 6)\",\n",
       " \"('Rutin', 6)\",\n",
       " \"('Sterigmatocystin', 6)\",\n",
       " \"('Thiophenes', 6)\",\n",
       " \"('Thiostrepton', 6)\",\n",
       " \"('Thyroxine', 6)\",\n",
       " \"('Trifluoperazine', 6)\",\n",
       " \"('Verapamil', 6)\",\n",
       " \"('9,10-Dimethyl-1,2-benzanthracene', 6)\",\n",
       " \"('Pravastatin', 6)\",\n",
       " \"('Glycyrrhizic Acid', 6)\",\n",
       " \"('Phenol', 6)\",\n",
       " \"('Benzoic Acid', 6)\",\n",
       " \"('Chlorodiphenyl (54% Chlorine)', 6)\",\n",
       " \"('Chitosan', 6)\",\n",
       " \"('Equol', 6)\",\n",
       " \"('Atazanavir Sulfate', 5)\",\n",
       " \"('Imiquimod', 5)\",\n",
       " \"('Telmisartan', 5)\",\n",
       " \"('Crizotinib', 5)\",\n",
       " \"('Dronedarone', 5)\",\n",
       " \"('Adenosine', 5)\",\n",
       " \"('Adenosine Diphosphate', 5)\",\n",
       " \"('Aldosterone', 5)\",\n",
       " \"('Allopurinol', 5)\",\n",
       " \"('Benzoates', 5)\",\n",
       " \"('Benzofurans', 5)\",\n",
       " \"('Bezafibrate', 5)\",\n",
       " \"('Bungarotoxins', 5)\",\n",
       " \"('Cannabinoids', 5)\",\n",
       " \"('Carbon Monoxide', 5)\",\n",
       " \"('Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone', 5)\",\n",
       " \"('Cholesterol', 5)\",\n",
       " \"('Cotinine', 5)\",\n",
       " \"('Desipramine', 5)\",\n",
       " \"('Dianhydrogalactitol', 5)\",\n",
       " \"('Dimethylnitrosamine', 5)\",\n",
       " \"('Dioxins', 5)\",\n",
       " \"('Environmental Pollutants', 5)\",\n",
       " \"('Epinephrine', 5)\",\n",
       " \"('Farnesol', 5)\",\n",
       " \"('Fenbendazole', 5)\",\n",
       " \"('Fenthion', 5)\",\n",
       " \"('Fluorides', 5)\",\n",
       " \"('Fluorometholone', 5)\",\n",
       " \"('Gentamicins', 5)\",\n",
       " \"('Hydrochloric Acid', 5)\",\n",
       " \"('Iohexol', 5)\",\n",
       " \"('Latex', 5)\",\n",
       " \"('Thioctic Acid', 5)\",\n",
       " \"('Loperamide', 5)\",\n",
       " \"('Methylnitrosourea', 5)\",\n",
       " \"('Methylthiouracil', 5)\",\n",
       " \"('Nitrogen', 5)\",\n",
       " \"('Norepinephrine', 5)\",\n",
       " \"('Patulin', 5)\",\n",
       " \"('Peptidoglycan', 5)\",\n",
       " \"('Phenylbutyrates', 5)\",\n",
       " \"('Phenylephrine', 5)\",\n",
       " \"('Phloretin', 5)\",\n",
       " \"('Polymyxin B', 5)\",\n",
       " \"('Prednisone', 5)\",\n",
       " \"('Prodigiosin', 5)\",\n",
       " \"('Ruthenium', 5)\",\n",
       " \"('Serotonin', 5)\",\n",
       " \"('Suramin', 5)\",\n",
       " \"('Taurine', 5)\",\n",
       " \"('Tetracaine', 5)\",\n",
       " \"('Toluene 2,4-Diisocyanate', 5)\",\n",
       " \"('Tubocurarine', 5)\",\n",
       " \"('Vitamin D', 5)\",\n",
       " \"('2-Acetylaminofluorene', 5)\",\n",
       " \"('Oxyquinoline', 5)\",\n",
       " \"('Thiorphan', 5)\",\n",
       " \"('Epirubicin', 5)\",\n",
       " \"('Terfenadine', 5)\",\n",
       " \"('Fluorescein-5-isothiocyanate', 5)\",\n",
       " \"('beta Carotene', 5)\",\n",
       " \"('Vitamin K 2', 5)\",\n",
       " \"('gamma-Tocopherol', 5)\",\n",
       " \"('Plant Preparations', 5)\",\n",
       " \"('Phytoestrogens', 5)\",\n",
       " \"('Betalains', 5)\",\n",
       " \"('Iron Compounds', 5)\",\n",
       " \"('Coal Ash', 5)\",\n",
       " \"('Fluticasone', 4)\",\n",
       " \"('Valsartan', 4)\",\n",
       " \"('Antineoplastic Agents, Immunological', 4)\",\n",
       " \"('Meloxicam', 4)\",\n",
       " \"('Eucalyptol', 4)\",\n",
       " \"('Trabectedin', 4)\",\n",
       " \"('O-(Chloroacetylcarbamoyl)fumagillol', 4)\",\n",
       " \"('Afatinib', 4)\",\n",
       " \"('Matrines', 4)\",\n",
       " \"('Aconitine', 4)\",\n",
       " \"('Adenine', 4)\",\n",
       " \"('Aldehydes', 4)\",\n",
       " \"('Amino Acids', 4)\",\n",
       " \"('Amino Acids, Peptides, and Proteins', 4)\",\n",
       " \"('Anthraquinones', 4)\",\n",
       " \"('Biological Products', 4)\",\n",
       " \"('Carbamates', 4)\",\n",
       " \"('Carbon Tetrachloride', 4)\",\n",
       " \"('Contrast Media', 4)\",\n",
       " \"('Cuprizone', 4)\",\n",
       " \"('Diamide', 4)\",\n",
       " \"('Dimethylformamide', 4)\",\n",
       " \"('Dipyridamole', 4)\",\n",
       " \"('Dobutamine', 4)\",\n",
       " \"('Fonofos', 4)\",\n",
       " \"('Emetine', 4)\",\n",
       " \"('Ethidium', 4)\",\n",
       " \"('Gadolinium', 4)\",\n",
       " \"('Galactose', 4)\",\n",
       " \"('Gentian Violet', 4)\",\n",
       " \"('Glucocorticoids', 4)\",\n",
       " \"('Guanosine', 4)\",\n",
       " \"('Haloperidol', 4)\",\n",
       " \"('Heterocyclic Compounds, 3-Ring', 4)\",\n",
       " \"('Hydroxychloroquine', 4)\",\n",
       " \"('Hypochlorous Acid', 4)\",\n",
       " \"('Isoniazid', 4)\",\n",
       " \"('Cholesterol, HDL', 4)\",\n",
       " \"('Maleates', 4)\",\n",
       " \"('Malondialdehyde', 4)\",\n",
       " \"('Methimazole', 4)\",\n",
       " \"('Methyl Parathion', 4)\",\n",
       " \"('Naloxone', 4)\",\n",
       " \"('Nitric Oxide', 4)\",\n",
       " \"('Nitrogen Oxides', 4)\",\n",
       " \"('Oligopeptides', 4)\",\n",
       " \"('Omeprazole', 4)\",\n",
       " \"('Palmitates', 4)\",\n",
       " \"('Pentamidine', 4)\",\n",
       " \"('Pergolide', 4)\",\n",
       " \"('Phosphorus', 4)\",\n",
       " \"('Vitamin K 1', 4)\",\n",
       " \"('Platinum', 4)\",\n",
       " \"('Polyphosphates', 4)\",\n",
       " \"('Povidone', 4)\",\n",
       " \"('Propolis', 4)\",\n",
       " \"('Propranolol', 4)\",\n",
       " \"('Pyocyanine', 4)\",\n",
       " \"('Pyrimidines', 4)\",\n",
       " \"('Radon', 4)\",\n",
       " \"('Riboflavin', 4)\",\n",
       " \"('S-Adenosylmethionine', 4)\",\n",
       " \"('Sodium Salicylate', 4)\",\n",
       " \"('Superoxides', 4)\",\n",
       " \"('Tartrazine', 4)\",\n",
       " \"('Tetrachloroethylene', 4)\",\n",
       " \"('Thioacetamide', 4)\",\n",
       " \"('Toluene', 4)\",\n",
       " \"('Triterpenes', 4)\",\n",
       " \"('Uranium', 4)\",\n",
       " \"('Uridine Triphosphate', 4)\",\n",
       " \"('Viper Venoms', 4)\",\n",
       " \"('Warfarin', 4)\",\n",
       " \"('Water Pollutants', 4)\",\n",
       " \"('Zeranol', 4)\",\n",
       " \"('Ziram', 4)\",\n",
       " \"('Eicosapentaenoic Acid', 4)\",\n",
       " \"('Mercaptopurine', 4)\",\n",
       " \"('1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine', 4)\",\n",
       " \"('Cytochalasin D', 4)\",\n",
       " \"('N-Methylaspartate', 4)\",\n",
       " \"('Organoselenium Compounds', 4)\",\n",
       " \"('Levonorgestrel', 4)\",\n",
       " \"('Acitretin', 4)\",\n",
       " \"('Cladribine', 4)\",\n",
       " \"('Isocyanates', 4)\",\n",
       " \"('Hexamethonium', 4)\",\n",
       " \"('1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine', 4)\",\n",
       " \"('12-Hydroxy-5,8,10,14-eicosatetraenoic Acid', 4)\",\n",
       " \"('Succinic Acid', 4)\",\n",
       " \"('Sodium Azide', 4)\",\n",
       " \"('2-Propanol', 4)\",\n",
       " \"('Styrene', 4)\",\n",
       " \"('Shiga Toxin', 4)\",\n",
       " \"('Permethrin', 4)\",\n",
       " \"('S-Nitrosoglutathione', 4)\",\n",
       " \"('Diketopiperazines', 4)\",\n",
       " \"('Selenic Acid', 4)\",\n",
       " \"('Salmeterol Xinafoate', 3)\",\n",
       " \"('Pemetrexed', 3)\",\n",
       " \"('Tenofovir', 3)\",\n",
       " \"('Capecitabine', 3)\",\n",
       " \"('Acebutolol', 3)\",\n",
       " \"('Peanut Oil', 3)\",\n",
       " \"('Carvedilol', 3)\",\n",
       " \"('Moxifloxacin', 3)\",\n",
       " \"('Bosentan', 3)\",\n",
       " \"('Aluminum Chloride', 3)\",\n",
       " \"('Deferiprone', 3)\",\n",
       " \"('Ciclopirox', 3)\",\n",
       " \"('Axitinib', 3)\",\n",
       " \"('Ado-Trastuzumab Emtansine', 3)\",\n",
       " \"('Alcohols', 3)\",\n",
       " \"('Allethrins', 3)\",\n",
       " \"('alpha-Chlorohydrin', 3)\",\n",
       " \"('Aluminum', 3)\",\n",
       " \"('Aminoglutethimide', 3)\",\n",
       " \"('Antimony', 3)\",\n",
       " \"('Antineoplastic Agents', 3)\",\n",
       " \"('Atenolol', 3)\",\n",
       " \"('Benzalkonium Compounds', 3)\",\n",
       " \"('Benzoyl Peroxide', 3)\",\n",
       " \"('Biological Factors', 3)\",\n",
       " \"('Carbon', 3)\",\n",
       " \"('Chloramphenicol', 3)\",\n",
       " \"('Chlordan', 3)\",\n",
       " \"('Chloroform', 3)\",\n",
       " \"('Chlorogenic Acid', 3)\",\n",
       " \"('Cholic Acids', 3)\",\n",
       " \"('Choline', 3)\",\n",
       " \"('Cysteine', 3)\",\n",
       " \"('Dapsone', 3)\",\n",
       " \"('Diazepam', 3)\",\n",
       " \"('Diazoxide', 3)\",\n",
       " \"('Dietary Fats', 3)\",\n",
       " \"('Diethylnitrosamine', 3)\",\n",
       " \"('Diphtheria Toxin', 3)\",\n",
       " \"('Cromolyn Sodium', 3)\",\n",
       " \"('Erythromycin', 3)\",\n",
       " \"('Erythrosine', 3)\",\n",
       " \"('Estriol', 3)\",\n",
       " \"('Estrone', 3)\",\n",
       " \"('Ethylnitrosourea', 3)\",\n",
       " \"('Ferric Compounds', 3)\",\n",
       " \"('Flavonoids', 3)\",\n",
       " \"('Floxuridine', 3)\",\n",
       " \"('Glycerol', 3)\",\n",
       " \"('Gossypol', 3)\",\n",
       " \"('Hexachlorophene', 3)\",\n",
       " \"('Humic Substances', 3)\",\n",
       " \"('Immunologic Factors', 3)\",\n",
       " \"('Indoprofen', 3)\",\n",
       " \"('Iopamidol', 3)\",\n",
       " \"('Iron-Dextran Complex', 3)\",\n",
       " \"('Ketanserin', 3)\",\n",
       " \"('Ketoconazole', 3)\",\n",
       " \"('Levamisole', 3)\",\n",
       " \"('Lobeline', 3)\",\n",
       " \"('Maneb', 3)\",\n",
       " \"('Mannitol', 3)\",\n",
       " \"('Memantine', 3)\",\n",
       " \"('Methohexital', 3)\",\n",
       " \"('Mimosine', 3)\",\n",
       " \"('Minocycline', 3)\",\n",
       " \"('Plicamycin', 3)\",\n",
       " \"('Mitotane', 3)\",\n",
       " \"('NAD', 3)\",\n",
       " \"('Naproxen', 3)\",\n",
       " \"('Neurotensin', 3)\",\n",
       " \"('Norethindrone', 3)\",\n",
       " \"('Oligosaccharides', 3)\",\n",
       " \"('Paraoxon', 3)\",\n",
       " \"('Pentobarbital', 3)\",\n",
       " \"('Phenylbutazone', 3)\",\n",
       " \"('Phloroglucinol', 3)\",\n",
       " \"('Probenecid', 3)\",\n",
       " \"('Procaine', 3)\",\n",
       " \"('Progestins', 3)\",\n",
       " \"('Pyrimethamine', 3)\",\n",
       " \"('Razoxane', 3)\",\n",
       " \"('Ruthenium Red', 3)\",\n",
       " \"('Sulfasalazine', 3)\",\n",
       " \"('Sarin', 3)\",\n",
       " \"('Secobarbital', 3)\",\n",
       " \"('Shikimic Acid', 3)\",\n",
       " \"('Simazine', 3)\",\n",
       " \"('Soil Pollutants', 3)\",\n",
       " \"('Sucrose', 3)\",\n",
       " \"('Terbutaline', 3)\",\n",
       " \"('Thiamylal', 3)\",\n",
       " \"('Thiram', 3)\",\n",
       " \"('Uric Acid', 3)\",\n",
       " \"('Uridine Diphosphate', 3)\",\n",
       " \"('Vinyl Chloride', 3)\",\n",
       " \"('Vitamin A', 3)\",\n",
       " \"('1-Naphthylisothiocyanate', 3)\",\n",
       " \"('2,6-Dichloroindophenol', 3)\",\n",
       " \"('4-Nitroquinoline-1-oxide', 3)\",\n",
       " \"('Phorbol 12,13-Dibutyrate', 3)\",\n",
       " \"('Josamycin', 3)\",\n",
       " \"('Famotidine', 3)\",\n",
       " \"('Cysteine Proteinase Inhibitors', 3)\",\n",
       " \"('Iloprost', 3)\",\n",
       " \"('Dizocilpine Maleate', 3)\",\n",
       " \"('Crack Cocaine', 3)\",\n",
       " \"('Aphidicolin', 3)\",\n",
       " \"('Bupropion', 3)\",\n",
       " \"('Dimaprit', 3)\",\n",
       " \"('Doxazosin', 3)\",\n",
       " \"('Asbestos, Amosite', 3)\",\n",
       " \"('Silicon Compounds', 3)\",\n",
       " '(\"4,4\\'-Diisothiocyanostilbene-2,2\\'-Disulfonic Acid\", 3)',\n",
       " \"('Zinc Compounds', 3)\",\n",
       " \"('Citric Acid', 3)\",\n",
       " \"('15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid', 3)\",\n",
       " \"('Nelfinavir', 3)\",\n",
       " \"('Tetrahydroisoquinolines', 3)\",\n",
       " \"('Frankincense', 3)\",\n",
       " \"('Risedronic Acid', 2)\",\n",
       " \"('Varenicline', 2)\",\n",
       " \"('Emtricitabine', 2)\",\n",
       " \"('Formoterol Fumarate', 2)\",\n",
       " \"('Dibenzofurans, Polychlorinated', 2)\",\n",
       " \"('Clopidogrel', 2)\",\n",
       " \"('Olanzapine', 2)\",\n",
       " \"('Vinorelbine', 2)\",\n",
       " \"('Pamidronate', 2)\",\n",
       " \"('Terbinafine', 2)\",\n",
       " \"('Fluvastatin', 2)\",\n",
       " \"('Irbesartan', 2)\",\n",
       " \"('Eplerenone', 2)\",\n",
       " \"('Aprepitant', 2)\",\n",
       " \"('Tirapazamine', 2)\",\n",
       " \"('Acetylmuramyl-Alanyl-Isoglutamine', 2)\",\n",
       " \"('Allantoin', 2)\",\n",
       " \"('Alprenolol', 2)\",\n",
       " \"('Aminacrine', 2)\",\n",
       " \"('Aminolevulinic Acid', 2)\",\n",
       " \"('Amphetamine', 2)\",\n",
       " \"('Androgens', 2)\",\n",
       " \"('Anethole Trithione', 2)\",\n",
       " \"('Aniline Compounds', 2)\",\n",
       " \"('Antifungal Agents', 2)\",\n",
       " \"('Apomorphine', 2)\",\n",
       " \"('Arachidonic Acids', 2)\",\n",
       " \"('Beclomethasone', 2)\",\n",
       " \"('Benomyl', 2)\",\n",
       " \"('beta-Endorphin', 2)\",\n",
       " \"('Biliverdine', 2)\",\n",
       " \"('Bupivacaine', 2)\",\n",
       " \"('Buprenorphine', 2)\",\n",
       " \"('Butylated Hydroxytoluene', 2)\",\n",
       " \"('Calcium Chloride', 2)\",\n",
       " \"('Carbachol', 2)\",\n",
       " \"('Carbenoxolone', 2)\",\n",
       " \"('Carbidopa', 2)\",\n",
       " \"('Carbofuran', 2)\",\n",
       " \"('Estrogens, Catechol', 2)\",\n",
       " \"('Cerium', 2)\",\n",
       " \"('Chlorine', 2)\",\n",
       " \"('Chondroitin Sulfates', 2)\",\n",
       " \"('Chromium Alloys', 2)\",\n",
       " \"('Chromones', 2)\",\n",
       " \"('Cimetidine', 2)\",\n",
       " \"('Clonidine', 2)\",\n",
       " \"('Colistin', 2)\",\n",
       " \"('Cosmetics', 2)\",\n",
       " \"('Coumarins', 2)\",\n",
       " \"('Dacarbazine', 2)\",\n",
       " \"('Danazol', 2)\",\n",
       " \"('Dichlororibofuranosylbenzimidazole', 2)\",\n",
       " \"('Dietary Carbohydrates', 2)\",\n",
       " \"('Dihydro-beta-Erythroidine', 2)\",\n",
       " \"('Diltiazem', 2)\",\n",
       " \"('Succimer', 2)\",\n",
       " \"('Diphenhydramine', 2)\",\n",
       " \"('Diquat', 2)\",\n",
       " \"('Domperidone', 2)\",\n",
       " \"('Doxycycline', 2)\",\n",
       " \"('Edetic Acid', 2)\",\n",
       " \"('Epoxy Compounds', 2)\",\n",
       " \"('Erythropoietin', 2)\",\n",
       " \"('Ethylmaleimide', 2)\",\n",
       " \"('Fatty Acids, Nonesterified', 2)\",\n",
       " \"('Fenoterol', 2)\",\n",
       " \"('Fentanyl', 2)\",\n",
       " \"('Ficusin', 2)\",\n",
       " \"('Flucytosine', 2)\",\n",
       " \"('Flutamide', 2)\",\n",
       " \"('Fructose', 2)\",\n",
       " \"('Galactosamine', 2)\",\n",
       " \"('Glyburide', 2)\",\n",
       " \"('Gliotoxin', 2)\",\n",
       " \"('Glutaral', 2)\",\n",
       " \"('Cyclic GMP', 2)\",\n",
       " \"('Harmaline', 2)\",\n",
       " \"('Heme', 2)\",\n",
       " \"('Hydrogen', 2)\",\n",
       " \"('Hydrogen Sulfide', 2)\",\n",
       " \"('Insulin', 2)\",\n",
       " \"('Isatin', 2)\",\n",
       " \"('Ketamine', 2)\",\n",
       " \"('Ketoglutaric Acids', 2)\",\n",
       " \"('Labetalol', 2)\",\n",
       " \"('Levodopa', 2)\",\n",
       " \"('Lipids', 2)\",\n",
       " \"('Cholesterol, LDL', 2)\",\n",
       " \"('Mecamylamine', 2)\",\n",
       " \"('Melarsoprol', 2)\",\n",
       " \"('Mercaptoethanol', 2)\",\n",
       " \"('Methadone', 2)\",\n",
       " \"('Methionine', 2)\",\n",
       " \"('Neomycin', 2)\",\n",
       " \"('Nicardipine', 2)\",\n",
       " \"('Nicotinic Acids', 2)\",\n",
       " \"('Nitrogen Dioxide', 2)\",\n",
       " \"('Nitrogen Mustard Compounds', 2)\",\n",
       " ...]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "xOrden_degree"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2464fe4c",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "339359f1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "nodes = [x[0] for x in Orden_degree]\n",
    "degrees = [x[1] for x in Orden_degree]\n",
    "plt.bar(nodes, degrees)\n",
    "plt.ylabel('Nodes')\n",
    "plt.xlabel('Degree')\n",
    "plt.title('Distribución de Grados')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f62e9938",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1d2d5ee7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "32cebbbf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4370af1e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9f815039",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ad274199",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
